<SEC-DOCUMENT>0000064803-20-000041.txt : 20201106
<SEC-HEADER>0000064803-20-000041.hdr.sgml : 20201106
<ACCEPTANCE-DATETIME>20201106064129
ACCESSION NUMBER:		0000064803-20-000041
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201106
DATE AS OF CHANGE:		20201106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		201292341

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cvs-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894,d:a22d2c07ccb343e8b651f8e8c378e259--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:cvs="http://www.cvshealth.com/20200930" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl8zLTEtMS0xLTA_ec841949-7c58-4564-8de1-ce7df316b46b">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl80LTEtMS0xLTA_fb947b18-3592-44ff-8510-625b45408351">12/31</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl81LTEtMS0xLTA_5bd75e5b-7bb7-4ed9-9dee-c3b47196c4ba">2020</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl82LTEtMS0xLTA_ad11a8ac-ebee-48c8-9251-dbeafc6671d6">Q3</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl83LTEtMS0xLTA_0763b79e-f79a-4796-b7fd-ce00bfa119e8">false</ix:nonNumeric><ix:nonNumeric contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_0cf7ad7c-7efe-4c9c-a45c-4fe5d88f19e3">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_0f7ba638-0984-46b0-96a1-1daf5b816298">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_54994f3c-bb36-438e-9f66-370e220863b5">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_7053a555-8b41-41ee-8758-88dfdffe588c">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80Ni9mcmFnOjRhZTVhZjkzNjA1NDQ1OTk5M2FkZDMyMDMxODg4M2UzL3RleHRyZWdpb246NGFlNWFmOTM2MDU0NDU5OTkzYWRkMzIwMzE4ODgzZTNfMTU5_56efa174-a0f8-4777-b2ed-dc48ef3b9aae">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80Ni9mcmFnOjRhZTVhZjkzNjA1NDQ1OTk5M2FkZDMyMDMxODg4M2UzL3RleHRyZWdpb246NGFlNWFmOTM2MDU0NDU5OTkzYWRkMzIwMzE4ODgzZTNfMTYw_0c4059f0-e416-4ef0-bddb-160af0c229bc">us-gaap:AccountingStandardsUpdate201615ProspectiveMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6240724c7d9c4678ae6da9372625561e_I20201028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6e317fd9f8534d0cb3cf959627c9697d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dd89c5723a44719ef9af5db71ec31b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901f58f3faaf41e481c42824eca1769f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b2fd3771d794132920c7f4a242129fb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa740d08066d4d9abde1a5fbf7722b66_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319e1b9809144db8acea0d84bd5a1ec3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0adc77af7e44ca9b7a5e0aa1830398d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff8425b591444783833edd8e815331a8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83b41fef1b864e01ba3e78d118b8243b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1760dd0c327472392df2791068fb782_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7e2874d0ab43299169519779fbc2d9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7930220d914f419297614a660281ef47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be942208dc1421797995bf453709517_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8a0caabdab46cc88debaa0c046f3dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a539619c134838a1d5f4cca14f9441_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3172dd72e85d49daa20d2cb9b4f7f9b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2286aab200f4a1892c679ab6e3b1b9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea3ad7fbde3466cb0d05dc9cd11a22b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca7c827c69941c5994247c772125139_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia87850112c6a4030818cf4c061f75276_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9860b6f9816341359067357c7c165e5d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d35ebf9c824b0b907f4c0adae223ca_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie94974140e414714a3341c252c984f66_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a375bd4d6f48e89dfffc71946f4a55_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a44be297eb413184028063b42c5faa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16cc05efec2c470d9c2d81b1369a192d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e1e6cd716a4e87bfd329666134d286_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i814ed0bf8ff04a1ab4a1a2b6668545f1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe3dc5bd7df49b582bcd4fb537c3ff8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df330f945fe40ae939aeecf46b997a6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f3de2ba29874b91820a6e8738735819_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i331e56114e3c422584fccdc1dc247161_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec4c75a50fb4463093ce50049b985383_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3167dd9c7bcb4190a46ac3616a6096d1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i571ceac717c84c4a94f70faf7c363371_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe21c1301c6497aadc7f6002c446161_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if497738f73ef48128d544b2866a6b773_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae7992d69654cb097446acf9b33e297_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f29445f39bd4b9d9c0596805a0d36fa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b7c1d38bf884811b17e7b37aa5fc599_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54229e328244a16acdf5c0ec0ddae47_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idead255cd4d14401a0f371fbde8693f8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifafcb02d59004fedbb9332ce962bbb50_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd79123bcc14c2fb1cc1eeb95efcaba_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id36f48bb62074ed38935780980244861_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98a850eb95d4b82868c9616941ead34_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59819bcb087468789cf0b7b87860688_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e254dc8fb204c0aa8e1af10b2125b4f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e91a6c1593e4ec4ac7aad6c113f284a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859721481833446fa96d26363301759a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i106be2d3ad604360afa2a6c2657acdef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b816b179cf48c3875bfe79f11415be_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i304666a201b045b7ba84e7a502222b26_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514d9c71e8e34b73be0290f1502a1722_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i322a9dc17b8243e6b3fea397bd95e1a8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7770f7a96734fbf946266bf7257161a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4657fb3ee8e24f7c8bd16ec46224e2f2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac7aa78682f147f48082f382fecfef81_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i536638a93faa4b458e82d77598e46897_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1aa9ee857c04106b4ddeb51bba6580f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73aa0acfcc2a4286bbdbe36223128682_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29d78d69f63e43bfbbf2c9b5b9e3a9c2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebcab56786dc42feae377f091296982e_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abb168a5e6441d18beffe97e1f3d94a_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia143f7ee313e44f7870d98c64e6439b5_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae75737b267456a808c79a40b150435_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c27729e16e4e42ac7509026e75dd51_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2900867654474cd28dd5045d196ec575_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aca7df593c34ab7b0fbb5ea78f926f8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd1a561806047208b4db1ab9fce4f98_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd7700a44a0248e48d1b6d80b0fc2ae4_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab629bbd58a4de092289e615211980b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6599ba05330a4711990ed70a0a265e49_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7085a825e90c4759a1618f00e3ab81f2_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i203b5e3c33e4404c9d4ea2fe1f4e7ac8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4364493f5734455bb1f6e765963518f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecfc6612a6ec4564bba6c3ed1e8a1395_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7beb7ff5e17d4a42968bb035cef774e6_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2853021c8b491f9255dba3609410aa_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463603c2f27845d28c9d3b99a405ff6c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c617f7479a44823b94ae95b119c3a70_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389b0e105fc642fda8f98138b1769f1c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14f47d35d4043e5bc16b18b14abb993_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2525b67907774a24a2fbd98d30d59e57_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4d513c870c43be98b93640f3f9ccef_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfa97c4646a4f34acb951255063b626_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8030574e46c54dc78075514e087d6aa8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48b23f611534468684876d12f664352e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b5cd1dd7304ec283b1ce0b506b7741_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a47d2a1fec45c3b9b7adb20e61d257_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809b9db9db554177ae44049fc6336a94_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a6a67cb47374fb9b4cc4ed07e526591_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a73bed99bba493485113c4e922d1192_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa1b8f41c19444e9be024f7f3599370d_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113463dad55e48bda48e770726d59193_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="building"><xbrli:measure>cvs:building</xbrli:measure></xbrli:unit><xbrli:context id="if0e1c13224e342d4bf505740f3a173b1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="person"><xbrli:measure>cvs:person</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:context id="i0f1e2d2eb6e14cfc96ce16ba745cd95d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="if60c2fe38b9e4eb8b33cbc4e89326d14_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68abf3331714f0cb8a2e46831fee06c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f85725267e4b2da9c4bd28ed0c0d5d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5fcf3cc86944847b4a31907d7b35e8f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd74224b2d0e435b95718f3c4dca914f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98dc5453e7af45f08155c02c68159539_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9af031c4a92b4ad09fedaada5da439a2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06443f5cef314ba49659eb8a8ac32230_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i681ef3f1a45145e38eba1e776de4f06a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica0c012858fe46d3aaab3baf1065534f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2f456b2af8343678bde493f23d04c00_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ae828c5b2cf449c9ac7a99073a1bd39_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bfa1ea471448ce90b4228202b8064a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i152019c18b244202a6b98ccc912ef82b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdea441b1eab46d9958833bd142b99ce_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba29cf25cfe44f295754a8809ab4023_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c12bcab38f4db5a180e1dac74519b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5785795924964ac09b3c91188817854c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae9c586bcf364c249392b219a423f528_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40fb27941a97406982ff1445053b5d0c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb3729dd099643528282f816f5be4d23_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316742918ca24a9880fcfd2fb281fdc1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e48083166d94041bb1bde8d8d498c7a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cfa15ecb949457f94a09cad78662bec_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435b0304464f47fe8980149c5a3e3bb2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b91e17e6a24590b4303687758fe4b9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2467201147a4f38bd1790ba260c4d27_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0347d869b3534eed97cc367c2b34c716_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i432f620c091b4bd78b8965de6106dafc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d19937733dc48c19bbe4192a695643f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2cd40721bbb44c7a65f88f72c256ff2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeda413cd32f4c61bb785163c7baf76d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47ac41f57acb41e09f8949a2f24746c4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838b21cb58bd4282b74606c9a0a75ca6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i715ce306fefc4081b49c626cdda6c223_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i411aec8a49dd43e89d1ec6ac18e88d30_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i449b3a0364494dc2958f100fb42e4bcd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bec87bd7c13489ba49dd87596bd5303_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660decdad883483cafae88aabfe86ae0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae42a1df12e4c469ad1f6c21e69a11d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e2d37b8ab1f48a890ac86f4563c36d3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ff9ed846af4552a659faf486506f87_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e3a2bcfa204f0fbf7d7eebd45dafcd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e3a4c36dd343c2ba601ebcd3081b81_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9b827c136747b2a88c80753d888899_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaa97cbcb3614677b33155fc7cf8cfaa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i015e3b88519741cfb822c70694388488_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb782656964430b9ec2cab98566a145_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e1d6d67a0041b280b5effb5c549db0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i533429b9306d4879913c046da9f37100_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i239d475ffe78452ea7477598c48a053e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f98e97d40c5423b825abdc89e4ccb51_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5e2b880bdb4f68b5c1392e7e118d42_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e3e29c4fa547aa815092b174966dd8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e4c02ab9b2540858add46268ffa4322_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab42df5d6404b6aac64b89dd954f364_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b94001396f40909619fbef9b1c041f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd1a6a30d65c40cd90c753b012d08b88_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12ff9d95029482297d72d6a5dac7ac5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93eb393efd5947c6bd3a1fa1231f671d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087ffe62239e4208bc8c4970e058712b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib473644cf5364dc5b2441b72f3e53b43_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64a1c66ce18d42d0877b39057bc2673e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0d8f9bf90e4c8699e03540f1dd8563_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47677f4138234c60890d66d2bf6418c3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bef237b09b44c78b77e40b1baf100d9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6fe708235e4a8b85cd7b931c2f83e4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94671fdaa22443daacafbd02d1f71e93_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb21a4e70f24d6fabbb04939d9545c2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b1d663af0b8401a87dc8961f33034af_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7ca939d3fb408f88e8741191e0ec27_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142289bb8d554d3dba89eaf41db49f77_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aada21c113948f5a84bb2a89d8c538e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b0b26bd74b14fe0af4dc258245d4a4c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc9f76f4e106478f9f7987221d24fea6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146fec50f41a4066b18078ed43353a6a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3438bddea238412d98d4e213a4e7b658_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150c031257f14e08a64ab6d6a0e1c8b7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f8342dcb699462da75f023641350930_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i607580aaee174297b74cd851382e412e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8776f7019c0d4b02bb20bab4edd1ed55_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e4d5a1e39de4128aa906bd1685a2ae3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe61efd7ac648258b3bf73ea2907f45_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320c9806d95e4a99a10d60ce8e71c1c9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9967f494d4c041b0b67ba0b3f772077b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f838618c784289b3828bffba708455_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386fd0e763c84defbd4f0294954a23ea_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c443934e4dc4f1e965f9c54fcfc217b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f042616910a49ada119e413e89e0e93_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64110bc1e619481eb011726e790e889c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ea9166ed44a45cd9916cb9d1531b2b2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica91574825624707af2b7d055d492214_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34993c6bdba44671ad08a231acdcfe11_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244b1545347c4b0fba00cd7e0537b12c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eece7da79844b81a88e0f6c39018f57_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25083b6bc234531b154c27aa6adaa6d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if67f1e55874b4139aedf9e515c8e7960_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia569eb9b80b044f3b51c6f4972c0f31e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3403a6bf73644e22b0ddb226f5361865_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib77d598c37e24619b64ce36f408cea80_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f3cd5501d3844e8a92c6e7b9f858352_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib083a611dfa748bca057628defb1a140_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9660fb77d4984d64ac93c4db44804b30_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6a9d2c4000f4239977b19d16ba37d4c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd799ddeb88438e89d5c5d78dceda1b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i521b36cc1f1249c78083a5dd3ae92540_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237b71611de94c4aa41507133bd24f34_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cbec7d8ab8e4c3cb30b140669a8cdf9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0add470a8c5f49b899b9f413ff91d02b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46597caa3b364945b2d7360795884f6f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef78d632fbb4792bd265cce79e92c17_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="ieacdea7e3b834282abaee6b57e493b85_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b05ec92127409d8b14837cfb2ca48f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a486a6add824c1a92ba6c55d3d50c15_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:context id="i0bf70ec2a8ba4060b9ae0ba5571df5d7_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc9af3b8a554fbf97555c8eb6980261_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f4fdba61e842189cfa49c83ec10819_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5a85409a01d450381c1b2224ea4c3b5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc728f8b775348d4957fcbc0f71e7f96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d9eacd813548bba5ca12f875c2a76c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i120ad616a34646769659abc5ca27affc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d2438801f7c44c98ea4e95749087498_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b15565a9a35453b9b987af9593bf001_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1897d8c36747ee8a7fc20fb298b973_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf3e6151680b451eb6ef567620281acb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e576f48da934434adff3d93da16066c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f4a654db5e4221b06e356876c0b885_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6e3c903578a4562993ab15cb728ca44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i383d7512151242da970974ef3fe1ddb0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972eda3e75e84307a6e92704398a9a97_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2258986997d4a6ca66cd9e77de4dd87_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="ia33d5501abdd4ab29455629f2219842a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69dfbb0081244aac89b4345d22699e63_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i960e086fbf114fa085cd3503d8537bc4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff1e365008244ed5a70514a60e56cccb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ab420c501cf46d49e7efcb16f91f34d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7daccfbe8e14d87837c7793f712536e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0db8b085494ad9aa4eead23953af4e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia45efd93510c49a7ac479600054af81d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb089804391419e80d1a1823db3e201_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie795c4847dad4a2fa2321b0a489f207b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic175d1191a1c4781a30676aa11276f4d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30256990638e428f824cbe808d6ed528_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad431944c36d4aae9608be12244efbd3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913a4bd7a8594a62a5156370bb48bcf6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b30e7ac4294106a93b48a59cbf0bac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6479057a341c45c984deedf142835644_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd382360a1a54ca085c48b6b0eea3f9d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0610c938c1724db88d4cb79675b700cd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c351fcfc74e43169c42882a035900a0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057fc0d413b94de5b39c6573f51d2e09_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42dddd2f744647acb266706378ec5df3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4edce924dd046b6a5eaa1536dc0f333_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d795e3743e64e26965aa5f2e4573e19_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68eb5bdcaf264b40b40588bd26e81268_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3754c364a7504543bf52097c1f644ce5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9122fa3ecf054a24bff9ed44808cb012_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida44d0acf7984a62bdefb2c50f6d6407_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i194339829ef54e0bae1c684cadaded1e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c85adc56b7c43e3996b5bce465f37df_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e53524f057f4999ad2443b434cce091_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af70922f678434488f766f73af3cade_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0d1c549803e41469de47806ff2e4fa1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f844fe095a41dfbceda6a1d04bfdc2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica452037f76f48e9af4b93d468452d6f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94354f726744ff8bee2090d1ad35db2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00c125fab00b42f59120a0bca28c2067_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c8ac8af61cf49b9a4ecdf639848435b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08a76e0bcc84d49adefc8bbec4d213b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90ec21d6d594b7da461da5300391997_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b4e703d104427790286808c54d1366_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida34879a6c634fd1b420b3bb6585dd5a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6ee7fd60e8a42afb969aa603a251749_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154a60403daf439ea051436669caed62_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8567e379ddb1457cac777037b4375361_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbcdd26a0874198b1491985af3d6caa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626f99181aa943b0b51f0d50e860b3cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id978749041e44e299bcf3f700443a8f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc1876da69d543fbbfd2d97bed949c96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eeeb3c201f44e02925fb433c54875c9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66c23adb4244b9cbd61f92daf51edb2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9980f4284414635a8f0e3dba2c1cf2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce7c6728c90483e9b8bfdd9962b5710_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if749a1d078424bd0ac0f4ee34e5390a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13c1913598034217b44872960f615f0f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie023e0b3bf5c4d45b331cdca88d01e53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cdbe7b61cea4120b2f5472d61487f8a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf1cfbdd6b04ecfbd78c7310035476e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i186f364822c04e9d9d7bc13d20f7bc13_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa78344f4d0c46538a8cbcae3b2a7c42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e6acb9733404822913cf42bb35c9631_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67170a9e296943109aa58736f02ebaca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8430b0f5491b42719a2b3726e4de3cec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccc0eb7aab1f475eae71c3312f0c686c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c2af4550a64d90a95e4c647320413a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20da4428912141408240e337515e04a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i622e43fcdd484d2aab4eae3e5164bc8c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa714440d01840109a1cf5efeef3955d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i396244e89f5b4c28ac5d4147e815e9b7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b24009c9df475d90e186eab28b123b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d3306d339a94c2381177e129b5210ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac5e26c358547b0a83b36b4ba5416a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib681cd685e4741c485fded4dee9a4f19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992d499671994e22be809371d4cfad4e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0374e01374ba4315b4b99fb4d6263f56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib818fadd5f0e4ddcb1522c0c0ac9d976_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fae26ed04184bfdaca7066ae8a753f6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if716a3c271cf46b39d3e4ba483d859ac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744c94aba9ef4754a45ccd4484daef93_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia04fde7379954a4981ed81ebf2b5afb0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2db42393af54e53ad14dbc08d486114_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c00b913c81f4dd0bd7784fd75297758_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f6aae1b4284431bcdd2e4827898dc9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5690f0cca3ea4531914b67ef16f42948_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if045682f0a244fb9b7c118b70cbd74df_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17291e3b05464689b6efa05815c1f0ab_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c372f3418a4938be710525fc278530_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbcc194ba2834984937ecc92d1e291ab_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f6b833db21459d8fe1d58b988e57bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i420d31c38e0944e3bb697025075df15e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af618046aa747559d1a45f61351ac8a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cbb249c57e548daa8401983dea3fb69_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9888da910534133b2a13752e0039eda_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002016e409a046ca82eb2a7e9dbf5f44_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4ea2ffdeae48c092313d22b4f64e1c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0535ddebc7eb4e54bebfe38fe2a9b22b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03ca448ca5c45b495bb1c94af6ea7f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a642414691e4b29b29ab8baba0a10a5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec3f94d59bd417b802264c8aefae9b3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f229849b6c24840ae258b5ab8a06762_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2675c3b1d0543ea9aa4c53740042175_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95925aab9f5b4fcaa0bccf22427e5e67_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3c6cdcdd4340a4ba6b3cb06502146c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c8083ca7f924d47b17ce8940d650a38_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468dd4fda3b442e99fc8328fba905b67_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf20fa45ec74aefb3382146c0b20236_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6d327fadfd4b23954ab240ff677c47_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb1a14e2e774b2d837d4d7cdc423714_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7045e35aa3d42f8b85edee8aa4d38ef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i364069c2b8ac4c28b31b5e1a40e551c3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8997d1471cf34a75beffddbb3c6148e4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37b8520c2d34c29948b799a01af328f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1dfa73f59a451681e979540ce540ae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e538c30b555469794e0be3a6f8ed046_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb8f83e7c124df8a6cbf59fd5ce2c8f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia29caa6d3bc347128a52855fa834c203_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7526eeb0a2fd4ef4b130b931e3eb519e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1dff5e36324924a4f2feec7a5a73d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4060526c2c496981cc55c6977adb37_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f4c4734bcc24fb0ae7cab1d303bded7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ec813f07a334f08955f4a12ac4902a5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9add6b9a8641dfba7ba3deccb48b41_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf45d10b231a4274b5a9ad0d08f997a7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe734fa96d842cc869a0c54975c7cac_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eba4bdd839a45388341859be447f171_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eecc9a6d3764bed91d04d9833777391_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic92eabbcfc0e41129c6ebe1c3bb58c1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i167492c1a5134840a68af5838d92c0a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4875b0b5876478ea38a39e3ca94f3e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i635d4a19627941fbabf18b73ba4a7f69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaaedc48c33f4ce9b4d61713e708492a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708f6416e0d84b7a86d62ca235435207_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439528f07f334a2e9f9e37ae4c771d44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229361a7197a4afeb15eb2425729c789_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i769f8ad79eaf46d4b177922dba08206d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b8f23ae3b94a519cee02e63f7e0a3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6743b7888dc0448685e1853c25ff8440_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c704d6d14fc4be98279325dd3287aa2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f13f39c72a49049b8ef64e5f5c7c0c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a2c5cc590d64e41aaf1d4feb53683e2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5abbd3b9f046aeb99c9fba1e6dca0b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129439a18c454d088d7a6a8c35f27f78_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7595fc1bc6054a7190199e2e60736d28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib748f4e8d7b5461196a5145bd6da1195_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f855925c0344cb8356da40cd655821_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8fd736ba76478e9162d84858b27634_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f07defd6e1d4056a5169e425552d20b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809ae28eeac24a9f9310746684a864d0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i155016131fca4d64850212170f3783f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i060cabf68768492aa7a6026696eef9be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96b2f88bdb4a467e9d789f375c58180a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a547cc68174a39b3376c9fff4a8994_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198821e71bd845749eae39a08b218939_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i301877cb06e8403a8812ea5b4d398af3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0efa799796949ae89d8f49114056097_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89390455960d4f9f9c95e118937a1dc5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d17013fe24947c1b861b4825165d690_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc84a509c29542e8b93af8e853807f78_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfbab09e275415b941c75475ce6fde8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0edebf547f4905a41bc330aa523177_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49246bbb41534ab9ab8993460e449ffb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d67531f617f4a779c4402a048cc3bb0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i995c07a91519440c88d67c6c40193064_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fd8f52e738441778cf1253aee1efcb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe0ca53a694483a9013de0430acc1ca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb5308533d344a3a8a7f42fb04088c3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b120b41b4c4aae917c5be4d6c7787a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08dd08cbd4454361a90dbab797cd3aa2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7a45a7920b14acea3f4b36636c4b5fd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a7cc610f9a46e2972dabe60f274ea7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc004478531a4eadb516f49ab8f04d57_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc87fccbde24356929e17da657ef9be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec68f98e99d43249445dac606bfea53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fe31f16b9d42d596559a375bd059c4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ecc8d5ee49f4089bcaf72ed79a73d73_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f42424f53594322a0bc648503fa4144_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c32977c1a344a48577bd5d98e4ae14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i177b612dc9f549628390175ae5e60944_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96792d9941740519779008d23a17bf0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0d1b93e21d042618a7cdb163a1f9a53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6a2a3e0816441b96633eaefaae2f1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i677b008b5750476a9b99ad7d720cd5aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i320389b0cf034ae5a57bfdd9b1a683c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e83a1132c904e35a130f8abd67d5f4a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5079511b3a450aaca64bc154348d61_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804c778ec2814834b3d84dcb0310f508_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id17cc174a92c415eb0fc76b28ecf0e1f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60fa68066dc24311b7c8ce0a1c65ccc8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c741d96e344754add90a7638be6b23_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24208d25b4f412ebb677befba70dfd9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb8de0cf862543a28ac57b9c9b4d9da1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8da6c47de724df685363819d15fd5d2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i435b788198344ed889fb7f41075b6e67_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cf955793ec45129bc32f05a30f217d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e169ba85c734e9abcf8020fd97a8db5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5856fd2c216349b8aeedbb9e1974b765_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c9b66131ca4a539a74369e6146272b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bae9f24886e4178959c9e4374cf2d26_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b413c6d9cad4b9eacf86b8d064d8f7f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aeba235b9cc4d79a2f135126e309786_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if156a997688c4e66837675d203bd1c98_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie178c63026e949e8b2151622fca0263c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f09e46e454f4475bc40352c0231eb93_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c30244244a04895b2eb8f7a3183ed76_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i10e7590255dd44f183ff6175bce29c5c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5880b165e61f444ab0e29a376c321d60_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0914af72006548ebbba484408464ae69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1a7383071e4cc980e6c0e5a4147dea_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05a1bb77adf449c9b884c612d910d6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd7c4fa4868462fa55280d3ecac3953_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i290ff092291647068477c613b2614b53_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1687e1197697447ab1e252f736563f04_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1096032d00f44b71b617c36d63d7f27e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39b967136734ffebac4fa125d5df5e3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef7edab39324e21abec728d47812d6b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c6b0f2f62c74a8681f9cf380a9e3f2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee6ead635de4c95add163849dd94827_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie05261bf78de439e95e77a97f7a95197_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12e87c001794aeea0e7834103d4e29e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5b12f048374362ba07cace90c8eba9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53697dbc20eb4716841fa78a5b6d61e9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671fb7b57b204d38a5ec9cc8478dd71a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if99da7bf0574479c90df5ab707ce9ea4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee9602d63244d01b24b8058303bf440_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b151bd651d4e21ad5aef18942c57f6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae6c86974674b649712b3bfcb54b956_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc962ffe7759429a8437aeaf65091ad1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30331d814224442fb860f94b9c7bdefb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd553eacf7843ce91290bdb3c9f651e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72d1e6a2e2e41db9701a9fd8bee5fa0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d529d43e45b4cdd914b2000673d53c8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f2a6050d8c9472cad7e74ccbac0d7d3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692d39424ece4bfe9add19706ba7a75e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb1eda40037470b87e5c84de8742351_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1068e9886f384012b47c77ddf7440959_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7982711b6d1a4518aa5760f4b6d81aca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20445c4013da41559dd716a5e301fa58_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2390853230664b71977471726c73ba84_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddf756027c647808636299b132f954c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fbf2ddab2d45868cf34d8af1dc6657_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725a1515335644b2aaaf163a4dacff94_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f09caa84ded47ba85c938f104c825d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c767f7afed44d296aad898e2be1125_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54826d3a4d644b189399b609a6f6a24b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8e1cf76b454cd8a76cf064eb597d2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d1a497cfd74fb8889de9ea721571bf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36df838d786c4c5d9ef71e79fbde110b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic728b575d27e4aa8898383cf541680d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a690e438fc46c8ae47a61d1dbb1690_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b249377f2f4ddab5d99416f68657bc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b718b817d44528988a876de7fc8bf2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8172ab47664fa9a3cd78759a4453a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba7f24a8dbd0437fac060bebccc39eed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853ba9286f1a4fcabce9a8524c725b25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709dc9e5843a46c29f7c3a14b5732a22_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2b20e6c49d45d1ada51a71917b422a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4ac59124dea453b8f6a7a1027357fb5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ed3fbf4b98415aa629e39f421a73fd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee41f66d2eb34db7a37a170823c4e89a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ee350b35ee4777be370e11b5e0e8a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i403edd61e4434a99a5791f10cbd76c78_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad6f61c9e98c4ce3b04854b705260b28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a81af6ba40a441fbb99ba18d09073bf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53136fbe8f8d484aafe459d75dd67da8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83e3ca5e5b74832b482dc21dac47b15_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4832233814146d4a72a43f532a81304_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1421fac4a46640f488484d0d2bb2f5da_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2c6ca07a2948c2bb32301edab7a7ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295cc3434aa14c899d92fd789d23e4c9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f38e39469ec4110a0d65096dc00df6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5334156d0c3043a1a13513caab4134b3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1d294aded084369be74447b0566b76d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b2ae62b51d4971b13d4146936f76ea_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a403ce8c3b4b3984c2e9eae3632214_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7698bdf5f484e289bdc4f09e25197fd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71438155734c4195a0f18f432a418662_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac14079640e4ff682a4487baa41cc7b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id795774182b2476bac2cbbb06963df80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24823ffe3a604cfd87e5693bf137f94f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8323c41a0e402cb82a2088c5ac0ff1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibddae3f3a8b04e22adc4e54bc250df78_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2004ef6f6a8e4c5ab2d44ad733bf043e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5b0ad50d4e42e6b07ebd012cfdd8ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36748522e5764894aa532ad0b07acd87_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i525c1d0146e54a86aa63f93fea6b7bdc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d21c6312ff4432b75d3a29c30a960a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f231c679a8f48f69959c46f3f43d5cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc6e467e0a04d77af59fb7584d3b906_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0bf72645713412a86166f550c1f16e5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba1978e8f8a84e28a8a31288a3036505_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0cdcd3fc23d468e902240ab83df8b0d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d07faa35b614fb1882b9aa697a66dec_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia351b17fd331488f9c19c7092046c881_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef337dc67864f7eace3d523637349d6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5af1f185b125480693a0d0bad7b64abd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843befc9d57d4321b9c38aa68be69ba6_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-21</xbrli:startDate><xbrli:endDate>2020-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i061be2ce53a44ed8a847d35fea3c64f7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87452d10eac74833a26ccdf16f72be6f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e003f03dceb45b6a401dd0a2c15619a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if192035447e74302b3b24be7e300f710_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498d25aa22054a10a2a7f7f86ba2b5ca_D20200331-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4418eeeb9274602937c479510064c2a_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e13a337db4543e2918ef2db378c71fb_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1fdce6ad75c4a94a2c9df47616acacf_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19527741ed594ba2a6a1b439f15d1f49_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8896274f8aba4673b336164474916d80_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1086a45a45914803b4b5787dac081a9a_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa43f5d114584fe4aa281801f4cb6df2_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8025ef9777c14c2b9d133e87af8de5dd_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c9892023b049bb895d5033c451c441_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if455866bb2bd467f974a25ce7e9a0bd0_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8891142b6e684accbc9446f2c1da9ada_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8d8f94b69f47a29ef2ae02ad7c9700_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49583a4b71eb4d35821c7a34fc9f5dc6_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife76a2daf76247ed84df033b3381b3d4_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if522a3140edc49cbb22c0b24dc66107e_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36780b12a24c4197ae6e8c1e76989a48_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bf38eeaba3449eb825327fa22f6ee32_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d7b49b81174a188a7693f6caaa62e3_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e462393116f4c15aeb568f785179398_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i294e2fe0bdae40f7931db52b0a256b5d_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c3d891d1084f4599405d17248e8c8e_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3a22a87b43d4b3db25373c50b610cbe_I20161102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c166ab9cb14308b8faee78e708c5d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785fe01249e54049baf6e493c3802193_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia090d3a8eb844f89a10619bb3d2a6fff_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d6f831699a4635bb458cb2de3b84ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c203fef43742668e532cda7f2c1fa5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806e7c9717c24de5ae7010f0f10b6be1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532f29edecec4969bbca5c16efb1f7f8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i887ee4a7facc4fa4b18507f044b04878_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d0c1e1127646cf9d2d9831c80debd3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a5c8430936e43eda7f07b5c38c9388f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f2fc8638c748e2aca4140e502531b2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45fef1a06e3647a1aef2f530c536a606_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ece21beb781421ebe511d131b9e50d9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66dda08c143247a8bae039ee8451ac6b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4fa9aa910d43589adddf698dcbd90b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f0779cac2746f3a5ecc01ccf789c9e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d064b39213426da21f09c4238e271a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfc549e0d312441788064313343cf78c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6190bd16f5314ec1bdde0d0603987e3b_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4143146fd434706bd94dc49340308eb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4112b74f164d22820352e1af27ca00_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib11a29381a70499098c887d742f41133_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d24c8cf0b2f4ec892c7ae20e2399ec6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10179039b234603bf7b505426fc8472_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13d90c20531f46398a0d5445c1b3360a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002debbf693d45699dc102ddca977a67_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c1de9ff69c5421ebd0d98eec11a8353_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06db64b58cdf443580404215eb0ca740_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23da5ced3c0741f280bab78905895c3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3b96dd953547cc8f60a7fa1546fe88_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d6c79cc9de846d4be742316c0e6e179_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5756ad275741ff8df69fcff86a17b8_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="entity"><xbrli:measure>cvs:entity</xbrli:measure></xbrli:unit><xbrli:context id="i179f470a0b494d8983ec636725d8d119_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36fa8765529c434ca15131ebec0fef35_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:BlueCrossAndBlueShieldOfNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:context id="i3ee66866f8fa4cbea112996fc3ef1389_D20130101-20130331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2013-01-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8388f3cbdf204618a0c21ce87efec0fc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa4c5da31094c308e8bb540b1f730da_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae38a4835db41f4845bb963973a4035_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f49f9e47124de881a13135342b7fe2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a375fb5ee4c4b4d97090ae3ad666b3f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd7496cf7d94ef5b1210da043c5d38e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1a8fb583a743f49a6dc705dc12e525_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a1f86796440475bb5dab254521c724b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a503222dd594312b47e70f69e82a446_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2627fbff46e64b4f9394931c3b370f52_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id92c3e405f2548aba08212e6d6583ed7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8df98cf0a04c339a50aa5f67d358ee_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a36eaad3694582835456f3a0082533_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b9aea230b9c4ec19e0946224068182f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0a911dfbb042d1a2a8141db4da783a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3407b4198a444fda8eddc128dd850666_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc6d00c651d4a9881f30a84231714f1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b3a1807d6d941108c13c5bb50477adc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b9b581f26241d4b1c1a12c4ed7691e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9869200a1f51442783697741cd784346_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12078e54516c4cbea23a4ae0ac86658c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f020cf3db944a72b9e11f66eafb85a6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i219c9f0ab1634e62be0cec75eb3d097b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i638894f045654cdb9cec4484de9042e8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab600fe96ebf4cc0915b310db63417df_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-22</xbrli:startDate><xbrli:endDate>2020-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i775061c4d39a416ab23c7dc563cf24b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cvs:PremiumRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6 id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_1"></div><div style="min-height:22.5pt;width:100%"><div style="padding-left:202.5pt;text-align:center;text-indent:-184.5pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV84Nw_d61a8304-80b0-4692-8a14-68c0a2a3fb14">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMx_9acb462c-0ab2-494e-a92b-1febb422666d">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMjU_2186b1ce-9db7-480d-bff2-438d1b281796">September&#160;30, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMy_22a62f68-fb4e-4d41-a8ed-fc561cbf88c2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMz_b1168667-d3bb-4bdd-8b60-99bafe44ced8">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="cvs-20200930_g1.jpg" alt="cvs-20200930_g1.jpg" style="height:18px;width:104px;"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM0_1c9154de-d154-4c64-92e1-fe1cc409e3aa">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YzY5YmQwMjRkMGU2NDAyOGJjODFjMzRhYzRkODRmYWEvdGFibGVyYW5nZTpjNjliZDAyNGQwZTY0MDI4YmM4MWMzNGFjNGQ4NGZhYV8wLTAtMS0xLTA_c25723c4-1ed1-4f46-80c1-a9c7d8597c0f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YzY5YmQwMjRkMGU2NDAyOGJjODFjMzRhYzRkODRmYWEvdGFibGVyYW5nZTpjNjliZDAyNGQwZTY0MDI4YmM4MWMzNGFjNGQ4NGZhYV8wLTItMS0xLTA_b4f0ca5f-4f3f-4cf6-8288-653886498aa2">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTEtMS0xLTA_1b5bba26-7230-4dfd-b20d-adb9ef795f18">One CVS Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTItMS0xLTA_fa295f82-2ef7-4659-b330-f593adcb1f81">Woonsocket,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTMtMS0xLTA_ef76818f-cf07-4e9e-9a47-a4eabea44bb7">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTUtMS0xLTA_5f1fcfec-a209-43e1-8c45-9d65e2d064f1">02895</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Zip Code)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8zLTUtMS0xLTA_d1540d48-1e43-4533-8c2e-b78223897aff">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8zLTYtMS0xLTA_0e23e0de-62b7-4839-853e-118b3e65df20">765-1500</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name, former address and former fiscal year, if changed since last report:</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTAtMS0xLTA_fa4ffc76-6d1a-436c-919c-bdd2a62f372f">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTEtMS0xLTA_661f6470-ae0b-49b4-977e-ad19cbcb3924">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTItMS0xLTA_0e6438c9-3b7f-4480-8672-6d0b284fb9b4">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                            </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM1_9cf20947-5fcd-484e-9f60-ddb9fe1a83c8">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                                                               &#160;&#160;&#160;&#160;                  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM2_d78267cb-114b-4b8e-a449-4b6630207172">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8wLTAtMS0xLTA_5a9927fd-992c-4176-af4d-ad6eb6d54ae8">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt 2px 96.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer                     </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 96.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8xLTMtMS0xLTA_0ba6546e-082b-47c0-8f86-33cdc51ea940">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 96.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8yLTMtMS0xLTA_0826cfff-bf14-44af-8c9d-6b86b778bd01">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMw_67451c4b-81ce-4f3b-851d-925152182f89">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;28, 2020, the registrant had <ix:nonFraction unitRef="shares" contextRef="i6240724c7d9c4678ae6da9372625561e_I20201028" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8xOTgy_7398045f-aff4-400c-8ee9-07bb81f99cfe">1,308,913,498</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_97">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_136">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_136">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_139">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_139">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_145">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_145">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_148">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_148">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_151">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_151">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_154">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_154">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_157">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_157">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_160">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_160">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_163">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_163">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_166">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_166">76</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.25pt">Financial Information</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_13"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Financial Statements</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2020 and December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2020 and 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_31">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Shareholders&#8217; Equity (Unaudited) for the three months ended September 30, 2020 and 2019, the three months ended June 30, 2020 and 2019 and the three months ended March 31, 2020 and 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_34">7</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_40">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_94">39</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_16"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e317fd9f8534d0cb3cf959627c9697d_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy0xLTEtMS0w_243e3c82-599d-4224-90cb-a5479e208aeb">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dd89c5723a44719ef9af5db71ec31b_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy0zLTEtMS0w_21552950-409b-49bb-81da-004f00f6f604">47,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901f58f3faaf41e481c42824eca1769f_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy01LTEtMS0w_ec19bc57-076b-4bd3-9084-2dc6ef543dfe">141,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2fd3771d794132920c7f4a242129fb_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy03LTEtMS0w_d264e9b4-246f-4568-a5f5-edd770898c40">136,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC0xLTEtMS0w_b137ab5b-5863-45aa-adc1-5076df42e095">17,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC0zLTEtMS0w_625279e9-5230-4851-b346-81a3e5e32d4b">15,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC01LTEtMS0w_83136cf6-78da-4a98-9651-168b88d1f328">51,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC03LTEtMS0w_25878371-e91f-489d-b7d6-5d13366231e7">47,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa740d08066d4d9abde1a5fbf7722b66_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS0xLTEtMS0w_768d4b91-8dc3-43c2-87e2-fbd41a57d635">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319e1b9809144db8acea0d84bd5a1ec3_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS0zLTEtMS0w_22095c0f-81d7-4ea5-b8b5-988b1fde7e23">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0adc77af7e44ca9b7a5e0aa1830398d_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS01LTEtMS0w_41a6333e-dea8-4a49-bdf9-b45933215055">5,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8425b591444783833edd8e815331a8_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS03LTEtMS0w_dcc17c7c-8f99-4be1-a5a9-8f35d2f979ff">5,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi0xLTEtMS0w_92cda39d-c1ad-4a55-9e06-746cc11860fc">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi0zLTEtMS0w_4b1048bf-88e4-4e9e-b4e1-e20c22cabf16">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi01LTEtMS0w_074c48ae-a4ed-407e-941c-05c591d651b5">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi03LTEtMS0w_f36cec3e-6de1-4e70-b5c6-9ebb18788519">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy0xLTEtMS0w_16e25f56-ccde-4b89-abf5-eabcad37faab">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy0zLTEtMS0w_ac8cbe72-66a7-4156-af32-a5b78e270219">64,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy01LTEtMS0w_2eec0029-b9ff-4c9b-837f-0ae5f1f95921">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy03LTEtMS0w_5433addb-aad3-48b2-b9f2-95cf359a73d2">189,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS0xLTEtMS0w_e2de0286-33c4-45e5-9faf-46382c51491e">40,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS0zLTEtMS0w_15461329-3b14-445c-b7a5-b0b416c9a34a">40,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS01LTEtMS0w_1c70c9d5-a25f-457c-bc6a-53ae62bee6bf">121,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS03LTEtMS0w_2e91f658-403b-4575-86c0-d750047ebd38">116,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtMS0xLTEtMA_3d482f57-9229-41fb-b220-cb09d62dc103">14,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtMy0xLTEtMA_98331007-3d63-49d7-8bbd-61e906227a92">12,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtNS0xLTEtMA_64bfe85a-c43e-489a-87f7-c308b99bce9b">40,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtNy0xLTEtMA_eac1f33e-1327-4063-b7d6-8ec5c64a51b0">39,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtMS0xLTEtMA_671039c6-1679-442b-82c5-424564615d2a">8,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtMy0xLTEtMA_cc8b4f87-6016-49d4-9032-d112224f466d">8,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtNS0xLTEtMA_d33cbfcd-2f7c-47e6-ba01-22c3373efe7e">25,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtNy0xLTEtMA_536e3447-4740-41af-9f3d-0e858cc3f920">24,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItMS0xLTEtMA_5836abc3-1ff2-4711-b5d0-6ac41d77364a">63,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItMy0xLTEtMA_f3f99196-53e1-41df-8d6c-438941f27140">61,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItNS0xLTEtMA_355736a5-2a3e-4bad-8b46-8b187becf17e">187,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItNy0xLTEtMA_edc8430f-ab31-4373-8491-fadbfb97424d">180,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtMS0xLTEtMA_69d683d6-ed69-4333-99d9-2e6b38dce50d">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtMy0xLTEtMA_63af6ea5-58f2-4373-9199-37c0f6752a61">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtNS0xLTEtMA_97a11e81-06a6-4498-b74a-6352ce0b367a">11,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtNy0xLTEtMA_429e653d-6f1c-4a00-ae51-de48a9ac37ab">8,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtMS0xLTEtMA_3842edc7-2147-4edf-9f8a-7ace56572572">731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtMy0xLTEtMA_fdad0dc5-210b-49e4-84bd-a4f48333a8e9">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtNS0xLTEtMA_925b9fb7-6e91-4b35-bfeb-ebd07fd46f19">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtNy0xLTEtMA_65a26435-a6a3-4b0f-ab05-0f174b09f807">2,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMS0xLTEtMTEy_fb626a60-264a-4eb8-9528-76f9e6f5a2db">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMy0xLTEtMTEy_f2ebee42-8880-4385-906c-44b129ed2e87">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNS0xLTEtMTE1_3147ffb9-e209-45e0-986a-af7e98115c73">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNy0xLTEtMTE1_e83f3dd5-fdbf-4a3a-a6e3-d2196b59ce9f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMS0xLTEtMA_d594af64-e321-439f-85cd-316da0bb9f95">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMy0xLTEtMA_4e8591c4-0589-4b6a-8354-61736bd2b70f">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNS0xLTEtMA_06c3421d-939f-4031-956b-ab3e61b67391">153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNy0xLTEtMA_d268ff47-003a-41c5-9237-442853df799d">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtMS0xLTEtMA_63ca7fe7-312f-4e38-a2c2-fee85daa74b1">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtMy0xLTEtMA_724796d8-cad4-415d-a9f5-bd67b5cdd99d">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtNS0xLTEtMA_8bcfbd18-314e-4537-b0b4-c1b1ffdb6fb1">8,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtNy0xLTEtMA_0aa566f8-7a6d-4240-8852-36ef68429c4a">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctMS0xLTEtMA_0cbd00df-75ff-4980-8b6c-878690f706d2">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctMy0xLTEtMA_e6ff6bf2-f379-495c-9104-f7e8791dbb57">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctNS0xLTEtMA_2c0a7ae5-16a3-4ddf-8b35-16562fce2d34">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctNy0xLTEtMA_41377f47-e23f-4ae1-900f-2fda9bc0309b">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtMS0xLTEtMA_40e4c74e-bad3-4d6c-b1de-96a6000fbc62">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtMy0xLTEtMA_4ed34740-c9b1-425e-821b-c3fc049141ee">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtNS0xLTEtMA_2268025f-fe6e-46a8-86b5-7b9d4c0289ff">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtNy0xLTEtMA_2c73ec5e-901f-418c-9d98-0dde24eaca50">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtMS0xLTEtMA_c7d58cb7-c378-4b4d-94e1-4cb17c1fcde6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtMy0xLTEtMA_286244a4-d88d-44f5-9ad3-ac03b14b64cb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtNS0xLTEtMA_a51ad6ba-b563-4985-a4d9-ed2b3feb6751">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtNy0xLTEtMA_50e3b289-63bd-4a9b-bb6e-83e4e9aaa566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItMS0xLTEtMA_d3c7fc2f-e78a-4ec1-b859-1a77c177fe0e">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItMy0xLTEtMA_71e05385-f00c-44da-812c-67c7c3dc0d15">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItNS0xLTEtMA_a4092de6-d63e-4aeb-a490-8445d520261d">6,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItNy0xLTEtMA_c524bad5-1a39-4dff-8619-4348e49767b5">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtMS0xLTEtMA_7d7e2802-6833-4a0c-ae42-ba4076387bbe">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtMy0xLTEtMA_dcc1c113-6c9f-4fd7-a24e-bec2050abd21">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtNS0xLTEtMA_be465134-1fc1-4638-804e-c21734d6121f">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtNy0xLTEtMA_67cd104d-84b0-4fa4-a95e-7820acc32c13">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtMS0xLTEtMA_5c81ed09-5119-4ba9-a6c5-0a489dcf1a98">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtMy0xLTEtMA_e3392bc0-2eaf-44fc-b828-dea99764e9b1">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtNS0xLTEtMA_f9f5ffbe-5ae3-410f-b958-50bf948c7283">4.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtNy0xLTEtMA_47fb7afa-5022-4339-a8af-1d130dea8daa">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtMS0xLTEtMA_82a052ae-0526-4e62-8c88-961ace14adee">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtMy0xLTEtMA_e1b7422d-b4d0-4276-92b7-25613635ae50">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtNS0xLTEtMA_65dc8192-b31b-444a-a8ae-74285b737e4c">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtNy0xLTEtMA_1397b619-08b8-4390-bb33-6896eda07668">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktMS0xLTEtMA_bcc933d0-7bd3-4107-8b0a-544a1f5abfc7">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktMy0xLTEtMA_ac5eeadf-7355-4060-a049-4f6fd36776bd">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktNS0xLTEtMA_38cd2c6c-9bbb-4bd2-a200-96ed9c953d24">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktNy0xLTEtMA_0bc4b594-6365-4593-b15d-1fd933bf9424">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtMS0xLTEtMA_5e9c46a5-dfea-4156-8dc0-78ea15f23d9e">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtMy0xLTEtMA_f540d62e-9244-41d9-bd0a-46f062a0a14d">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtNS0xLTEtMA_ddecab82-0eb1-4cff-9ba1-a994fbe7fcda">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtNy0xLTEtMA_88edc237-06d0-48c4-82da-183d6842ef86">1.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi0xLTEtMS0w_40e4c74e-bad3-4d6c-b1de-96a6000fbc62">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi0zLTEtMS0w_4ed34740-c9b1-425e-821b-c3fc049141ee">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi01LTEtMS0w_2268025f-fe6e-46a8-86b5-7b9d4c0289ff">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi03LTEtMS0w_2c73ec5e-901f-418c-9d98-0dde24eaca50">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC0xLTEtMS0w_0b45e1bc-ff7f-42e5-b893-b20734c62a89">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC0zLTEtMS0w_9ded0518-6a36-4272-80a5-6a61c8dec60c">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC01LTEtMS0w_eb7157be-1b1a-433d-9871-918f2615bf91">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC03LTEtMS0w_287c7c0f-177c-4541-bddc-189575e90334">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS0xLTEtMS0w_ee560bb1-f29e-4c3e-97df-f0ea33e9b642">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS0zLTEtMS0w_c5577455-d142-421c-87d6-c4c6f893e575">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS01LTEtMS0w_4b7fd8c5-c833-4160-99fe-7c1ec8e5e982">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS03LTEtMS0w_fdc84569-4d8f-45fe-a02f-2d4ea22454a8">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi0xLTEtMS0w_cce6c74b-7cf4-49ac-a8c6-1e19dd516eb6">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi0zLTEtMS0w_7ab27a0f-d700-474b-a7f2-f0c720d3590c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi01LTEtMS0w_9384b627-36ed-45df-ba7f-647d2052df40">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi03LTEtMS0w_5a99f570-a0fb-41c8-a585-0c729c74dd66">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy0xLTEtMS0w_83ff2363-f299-4585-bdd4-df905ea1ac78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy0zLTEtMS0w_f53bf969-f5b6-4681-b2d5-ec1acbc5568c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy01LTEtMS0w_61867a71-982a-4057-8524-838086e4ac35">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy03LTEtMS0w_5f3b287a-dc1a-438d-8186-c85c9d088c77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC0xLTEtMS0w_98fe7f59-8510-44d8-8728-ce4d83a3a579">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC0zLTEtMS0w_450fe72d-68d7-4bc8-974b-d3b6a749558e">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC01LTEtMS0w_c24fd712-7681-4602-8442-395a359380d9">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC03LTEtMS0w_7586ac89-5e5f-4231-870f-755fa37e6e4e">848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS0xLTEtMS0w_151ce4ae-fa04-4527-94e9-8257afeb0856">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS0zLTEtMS0w_63095918-032e-4bc1-bdd8-8d025999abc2">1,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS01LTEtMS0w_322350c2-73b7-44dc-a01a-62af9b9fc17e">6,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS03LTEtMS0w_ad4121f8-0ca2-48ee-bd7d-0599ba70dc51">5,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtMS0xLTEtMA_c7d58cb7-c378-4b4d-94e1-4cb17c1fcde6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtMy0xLTEtMA_c69b4172-bb66-4308-9c7a-08c046e8e79e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtNS0xLTEtMA_a51ad6ba-b563-4985-a4d9-ed2b3feb6751">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtNy0xLTEtMA_50e3b289-63bd-4a9b-bb6e-83e4e9aaa566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtMS0xLTEtMA_589aa363-524b-4050-85da-5db48db70d5a">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtMy0xLTEtMA_7e7914e9-7764-477c-8ac2-97154473dcd9">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtNS0xLTEtMA_a939e931-09d8-43cf-85b9-10bdbfa2932d">6,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtNy0xLTEtMA_dfda088e-1218-45e6-aebe-4dbd14bb1d8d">5,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMi0xLTEtMS0w_c2b03227-5572-4dbb-b56c-83e8bead8acb">9,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMi0zLTEtMS0w_26abf10c-55bb-4ffd-b719-49bd753c9c7b">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMy0xLTEtMS0w_3bf6474e-b109-47f0-81d9-7daaa588fd4c">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMy0zLTEtMS0w_c6307c42-78ca-4e2b-8031-f87380e63ea2">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNC0xLTEtMS0w_d915c9fd-88bd-4c31-a779-b0c562a44e98">23,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNC0zLTEtMS0w_c355723e-7c7f-469c-89c2-c4181ef26eee">19,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNS0xLTEtMS0w_37b9c316-3fe3-433e-ba01-4170db258a20">17,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNS0zLTEtMS0w_5b7fb2ab-cdf1-4887-a889-6e9ccf77889b">17,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNi0xLTEtMS0w_4a6f874b-4b09-4d5b-861b-00eda0628ba7">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNi0zLTEtMS0w_a9cc5b5e-cf55-4493-ab8c-695b5f58d31e">5,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNy0xLTEtMS0w_750eeb7b-c776-49b5-af65-ccf7b269f522">59,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNy0zLTEtMS0w_70547004-9f54-421f-a13e-761a3322a4c1">50,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOC0xLTEtMS0w_45843e73-85de-4c6b-ab63-69786507310b">20,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOC0zLTEtMS0w_f0090fb9-1b61-4a3f-8e7c-5bf14d16a838">17,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOS0xLTEtMS0w_f418dcf9-97e9-400d-9ef8-12aa652ebf34">12,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOS0zLTEtMS0w_0d5385f2-b2fb-439a-915d-73618b0a02b8">12,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTAtMS0xLTEtMA_ddf30ed9-b37e-4962-ad88-1f587b8995cf">20,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTAtMy0xLTEtMA_c2982adf-a519-45b6-8a47-93ee06b0873f">20,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTEtMS0xLTEtMA_b5512fd8-ff2c-4126-8c62-bb5ce008e9ca">79,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTEtMy0xLTEtMA_6d6d8b3e-2649-495d-9f89-c09a8db2e3ea">79,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTItMS0xLTEtMA_062179a7-5107-4e0c-af10-081d3799ac59">31,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTItMy0xLTEtMA_0680dee2-dcfc-436f-b01b-86cb43686b9d">33,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTMtMS0xLTEtMA_13c9f9f3-f6e9-41a0-af3f-e3f945f32d5a">4,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTMtMy0xLTEtMA_6d819780-df9f-4dc0-b046-1de0f1a0b7cc">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTQtMS0xLTEtMA_f33be83b-fb58-4263-9aa8-3f0be7baf942">4,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTQtMy0xLTEtMA_6981b9ef-cb1c-4418-b5f3-8672afd98c4b">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTUtMS0xLTEtMA_0022791a-87d4-4db1-a676-83be1d7835c8">232,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTUtMy0xLTEtMA_fa17c6ce-0c01-4a25-a302-13ef8b810156">222,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTgtMS0xLTEtMA_83e4032c-285c-4290-acd1-e927fadae115">11,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTgtMy0xLTEtMA_20d2b431-dc04-48b3-a0f0-557e5ab39464">10,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTktMS0xLTEtMA_574cfff7-69cb-4452-ba90-0b7f82dade04">15,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTktMy0xLTEtMA_e551ddeb-e242-4fbf-92e3-5e2e50253f5c">13,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjAtMS0xLTEtMA_978a94ab-1690-4fdd-8167-a4002551a840">7,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjAtMy0xLTEtMA_9fcc4598-a64e-4779-a205-dac7e591b817">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjEtMS0xLTEtMA_da4ef21b-2fad-4e69-9d27-25b6a86d8d01">3,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjEtMy0xLTEtMA_0403faec-19ce-4648-a9ed-4673f2c84ff4">2,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjItMS0xLTEtMA_a7b0de32-6b86-4aac-8001-1e3227e3173b">14,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjItMy0xLTEtMA_f21d328f-982b-43ed-ad7b-982aed6ad960">12,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjMtMS0xLTEtMA_8e571040-daf3-4f43-a3f9-e1ab979f3805">1,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjMtMy0xLTEtMA_bf915cca-29b1-4080-a24c-caa3fa0be81d">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjQtMS0xLTEtMA_1b71c37b-f163-412c-ba0e-88c39e605e90">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjQtMy0xLTEtMA_1d296d63-36f4-45c9-a71b-c1d953379c1f">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjYtMS0xLTEtMA_978bb31a-addd-471a-bcb1-d1c1850bf732">5,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjYtMy0xLTEtMA_3059af10-2201-4f4f-8ef1-a668f7a5b131">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjctMS0xLTEtMA_e392661c-8c64-474e-bf5a-74c8bdcdabbc">62,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjctMy0xLTEtMA_a4c4abca-1511-499e-87ff-7f3146f7faf9">53,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjgtMS0xLTEtMA_9b3eddfa-66b2-429f-a962-bd50d6dac47f">18,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjgtMy0xLTEtMA_a28827d1-f310-4ed2-bb48-e4ba317c565a">18,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjktMS0xLTEtMA_a13ab023-4b97-4a4d-8c42-cb42a67fac8e">61,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjktMy0xLTEtMA_3da871e6-3f2b-414e-b508-2e3f2508c14e">64,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzAtMS0xLTEtMA_29a650b6-9523-4c9c-8855-b951e8658a24">7,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzAtMy0xLTEtMA_8528b333-83da-415b-8a06-993f2da3103f">7,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzEtMS0xLTEtMA_211b5a5e-e4e2-4e78-92b1-32b782b6cda4">4,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzEtMy0xLTEtMA_74b93185-b421-4778-83be-303f7f639675">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzItMS0xLTEtMA_399d6524-b233-4284-a78b-843e53069d03">7,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzItMy0xLTEtMA_0aacf478-3624-49bd-acbe-371732fb3930">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzMtMS0xLTEtMA_d7b2a5e0-d5d4-445e-91df-37bbc05e2347">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzMtMy0xLTEtMA_13e0f1a0-b730-47bd-ae44-f35f54a474f8">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzQtMS0xLTEtMA_105273d7-b2ca-4215-9216-1e63f32b9a0b">163,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzQtMy0xLTEtMA_5715bc93-ca03-4f2f-be49-b21344345f7e">158,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NDU_3aa82b0e-a1e5-4199-ac3e-8377f9cac95e"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NDU_586df305-4d4f-4df4-8f8d-ba63ac926a9c">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NzI_6441328a-6b8a-444d-befa-170da6c87925"><ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NzI_70efd269-7e13-450e-a661-68c4d7b63016">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_497cb6aa-229f-43f7-beb0-a27c0422ae85"><ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_4c70d3a8-b464-46cc-b023-bf9d13e4eb8b"><ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_aa280098-0293-4a4b-a94f-1ed78fb2973d"><ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_e7cfa6a5-f67f-4b34-ad88-d3948fd4f854">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMS0xLTEtMA_18075276-bc1c-46e9-aa15-918ff49fb912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMy0xLTEtMA_613e2f89-228e-4b13-b5ff-1333010bad33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDA_133ad208-a3de-4d2e-b0e4-dc19f283cd6d"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDA_a7752080-9ea6-4ff4-a009-95a0d686de33">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MzI_7d8e91ce-34aa-4f74-8402-706d7fe24c75"><ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MzI_ba641897-7bfc-4410-b43c-4d5dcff9bcd3">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDY_8a562a42-5dfc-4e8e-93d4-b9b7c48fa4a5">1,732</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NTI_db036184-321a-4a52-a185-ef8f15fd612a">1,309</ix:nonFraction> shares outstanding at September 30, 2020 and <ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MjQ_aed5be30-9df5-4ace-9ad9-d7ac0ad5a18a">1,727</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MTU_699685da-bfb6-4b10-92a9-7a8d5028f286">1,302</ix:nonFraction> shares outstanding at December 31, 2019 and capital surplus</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMS0xLTEtMA_777fc57c-c9f4-4f65-8976-095076b662ab">46,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMy0xLTEtMA_ddfb0b04-c186-431e-9f61-8c0ef46a5eaa">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjM5YzMxNjk5Nzk3MjQyZjY4ZDkxYTZiZmU1MjE2ZDg2XzIxOTkwMjMyNTU2NjA_2e6861ad-ea00-401f-89d0-04d687aaad49">423</ix:nonFraction> shares at September 30, 2020 and <ix:nonFraction unitRef="shares" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjM5YzMxNjk5Nzk3MjQyZjY4ZDkxYTZiZmU1MjE2ZDg2XzIxOTkwMjMyNTU2NTQ_4314189d-9b61-44b3-a39b-6c0615ad9061">425</ix:nonFraction> shares at December&#160;31,&#160;2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMS0xLTEtMA_136bd169-8f73-4cc6-8f8a-3d8358f473c3">28,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMy0xLTEtMA_f189fe9d-fe1a-4927-b700-5648c81d2498">28,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDAtMS0xLTEtMA_9ae51b24-ab28-4090-9c4a-9f39f7c2fb8b">49,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDAtMy0xLTEtMA_d53bdd90-91b4-4b53-b5da-da6a44d35936">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDEtMS0xLTEtMA_f8fb4d84-ed56-44d5-b7e7-79aa6c325c32">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDEtMy0xLTEtMA_ed57fec6-a9a5-48e2-b051-61f1550a5a29">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDItMS0xLTEtMA_45f7f0e9-f27b-4202-bc46-f46d2456b4a7">68,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDItMy0xLTEtMA_ff62f909-b34a-4e14-a095-5e9aa6b1eaf2">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDMtMS0xLTEtMA_e0b22085-4e43-427f-ac8d-52ddb7d1eeb9">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDMtMy0xLTEtMA_64f9a508-3de4-44cb-90d0-e854fb244404">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDQtMS0xLTEtMA_2229b940-b99a-461f-99a7-fd67c03a576a">69,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDQtMy0xLTEtMA_2b799bf0-6da5-4489-9bdd-1972069ab22e">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDUtMS0xLTEtMA_765daf29-eccc-473a-bc85-09cd6ab19e56">232,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDUtMy0xLTEtMA_c5394edf-5123-4126-ae22-07173dd26e82">222,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMy0xLTEtMS0w_f54bb764-c905-482a-adc6-daeaad00bf51">195,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMy0zLTEtMS0w_34385c18-ba63-4e45-9677-88dc85b24424">184,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNC0xLTEtMS0w_f0ccc698-03a7-4cf9-9e85-68f9d47e0b55">116,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNC0zLTEtMS0w_fb1ac998-2c05-406a-8c0b-2ba4b2ad19e1">109,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNS0xLTEtMS0w_caf75e8f-34f4-4cda-93c0-21a492dce99a">40,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNS0zLTEtMS0w_ab8e984a-c140-47aa-8944-01f520630190">38,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNi0xLTEtMS0w_c51415e8-6cdd-445a-91ad-2c8d9a48d410">22,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNi0zLTEtMS0w_bd8bf17f-3281-41a9-af5f-432f45353e13">21,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNy0xLTEtMS0w_bacea0a0-5a2b-4e9e-8ef3-967b5ed790a3">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNy0zLTEtMS0w_9787e274-04b4-4b52-9509-dfd10e427e68">756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOC0xLTEtMS0w_223083be-7301-45dc-95ec-55fbfe454e6d">2,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOC0zLTEtMS0w_6c71f4d9-b1f7-4477-9b18-d93cc5849436">2,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOS0xLTEtMS0w_ce83cb95-d3a6-4b89-99b3-be1498de7ae1">2,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOS0zLTEtMS0w_a5f0f91b-62e9-4b0e-a686-e21fd27a58ff">2,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTAtMS0xLTEtMA_350f5fcb-8698-478d-98d7-b42b70a7d634">12,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTAtMy0xLTEtMA_dde80eb7-68b2-4a64-91ee-a44c575b5c1b">10,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTMtMS0xLTEtMA_f970070f-6d81-4c07-abd8-7340aab7570f">3,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTMtMy0xLTEtMA_3b987535-dc96-4090-8cdc-6035ca3ebaba">5,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTQtMS0xLTEtMA_ff8d8114-3e6a-407e-8884-065a00be33c4">6,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTQtMy0xLTEtMA_d14198c8-6f59-4abc-8db4-e467433b4543">6,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTUtMS0xLTEtMA_9f51c966-32c7-46e7-b34f-422cf5e7284a">1,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTUtMy0xLTEtMA_bb73d770-52ed-4afd-99af-841319956e62">1,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTYtMS0xLTEtMA_40a0dd36-5ba7-4418-94b6-98e0b1541da4">828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTYtMy0xLTEtMA_0495b677-aa0a-45d7-9b22-c1d2c570cc67">361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTctMS0xLTEtMA_e79016cd-9d98-4cca-ae5d-4bd64faa1dee">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTctMy0xLTEtMA_eba6fee8-7654-42cf-a061-e9bdf848c6e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTgtMS0xLTEtMA_35818ea1-7c81-4049-b66e-458efbb56404">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTgtMy0xLTEtMA_9390ea12-b285-4f83-abb2-f03cd243535e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTktMS0xLTEtMA_3bd04457-686b-412d-82a9-eea666618e76">4,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTktMy0xLTEtMA_7d292343-0c7b-4a0e-86b7-e2b021ecb1b6">2,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net borrowings of short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjItMS0xLTEtMA_2813c798-3ec1-499b-8fcc-ddcc11763ddf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjItMy0xLTEtMA_ff9acee7-ae98-409a-b144-52921383c11b">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjMtMS0xLTEtMA_0539d105-1f19-40bd-8e90-5dda18a66e7e">7,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjMtMy0xLTEtMA_49a134ac-7365-4f67-ae10-fa89c60dfc3d">3,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjQtMS0xLTEtMA_c8509111-0f84-4b7a-82ef-591adfbee94e">10,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjQtMy0xLTEtMA_1c84e9c6-f208-4a33-9d34-1ea2a4456edf">8,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjUtMS0xLTEtMA_0c6475b8-15f0-4b14-b71f-bb1a6bf22b7d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjUtMy0xLTEtMA_5bd39acc-eb6d-4c7f-95d8-1db4cafe4662">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjYtMS0xLTEtMA_be6da3df-fd96-4f40-b447-703d000d0197">1,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjYtMy0xLTEtMA_23215908-068d-4e7c-a12c-3de6c9342059">1,952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjctMS0xLTEtMA_8b22f9fc-cda0-45b6-bf26-fca92df1f466">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjctMy0xLTEtMA_c09e49d1-c6d8-44e7-bd37-e39364b25195">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjgtMS0xLTEtMA_174da498-2e22-4ef9-8c1d-b408eeb08bb9">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjgtMy0xLTEtMA_9a3fc048-0e0c-4413-8ce9-b81ca7d45e9b">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjktMS0xLTEtMA_2e8a5583-16c9-4bad-8447-155570085284">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjktMy0xLTEtMA_28115b0f-22f4-44b8-9ad5-74f9b9487dfd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzAtMS0xLTEtMA_eca96f30-fed3-4552-9169-ff4ec633530e">4,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzAtMy0xLTEtMA_23de2402-b391-4301-aadc-78d660fed96d">6,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzEtMS0xLTEtMA_2859fbde-09b5-464d-b6be-25211cad6451">3,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzEtMy0xLTEtMA_720807d4-966d-406f-901e-7abc3982803f">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzItMS0xLTEtMA_b1f7d448-eb57-4c3b-aadd-a55efed2aff8">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzItMy0xLTEtMA_1a2d078f-c73e-41cb-b4ef-a333d57e3714">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzMtMS0xLTEtMA_73575e66-c091-4d1b-9cb5-fbc64de50e75">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzMtMy0xLTEtMA_61ae18aa-738c-46d8-9b1c-daca00e18641">5,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMy0xLTEtMS0w_2268025f-fe6e-46a8-86b5-7b9d4c0289ff">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMy0zLTEtMS0w_2c73ec5e-901f-418c-9d98-0dde24eaca50">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNS0xLTEtMS0w_92f18e07-b590-4129-8cee-c95554a833c8">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNS0zLTEtMS0w_e579efff-48b8-46fb-a3de-0dd9cd684c02">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNy0xLTEtMS0w_83b0655f-14dd-41ca-9ced-fdcd9a5f746f">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNy0zLTEtMS0w_1cce8c77-5a36-4475-9bda-30a0cefd55a8">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOC0xLTEtMS0w_482982ea-9816-4cc5-9aba-faefe4ef2d36">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOC0zLTEtMS0w_737dce46-765b-4220-8305-7120176da975">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOS0xLTEtMS0w_5f4d12c0-d604-43aa-a4e4-153be3db8884">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOS0zLTEtMS0w_2ff8bdc4-b333-4727-875e-37924395171f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTAtMS0xLTEtMA_0184c787-cb85-4185-af81-fb084812821d">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTAtMy0xLTEtMA_4aa2f726-9ad0-4882-9124-0605da74bce8">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTItMS0xLTEtMA_8ed8fd02-e94e-48ef-a017-445b8fbe078a">3,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTItMy0xLTEtMA_45cad997-ad5e-4d85-92d7-116d978bc078">2,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTMtMS0xLTEtMA_6c00bb3a-8c6e-43d4-ba6e-46c08132e201">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTMtMy0xLTEtMA_7c1f9a2b-29bd-4d0a-acce-e31cac171664">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTQtMS0xLTEtMA_77dad843-4c65-4133-ab41-be9fceaeaa0a">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTQtMy0xLTEtMA_b42f06f3-3e99-4f84-9b88-f28ecedc40ae">374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTUtMS0xLTEtMA_08bc6b75-ef42-43e0-8555-6a870cbb25fc">3,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTUtMy0xLTEtMA_36d60b8c-f12d-457a-9e7f-13e151a9c2cd">2,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTYtMS0xLTEtMA_5280d934-77d8-4f0d-ad09-678e0ff80da8">474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTYtMy0xLTEtMA_c502743d-ee28-4fb1-8efe-75e5c1dddb21">535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTctMS0xLTEtMA_478b47ca-aca6-48db-a41e-aa7f219f7024">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTctMy0xLTEtMA_e4d47c02-8420-49d1-84ca-4aba7e18469a">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTgtMS0xLTEtMA_45a70abf-4742-41fe-ba85-900f1e9421cd">12,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTgtMy0xLTEtMA_7a92f789-5a6b-45e6-93c5-acc296a218f5">10,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/> Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7930220d914f419297614a660281ef47_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0xLTEtMS0w_4fd87ab6-75ab-4ca1-b49e-19caff955270">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5be942208dc1421797995bf453709517_I20191231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8a0caabdab46cc88debaa0c046f3dd_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5be942208dc1421797995bf453709517_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a539619c134838a1d5f4cca14f9441_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS02LTEtMS0w_55682ca7-d24d-4461-9b92-55c05da064eb">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3172dd72e85d49daa20d2cb9b4f7f9b2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS03LTEtMS0w_8e33aa92-b894-4687-92b0-222d60b793d1">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2286aab200f4a1892c679ab6e3b1b9b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS04LTEtMS0w_89508335-41eb-4b03-8ae7-0665b3f5cb3d">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea3ad7fbde3466cb0d05dc9cd11a22b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS05LTEtMS0w_ab4578ab-b482-40dd-8454-3acdabb48355">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0xMC0xLTEtMA_bd551f50-efa6-400a-ad84-e87ca143fe34">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of new accounting standard (Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi02LTEtMS0w_3f8e2ec0-4eb9-45f4-b802-36fe08de89e6">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca7c827c69941c5994247c772125139_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi04LTEtMS0w_0d894060-9463-45a3-8bc8-47b9f6fbe519">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia87850112c6a4030818cf4c061f75276_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi0xMC0xLTEtMA_a810d541-ab6d-4a61-a3d2-1b331a95a310">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy02LTEtMS0w_9e4618e7-ec6d-46da-8601-32c134ff805c">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy04LTEtMS0w_5c5ea346-a386-48bc-b86e-9985989ff854">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9860b6f9816341359067357c7c165e5d_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy05LTEtMS0w_7103010f-1a44-4e4d-90b6-c8aa5891be91">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy0xMC0xLTEtMA_6d9e09df-92bd-422a-93a8-7814bfe1ba28">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4d35ebf9c824b0b907f4c0adae223ca_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC03LTEtMS0w_f759aea1-6606-4e02-934f-3f4395f5b8e8">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC04LTEtMS0w_1ac32a5b-2021-4d97-b618-d5e4e6b78c44">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC0xMC0xLTEtMA_87522e71-ffab-4055-839f-ca23724cbbee">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie94974140e414714a3341c252c984f66_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS0xLTEtMS0w_49fcb724-0fe8-4258-b6c7-d9e74174b7c7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a375bd4d6f48e89dfffc71946f4a55_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS04LTEtMS0w_ad6af61a-fe0d-4255-82db-8034db77b213">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS0xMC0xLTEtMA_00460b9c-72a9-46ac-a05c-a07a1186b4f8">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtOC0xLTEtMA_77e0ba07-3541-47cc-8cbc-00c7b00cc530">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMTAtMS0xLTA_5eb92ad7-b1cc-4297-aada-331861aabc50">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtNi0xLTEtMA_19fe7c7c-285f-4557-a735-4b87be2fc35f">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtOC0xLTEtMA_5da596c6-aced-43f0-a2a5-b69010e86245">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtMTAtMS0xLTA_69439fcb-6b27-4a43-8b0d-b92ac1c3fdee">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9860b6f9816341359067357c7c165e5d_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTItOS0xLTEtMA_641536b1-6fe7-4353-9ed8-d2a1fef80420">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTItMTAtMS0xLTA_370af8c1-9e6d-439e-be9b-c7b16186c98d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a44be297eb413184028063b42c5faa_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMS0xLTEtMA_619be8e8-216c-4c64-b576-eb42b77f57d1">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i16cc05efec2c470d9c2d81b1369a192d_I20200331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e1e6cd716a4e87bfd329666134d286_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781">46,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16cc05efec2c470d9c2d81b1369a192d_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e">28,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i814ed0bf8ff04a1ab4a1a2b6668545f1_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNi0xLTEtMA_0d6960b3-8c15-4d31-9d73-222f7a3e051f">46,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe3dc5bd7df49b582bcd4fb537c3ff8_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNy0xLTEtMA_67b60f34-e1a5-4a19-a004-41f1631cfbaa">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df330f945fe40ae939aeecf46b997a6_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtOC0xLTEtMA_ccf3eae0-1b18-4600-85d1-31ba8814906f">65,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3de2ba29874b91820a6e8738735819_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtOS0xLTEtMA_759f758e-6c60-440c-aadd-9b982bed7575">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331e56114e3c422584fccdc1dc247161_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMTAtMS0xLTA_725f810b-fb8d-40f4-b4a1-c3f3088f0916">65,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtNi0xLTEtMA_31de8147-57fe-4b63-a188-33af5eea9986">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtOC0xLTEtMA_c7013aa6-fe8f-4f9d-bc4e-6526c2448adc">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4c75a50fb4463093ce50049b985383_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtOS0xLTEtMA_c2cb4bc1-4fc7-4029-adc5-aa819792fb14">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtMTAtMS0xLTA_bead2e45-1a49-49ec-9f44-63a62aacfa08">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3167dd9c7bcb4190a46ac3616a6096d1_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtNy0xLTEtMA_ec8659cf-5fa9-49c9-ae75-90487c1d986e">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtOC0xLTEtMA_6952b2f5-fa30-4f50-8430-987516624e13">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtMTAtMS0xLTA_59e45177-132e-4927-a0b5-42a3bbaab5b0">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i571ceac717c84c4a94f70faf7c363371_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtMS0xLTEtMA_2f28c656-ad93-4bba-98de-47ddb130ea9b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe21c1301c6497aadc7f6002c446161_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtOC0xLTEtMA_d0b6b509-51f8-488f-b865-9dfc8b3f2c54">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtMTAtMS0xLTA_d047a976-89cc-4095-af4b-e355e98f2d6e">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctOC0xLTEtMA_5da83a20-dd50-418c-9be7-606a1258ab69">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMTAtMS0xLTA_608aa31a-91eb-4126-bd2f-51eda4744100">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtNi0xLTEtMA_8be91890-6bec-4ebe-a3fc-88eb97646dff">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtOC0xLTEtMA_4ed10a71-e089-4a8f-a54c-566575a30d01">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtMTAtMS0xLTA_830b5a2d-d763-433a-8508-9111578f8bb2">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec4c75a50fb4463093ce50049b985383_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTktOS0xLTEtMA_beff93cc-6498-4232-bf43-b4803c1a1147">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTktMTAtMS0xLTA_95777f98-3e14-4e99-be3f-004f312ba323">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if497738f73ef48128d544b2866a6b773_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMS0xLTEtMA_b819b7bb-1407-4538-b84c-071cab51981e">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7992d69654cb097446acf9b33e297_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a">46,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a">28,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f29445f39bd4b9d9c0596805a0d36fa_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNi0xLTEtMA_aaf448f9-cfc5-474b-8d9d-295202aded9e">48,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7c1d38bf884811b17e7b37aa5fc599_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNy0xLTEtMA_673da8ac-c713-446b-baac-d078d9df9637">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54229e328244a16acdf5c0ec0ddae47_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtOC0xLTEtMA_51af6c68-bd8b-4d45-9353-88fffdf076d4">68,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idead255cd4d14401a0f371fbde8693f8_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtOS0xLTEtMA_763b6a03-752c-4067-a297-b9df13abe459">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMTAtMS0xLTA_875bdcd0-8f02-42c5-bc00-1abc4dc1a4fc">68,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtNi0xLTEtMA_b31450bd-6986-489f-a261-3ab5c78e4e25">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtOC0xLTEtMA_e79187fc-d1af-4d3c-8bed-cc8c0c1611e5">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtOS0xLTEtMA_f38e4e5c-7c1b-405f-bb31-d6fb7b0b0ba6">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtMTAtMS0xLTA_8107e5c9-cdcd-4f09-a1db-1e3b3c7008e7">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItNy0xLTEtMA_bca3fc5e-b6be-4645-8efe-fcfcc71580e7">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItOC0xLTEtMA_9e509b9f-d6b1-41ce-9f33-371bdcc85d5b">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItMTAtMS0xLTA_0b850786-d5fd-47be-9d1d-6aa643c3c3e0">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbd79123bcc14c2fb1cc1eeb95efcaba_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtOC0xLTEtMA_ea0c4dcf-45cd-4705-b8a9-a8bac9600cdd">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtMTAtMS0xLTA_10c6ce53-6568-482b-86f0-f6b42fd187c5">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id36f48bb62074ed38935780980244861_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36f48bb62074ed38935780980244861_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtOC0xLTEtMA_49500b7b-4218-43ab-84e6-a552f0f353a5">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMTAtMS0xLTA_259fbead-40f2-4a75-bc7c-d90e964c0f7b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtNi0xLTEtMA_e0dcde40-0b05-4ced-9b20-0eed3227dc78">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtOC0xLTEtMA_d3dfc810-7c06-4ea6-b198-cea11b7de9d1">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtMTAtMS0xLTA_4fe597f9-0fa4-4554-9d17-9a9dd880050b">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases  in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjYtOS0xLTEtMA_af3faa6c-b88e-4ea6-85ea-03878943085e">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjYtMTAtMS0xLTA_47524aaf-bf23-4143-b15d-996576fd9ecc">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia98a850eb95d4b82868c9616941ead34_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMS0xLTEtMA_f1623710-2e6b-4848-848a-72e026dac5f0">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib59819bcb087468789cf0b7b87860688_I20200930" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e254dc8fb204c0aa8e1af10b2125b4f_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda">46,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib59819bcb087468789cf0b7b87860688_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d">28,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e91a6c1593e4ec4ac7aad6c113f284a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNi0xLTEtMA_c5cd1dd5-956a-4b53-b6c7-63fffc5de911">49,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859721481833446fa96d26363301759a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNy0xLTEtMA_76879a22-3faf-457e-949a-3ea3039c5f60">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106be2d3ad604360afa2a6c2657acdef_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctOC0xLTEtMA_1daa1b49-2572-4da7-a90a-4fb944a589c6">68,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b816b179cf48c3875bfe79f11415be_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctOS0xLTEtMA_e526d1d7-1912-4a4a-a390-775506992f11">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMTAtMS0xLTA_35625ea0-0720-409e-be6c-603a0d941078">69,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTcy_0c73572a-6878-495b-ba0e-c320120f29c7">1</ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_165a15a9-035c-48bf-b3aa-3d8d6e1d0463"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_1d6eb76a-1f80-4ffc-8254-101d19e37b25"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_43d2d5b4-e3d3-499c-8b0a-cf24a89aa700"><ix:nonFraction unitRef="usd" contextRef="i331e56114e3c422584fccdc1dc247161_I20200331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_ba76d0be-7d02-420a-87e6-f7fc16ed3d6b">29</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019. </ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_53ad5b85-df56-4f6a-9d17-54cf7dba2614"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_87052ec5-8ddf-4eb9-9b3e-7da45a202fe2"><ix:nonFraction unitRef="usd" contextRef="i331e56114e3c422584fccdc1dc247161_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_aa0ee566-bc1d-4be7-b5d9-dc50ab4bd38b"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_c405a5f8-30b7-453f-891e-dadd53db4154">17</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</ix:footnote></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/> Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i304666a201b045b7ba84e7a502222b26_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0xLTEtMS0w_ed08de51-89ab-4fda-9a94-677357454a2a">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i514d9c71e8e34b73be0290f1502a1722_I20181231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i322a9dc17b8243e6b3fea397bd95e1a8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f">45,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i514d9c71e8e34b73be0290f1502a1722_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac">28,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7770f7a96734fbf946266bf7257161a_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS02LTEtMS0w_9e0b00d9-1ca2-423a-beba-b605f24d6214">40,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4657fb3ee8e24f7c8bd16ec46224e2f2_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS03LTEtMS0w_5f6afe6c-ab1e-4b4a-be2a-5559dc6d2c49">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac7aa78682f147f48082f382fecfef81_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS04LTEtMS0w_e41fd32c-15b0-4ca9-b1cb-994a5e2c27d4">58,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536638a93faa4b458e82d77598e46897_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS05LTEtMS0w_7155417a-07f9-4900-99e2-5999fa110823">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0xMC0xLTEtMA_8678eb05-dabd-4a69-a0ff-1b281368075f">58,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1aa9ee857c04106b4ddeb51bba6580f_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73aa0acfcc2a4286bbdbe36223128682_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29d78d69f63e43bfbbf2c9b5b9e3a9c2_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebcab56786dc42feae377f091296982e_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy02LTEtMS0w_1ce92be7-e26a-4a76-8808-5a6246a8c0b7">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy04LTEtMS0w_b79c5b18-8cc9-4e2e-ba26-d422828f3334">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy05LTEtMS0w_ddfbcf36-b97d-4744-9585-a8b198764645">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy0xMC0xLTEtMA_ea3210ab-dc36-4649-bc45-214d1d5bba4e">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1abb168a5e6441d18beffe97e1f3d94a_D20190101-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC03LTEtMS0w_8e05030d-2e27-46c2-866a-1970b4441db6">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC04LTEtMS0w_d0e1b166-9dc0-4f8d-a2a2-8cfa744cb607">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC0xMC0xLTEtMA_bdd9bbfa-b596-4bd8-b12b-a6fbbc1576c9">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia143f7ee313e44f7870d98c64e6439b5_D20190101-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS0xLTEtMS0w_5f9bd4bf-a587-47a4-963b-b8ada6a4194c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae75737b267456a808c79a40b150435_D20190101-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS04LTEtMS0w_84bd7042-71cb-41d8-bb00-4a83a6c5dac8">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS0xMC0xLTEtMA_b358fabb-5fdf-4246-bd49-9f45101773bb">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtOC0xLTEtMA_6b90a6c5-93e7-417d-86ef-0c146fb279ac">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMTAtMS0xLTA_301a6b1a-bf09-45a4-b568-1bc311729cc0">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebcab56786dc42feae377f091296982e_D20190101-20190331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtNi0xLTEtMA_e3d47582-8e5f-4fc8-b78b-b82872019838">651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtOC0xLTEtMA_73c094f5-d952-43d0-abfe-76a7b13a0be8">651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtMTAtMS0xLTA_d28a436d-1d57-4476-9030-9aadcf49a000">651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTItOS0xLTEtMA_fe58b632-5f7a-450e-b61a-d94848442989">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTItMTAtMS0xLTA_14173ca4-0828-4846-9189-9a42cf3a3ec6">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06c27729e16e4e42ac7509026e75dd51_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMS0xLTEtMA_56249f4e-8316-455d-bd48-7451d8e135cd">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2900867654474cd28dd5045d196ec575_I20190331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aca7df593c34ab7b0fbb5ea78f926f8_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25">45,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2900867654474cd28dd5045d196ec575_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425">28,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd1a561806047208b4db1ab9fce4f98_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNi0xLTEtMA_81936578-6494-4612-b877-50ab609a3b00">41,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7700a44a0248e48d1b6d80b0fc2ae4_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNy0xLTEtMA_46a214c2-0ffb-48c4-a8aa-ec1e903085f5">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab629bbd58a4de092289e615211980b_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtOC0xLTEtMA_cd897660-5809-4609-b719-cbc405bc3eba">59,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6599ba05330a4711990ed70a0a265e49_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtOS0xLTEtMA_d403db8f-794c-46bb-a8c1-b56b5906f53c">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMTAtMS0xLTA_a6c89c21-322a-43db-a64f-36d914eefb0b">60,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtNi0xLTEtMA_01ed7fc6-a4af-4086-9c4c-885ed4e9c63e">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtOC0xLTEtMA_86648975-fdbd-4f8f-920e-eb2fc49a44f2">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtOS0xLTEtMA_749d154e-8ffe-44b8-9384-eca26c7bd969">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtMTAtMS0xLTA_38116780-16ac-4d8f-a7ac-88d247d0af88">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203b5e3c33e4404c9d4ea2fe1f4e7ac8_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtNy0xLTEtMA_ce7e5dc0-a731-462a-977e-bc1e5ac28ee2">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtOC0xLTEtMA_511899a4-e9b7-4fd9-add4-98e348fd22ba">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtMTAtMS0xLTA_b2577296-ee37-4a05-a541-27e51ee41b46">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4364493f5734455bb1f6e765963518f_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtMS0xLTEtMA_4a6c6063-52b9-4142-a2e9-2f95becf6b10">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecfc6612a6ec4564bba6c3ed1e8a1395_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtOC0xLTEtMA_18a142ef-e2b7-43ce-a67d-b33d75ebfe24">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtMTAtMS0xLTA_bf6b1388-8c1a-4ca9-85f9-e64f51023a0d">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctOC0xLTEtMA_e5f43b83-5f5f-461f-8bcc-00f7fe011711">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMTAtMS0xLTA_a829d266-f68d-4edb-b96c-a01cdb380030">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtNi0xLTEtMA_885e0da2-fe73-4dfa-8714-aeb043554a3a">659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtOC0xLTEtMA_713d424c-8bbd-4d0f-bb05-ef497483a11b">659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtMTAtMS0xLTA_8559c578-67ab-4d3d-9439-cae2a357f78f">659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTktOS0xLTEtMA_0231e503-e190-4cba-9b1e-c31a3c197063">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTktMTAtMS0xLTA_d35c88e6-e8f7-48df-80d3-df99d23af901">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7beb7ff5e17d4a42968bb035cef774e6_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMS0xLTEtMA_e12862f2-e938-4d8e-959c-60c3efb6edf6">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iff2853021c8b491f9255dba3609410aa_I20190630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463603c2f27845d28c9d3b99a405ff6c_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79">45,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff2853021c8b491f9255dba3609410aa_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb">28,257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c617f7479a44823b94ae95b119c3a70_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNi0xLTEtMA_1d7ddbfd-cc6b-4f10-8a73-56f66c79d309">43,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389b0e105fc642fda8f98138b1769f1c_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNy0xLTEtMA_86c9cd90-608c-4064-aa9b-42befc75f3c0">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id14f47d35d4043e5bc16b18b14abb993_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtOC0xLTEtMA_128f146e-ead9-411f-9e55-f06decd18026">61,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2525b67907774a24a2fbd98d30d59e57_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtOS0xLTEtMA_d2061d8e-98db-47f4-9e86-4318db205b2f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMTAtMS0xLTA_77ba1225-e75f-4317-8db0-b9eb67b1fa8a">61,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtNi0xLTEtNTQ1_00648ce9-739f-441b-994a-689402a72d23">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtOC0xLTEtNTQ1_38f7cb9d-3452-4e87-86ae-e7cd9e6a061c">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedfa97c4646a4f34acb951255063b626_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtOS0xLTEtNTQ1_53962c91-8209-48d1-8086-da3000957277">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtMTAtMS0xLTU0NQ_55c2d545-eabb-41f5-9f39-e49919d2f6da">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8030574e46c54dc78075514e087d6aa8_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItNy0xLTEtNTQ1_ef33e8cd-c6f2-4b25-ad95-7eafe00649c4">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItOC0xLTEtNTQ1_f82595e8-948e-4672-80ec-7e2d6f58e02b">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItMTAtMS0xLTU0NQ_feeccd73-8845-4219-8882-3f10797377f6">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48b23f611534468684876d12f664352e_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtMS0xLTEtNTQ1_58a86183-dbed-4510-b51d-3afadad7e90a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b5cd1dd7304ec283b1ce0b506b7741_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtOC0xLTEtNTQ1_c59496b7-63d7-4e3c-b61a-c6bd0d394595">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtMTAtMS0xLTU0NQ_fa4a3fed-5e0e-4f6a-849f-183d664deffc">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtOC0xLTEtNTQ1_8ca45fb2-7b2d-4294-8539-f731731732f6">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMTAtMS0xLTU0NQ_6e3f6859-ea14-4089-90a1-39f03e1ebd66">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtNi0xLTEtNTQ1_9972b4f3-2397-4f3f-9cc1-bfb7a2c3f3d1">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtOC0xLTEtNTQ1_dbecce7a-0f40-4e3b-b73e-a06cef3c2428">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtMTAtMS0xLTU0NQ_fd10fd91-07de-4778-b775-603195256e6a">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfa97c4646a4f34acb951255063b626_D20190701-20190930" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjYtOS0xLTEtNTQ1_c032d139-8fc1-4d01-9f64-7923cca06520">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjYtMTAtMS0xLTU0NQ_7c9c7ee2-5b63-44f1-ab46-b2691b7d3ac5">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4a47d2a1fec45c3b9b7adb20e61d257_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMS0xLTEtNTQ1_4cf5966b-54a6-4605-a312-111ca4ea1c1d">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809b9db9db554177ae44049fc6336a94_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3">45,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec">28,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a6a67cb47374fb9b4cc4ed07e526591_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNi0xLTEtNTQ1_9b1bda8e-5c32-40ac-8f64-63b4f3704129">44,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a73bed99bba493485113c4e922d1192_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNy0xLTEtNTQ1_53567611-4481-4ac0-9b95-9a4ab78d3d85">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa1b8f41c19444e9be024f7f3599370d_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctOC0xLTEtNTQ1_de899f9a-11ba-4ec0-8c73-a0f3a62612ab">62,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113463dad55e48bda48e770726d59193_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctOS0xLTEtNTQ1_e2adbdf6-7af4-4a93-a96a-c196a534c48f">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMTAtMS0xLTU0NQ_0348f69a-2927-4f30-9c2e-6707b2bd0fad">62,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTMw_f61509d3-e4a3-44fb-b01a-054a0e00d368">1</ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_00cc998d-eea9-4449-912b-f720bcb7a07a"><ix:nonFraction unitRef="usd" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_42905d89-3d6d-4102-9de1-bba698a43d90"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_47a34913-9400-401a-8d41-8dfea913f5f0"><ix:nonFraction unitRef="usd" contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_83d78f80-c81d-4288-b2a0-42ac3a0b154f">29</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018. </ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_57e87b25-b5cc-463e-86a5-3a822fd25bec"><ix:nonFraction unitRef="usd" contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_936a7c25-e468-4bce-b3bd-e540593bbf28"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_9a785e57-45a8-47dc-b71b-6f39d942dafb"><ix:nonFraction unitRef="usd" contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_f2009d9c-a27b-4f00-8d86-519ea060e5e1">17</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018.</ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 842), which resulted in an increase to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="id1aa9ee857c04106b4ddeb51bba6580f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf">178</ix:nonFraction> million during the three months ended March 31, 2019.</span></ix:footnote></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_43"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njg_7951009d-cbd5-4d9e-9115-14a83d50c10b" continuedAt="id4473c14cbaa44c08c0e17a784230178" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id4473c14cbaa44c08c0e17a784230178" continuedAt="i83bae2aa72924630b3952986d8ad9914"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="building" contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTgx_0718fe02-000d-4f7b-8dcb-1881fb677d5f">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjE2_208cdcd9-828e-452a-97f4-01433c3603e3">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with approximately <ix:nonFraction unitRef="person" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberofPharmacyPlanMembers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjk5_cc376421-36af-4f04-8f8d-68379baaebd8">103</ix:nonFraction> million plan members, a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt-sec:numwordsen" name="cvs:NumberofPatientsServedperYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzc2_308a593e-d56f-49de-9af6-e17fb3beabef">one million</ix:nonFraction> patients per year and expanding specialty pharmacy services. The Company also serves an estimated <ix:nonFraction unitRef="person" contextRef="i0f1e2d2eb6e14cfc96ce16ba745cd95d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfNDc3_cec299a4-b23c-4994-9f7c-9310547430b8">33</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the three and nine months ended September 30, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzk_b25aceb3-967b-4b8e-93d4-4f67695940ea" continuedAt="i4c18446ba5f3446b824a78633c5766e3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMyNQ_f6f19f29-ee8e-4410-b743-118a7448fb19">four</ix:nonFraction> reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than <ix:nonFraction unitRef="building" contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzAxNw_0718fe02-000d-4f7b-8dcb-1881fb677d5f">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzA1Mg_208cdcd9-828e-452a-97f4-01433c3603e3">1,100</ix:nonFraction> MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i83bae2aa72924630b3952986d8ad9914" continuedAt="ib496a0cd4e3c4eafa467e616b4788d27"><ix:continuation id="i4c18446ba5f3446b824a78633c5766e3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NjY_df16075b-f436-47a4-b956-336da2536eab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 (the &#8220;2019 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njc_1a8ac574-163c-4ec0-a255-f216f7d9b220" escape="true"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njc_a29e659c-07f5-4714-afae-e97e567a2478" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMjQ_0fefcae1-57f8-45f5-bcab-a172cfe94a03" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njk_f6cae31f-8460-4dfc-b6af-94a2ee76e1a7" continuedAt="i0f3708996b474ee392daff5941ca5af7" escape="true">Restricted Cash</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0f3708996b474ee392daff5941ca5af7">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib496a0cd4e3c4eafa467e616b4788d27" continuedAt="iebcbb44345aa4a08b5df891fd88f0d81"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNjI_b25f112d-acb4-4e6d-a70e-e7a31e7cc714" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMS0xLTEtMS0w_c2b03227-5572-4dbb-b56c-83e8bead8acb">9,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMS0zLTEtMS0w_26abf10c-55bb-4ffd-b719-49bd753c9c7b">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMi0xLTEtMS0w_f626d79b-3232-4f85-b9da-973843cb7eef">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMi0zLTEtMS0w_a732d875-dd3b-4792-a146-e03034aa5a5e">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMy0xLTEtMS0w_7808754c-05c6-453b-847d-da281776ab34">9,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMy0zLTEtMS0w_889e812b-d1c7-4012-8564-ffe8cbf62203">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzA_ff0f576a-95ce-4a26-bd83-f8ec4d119859" continuedAt="ib339987f083940a5a9be0b0215288b02" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib339987f083940a5a9be0b0215288b02">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</ix:continuation>. <ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMjU_3e0d6ada-38b8-452c-b07d-074b994ab95f" continuedAt="i3aca549ab087429095ce96a3118d28a1" escape="true">Accounts receivable, net is composed of the following:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i3aca549ab087429095ce96a3118d28a1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMS0xLTEtMS0w_f7e854b8-e46f-4f73-90e1-cbf1ad629f5d">7,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMS0zLTEtMS0w_cee39850-c35b-4505-87b5-8f03e6254424">6,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMi0xLTEtMS0w_20b7d012-f6c1-4353-b08b-217d9cd5f67d">10,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMi0zLTEtMS0w_8b5a8966-3bd4-4615-b1d2-8cc1dffd4f57">7,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMy0xLTEtMS0w_75487e4a-76b3-4b32-8d3b-6472df0e686d">2,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMy0zLTEtMS0w_63fc1c4f-8308-480f-a160-e21767c167dc">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNC0xLTEtMS0w_c3a2f3d3-823c-4c28-8c14-65e2f7bc54b6">3,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNC0zLTEtMS0w_0dfe7f3f-d0fd-4ed0-8d9d-5d3afc433975">2,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNS0xLTEtMS0w_0c8e78b0-fb0f-4a1d-8144-1462c0e5760f">23,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNS0zLTEtMS0w_b97b8e46-ad00-40da-bcf9-974952402859">19,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNTc_bea399b3-2d80-4e8d-9158-e20a38d2d655" escape="true">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfODg0Mg_f068c62d-fbc5-42f8-8463-453e3f2a06b1">363</ix:nonFraction> million as of September&#160;30, 2020. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#8217;s allowance for doubtful accounts was $<ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfOTM1MA_f3a590cc-554e-4744-b017-f63a66383abe">319</ix:nonFraction> million as of December 31, 2019.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iebcbb44345aa4a08b5df891fd88f0d81" continuedAt="i4b98c0d4b4f34951a751e78e86c75cf2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzY_77443db6-32fc-44b2-a24e-8a5e1e09ede2" continuedAt="i90f466da74874bfd8119f7e206483ee5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c2fe38b9e4eb8b33cbc4e89326d14_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0xLTEtMS0w_c78619d5-6300-4928-9312-4030faa2c7f9">35,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68abf3331714f0cb8a2e46831fee06c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0zLTEtMS0w_d8ce6190-61b7-471b-99be-a7e3a09871a4">17,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6f85725267e4b2da9c4bd28ed0c0d5d_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy01LTEtMS0w_8ceedf5f-7972-4933-adc5-a93aa9592364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fcf3cc86944847b4a31907d7b35e8f_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy03LTEtMS0w_caa5134b-2771-43ca-b8c2-5faa7e577b39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd74224b2d0e435b95718f3c4dca914f_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy05LTEtMS0w_d1bab68e-0b98-4dab-9baf-da97ddf762c5">10,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98dc5453e7af45f08155c02c68159539_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0xMS0xLTEtMA_c48a7974-7778-4aa1-ad6f-c50d489eb2c9">43,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af031c4a92b4ad09fedaada5da439a2_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0xLTEtMS0w_b56dbc6c-d182-4473-8f40-7e2690067ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06443f5cef314ba49659eb8a8ac32230_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0zLTEtMS0w_73e48955-44f0-4849-bb91-0b4a49ba9d0d">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681ef3f1a45145e38eba1e776de4f06a_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC01LTEtMS0w_758a3447-22dd-4798-a6fa-367fc1b6f47d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica0c012858fe46d3aaab3baf1065534f_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC03LTEtMS0w_21e45598-55ba-423b-90d4-fdc22025cddd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2f456b2af8343678bde493f23d04c00_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC05LTEtMS0w_1cee113e-5076-4be3-965f-ee6a1a88a6a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ae828c5b2cf449c9ac7a99073a1bd39_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0xMS0xLTEtMA_4916d3a1-d416-4fb3-857c-9f429249713f">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa1ea471448ce90b4228202b8064a_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0xLTEtMS0w_a6229f1f-126b-449c-a18b-46f03dc6848e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152019c18b244202a6b98ccc912ef82b_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0zLTEtMS0w_d24ecc5a-672a-4a91-82ff-52fe66b359a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdea441b1eab46d9958833bd142b99ce_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS01LTEtMS0w_9a7aa2bc-b819-4d52-bd56-acfdb23d96a1">17,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba29cf25cfe44f295754a8809ab4023_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS03LTEtMS0w_ac547e75-f96a-4405-8b04-f26372a1d954">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c12bcab38f4db5a180e1dac74519b5_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS05LTEtMS0w_f7344e7d-5d70-40fe-a802-7bfcbe2ed545">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5785795924964ac09b3c91188817854c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0xMS0xLTEtMA_e80ccd5b-121e-4ded-9f55-2a026f235732">17,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0xLTEtMS0w_fcee38e0-6ebd-4ac3-9832-e3a35784dc88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0zLTEtMS0w_21f3f2ca-5e25-4f18-9143-82734a502593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi01LTEtMS0w_6ae7fa67-a1b0-4332-96d4-bbb366b665e1">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi03LTEtMS0w_7a0a9eba-5a34-48b0-aab9-fbd28fcb8e54">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi05LTEtMS0w_ba8323ab-f2bb-4545-851f-04430afa57b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0xMS0xLTEtMA_8985122c-4c3d-453a-896c-dd4b4514cb6d">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40fb27941a97406982ff1445053b5d0c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0xLTEtMS0w_0afb284a-c466-4a01-8ad9-a01e25a8f0f6">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3729dd099643528282f816f5be4d23_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0zLTEtMS0w_c940f142-faf1-4253-ad65-eb73ff174c75">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316742918ca24a9880fcfd2fb281fdc1_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy01LTEtMS0w_c4f9a73c-5c07-4fe0-a26d-019fb4bfb1c7">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e48083166d94041bb1bde8d8d498c7a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy03LTEtMS0w_c9c31bfe-67d2-4ab4-bd51-8d746fa58919">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cfa15ecb949457f94a09cad78662bec_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy05LTEtMS0w_f354639f-dad7-476d-8165-63182a63a9f8">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435b0304464f47fe8980149c5a3e3bb2_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0xMS0xLTEtMA_708ee400-1376-419c-b3da-d345aa440557">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0xLTEtMS0w_13321d59-967c-4143-8e6d-d08ab7a75762">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0zLTEtMS0w_dbd70e17-976b-44b7-974a-10200144b0a4">22,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC01LTEtMS0w_1c610931-656c-47cd-8e16-18bd2dccde4f">18,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC03LTEtMS0w_1230cca0-98cb-4623-8859-70089d5237dd">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC05LTEtMS0w_2aa9b29f-13d6-418f-9b88-aefa1e57d4b2">10,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0xMS0xLTEtMA_dac5424d-a261-494c-9220-2b500afec7bd">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b91e17e6a24590b4303687758fe4b9_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTEtMS0xLTEtMA_a4bcf958-3ea8-4c59-80e5-f8e40644a8ec">21,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2467201147a4f38bd1790ba260c4d27_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTItMS0xLTEtMA_e53f8ac7-f456-45a2-858d-09688071e079">14,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0347d869b3534eed97cc367c2b34c716_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTMtMS0xLTEtMA_5bca5515-5416-4171-9ce5-03b11c83faa4">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTQtMS0xLTEtMA_8f694000-ca08-43f1-97b2-c2b0c7805bf7">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432f620c091b4bd78b8965de6106dafc_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMS0xLTEtMA_3d4e2a24-d646-44ac-946d-ebba322af359">35,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d19937733dc48c19bbe4192a695643f_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMy0xLTEtMA_97f17b03-06e7-4612-9c10-f3a96cd58076">16,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2cd40721bbb44c7a65f88f72c256ff2_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtNS0xLTEtMA_20d884b0-af86-4382-bf90-844eab81822d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeda413cd32f4c61bb785163c7baf76d_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtNy0xLTEtMA_1222d257-d41e-4aec-997b-769f9b16ed15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47ac41f57acb41e09f8949a2f24746c4_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtOS0xLTEtMA_3096c796-2bd3-49ce-b342-fd0a1a4c699e">9,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838b21cb58bd4282b74606c9a0a75ca6_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMTEtMS0xLTA_cd3617fd-2075-42a9-9991-5257a28aedd5">42,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715ce306fefc4081b49c626cdda6c223_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMS0xLTEtMA_79a84557-e310-4d4f-87e3-a1de240a498f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411aec8a49dd43e89d1ec6ac18e88d30_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMy0xLTEtMA_edd200b5-6a01-4dc6-b51c-85df1f0e421b">4,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i449b3a0364494dc2958f100fb42e4bcd_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktNS0xLTEtMA_c6a07b31-a662-4122-93b4-8ad5dda277a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bec87bd7c13489ba49dd87596bd5303_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktNy0xLTEtMA_1eaee736-9e3a-4c34-9a21-16bd60d42b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660decdad883483cafae88aabfe86ae0_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktOS0xLTEtMA_a75730a8-d872-4df6-a09e-c50b451c33d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae42a1df12e4c469ad1f6c21e69a11d_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMTEtMS0xLTA_8cccb85a-502f-4292-a1b7-4ed06d06a95e">4,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2d37b8ab1f48a890ac86f4563c36d3_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMS0xLTEtMA_3b8f50c0-52cf-4567-95af-72111b08a768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ff9ed846af4552a659faf486506f87_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMy0xLTEtMA_99e8b98a-0be5-4b83-be5d-e44eca311a1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77e3a2bcfa204f0fbf7d7eebd45dafcd_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtNS0xLTEtMA_b793f836-7022-4ce0-ad31-ccc0ea3ce9f5">15,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e3a4c36dd343c2ba601ebcd3081b81_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtNy0xLTEtMA_c1a1af85-dc69-4ab5-91f2-07894d5d5c98">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9b827c136747b2a88c80753d888899_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtOS0xLTEtMA_fd2f3584-e8f5-4005-ae8c-06a8b13e70d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaa97cbcb3614677b33155fc7cf8cfaa_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMTEtMS0xLTA_76875f48-5e35-4b8c-85a0-d0c68ab5f9f9">15,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMS0xLTEtMA_11b867ac-f894-48c6-8c66-745939dfb89a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMy0xLTEtMA_e8bc5ce8-8f46-43fe-be25-7d64befc65a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtNS0xLTEtMA_fe1b2512-20b5-4124-bda1-f378a5cfd749">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtNy0xLTEtMA_492af779-ee9a-426e-b208-ff0effecb122">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtOS0xLTEtMA_6d7972ef-d982-4495-b7c8-d1f905237b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMTEtMS0xLTA_2b25f8e4-9f85-43ae-bb55-2782dd4046b7">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb782656964430b9ec2cab98566a145_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMS0xLTEtMA_afb2efcc-1c08-44d6-9d6b-0ffb28122e69">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e1d6d67a0041b280b5effb5c549db0_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMy0xLTEtMA_eefc493f-0fc2-4281-9868-cdddc12ad344">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533429b9306d4879913c046da9f37100_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItNS0xLTEtMA_e4ca0cdf-3e08-4dc8-8313-b77835026d61">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i239d475ffe78452ea7477598c48a053e_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItNy0xLTEtMA_0823ae02-d8fb-4e69-bee0-710e6dae0dcc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f98e97d40c5423b825abdc89e4ccb51_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItOS0xLTEtMA_1cb51b48-8cd1-4a81-961b-a6e990d50c41">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5e2b880bdb4f68b5c1392e7e118d42_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMTEtMS0xLTA_ee5ce337-cb6c-4ec9-9e49-99f9c6aaed6f">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMS0xLTEtMA_76896e40-b890-4ee4-8113-21cc24c55fb0">36,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMy0xLTEtMA_af6cc23c-5a2a-4ecb-a56d-ec771c5be17b">21,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtNS0xLTEtMA_f10c9e09-ac5a-4966-a628-206149a311cd">17,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtNy0xLTEtMA_76fe3ccf-ce07-4efa-91d2-7db6766b3476">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtOS0xLTEtMA_b640e26d-b6d3-4eb4-9eb1-690bd55f9c23">10,007</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMTEtMS0xLTA_089c5cc9-4b53-4f61-b62e-643656b821fb">64,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e3e29c4fa547aa815092b174966dd8_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjYtMS0xLTEtMA_289767d3-27b0-4ba5-ba8b-6a52c7703c17">22,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4c02ab9b2540858add46268ffa4322_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjctMS0xLTEtMA_215ddacb-99c7-4fd4-bb60-2497d16b79db">13,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab42df5d6404b6aac64b89dd954f364_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjgtMS0xLTEtMA_0f812cba-7fb1-45b5-9989-ab2cb4cccced">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjktMS0xLTEtMA_5220d8cf-8b21-40b3-8cce-beba5ddb0c35">36,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4b98c0d4b4f34951a751e78e86c75cf2" continuedAt="i31bfd340d0244016a49a0da26655e653"><ix:continuation id="i90f466da74874bfd8119f7e206483ee5"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b94001396f40909619fbef9b1c041f_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0xLTEtMS0w_ee57d427-75f3-4ba6-a37c-e3bf62162f19">104,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1a6a30d65c40cd90c753b012d08b88_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0zLTEtMS0w_95d7f10d-37ad-423a-972a-085827cc1576">51,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12ff9d95029482297d72d6a5dac7ac5_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy01LTEtMS0w_d1fa2c41-7770-4a97-9867-933366f95bf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93eb393efd5947c6bd3a1fa1231f671d_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy03LTEtMS0w_5a1c966c-6fad-4451-9d5a-d98807257b2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i087ffe62239e4208bc8c4970e058712b_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy05LTEtMS0w_d6986afa-45be-4428-8f94-5c894979af15">30,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib473644cf5364dc5b2441b72f3e53b43_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0xMS0xLTEtMA_2514f8cd-09c5-43cc-866d-f1585336b7eb">126,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64a1c66ce18d42d0877b39057bc2673e_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0xLTEtMS0w_a3dffcda-0ef7-4e2b-96e7-b095fb32a112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0d8f9bf90e4c8699e03540f1dd8563_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0zLTEtMS0w_b2bdbb45-5d9e-4160-b3b5-54b7a03e3873">14,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47677f4138234c60890d66d2bf6418c3_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC01LTEtMS0w_08eacb85-f2c4-4ae5-a04a-fb20eef53bde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bef237b09b44c78b77e40b1baf100d9_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC03LTEtMS0w_11f2deb0-4aaf-4827-82cb-631c3e381c3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6fe708235e4a8b85cd7b931c2f83e4_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC05LTEtMS0w_3108ba0a-44ff-4499-a7b8-f16e3ae588e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94671fdaa22443daacafbd02d1f71e93_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0xMS0xLTEtMA_119a83b7-14bd-456a-88f2-93790d314d62">14,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb21a4e70f24d6fabbb04939d9545c2_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0xLTEtMS0w_5f6d98b4-d836-479e-beed-8b4156663bc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1d663af0b8401a87dc8961f33034af_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0zLTEtMS0w_cbeedb3a-85ef-4e30-8dcf-f0463548030f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7ca939d3fb408f88e8741191e0ec27_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS01LTEtMS0w_6f2febe7-d081-4a30-8bfe-21f3b13c5595">51,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142289bb8d554d3dba89eaf41db49f77_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS03LTEtMS0w_103ef18f-09e4-4037-8bc3-3c401d4195c7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aada21c113948f5a84bb2a89d8c538e_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS05LTEtMS0w_a6863371-09ca-4302-b8eb-f52a8a42376c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b0b26bd74b14fe0af4dc258245d4a4c_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0xMS0xLTEtMA_f69949bd-e53d-4d5b-9662-36fe45dff10c">51,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0xLTEtMS0w_f943de20-a510-46e8-a3e0-fad4c9f7a36f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0zLTEtMS0w_82c2a638-6f6f-48f0-bd0a-45016fad29e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi01LTEtMS0w_2f67a743-4b17-47a9-b6f7-c3c1fce95e58">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi03LTEtMS0w_3dcc9a8d-441b-4fc0-8fd9-446423e5cae6">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi05LTEtMS0w_7a21d60e-5c21-496e-9b6e-1d462668c084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0xMS0xLTEtMA_b7350639-9e09-4e57-a09b-75ad410054a9">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9f76f4e106478f9f7987221d24fea6_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0xLTEtMS0w_73b22362-e1df-4641-a1ed-5fa951353da7">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146fec50f41a4066b18078ed43353a6a_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0zLTEtMS0w_c2c27eef-b175-445d-a7d2-f10e614ffd2f">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3438bddea238412d98d4e213a4e7b658_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy01LTEtMS0w_1554583e-c60b-4c51-bc3e-082128d9110f">4,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150c031257f14e08a64ab6d6a0e1c8b7_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy03LTEtMS0w_e4d6ec15-10bd-4fd7-ade7-78213300c900">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f8342dcb699462da75f023641350930_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy05LTEtMS0w_a9f28056-5002-4523-925a-3bac06b33056">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i607580aaee174297b74cd851382e412e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0xMS0xLTEtMA_55138e6a-ed8e-47ef-a6cd-e35b372012e0">5,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0xLTEtMS0w_e0a53b68-f2eb-4b2d-bbe4-c9b6ea9f0485">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0zLTEtMS0w_53195ba6-e7b3-4400-a3f0-7f2a2fc711bc">67,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC01LTEtMS0w_3db36c18-e645-4caa-8779-48202177c242">56,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC03LTEtMS0w_79327dcb-09f3-44a1-959f-f7da27370de6">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC05LTEtMS0w_28bf4789-a330-476b-961a-443770cac5e1">30,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0xMS0xLTEtMA_9357d7d5-6c6e-4521-9c47-3facdd31b971">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8776f7019c0d4b02bb20bab4edd1ed55_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTEtMS0xLTEtMA_65c2c74c-d518-42f3-ae50-5807e55a4acf">63,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4d5a1e39de4128aa906bd1685a2ae3_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTItMS0xLTEtMA_fe0d8c3b-d1c2-4297-9afb-c85562e65a1c">41,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe61efd7ac648258b3bf73ea2907f45_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTMtMS0xLTEtMA_27ecc178-46fa-43fa-84d7-43597aab2ef9">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTQtMS0xLTEtMA_00914a20-a819-4b26-9901-d0395bf0f990">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320c9806d95e4a99a10d60ce8e71c1c9_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMS0xLTEtMA_3fbd8d99-afd4-4879-a8e0-abb93037fa07">103,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9967f494d4c041b0b67ba0b3f772077b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMy0xLTEtMA_221abfdb-0637-4498-8b5e-284d56fd64fd">49,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66f838618c784289b3828bffba708455_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtNS0xLTEtMA_4e0c1531-09df-4385-bf07-8ed2753adcb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386fd0e763c84defbd4f0294954a23ea_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtNy0xLTEtMA_b412e0ee-c521-4b7b-b7d2-4d01f2e26141">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c443934e4dc4f1e965f9c54fcfc217b_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtOS0xLTEtMA_3da815bc-7348-4b29-9acf-57b8101773ea">31,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f042616910a49ada119e413e89e0e93_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMTEtMS0xLTA_6e65b242-0471-4e9e-bc81-206cf99e09c3">121,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64110bc1e619481eb011726e790e889c_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMS0xLTEtMA_bcb63d99-7d1d-47ab-b0fb-4ca0a2971b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea9166ed44a45cd9916cb9d1531b2b2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMy0xLTEtMA_fbcfff77-b377-4f78-b4a5-b95311b7b475">14,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica91574825624707af2b7d055d492214_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktNS0xLTEtMA_34a97f9c-133b-4adf-8be7-b497caf76c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34993c6bdba44671ad08a231acdcfe11_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktNy0xLTEtMA_80a8e695-08be-4cc3-a316-1c4990603342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244b1545347c4b0fba00cd7e0537b12c_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktOS0xLTEtMA_a86bb973-d787-4c78-80e4-cb4093adcaba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eece7da79844b81a88e0f6c39018f57_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMTEtMS0xLTA_2aea3902-8700-4852-8f40-6809322e7b88">14,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25083b6bc234531b154c27aa6adaa6d_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMS0xLTEtMA_4d636c60-3c45-4ba1-9d22-47389d1342c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67f1e55874b4139aedf9e515c8e7960_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMy0xLTEtMA_71eabe6a-5892-4327-bec0-119cd56d3e50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia569eb9b80b044f3b51c6f4972c0f31e_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtNS0xLTEtMA_85696d83-4b08-4044-9767-f5db7c1de180">47,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3403a6bf73644e22b0ddb226f5361865_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtNy0xLTEtMA_cf18e4ca-ec57-4b19-a95e-8e07b554512d">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77d598c37e24619b64ce36f408cea80_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtOS0xLTEtMA_9d7a6175-786a-4c2a-82bd-309ddfed4fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3cd5501d3844e8a92c6e7b9f858352_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMTEtMS0xLTA_dde8f337-1641-4dbb-9643-4344fe9b7264">47,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMS0xLTEtMA_489744cb-ecb1-4649-b033-d2f13e4155fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMy0xLTEtMA_ec2b5070-d4a0-426f-9d61-27c5b541ceb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtNS0xLTEtMA_f3bd9b40-b4ed-4d4b-9b09-76f0a7e6a999">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtNy0xLTEtMA_444e237f-38bb-459d-947f-e52da4f5e65e">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtOS0xLTEtMA_da051905-6790-4a91-b1a9-e225da91f1ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMTEtMS0xLTA_9f439ca9-c225-4708-b253-6f0179ebe75e">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9660fb77d4984d64ac93c4db44804b30_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMS0xLTEtMA_df542f86-8cd7-4e7c-8904-c89eb06d6314">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a9d2c4000f4239977b19d16ba37d4c_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMy0xLTEtMA_1cf2bd33-c0ee-40b1-8b9c-240b6ab7c91b">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd799ddeb88438e89d5c5d78dceda1b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItNS0xLTEtMA_c94c04e7-5e93-4459-a5d6-59a137333423">4,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521b36cc1f1249c78083a5dd3ae92540_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItNy0xLTEtMA_10d90254-3f01-42de-8938-f6b9f768655e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i237b71611de94c4aa41507133bd24f34_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItOS0xLTEtMA_26790e86-34c9-458f-bebf-06a128294e28">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cbec7d8ab8e4c3cb30b140669a8cdf9_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMTEtMS0xLTA_16d5112a-1761-4d6a-aa00-94b3522547b0">5,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMS0xLTEtMA_b1ca7332-934e-4b0f-802b-c70a36636543">104,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMy0xLTEtMA_6c1a499c-8fde-447f-a696-31fd55b4ef42">64,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtNS0xLTEtMA_23c8b838-cf9d-4c24-b577-64997b209abf">52,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtNy0xLTEtMA_d339927e-4fa0-47b1-833e-06484aa329be">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtOS0xLTEtMA_f5b8388d-7c9f-4843-b508-20262b5a4a9e">31,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMTEtMS0xLTA_b487745c-203e-4bca-adee-7ed54c2fcf67">189,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0add470a8c5f49b899b9f413ff91d02b_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjYtMS0xLTEtMA_bfd507ea-f7f3-40af-8bec-6ad922ffea6b">65,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46597caa3b364945b2d7360795884f6f_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjctMS0xLTEtMA_37914af6-43ae-4f85-a3bd-b011a3c72db0">38,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef78d632fbb4792bd265cce79e92c17_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjgtMS0xLTEtMA_67b815c0-2200-4227-905b-b72b57b9eabb">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjktMS0xLTEtMA_c285a5ca-b6b5-469d-bcc7-57d8b045b693">104,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNDg_9e9bdf02-4502-423d-b74d-f1c6516b9d7b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzI_3aa5a710-0cfd-44b6-9f58-2de802040e65" continuedAt="i67c5a6e7b2f742c092d2f7904eacc06c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMS0xLTEtMS0w_f7e854b8-e46f-4f73-90e1-cbf1ad629f5d">7,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMS0zLTEtMS0w_df4301eb-4142-4aef-bf54-5103a481b5dc">6,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMi0xLTEtMS0w_2e4ebdd7-9d70-4081-ac57-bd823bdd218a">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMi0zLTEtMS0w_9604c0a7-e503-4221-89b1-d8e68edddc86">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i31bfd340d0244016a49a0da26655e653" continuedAt="i74dba26cf870459988b955858565af95"><ix:continuation id="i67c5a6e7b2f742c092d2f7904eacc06c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMi0xLTEtMS0w_9604c0a7-e503-4221-89b1-d8e68edddc86">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1760dd0c327472392df2791068fb782_I20181231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMi0zLTEtMS0w_22ebcade-15cb-4b72-b6ee-788d49284b1a">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMy0xLTEtMS0w_1c9516f5-4e3c-4941-bfae-53097dbbe7d2">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMy0zLTEtMS0w_45d1a240-9168-4d35-b63b-348ea84cf99c">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNC0xLTEtMS0w_2a971420-a4ed-4294-89ab-d9a459b3ea98">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNC0zLTEtMS0w_91dc4c3a-0c8a-41e9-8aba-02fd89e283ba">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNS0xLTEtMS0w_2e4ebdd7-9d70-4081-ac57-bd823bdd218a">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNS0zLTEtMS0w_2def2ae0-8ee3-4312-80e7-63002a7cf7b0">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzE_0ed22279-fe62-4514-ad08-0c1e9b94ed71" continuedAt="i3eb3ddbbed384882b6f69969de7dade6" escape="true">Health Insurer Fee</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3eb3ddbbed384882b6f69969de7dade6">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes. There was no expense related to the HIF in the three and nine months ended September 30, 2019, since there was a one-year suspension of the HIF for 2019. In the three and nine months ended September&#160;30, 2020, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTE5NjE_a8dcb410-a5b6-49f4-92d1-f1efcac39b1a">255</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTE5Njg_15cee080-4644-47ad-b1e0-42733586ec35">774</ix:nonFraction> million, respectively, related to the Company&#8217;s share of the 2020 HIF. The Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="cvs:NonTaxDeductibleHealthInsuranceFee" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjc0ODc3OTA5MzQ5Mw_a2110dbc-ab8c-43e2-826f-0de8c59434ce">1.0</ix:nonFraction> billion, representing the Company&#8217;s portion of the non tax-deductible HIF in 2020. In December 2019, the HIF was repealed for calendar years after 2020.</ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzI_387aefe8-92cd-48fc-8e4a-476ad37142ae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI0Njk_8085e3d8-1bb4-47c0-a78a-1cba6443b141">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI0NzY_05b3e570-2d2c-4fdb-9742-a2c5852f95ab">14</ix:nonFraction> million in the three months ended September&#160;30, 2020 and 2019, respectively, and expensed fees for the use of this network of approximately $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI1OTM_730a858d-54ff-4cf6-8d84-57a9634761d3">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI2MDA_702f7ff4-b0eb-4dfd-a3af-39e33dd68b70">26</ix:nonFraction> million in the nine months ended September&#160;30, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="ieacdea7e3b834282abaee6b57e493b85_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5MDY_c389ce27-9c22-4169-b486-1477d73ab95a">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5NDQ_8070ab6f-37b1-4779-8d45-dc158630048b">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5NTE_dcafe791-6510-487f-af98-988e8a48b238">20</ix:nonFraction> million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2020 and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMwNTI_6d5997dc-7c17-428d-a7e6-bf0c9802ad3d">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMwNTk_e060a93a-6e2b-4200-9950-f1e8ba461e9a">72</ix:nonFraction> million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzM_569e974b-cd96-41c7-b405-e80287392e3c" continuedAt="ic1651131231b4b1cad1b4a382366c0ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $<ix:nonFraction unitRef="usd" contextRef="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTQxODY_3f8e2ec0-4eb9-45f4-b802-36fe08de89e6">3</ix:nonFraction> million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i74dba26cf870459988b955858565af95" continuedAt="i54eeaf5d792b42a8903f5dbc7eb7f140"><ix:continuation id="ic1651131231b4b1cad1b4a382366c0ac" continuedAt="iefa7b608f0354ebc904b79cf3670ba72"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Accounts Receivable&#8221; above for a discussion of the Company&#8217;s expected credit loss impairment policy for its accounts receivable. The following is a discussion of the Company&#8217;s available-for-sale debt security impairment policy and expected credit loss impairment policy for mortgage loans under the new credit loss impairment standard:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of United States Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next 12 months, in which case it is classified as current within the unaudited condensed consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the unaudited condensed consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i54eeaf5d792b42a8903f5dbc7eb7f140"><ix:continuation id="iefa7b608f0354ebc904b79cf3670ba72"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_91"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzgw_db67b980-efb0-4154-8145-77d2d98e6b53" continuedAt="ib9da584a9d204e578d221349b3f2378f" escape="true">Divestitures</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib9da584a9d204e578d221349b3f2378f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for $<ix:nonFraction unitRef="usd" contextRef="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMTE4_24ed2982-37fe-4bc7-bb77-48388e775fec">850</ix:nonFraction> million, subject to a working capital adjustment. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i06b05ec92127409d8b14837cfb2ca48f_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzQ4_71e8ab6b-1ef8-4c1d-8875-b97dff1f22dd"><ix:nonFraction unitRef="usd" contextRef="i4a486a6add824c1a92ba6c55d3d50c15_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzQ4_e6e8f123-903e-4367-b00c-e70184c15a7a">271</ix:nonFraction></ix:nonFraction> million in the three and nine months ended September&#160;30, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statement of operations within the Health Care Benefits segment.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Brazilian Subsidiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) for an immaterial amount. Onofre operates <ix:nonFraction unitRef="store" contextRef="i0bf70ec2a8ba4060b9ae0ba5571df5d7_I20190701" decimals="INF" name="cvs:DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfODI0NjMzNzIxMTM5Mg_d081c9ce-486d-4c72-bd40-938172eb4b0e">50</ix:nonFraction> retail pharmacy stores, the results of which have historically been reported within the Retail/LTC segment. The Company recorded a loss on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i8cc9af3b8a554fbf97555c8eb6980261_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfODI0NjMzNzIxMTM3OA_49e76c16-c0ac-4dab-b882-77c27a2c88ee">205</ix:nonFraction>&#160;million in the three months ended September 30, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s unaudited condensed consolidated statements of operations within the Retail/LTC segment.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU1MA_413b4ee5-c000-43da-93f9-413aa84d2d68" continuedAt="ic5834f746b39443c879591a7cc87423d" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic5834f746b39443c879591a7cc87423d" continuedAt="iefb29392dd8546fd8a8fabcbf5a1869c"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUwNQ_b223dee3-1927-465d-86a3-2377f21bc842" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0xLTEtMS0w_cd93ac7e-d33f-415f-9ea8-65813c495f8d">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0zLTEtMS0w_67549d10-31f5-417d-8481-8d6af5932913">17,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi01LTEtMS0w_fee62436-d1c5-4984-bdf3-6962afa65d04">20,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi03LTEtMS0w_c9cbf007-8442-4ba7-a1b8-373547924a8a">2,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi05LTEtMS0w_4dfcec4b-eba5-4049-a669-b21c827b6840">14,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0xMS0xLTEtMA_17eb29fa-1a6f-4da6-8d14-d46d4c377eeb">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0xLTEtMS0w_3e29dcd0-9082-401e-b027-a27660054c92">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0zLTEtMS0w_cd04fccf-3d0b-4f2d-9ea5-18561d30f420">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy01LTEtMS0w_298f2f00-4fe2-4c8f-ab46-87c51feb3c50">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy03LTEtMS0w_a731c2d7-53c1-44f2-840a-e9b7d71a674c">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy05LTEtMS0w_376121c6-cafe-4087-adaf-beae95b73fac">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0xMS0xLTEtMA_a282000b-30df-4413-a5bd-661b2d194c55">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0xLTEtMS0w_2f5a3705-4671-4264-a386-ad989d89a15c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0zLTEtMS0w_5e11a0a8-4e5d-4654-94a2-2d3c5be2f806">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC01LTEtMS0w_941611c5-22f1-487e-a7be-508d2908b737">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120ad616a34646769659abc5ca27affc_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC03LTEtMS0w_58ac2183-0578-4571-8a2c-057095194c39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120ad616a34646769659abc5ca27affc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC05LTEtMS0w_e17ec6ab-fe7d-494e-a310-21c23a846dbf">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120ad616a34646769659abc5ca27affc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0xMS0xLTEtMA_12a8d32b-ce41-4c71-a1d0-b09d325ae30d">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0xLTEtMS0w_583dc710-fd49-4765-b516-fea551dcc09d">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0zLTEtMS0w_a1f4c050-1aed-4c21-8d12-8907f4d92d7e">20,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS01LTEtMS0w_2ee4ba3c-a406-429c-b0fb-97d904eef3ce">23,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS03LTEtMS0w_1e077436-2d32-4b3e-8574-9ddafea74c0d">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS05LTEtMS0w_d87dae31-5ef4-44bb-a3d4-1fda1634abd7">17,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0xMS0xLTEtMA_3e6db5a3-aa0b-4a64-8960-6a1c75b271fd">19,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU1MQ_8c70984b-c9df-49fc-a975-ffcb9965fff0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.222%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for Credit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0xLTEtMS0w_923b6d7e-d2ba-4ee5-9fe8-798b11f6675d">2,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0zLTEtMS0w_97be8f6e-a83d-4006-94a4-eda69cc9984a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy01LTEtMS0w_38e5db15-c583-4e1b-93f5-c18dd482140f">2,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy03LTEtMS0w_02f72e6a-8bfe-407e-aa7a-45c9708c1d7d">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy05LTEtMS0w_bd23857c-a0b8-4d56-a74f-0dcde772bc36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0xMS0xLTEtMA_6c0090d2-ec38-493b-a4c1-0100b54a7b54">2,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0xLTEtMS0w_1128db45-78b6-48be-927b-5023053549ad">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0zLTEtMS0w_7348634d-da7c-421c-880c-5bc982784f87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC01LTEtMS0w_b72b3443-a4e3-4bb4-bb6e-863e39979c98">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC03LTEtMS0w_95c22409-1547-4a8a-b9fa-b4706cfec190">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC05LTEtMS0w_66ba4d4d-5af1-4e1d-8a44-e8ab306a3785">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0xMS0xLTEtMA_7d345453-2ef0-4f81-8efb-c4019af531c4">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0xLTEtMS0w_3b05fe86-9b45-4460-992b-784fed97a1c1">7,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0zLTEtMS0w_8feb5894-acac-456e-82f9-685988fd3cb8">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS01LTEtMS0w_319ef358-1218-41eb-b825-38ca0deda7e7">7,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS03LTEtMS0w_1d4964b0-4504-4607-81fd-9131867ba676">878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS05LTEtMS0w_cedf16cc-87bb-4e54-a031-252733627b6f">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0xMS0xLTEtMA_1a688190-c83b-4c4f-b251-66bc3ed58562">8,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0xLTEtMS0w_2c0917ed-2594-41be-83e4-a1b090d43d37">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0zLTEtMS0w_276dafc0-136b-4e2e-b86b-f62fea8ebc23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi01LTEtMS0w_a3e4f6cc-7614-44a5-bd75-a081a88b7503">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi03LTEtMS0w_54d69b87-32bc-43d5-842a-29552c40577f">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi05LTEtMS0w_7370d9cf-eb8a-4c79-a698-13c3bf6fe414">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0xMS0xLTEtMA_04d8f7a8-3ffd-4eaf-a3c5-07d69fb81851">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0xLTEtMS0w_11f3aa4f-710a-409c-a2b0-9890ba41662c">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0zLTEtMS0w_739e9f5f-5b8a-494b-bf70-c691c46f49c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy01LTEtMS0w_9d2d90af-0c2b-4e64-9919-a40d0df06497">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy03LTEtMS0w_4ce658e1-f0b1-4637-98f1-80ec230e30b2">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy05LTEtMS0w_a6234ca9-6eee-437f-b2df-4d4927385eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0xMS0xLTEtMA_267005c4-f060-44e8-800b-4251371950dd">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0xLTEtMS0w_dd613281-07f7-4380-a3dd-351905d7e6cb">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0zLTEtMS0w_2f524015-c4ea-4c98-8dae-5a7f200424dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC01LTEtMS0w_d971e434-5604-4876-a189-ba7c1d7f52a3">930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC03LTEtMS0w_1fb6e360-b05c-4b2a-898c-883bb4f51ef9">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC05LTEtMS0w_ffc3d7cb-a97d-4fc2-b5d1-26fddf681afc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0xMS0xLTEtMA_e42b86ad-a14c-44d6-91f8-1d15ed01ee01">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0xLTEtMS0w_df1054c1-2cdc-424f-b15f-12aa4591b5cc">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0zLTEtMS0w_58731f6e-6725-4272-afcc-4671ca7c3c6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS01LTEtMS0w_282ae7be-3dc1-4828-ac2c-de69ea0b8776">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS03LTEtMS0w_297bef02-20a7-43e6-bb73-c259ccf70ddc">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS05LTEtMS0w_2ac49e18-d67d-4e52-9e1c-7b577291d6be">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0xMS0xLTEtMA_682ccec1-a887-4b21-8515-5518672bb3c1">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMS0xLTEtMA_19d1cef5-a30b-4880-a9d0-13ea1a286c20">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMy0xLTEtMA_aa97fb63-1b99-40cc-bb65-46cd818f4de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtNS0xLTEtMA_0e3dba66-d7d5-4b81-bc60-21399ce220a2">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtNy0xLTEtMA_61abd418-b875-4dc4-960e-c22401b46d16">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtOS0xLTEtMA_55470918-7bc7-4c7c-b681-92ba42d5dabd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMTEtMS0xLTA_8ceb4eb4-6fcc-4340-a353-347d3c331315">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMS0xLTEtMA_4ab9cb92-154d-48aa-b72f-85c7f198d52e">18,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMy0xLTEtMA_8aa1b22c-9f37-4140-b003-144a200f6e32">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtNS0xLTEtMA_328f2333-d7f0-43e2-b236-b3938bdcd6b0">18,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtNy0xLTEtMA_e3444f80-5758-4d59-9092-3f187dff1378">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtOS0xLTEtMA_eeb904fc-6ae9-47d2-b924-b34fa675092f">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMTEtMS0xLTA_522086a0-cd28-4700-a9c4-111186e7f6d7">20,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMS0xLTEtMA_146735de-8107-4ddf-9b89-7662623727ac">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMy0xLTEtMA_b7dfc247-4cf6-4b5e-9b6b-bbe1ab57025d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtNS0xLTEtMA_b7c90a1a-59f9-43b6-836f-08b6c054251e">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtNy0xLTEtMA_2d7dd4f8-b054-45c2-8bbc-51cf402f4cca">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtOS0xLTEtMA_1614155e-2335-4878-a8e0-ecbbed0dbca5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMTEtMS0xLTA_142a8fa7-99a1-4769-9190-b665edc1eb62">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMS0xLTEtMA_f24d5dbf-73b3-4500-9b84-19953e34cd38">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMy0xLTEtMA_6916ac69-b76b-4e7a-8be4-73dbc34f353d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtNS0xLTEtMA_afb17d2f-c5cd-41b5-b9dc-465095bf8b7b">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtNy0xLTEtMA_61962029-74b7-47c7-80e8-5b31e656aeaf">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtOS0xLTEtMA_39f69c9f-4a15-4f80-b923-a2c8765de358">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMTEtMS0xLTA_121a6729-2a5a-4547-8a4e-3d66f2fe0c72">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMS0xLTEtMA_11b99440-c830-4621-974f-5ac0ef230e07">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMy0xLTEtMA_32c30da9-d9ae-48a4-abd2-863378f9bb8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctNS0xLTEtMA_d266ea70-5791-46e6-bad8-39a1fd80c0cc">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctNy0xLTEtMA_f406d7e5-62d6-46e3-927f-c71b7a4ec6dd">573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctOS0xLTEtMA_5cf64e2f-2b07-41ee-966d-b62162ba8889">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMTEtMS0xLTA_eb2d3acd-e8d8-49db-9fd8-30faefdefb71">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMS0xLTEtMA_52188d8d-66f6-4e4b-ad3d-69bbd272c8e1">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMy0xLTEtMA_0f87a39f-b80c-40a1-8cff-1f09e7fcba7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtNS0xLTEtMA_bc8d2f26-4078-469a-9773-bda012ce3b07">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtNy0xLTEtMA_0e9051db-2d8a-417b-a04b-f48700b148be">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtOS0xLTEtMA_d79fecb6-58e6-4a7e-82fa-084779bab1b6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMTEtMS0xLTA_bddc2835-4581-42c6-93ea-82484147c427">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMS0xLTEtMA_586e3b62-fcee-4d26-9235-92d9b9930a57">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMy0xLTEtMA_7c3c35f1-2482-4765-9031-ef9e285ed292">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktNS0xLTEtMA_faf8107c-a065-4a84-bf91-cb3726f05b9b">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktNy0xLTEtMA_fdf9e29b-562b-4680-b780-2fcac0c07932">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktOS0xLTEtMA_a436f497-fe3f-43ef-bfed-e93b307224d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMTEtMS0xLTA_ea0e566f-f11d-4b9d-b073-5ffffa8ec72a">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMS0xLTEtMA_0f6967bd-1cce-4b7c-a1ff-69c7b9de5656">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMy0xLTEtMA_4ebb9122-8290-49bb-a1ef-76042d6a0687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtNS0xLTEtMA_08961af3-84f1-48cf-93c7-20c269c28342">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtNy0xLTEtMA_e143c283-5e7d-4ea4-a046-d8f49a5eb6a2">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtOS0xLTEtMA_37e8d315-bb9f-4acf-a92c-999ed9aacadb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMTEtMS0xLTA_1999a38d-4648-47a3-a585-ece78b4181d9">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMS0xLTEtMA_4e5cede3-5db7-4b25-b6ea-f7da6e974b21">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMy0xLTEtMA_8a134598-4197-4242-9f1e-1d1683938375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtNS0xLTEtMA_71f640fc-50f3-4fe1-8e0f-e86554c6f7b7">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtNy0xLTEtMA_7211cfa0-a7c1-489e-8e61-5f1f0368bb3b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtOS0xLTEtMA_69918df2-a58f-4750-86ad-883eb8eb4cec">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMTEtMS0xLTA_a00eabf0-9ba1-4d3f-b215-b99b02c76b24">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMS0xLTEtMA_ba4ba4a8-ba7a-4dfb-953c-353a41fce0c9">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMy0xLTEtMA_6aa4921d-ff1a-4e6a-adbb-48d4d11e8914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItNS0xLTEtMA_43041ee5-678c-46ba-bf5a-2014af7a458c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItNy0xLTEtMA_36db61b4-be0b-4d55-b2e6-f240b48f78b4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItOS0xLTEtMA_e20a6aa0-05e6-437b-8f84-de5c7bb2df8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMTEtMS0xLTA_efcd0ac8-fd28-4fb8-a52a-b489229ed8af">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMS0xLTEtMA_ea7b660b-046b-44a2-8279-9aaf9fd272cc">15,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMy0xLTEtMA_5eecb7b9-3832-42a6-a184-30967b40af87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtNS0xLTEtMA_eb089833-209a-4002-ada0-3ae73d440586">15,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtNy0xLTEtMA_11092992-5b81-4cc5-b6be-ceff4438ac81">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtOS0xLTEtMA_5102f107-ab7f-45cf-974c-0cc5de93f147">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMTEtMS0xLTA_3d8d7dba-69b1-4c09-b460-938679097c90">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was <ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNjk2_3c8b97a6-19c2-4997-b4a2-8535a7253616">no</ix:nonFraction> allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2020, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfOTgz_ec6571ac-7056-40de-b72e-26373d6badab">928</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTAyMQ_a71aedd4-b05e-4357-8595-c0ad969bcece">122</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTA2Mw_484b80af-e670-4672-9200-f116e90ccfac">1</ix:nonFraction> million and at December&#160;31, 2019, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTExNA_050333d2-26b1-41c8-95bd-e900b0215c98">965</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTE1Mg_d8e2f6e8-5ecc-410e-aebe-8dd7aa6f22f0">83</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTE1OQ_fa709083-c48c-45e5-a6ce-f20e2c13773f">no</ix:nonFraction> gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iefb29392dd8546fd8a8fabcbf5a1869c" continuedAt="i987022e6b7e94c51a58778e79a01b64a"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTQ3OA_d3251461-3bc2-4392-9f09-2ce13ff9a75c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at September&#160;30, 2020 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMi0xLTEtMS0w_9fbf70a7-846d-4f19-b531-18141084dd50">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMi0zLTEtMS0w_8fbae646-5b5f-4adf-aecd-e201ad66a8a3">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMy0xLTEtMS0w_658892e1-a954-414b-8667-a0383613316c">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMy0zLTEtMS0w_9a072c18-dafc-4f72-8d1d-586f092dc6aa">6,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNC0xLTEtMS0w_39f44df4-2fd6-45d8-ab7b-0e575af18e03">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNC0zLTEtMS0w_201e5376-5f88-4786-9e59-a411eb1b3cfe">3,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNS0xLTEtMS0w_2655860a-33cd-43d5-b0bf-642ce7fd08a2">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNS0zLTEtMS0w_fef3421a-bc52-4f23-ac9d-533ab71b15aa">4,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNi0xLTEtMS0w_56607a88-1986-4abc-947e-a575ece33992">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNi0zLTEtMS0w_89f9ac99-dfc9-4460-bff8-6b53667a140b">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNy0xLTEtMS0w_52049013-dff7-4f5e-87ed-038067235d9a">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNy0zLTEtMS0w_5f254cc6-edf4-4bd8-bbf0-92c44537c552">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOC0xLTEtMS0w_e08dfabd-729b-4504-84ea-d3bc7c459330">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOC0zLTEtMS0w_2455c347-1cab-45dd-994f-3acea9a27250">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOS0xLTEtMS0w_6e9694de-b1e5-4bf5-8285-d1c867c4d6b1">18,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOS0zLTEtMS0w_311ced9d-0a9e-4a10-99f2-853acf8917e3">20,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i987022e6b7e94c51a58778e79a01b64a" continuedAt="i69445132bb1e4f8bbdca3f01bfee1c09"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU3Mg_049d49d5-2e7b-454a-8cd9-7807c921e7f1" continuedAt="i5361227e814b4507ab299c7d6350afdb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2020 and December&#160;31, 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xLTEtMS0w_9ca4937e-a25f-47d3-8ec4-998867ded0d6">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0zLTEtMS0w_28dead3d-2421-4fae-a509-42ffb3b02895">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC01LTEtMS0w_6c1f30d5-8b07-4a16-8eed-20976ce903a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC03LTEtMS0w_bdb8fe36-673c-45fe-9c6b-8f9809d27fd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC05LTEtMS0w_963b8003-b084-45df-8fd8-2915b5cce8f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xMS0xLTEtMA_e483e595-ba51-4289-9140-1b924ff1f555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xMy0xLTEtMA_a9b734a2-717b-465d-b668-e9c5e251dc2b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xNS0xLTEtMA_25e9cd14-d056-4dc2-9a49-0bd149a3b8f6">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xNy0xLTEtMA_b7abb0b5-d94e-4f58-83cf-05ecc2fc875d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xLTEtMS0w_64b6efcb-3f2e-46e8-b3fe-764dbad341b7">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0zLTEtMS0w_e33415db-ce03-4f67-bc44-e2289d7acfcd">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS01LTEtMS0w_80cf4152-c2c4-4982-86f5-f095394bc670">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS03LTEtMS0w_f3e6de54-5e9a-47af-84ab-7bc754e6acf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS05LTEtMS0w_01cdcc46-bde6-459d-8f48-71a5b30bd78c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xMS0xLTEtMA_20259b99-599f-430b-a67b-3133d597c92b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xMy0xLTEtMA_04932f3a-f750-45bb-9d09-febb099b5535">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xNS0xLTEtMA_fea4f788-622b-4ea2-88db-f0b7ede7ead2">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xNy0xLTEtMA_8482f6c9-5917-45e1-bcab-9922eee4cb76">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xLTEtMS0w_98a77ee5-421d-4413-88e5-b466827b742b">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0zLTEtMS0w_790782df-a0d5-40ba-94f0-9c550f5147c8">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi01LTEtMS0w_57e3b317-4daa-4754-901d-5773a9b24ea3">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi03LTEtMS0w_877c20b1-212c-4d9e-8527-ecdddc6f8696">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi05LTEtMS0w_f79e5257-2fad-45f9-a826-2e1c7f4af660">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xMS0xLTEtMA_5fbb5354-e5f9-4cd5-b07b-09815e90053e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xMy0xLTEtMA_dcfd2986-aa0d-4c0f-a300-e69cf8698c74">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xNS0xLTEtMA_2b5274aa-f119-4c9f-b203-771ac5ddda5a">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xNy0xLTEtMA_ed1fcabb-1e24-422f-9061-29376fb1e461">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xLTEtMS0w_868f4d62-eae9-4dfa-9e7c-9298359dbdad">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0zLTEtMS0w_75da5aaa-4825-4980-aa90-ecc1f08c536f">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy01LTEtMS0w_59c5f2b1-a74e-4b3d-9829-d8cd8e6612c3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy03LTEtMS0w_d22b49b3-e709-4737-8ce9-b3f8653b2bfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy05LTEtMS0w_10355a11-cd12-4742-bb66-2e1649c181db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xMS0xLTEtMA_d70659c4-7325-48c1-bb78-bb1ea202125f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xMy0xLTEtMA_b2425051-ecfd-408e-b355-ad00a493deef">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xNS0xLTEtMA_88833548-21e8-4713-9c18-8d5d3a7ea50d">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xNy0xLTEtMA_7d4ee173-8061-475a-8a38-4784ce7915d0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xLTEtMS0w_b821d548-0446-45e1-972f-f0e158c29852">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0zLTEtMS0w_e13fd6d9-7759-4c16-aa47-530c119b8b52">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC01LTEtMS0w_a9f31c4e-bf11-4c22-8530-407510f3ccb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC03LTEtMS0w_5518dd21-c168-40a4-bd95-539c3e33e0b5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC05LTEtMS0w_12a0fb42-b7fe-468f-8996-45d8ac32cce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xMS0xLTEtMA_48cf3e91-ac81-4bda-8041-366c762783ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xMy0xLTEtMA_b823fa36-0fc7-4150-a3ab-27967e6e6711">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xNS0xLTEtMA_7e3ae4f9-b08b-4e93-b3ed-81f40205a029">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xNy0xLTEtMA_2fb18a70-b3c3-4ce4-9007-8d2af9199369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xLTEtMS0w_3269e977-1167-48f3-810a-35ab7ef2b088">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0zLTEtMS0w_ad7ebad9-b92f-46cb-a176-0a068b78ef5f">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS01LTEtMS0w_77522f0a-c440-4f5e-bb4c-2a915694e086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS03LTEtMS0w_fe377bf5-8b11-44d4-ab62-e1219ca55885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS05LTEtMS0w_711426de-3f07-4de6-9b0a-cb61f7c583e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xMS0xLTEtMA_c45761df-5b8b-46c9-985c-0a58da11a8fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xMy0xLTEtMA_57ba62c4-5dbc-4766-823f-32f4c24a5cf0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xNS0xLTEtMA_6d82c041-f9b0-4dc4-970e-ee8e6d956c89">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xNy0xLTEtMA_a96f5fab-d33f-42a3-9ca3-e365b4c56811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMS0xLTEtMA_308d2116-e28a-41e2-b834-e195302068c9">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMy0xLTEtMA_e31aeced-7911-4770-9ab6-42f8af130546">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtNS0xLTEtMA_61592467-2fdb-4a54-be3c-aa565f3dad34">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtNy0xLTEtMA_06b8c006-83c5-4d17-af42-dc95d0f44d94">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtOS0xLTEtMA_2b199198-0f7e-4650-99a2-35457c6750e8">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTEtMS0xLTA_07462728-b177-4283-9b1a-bbcebf5e9f34">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTMtMS0xLTA_4a650d71-74d5-48bd-9247-bd3dc4fa8187">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTUtMS0xLTA_3469a208-4287-4d03-9228-1fe38bcec3db">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTctMS0xLTA_b0eb69a6-e0d5-4b99-a531-7a4f05c905a1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMS0xLTEtMA_eb3b0f28-ec5d-453c-9ed4-2b46ab17d4e9">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMy0xLTEtMA_405b9904-aa2c-4540-8a9c-04c10062a4d0">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItNS0xLTEtMA_9b2a2b6b-3294-4783-ac68-f1d0a14776b7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItNy0xLTEtMA_dced08ab-a2f8-4464-9304-bca480727e2d">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItOS0xLTEtMA_19f93eca-177d-44f9-bc2a-865bcd73cd3e">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTEtMS0xLTA_b9b93df3-bbfa-4b39-ab50-08cda321e795">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTMtMS0xLTA_6ca8d9ae-7d8e-4671-ad7a-0a06411f9da0">1,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTUtMS0xLTA_d2ed233f-3068-4548-8746-dcacea08c5d8">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTctMS0xLTA_238cdb89-4f50-48f4-8d11-8b6d651f266e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMS0xLTEtMA_812f586d-b0ca-469e-9a0c-67c74cebbe33">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMy0xLTEtMA_e31df747-09c3-4321-894d-6c1889f5a191">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtNS0xLTEtMA_550fe1ac-19ed-45b0-a309-ba2f9afc23d1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtNy0xLTEtMA_4f3bdeb0-ff0f-4d0c-923b-484f8cd09c01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtOS0xLTEtMA_e50e20cc-eba7-480d-8208-45ac86fcff87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTEtMS0xLTA_9ac9ba56-baa5-4af0-a772-a8b3f2d32d7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTMtMS0xLTA_4d97e23c-d83a-48d0-848b-113be9e4fccc">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTUtMS0xLTA_fa6c98b3-87db-48cf-b9a1-5d7bb3dbc6cb">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3e6151680b451eb6ef567620281acb_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTctMS0xLTA_e60ab710-10e3-4fae-8894-488832c914a3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMS0xLTEtMA_292460ac-377d-41a1-9bd3-f24f348d38d8">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMy0xLTEtMA_5738e651-770a-4fb4-a9fa-382373a55862">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctNS0xLTEtMA_3f9bdef9-792f-41cf-8ed5-20b26f6387e7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctNy0xLTEtMA_354a816b-c380-4a15-bd69-ce33e2e7b0f3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctOS0xLTEtMA_fa58913f-2352-4abd-ad6d-2069f7d4db84">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTEtMS0xLTA_9add709d-8995-4647-ba83-753f23ac22c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTMtMS0xLTA_519a7eb1-101f-41c6-80a8-53727259f4fb">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTUtMS0xLTA_8dc5d1ab-6774-4980-9d59-0c8d98e086a2">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e576f48da934434adff3d93da16066c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTctMS0xLTA_20168bb2-c21d-450a-8178-31381fde028e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMS0xLTEtMA_5b7e2070-69af-4790-8880-da4ec3fc8428">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMy0xLTEtMA_7176f5f4-eaeb-4dd2-949e-1a891bd1625e">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtNS0xLTEtMA_6b7d21c1-cc39-4b6e-95cf-5bf0b54dc4f0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtNy0xLTEtMA_b1fd65ac-ac2a-4bdd-8363-6fc373d88df4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtOS0xLTEtMA_2871a9a6-dd1a-4c4a-afc7-b3bc5c4db5bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTEtMS0xLTA_4d5af369-34ec-417c-8ddb-d45d33602fda">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTMtMS0xLTA_2aa20ead-8fd9-4d3c-a06d-570179675a16">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTUtMS0xLTA_f34ff34a-0128-40ef-9d55-ae1ea832cc76">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTctMS0xLTA_45c43ceb-b5d8-4024-8477-273598fbf66e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMS0xLTEtMA_94d902b9-fa94-4640-aeef-313cc1c2882d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMy0xLTEtMA_b3c877da-9778-49d4-9552-38ab5bacc210">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktNS0xLTEtMA_cb0595d8-2101-4a3d-a5ec-270d2603d075">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktNy0xLTEtMA_2452ecc0-e886-491b-ab05-20daa7deccbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktOS0xLTEtMA_6ccbc831-a383-4aa8-91de-3bda5047ef6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTEtMS0xLTA_49f20947-d8e2-4aaf-b03b-39b7a8239ecc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTMtMS0xLTA_29657f30-9646-412d-8c5a-0ed1403f430f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTUtMS0xLTA_557b418d-1252-4b74-bc32-ec021b116e0f">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTctMS0xLTA_28ed6ca8-c320-41c4-a548-5b5dc2ba96b7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMS0xLTEtMA_74491007-500f-46b1-8e6c-8c32300e6d7e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMy0xLTEtMA_ad955adb-9a31-4f45-9b41-ce55095754ca">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtNS0xLTEtMA_df6f8e86-4974-4976-98b2-a5d0fae91d12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtNy0xLTEtMA_e556b532-9850-4485-ba1c-996cc073ef05">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtOS0xLTEtMA_8c9c027c-1af7-4035-8c4f-0a3a3e18b8f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTEtMS0xLTA_3cfd7872-766e-4a64-a0e9-11666aa4e863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTMtMS0xLTA_db3a6ff3-c05c-4965-8b47-1222228c183e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTUtMS0xLTA_18bba438-671c-4299-8df5-49a7e1324d72">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTctMS0xLTA_6985d676-ca7e-4aa0-a1e6-0efdad943f1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMS0xLTEtMA_8db20dde-e60e-47b2-85df-d5a9a07fe93c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMy0xLTEtMA_bc24835f-01b9-4ee3-b9ea-f0a708d63c15">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtNS0xLTEtMA_c2768e3e-f771-49a5-aeb2-02aa5865d6a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtNy0xLTEtMA_b445796f-4ee1-4d53-8ae7-5a92c084fb29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtOS0xLTEtMA_92d04dfb-2095-4592-9cf5-b67367b3a766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTEtMS0xLTA_d7d83f7c-9f2f-4c7a-969a-5e1663175c48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTMtMS0xLTA_9b4c5d5a-2681-4cad-a416-3b7d10993898">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTUtMS0xLTA_dca5d460-c56a-4bf3-8e3c-4c2d2def9980">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTctMS0xLTA_42f3c0ec-202e-4dce-a4a7-691daece6d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMS0xLTEtMA_2c161761-0ddb-4991-be2c-4b51ecd6735d">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMy0xLTEtMA_6a931989-2a19-4c61-9593-c54f9dd23201">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItNS0xLTEtMA_6017962d-fa99-4070-ac49-3a00070da1ae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItNy0xLTEtMA_9e0e6c99-f2ca-4ac2-be6c-9a8b71377fad">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItOS0xLTEtMA_d7e86775-8c14-4196-8e7c-6c220ef7d8e1">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTEtMS0xLTA_86dc3289-e95e-48e0-8a68-d130b3ef3e06">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTMtMS0xLTA_3144dfb8-64ae-4ae6-9e52-4c61f80542e3">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTUtMS0xLTA_6d278a99-6e4b-45c2-b4fb-cc4512455fa0">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTctMS0xLTA_9078eeac-4658-4713-b909-98d174428f5a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMS0xLTEtMA_82f0d4cd-29d1-49ea-997d-362a05bf2dfa">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMy0xLTEtMA_327ec04c-ce4e-4b01-9bbd-75fbeb840d77">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtNS0xLTEtMA_23f10af1-c716-4328-9e95-cba4cfa46e41">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtNy0xLTEtMA_029a9b24-a0db-4937-a52b-eb912b7ef68c">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtOS0xLTEtMA_5e40e765-da5c-4913-9891-7fec75f2fc13">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTEtMS0xLTA_384717a9-ebc5-4cc2-a3cc-3c678a50b793">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTMtMS0xLTA_5a996daa-89cc-4031-8d3c-5ce025858dad">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTUtMS0xLTA_5b473c9d-b615-4ca4-9f65-e3837aa35425">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTctMS0xLTA_b598b03f-2950-486c-b9a4-06a3a1eb86ae">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2020 were generally caused by the widening of credit spreads on these securities relative to the interest rates on U.S. Treasury securities, driven by the adverse economic conditions in the U.S. and abroad caused by the COVID-19 pandemic.&#160;As of September&#160;30, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i69445132bb1e4f8bbdca3f01bfee1c09" continuedAt="iaf20483aaeae4aada80756559a4b2ad7"><ix:continuation id="i5361227e814b4507ab299c7d6350afdb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0xLTEtMS0w_c4f3964c-aeb5-4c70-8521-8543acffe5ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0zLTEtMS0w_136ef4f4-3ba2-4741-83ce-aaed17e76364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy01LTEtMS0w_bd06e5db-3a5c-462c-9d44-95aae407a3a3">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy03LTEtMS0w_31843af1-aec4-4639-b694-a2b814bd9eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy05LTEtMS0w_eae9b1f9-e017-4c85-aae5-d57cb122546c">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0xMS0xLTEtMA_ee02f1b9-e6ca-464d-bd50-8a39b3d0e87e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0xLTEtMS0w_c63f505c-11be-4af0-84f9-400dab27748d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0zLTEtMS0w_e2221bfb-2e21-4864-a161-bd5e12c67076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC01LTEtMS0w_f109f1d2-e8ed-4a24-b681-ac1ce275308f">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC03LTEtMS0w_2cbca3b8-1fe0-4f2d-83ab-95aefca7fcd1">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC05LTEtMS0w_9d629dc8-8c1b-415d-a914-518261138b78">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0xMS0xLTEtMA_2ebe50ef-88e9-4f52-8338-e29566b31613">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0xLTEtMS0w_4b36ab15-b36f-4374-a729-0db50122afac">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0zLTEtMS0w_7101217c-0b5a-4771-8bf2-6da47b595e2c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS01LTEtMS0w_8a2db0ce-d166-4081-8977-9fdbd8636bae">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS03LTEtMS0w_6a6132bf-a598-4638-b7a6-5df993d42443">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS05LTEtMS0w_96bd8987-505c-46a9-be74-b2f099f743e9">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0xMS0xLTEtMA_34e8336d-904b-4732-ace8-7f2761d20354">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0xLTEtMS0w_bbc770ea-001a-4dbe-bf9b-d2e40dc437d1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0zLTEtMS0w_a2b2211b-c94b-4aad-b6c8-70d3b7ece57d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi01LTEtMS0w_e7d2fc8f-2462-4de0-9a88-e04c80f9bf85">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi03LTEtMS0w_9d323586-3618-45b9-b996-d04473d31b8c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi05LTEtMS0w_1f1f6ed9-d90d-49c2-a7b4-9291f708847b">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0xMS0xLTEtMA_caa04f50-bc3f-4b30-a376-ec53e1f588e5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dfbb0081244aac89b4345d22699e63_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0xLTEtMS0w_211eefc8-bf3a-4d8a-a688-88fdedb6b9c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69dfbb0081244aac89b4345d22699e63_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0zLTEtMS0w_72040a58-2a5f-40b7-a0fd-bf49c3043b67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960e086fbf114fa085cd3503d8537bc4_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy01LTEtMS0w_1522842f-eebc-40b9-bbf0-3c4f07b1d3bd">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960e086fbf114fa085cd3503d8537bc4_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy03LTEtMS0w_d720c9cd-4aac-44cf-b4a8-af90e32a2ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy05LTEtMS0w_4d65b3c0-b8e4-4328-a527-71a198bf5e61">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0xMS0xLTEtMA_aeb46949-6e01-4deb-9002-08626cae5110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1e365008244ed5a70514a60e56cccb_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0xLTEtMS0w_e821ce5c-43b4-42ee-8f42-a23d229d9d7a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1e365008244ed5a70514a60e56cccb_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0zLTEtMS0w_3ca98fd2-51cf-494a-b743-8d2c613429b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab420c501cf46d49e7efcb16f91f34d_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC01LTEtMS0w_1d36fe74-bd22-4da2-afc7-d6f266d8c604">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab420c501cf46d49e7efcb16f91f34d_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC03LTEtMS0w_ce68fe33-af0b-4852-8807-82d57f235bd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC05LTEtMS0w_09aa33fb-9a68-42a7-b328-392d9ee0ede5">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0xMS0xLTEtMA_2675d6b2-d688-4fb2-a718-71eedf605c7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7daccfbe8e14d87837c7793f712536e_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0xLTEtMS0w_27dbcdd0-b264-42bb-8bfc-c716dfe9744f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7daccfbe8e14d87837c7793f712536e_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0zLTEtMS0w_5a8634b9-710b-4ffc-8720-f99c247d6ecf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0db8b085494ad9aa4eead23953af4e_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS01LTEtMS0w_e5599fc8-d15f-4360-9dbf-cc08b5450873">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0db8b085494ad9aa4eead23953af4e_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS03LTEtMS0w_925d5a8e-717f-4a5a-9e8c-687005075169">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS05LTEtMS0w_7112fae0-a0bf-4f08-8664-803771f6fcee">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0xMS0xLTEtMA_858f2254-32e2-4ca9-9822-d883a0c2886e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMS0xLTEtMA_1d865ac1-9c3e-435b-8411-27ee0f1d2086">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMy0xLTEtMA_c1c9eb97-a261-41fc-afb6-ef0f7be383ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtNS0xLTEtMA_2cf7a837-1ae9-4bec-99b8-8b5c68140abf">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtNy0xLTEtMA_c9a3df34-1b21-488a-9c80-de96d3259c34">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtOS0xLTEtMA_5327a49b-0508-41a1-8587-f74fcb3aa844">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMTEtMS0xLTA_51811ac3-f33d-4043-aa4a-bb3393857e29">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;<ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUxOA_1c629b99-08a0-4673-b576-8cd1fc57cfab" continuedAt="i224e89d7e1994ea6bc8a82562c32e8ea" escape="true">During the three and nine months ended September&#160;30, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i224e89d7e1994ea6bc8a82562c32e8ea"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi0xLTEtMS0w_e1ad07ec-4bbc-4eab-a2b9-f3c67a82c265">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi0zLTEtMS0w_0d1434ed-6712-462b-9a69-8149363c4867">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi01LTEtMS0w_ee01336e-9f80-43c9-8d78-01e3c3306817">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi03LTEtMS0w_4c3451ff-7416-44db-a6fd-eb7f3c44a6d8">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy0xLTEtMS0w_24e9cc97-5922-4efa-8a15-9dc9af2fd0d8">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy0zLTEtMS0w_77503a7e-8338-49f2-a3a8-1f2ac3d5d05e">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy01LTEtMS0w_5028547d-8a76-466b-8be1-7cbaa4204124">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy03LTEtMS0w_99210835-2ef8-4a74-9817-fa9ed7c0f66a">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC0xLTEtMS0w_c23f9f35-5690-4ce7-84ac-7ecea14a8265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC0zLTEtMS0w_e318d519-3f61-40f5-8587-7320a15c0f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC01LTEtMS0w_621bd790-cf1e-46d3-932e-0829801fc081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC03LTEtMS0w_843c509a-bcbd-418d-bea8-337372d406bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaf20483aaeae4aada80756559a4b2ad7"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUyNQ_f56b3cb2-aef4-4d85-b5b1-fdfc634bb8b5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2020 and December&#160;31, 2019, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie795c4847dad4a2fa2321b0a489f207b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xLTEtMS0w_670fe64a-704a-4bc6-a208-7d576923ca11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic175d1191a1c4781a30676aa11276f4d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0zLTEtMS0w_246d025e-e7ed-4619-875c-a956f2010a72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30256990638e428f824cbe808d6ed528_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy01LTEtMS0w_cebbf108-2f9c-40d8-8960-0e9254d00147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad431944c36d4aae9608be12244efbd3_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy03LTEtMS0w_cbd117e6-3fdb-4ecc-8633-875d94fa782e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913a4bd7a8594a62a5156370bb48bcf6_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy05LTEtMS0w_ba53bfaf-3771-4db7-a1ca-f053a7ec201f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b30e7ac4294106a93b48a59cbf0bac_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xMS0xLTEtMA_a7dc82c8-3be4-4650-afb6-918a1f936692">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6479057a341c45c984deedf142835644_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xMy0xLTEtMA_e6c412bd-411e-4abb-a943-bac3e11fa68a">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd382360a1a54ca085c48b6b0eea3f9d_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xLTEtMS0w_31feb336-256a-4242-864f-1ae629a45001">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0610c938c1724db88d4cb79675b700cd_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0zLTEtMS0w_fcf2f22e-eadb-475f-9451-9f31593c08ae">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c351fcfc74e43169c42882a035900a0_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC01LTEtMS0w_827ac913-1f0d-46d3-888a-f9994dcb0a3c">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057fc0d413b94de5b39c6573f51d2e09_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC03LTEtMS0w_580b7cce-0012-42f0-bdf5-034c20812658">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42dddd2f744647acb266706378ec5df3_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC05LTEtMS0w_ba193551-98f9-491e-8bff-e5e6689b9714">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4edce924dd046b6a5eaa1536dc0f333_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xMS0xLTEtMA_d33ba2e7-8227-446f-a356-e9367ae4cb1d">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d795e3743e64e26965aa5f2e4573e19_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xMy0xLTEtMA_dac1bd45-3055-4f67-b172-248aadaaa41f">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68eb5bdcaf264b40b40588bd26e81268_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xLTEtMS0w_3aafa34b-ef61-45bc-99b1-4ea1eb3d50bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3754c364a7504543bf52097c1f644ce5_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0zLTEtMS0w_bbc6ddd1-c620-4c04-87a8-016ebd785394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9122fa3ecf054a24bff9ed44808cb012_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS01LTEtMS0w_f98bb061-4acb-4040-a8e7-cadd4cebbe63">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida44d0acf7984a62bdefb2c50f6d6407_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS03LTEtMS0w_83398114-78db-46e4-ac47-fcb77d01f56f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194339829ef54e0bae1c684cadaded1e_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS05LTEtMS0w_1c5e6a8c-8f65-402d-b50b-07462ac3821a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c85adc56b7c43e3996b5bce465f37df_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xMS0xLTEtMA_d4408f03-e403-4afb-b958-6c6d7268058e">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e53524f057f4999ad2443b434cce091_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xMy0xLTEtMA_e816e672-210e-41cc-911e-5f1fcfb3d383">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af70922f678434488f766f73af3cade_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xLTEtMS0w_0dfd8bfb-d337-4c2b-a332-44048d92b212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d1c549803e41469de47806ff2e4fa1_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0zLTEtMS0w_fee9b6e5-6a79-4f36-a164-cde2e1282078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f844fe095a41dfbceda6a1d04bfdc2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi01LTEtMS0w_fde93f8b-f4c8-4b8d-9b11-2d5c509a8b1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica452037f76f48e9af4b93d468452d6f_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi03LTEtMS0w_83089c45-e234-4d73-bc2c-f7eb00561a1c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94354f726744ff8bee2090d1ad35db2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi05LTEtMS0w_7bc43674-6c61-4267-bfca-77c4a9409948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c125fab00b42f59120a0bca28c2067_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xMS0xLTEtMA_89719a2c-1917-488b-a3f7-f77d909238d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8ac8af61cf49b9a4ecdf639848435b_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xMy0xLTEtMA_9ccc2686-66a7-4c15-85c4-36c165eeb7dc">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08a76e0bcc84d49adefc8bbec4d213b_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xLTEtMS0w_be682d91-10a9-4931-8d9c-3a2a662fdbbf">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90ec21d6d594b7da461da5300391997_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0zLTEtMS0w_2d097cf6-84e8-4e38-85b0-0327530e395f">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4e703d104427790286808c54d1366_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy01LTEtMS0w_e53d21c3-8f0b-439f-a887-38930fc388df">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida34879a6c634fd1b420b3bb6585dd5a_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy03LTEtMS0w_798215d8-9860-4f25-9fe6-9cbb3714fbc3">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ee7fd60e8a42afb969aa603a251749_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy05LTEtMS0w_fd0d5c97-4abb-41f7-b588-92ac117fa159">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154a60403daf439ea051436669caed62_I20200930" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xMS0xLTEtMA_9c3fd1cf-e354-4c3c-b054-8109c76e6235">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8567e379ddb1457cac777037b4375361_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xMy0xLTEtMA_26753c1e-dda9-4bb6-b6ef-c792bc64e986">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fbcdd26a0874198b1491985af3d6caa_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMy0xLTEtMA_62052f08-5a22-47b9-aca6-5ec5cbf8440b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626f99181aa943b0b51f0d50e860b3cf_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtNS0xLTEtMA_b0303174-80de-4bfe-8bb7-796af167e9d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id978749041e44e299bcf3f700443a8f8_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtNy0xLTEtMA_098e2d39-2f4b-4665-9d25-1530398ab8dc">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1876da69d543fbbfd2d97bed949c96_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtOS0xLTEtMA_8ded8fb1-58aa-404a-8ee5-7e7826e8eb3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eeeb3c201f44e02925fb433c54875c9_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMTEtMS0xLTA_4b4f79ee-bc47-4277-a992-0acbb784c557">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66c23adb4244b9cbd61f92daf51edb2_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMTMtMS0xLTA_d9a9457c-4772-4c23-a3bc-1e3970be79ba">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9980f4284414635a8f0e3dba2c1cf2a_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMy0xLTEtMA_4e93ba8d-e434-42a1-b44b-b0182085726e">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifce7c6728c90483e9b8bfdd9962b5710_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtNS0xLTEtMA_33a4f39f-c7d5-49ab-beef-2b41ee4a7359">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if749a1d078424bd0ac0f4ee34e5390a4_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtNy0xLTEtMA_b6d1de6e-4533-446e-8911-35ce08ec46ec">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c1913598034217b44872960f615f0f_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtOS0xLTEtMA_30de4161-b9cd-4730-85c2-8c78528fd7a3">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie023e0b3bf5c4d45b331cdca88d01e53_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMTEtMS0xLTA_06d8390e-49a4-4d01-b117-d54d683cc5be">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cdbe7b61cea4120b2f5472d61487f8a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMTMtMS0xLTA_c9e5223c-fd97-474f-871c-6ceffaaa6bf4">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf1cfbdd6b04ecfbd78c7310035476e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMy0xLTEtMA_28fb4cb8-7084-4a08-ab50-d30dfa5d372b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i186f364822c04e9d9d7bc13d20f7bc13_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItNS0xLTEtMA_8d7a1620-a095-4d68-b16a-5021c6a887ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa78344f4d0c46538a8cbcae3b2a7c42_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItNy0xLTEtMA_7a075c0a-be60-4b52-96af-fad06edc7836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6acb9733404822913cf42bb35c9631_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItOS0xLTEtMA_2d794091-d0af-4c4f-ace3-90fe19db686c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67170a9e296943109aa58736f02ebaca_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMTEtMS0xLTA_9339c0f6-fc71-4136-bc82-a5b751140c3a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8430b0f5491b42719a2b3726e4de3cec_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMTMtMS0xLTA_f9364b85-e06f-4fc9-ba4a-da00f41668f7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc0eb7aab1f475eae71c3312f0c686c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMy0xLTEtMA_7069bab8-5dab-47da-bc3c-314af1c1c76c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c2af4550a64d90a95e4c647320413a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtNS0xLTEtMA_8b490846-83b3-46ed-b9b2-1e2a11b6e8a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20da4428912141408240e337515e04a0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtNy0xLTEtMA_55e0eb51-ceef-4b42-b954-90dbe1260ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i622e43fcdd484d2aab4eae3e5164bc8c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtOS0xLTEtMA_77445f46-b3d4-4f33-ba08-7c2d22d0b457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa714440d01840109a1cf5efeef3955d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMTEtMS0xLTA_7bf6b3b4-f08a-48ab-928b-164ae454c92f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i396244e89f5b4c28ac5d4147e815e9b7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMTMtMS0xLTA_de6f486a-0a72-4181-aa39-5651c38d23b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b24009c9df475d90e186eab28b123b_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMy0xLTEtMA_b95bf3df-82af-4874-ae15-cb582460085a">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3306d339a94c2381177e129b5210ab_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtNS0xLTEtMA_b8980673-de06-4736-aa28-ae247c910123">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac5e26c358547b0a83b36b4ba5416a8_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtNy0xLTEtMA_439cf9f6-97c8-4c7e-b3f9-244e5191fe56">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib681cd685e4741c485fded4dee9a4f19_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtOS0xLTEtMA_b4cc6871-f51a-480c-9f8b-b61f1fb023c0">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992d499671994e22be809371d4cfad4e_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMTEtMS0xLTA_2e78cac0-c599-4613-89ff-298ecbc50f16">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0374e01374ba4315b4b99fb4d6263f56_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMTMtMS0xLTA_492c71f5-9292-4c63-a327-5656aabc9509">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU2Mw_6f6e42ec-2b44-4885-97d9-d2d4d525e841" continuedAt="ia47ac55058744f1280559a2c6b3395c4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib818fadd5f0e4ddcb1522c0c0ac9d976_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi0xLTEtMS0w_b659cefd-0e7f-4bc4-b3b0-ebb75713d562">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fae26ed04184bfdaca7066ae8a753f6_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi0zLTEtMS0w_c61492b5-5c8d-4f54-a12e-48ca2b82e05f">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if716a3c271cf46b39d3e4ba483d859ac_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi01LTEtMS0w_00e98c40-2ab4-4b40-aac1-3c3fd51a7326">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744c94aba9ef4754a45ccd4484daef93_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi03LTEtMS0w_9cb6a060-2ca0-433a-9f5c-fd45ccab6bac">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia04fde7379954a4981ed81ebf2b5afb0_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy0xLTEtMS0w_31aebe41-dd94-4de2-9220-0a2f26633f45">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2db42393af54e53ad14dbc08d486114_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy0zLTEtMS0w_76192faa-61a7-4326-abbd-77a73467aaab">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c00b913c81f4dd0bd7784fd75297758_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy01LTEtMS0w_9f502343-b615-44e3-b9ca-3e709a838185">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f6aae1b4284431bcdd2e4827898dc9_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy03LTEtMS0w_18173eb5-a79a-433c-8911-3ccadfb5ad02">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5690f0cca3ea4531914b67ef16f42948_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC0xLTEtMS0w_c6134ac3-680f-41c1-b20e-6664265d6291">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if045682f0a244fb9b7c118b70cbd74df_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC0zLTEtMS0w_904747d6-73a3-47e6-a8c5-5191c4a96586">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17291e3b05464689b6efa05815c1f0ab_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC01LTEtMS0w_fd7d54cc-4096-473b-b5f3-20e83cb86565">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c372f3418a4938be710525fc278530_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC03LTEtMS0w_c42d124a-180f-418e-81b9-1dc7d2f96dfd">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS0xLTEtMS0w_881cc885-f54e-4224-98e1-ee40918d243a">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS0zLTEtMS0w_f51f72cc-318d-4879-a2a6-c5438622178b">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS01LTEtMS0w_48e4b294-8b9c-498d-94aa-8a95a9588c5b">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS03LTEtMS0w_61cc65cc-f7af-49fc-8f2d-a8a0db0f3290">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi0xLTEtMS0w_0cf41aee-db8a-47a2-8c81-7f6e98760889">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi0zLTEtMS0w_a176fd72-c1c1-4fb7-9eed-cbb437999131">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi01LTEtMS0w_36129893-ae3a-4433-a265-c038a8a83d01">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi03LTEtMS0w_d5ca322f-114c-4ecc-8b0c-4f21a3cec76e">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy0xLTEtMS0w_55830350-85a3-40c3-a04f-a89d7c81a9c0">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy0zLTEtMS0w_1d7f933c-918b-40b4-95c2-afe59e1dd135">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy01LTEtMS0w_c6cbe491-a980-4945-8c57-6d1fb1545def">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy03LTEtMS0w_4be44a3e-2de0-469e-9f91-f09fc01cd099">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC0xLTEtMS0w_0c6418bd-49e6-4ceb-b2d5-ec5038a7ac18">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC0zLTEtMS0w_78aa0dbf-aacd-4a4f-9173-ab0c785c52ce">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC01LTEtMS0w_3c8a2049-869f-4ca5-86ed-9fa05f8df542">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC03LTEtMS0w_df8903a5-3e5d-45fb-8622-60386920ad4c">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS0xLTEtMS0w_9084cff9-4dd5-4118-838f-7841a4f32ecd">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS0zLTEtMS0w_000fb1fa-0e7a-4915-9a3c-3153c8543658">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS01LTEtMS0w_f1654abe-f767-4b55-9247-1e899db2a2e5">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS03LTEtMS0w_a25a7466-cdc7-44f7-8ee4-110074e2210a">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDU3Nw_7679174c-7051-405b-ae1c-b8be719b943f">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDYzOA_bb1cb827-9fc3-40af-a7b8-0216ba6b9d53">2</ix:nonFraction> million, respectively, in the three months ended September 30, 2020. Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDc5MA_6c91dd3e-f935-432b-801f-f2a09d13abbf">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDc5Nw_49195428-baa0-44cb-87c4-2365f4881283">44</ix:nonFraction> million, respectively, in the nine months ended September 30, 2020. Net realized capital gains are net of other than temporary impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDk1Mw_f6d59a67-1d5f-44b8-8b13-f33a3ee27232">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDk2MA_df01916c-c8a0-4a9e-8488-13a3317a4736">22</ix:nonFraction> million, respectively, in the three and nine months ended September 30, 2019.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia47ac55058744f1280559a2c6b3395c4" continuedAt="id110c055f0d74200957ea5971239e99a">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="id110c055f0d74200957ea5971239e99a">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="icbcc194ba2834984937ecc92d1e291ab_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTA1OA_c7dabe5c-1fa5-4d72-add7-14d49cbbf5a1">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6f6b833db21459d8fe1d58b988e57bf_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTA2NQ_5698700c-0217-4233-8d66-d714ed5b6271">31</ix:nonFraction> million for the three and nine months ended September&#160;30, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i420d31c38e0944e3bb697025075df15e_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTEwMQ_c07a1a83-bb14-4f88-b0d3-18f450f43b1e">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6af618046aa747559d1a45f61351ac8a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTEwOA_363a9df4-0c4f-4cdc-8378-02e85f365c7a">33</ix:nonFraction> million for the three and nine months ended September&#160;30, 2019, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUwMA_a1402bc0-3b67-499a-a84e-3211a15a5d16" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi0xLTEtMS0w_3bc45f77-e8f5-447a-b841-aba1293c3ae8">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi0zLTEtMS0w_2c85b632-4da8-4094-8da2-865274d7253b">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi01LTEtMS0w_c9324b76-68fa-49dd-87c3-1b7733fe7fe9">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi03LTEtMS0w_0cc9ef65-d77e-455d-aac4-794029632ff4">4,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy0xLTEtMS0w_111fd3ce-7dc4-476f-851c-8e4dd12d362f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy0zLTEtMS0w_309fb649-e43f-43e7-8d37-97a6a27ed76f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy01LTEtMS0w_7f624fe0-7c28-4024-8813-443626128747">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy03LTEtMS0w_289f471b-354c-4818-a4f0-3466e7ef9343">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC0xLTEtMS0w_c676ee8d-0d4e-49f1-9151-c86a5b4dcc52">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC0zLTEtMS0w_d0909f3e-b364-401e-b382-826134597731">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC01LTEtMS0w_dffaf5bd-d11e-48a5-9648-dba1ac9471d1">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC03LTEtMS0w_250f3d5f-618f-4f2c-b7ed-31a8b33a925b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY0Nw_fd81aa24-e7b1-4712-ad62-0000ba7e7ff5" continuedAt="if28bd256b4e8496686471fef3ac91afa" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if28bd256b4e8496686471fef3ac91afa" continuedAt="i914347fdb9c64dadacedf31780f97dd1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2019 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i914347fdb9c64dadacedf31780f97dd1" continuedAt="i5025179cc421469eb235d4451e51e899"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMTQzNQ_4927195d-6036-421d-9e3b-a8c47aad471e"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMTQzNQ_94b2f75a-90e8-46f6-8376-6217e8fadfb0">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 or December&#160;31, 2019. <ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY1Mg_6379f98a-1742-442d-b473-bcb28fbc5b61" continuedAt="i9883d9f0e74d4e12a3ee822c2fd86b10" escape="true">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</ix:nonNumeric></span></div><ix:continuation id="i9883d9f0e74d4e12a3ee822c2fd86b10"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi0xLTEtMS0w_ed743942-d8ea-4dcb-9c70-3a5de40ad163">5,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9888da910534133b2a13752e0039eda_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi0zLTEtMS0w_aef62c93-8408-4273-818b-13b3e9d6d7dd">3,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi01LTEtMS0w_5f5f1793-416d-438a-8123-2c94c025128a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi03LTEtMS0w_0c382210-9392-4990-a93d-7292bbe0c4a8">9,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002016e409a046ca82eb2a7e9dbf5f44_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC0xLTEtMS0w_7256af20-5a9b-4d3e-88a1-3e5bf6aaf443">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4ea2ffdeae48c092313d22b4f64e1c_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC0zLTEtMS0w_92967ae3-c627-40f1-93d3-1e8ffb973d13">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0535ddebc7eb4e54bebfe38fe2a9b22b_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC01LTEtMS0w_affba0e9-e4fa-4aee-af04-8327c574dca7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib03ca448ca5c45b495bb1c94af6ea7f7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC03LTEtMS0w_d7c0ff02-9070-4ec7-86e8-c832d9686fa5">2,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a642414691e4b29b29ab8baba0a10a5_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS0xLTEtMS0w_1ff52993-2c01-47ee-b531-df9d616c3497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec3f94d59bd417b802264c8aefae9b3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS0zLTEtMS0w_7ca85638-57f8-4c79-adb1-503b56a76605">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f229849b6c24840ae258b5ab8a06762_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS01LTEtMS0w_99c43603-4997-4989-b131-8f5c6d90a8a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2675c3b1d0543ea9aa4c53740042175_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS03LTEtMS0w_b1297f35-b845-460c-80b6-a849db8a9e40">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95925aab9f5b4fcaa0bccf22427e5e67_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi0xLTEtMS0w_a860b18f-26e4-49be-b5ff-3269ff1330a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3c6cdcdd4340a4ba6b3cb06502146c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi0zLTEtMS0w_281c33aa-e5eb-49a0-8409-6f3004fecf14">8,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8083ca7f924d47b17ce8940d650a38_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi01LTEtMS0w_d7600107-26ec-4793-a7c9-9b3f94769a09">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468dd4fda3b442e99fc8328fba905b67_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi03LTEtMS0w_475be189-4286-4745-88b9-e434e537bde3">8,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf20fa45ec74aefb3382146c0b20236_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy0xLTEtMS0w_c1a982bc-0bfd-4d13-85dc-7d0c6dbf512a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6d327fadfd4b23954ab240ff677c47_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy0zLTEtMS0w_cafd25d2-a05c-481f-be52-68e8777315b3">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb1a14e2e774b2d837d4d7cdc423714_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy01LTEtMS0w_d3c1347c-3d20-40f8-ac69-e02192834e4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7045e35aa3d42f8b85edee8aa4d38ef_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy03LTEtMS0w_5c634fbd-1c4e-47d7-94ee-b4a30fb582b1">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364069c2b8ac4c28b31b5e1a40e551c3_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC0xLTEtMS0w_fae90e49-2b22-4145-8918-a4d8f0462d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8997d1471cf34a75beffddbb3c6148e4_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC0zLTEtMS0w_18b1e1bb-4782-49f1-9aaf-1f28ecad0c18">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37b8520c2d34c29948b799a01af328f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC01LTEtMS0w_d23ba829-00f0-4d08-b703-3cbe0af2bcdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1dfa73f59a451681e979540ce540ae_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC03LTEtMS0w_466f069d-54ff-4e0e-abac-2f80fdd8b752">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e538c30b555469794e0be3a6f8ed046_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS0xLTEtMS0w_cc0b6af6-ef24-4836-9c06-89e6b30c6853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb8f83e7c124df8a6cbf59fd5ce2c8f_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS0zLTEtMS0w_23cf689d-34e2-4620-94a1-c601c39d1459">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia29caa6d3bc347128a52855fa834c203_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS01LTEtMS0w_4d962a83-0eb1-4a44-820f-7a9b4502ad87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7526eeb0a2fd4ef4b130b931e3eb519e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS03LTEtMS0w_d6936507-6270-4709-85b7-a8aaa76d5b5d">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1dff5e36324924a4f2feec7a5a73d7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtMS0xLTEtMA_0d250963-aaa7-41e4-a4cd-b4b8ff24cca9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4060526c2c496981cc55c6977adb37_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtMy0xLTEtMA_e3aac57c-8f31-45d2-ba16-d160869b18d8">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4c4734bcc24fb0ae7cab1d303bded7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtNS0xLTEtMA_aef4dc84-8be1-4579-977b-1793460986a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec813f07a334f08955f4a12ac4902a5_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtNy0xLTEtMA_b95abb0b-3d39-4047-9f0b-02a2ffe2d587">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9add6b9a8641dfba7ba3deccb48b41_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtMS0xLTEtMA_bb7eb60e-cac1-49c3-8b0b-cfbbf59e62ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf45d10b231a4274b5a9ad0d08f997a7_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtMy0xLTEtMA_361e1b6c-56e1-42d0-8ad3-7b2ce2b7d4bc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe734fa96d842cc869a0c54975c7cac_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtNS0xLTEtMA_e7c58d75-0c67-4b2c-92f7-4164650455ff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eba4bdd839a45388341859be447f171_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtNy0xLTEtMA_ca2c486c-28dd-44ed-9742-1c3d93a8775c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItMS0xLTEtMA_652fe20b-c5fa-4990-a9d2-c9c68cf75484">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9888da910534133b2a13752e0039eda_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItMy0xLTEtMA_69b30bee-b93f-4b35-9d32-169b1fb227e6">17,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItNS0xLTEtMA_7b7d84ec-8cef-4c44-ac65-c41c22630417">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItNy0xLTEtMA_8f0ffc4d-08fd-47b0-98b4-ca9ba3c021b0">20,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtMS0xLTEtMA_46571cd5-80bf-4347-913f-19e50cdaf6d0">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9888da910534133b2a13752e0039eda_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtMy0xLTEtMA_542fd0ed-5de8-4d07-b9f2-14c007bd1bb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtNS0xLTEtMA_e23e8d35-954d-4a52-a7b4-1007f738bb43">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtNy0xLTEtMA_89096c7e-b981-43d2-a97b-87238a7ffd44">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtMS0xLTEtMA_3c7daf5a-cf17-444b-bc95-7607e95c1bd2">8,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9888da910534133b2a13752e0039eda_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtMy0xLTEtMA_ba69006f-16c0-4413-8a02-f00a437f19d7">21,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtNS0xLTEtMA_f5050fbf-ae12-4e4b-b5a6-31ee8feb63ed">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtNy0xLTEtMA_a1de1116-71cd-48bb-890d-5429fec57bdd">29,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctMS0xLTEtMA_2b71bcd0-466a-45c6-ae2a-7bd60772b7af">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctMy0xLTEtMA_fb032953-3aca-468c-b6bd-3ec7894a54d1">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctNS0xLTEtMA_62819a1d-08f5-4e8e-9451-3c11aa54984d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctNy0xLTEtMA_76877401-74a6-47ba-9944-de50d0ae49f1">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic92eabbcfc0e41129c6ebe1c3bb58c1c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktMS0xLTEtMA_499bbadb-041d-4ed8-94cd-758859a873ce">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i167492c1a5134840a68af5838d92c0a5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktMy0xLTEtMA_a8a907c7-7673-4738-abe2-15d7c7ee8fe8">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4875b0b5876478ea38a39e3ca94f3e4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktNS0xLTEtMA_4b4c529e-5451-4372-8457-d444986cac43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635d4a19627941fbabf18b73ba4a7f69_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktNy0xLTEtMA_e59deee4-0c0e-4d1b-895c-04426a09336a">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaaedc48c33f4ce9b4d61713e708492a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtMS0xLTEtMA_4880a98a-e914-4d91-b027-10e4a302017b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708f6416e0d84b7a86d62ca235435207_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtMy0xLTEtMA_2d5ea4a7-528e-46f7-bb9b-68ade9a15e23">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439528f07f334a2e9f9e37ae4c771d44_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtNS0xLTEtMA_0bc33fad-fcce-4a04-9415-13d5de69c87c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229361a7197a4afeb15eb2425729c789_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtNy0xLTEtMA_a3533182-a15b-432b-8b4a-8b02b38483bf">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769f8ad79eaf46d4b177922dba08206d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtMS0xLTEtMA_4fc7320a-6175-4987-8dfc-f0e21be8ceee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8f23ae3b94a519cee02e63f7e0a3c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtMy0xLTEtMA_990c1592-b021-47bd-b3d4-885a1466ba82">7,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6743b7888dc0448685e1853c25ff8440_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtNS0xLTEtMA_defd87ce-7b26-42b0-a1bd-b70908579629">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c704d6d14fc4be98279325dd3287aa2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtNy0xLTEtMA_e916c160-a62c-4614-beb8-b4a35eb47d74">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f13f39c72a49049b8ef64e5f5c7c0c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItMS0xLTEtMA_03fc7d77-bc77-4da0-8ff7-23a84633cae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2c5cc590d64e41aaf1d4feb53683e2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItMy0xLTEtMA_4e9a7bf1-f77a-47d9-a3eb-88491a7b646b">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5abbd3b9f046aeb99c9fba1e6dca0b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItNS0xLTEtMA_fd5aa5cb-d7d5-478b-a529-3937fe64fdad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i129439a18c454d088d7a6a8c35f27f78_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItNy0xLTEtMA_3754eb92-7d4f-45f1-8786-f735c3d26c0c">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7595fc1bc6054a7190199e2e60736d28_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtMS0xLTEtMA_85d74bc4-bda0-42bd-8181-d8ad941456c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748f4e8d7b5461196a5145bd6da1195_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtMy0xLTEtMA_894d6e90-9476-44d2-87ae-696ac110051f">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f855925c0344cb8356da40cd655821_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtNS0xLTEtMA_e7053df2-c07d-424b-b688-32d20e6d9372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8fd736ba76478e9162d84858b27634_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtNy0xLTEtMA_f8b966f2-f08d-42eb-9306-0c79d776eeb0">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07defd6e1d4056a5169e425552d20b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtMS0xLTEtMA_733b0eed-5292-46db-b83e-12c7d2b0302c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809ae28eeac24a9f9310746684a864d0_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtMy0xLTEtMA_7437394d-3d53-4586-b904-9e07fc4129fe">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155016131fca4d64850212170f3783f0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtNS0xLTEtMA_38b04f02-6d24-4dc4-a0f9-f0a3a6788d9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060cabf68768492aa7a6026696eef9be_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtNy0xLTEtMA_9205c685-ac10-4b91-acd1-3fea74aa575d">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b2f88bdb4a467e9d789f375c58180a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtMS0xLTEtMA_194d2dab-c9b1-4a4b-88ea-73b90104e568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a547cc68174a39b3376c9fff4a8994_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtMy0xLTEtMA_0a4eda9c-aef3-4eb3-9f9d-31a35f16a8de">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198821e71bd845749eae39a08b218939_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtNS0xLTEtMA_0b36a015-de98-486f-a17b-2d563940c77d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301877cb06e8403a8812ea5b4d398af3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtNy0xLTEtMA_866c9850-f220-49ba-8bc9-9f26bd2158c0">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0efa799796949ae89d8f49114056097_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtMS0xLTEtMA_97bd2969-8b71-4488-8e4d-d68bdb22ba19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89390455960d4f9f9c95e118937a1dc5_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtMy0xLTEtMA_66a751f3-ed97-4a9e-8f72-4f4d2d8318e2">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d17013fe24947c1b861b4825165d690_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtNS0xLTEtMA_4a926b93-af29-48bc-ade9-81a350a6b95d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc84a509c29542e8b93af8e853807f78_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtNy0xLTEtMA_c66d461e-0dd8-45d2-883c-1f4c6cb9ff0b">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctMS0xLTEtMA_13bb8dbf-5b3d-4867-a807-e682f9ef4cd8">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctMy0xLTEtMA_ec613497-801d-4a56-9bcf-5dad00c1df8b">15,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctNS0xLTEtMA_a0501e4b-4b1e-4f36-baa0-292ceef987c5">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctNy0xLTEtMA_46ce2e16-d55b-4565-9836-2a639a4c7fb7">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtMS0xLTEtMA_f6a0906b-0d10-4174-8ace-fbacf70ae788">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtMy0xLTEtMA_e0953027-b173-4cc5-a1ab-eba4f10e3b82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtNS0xLTEtMA_702c4c76-fe51-4615-8cb1-7f19462b4c5e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtNy0xLTEtMA_62913e46-8135-49da-b540-8340c25ff97f">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktMS0xLTEtMA_a894e92d-3ef1-43a5-bc80-bf259c93cd26">5,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktMy0xLTEtMA_8911a46d-79ee-4e44-b675-0462da84bd74">17,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktNS0xLTEtMA_335fa1ed-fa71-409c-8bc1-877034d5060e">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktNy0xLTEtMA_7e759bb8-af2a-485f-9ed9-4b63d8a264f7">22,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2020 and 2019, there were no transfers into or out of Level 3.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5025179cc421469eb235d4451e51e899"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY2MQ_6785bf1e-4a06-4f00-b7d9-5401d4b43529" continuedAt="i3719903b5b414b48a4af34df825479b1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC0xLTEtMS0w_b6886918-1703-402b-893b-f63bfa1c966a">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC0zLTEtMS0w_ed7948af-459c-4e1c-88c2-b20aa498af5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC01LTEtMS0w_f47de689-53ff-44e3-960f-8b917263a602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC03LTEtMS0w_32861a5a-9865-4d32-8b92-424958d9f9a6">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995c07a91519440c88d67c6c40193064_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC05LTEtMS0w_c0c07dfe-3375-446e-8cc0-c9225c9e1961">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNS0xLTEtMS0w_9389d2a0-0c4d-429b-bbaa-283f5cebe672">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC0xLTEtMS0w_9bd82808-3ddb-4cb0-b9c6-eab10197d2ed">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC0zLTEtMS0w_90ce0882-9744-40ce-8eea-a0bd3396d94c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC01LTEtMS0w_d4427de4-59d4-4735-b91a-e62ecf3feedd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC03LTEtMS0w_e858f557-aad5-4865-be14-822d8e067464">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995c07a91519440c88d67c6c40193064_I20200930" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC05LTEtMS0w_d503792a-9ced-462d-a584-513c23e6f057">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS0xLTEtMS0w_0d1236d9-999f-4711-ad77-7367590817ef">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS0zLTEtMS0w_25991d31-3a76-4421-b2a4-2b89683a3f8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS01LTEtMS0w_8a0ab6e5-e2ff-4de8-af4f-4d314bf3290c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS03LTEtMS0w_d4aebf07-34d7-444a-a195-b01f2783c509">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995c07a91519440c88d67c6c40193064_I20200930" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS05LTEtMS0w_2bbb5bb5-82dc-436f-8f8d-bd3d846dbc0a">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtMS0xLTEtMA_f17e2df2-077a-486d-84d9-cb471460816c">66,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtMy0xLTEtMA_446a1d81-59eb-4cd9-941d-f255f4f1fad7">76,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtNS0xLTEtMA_a9434cd1-5ed5-4080-a135-8e0047a57f6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtNy0xLTEtMA_bccd1baa-e660-404a-ab1a-91968263b159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995c07a91519440c88d67c6c40193064_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtOS0xLTEtMA_076cd3ed-f87b-4273-a629-51ee65855776">76,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtMS0xLTEtMA_3fbbce12-fdf6-4fc7-93ac-afc7203df577">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtMy0xLTEtMA_9b653b02-8a8b-437e-b9cf-791116102320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtNS0xLTEtMA_79247455-9294-4f43-acb6-1344f4974e2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtNy0xLTEtMA_ff36d747-fa00-423c-bffd-23aed0e601ae">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtOS0xLTEtMA_729b05a2-f3c2-4db1-b0e3-5c3f8eeab25d">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTUtMS0xLTEtMA_5d192544-620b-4cb1-a3c1-2814898da411">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtMS0xLTEtMA_1fc3c64e-9df1-406b-9714-34f33338808f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtMy0xLTEtMA_6b4215e6-3ad4-43f2-8e72-d1a3c94ff8af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtNS0xLTEtMA_82b107e4-0e4d-4c70-9ff4-9d4e694ec489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtNy0xLTEtMA_64353b95-68c3-4c73-bb76-6d75820c7041">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtOS0xLTEtMA_e3dd8ca6-5462-4043-a291-26845f798d7b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktMS0xLTEtMA_4dd12a04-e28c-41fe-af55-81fc5a7bd745">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktMy0xLTEtMA_dda7acdf-e267-4abb-9a0e-35d347fc077c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktNS0xLTEtMA_3819d4c6-03b8-43d4-a2b0-b1758ddfeb98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktNy0xLTEtMA_621f40cf-3282-4f6e-a8f2-bbb67b46d396">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktOS0xLTEtMA_f5cf18c2-0f81-474a-9473-f1fcd10fd61e">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtMS0xLTEtMA_29604d85-d641-48e7-9ed3-f59e74e443e4">68,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtMy0xLTEtMA_d28144af-5d76-4558-9904-0ab56c293295">74,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtNS0xLTEtMA_9044dc37-5eb9-4de9-b6d9-b23c8a0f4ea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtNy0xLTEtMA_31ebe259-1c91-44ba-9980-03d37a371c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtOS0xLTEtMA_fd2278e0-2839-4fcd-9c69-9483327edf55">74,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i3719903b5b414b48a4af34df825479b1" continuedAt="i334f51c778b245dbbd23cc3e4be1de27">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i334f51c778b245dbbd23cc3e4be1de27">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;<ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY1Nw_9aa02cf4-f651-4754-92df-1046b5579a15" continuedAt="i6ee9f42dd0b747b3ba634a2b20198c0e" escape="true">Separate Accounts financial assets as of September&#160;30, 2020 and December&#160;31, 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i6ee9f42dd0b747b3ba634a2b20198c0e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.243%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08dd08cbd4454361a90dbab797cd3aa2_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0yLTEtMS0w_18c9192d-28d4-4ff6-91b3-3edf65e35343">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a45a7920b14acea3f4b36636c4b5fd_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi00LTEtMS0w_f6a7f6bd-1646-4e56-b39b-5aa1ae6b1690">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a7cc610f9a46e2972dabe60f274ea7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi02LTEtMS0w_5dc4da48-d39f-407a-a9fc-c445dc2a8e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc004478531a4eadb516f49ab8f04d57_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi04LTEtMS0w_228327d7-14a2-4294-87d0-85bbc1fc7742">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc87fccbde24356929e17da657ef9be_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xMC0xLTEtMA_0650deca-0b21-440c-b505-100909fcee7f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec68f98e99d43249445dac606bfea53_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xMi0xLTEtMA_2f200d2d-2103-4b71-b17c-21a56324b932">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fe31f16b9d42d596559a375bd059c4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xNC0xLTEtMA_50524a1f-6853-4897-9054-5db641c87c58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecc8d5ee49f4089bcaf72ed79a73d73_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xNi0xLTEtMA_c2370de8-ea32-466e-9a65-db64105b8217">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f42424f53594322a0bc648503fa4144_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0yLTEtMS0w_1ec7f5ce-e3b1-427b-b024-ebfb40d71519">1,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c32977c1a344a48577bd5d98e4ae14_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy00LTEtMS0w_d01c6eaa-b9dc-45d0-8604-2e8870e3fd11">2,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177b612dc9f549628390175ae5e60944_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy02LTEtMS0w_e546d124-50f2-492a-a805-a0ce2cb434ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96792d9941740519779008d23a17bf0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy04LTEtMS0w_54432cb7-cea1-4bb7-9334-69bf65879642">4,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d1b93e21d042618a7cdb163a1f9a53_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xMC0xLTEtMA_4521a098-3c38-4874-8333-39ec8214e4be">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a2a3e0816441b96633eaefaae2f1c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xMi0xLTEtMA_cdda6f07-e12f-4978-8dab-a25ec5cfa437">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677b008b5750476a9b99ad7d720cd5aa_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xNC0xLTEtMA_9a6eae61-e4ed-4428-93a3-e17ea1b1c3bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320389b0cf034ae5a57bfdd9b1a683c2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xNi0xLTEtMA_6798d1f9-bd63-40c3-8000-889e0a8930ec">3,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e83a1132c904e35a130f8abd67d5f4a_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0yLTEtMS0w_e5538560-3737-4c2a-942f-f501df0de828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5079511b3a450aaca64bc154348d61_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC00LTEtMS0w_33d7edd4-ec4e-4e05-9511-56bda2193495">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804c778ec2814834b3d84dcb0310f508_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC02LTEtMS0w_8290784a-9e58-4784-b8c3-a3847622e0a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17cc174a92c415eb0fc76b28ecf0e1f_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC04LTEtMS0w_6b0d862b-8fba-442c-9c03-379630209063">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fa68066dc24311b7c8ce0a1c65ccc8_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xMC0xLTEtMA_ebfc7acc-b112-4c25-9e7f-28305c50acdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c741d96e344754add90a7638be6b23_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xMi0xLTEtMA_af283df6-551c-4b8c-be02-c2bba4f8c23c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24208d25b4f412ebb677befba70dfd9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xNC0xLTEtMA_2c3e32de-dcd7-4b70-89f1-86a92b3ea2d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb8de0cf862543a28ac57b9c9b4d9da1_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xNi0xLTEtMA_92b4b831-d321-4896-bc85-9183fe7a398a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8da6c47de724df685363819d15fd5d2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0yLTEtMS0w_00f1e704-60b8-40d6-b2b0-da63f8ce982e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435b788198344ed889fb7f41075b6e67_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS00LTEtMS0w_36ea55a2-1536-443d-83d3-8a23c4c2f4f8">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cf955793ec45129bc32f05a30f217d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS02LTEtMS0w_f92a9891-17d2-4160-af1e-f98bfed233fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e169ba85c734e9abcf8020fd97a8db5_I20200930" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS04LTEtMS0w_f30a5b76-1de1-4baf-a43a-913475b37fb2">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5856fd2c216349b8aeedbb9e1974b765_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xMC0xLTEtMA_bc7efac7-e174-43ff-b995-2f08d55ebeb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c9b66131ca4a539a74369e6146272b_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xMi0xLTEtMA_b32fdc1a-2e70-4777-ab98-c647d896b690">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bae9f24886e4178959c9e4374cf2d26_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xNC0xLTEtMA_6c407741-b124-4ad6-8c4f-c8e553287d31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b413c6d9cad4b9eacf86b8d064d8f7f_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xNi0xLTEtMA_36d21a65-1ab0-4f2f-bd8c-0c725ac50bd4">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0yLTEtMS0w_9b58e2b4-215e-45d5-bd18-72083f93d063">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9888da910534133b2a13752e0039eda_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi00LTEtMS0w_0fcff076-6b6e-474b-b5c8-c0aca8d3debe">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi02LTEtMS0w_c7fad4cb-6666-4580-83e7-671ff72338e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi04LTEtMS0w_285d3234-9c5c-4a7a-a3ce-d9583120ea42">4,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xMC0xLTEtMA_714d54fa-f0e7-477e-a803-89ce95e7d0ec">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xMi0xLTEtMA_69f9c4b2-1973-4fe6-801a-23598a939e73">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xNC0xLTEtMA_598d9568-20fe-49ba-9f2e-f491f155e546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xNi0xLTEtMA_e87d04aa-d61e-4575-9446-bc32121e54ea">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTgyMA_e5060f9e-37bb-4c9a-98fc-c2aab87f9d97" continuedAt="i5c91cc6a596f4bdb86270a376e375bcf" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5c91cc6a596f4bdb86270a376e375bcf"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTgwMA_e26bc72f-613a-453a-81a3-c93e1cb688b2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMi0xLTEtMS0w_c902659d-a2a1-4155-b262-cd4e879bc767">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMi0zLTEtMS0w_b62f92c9-f15a-454d-ad94-5579e2ea95f6">6,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMy0xLTEtMS0w_a29a8f7a-81c7-453c-95d5-6b8c4e461e60">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMy0zLTEtMS0w_5668820b-3c62-4b8d-80fe-344ff91d61db">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNC0xLTEtMS0w_67dd80c9-3d1f-4bd4-abba-8dc870f09594">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNC0zLTEtMS0w_2014af84-67d2-4f5e-bbce-0490276a75e0">6,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNS0xLTEtMS0w_15117df8-0b3b-4de3-bac6-cb50eada4412">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNS0zLTEtMS0w_bb6c028e-c3e7-4df9-b0bd-ec5de2f19058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNy0xLTEtMS0w_800e2064-d580-41a3-b5c7-e81bc00551c1">40,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNy0zLTEtMS0w_b5f89e65-1632-4b86-b90e-5812100f3dcb">39,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOC0xLTEtMS0w_fc1b6fb9-a351-486d-a5ac-124d22851265">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOC0zLTEtMS0w_2fad76c3-ad5b-4f5a-8f69-9023766ed85d">511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOS0xLTEtMS0w_c762bb83-9d13-4907-9fbc-c2fcfe3eb46a">40,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOS0zLTEtMS0w_2d5433fc-f142-4cd9-ae76-bcacd2db196c">39,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTEtMS0xLTEtMA_395a9a98-d8cb-4625-832f-7f4804caa659">34,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTEtMy0xLTEtMA_e1ed6744-744a-4b76-952c-767cae8e34fd">33,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTItMS0xLTEtMA_19bf1ffb-8850-4f47-92e7-2a8874d7e7db">5,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTItMy0xLTEtMA_2cea8399-04ed-4f9e-8799-bd9669e6e12d">5,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTMtMS0xLTEtMA_e33c608a-2da4-4339-9e98-64063004aa32">40,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTMtMy0xLTEtMA_5acacbd6-979f-4729-a016-913c8006bc8c">38,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie178c63026e949e8b2151622fca0263c_I20200930" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTQtMS0xLTEtMA_fa885f24-d70c-455f-9145-b7a20062e6c8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTQtMy0xLTEtMA_1f153d1d-75c5-4241-bcc9-ceb456d56abd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie178c63026e949e8b2151622fca0263c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTUtMS0xLTEtMA_5e5af134-1110-49a8-b631-adbb77074b97">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTUtMy0xLTEtMA_95b09848-940c-408d-8401-cb31b825896c">7,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie178c63026e949e8b2151622fca0263c_I20200930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTYtMS0xLTEtMA_14ea6572-c1d9-4ea5-865b-88e8a988ebf0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTYtMy0xLTEtMA_9dc68f11-a724-4267-8028-b96a6b645c8f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie178c63026e949e8b2151622fca0263c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTctMS0xLTEtMA_9d75367f-d263-4a30-9a30-d6c1b2a4bc00">7,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTctMy0xLTEtMA_cb22f8de-4950-4d8f-8eeb-67d828e2a39a">7,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2020 and 2019 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="ie178c63026e949e8b2151622fca0263c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMjc5_fa885f24-d70c-455f-9145-b7a20062e6c8">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMjg2_1f153d1d-75c5-4241-bcc9-ceb456d56abd">6</ix:nonFraction> million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMzkz_2a747f52-9497-4f4a-a127-ae605d375842">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNDAw_f3d2ac6e-ab73-4281-8da1-537bbefff3d1">31</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="i2f09e46e454f4475bc40352c0231eb93_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNjA0_4201f2db-9503-4180-991a-3dc4c1c321ac">173</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2c30244244a04895b2eb8f7a3183ed76_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNjEx_e7ef5ad2-532d-44f9-a74a-6bd01dcb5ab3">213</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfODgx_fc1b6fb9-a351-486d-a5ac-124d22851265">448</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfODg4_2fad76c3-ad5b-4f5a-8f69-9023766ed85d">511</ix:nonFraction> million, respectively, in the nine months ended September&#160;30, 2020 and 2019, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTY2MQ_70cea66b-a175-4de0-b02d-cb2b766b406e">5.8</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2020 related to the current year.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTA0NDUzNjA0Nzk1NzA_a2775197-5f6e-4a87-8b9f-8a2040a28e86" continuedAt="i43fa6281b9584e838d785bd1dbd1e02c" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="i43fa6281b9584e838d785bd1dbd1e02c" continuedAt="i0432d6191fa4495abe5fbc3ebdd5b4d8"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTcyOA_73714a92-9f82-4c67-924d-9f7d9c0a0116" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10e7590255dd44f183ff6175bce29c5c_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0wLTEtMS0wL3RleHRyZWdpb246MGE3M2E5ZTU1YmIzNDdiOGIwYjMzMzBiYmNjZmI5NWFfMjE5OTAyMzI1NTU5Ng_792c08c6-632b-48ed-b634-3679f0730286">3.125</ix:nonFraction>% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5880b165e61f444ab0e29a376c321d60_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0xLTEtMS0w_c07180dc-d275-4e9c-9c9d-4046725c56e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10e7590255dd44f183ff6175bce29c5c_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0zLTEtMS0w_b003d707-0afb-4269-9729-0a6fd824470e">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (<ix:nonFraction unitRef="number" contextRef="i0914af72006548ebbba484408464ae69_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0wLTEtMS0wL3RleHRyZWdpb246N2EwOGUzNzI5ODExNGRiOWE4YzFiNjM2MGJiN2I4MWRfMjE5OTAyMzI1NTYyNg_24255230-1906-47e7-8c50-38f3cc70c9b7">2.515</ix:nonFraction>% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1a7383071e4cc980e6c0e5a4147dea_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0xLTEtMS0w_9c990668-7131-496c-a8c8-2023ed3178f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0914af72006548ebbba484408464ae69_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0zLTEtMS0w_2e7b7a83-9ae1-42a0-8d3a-adba284e3e9a">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic05a1bb77adf449c9b884c612d910d6e_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0wLTEtMS0wL3RleHRyZWdpb246YjMyMDZkNjBlYjA2NGE3M2I3NjUzZWZkNjk1NWI0MTVfMjE5OTAyMzI1NTU5MQ_5c10ce24-c780-408a-9015-0fd74978429f">2.8</ix:nonFraction>% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd7c4fa4868462fa55280d3ecac3953_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0xLTEtMS0w_a712f63b-4f66-4c38-9504-33fa23ec153e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05a1bb77adf449c9b884c612d910d6e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0zLTEtMS0w_48471301-1b33-47ce-99a3-71fadf07c5b7">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i290ff092291647068477c613b2614b53_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0wLTEtMS0wL3RleHRyZWdpb246OTk1NjZhMjFmNDRiNGIxODg5NWUwYzI4N2I3MTE4MTlfMjE5OTAyMzI1NTU5NA_c478db03-d6e8-43a2-955a-007d61aa8f4d">3.35</ix:nonFraction>% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290ff092291647068477c613b2614b53_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0xLTEtMS0w_2cb915cc-d759-48d3-b939-a06e677c4004">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1687e1197697447ab1e252f736563f04_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0zLTEtMS0w_da9e0f73-0f7e-4edd-932b-16e7b463f88a">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (<ix:nonFraction unitRef="number" contextRef="i1096032d00f44b71b617c36d63d7f27e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0wLTEtMS0wL3RleHRyZWdpb246OGY3ZjVmZmY1OGExNDM2ZmIwMzdiZjVmZjM5OTZmNDZfMjE5OTAyMzI1NTY1OQ_9fffe524-cc3f-442b-9ae5-3013dda222cb">0.968</ix:nonFraction>% at September 30, 2020 and <ix:nonFraction unitRef="number" contextRef="id39b967136734ffebac4fa125d5df5e3_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0wLTEtMS0wL3RleHRyZWdpb246OGY3ZjVmZmY1OGExNDM2ZmIwMzdiZjVmZjM5OTZmNDZfMjE5OTAyMzI1NTY2OA_3ff38ec1-ed96-4428-8207-4b584a1da34a">2.605</ix:nonFraction>% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1096032d00f44b71b617c36d63d7f27e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0xLTEtMS0w_02ac3b6f-50bd-4737-be58-316dfd9a6785">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39b967136734ffebac4fa125d5df5e3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0zLTEtMS0w_f362ec98-0ee1-488f-857e-08119012691f">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieef7edab39324e21abec728d47812d6b_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0wLTEtMS0wL3RleHRyZWdpb246YmYzYWQwMDhlYmY2NDNiNGI4ZGY0ZDY4ZjgxOWVlMmVfMjE5OTAyMzI1NTU5NA_e1a5a21b-4205-483f-a375-ec71fb4b60c4">4.125</ix:nonFraction>% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef7edab39324e21abec728d47812d6b_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0xLTEtMS0w_adbfc993-d9c1-4ff9-953e-d2fa89a1cc09">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c6b0f2f62c74a8681f9cf380a9e3f2c_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0zLTEtMS0w_44fcbf32-72f4-485d-98ba-537fbf8887a2">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ee6ead635de4c95add163849dd94827_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MmNlNzRmMzRiNzRhMmI5OWQ5ZThlYWYyNmI1MTJlXzIxOTkwMjMyNTU1OTU_76accc0e-92a7-4b3c-8b7e-6e8c15e8ea92">2.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee6ead635de4c95add163849dd94827_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMS0xLTEtMA_08046627-421f-4184-8071-b97da40c3f3d">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05261bf78de439e95e77a97f7a95197_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMy0xLTEtMA_0dcfd32e-4ef2-42e8-a91d-e8f52acc2ebe">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib12e87c001794aeea0e7834103d4e29e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmNjYWI2YzQwMzQzMzRlYjdhM2RlZGY2ZDhmOTQ2MTFiXzIxOTkwMjMyNTU1OTU_e05065df-df93-41f3-8766-a78b4354437b">4.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12e87c001794aeea0e7834103d4e29e_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMS0xLTEtMA_c89e69e0-add8-41a8-9063-6facdede9a1f">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5b12f048374362ba07cace90c8eba9_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMy0xLTEtMA_b79ab6ae-3a40-4e63-a892-1af0ab539954">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53697dbc20eb4716841fa78a5b6d61e9_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjI1NjExODhhZmFjZjQyM2FhNjIxZTg0YWY1MDJjMmRkXzIxOTkwMjMyNTU1OTM_cea9055a-4bba-4a4a-bdf8-b4b4be00269d">5.45</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53697dbc20eb4716841fa78a5b6d61e9_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMS0xLTEtMA_516238aa-3b44-425a-99e1-1ff7938a3139">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671fb7b57b204d38a5ec9cc8478dd71a_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMy0xLTEtMA_b1f5bfbc-2b30-4866-a015-406dd85aa6c5">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99da7bf0574479c90df5ab707ce9ea4_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmRkMmRkY2EzNTlkYTQ2YTU4YjMzOTEzZjA4MWEwMjA3XzIxOTkwMjMyNTU1OTE_a0b28401-0dc1-4404-b0ab-3143c0c2428c">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99da7bf0574479c90df5ab707ce9ea4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMS0xLTEtMA_8b184767-aa1b-4628-9805-85c5d0b87806">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee9602d63244d01b24b8058303bf440_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMy0xLTEtMA_26c53af4-975a-4516-a2c4-8a3e2c5df990">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9b151bd651d4e21ad5aef18942c57f6_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjEwOTdmMGFkNGY0YjQ5YjY4YjA0OGY2MWZjZWM5NzAxXzIxOTkwMjMyNTU1OTc_524d2aef-9bd4-4b46-9bbe-80e37c097574">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b151bd651d4e21ad5aef18942c57f6_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMS0xLTEtMA_885cec6d-6f8a-45af-a451-3a524d65c3a6">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6c86974674b649712b3bfcb54b956_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMy0xLTEtMA_cba07b8d-1a1d-4c1a-b26d-5274469ee2b2">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc962ffe7759429a8437aeaf65091ad1_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjE2ZWFjNDYxZDFiOTQzNmViZmQ5OWI3ZjliYmIyOGNjXzIxOTkwMjMyNTU1OTc_43c82efe-a08d-4645-b74b-bddc55067709">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc962ffe7759429a8437aeaf65091ad1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMS0xLTEtMA_93426c1f-4ca6-4cb9-9918-570e5b953585">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30331d814224442fb860f94b9c7bdefb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMy0xLTEtMA_7f1668ab-e545-4889-a316-b6d6f27f6824">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dd553eacf7843ce91290bdb3c9f651e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZhNzY5NWEwZjM5MDQyNjQ5MTk1MTBkZmJkOGZlMDA2XzIxOTkwMjMyNTU1OTc_52f410dc-7c4e-4566-8a00-ccb0e311bbe4">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd553eacf7843ce91290bdb3c9f651e_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMS0xLTEtMA_99826068-d730-4160-8e2b-7e45f71aba44">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72d1e6a2e2e41db9701a9fd8bee5fa0_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMy0xLTEtMA_5f1e4036-db84-436b-9f5e-6c030b63d28b">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d529d43e45b4cdd914b2000673d53c8_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmExNTUzZmE0NjBhMDRjMmNiM2RmYWE4Y2VmN2UyNTIwXzIxOTkwMjMyNTU1OTI_33c4710a-33cb-4147-bc03-80b2ddfd3429">3.7</ix:nonFraction>% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d529d43e45b4cdd914b2000673d53c8_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMS0xLTEtMA_f1476fc8-15f5-4272-97f7-cffa5c07e520">3,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f2a6050d8c9472cad7e74ccbac0d7d3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMy0xLTEtMA_e09952d3-3505-48a4-aed5-ce5af29afe27">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i692d39424ece4bfe9add19706ba7a75e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNkNWFmYjExOWI5MzQ5MTBhYmZiMjgzYTQ1YTk1ZDNjXzIxOTkwMjMyNTU1OTE_5b18d48c-b4ac-41a7-8294-c8ebc4277b4a">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692d39424ece4bfe9add19706ba7a75e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMS0xLTEtMA_a19fa136-27f8-4760-9307-6b22feb407e2">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb1eda40037470b87e5c84de8742351_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMy0xLTEtMA_6d7f93ae-b14c-4371-bc68-dc2654ee6e3c">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1068e9886f384012b47c77ddf7440959_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjA2ZTNlZWQ0YjY2MDRlNDhiYjRiMTMxOTM2MDU3MjEyXzIxOTkwMjMyNTU1OTE_861949de-50cb-4079-85f6-f725535b81d5">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1068e9886f384012b47c77ddf7440959_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMS0xLTEtMA_8405b8ac-3423-4140-ad7a-d9eb5dc24444">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7982711b6d1a4518aa5760f4b6d81aca_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMy0xLTEtMA_58db42a3-5ffb-42c0-a59e-794533b02d58">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20445c4013da41559dd716a5e301fa58_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjRhNDg0OWMyMjAyYzQ4MjU4YjI5ZjZlNDhiMzFiYjJlXzIxOTkwMjMyNTU1OTc_7736e0b1-3d52-4020-822b-4752af91d28d">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20445c4013da41559dd716a5e301fa58_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMS0xLTEtMA_2f34b5ab-adff-4ad7-b972-2cc3e4c60c49">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2390853230664b71977471726c73ba84_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMy0xLTEtMA_cc2b6bed-50f2-408d-9fec-798eef91a282">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ddf756027c647808636299b132f954c_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjAzNWNkNjUyNDk2NjRkZGQ5ZGIwMmY4ZmJhNzU2MmFhXzIxOTkwMjMyNTU1OTc_1c5a6628-36db-46ba-986b-ec6c1f2e739f">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddf756027c647808636299b132f954c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMS0xLTEtMA_e101a58e-d7fe-46c7-88a1-4108fc5f46ab">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fbf2ddab2d45868cf34d8af1dc6657_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMy0xLTEtMA_2d1cd50d-aec3-4d43-9005-8039d09acf6d">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMC0xLTEtMC90ZXh0cmVnaW9uOmQwMGU3NzhhMjI2MDRlMDdhN2MwNTMxOTE1ZjBhZjQxXzIxOTkwMjMyNTU1OTU_a9e8810d-df48-4c71-a2b5-02e27d6a3366">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMS0xLTEtMA_9a585fc8-48ea-4a75-927a-2504741a42f4">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725a1515335644b2aaaf163a4dacff94_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMy0xLTEtMA_3f93bb37-3ef3-46a0-8aac-7bb964be9512">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f09caa84ded47ba85c938f104c825d0_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjMjQ1ODNlNzg3NjQ0ZDY5M2RmYTU2ZjMzNmY1ZWI5XzIxOTkwMjMyNTU1OTE_df6dd569-98cf-4848-9efb-0ff0dbf702bc">5</ix:nonFraction>% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f09caa84ded47ba85c938f104c825d0_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMS0xLTEtMA_3938caf2-ba04-4a47-80c7-35b26ff9eae9">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c767f7afed44d296aad898e2be1125_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMy0xLTEtMA_2fcabf67-deec-4a89-85f9-3fa0d6c784eb">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54826d3a4d644b189399b609a6f6a24b_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjM0MGEyYWYxNWI1ZDQ2OTU4NTk4NmNmNTAyYzZkMDg0XzIxOTkwMjMyNTU1OTI_e8381829-094d-4970-803d-92370e895f49">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54826d3a4d644b189399b609a6f6a24b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMS0xLTEtMA_e03fad10-34a0-4e89-92b9-85e8c80d5513">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8e1cf76b454cd8a76cf064eb597d2b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMy0xLTEtMA_14ed4292-7bcf-4bbf-9293-bf0c1915e2a0">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91d1a497cfd74fb8889de9ea721571bf_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmY2OWQyZGE0MDQ3YTRkZjliOWI2ODkwNzJmMTUzY2UzXzIxOTkwMjMyNTU1OTU_a951c6f2-f6e1-4c20-80e0-e9eba269146b">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d1a497cfd74fb8889de9ea721571bf_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMS0xLTEtMA_f8c89b4b-0add-4585-82a2-5dfb6180445b">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36df838d786c4c5d9ef71e79fbde110b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMy0xLTEtMA_831350c5-dc61-4dcd-ba72-088af0fed3e9">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic728b575d27e4aa8898383cf541680d0_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmE0NDdlZTg2ZThjNDRkZGZhZTJmOGY2NDYzNTgxNGM3XzIxOTkwMjMyNTU1OTU_f3cf8355-6add-456c-9346-6ca5d056caf7">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic728b575d27e4aa8898383cf541680d0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMS0xLTEtMA_9d964287-b3e8-4c17-9ead-84632a135d17">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a690e438fc46c8ae47a61d1dbb1690_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMy0xLTEtMA_bc70f99d-1ac6-4150-9da8-90ad7fcc8613">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0b249377f2f4ddab5d99416f68657bc_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmE0OTFiMmY1YzYxMTQ4NzNiMGY0YTBkOTE3NjBlNzJkXzIxOTkwMjMyNTU1ODk_29a1d386-5e69-4c26-9e78-653c073d8284">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b249377f2f4ddab5d99416f68657bc_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMS0xLTEtMA_dcbd60fa-ab37-4cf2-b86b-cb3d58da42ef">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b718b817d44528988a876de7fc8bf2_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMy0xLTEtMA_b0547ddd-4ebe-4aa1-a7ee-c192ff19e76a">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjhkMTI1MGU1OGYyYjQ1YmRhOTRmYzU5YTUxYzNmMWMzXzIxOTkwMjMyNTU1OTY_09f31c0e-9578-4918-bbc2-f7dbd24b7fd9">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMS0xLTEtMA_a111e3be-3e31-4cc8-b920-ce501e9c6301">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice8172ab47664fa9a3cd78759a4453a4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMy0xLTEtMA_ad9ba081-e5d0-457e-90f3-cc3e8fd3cfdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba7f24a8dbd0437fac060bebccc39eed_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmUxZDlmODdlNGIyNjRiNjJiZjdhNmU4MThkNWY3MzM1XzIxOTkwMjMyNTU1OTM_e4b8d9e5-ab3e-4a62-941d-766bbeb1f896">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7f24a8dbd0437fac060bebccc39eed_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMS0xLTEtMA_4aa3814d-d52b-458a-af14-f714e666e8f5">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853ba9286f1a4fcabce9a8524c725b25_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMy0xLTEtMA_faaf3716-3752-477f-9bb6-799d088c0dfb">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i709dc9e5843a46c29f7c3a14b5732a22_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMC0xLTEtNzgxL3RleHRyZWdpb246MjgzODJkYWM2ZGNhNDM4Y2FjNjYwZDRiM2NlOWViODRfMjE5OTAyMzI1NTU5Mw_49eb3ce5-7eaf-4a8f-b7c8-48575b0291ed">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709dc9e5843a46c29f7c3a14b5732a22_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMS0xLTEtNzg4_5405fbc1-7011-4d89-b2ee-a75988291124">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2b20e6c49d45d1ada51a71917b422a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMy0xLTEtNzg4_7e2eaf86-6c30-424f-a591-8bca2202af23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4ac59124dea453b8f6a7a1027357fb5_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmNjNTI0MTJiZTFjNzQ1Zjk4YTA0YzlkNmFhZjE3ZTEzXzIxOTkwMjMyNTU1OTI_76cd36fb-99d6-46fd-bbb9-957ec7aef820">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ac59124dea453b8f6a7a1027357fb5_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMS0xLTEtMA_2feb38f7-5d2d-4924-9bd1-9f397e2123a1">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ed3fbf4b98415aa629e39f421a73fd_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMy0xLTEtMA_9f716c89-c057-41ca-8b30-499ff09a8565">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee41f66d2eb34db7a37a170823c4e89a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjFhODc2ZjRiMWJjMDQyNDA5NGJlMzk0NjRiYmU1N2ZlXzIxOTkwMjMyNTU1OTU_921dec4b-63c0-4a24-896f-813390090c10">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee41f66d2eb34db7a37a170823c4e89a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMS0xLTEtMA_bdb31e78-d934-40e8-ae2e-482edf052100">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ee350b35ee4777be370e11b5e0e8a4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMy0xLTEtMA_bcd5f827-7535-47ab-aa8a-12fbed91503e">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i403edd61e4434a99a5791f10cbd76c78_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmMzZWNmMmJjNjI2YTQ3ZTc4NWFkNjJhYWU3MDA3MzIzXzIxOTkwMjMyNTU1OTQ_d2763cbf-e7b9-41be-a2fb-afbce0639ea4">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403edd61e4434a99a5791f10cbd76c78_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMS0xLTEtMA_25d01d65-78f5-46fa-868a-c9b2d11d973d">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6f61c9e98c4ce3b04854b705260b28_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMy0xLTEtMA_89d7d84e-230b-4a5d-8481-0205c46efe9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a81af6ba40a441fbb99ba18d09073bf_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMC0xLTEtNzkzL3RleHRyZWdpb246Mjk4YzE4YzI3NTdhNGM3OThhZWI5ZmQzZTFjZjU4ZTdfMjE5OTAyMzI1NTU5NQ_fcd00dcb-fe12-48e1-90c4-e0678e3f68ea">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a81af6ba40a441fbb99ba18d09073bf_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMS0xLTEtNzkz_e8418f1c-0b17-412d-9bd2-7a7dd05b2bc6">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53136fbe8f8d484aafe459d75dd67da8_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMy0xLTEtNzkz_5a143341-5a21-456d-9f58-3b52d653fda9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id83e3ca5e5b74832b482dc21dac47b15_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjRmMWU0ZDE1MGMwZDQ1NjI5M2Y5ZTNmMzcwNjMyZDU1XzIxOTkwMjMyNTU1OTU_b7ef5ae6-df44-4ce9-b6ce-b342afdf6c14">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83e3ca5e5b74832b482dc21dac47b15_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMS0xLTEtMA_66adc3a7-3851-41a5-8d09-3eed0f401f10">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4832233814146d4a72a43f532a81304_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMy0xLTEtMA_3fcf4332-1ed5-4c99-8786-8d702795d952">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1421fac4a46640f488484d0d2bb2f5da_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNDFhYjQ3NDc4NDRkYjg5MDVjYzk5MDZiM2IxOTcwXzIxOTkwMjMyNTU1OTU_fa3ec316-51eb-486b-a9a5-27008a5a2289">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1421fac4a46640f488484d0d2bb2f5da_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMS0xLTEtMA_6f96e781-ba80-4f49-87e9-48d725388164">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2c6ca07a2948c2bb32301edab7a7ef_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMy0xLTEtMA_60579b6f-9787-4a71-82c1-854d4359fb5d">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i295cc3434aa14c899d92fd789d23e4c9_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjc3ZjJhMGVjMDNiYzRlYjliZTk0MTA2MWE2NWI1ZGZkXzIxOTkwMjMyNTU1OTc_ea2c9133-c2b4-496e-9247-68ba748ec4b2">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295cc3434aa14c899d92fd789d23e4c9_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMS0xLTEtMA_bf6d5650-c0ba-49f3-bb88-919e0b123d0f">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f38e39469ec4110a0d65096dc00df6f_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMy0xLTEtMA_49c9bc93-0988-480e-be72-b42bba271bd9">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5334156d0c3043a1a13513caab4134b3_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmODE2NTEzYTk5NTQwMGI4MzViNzNmMTc5ODliMjI0XzIxOTkwMjMyNTU1OTQ_52cbe216-3b6f-481c-980a-ac3d0fe66bfa">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5334156d0c3043a1a13513caab4134b3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMS0xLTEtMA_e0828341-d628-4b57-93c7-14f1dca52765">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d294aded084369be74447b0566b76d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMy0xLTEtMA_f0e2dd3c-a6d7-40f7-b022-17c4cd4f39ce">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53b2ae62b51d4971b13d4146936f76ea_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjM1NTgwNTk2YjlhNjQ5OTliMzhhNDNmYjNhNWRlYWU1XzIxOTkwMjMyNTU2MDA_ff1981b0-d18a-4cdb-b584-376caca75049">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b2ae62b51d4971b13d4146936f76ea_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMS0xLTEtMA_c2a1500a-8f66-4633-a10f-03be371baea8">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a403ce8c3b4b3984c2e9eae3632214_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMy0xLTEtMA_26a9c359-353b-4b00-95f1-1ff1f00d5082">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7698bdf5f484e289bdc4f09e25197fd_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBhNjQ1ODMwNjI0NzQzNGJiYmY1NDI1NTg5NDZhYzQ1XzIxOTkwMjMyNTU1OTY_58d57713-6c5d-4e35-ac91-fc6c77a72fed">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7698bdf5f484e289bdc4f09e25197fd_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMS0xLTEtMA_995e786a-890c-465f-b4db-78ae128f10a5">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71438155734c4195a0f18f432a418662_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMy0xLTEtMA_aa5e5e21-b855-4539-8170-66d767225852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMC0xLTEtNzk4L3RleHRyZWdpb246MTgyNGM1NzQ2MmQ3NDQ0MDk3YWYwYTNiNWJhYTQwMTVfMjE5OTAyMzI1NTU5Mw_310aa345-8170-4c89-b079-8598afee7bdb">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMS0xLTEtNzk4_4190f4e9-ce53-4e62-9ed2-b164e84dde49">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac14079640e4ff682a4487baa41cc7b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMy0xLTEtNzk4_8ebe08fb-219d-45fd-8891-69e1ed5c1ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjFmMDlkN2I2MDJkZjRhZmY4MWY2OGM0MmYxOWM3NzMxXzIxOTkwMjMyNTU1OTI_0d11d0de-2a78-4c37-87f0-62223eea7b61">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMS0xLTEtMA_c5051bcd-1e61-479d-98f2-92adbd41a841">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id795774182b2476bac2cbbb06963df80_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMy0xLTEtMA_b6105281-0bda-46ff-a7a2-baa7a4e829e5">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24823ffe3a604cfd87e5693bf137f94f_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjA0OGM1NDBiMGFiMjRjYTQ4ODAzNTljZWU2OTRkZjk2XzIxOTkwMjMyNTU1OTA_0f019e16-259c-426e-9f92-340355330db9">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24823ffe3a604cfd87e5693bf137f94f_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMS0xLTEtMA_93a6aa23-1edc-45b8-bcc5-f4e80003a67e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8323c41a0e402cb82a2088c5ac0ff1_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMy0xLTEtMA_3eed6d70-fdc7-4d06-8b41-3bcda7e4813c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibddae3f3a8b04e22adc4e54bc250df78_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjVjMTJlMWU1YzU5YjRlYTY5ODhhNGMyMjIxODU4YjE4XzIxOTkwMjMyNTU1OTk_d016b50c-ed62-4f83-ac99-e5a535b8fddb">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddae3f3a8b04e22adc4e54bc250df78_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMS0xLTEtMA_ad51a8ee-51fa-428f-9844-e1acccaf7b77">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2004ef6f6a8e4c5ab2d44ad733bf043e_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMy0xLTEtMA_394fc80a-b783-44f7-9a6f-ccb4e38e9767">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMC0xLTEtMC90ZXh0cmVnaW9uOjE3MWVmM2VhOWJlMDRiMmI5NDAzN2M1ZWY3ODYzOWIxXzIxOTkwMjMyNTU1OTU_bdaeb1c2-85d6-4783-a847-7a92387c42b9">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMS0xLTEtMA_274871c8-32de-40c5-b67d-55eb46fe7293">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5b0ad50d4e42e6b07ebd012cfdd8ce_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMy0xLTEtMA_a028ffbb-629b-47a3-9ec6-ef568a19f1a5">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36748522e5764894aa532ad0b07acd87_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmM3MGRhMzA2NDVhMDQ3NGE5YTliNjY4ZTY3MTcwYTg2XzIxOTkwMjMyNTU1OTQ_2fa62041-eb7c-45ed-98fd-b23564ffcb5d">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36748522e5764894aa532ad0b07acd87_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMS0xLTEtMA_9327603d-9c54-438e-8adf-6b665727065e">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525c1d0146e54a86aa63f93fea6b7bdc_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMy0xLTEtMA_d5c65f4a-f94c-4587-b917-c367b234df27">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i78d21c6312ff4432b75d3a29c30a960a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ZjgzYTg4YzI1ZTRhNmU4Y2EyMDkwMmMwMTVhZDlkXzIxOTkwMjMyNTU1OTU_44c2b3ca-346b-4395-afe4-2e2c431b9adc">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d21c6312ff4432b75d3a29c30a960a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMS0xLTEtMA_3d7668a6-e098-4cd6-826c-5ff2e881bae6">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f231c679a8f48f69959c46f3f43d5cb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMy0xLTEtMA_af45d6da-f111-49a2-b37e-7386ba423cea">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cc6e467e0a04d77af59fb7584d3b906_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmYyNWQzMTcyY2IwNjQ5YTA4Y2RiMDMyZmI2Y2QzNjQ3XzIxOTkwMjMyNTU1OTc_ebc3da5f-478f-4528-9096-c0acbefa86da">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc6e467e0a04d77af59fb7584d3b906_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMS0xLTEtMA_73e7cf09-c99f-48bf-b5f2-d91adac0a4c3">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0bf72645713412a86166f550c1f16e5_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMy0xLTEtMA_66b3d54d-99aa-480a-9b88-444ee439f6d7">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba1978e8f8a84e28a8a31288a3036505_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4OWYwOGJhODI1ZjQ1NjI5MDM3YmM1ZDlkNTg3ZGE4XzIxOTkwMjMyNTU1OTQ_a749b7d5-6899-463b-8dda-1802c431e152">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba1978e8f8a84e28a8a31288a3036505_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMS0xLTEtMA_3d8fdd99-8b26-41e1-86ec-1dadab709dd1">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cdcd3fc23d468e902240ab83df8b0d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMy0xLTEtMA_b9f3eb69-a713-408e-9b5d-a8f45993abe3">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d07faa35b614fb1882b9aa697a66dec_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMC0xLTEtMC90ZXh0cmVnaW9uOmIxMjc1YWM4NjdlZDQ0MDM4NjEzN2NmNWU4MmNlNThjXzIxOTkwMjMyNTU1OTQ_a3f023ab-5505-4b74-998c-40b6de80605d">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d07faa35b614fb1882b9aa697a66dec_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMS0xLTEtMA_04911ac0-36b8-4c0a-a82d-2177322c8704">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia351b17fd331488f9c19c7092046c881_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMy0xLTEtMA_15f8290d-b972-4863-8732-bf3938130d56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDgtMS0xLTEtMA_ad247bd5-4178-47ab-9ae4-1e9f7242402b">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDgtMy0xLTEtMA_bc8582df-45a4-4a25-ae7f-30a947be8d15">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef337dc67864f7eace3d523637349d6_I20200930" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDktMS0xLTEtMA_0b0e9b4e-8575-485d-9202-91c1e775a6e1">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af1f185b125480693a0d0bad7b64abd_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDktMy0xLTEtMA_1037f69f-e003-4f6a-91f9-c2d5b940de91">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTAtMS0xLTEtMA_76ce274e-12c6-4f88-981b-8e34e33f0d76">67,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTAtMy0xLTEtMA_261c5e79-2f2f-4ce2-b835-9d478c0ef861">69,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTEtMS0xLTEtMA_4913e2a9-d1c3-42b7-8814-07d7cb3bcff7">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTEtMy0xLTEtMA_c5c9c33b-3e1c-48db-971b-a068781c1818">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTItMS0xLTEtMA_39461eb4-f0b6-433a-9136-5e277a7a1a1b">971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTItMy0xLTEtMA_0fc632d7-8290-48d0-9e54-bfc825f59ec5">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTMtMS0xLTEtMA_946db5b3-fde3-4a62-84b9-c9904f58feee">66,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTMtMy0xLTEtMA_3c0e09d5-a0af-438b-a221-e2cab0ad4847">68,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTYtMS0xLTEtMA_6573f1c4-40d0-4dfd-b014-c6bc1f0d4910">5,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTYtMy0xLTEtMA_aa40c2e2-4037-4a51-92f1-2621795c65b8">3,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTctMS0xLTEtMA_545fc636-d803-44f5-bdea-5fc3d8053520">61,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTctMy0xLTEtMA_42f37814-aab0-4eec-8584-8d6ac3ca2422">64,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0432d6191fa4495abe5fbc3ebdd5b4d8" continuedAt="i951dc8eb39644db1b5a20f234b39ba7a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i843befc9d57d4321b9c38aa68be69ba6_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQzMA_93210a8f-9677-4a02-a4b6-0e5c8ed111e4">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i843befc9d57d4321b9c38aa68be69ba6_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ0NA_e2f2b135-aed0-4325-a733-a3b32dc38847">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027, $<ix:nonFraction unitRef="usd" contextRef="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ1Nw_3366a195-4dab-4f72-b410-e67808038632">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ1MA_ba456f03-cd02-4852-b11e-ad6526489f12">1.75</ix:nonFraction>% unsecured senior notes due August 21, 2030 and $<ix:nonFraction unitRef="usd" contextRef="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ5Mw_cd3d8bda-fd37-490b-a1d5-4a3a98d5010c">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ3Mg_efb0cc1d-b005-4530-a79c-1e0169cafbb3">2.7</ix:nonFraction>% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ3OA_47f571b6-d02f-4b9d-903f-97868461488e">3.97</ix:nonFraction>&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i061be2ce53a44ed8a847d35fea3c64f7_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTY4_271ce3b3-c4e2-472c-932a-d1b52a96a947">750</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i061be2ce53a44ed8a847d35fea3c64f7_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjAx_2d58f738-884d-4f15-8d18-9b17e1ab5e3f">3.625</ix:nonFraction>% unsecured senior notes due April 1, 2027, $<ix:nonFraction unitRef="usd" contextRef="i87452d10eac74833a26ccdf16f72be6f_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjQ2_6bc7e3f6-1ded-4c43-b3f6-2e3b24a3af90">1.5</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i87452d10eac74833a26ccdf16f72be6f_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjc5_1548d19f-7ad9-47f1-b237-4ce076b591ef">3.75</ix:nonFraction>% unsecured senior notes due April 1, 2030, $<ix:nonFraction unitRef="usd" contextRef="i9e003f03dceb45b6a401dd0a2c15619a_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMzI0_da766d49-1d26-48f3-83e7-5a0f7b0e0c85">1.0</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i9e003f03dceb45b6a401dd0a2c15619a_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMzU3_2482ec0b-cd38-4dc8-a191-47850d2a5918">4.125</ix:nonFraction>% unsecured senior notes due April 1, 2040 and $<ix:nonFraction unitRef="usd" contextRef="if192035447e74302b3b24be7e300f710_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNDA1_90ea6b69-c09a-4a11-a1d7-5733689590aa">750</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if192035447e74302b3b24be7e300f710_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNDM4_0baf885c-3405-40f0-9971-a3013cb6f037">4.25</ix:nonFraction>% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i498d25aa22054a10a2a7f7f86ba2b5ca_D20200331-20200331" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNTUx_c354662b-a04f-4625-bb7e-b47525b1b80a">3.95</ix:nonFraction> billion, net of discounts and underwriting fees..</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings will be used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness. Net proceeds from these offerings that had not been used for these purposes were held in cash or temporarily invested in cash equivalents and short-term investment-grade securities from the date of issuance through September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $<ix:nonFraction unitRef="usd" contextRef="ic4418eeeb9274602937c479510064c2a_D20200301-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTQ3Ng_dc9550ee-600b-403c-9906-2ff21122bf22">7</ix:nonFraction> million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="ic4418eeeb9274602937c479510064c2a_D20200301-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTU3MA_ad0beb28-600e-4e9d-bea8-d8c9a7937380">5</ix:nonFraction> million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 8 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i5e13a337db4543e2918ef2db378c71fb_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUwOA_5f9e6789-41f2-4485-9d8a-176b92183a43">6.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="id1fdce6ad75c4a94a2c9df47616acacf_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUyMg_c5b2baaa-6db2-4ad1-8bec-afd2afb02c6d">723</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i19527741ed594ba2a6a1b439f15d1f49_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUzNg_6b60d057-87a3-4f63-8113-2f4f8fcdac99">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i8896274f8aba4673b336164474916d80_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU0Mg_719ec146-fa44-47f9-97c7-e96cc4c97ed3">2.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i1086a45a45914803b4b5787dac081a9a_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU1Ng_f09c5f02-72ca-4506-98c2-0e65073c204b">3.7</ix:nonFraction>% senior notes due 2023 and $<ix:nonFraction unitRef="usd" contextRef="ifa43f5d114584fe4aa281801f4cb6df2_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU2Mg_756cbd80-f697-4d5c-a68e-4d7165325e92">3.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i8025ef9777c14c2b9d133e87af8de5dd_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU3Ng_bc2c74ec-6258-412c-85c4-f94cb863e805">4.1</ix:nonFraction>% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU4Mg_93a4838f-2abe-4056-a8f8-db64c05c53cd">706</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjc0ODc3OTA4Mzg0MQ_4a599a17-473b-4308-9038-14e161155baa">47</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU5Ng_d10aa482-15dc-4c4a-8517-9674281977e9">13</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjYyMw_248abbc6-5f81-48e9-b162-bab86c62fa04">766</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i951dc8eb39644db1b5a20f234b39ba7a">In August 2019, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="if455866bb2bd467f974a25ce7e9a0bd0_D20190801-20190831" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTAzNg_13af9a79-52c8-4121-93ba-b49b7474c4a4">4.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i8891142b6e684accbc9446f2c1da9ada_D20190801-20190831" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA1MA_e59cee79-9900-4f69-9aa6-3ca3a5ff1946">1.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i0f8d8f94b69f47a29ef2ae02ad7c9700_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA2NA_46dcb06a-64c3-41b9-ad55-3a3a18171595">3.125</ix:nonFraction>% senior notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="i49583a4b71eb4d35821c7a34fc9f5dc6_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA3Mg_0c8d6e5b-efed-4748-a51e-baf8868b1ece">723</ix:nonFraction>&#160;million of its floating rate notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="ife76a2daf76247ed84df033b3381b3d4_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA4Ng_51021b45-3218-4821-905f-9ad22dd15b65">328</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="if522a3140edc49cbb22c0b24dc66107e_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEwMA_d9f25804-362d-4346-826d-b8fe7842baf3">4.125</ix:nonFraction>% senior notes due 2021, $<ix:nonFraction unitRef="usd" contextRef="i36780b12a24c4197ae6e8c1e76989a48_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEwOA_14ed443e-332b-497a-8b05-b0fd300637b6">297</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i6bf38eeaba3449eb825327fa22f6ee32_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEyMg_483f6d69-c750-4a8b-862a-c0cbb0b1579a">4.125</ix:nonFraction>% senior notes due 2021 issued by Aetna, $<ix:nonFraction unitRef="usd" contextRef="i59d7b49b81174a188a7693f6caaa62e3_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEzMA_10d09549-bd9d-4aaf-a76f-9979980f1277">413</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i7e462393116f4c15aeb568f785179398_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE0NA_537b371c-2b84-4cdf-81c0-dd1878150a37">5.45</ix:nonFraction>% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna and $<ix:nonFraction unitRef="usd" contextRef="i294e2fe0bdae40f7931db52b0a256b5d_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE2Mw_cdfcd4e6-64a8-4ae3-8b84-944f6def759d">962</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i34c3d891d1084f4599405d17248e8c8e_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE3Nw_8cd1f15e-fbd8-405f-9749-88374b979154">3.35</ix:nonFraction>% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE4NA_fbc6ed54-7497-436d-908e-5fb447b12e12">76</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $<ix:nonFraction unitRef="usd" contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE5Nw_32f30f1e-d665-4e63-87c7-fd994ae8faaa">8</ix:nonFraction>&#160;million in fees and recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTIwOQ_17bec69e-a1ea-413d-b7ee-877ccf55e0ec">5</ix:nonFraction>&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTIyMQ_630aa8c3-33b0-45f9-abb6-9d5cb1212cbc">79</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_67"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTM0Nw_43034f01-8fcd-4527-a70c-b7cc8d966c85" continuedAt="ib7d5261bfb194eeab64ce5af19d3ba8d" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib7d5261bfb194eeab64ce5af19d3ba8d" continuedAt="i133c3214cd2a4a00986505cdd3385d01"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$<ix:nonFraction unitRef="usd" contextRef="ic3a22a87b43d4b3db25373c50b610cbe_I20161102" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTk3_42d72815-deba-44c7-bb24-685dd25e026c">15.0</ix:nonFraction> billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the Company did <ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMjE5OTAyMzI1NjkzNg_6fad905d-9c6c-4538-ab8c-bb0becc1cb35"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMjE5OTAyMzI1NjkzNg_fc34cbec-1254-4c32-a90b-23fab1235178">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of its common stock. At September&#160;30, 2020, the Company had remaining authorization to repurchase an aggregate of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i92c166ab9cb14308b8faee78e708c5d7_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfNzcy_567b1f67-cc5a-47dc-afc1-9aa7dd1c941c">13.9</ix:nonFraction> billion of its common shares under the 2016 Repurchase Program. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i133c3214cd2a4a00986505cdd3385d01" continuedAt="iedb54f62030441648fdc899c9bc2ca22">Dividends</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iedb54f62030441648fdc899c9bc2ca22">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfODk4_f6f0993a-4e96-43f5-adef-3d0bb189df7f"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfODk4_fe9f2578-ef25-4bd7-9a2a-de19516e3526">0.50</ix:nonFraction></ix:nonFraction> per share in each of the three-month periods ended September&#160;30, 2020 and 2019. Cash dividends declared by the Board were $<ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTAwNQ_3eb4cf56-19fb-4015-a254-32cb73538494"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTAwNQ_f3f9aaab-5488-4cb8-aca5-f247bd752a61">1.50</ix:nonFraction></ix:nonFraction> per share in each of the nine-month periods ended September 30, 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfMTAxMg_fcde440e-2059-4608-8be3-7726d09ce76e" continuedAt="ic47ab36604c54d39bb656d74d6e4476b" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><ix:continuation id="ic47ab36604c54d39bb656d74d6e4476b" continuedAt="i14e8af6089a04878aa0ad69b326e686a"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfMTAyMw_5d098008-e06c-482c-b43a-bd0f763e5e48" continuedAt="i6872d430baba451e9b84b4e1e9daf30d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fe01249e54049baf6e493c3802193_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy0xLTEtMS0w_6cdaadf2-f7f0-41ec-94f4-645425108144">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia090d3a8eb844f89a10619bb3d2a6fff_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy0zLTEtMS0w_e5acac34-63e0-4cb7-90ad-637fa45ad14a">682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3d6f831699a4635bb458cb2de3b84ed_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy01LTEtMS0w_ebf35c94-e26a-4f70-83a5-00e3b20b5587">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c203fef43742668e532cda7f2c1fa5_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy03LTEtMS0w_4dbb0ce4-b3e3-4e75-a26c-feba9a4b69a9">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc1Nw_20a067ce-b7e2-4de8-8f90-fe33846b7fcc">83</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc2OQ_9e15f8ef-4812-46e3-9149-f42b3f2b0b5c">214</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc3NA_b7356065-c030-4f7f-a131-05db40dd6a7c">278</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc4Mw_1894d8f3-7c6a-421d-bc47-80d82f39206a">933</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0xLTEtMS0w_68d84624-da55-4dea-938c-5cfde6aa9cc7">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0zLTEtMS0w_c4f57fa1-1fb0-49af-8890-5bd0199eb894">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC01LTEtMS0w_19b679c9-5802-48e2-8f3d-11f8bdff864c">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC03LTEtMS0w_3af51fc4-b2ad-4207-92c7-f19bdb0cf2b0">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTc4Ng_7d0e310f-59a4-461a-99bf-486970c4a455">10</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTc5Ng_7b02b3de-6313-4173-a461-3216cb3a5d30">63</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTgwMQ_85973069-8ad7-4a10-b3a2-34ad0e7d991c">47</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTgxMQ_0ec14bb7-0e40-4b93-8a08-caa08044232a">93</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0xLTEtMS0w_e4729e22-234d-4e6e-8b93-00afa09e323e">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0zLTEtMS0w_43d2ec23-3f71-42d4-aa9f-7916d00f2db9">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS01LTEtMS0w_aec82515-d38e-4298-b7ea-7bc3d2f3c124">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS03LTEtMS0w_93c7d777-4baa-42ba-b85e-9678f6c54171">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi0xLTEtMS0w_be9f6680-bb6a-44d4-9de4-4143f8cdf543">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi0zLTEtMS0w_d9247206-6ceb-48da-b63d-1181f3e19e52">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi01LTEtMS0w_1470494c-7389-47b6-b325-f29af6c06da7">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi03LTEtMS0w_7761045c-edaf-4d60-bc7e-879e6bd5ee83">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806e7c9717c24de5ae7010f0f10b6be1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy0xLTEtMS0w_80d96037-af61-4ecf-a4ce-94353623eeaf">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy0zLTEtMS0w_8c3b745e-6477-4768-9af6-1c6e26ec7c16">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806e7c9717c24de5ae7010f0f10b6be1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy01LTEtMS0w_527f4b62-5250-4652-827f-d7a8aa72ce16">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy03LTEtMS0w_c2134718-caea-4049-a249-32368f665633">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i532f29edecec4969bbca5c16efb1f7f8_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtMS0xLTEtMA_13b63c0c-6b07-4ca0-8762-d00bdbdab1f0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i887ee4a7facc4fa4b18507f044b04878_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtMy0xLTEtMA_2bf67543-7e56-4d3f-b3c0-59bce90875f1">154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d0c1e1127646cf9d2d9831c80debd3_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtNS0xLTEtMA_306efc45-fbd0-45fd-a170-e6f5fda35fe3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a5c8430936e43eda7f07b5c38c9388f_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtNy0xLTEtMA_2f468e7d-36f2-4d8a-b3df-320f17250210">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtMS0xLTEtMA_5549e589-ceee-4e21-8644-a08f7a4b6756">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtMy0xLTEtMA_1883afd1-4f6f-40ef-b65c-e98348015b69">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtNS0xLTEtMA_890e3beb-3cb6-40f5-b3d9-022c941944f9">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtNy0xLTEtMA_0a163dd5-12e4-4c64-a1fa-e0a5a03fd979">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItMS0xLTEtMA_0ea80853-f843-4bf9-be2a-99c66823828b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItMy0xLTEtMA_7e1a18ac-b803-4c8b-9ba4-4e3b3da6a849">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItNS0xLTEtMA_1f900ed2-1a88-48da-99a6-550ec9542586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItNy0xLTEtMA_87c27b3a-5a20-4148-b229-791009198b9e">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtMS0xLTEtMA_87fd0c54-22e9-47ca-86f7-d74f05525350">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtMy0xLTEtMA_8800566c-38bd-4958-8b0c-4815f86ac1b0">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtNS0xLTEtMA_e6497d91-d86e-4723-b72c-caa8fd317273">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtNy0xLTEtMA_bf8d2223-eeac-4576-ae04-599ec6256d1c">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1f2fc8638c748e2aca4140e502531b2_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtMS0xLTEtMA_79f23402-8b42-470b-ab74-2e9560e09920">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45fef1a06e3647a1aef2f530c536a606_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtMy0xLTEtMA_a2708201-48d3-45f4-9699-9298aa42d0e2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1f2fc8638c748e2aca4140e502531b2_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtNS0xLTEtMA_1e99204b-d89b-4866-9a4c-f53fb1ab6d8c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45fef1a06e3647a1aef2f530c536a606_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtNy0xLTEtMA_e4a573ec-7341-4f90-8497-d570f5745d93">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ece21beb781421ebe511d131b9e50d9_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctMS0xLTEtMA_be5a9c9f-74d0-4406-9aa2-0879c4050647">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66dda08c143247a8bae039ee8451ac6b_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctMy0xLTEtMA_e1cee1d3-f586-4194-ba8e-b8b541c55287">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida4fa9aa910d43589adddf698dcbd90b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctNS0xLTEtMA_5e507725-3e89-46c7-919e-134c2e75d621">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f0779cac2746f3a5ecc01ccf789c9e_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctNy0xLTEtMA_f2a6900d-b90b-404c-8827-e579e3003f68">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3Mjk_d16feb34-aaa2-40d6-b082-ae56ecef1182">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3Mzk_6c0e80c9-5666-49bd-8abf-87b0a1ceb292">25</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3NDQ_754a1ac2-f441-4a6e-8a66-21a9cb963ab2">7</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3NTQ_af5cb58d-dcf9-4eb5-85d5-0dfd37976d9d">25</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMS0xLTEtMA_71878114-8b36-4505-a378-0c863eebb09f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMy0xLTEtMA_53bca2f6-e29e-4b2a-8acd-020ce16a1dba">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtNS0xLTEtMA_b0c3ffef-bff7-434d-861f-a1be485757aa">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtNy0xLTEtMA_491c4182-1dca-4856-b7ea-b847c0fbd1e9">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzIxOTkwMjMyNTU3Nzk_77eb0098-462d-4c7b-9910-02b3fbe05640">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2NzY_e224f66f-462c-4eb4-b068-95d56b18e940">7</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2ODE_16a0c8ba-8d5e-467a-a8c2-8a13a5958005">14</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2OTE_85d2dd1d-3c59-4eb8-b28a-d85a89f88430">16</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMS0xLTEtMA_2bd0be5a-25bb-4ffa-bec9-e10ed5d7eeed">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMy0xLTEtMA_2d871e50-d849-4f91-b805-ecccc2bbdf92">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktNS0xLTEtMA_e1bbdb27-57ef-46bf-8652-e1a1c48766c2">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktNy0xLTEtMA_c11fddf5-e32f-4a66-80b4-53811bf9a699">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtMS0xLTEtMA_8b786bf8-bb24-44b3-9303-9557a94863d5">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtMy0xLTEtMA_1cd1f953-3e84-4fb0-9ebb-fa257f287c67">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtNS0xLTEtMA_0e4f6edc-770b-4422-b06c-3023682f9dcb">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtNy0xLTEtMA_c086454f-3f64-4662-989a-43b2d082b173">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc549e0d312441788064313343cf78c_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtMS0xLTEtMA_ffa7ed06-c624-40c0-bf2b-c498ede30a24">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6190bd16f5314ec1bdde0d0603987e3b_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtMy0xLTEtMA_fbd29e14-24ab-4945-944f-b1432a8caa57">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc549e0d312441788064313343cf78c_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtNS0xLTEtMA_6a852d39-d821-47a6-a8d9-2f52d092af66">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6190bd16f5314ec1bdde0d0603987e3b_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtNy0xLTEtMA_e4c3d529-5052-4e45-844d-9f4889c2e49b">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4143146fd434706bd94dc49340308eb_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtMS0xLTEtMA_33d5530b-9c49-4e29-917f-0ec0f2c13cb7">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f4112b74f164d22820352e1af27ca00_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtMy0xLTEtMA_d9dfc464-5912-4ed6-9824-62488af7e911">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib11a29381a70499098c887d742f41133_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtNS0xLTEtMA_93ebb2de-5540-407e-b1e8-cf519370b1b1">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d24c8cf0b2f4ec892c7ae20e2399ec6_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtNy0xLTEtMA_b5b7e045-ae45-45f5-9fe1-174c1fcadbde">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MjY_8a7a2de5-2062-4dd0-9b6c-7601ed41d73b">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MzE_f678e11d-637e-4bfa-8f51-6e829331e9ea">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MzY_da443afa-dc7d-4147-b47d-a558c071093b">8</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1NDI_02d1912a-8f81-422b-89e5-b2d2380c0ff4">0</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMS0xLTEtMA_08b37113-e7d0-4ce5-bce3-e6ace9d0c58a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMy0xLTEtMA_3e8a5ac9-35de-45b5-8ff5-79d95f862f7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtNS0xLTEtMA_2fe79174-ff1d-41dd-9117-aa2927120f40">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtNy0xLTEtMA_47ce3e52-7bb6-4fbd-ac49-2667476f4977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MTU_674f10c0-9412-4711-adb6-3dbfa63c552d">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MjA_5dc23edd-24cc-4c2a-b203-44ef239e11dd">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MjU_4adf6341-aaad-468c-9f17-e866c1680cb4">7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MzA_bed656c3-ca3d-445d-a29e-4cff7035a3b6">0</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMS0xLTEtMA_a4b9237e-7330-456d-a982-4463d3a3b715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMy0xLTEtMA_cfdde4db-0508-46b3-88f2-2462fc0f53b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtNS0xLTEtMA_339ac4ad-704a-4ad4-9a90-905d5464720e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtNy0xLTEtMA_975f618b-c119-445e-a85e-8ae00f8d9540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctMS0xLTEtMA_501db79a-f722-4f16-b05c-bddc91384d2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctMy0xLTEtMA_31f8b024-e5fd-4f65-96df-78954cdd7992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctNS0xLTEtMA_bf319cdd-facd-4186-963d-a480ebbe7598">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctNy0xLTEtMA_052998ba-2e15-4ede-b617-6a57791a6ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13d90c20531f46398a0d5445c1b3360a_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtMS0xLTEtMA_77bd4563-ddf6-483c-baf3-3fa4ae18eaca">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i002debbf693d45699dc102ddca977a67_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtMy0xLTEtMA_719a0426-b12b-4764-947a-7b846ff546ba">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13d90c20531f46398a0d5445c1b3360a_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtNS0xLTEtMA_c5233b24-a323-45ea-a055-1fdfa3c395d7">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i002debbf693d45699dc102ddca977a67_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtNy0xLTEtMA_782c9c53-5e6c-49ad-ac27-d1ff4326fbc7">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1de9ff69c5421ebd0d98eec11a8353_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtMS0xLTEtMA_2b593809-da42-4353-b301-04c7d9243c38">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06db64b58cdf443580404215eb0ca740_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtMy0xLTEtMA_3f0a8b13-085a-4b9f-8052-9db53b35a30c">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23da5ced3c0741f280bab78905895c3c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtNS0xLTEtMA_c1413648-50d5-4079-bdeb-58fe6af0ff5c">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice3b96dd953547cc8f60a7fa1546fe88_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtNy0xLTEtMA_7f0309a0-f63f-49dd-9136-d5be52a9897f">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtMS0xLTEtMA_bca3fc5e-b6be-4645-8efe-fcfcc71580e7">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtMy0xLTEtMA_fccc7b60-34ce-46f9-be4c-4527f6b6c001">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtNS0xLTEtMA_dc8b9682-12d2-4d63-aa34-740cbe47499e">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtNy0xLTEtMA_e831ce69-fc13-4a11-9b1c-386507c8adf9">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6c79cc9de846d4be742316c0e6e179_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItMS0xLTEtMA_6ba900fc-1b74-49f4-83a3-4f7f0f174b5e">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5756ad275741ff8df69fcff86a17b8_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItMy0xLTEtMA_7f3632c1-8866-40bd-8502-404ee72861ba">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6c79cc9de846d4be742316c0e6e179_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItNS0xLTEtMA_50963bfa-bf36-43bd-9ea1-2b05bc8c8402">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5756ad275741ff8df69fcff86a17b8_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItNy0xLTEtMA_2448ea2d-168e-434a-a2f4-81ff0cb8b1a2">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="idfc549e0d312441788064313343cf78c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfNjcy_ca6ba635-2e14-45a0-8d9c-4ad31029fa75">15</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i14e8af6089a04878aa0ad69b326e686a" continuedAt="i167650fc2e7f41f282d788b60e5c3c9d"><ix:continuation id="i6872d430baba451e9b84b4e1e9daf30d" continuedAt="i7f694d7d118c48248c75b3f9c63615a4">(4)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i167650fc2e7f41f282d788b60e5c3c9d"><ix:continuation id="i7f694d7d118c48248c75b3f9c63615a4">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_79"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfODAz_35769693-945d-4967-bd5a-15ed59201917" continuedAt="iab327b4a2f9c4e3abb29b603313bcc06" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iab327b4a2f9c4e3abb29b603313bcc06"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfMTM1_70defab6-e7cc-4835-b590-f1faa9ebd29b">17</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfMTQy_6a3cc2ec-12e5-4865-a6a4-5c06475b8ead">16</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfNDk5_fb2cc34f-e6cc-487e-be0b-d75c304694a9">18</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfNTA2_29320977-d57e-44b1-bda7-0bd175f83a6b">19</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2019, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfODMw_ca280141-4334-497c-b7e5-566a6a57ccca" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy0xLTEtMS0w_9eb49812-b171-49a4-8005-8446a6962172">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy0zLTEtMS0w_298ff584-560f-4a88-be7d-6b6570721fb7">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy01LTEtMS0w_7523dadf-16e5-44be-99d2-59e4e2d4972e">6,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy03LTEtMS0w_48d58dfd-c254-4dfe-ab2d-422c5f8aed92">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC0xLTEtMS0w_2657533a-feef-4026-9cea-e7facdd41db9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC0zLTEtMS0w_97192140-7b65-47c0-9069-b8090b85f160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC01LTEtMS0w_6e5e72d7-4ad4-455f-af80-1baf5f47b9f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC03LTEtMS0w_6381fcb0-fd14-4e47-8cd1-dab3cbc1aac7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS0xLTEtMS0w_0eea4882-d369-49c9-ab85-439b96d4a6dc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS0zLTEtMS0w_3a15542f-9a99-4d70-aea0-20c4f22d425a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS01LTEtMS0w_e2f1e04e-3de2-458c-9b15-95b9da1ae09e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS03LTEtMS0w_07fb8865-76d5-48ca-829e-1f426f1a5ccd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi0xLTEtMS0w_e5bc22e4-1234-4b97-9284-5a2860e06e96">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi0zLTEtMS0w_c14f6f56-d958-48f3-84fc-6a25896638da">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi01LTEtMS0w_cd1edb3a-d216-48d1-84cb-a634ec628b3a">6,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi03LTEtMS0w_53770fcb-37cb-458d-8fc8-49ea89b9dc99">4,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS0xLTEtMS0w_82a052ae-0526-4e62-8c88-961ace14adee">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS0zLTEtMS0w_e1b7422d-b4d0-4276-92b7-25613635ae50">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS01LTEtMS0w_65dc8192-b31b-444a-a8ae-74285b737e4c">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS03LTEtMS0w_1397b619-08b8-4390-bb33-6896eda07668">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtMS0xLTEtMA_30587cb6-d89c-4b49-ac57-a33afa2ea106">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtMy0xLTEtMA_c9f037fb-780d-43a6-9842-c1c8ffc277bd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtNS0xLTEtMA_2503a495-6d0d-44f9-a401-550698733a0f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtNy0xLTEtMA_2f578c5e-51fc-452d-98ae-638d1c68cb65">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtMS0xLTEtMA_bcc933d0-7bd3-4107-8b0a-544a1f5abfc7">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtMy0xLTEtMA_ac5eeadf-7355-4060-a049-4f6fd36776bd">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtNS0xLTEtMA_38cd2c6c-9bbb-4bd2-a200-96ed9c953d24">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtNy0xLTEtMA_0bc4b594-6365-4593-b15d-1fd933bf9424">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtMS0xLTEtMA_9b742e8c-9ec0-40b8-8063-1a21d4a264c9">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtMy0xLTEtMA_4e040dc8-43b9-4753-b56c-5aea7171b83e">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtNS0xLTEtMA_fd7295ff-a517-4fbe-ad9d-f68b17374abd">4.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtNy0xLTEtMA_7e46e5f7-6b3b-411d-90c5-2c684a4efdf1">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtMS0xLTEtMA_eeea538d-9613-490c-867e-3831a66a93a1">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtMy0xLTEtMA_93dcfa0a-c9fc-41a9-927e-4b6fee039b83">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtNS0xLTEtMA_11bab2f5-cace-4e49-8a41-06abb9996ddb">4.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtNy0xLTEtMA_64ca15c0-54ba-40d0-8023-097dfbfed762">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_82"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMzQ2Mzc_3f953902-0f4d-45d8-92d7-a8de54fc06f7" continuedAt="ia2f99ac31f9d47b0ba855e8c038ed386" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia2f99ac31f9d47b0ba855e8c038ed386" continuedAt="iff6c802a1b2f4d26b3947d42adda7b70"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2020, the Company guaranteed <ix:nonFraction unitRef="store" contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjAxNA_7a338ac6-8c03-4b5b-8a38-2792b21aa9e7">76</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="iff6c802a1b2f4d26b3947d42adda7b70" continuedAt="i46c092b4f396446b89656746448f3963"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and this risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care insurers and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to numerous legal proceedings, investigations, audits and claims arising, for the most part, in the ordinary course of its businesses, including the matters described below. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. It is reasonably possible that the outcome of such legal matters could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company&#8217;s retail stores overcharged for prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price, and related theories. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Northern District of California) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Podgorny </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Northern District of Illinois). These putative class actions were filed against the Company in July and September 2015. The cases were consolidated in the U.S. District Court for the Northern District of California. Plaintiffs seek damages and injunctive relief under the consumer protection statutes of certain states on behalf of a class of consumers who purchased certain prescription drugs. Several third-party payors filed similar putative class actions on behalf of payors captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheet Metal Workers Local No. 20 Welfare and Benefit Fund v. CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plumbers Welfare Fund, Local 130 v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(both pending in the U.S. District Court for the District of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i46c092b4f396446b89656746448f3963" continuedAt="if2c724f1280545cd9d0526572632118f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rhode Island) in February and August 2016. In all of these cases the plaintiffs allege the Company overcharged for certain prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price. In the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case, the U.S. District Court granted summary judgment to the Company on plaintiffs&#8217; claims in their entirety and certified certain subclasses in September 2017. In June 2019, the U.S. Court of Appeals for the Ninth Circuit reversed the U.S. District Court&#8217;s grant of summary judgment and reversed the U.S. District Court&#8217;s narrowing of the requested class. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">case is proceeding to a trial on a six state class basis, and trial is scheduled to occur in 2021. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheet Metal Workers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiffs have amended their complaint to assert a claim under the federal Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;) premised on an alleged conspiracy between the Company and other PBMs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of Mississippi v. CVS Health Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (Circuit Court of DeSoto County, Mississippi, Third Judicial District). In July 2016, the Company was served with a complaint filed on behalf of the State of Mississippi. The complaint alleged that CVS retail pharmacies in Mississippi submitted false claims for reimbursement to the Mississippi Medicaid program by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price. In June 2019, the Company&#8217;s motion for judgment on the pleadings was granted in part and denied in part. Also in June 2019, the State of Mississippi&#8217;s motion to dismiss the Company&#8217;s counterclaim for declaratory relief was granted. In April 2020, the Company&#8217;s motion to dismiss the State of Mississippi&#8217;s second amended complaint was denied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blue Cross and Blue Shield of Alabama</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. v. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">CVS Health Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Horizon Healthcare Services, Inc. (d/b/a Horizon Blue Cross Blue Shield of New Jersey) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> CVS Health Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al. (U.S. District Court for the District of Rhode Island).  In May 2020, <ix:nonFraction unitRef="entity" contextRef="i179f470a0b494d8983ec636725d8d119_D20200501-20200531" decimals="INF" format="ixt-sec:numwordsen" name="cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfOTY3Ng_f55a075e-5b51-46f6-a12d-cdca5f2ecb5e">eight</ix:nonFraction> Blue Cross Blue Shield entities from <ix:nonFraction unitRef="state" contextRef="i179f470a0b494d8983ec636725d8d119_D20200501-20200531" decimals="INF" format="ixt-sec:numwordsen" name="cvs:LossContingencyNewClaimsFiledNumberOfStatesInvolved" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfOTcxNg_b4b448a8-4044-4d8f-b246-43b5e28ca1b7">six</ix:nonFraction> states filed a lawsuit against the Company alleging fraud and other state causes of action premised on a theory that the Company&#8217;s retail stores overcharged for prescription drugs by not submitting accurate usual and customary prices, including by not submitting the price available to members of the former CVS Health Savings Pass program. In October 2020, <ix:nonFraction unitRef="entity" contextRef="i36fa8765529c434ca15131ebec0fef35_D20201001-20201031" decimals="INF" format="ixt-sec:numwordsen" name="cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjE5OTAyMzI5ODQ1OQ_4b7d09c5-b1d0-4b75-8bd1-4cd923d54320">two</ix:nonFraction> Horizon Blue Cross Blue Shield entities from New Jersey filed an almost identical lawsuit premised on the same theories.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Klein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. v. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prime Therapeutics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. (U.S. District Court for the District of Minnesota). This putative class action was filed against the Company and other PBMs in June 2017 on behalf of ERISA plan members who purchased and paid for EpiPen or EpiPen Jr. Plaintiffs allege that the PBMs are ERISA fiduciaries to plan members and have violated ERISA by allegedly causing higher inflated prices for EpiPens through the process of negotiating increased rebates from EpiPen manufacturer Mylan. This case was consolidated with a similar matter and was proceeding as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re EpiPen ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In October 2020, the lawsuit was voluntarily dismissed with prejudice following denial of the plaintiffs&#8217; motion for class certification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">County of Harris, Texas v. Eli Lilly and Company, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Southern District of Texas).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This lawsuit was filed against Caremark, Aetna, the manufacturers of insulin and other PBMs in November 2019 by Harris County. Harris County alleges that it was overcharged for insulin as a result of a &#8220;price fixing conspiracy&#8221; between the manufacturers and PBMs to artificially increase the price of insulin and other diabetes medications. The complaint alleges violations of RICO and claims that the manufacturers and PBMs engaged in an &#8220;Insulin Pricing Scheme&#8221; whereby the manufacturers artificially increased the reported prices of their insulin products while &#8220;secretly&#8221; paying rebates to the PBMs in exchange for preferred treatment on the PBMs&#8217; drug formularies. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Direct Purchaser EpiPen Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the District of Minnesota). This putative class action (originally captioned as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rochester Drug Cooperative, Inc. v. Mylan Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was filed in March 2020 against Caremark, other PBMs and the manufacturer of EpiPen products and their authorized generics on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturer and PBMs caused the direct purchasers to pay inflated prices for these drug products. A nearly identical case was separately filed in the same court (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dakota Drug, Inc. v. Mylan Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.). The court granted a motion to consolidate the two complaints. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Direct Purchaser Insulin Pricing Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the District of New Jersey). This putative class action (originally captioned as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rochester Drug Cooperative, Inc. v. Eli Lilly and Co., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was filed in March 2020 against Caremark, other PBMs and the manufacturers of analog insulin products on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturers and PBMs caused the direct purchasers to pay inflated prices for these drug products. Two nearly identical cases were </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if2c724f1280545cd9d0526572632118f" continuedAt="iaac5ecda74c14ace8e5f7059bc0e18c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">separately filed in the same court (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FWK Holdings, LLC v. Novo Nordisk, et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Value Drug Company v. Eli Lilly &amp; Co., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court granted a motion to consolidate all three complaints. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. In April 2020, the Company&#8217;s motion to dismiss was granted in part and denied in part. The Company is defending itself against these claims.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states regarding its PBM practices, including pricing and rebates. In addition, the Company has received inquiries from congressional committees regarding insulin pricing. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several states. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company routinely is audited by the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;). In some instances, the Company is in discussions with the DEA and U.S. Attorney&#8217;s Offices concerning allegations that the Company violated certain requirements of the federal Controlled Substances Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Mohajer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed complaints-in-intervention in these two previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. With respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#8217;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mohajer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaac5ecda74c14ace8e5f7059bc0e18c6" continuedAt="i180eb4c6d9ad4984b656eabca29fed14"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by health care providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for these services and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by health care providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by health care providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of Health and Human Services (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately <ix:nonFraction unitRef="member" contextRef="i3ee66866f8fa4cbea112996fc3ef1389_D20130101-20130331" decimals="-2" name="cvs:LossContingencyAuditMethodologySampleSize" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjM3Nzk_68df1bfd-78d7-4972-9927-351b290585fc">200</ix:nonFraction> members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i180eb4c6d9ad4984b656eabca29fed14" continuedAt="ib53e9a2bade04f029a49beab336eacdd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RADV, Public Exchange related or other audits by CMS, the OIG, the U.S. Department of Health and Human Services or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and/or its current and/or former directors and/or executive officers are named as defendants in a number of lawsuits and a request for access to information initiated by holders or putative holders of CVS Health common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February and August 2019, <ix:nonFraction unitRef="claim" contextRef="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjY3MDM_85769abb-af9c-48a1-9554-5e9b9183d89d">six</ix:nonFraction> class action complaints were filed by putative plaintiffs against the Company and certain current and former officers and directors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat v. CVS Health Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., et al. (U.S. District Court for the District of Rhode Island); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund of Central and Eastern Canada v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (New York Supreme Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren Police and Fire Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et. al. (Rhode Island Superior Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambria Co. Employees Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (New York Supreme Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (Rhode Island Superior Court); and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford Twp. Police &amp; Fire Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al.) (U.S. District Court for the District of Rhode Island). The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit, which allegedly injured investors who acquired CVS Health securities between February 9, 2016 and February 20, 2019. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambria County</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases have been consolidated into a single action based on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases have been consolidated into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and stayed in favor of the earlier-filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a derivative complaint was filed against the Company&#8217;s directors and current and former executive officers in the U.S. District Court for the District of Rhode Island by a stockholder.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Lovoi v. Aguirre, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. makes allegations similar to those contained the <ix:nonFraction unitRef="claim" contextRef="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjg1NjI_6846dea7-3339-4782-ae08-6d0bf3107090">six</ix:nonFraction> stockholder class action complaints described above, including that the Company made false or misleading statements about its LTC business unit&#8217;s financial health. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint alleges claims for breach of fiduciary duty against the Company&#8217;s directors and certain of its current and former executive officers and for violation of the federal securities laws. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint seeks damages, restitution and equitable relief on behalf of the Company. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case has been stayed pending the resolution of the two federal class action complaints described above. The Company&#8217;s directors and current and former executive officers are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court in the District of Connecticut against CVS Health Corp., Aetna Inc., and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The Company also received a related document request pursuant to ERISA &#167; 104(b). The Company is evaluating these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information, arising, for the most part, in the ordinary course of its businesses. These other legal </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib53e9a2bade04f029a49beab336eacdd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTA0NDUzNjA0Njc3MzU_811b6ab3-44e4-4615-a8cd-204e03a3b195" continuedAt="ie2ecb1ee704c43d0a9b2de460480cee1" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie2ecb1ee704c43d0a9b2de460480cee1" continuedAt="i8a5c1f7b0be24c2d8f7e9a8b8897513a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfNDE_2a20636f-8c9c-4c2b-973c-15b984cca652">three</ix:nonFraction> operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMjA4Mg_2471abf5-17af-4f3f-937c-f25cfcb0a5fe" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0xLTEtMS0w_dcca9447-573c-487f-8bf8-6839b0a49939">33,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0zLTEtMS0w_858bff52-6629-4fe2-aa35-644dbfe67b5d">14,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy01LTEtMS0w_823584af-2b25-4d73-b281-5aee24599305">18,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy03LTEtMS0w_a7a44c78-7424-4956-955d-ee731406d128">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0xMS0xLTEtMA_41cf1534-d912-4e7f-a813-a0d440cb9731">66,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8388f3cbdf204618a0c21ce87efec0fc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC0xLTEtMS0w_a6af13ec-3aea-4671-86e6-466a78399774">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4c5da31094c308e8bb540b1f730da_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC0zLTEtMS0w_462e0d54-8bb7-4ed2-9993-434bd4cb961f">7,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ae38a4835db41f4845bb963973a4035_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC01LTEtMS0w_b2407eb7-3b99-4b5f-b6c9-d48d0dd43b9f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f49f9e47124de881a13135342b7fe2_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC03LTEtMS0w_d5dd496d-131f-4272-9e57-5e30a913d872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC05LTEtMS0w_fd01afbe-20ff-4d0b-b3d3-4d25408b616f">10,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0xLTEtMS0w_fcee38e0-6ebd-4ac3-9832-e3a35784dc88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0zLTEtMS0w_21f3f2ca-5e25-4f18-9143-82734a502593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS01LTEtMS0w_6ae7fa67-a1b0-4332-96d4-bbb366b665e1">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS03LTEtMS0w_7a0a9eba-5a34-48b0-aab9-fbd28fcb8e54">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS05LTEtMS0w_ba8323ab-f2bb-4545-851f-04430afa57b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0xMS0xLTEtMA_92cda39d-c1ad-4a55-9e06-746cc11860fc">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a375fb5ee4c4b4d97090ae3ad666b3f_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0xLTEtMS0w_c1a9e876-7df2-437d-a04f-a20d9f3538a2">35,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd7496cf7d94ef5b1210da043c5d38e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0zLTEtMS0w_4e6de545-affa-4c16-a788-5439e86a1dc1">22,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1a8fb583a743f49a6dc705dc12e525_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi01LTEtMS0w_f80daab3-a93b-49be-aaf0-fe59bfa0e8e0">18,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi03LTEtMS0w_946d22b9-2c88-470a-8956-850d6b875555">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi05LTEtMS0w_560984f9-6470-4959-9f18-fee1916db605">10,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0xMS0xLTEtMA_8e1a1081-6c78-4992-9414-d46d408dc294">67,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0xLTEtMS0w_1f9262a6-d72c-4958-b3fb-3c4dde47690c">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0zLTEtMS0w_acb3c950-8ea5-4294-89a4-ede7428fc301">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy01LTEtMS0w_217c3d31-02b4-4e48-8804-8543ec17ff2c">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy03LTEtMS0w_58ca6c95-8a34-40da-8ae0-f33f376c459b">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy05LTEtMS0w_5278e528-a61f-4ba8-8a2f-7ab9bed3685d">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0xMS0xLTEtMA_e4bf09bf-8821-4cf6-9475-0a4eb60726f3">3,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMS0xLTEtMA_71ff95f4-da16-4402-b143-6ed68636d33e">33,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMy0xLTEtMA_7b3c3006-c6c8-4334-99bf-bd6e4ac1c9b5">13,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtNS0xLTEtMA_dde99d67-cda9-4e8b-bdb9-0ebb2641fc55">17,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtNy0xLTEtMA_bb9df328-e9ed-43c1-a705-8c6583f6c47f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMTEtMS0xLTA_9644588d-38f5-43c6-b99d-8fd3fc5ebfaa">64,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1f86796440475bb5dab254521c724b_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtMS0xLTEtMA_ab242125-60b3-476e-8530-fd48bdb1e007">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a503222dd594312b47e70f69e82a446_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtMy0xLTEtMA_f3ad5d3c-bfea-4ae0-bc68-7fd97c9a2224">7,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2627fbff46e64b4f9394931c3b370f52_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtNS0xLTEtMA_c54bdbdc-e12a-473c-863e-fc0f2ee940ae">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92c3e405f2548aba08212e6d6583ed7_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtNy0xLTEtMA_42b76c3c-f4e8-4ff7-95b8-6974126500b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtOS0xLTEtMA_c5effbee-e945-48f9-89f8-64c5b6dab44e">10,007</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMS0xLTEtMA_11b867ac-f894-48c6-8c66-745939dfb89a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMy0xLTEtMA_e8bc5ce8-8f46-43fe-be25-7d64befc65a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItNS0xLTEtMA_fe1b2512-20b5-4124-bda1-f378a5cfd749">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItNy0xLTEtMA_492af779-ee9a-426e-b208-ff0effecb122">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItOS0xLTEtMA_6d7972ef-d982-4495-b7c8-d1f905237b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMTEtMS0xLTA_4b1048bf-88e4-4e9e-b4e1-e20c22cabf16">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8df98cf0a04c339a50aa5f67d358ee_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMS0xLTEtMA_8527061e-6844-4ef7-b537-b5d0e1038607">36,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMy0xLTEtMA_08b92ae1-7a6c-4499-9293-6932b3009e2a">21,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a36eaad3694582835456f3a0082533_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtNS0xLTEtMA_5b73cc77-5633-427b-a648-b5fec03ebc9e">17,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtNy0xLTEtMA_2ca1d05e-db2b-40a5-9508-14ce3c86a4b2">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtOS0xLTEtMA_a65cbfde-e4b0-4aa3-8330-f79eb4153d10">10,007</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMTEtMS0xLTA_0c3f49c9-db98-45cf-a707-edc72cfb1dff">64,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMS0xLTEtMA_67e87567-11b9-4b97-bd9f-0fa64266f0e4">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMy0xLTEtMA_e7a98c93-1342-4466-9359-2a41bb452be2">1,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtNS0xLTEtMA_d7fc5ec5-905a-45de-8435-bb93ee6669e7">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtNy0xLTEtMA_07f14265-12b9-49a6-9247-e7c7a584811d">252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtOS0xLTEtMA_43b2f059-3974-44ef-bf91-8d34d9bead94">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMTEtMS0xLTA_24edd912-c980-45ed-9b20-bda52d1426dd">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMS0xLTEtMA_9799b10e-7821-45e3-af81-773147087ed3">98,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMy0xLTEtMA_e6f9f6a8-17dd-4819-9aaa-db51079e651b">44,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtNS0xLTEtMA_f5beca17-b751-4558-ab1d-f33cfef9ab1e">55,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtNy0xLTEtMA_4d6ce627-4253-4b16-af65-b2273c307dd1">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMTEtMS0xLTA_48be7ce3-4c09-4698-9ba9-84cfe445333f">198,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9aea230b9c4ec19e0946224068182f_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktMS0xLTEtMA_a0718ded-0915-47ab-8a18-b545a5c4c0c7">7,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0a911dfbb042d1a2a8141db4da783a_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktMy0xLTEtMA_3bf9812a-c299-434d-bda1-ff0050c8bc81">22,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407b4198a444fda8eddc128dd850666_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktNS0xLTEtMA_9590892f-8b80-4365-9862-78ddf0233b8c">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc6d00c651d4a9881f30a84231714f1_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktNy0xLTEtMA_d93d67dc-ac18-41a9-b240-e77c82ba5725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktOS0xLTEtMA_c2404089-9f07-47da-a6b0-89ce3cd93310">30,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMS0xLTEtMA_f943de20-a510-46e8-a3e0-fad4c9f7a36f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMy0xLTEtMA_82c2a638-6f6f-48f0-bd0a-45016fad29e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtNS0xLTEtMA_2f67a743-4b17-47a9-b6f7-c3c1fce95e58">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtNy0xLTEtMA_3dcc9a8d-441b-4fc0-8fd9-446423e5cae6">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtOS0xLTEtMA_7a21d60e-5c21-496e-9b6e-1d462668c084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMTEtMS0xLTA_074c48ae-a4ed-407e-941c-05c591d651b5">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b3a1807d6d941108c13c5bb50477adc_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMS0xLTEtMA_e5d19016-9563-40bd-b894-1c0b05de3cb9">105,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b9b581f26241d4b1c1a12c4ed7691e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMy0xLTEtMA_f47eee04-5ba8-41a0-9e66-5a3f45236f8a">67,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtNS0xLTEtMA_ef50a517-d2b1-47a6-997f-6fa94a611e42">56,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtNy0xLTEtMA_00d65050-c5bf-4c5c-8b66-c9c32cac9da6">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtOS0xLTEtMA_a7292a34-c36e-47f3-9461-4b2197b89520">30,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMTEtMS0xLTA_9baff770-9043-4893-bd2c-61811fb0c967">199,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMS0xLTEtMA_5322a2a6-e628-48c2-a28d-6b13a9cb8c0d">4,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMy0xLTEtMA_764bc030-5beb-4699-be99-18097cebe88f">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItNS0xLTEtMA_301b019d-0583-4704-a359-ce90327e855b">6,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItNy0xLTEtMA_85b5a8d7-55eb-421b-af9c-d81095cd7ae4">931</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItOS0xLTEtMA_17b53bfd-19d6-44e4-a927-298069802f86">539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMTEtMS0xLTA_9548b6ac-3725-421c-8f4e-223aa13f6679">13,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMS0xLTEtMA_b04f5a07-f139-4361-9ceb-fbbbe04ae9ec">95,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMy0xLTEtMA_44dfc90f-fccb-4b4b-83a2-63932176c920">41,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtNS0xLTEtMA_691a232a-2927-4ef2-ac3c-a1bc5411e428">51,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9869200a1f51442783697741cd784346_D20190101-20190930" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtNy0xLTEtMA_e3e3f8ec-b68a-44db-a635-acc77277ba9c">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMTEtMS0xLTA_9f1479f3-06a5-42e5-9829-bcdac56c1a6b">189,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12078e54516c4cbea23a4ae0ac86658c_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtMS0xLTEtMA_ccb944d2-cf1f-4145-83ad-84911dc0fe97">8,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f020cf3db944a72b9e11f66eafb85a6_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtMy0xLTEtMA_2a38ef44-8bee-4025-ac05-cb6dee6cc173">22,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219c9f0ab1634e62be0cec75eb3d097b_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtNS0xLTEtMA_0b75b40b-b7f0-45d3-81b3-36e1a6c11605">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638894f045654cdb9cec4484de9042e8_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtNy0xLTEtMA_37586784-b533-4b52-b05e-b4cbd1be244e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtOS0xLTEtMA_93259c3a-533b-49db-96ad-1dae38e0b770">31,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMS0xLTEtMA_489744cb-ecb1-4649-b033-d2f13e4155fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMy0xLTEtMA_ec2b5070-d4a0-426f-9d61-27c5b541ceb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctNS0xLTEtMA_f3bd9b40-b4ed-4d4b-9b09-76f0a7e6a999">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctNy0xLTEtMA_444e237f-38bb-459d-947f-e52da4f5e65e">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctOS0xLTEtMA_da051905-6790-4a91-b1a9-e225da91f1ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMTEtMS0xLTA_f36cec3e-6de1-4e70-b5c6-9ebb18788519">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMS0xLTEtMA_38d54ef0-3bca-4604-acda-69ee9cf86d81">104,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMy0xLTEtMA_e4b4d0b9-c97c-4110-9b9d-9ab9030df612">64,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtNS0xLTEtMA_d59ec2b8-ab4c-407f-8e03-675bbde43f22">52,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtNy0xLTEtMA_0ede3688-95d1-4a3f-b01e-93470c422a0c">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtOS0xLTEtMA_57c1385d-1993-4d06-957a-0066507cedaa">31,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMTEtMS0xLTA_91a0a86a-108a-47bd-b867-cd0626e76248">189,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMS0xLTEtMA_05b4153c-16f6-4729-8a29-665291fae3c8">3,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMy0xLTEtMA_fe4a216e-7264-4307-8933-b2eedad4122e">4,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktNS0xLTEtMA_8969028c-3da0-46b8-b266-5f8b9cbd4aa8">4,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9869200a1f51442783697741cd784346_D20190101-20190930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktNy0xLTEtMA_847fe914-bfa9-41d2-b451-cc0ce64486df">685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktOS0xLTEtMA_72a83ffa-5d86-45c9-84b9-667baee7ae02">521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMTEtMS0xLTA_76457844-253d-411e-b207-22648b5d1a80">11,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTcxMw_b65d29ae-70f2-4c2e-839a-957bf04d99b3">2.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTcyMA_afafee93-0a58-4e06-a6ba-de7cd576b897">2.7</ix:nonFraction> billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTgwMQ_675d14ba-de47-4b98-84a3-132980d0f7f6">8.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTgwOA_122ead16-23e9-417d-bd1f-09c9477c9477">8.9</ix:nonFraction> billion of retail co-payments for the nine months ended September 30, 2020 and 2019, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span><br/></span></div><ix:continuation id="i8a5c1f7b0be24c2d8f7e9a8b8897513a" continuedAt="ie831ba7ceb844cc2a2d051ee1c582989"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMjA4Nw_ee2194f3-5e9e-43ab-92b5-15b54d8f9b05" continuedAt="i38f2818bf19e4957a921290ce5b512d0" escape="true"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi0xLTEtMS0w_69d683d6-ed69-4333-99d9-2e6b38dce50d">3,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi0zLTEtMS0w_63af6ea5-58f2-4373-9199-37c0f6752a61">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi01LTEtMS0w_97a11e81-06a6-4498-b74a-6352ce0b367a">11,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi03LTEtMS0w_429e653d-6f1c-4a00-ae51-de48a9ac37ab">8,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy0xLTEtMS0w_50099e62-198b-4c05-ab6e-5805862fc869">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy0zLTEtMS0w_54b25589-588d-4c34-8e97-2f3b899e6842">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy01LTEtMS0w_9239cda1-319f-491f-bef5-fc921bdc4ef6">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy03LTEtMS0w_7e89216c-8d61-4976-a862-b02678e723ed">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC0xLTEtMS0w_1f6b9042-8b9a-4f39-af0a-a001382f0e70">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC0zLTEtMS0w_d58fa948-ac12-45a8-9bc6-6f70cb5d94a3">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC01LTEtMS0w_e1c73087-dbd0-49cc-9ba2-f2ac8528e217">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC03LTEtMS0w_78e0f20d-0ddb-438a-ae6c-c7455c5879cd">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0xLTEtMS0xNjA0_fbd57d02-3835-4e31-8426-c8612f6cb2ec">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0zLTEtMS0xNjA0_25060fcb-fe36-430c-a415-e624983f2b4c">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS01LTEtMS0xNjA0_53499d52-cd7e-4ec5-9711-db5099a79bd0">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS03LTEtMS0xNjA0_34c0de12-be3c-4f38-ae2b-e2b6d76f3030">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0xLTEtMS0w_830812a6-5225-4897-b34a-10bacedf5c3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0zLTEtMS0w_0c22c60b-a788-453b-b0ab-332b198ee883">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS01LTEtMS0w_45b524b0-0dc4-473c-a124-9ef1cc63db7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS03LTEtMS0w_beae2782-b11c-4678-84e3-39180b260579">231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi0xLTEtMS0w_e4bf09bf-8821-4cf6-9475-0a4eb60726f3">3,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi0zLTEtMS0w_24edd912-c980-45ed-9b20-bda52d1426dd">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi01LTEtMS0w_9548b6ac-3725-421c-8f4e-223aa13f6679">13,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi03LTEtMS0w_76457844-253d-411e-b207-22648b5d1a80">11,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $<ix:nonFraction unitRef="usd" contextRef="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxMjIxMg_199a6b9e-39a1-4df0-8070-5fbf3bbe6b0b">850</ix:nonFraction>&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ie831ba7ceb844cc2a2d051ee1c582989" continuedAt="id862136eede442efb0d2e1c65384b27d"><ix:continuation id="i38f2818bf19e4957a921290ce5b512d0" continuedAt="i08afb29b4a374f1d9a9c8d35130cd638">(4)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="id862136eede442efb0d2e1c65384b27d"><ix:continuation id="i08afb29b4a374f1d9a9c8d35130cd638">During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of <ix:nonFraction unitRef="store" contextRef="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930" decimals="INF" name="cvs:NumberofUnderPerformingStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2Mw_d534b416-6b7a-443a-97ae-394ee8df09df"><ix:nonFraction unitRef="store" contextRef="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930" decimals="INF" name="cvs:NumberofUnderPerformingStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2Mw_fa5c0c93-670a-4b28-bb0c-a608aa38f87c">22</ix:nonFraction></ix:nonFraction> underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of <ix:nonFraction unitRef="store" contextRef="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930" decimals="INF" name="cvs:NumberofUnderPerformingStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2OQ_78537d59-d223-4db3-ab2f-85b29fb14ed3">46</ix:nonFraction> underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment.</ix:continuation></ix:continuation> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_1466"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8xMDQ0NTM2MDQ3OTYwOQ_c08aaca8-9e51-4116-844b-8c8b8eec8240" continuedAt="i1314b495945545a09700d6673b7e9524" escape="true">Subsequent Event</ix:nonNumeric></span></div><div style="text-indent:-9pt"><span><br/></span></div><ix:continuation id="i1314b495945545a09700d6673b7e9524" continuedAt="i00feaa180f194dc48fb8bf7e9d5ae90e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $<ix:nonFraction unitRef="usd" contextRef="iab600fe96ebf4cc0915b310db63417df_I20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainContingencyUnrecordedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjcxMjY0_eacb3440-81a6-4890-8436-8ff7fba81f4e">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. At September 30, 2020, the Company did not record any ACA risk corridor receivables because payment was uncertain. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i00feaa180f194dc48fb8bf7e9d5ae90e">On October 22, 2020, the Company received the $<ix:nonFraction unitRef="usd" contextRef="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjcyODIx_96b95e44-a729-47c5-a10e-99c7e7000ab2">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the fourth quarter of 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company expects to record pre-tax income of approximately $<ix:nonFraction unitRef="usd" contextRef="i775061c4d39a416ab23c7dc563cf24b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjY2NjY0_9e1aa5bc-a758-4854-a159-fd29f018ed54">305</ix:nonFraction>&#160;million and after-tax income of approximately $<ix:nonFraction unitRef="usd" contextRef="i775061c4d39a416ab23c7dc563cf24b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjY2Njc4_1cc69667-7db6-4968-8bbb-2eec122f8387">220</ix:nonFraction>&#160;million during the fourth quarter of 2020.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Review of Interim Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the accompanying condensed consolidated balance sheet of CVS Health Corporation (the Company) as of September&#160;30, 2020, the related condensed consolidated statements of operations and comprehensive income for the three-month and nine-month periods ended September&#160;30, 2020 and 2019, the related condensed consolidated statements of shareholders&#8217; equity for the three-month periods ended March 31, 2020 and 2019, June&#160;30, 2020 and 2019 and September&#160;30, 2020 and 2019, the related condensed consolidated statements of cash flows for the nine-month periods ended September&#160;30, 2020 and 2019, and the related notes (collectively referred to as the &#8220;condensed consolidated interim financial statements&#8221;). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December&#160;31, 2019, the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; equity and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated February 18, 2020, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December&#160;31, 2019, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Review Results</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November&#160;6, 2020</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is the nation&#8217;s premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, the Company is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. The Company is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 103 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 33 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services, and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and 2020 Outlook</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to severely impact the economies of the U.S. and other countries around the world, the Company continues to execute its preparedness plans to maintain continuity of our operations, while also taking steps to keep our colleagues healthy and safe. In accordance with governmental directions to shelter-in-place, eliminate large gatherings and practice social distancing, the Company has transitioned many office-based colleagues to a remote work environment. The various initiatives we have implemented to slow and/or reduce the impact of COVID-19, such as colleagues working remotely and installing protective equipment in our retail pharmacies, and the COVID-19-related support programs we have put in place for our customers, medical members and colleagues have increased our operating expenses and reduced the efficiency of our operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislative and regulatory environment governing our businesses is dynamic and changing frequently as described in more detail below under &#8220;Government Regulation,&#8221; including mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products. Federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 may not effectively combat the severity and/or duration of the COVID-19 pandemic and have resulted in, among other things, a significant reduction in utilization of medical services (&#8220;utilization&#8221;) that is discretionary, the cancellation of elective medical procedures, reduced customer traffic and front store sales in our retail pharmacies, our customers being ordered to close or severely curtail their operations, the adoption of work-from-home policies and a reduction in diagnostic reporting due to reductions in provider visits and restrictions on our access to providers&#8217; medical records, all of which impact our businesses. Among other impacts of these policies and initiatives, we expect an adverse impact on:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drug utilization due to the reduction in new therapy prescriptions; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store sales as a result of reduced customer traffic in our retail pharmacies due to shelter-in-place orders and COVID-19 related unemployment;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership in our Health Care Benefits segment and covered lives in our PBM clients due to reductions in workforce at our existing customers (including due to business failures) as well as reduced willingness to change benefits providers by prospective customers; </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Benefit costs due to COVID-19 related support programs we have put in place for our medical members and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The amount, timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items described above, we expect the adverse economic conditions in the U.S. and abroad caused by COVID-19 to continue at least throughout 2020 and possibly longer, resulting in increased unemployment, reduced economic activity, continued capital markets volatility, downward pressure on our net investment income and the value of our investment portfolio and lower interest rates. We also expect to see upward pressure on provider unit costs and changes in provider behavior as providers attempt to maintain revenue levels in their efforts to adjust to their own COVID-19 related impacts and other economic challenges. We may continue to experience similar adverse effects on our businesses, operating results and cash flows from a recessionary economic environment that is expected to persist after the COVID-19 pandemic has moderated. As a result, the quarterly cadence of our earnings is likely to continue to vary from historical patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the COVID-19 related matters described above, the Company expects it will experience the following key trends during the fourth quarter of 2020:</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to benefit from Specialty pharmacy growth and continued improvements in purchasing economics, partially offset by 2020 selling season net losses and continued price compression.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to experience continued reimbursement pressure. In addition, the Company expects the impact of COVID-19 will continue to result in incremental operating expenses associated with the Company&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pandemic response efforts, as well as reduced new therapy prescriptions and related front store volume, which will be partially offset by increased diagnostic testing.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The Health Care Benefits segment expects utilization of medical services to continue at more normal levels, with select geographies affected by COVID-19 waves. The Company expects to incur significant planned COVID-19 related investments in the Health Care Benefits segment, including premium credits, minimum medical loss ratio rebates and contractual requirements that benefit customers and members. The Company also expects to incur higher seasonal operating expenses during the fourth quarter to support readiness for the start of the 2021 plan year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue for the next several years as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern the Company&#8217;s businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above under &#8220;COVID-19 and 2020 Outlook&#8221; and below under &#8220;Government Regulation&#8221; are forward-looking statements. Please see &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; and the Risk Factors sections of this report, and the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the &#8220;2019 Form 10-K&#8221;), for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;) and the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) were enacted in March 2020. Each of the Families First Act and the CARES Act requires the Company to provide coverage for COVID-19 related medical services, in many cases without member cost sharing, in its Insured Health Care Benefits products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provides relief funding to health care providers to reimburse them for health care related expenses incurred in preventing, preparing for and/or responding to COVID-19 (provided no other source is obligated to reimburse those expenses) or lost health care related revenues that are attributable to COVID-19. The Company did not request any funding under the CARES Act. However, in the second quarter of 2020, the Company received $43 million from the CARES Act provider relief fund, all of which has been returned to the U.S. Department of Health and Human Services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also allows for the deferral of the payment of the employer share of Social Security taxes effective March 27, 2020. The Company has elected to defer its Social Security tax payments in accordance with this provision, and will remit the associated payments in two equal installments on or about December 31, 2021 and December 31, 2022, as required under the CARES Act. The Company deferred approximately $445&#160;million of its Social Security tax payments during the nine months ended September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Families First Act and the CARES Act, the Company is experiencing an unprecedented level of new laws, regulations, directives and orders from federal, state, county and municipal authorities related to the COVID-19 pandemic, most of which have been issued on an emergency basis with immediate, or in some instances retroactive, effect. These governmental actions include, but are not limited to, requirements to waive member cost sharing associated with COVID-19 testing and treatment, provide coverage for additional COVID-19-related services, expand the use of telemedicine, suspend precertification or other utilization management mechanisms (including review of claims for medical necessity), allow earlier or longer renewal of prescriptions, extend grace periods for payments of premiums or limit coverage termination based on non-payment of premiums or fees, modify health benefits coverage eligibility rules to help maintain employee eligibility, and facilitate, accelerate or advance payments to health care providers. Related governmental actions have required the Company to close or significantly limit operations at traditional office worksites and affected the hours of operation of MinuteClinic locations and the Company&#8217;s pharmacies. In some instances, the Company has taken permitted proactive actions consistent with more general regulatory directives, such as expanding home delivery of prescription medications, extending hours of operation for member assistance lines and liberalizing certain other terms of coverage. Similar directives have affected the Company&#8217;s international operations around the world. The Company anticipates additional mandates and directives from domestic and foreign federal, state, county and city authorities throughout the continuation of the COVID-19 pandemic and for some time thereafter, some of which may result in permanent changes in the Company&#8217;s operations or the health care and other benefits cost and other risks assumed by the Company. Further, although the Company has seen regulators relax certain requirements in light of the COVID-19 pandemic, such as temporary suspension of certain audits and extensions of certain filing deadlines, failure to provide regulatory relief or accommodations in other areas may result in increased costs or reduced revenue for the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of this governmental activity on the U.S. economy, consumer, customer and health care provider behavior and health care utilization patterns is beyond our knowledge and control. As a result, the financial and/or operational impact these </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 related governmental actions and inactions will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the collective impact could be material and adverse. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. The Company filed a lawsuit in August 2019 to recover the $<ix:nonFraction unitRef="usd" contextRef="iab600fe96ebf4cc0915b310db63417df_I20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainContingencyUnrecordedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xMDMvZnJhZzo3YTg2ZjA3NmU4MWM0M2IzYTZmMGVkMGUyMTMxYjAzOS90ZXh0cmVnaW9uOjdhODZmMDc2ZTgxYzQzYjNhNmYwZWQwZTIxMzFiMDM5XzU0OTc1NTgxNTU4NDM_eacb3440-81a6-4890-8436-8ff7fba81f4e">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. At September 30, 2020, the Company did not record any ACA risk corridor receivables because payment was uncertain. On October 22, 2020, the Company received the $<ix:nonFraction unitRef="usd" contextRef="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xMDMvZnJhZzo3YTg2ZjA3NmU4MWM0M2IzYTZmMGVkMGUyMTMxYjAzOS90ZXh0cmVnaW9uOjdhODZmMDc2ZTgxYzQzYjNhNmYwZWQwZTIxMzFiMDM5XzIxOTkwMjMyNzQ3OTg_96b95e44-a729-47c5-a10e-99c7e7000ab2">313</ix:nonFraction>&#160;million in funds owed to it under the ACA&#8217;s risk corridor program. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion explains the material changes in the Company&#8217;s operating results for the three and nine months ended September&#160;30, 2020 and 2019, and the significant developments affecting the Company&#8217;s financial condition since December&#160;31, 2019. We strongly recommend that you read our audited consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which are included in the 2019 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2020 vs 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2020 vs 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">136,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">121,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">187,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">180,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,950&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">869.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">869.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(74.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(64.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,663&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(327)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2020 vs. 2019 </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.2 billion, or 3.5%, in the three months ended September&#160;30, 2020 compared to the prior year driven by growth in the Health Care Benefits and Retail/LTC segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $124 million, or 1.4%, in the three months ended September&#160;30, 2020 compared to the prior year. Operating expenses as a&#160;percentage of total revenues were 12.6% in the three months ended September&#160;30, 2020, a decrease of 70 basis points compared to the prior year. The decrease in operating expenses was primarily due to (i) a $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business, which occurred on July 31, 2020, (ii) the absence </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of a $205 million pre-tax loss on the sale of the Company&#8217;s Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) and a $96 million store rationalization charge, both recorded in the three months ended September 30, 2019, and (iii) the favorable impact of enterprise-wide cost savings initiatives in the three months ended September&#160;30, 2020. These decreases were partially offset by the reinstatement of the HIF for 2020, incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and increased operating expenses associated with growth in the business.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $321 million, or 11.0%, in the three months ended September&#160;30, 2020 compared to the prior year. The increase in operating income was primarily due to (i) the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business, (ii) the absence of the $205 million pre-tax loss on the sale of Onofre and the $96 million store rationalization charge, both recorded in the three months ended September 30, 2019, (iii) improved purchasing economics in the Pharmacy Services segment, and (iv) the favorable impact of enterprise-wide cost savings initiatives in the three months ended September 30, 2020. These increases were partially offset by declines in the Health Care Benefits segment, largely attributable to the impact of planned COVID-19 related investments benefiting customers and members, and continued reimbursement pressure in the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating income of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $16 million, or 2.1%, in the three months ended September&#160;30, 2020 compared to the prior year primarily due to lower average debt in the three months ended September&#160;30, 2020. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended September&#160;30, 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million. During the three months ended September 30, 2019, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $4.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such senior notes in August 2019, which resulted in a loss of early extinguishment of debt of $79 million. See Note 6 &#8216;&#8216;Borrowings&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate was 32.5% for the three months ended September&#160;30, 2020 compared to 28.3% for the three months ended September 30, 2019. The increase in the effective income tax rate was primarily attributable to basis differences on the sale of the Workers&#8217; Compensation business in the three months ended September 30, 2020 and the reinstatement of the non-deductible HIF for 2020. These increases were partially offset by the absence of the impact of the sale of Onofre in the three months ended September 30, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $9.3 billion, or 4.9%, in the nine months ended September&#160;30, 2020 compared to the prior year driven by growth across all segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $815 million, or 3.3%, in the nine months ended September&#160;30, 2020 compared to the prior year. Operating expenses as a&#160;percentage of total revenues were 12.9% in the nine months ended September&#160;30, 2020, a decrease of 20 basis points compared to the prior year. The increase in operating expenses was primarily due to the reinstatement of the HIF for 2020, incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and increased operating expenses associated with growth in the business. The increase in operating expenses was partially offset by (i) the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business, (ii) the absence of the $231 million of store rationalization charges and the $205 million pre-tax loss on the sale of Onofre, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">both recorded in the nine months ended September&#160;30, 2019, and (iii) the favorable impact of enterprise-wide cost savings initiatives in the nine months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $2.4 billion, or 27.2%, in the nine months ended September&#160;30, 2020 compared to the prior year. The increase in operating income was primarily due to (i) the impact of the COVID-19 pandemic, which resulted in reduced benefit costs due to the deferral of elective procedures and other discretionary utilization in the Health Care Benefits segment in the nine months ended September&#160;30, 2020, (ii) improved purchasing economics in the Pharmacy Services segment, (iii) the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business, and (iv) the absence of the $231 million of store rationalization charges and the $205 million pre-tax loss on the sale of Onofre, both recorded in the nine months ended September&#160;30, 2019. These increases in operating income were partially offset by continued reimbursement pressure and incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts in the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating income of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $72 million, or 3.1%, in the nine months ended September&#160;30, 2020 compared to the prior year, primarily due to lower average debt in the nine months ended September&#160;30, 2020. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the nine months ended September&#160;30, 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million. During the nine months ended September 30, 2019, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $4.0&#160;billion of its outstanding senior notes pursuant to its tender offers for such senior notes in August 2019, which resulted in a loss of early extinguishment of debt of $79 million. See Note 6 &#8216;&#8216;Borrowings&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate was 27.2% for the nine months ended September&#160;30, 2020 compared to 26.7% for the nine months ended September 30, 2019. The increase in the effective income tax rate was primarily due to the reinstatement of the non-deductible HIF for 2020 and basis differences on the sale of the Workers&#8217; Compensation business in the nine months ended September&#160;30, 2020. These increases were partially offset by the absence of the impact of the sale of Onofre in the nine months ended September 30, 2019 and the favorable resolution of certain income tax matters in the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 11 &#8216;&#8216;Segment Reporting&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.5 billion and $2.7 billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.5 billion and $8.9 billion of retail co-payments for the nine months ended September&#160;30, 2020 and 2019, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment eliminations relate to&#160;intersegment revenue generating activities that occur between the Pharmacy Services segment, the Retail/LTC segment and/or the Health Care Benefits segment.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5.3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charge </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Company&#8217;s acquisition (the &#8220;Aetna Acquisition&#8221;) of Aetna Inc. (&#8220;Aetna&#8221;). The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2020 vs 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2020 vs 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">115.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel): </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">528.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">509.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,575.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,480.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">447.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">430.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,333.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">230.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Pharmacy Services segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $307 million, or 0.9%, to $35.7 billion in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by previously disclosed client losses and continued price compression, partially offset by growth in specialty pharmacy and brand inflation.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include store and administrative payroll, employee benefits and occupancy costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $40 million, or 10.6%, in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by lower amortization expense in the three months ended September 30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 0.9% and 1.0% in the three-month periods ended September&#160;30, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $224 million, or 16.7%, and adjusted operating income increased $180 million, or 12.5%, in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by improved purchasing economics and growth in specialty pharmacy. The increase was partially offset by continued price compression and previously disclosed client losses. The increase in operating income also was driven by lower amortization expense in the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on operating income and adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 4.1% to 447.7 million claims in the three months ended September&#160;30, 2020 compared to 430.2 million claims in the prior year. The increase in pharmacy network claims processed was primarily driven by net new business, partially offset by reduced new therapy prescriptions in the three months ended September&#160;30, 2020 as a result of COVID-19.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 1.5% to 80.5 million claims in the three months ended September&#160;30, 2020 compared to 79.3 million claims in the prior year. The increase in mail choice claims was primarily driven by net new business and the continued adoption of Maintenance Choice offerings. The increase was partially offset by reduced new therapy prescriptions in the three months ended September&#160;30, 2020 as a result of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 87.9% in the three months ended September&#160;30, 2020 compared to 88.1% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily due to an increase in brand prescriptions, reflecting an increase in flu immunizations in the three months ended September&#160;30, 2020 in comparison to the prior year. The Company believes the segment&#8217;s generic dispensing rate will likely increase in future periods, affected by, among other things, the number of new brand and generic drug introductions and the Company&#8217;s success at encouraging plan members to utilize generic drugs when they are available and clinically appropriate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $1.2 billion, or 1.1%, to $105.6 billion in the nine months ended September&#160;30, 2020 compared to the prior year primarily due to growth in specialty pharmacy and brand inflation. The increase was partially offset by previously disclosed client losses and continued price compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $62 million, or 5.6%, in the nine months ended September&#160;30, 2020 compared to the prior year primarily driven by lower amortization expense in the nine months ended September&#160;30, 2020, partially offset by incremental operating expenses associated with growth in the business. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.0% and 1.1% in the nine-month periods ended September&#160;30, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $562 million, or 16.6%, and adjusted operating income increased $445 million, or 12.1%, in the nine months ended September&#160;30, 2020 compared to the prior year primarily driven by improved purchasing economics and growth in specialty pharmacy, partially offset by previously disclosed client losses and continued price compression. The increase in operating income also was driven by lower amortization expense in the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 6.7% to 1.33 billion claims in the nine months ended September&#160;30, 2020 compared to 1.25 billion claims in the prior year. The increase in pharmacy network claims processed was primarily driven by net new business, partially offset by reduced new therapy prescriptions  in the nine months ended September&#160;30, 2020 as a result of COVID-19.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 4.7% to 241.1 million claims in the nine months ended September&#160;30, 2020 compared to 230.3 million claims in the prior year. The increase in mail choice claims was primarily driven by net new business and the continued adoption of Maintenance Choice offerings. The increase was partially offset by reduced new therapy prescriptions in the nine months ended September&#160;30, 2020 as a result of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate increased to 88.5% in the nine months ended September&#160;30, 2020 compared to 88.3% in the prior year. The continued increase in the segment&#8217;s generic dispensing rate was primarily due to the impact of new generic drug introductions and the Company&#8217;s ongoing efforts to encourage plan members to use generic drugs when they are available and clinically appropriate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2020 vs 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2020 vs 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">49,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">128.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">368.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">352.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,088.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,048.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Retail/LTC segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations and, in 2019, revenues and prescriptions from stores in Brazil. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful&#160;in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $1.3 billion, or 5.9%, to $22.7 billion in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by increased prescription volume, higher front store revenues, increased diagnostic testing and brand inflation. These increases were partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 6.7% in the three months ended September&#160;30, 2020 compared to the prior year. The increase was primarily driven by the 5.8% increase in pharmacy same store prescription volume on a 30-day equivalent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis, pharmacy drug mix and brand inflation. These increases were partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 2.2% in the three months ended September&#160;30, 2020 compared to the prior year. The increase was primarily due to strength in consumer health sales and an increase in basket size, partially offset by decreased customer traffic in the segment&#8217;s retail pharmacies as a result of the COVID-19 pandemic.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.15pt">Other revenues increased 128.5% in the three months ended September&#160;30, 2020 compared to the prior year. The increase was primarily due to increased diagnostic testing and the fulfillment of consumer health product boxes to support the Health Care Benefits segment&#8217;s Medicare members, both in response to the COVID-19 pandemic in the three months ended September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $172 million, or 3.6%, in the three months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily due to the absence of the $205 million pre-tax loss on the sale of Onofre and the $96 million store rationalization charge primarily related to operating lease right-of-use asset impairment charges in connection with planned closure of underperforming retail pharmacy stores, both recorded in the three months ended September 30, 2019. The decrease was partially offset by incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and the increased volume described above in the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 20.0% in the three months ended September&#160;30, 2020 compared to 22.0% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues and decreases in operating expenses described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $188 million, or 17.2%, in the three months ended September&#160;30, 2020 compared to the prior year. The increase in operating income was primarily driven by the absence of the $205 million pre-tax loss on the sale of Onofre and the $96 million store rationalization charge, both recorded in the three months ended September 30, 2019. This increase was partially offset by the decrease in adjusted operating income described below. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $104 million, or 6.9%, in the three months ended September&#160;30, 2020 compared to the prior year. The decrease in adjusted operating income was primarily due to continued reimbursement pressure, incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts in the three months ended September 30, 2020 and declines in long-term care. These decreases were partially offset by the increased pharmacy and front store volume described above, improved generic drug purchasing and increased diagnostic testing as a result of the COVID-19 pandemic in the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s operating income and adjusted operating income have been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the reimbursement pressure accelerates, the segment may not be able grow revenues, and its operating income and adjusted operating income could be adversely affected. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s operating income and adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand to generic drug conversions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 4.6% on a 30-day equivalent basis in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by the continued adoption of patient care programs. Prescriptions filled  in the three months ended September&#160;30, 2020 were adversely impacted by the COVID-19 pandemic, which resulted in reduced new therapy prescriptions, partially offset by greater use of 90-day prescriptions and increased immunizations.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 87.7% in the three months ended September&#160;30, 2020 compared to 88.2% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, reflecting an increase in flu immunizations in the three months ended September&#160;30, 2020 in comparison to the prior year. The Company believes the segment&#8217;s generic dispensing rate will likely increase in future periods, affected by, among other things, the number of new brand and generic drug introductions and the Company&#8217;s success at encouraging plan members to utilize generic drugs when they are available and clinically appropriate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.1 billion, or 4.9%, to $67.1 billion in the nine months ended September&#160;30, 2020 compared to the prior year primarily driven by increased prescription volume, higher front store revenues and brand inflation. These increases were partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 6.8% in the nine months ended September&#160;30, 2020 compared to the prior year. The increase was driven by the 5.4% increase in pharmacy same store prescription volume on a 30-day equivalent basis, pharmacy drug mix and brand inflation. These increases were partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 1.9% in the nine months ended September&#160;30, 2020 compared to the prior year. The increase was primarily due to strength in consumer health and general merchandise sales, which was primarily driven by COVID-19 related sales.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Other revenues increased 29.3% in the nine months ended September&#160;30, 2020 compared to the prior year. The increase was primarily due to increased diagnostic testing and the fulfillment of consumer health product boxes to support the Health Care Benefits segment&#8217;s Medicare members, both in response to the COVID-19 pandemic in the nine months ended September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $197 million, or 1.4%, in the nine months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily driven by the absence of the $231 million of store rationalization charges in connection with the planned closure of underperforming retail pharmacy stores and the $205 million pre-tax loss on the sale of Onofre, both recorded in the nine months ended September&#160;30, 2019, and the impact of cost savings initiatives in the nine months ended September&#160;30, 2020. The decrease was partially offset by incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and the increased volume described above in the nine months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 20.0% in the nine months ended September&#160;30, 2020 compared to 21.3% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues and decreases in&#160;operating expenses described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $112 million, or 2.9%, in the nine months ended September&#160;30, 2020 compared to the prior year. The increase in operating income was primarily driven by the absence of the&#160;$231 million of store rationalization charges and the $205 million pre-tax loss on the sale of Onofre, both recorded in the nine months ended&#160;September 30, 2019.  This increase was partially offset by the decrease in adjusted operating income described below. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $303 million, or 6.5%, in the nine months ended September&#160;30, 2020 compared to the prior year. The decrease in adjusted operating income was primarily due to continued reimbursement pressure, incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts in the nine months ended September 30, 2020 and declines in long-term care. These decreases were partially offset by the increased prescription and front store volume described above, improved generic drug purchasing and increased diagnostic testing as a result of the COVID-19 pandemic in the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 3.9% on a 30-day equivalent basis in the nine months ended September&#160;30, 2020 compared to the prior year primarily driven by the continued adoption of patient care programs. Prescriptions filled in the nine months ended September&#160;30, 2020 were adversely impacted by the COVID-19 pandemic, which resulted in reduced new therapy prescriptions, partially offset by greater use of 90-day prescriptions and increased immunizations, as well as decreased long-term care prescription volume.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate of 88.7% in the nine months ended September&#160;30, 2020 remained consistent with the prior year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2020 vs 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2020 vs 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(25.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(480)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Health Care Benefits segment.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2020 vs. 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $1.5 billion, or 8.8%, to $18.7 billion in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by membership growth in the Health Care Benefits segment&#8217;s Government products and the favorable impact of the reinstatement of the HIF for 2020. These increases were partially offset by the divestitures of Aetna&#8217;s standalone PDPs (which the Company retained the financial results of through 2019) and Workers&#8217; Compensation business, membership declines in the segment&#8217;s Commercial products and planned COVID-19 related investments benefiting customers and members in the three months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">The Health Care Benefits segment&#8217;s MBR increased 70 basis points from 83.3% to 84.0% in the three months ended September&#160;30, 2020 compared to the prior year primarily driven by the planned COVID-19 related investments described above, shifts in business mix and the divestiture of Aetna&#8217;s standalone PDPs, partially offset by the reinstatement of the HIF for 2020.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $102 million, or 3.2%, in the three months ended September&#160;30, 2020 compared to the prior year. The increase in operating expenses was primarily due to the reinstatement of the HIF for 2020 and incremental operating expenses to support the increased membership described above,&#160;including operating expenses to support additional Medicaid members onboarded during the first quarter of 2020. The increase was partially offset by the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business in the three months ended September&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 17.8% in the three months ended September&#160;30, 2020 compared to 18.8% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business in the three months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $87 million, or 8.4%, and adjusted operating income decreased $343 million, or 24.1% in the three months ended September&#160;30, 2020, compared to the prior year. The decrease in both operating income and adjusted operating income was primarily driven by the planned COVID-19 related investments described above and the divestitures of Aetna&#8217;s standalone PDPs and Workers&#8217; Compensation business. The decrease in operating income was partially offset by the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.9 billion, or 7.5%, to $56.4 billion in the nine months ended September&#160;30, 2020 compared to the prior year primarily driven by membership growth in the Health Care Benefits segment&#8217;s Government products and the favorable impact of the reinstatement of the HIF for 2020. These increases were partially offset by membership declines in the segment&#8217;s Commercial products, the divestitures of Aetna&#8217;s standalone PDPs and Workers&#8217; Compensation business and planned COVID-19 related investments benefiting customers and members in the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MBR</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment&#8217;s MBR decreased 480 basis points from 83.7% to 78.9% in the nine months ended September&#160;30, 2020 compared to the prior year primarily due to the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic in the nine months ended September&#160;30, 2020 and the reinstatement of the HIF for 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.1 billion, or 11.2%, in the nine months ended September&#160;30, 2020 compared to the prior year. The increase in operating expenses was primarily due to the reinstatement of the HIF for 2020 and incremental operating expenses to support the increased membership described above,&#160;including operating expenses to support additional Medicaid members onboarded during the first quarter of 2020. The increase was partially offset by the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues increased to 18.5% in the nine months ended September&#160;30, 2020 compared to 17.9% in the prior year. The increase in operating expenses as a percentage of total revenues was primarily due to the reinstatement of the HIF for 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $1.9 billion, or 57.1%, and adjusted operating income increased $1.6 billion, or 36.4% in the nine months ended September&#160;30, 2020, compared to the prior year. The increase was primarily driven by reduced benefit costs due to the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic and membership growth in the segment&#8217;s Government products, partially offset by membership declines in the segment&#8217;s Commercial products. The increase in operating income was also driven by the $271 million pre-tax gain on the sale of the Workers&#8217; Compensation business.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">22,908&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,088&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">22,809&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental membership information: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the Company&#8217;s SilverScript PDP membership only. Excludes 2.5 million members as of both December 31, 2019 and September 30, 2019 related to Aetna&#8217;s standalone PDPs that were sold effective December 31, 2018. The Company retained the financial results of the divested plans through 2019 through a reinsurance agreement. Subsequent to 2019, the Company no longer retains the financial results of the divested plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of September&#160;30, 2020 of 23.3 million decreased 316 thousand members compared with June 30, 2020, primarily reflecting a decline in Commercial products, partially offset by  increases in Medicare and Medicaid products. Medical membership as of September&#160;30, 2020 of 23.3 million increased 461 thousand members compared with September&#160;30, 2019, reflecting increases in Medicare and Medicaid products, partially offset by declines in Commercial products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the U.S. Centers for Medicare &amp; Medicaid Services issued its final notice detailing final 2021 Medicare Advantage benchmark payment rates (the &#8220;Final Notice&#8221;). Overall the Company projects the benchmark rates in the Final Notice will increase funding for its Medicare Advantage business, excluding the impact of the HIF, by approximately 1.8% in 2021 compared to 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2021 star ratings in October 2020. The Company&#8217;s 2021 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2022. Based on the Company&#8217;s membership at September 1, 2020, 83% of the Company&#8217;s Medicare Advantage members were in plans with 2021 star ratings of at least 4.0 stars, consistent with 83% of the Company&#8217;s Medicare Advantage members being in plans with 2020 star ratings of at least 4.0 stars based on the Company&#8217;s membership at September 1, 2019.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,<br/>2020 vs 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,<br/>2020 vs 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">433.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">371.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(35.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of operating loss (GAAP measure) to adjusted operating loss for the Corporate/Other segment.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $36 million in the three months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily driven by lower net investment income including a $27 million decrease in net realized capital gains in the three months ended September&#160;30, 2020 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses within the Corporate/Other segment consist of management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs. Segment operating expenses also include operating costs to support the Company&#8217;s large case pensions and long-term care insurance products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $16 million in the three months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily driven by a $54 million decrease in acquisition-related integration costs and lower investments in modernization in the three months ended September&#160;30, 2020 compared to the prior year. These decreases were partially offset by an increase in the Company&#8217;s investments in transformation in the three months ended September 30, 2020 compared to the prior year.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Nine Months Ended September&#160;30, 2020 vs. 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $131 million in the nine months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily driven by lower net investment income due to COVID-19 related capital markets volatility and a $95 million decrease in net realized capital gains in the nine months ended September&#160;30, 2020 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $15 million in the nine months ended September&#160;30, 2020 compared to the prior year. The decrease was primarily driven by a $169 million decrease in acquisition-related integration costs compared to the prior year. The decrease was partially offset by incremental operating expenses associated with the Company&#8217;s investments in transformation and COVID-19 pandemic response efforts in the nine months ended September&#160;30, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, sale-leaseback program, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of September&#160;30, 2020, the Company had approximately $9.3 billion in cash and cash equivalents, approximately $3.6 billion of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has severely impacted global economic activity and during the first half of the year caused significant volatility and negative pressure in the capital markets. As a result of the uncertainty generated by COVID-19, on March 31, 2020, the Company issued $4.0 billion aggregate principal amount of unsecured senior notes to enhance its liquidity and strengthen its capital. The net proceeds from this offering will be used for general corporate purposes, which may include working capital, capital expenditures and repayment of indebtedness. As markets stabilized, in August 2020, the Company purchased $6.0 billion of its outstanding senior notes through cash tender offers, while issuing $4.0 billion aggregate principal amount of unsecured senior notes. The Company will continue to monitor the severity and duration of the pandemic and its impact on the U.S. and global economies, consumer behavior and health care utilization patterns and our businesses, results of operations, financial condition, and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash during the nine months ended September&#160;30, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:51.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,670)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $2.1 billion in the nine months ended September&#160;30, 2020 compared to the prior year due primarily to higher operating income in the Health Care Benefits and Pharmacy Services segments and the deferral of approximately $445&#160;million of certain payroll tax payments to future years, as permitted in response to the COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $1.7 billion in the nine months ended September&#160;30, 2020 compared to the prior year primarily due to increased net purchases of investments and an increase in cash used for acquisitions, partially offset by $834 million in proceeds from the sale of the Workers&#8217; Compensation business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $4.4 billion in the nine months ended September&#160;30, 2020 compared to net cash used in financing activities of $6.4 billion in the prior year. The decrease in cash used in financing activities primarily related to a decrease in net debt repaid during the nine months ended September 30, 2020 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of September&#160;30, 2020. In connection with its commercial paper program, the Company maintains a $1.0 billion 364-day unsecured back-up revolving credit facility, which expires on May 12, 2021, a $1.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 18, 2022, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May&#160;16, 2024. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">average quarterly facility fee of approximately 0.03%, regardless of usage. As of September&#160;30, 2020, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of September&#160;30, 2020, was approximately $935 million. As of September&#160;30, 2020, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750 million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5 billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0 billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750 million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95 billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings will be used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness. Net proceeds from these offerings that had not been used for these purposes were held in cash or temporarily invested in cash equivalents and short-term investment-grade securities from the date of issuance through September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes.  See Note 8 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of September&#160;30, 2020, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the Company did not repurchase any shares of common stock. See Note 7 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information on the Company&#8217;s share repurchase program.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 10 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; to the unaudited condensed consolidated financial statements for information on the Company&#8217;s lease guarantees. </span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the unaudited condensed consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the unaudited condensed consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2020, the Company adopted Accounting Standards Update 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; to the unaudited condensed consolidated financial statements for a discussion of the adoption of this new accounting standard and associated updates to the Company&#8217;s accounting policies from those previously disclosed in the 2019 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2020, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 6% and 12%, respectively.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; the continued efforts of competitors to gain market share and consumer spending patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Aetna Acquisition in November 2018, the Company added the Health Care Benefits segment which includes the Commercial Business reporting unit. The transaction was accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. As a result, at the time of the acquisition the fair value of the Commercial Business reporting unit was equal to its carrying value. The Company has experienced declines in its Commercial Insured medical membership subsequent to the closing date of the Aetna Acquisition and may continue to do so for a number of reasons, including as a result of the competitive Commercial business environment. In  addition, COVID-19 has had and may continue to have an adverse impact on medical membership on the Commercial business due to reductions in workforce at existing customers (including due to business failures) as well as reduced willingness to change benefit providers by prospective customers. The Company&#8217;s fair value estimate is sensitive to significant assumptions including changes in medical membership, revenue growth rate, operating income and the discount rate. Although the Company believes the financial projections used to determine the fair value of the Commercial Business reporting unit in the third quarter of 2020 were reasonable and achievable, the challenges described above may affect the Company&#8217;s ability to increase medical membership or operating income in the Commercial Business reporting unit at the rate estimated when such goodwill impairment test was performed and may continue to do so.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC reporting unit continues to experience industry-wide challenges that have impacted management&#8217;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare Inc. Those challenges included lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. COVID-19 has also had an adverse impact on the financial health of the Company&#8217;s long-term care facility customers due to declines in occupancy rates and increased operating expenses. A number of these customers have relied on supplemental liquidity sources such as grants and advance Medicare payments under programs expanded or created under the CARES Act to maintain adequate liquidity during the COVID-19 pandemic and may require additional sources of liquidity throughout the duration of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes the financial projections used to determine the fair value of the LTC reporting unit in the third quarter of 2020 were reasonable and achievable, the LTC reporting unit has faced challenges that affect the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when such goodwill impairment test was performed and may continue to do so. These challenges and some of the key assumptions included in the Company&#8217;s financial projections to determine the estimated fair value of the LTC reporting unit include client retention rates; occupancy rates in skilled nursing facilities; the financial health of skilled nursing facility customers; facility reimbursement pressures; the Company&#8217;s ability to execute its senior living initiative; the Company&#8217;s ability to extract cost savings from labor productivity and other initiatives; the geographies impacted and the severity and duration of COVID-19; COVID-19&#8217;s impact on health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to COVID-19. The fair value of the LTC reporting unit also is dependent on market multiples of peer group companies and the risk-free interest rate environment, which impacts the discount rate used in the discounted cash flow valuation method. If the LTC reporting unit does not achieve its forecasts, it is reasonably possible in the near term that the goodwill of the LTC reporting unit could be deemed to be impaired by a material amount. As of September 30, 2020, the goodwill balance in the LTC reporting unit was $431 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic severely impacted global economic activity in the nine months ended September 30, 2020, including the businesses of some of the Company&#8217;s customers, and during the first half of the year caused significant volatility and negative pressure in the capital markets. In addition to adversely affecting the Company&#8217;s businesses, which may have a material adverse impact on the Company&#8217;s profitability and cash flows, these developments may adversely affect the timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them. For further information regarding the potential adverse impact of COVID-19 on the Company, please see </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221; in Part II, Item 1A of this report. The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us. If the Company&#8217;s businesses, results of operations, financial condition and/or cash flows are materially adversely affected, the goodwill of the LTC and Commercial Business reporting units could be deemed to be impaired by a material amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full description of the Company&#8217;s other critical accounting policies, see &#8220;Critical Accounting Policies&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2019 Form 10-K.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Quarterly Report on Form 10-Q (this &#8220;report&#8221;) is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to: &#8220;COVID-19 and 2020 Outlook&#8221; and &#8220;Government Regulation&#8221; of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) included in Part I, Item 2, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; included in Part I, Item 3, and &#8220;Risk Factors&#8221; included in Part II, Item 1A of this report. In addition, throughout this report and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of COVID-19 on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition; statements relating to corporate strategy; statements relating to future revenue or adjusted revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments; and statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and/or under &#8220;Risk Factors&#8221; included in Part II, Item 1A of this report; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this report, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s earnings and financial condition are exposed to interest rate risk, credit quality risk, market valuation risk, foreign currency risk, commodity risk and operational risk. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Interest Rate and Credit Quality Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages interest rate risk by seeking to maintain a tight match between the durations of assets and liabilities when appropriate.&#160;The Company manages credit quality risk by seeking to maintain high average credit quality ratings and diversified sector exposure within its debt securities portfolio.&#160;In connection with its investment and risk management objectives, the Company also uses derivative financial instruments whose market value is at least partially determined by, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/spreads.&#160;The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&#160;These instruments, viewed separately, subject the Company to varying degrees of interest rate, equity price and credit risk.&#160;However, when used for hedging, the Company expects these instruments to reduce overall risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio supported the following products at September&#160;30, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience-rated products </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment risks associated with experience-rated products generally do not impact the Company&#8217;s operating results. The risks associated with investments supporting experience-rated pension and annuity products in the large case pensions business in the Company&#8217;s Corporate/Other segment are assumed by the contract holders and not by the Company (subject to, among other things, certain minimum guarantees).&#160;Assets supporting experience-rated products may be subject to contract holder or participant withdrawals. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities in the Company&#8217;s investment portfolio had an average credit quality rating of A at both September&#160;30, 2020 and December&#160;31, 2019 with approximately $6.0 billion and $4.4 billion rated AAA at September&#160;30, 2020 and December&#160;31, 2019, respectively.&#160;The debt securities that were rated below investment grade (that is, having a credit quality rating below BBB-/Baa3) were $1.7 billion and $1.2 billion at September&#160;30, 2020 and December&#160;31, 2019, respectively (of which 2% and 4% at September&#160;30, 2020 and December&#160;31, 2019, respectively, supported experience-rated products).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, the Company held $322 million and $333 million, respectively, of municipal debt securities that were guaranteed by third parties, representing 2% of total investments at both September&#160;30, 2020 and December&#160;31, 2019.&#160;These securities had an average credit quality rating of AA at both September&#160;30, 2020 and December&#160;31, 2019 with the guarantee. These securities had an average credit quality rating of A and A+ at September&#160;30, 2020 and December&#160;31, 2019, respectively, without the guarantee.&#160;The Company does not have any significant concentration of investments with third party guarantors (either direct or indirect).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies debt securities as available for sale, and carries them at fair value on the unaudited condensed consolidated balance sheets.&#160;At both September&#160;30, 2020 and December&#160;31, 2019, less than 1% of debt securities were valued using inputs that reflect the Company&#8217;s assumptions (categorized as Level 3 inputs in accordance with accounting principles generally accepted in the United States of America).&#160;See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 for additional information on the methodologies and key assumptions used to determine the fair value of investments. For additional information related to investments, see Note 3 &#8216;&#8216;Investments&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews debt securities in its portfolio to determine whether a decline in fair value below the cost basis or carrying value has occurred.&#160;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. The accounting for and measurement of credit losses on financial instruments is considered a critical accounting policy.&#160;See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; to the unaudited condensed consolidated financial statements for a discussion of the Company&#8217;s accounting policy for debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Market Valuation Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates its risk from market-sensitive instruments by examining, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets and/or credit ratings/spreads. The Company also regularly evaluates the appropriateness of investments relative to management-approved investment guidelines (and operates within those guidelines) and the business objectives of its portfolios.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company reviews the impact of hypothetical net losses in its investment portfolio on the Company&#8217;s consolidated near-term financial condition, operating results and cash flows assuming the occurrence of certain reasonably possible changes in near-term market rates and prices. Interest rate changes (whether resulting from changes in treasury yields or credit spreads or other factors) represent the most material risk exposure category for the Company.&#160;The Company has estimated the impact on the fair value of market sensitive instruments based on the net present value of cash flows using a representative set of likely future interest rate scenarios. The assumptions used were as follows: an immediate increase of 100 basis points in interest rates (which the Company believes represents a moderately adverse scenario) and an immediate decrease of 15% in prices for publicly traded domestic equity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming an immediate increase of 100 basis points in interest rates, the theoretical decline in the fair values of market sensitive instruments at September&#160;30, 2020 is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The fair value of long-term debt would decline by approximately $5.2 billion ($6.5 billion pretax). Changes in the fair value of long-term debt do not impact the Company&#8217;s operating results or financial condition. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The theoretical reduction in the fair value of interest rate sensitive investments partially offset by the theoretical reduction in the fair value of interest rate sensitive liabilities would result in a net decline in fair value of approximately $480 million ($605 million pretax) related to continuing non-experience-rated products. Reductions in the fair value of investment securities would be reflected as an unrealized loss in equity, as the Company classifies these debt securities as available for sale. The Company does not record liabilities at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the value of the Company&#8217;s publicly traded domestic equity securities were to decline by 15%, this would result in a net decline in fair value of $4&#160;million ($5&#160;million pretax).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on overall exposure to interest rate risk and equity price risk, the Company believes that these changes in market rates and prices would not materially affect consolidated near-term financial condition, operating results or cash flows as of September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Foreign Currency and Commodity Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, the Company did not have any material foreign currency exchange rate or commodity derivative instruments in place and believes its exposure to foreign currency exchange rate risk is not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, 5.3% and 6.1%, respectively, of the Company&#8217;s investment portfolio was comprised of investments that have exposure to the oil and gas industry, with more than half that amount comprised of investment grade rated debt securities. These exposures are experiencing varied degrees of financial strains in the current depressed oil and gas price environment, and the likelihood of the Company&#8217;s portfolio incurring additional realized capital losses on these exposures may increase if such depressed prices persist and/or decline further.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also faces certain operational risks. Those risks include risks related to the COVID-19 pandemic and risks related to information security, including cybersecurity. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including communications, financial services and supply chains, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cyber attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its vendors have experienced and continue to experience a variety of cyber attacks, and the Company and its vendors expect to continue to experience cyber attacks going forward. Among other things, the Company and its vendors have experienced automated attempts to gain access to public facing networks, brute force, SYN flood and distributed denial of service attacks, attempted malware infections, vulnerability scanning, ransomware attacks, spear-phishing campaigns, mass reconnaissance attempts, injection attempts, phishing, PHP injection and cross-site scripting. The Company also has seen an increase in attacks designed to obtain access to consumers&#8217; accounts using illegally obtained demographic information. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, destroy data, disrupt or degrade service, sabotage systems or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through September&#160;30, 2020. The Board of Directors of CVS Health Corporation and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status. </span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_139"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Securities Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) as of September&#160;30, 2020, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective and designed to provide reasonable assurance that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that occurred in the three months ended&#160;September&#160;30, 2020 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_142"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:40.36pt">Other Information</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_145"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 10 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_148"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:34.8pt">Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information supplements the risk factors described in Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the &#8220;2019 10-K&#8221;) and should be read in conjunction with the risk factors described in the 2019 10-K. The COVID-19 pandemic underscores and amplifies certain risks we face in our businesses, including those discussed in the 2019 10-K. Due to the unprecedented nature of the pandemic, we cannot identify all of the risks we face from the pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The spread of, impact of and response to coronavirus disease 2019, or COVID-19, underscores and amplifies certain risks we face, including those discussed in our Form 10-K for the fiscal year ended December 31, 2019. The impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be material and adverse.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) has spread to every state in the U.S., has been declared a pandemic by the World Health Organization and has severely impacted, and is expected to continue to severely impact, the economies of the U.S. and other countries around the world. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislative and regulatory environment governing our businesses is dynamic and changing frequently, including the Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;), the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Health Care Benefits insurance products where we assume all or a majority of the risk for medical and dental care costs (our &#8220;Insured&#8221; products). As a result of COVID-19, including legislative and/or regulatory responses to COVID-19, the premiums we charge in our Insured Health Care Benefits products may prove to be insufficient to cover the cost of medical services delivered to our Insured medical members, which may increase significantly as a result of higher utilization rates of medical facilities and services and other increases in associated hospital and pharmaceutical costs. Federal, state and local governmental policies and initiatives to reduce the transmission of COVID-19, including shelter-in-place orders and social distancing directives, may not effectively combat the severity and/or duration of the COVID-19 pandemic and have resulted in, among other things, a reduction in utilization of medical services (&#8220;utilization&#8221;) that is discretionary, the cancellation of elective medical procedures, reduced customer traffic and front store sales in our retail pharmacies, our customers being ordered to close or severely curtail their operations, the adoption of work-from-home policies and a reduction in diagnostic reporting due to reductions in health care provider visits and restrictions on our access to providers&#8217; medical records, all of which impact our businesses. Among other impacts of these policies and initiatives on our businesses, we expect changes in medical claims submission patterns and an adverse impact on (i) drug utilization due to the reduction in discretionary visits with health care providers; (ii) front store sales as a result of reduced customer traffic in our retail pharmacies due to shelter-in-place orders and COVID-19 related unemployment; (iii) medical membership in our Health Care Benefits segment and covered lives in our PBM clients due to reductions in workforce at our existing customers (including due to business failures) as well as reduced willingness to change benefits providers by prospective customers; (iv) benefit costs due to COVID-19 related support programs we have put in place for our medical members and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products; and (v) the amount, timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them. Over time, these policies and initiatives also may cause us to experience increased benefit costs and/or decreased revenues in our Health Care Benefits segment if, as a result of our medical members not seeing their health care providers as a result of COVID-19, we are unable to implement clinical initiatives to manage benefit costs and chronic conditions of our medical members and appropriately document their risk profiles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in response to COVID-19, during the first half of 2020, we began to offer our medical members expanded benefit coverage and became obligated by governmental action to provide other additional coverage. This expanded benefit coverage is being provided without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products. We also are taking actions designed to help provide financial and administrative relief for the health care provider community. Such measures and any further steps we take or are required to take to expand or otherwise modify the services delivered to our Health Care Benefits members, provide relief for the health care provider community, or in connection with the relaxation of shelter-in-place orders and social distancing directives and other restrictions on movement and economic activity intended to reduce the spread of COVID-19, including the potential for widespread testing, and vaccination once available, as a component of lifting those measures, could adversely impact our benefit costs, medical benefit ratio and operating results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various initiatives we have implemented to slow and/or reduce the impact of COVID-19, such as colleagues working remotely and installing protective equipment in our retail pharmacies, and the COVID-19-related support programs we have put in place for our customers, medical members and colleagues have increased our operating expenses and reduced the efficiency of our operations. Our operating results will continue to be adversely affected so long as these initiatives continue or if they are expanded. In addition, the adverse economic conditions in the U.S. and abroad caused by COVID-19 have had, and may continue to have, an adverse impact on our net investment income and the value of our investment portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities, labor shortages and/or financial difficulties experienced by third-party service providers. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including communications, financial services and supply chains, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, increased risk of unauthorized dissemination of sensitive personal </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A number of factors, many of which are beyond our control, including COVID-19 and related testing and vaccinations, when available, contribute to rising health care and other benefit costs. We may not be able to accurately forecast health care and other benefit costs, which could adversely affect our Health Care Benefits segment&#8217;s operating results. There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of COVID-19, the current economic environment is adverse and less predictable than recently experienced, which has caused and may continue to cause unanticipated and significant volatility in our health care and other benefits costs, including COVID-19 related testing and vaccination (when available) and post-acute care skilled nursing facility and behavioral health costs. Premiums for our Insured Health Care Benefits products, which comprised 91% of our Health Care Benefits revenues for 2019, are priced in advance based on our forecasts of health care and other benefit costs during a fixed premium period, which is generally twelve months. These forecasts are typically developed several months before the fixed premium period begins, are influenced by historical data (and recent historical data in particular), are dependent on our ability to anticipate and detect medical cost trends and changes in our members&#8217; behavior and health care utilization patterns and medical claim submission patterns and require a significant degree of judgment. For example, our revenue on Medicare policies is based on bids submitted in June of the year before the contract year. Cost increases in excess of our projections cannot be recovered in the fixed premium period through higher premiums. As a result, our profits are particularly sensitive to the accuracy of our forecasts of the increases in health care and other benefit costs that we expect to occur and our ability to anticipate and detect medical cost trends. For 2020 those forecasts do not include any projections for COVID-19 related costs, including COVID-19 related testing and vaccination costs, post-acute care skilled nursing facility and behavioral health costs and government mandated and voluntary expansions of benefits coverage which may be significant. During periods such as 2020 when health care and other benefit costs, utilization and/or medical costs trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19, accurately detecting, forecasting, managing, reserving and pricing for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs is more challenging. There can be no assurance regarding the accuracy of the health care or other benefit cost projections reflected in our pricing, and our health care and other benefit costs (including COVID-19 related testing and vaccination (when available) and post-acute care skilled nursing facility and behavioral health costs) are affected by COVID-19 and other external events over which we have no control. Even relatively small differences between predicted and actual health care and other benefit costs as a percentage of premium revenues can result in significant adverse changes in our Health Care Benefits segment&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors contribute to rising health care and other benefit costs, including COVID-19, previously uninsured members entering the health care system, changes in members&#8217; behavior and health care utilization patterns, turnover in our membership, additional government mandated benefits or other regulatory changes (including under the Families First Act and the CARES Act), changes in the health status of our members, the aging of the population and other changing demographic characteristics, advances in medical technology, increases in the number and cost of prescription drugs (including specialty pharmacy drugs and ultra-high cost drugs and therapies), direct-to-consumer marketing by drug manufacturers, the increasing influence of social media on our members&#8217; health care utilization and other behaviors, changes in health care practices and general economic conditions (such as inflation and employment levels). In addition, government-imposed limitations on Medicare and Medicaid reimbursements to health plans and providers have caused the private sector to bear a greater share of increasing health care and other benefits costs over time, and future amendments or repeal or replacement of the ACA that increase the uninsured population may amplify this problem. Other factors that affect our health care and other benefit costs include epidemics or other pandemics, changes as a result of the ACA, changes to the ACA and other changes in the regulatory environment, the evolution toward a consumer driven business model, new technologies, influenza related health care costs (which may be substantial and were higher than we projected for the 2019-2020 influenza season), clusters of high-cost cases, health care provider and member fraud, and numerous other factors that are or may be beyond our control. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we are not able to accurately and promptly anticipate and detect medical cost trends or accurately estimate the cost of incurred but not yet reported claims or reported claims that have not been paid, our ability to take timely corrective actions to limit future health care costs and reflect our current benefit cost experience in our pricing process may be limited, which would further amplify the extent of any adverse impact on our operating results. These risks are particularly acute during periods such as 2020 when health care and other benefit costs, utilization and/or medical cost trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19. Such risks are further magnified by the ACA and other existing and future legislation and regulations that limit our ability to price for our projected and/or experienced increases in utilization and/or medical cost trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse economic conditions in the U.S. and abroad can materially and adversely impact our businesses, operating results, cash flows and financial condition, and we do not expect these conditions to improve in the near future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, the availability and cost of credit and other capital, higher unemployment rates and other factors have contributed to adverse conditions in the global economy and significantly diminished expectations for the global economy, and particularly the U.S. economy, at least through the end of 2020 and possibly longer. Our customers, medical providers and the other companies with which we do business are generally headquartered in the U.S.; however many of our largest customers are global companies with operations around the world. As a result, adverse economic conditions in the U.S. and abroad, including those caused by COVID-19, can materially and adversely impact our businesses, operating results, cash flows and financial condition, including: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Pharmacy Services segment, by causing drug utilization to decline, reducing demand for PBM services and adversely affecting the financial health of our PBM clients.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Retail/LTC segment, by causing drug utilization to decline, changing consumer purchasing power, preferences and/or spending patterns leading to reduced consumer demand for products sold in our stores and adversely affecting the financial health of our LTC pharmacy customers.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By leading to reductions in workforce by our existing customers (including due to business failures), which would reduce our revenues, the number of covered lives in our PBM clients and/or the number of members our Health Care Benefits segment serves.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By leading our clients and customers and potential clients and customers, particularly those with the most employees or members, and state and local governments, to force us to compete more vigorously on factors such as price and service to retain or obtain their business.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By leading customers and potential customers of our Retail/LTC and Health Care Benefits segments to purchase fewer products and/or products that generate less profit for us than the ones they currently purchase or otherwise would have purchased.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By leading customers and potential customers of our Health Care Benefits segment, particularly smaller employers and individuals, to forego obtaining or renewing their health and other coverage with us.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Health Care Benefits segment, by causing unanticipated increases and volatility in utilization of medical and other covered services, including COVID-19 related testing, vaccination (when available) and behavioral health services, by our medical members, changes in medical claim submission patterns and/or increases in medical unit costs and/or provider behavior, each of which would increase our costs and limit our ability to accurately detect, forecast, manage, reserve and price for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By increasing medical unit costs and causing changes in provider behavior in our Health Care Benefits segment as hospitals and other providers attempt to maintain revenue levels in their efforts to adjust to their own COVID-19-related and other economic challenges.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability or perceived ability of the issuers and/or guarantors of the debt or other securities we hold in our investment portfolio to perform on their obligations to us, which could result in defaults in those securities and has reduced, and may further reduce, the value of those securities and has created, and may continue to create, net realized capital losses for us that reduce our operating results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our customers, including self-insured customers in our Health Care Benefits segment, medical providers and the other companies with which we do business as well as our medical members to perform their obligations to us or causing them not to perform those obligations, either of which could reduce our operating results. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our former subsidiaries and/or their purchasers to satisfy their lease obligations that we have guaranteed and causing the Company to be required to satisfy those obligations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the financial condition of other insurers, including long-term care insurers and life insurers, which increases the risk that we will receive significant assessments for obligations of insolvent insurers to policyholders and claimants.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing, over time, inflation that could cause interest rates to increase and thereby increase our interest expense and reduce our operating results, as well as decrease the value of the debt securities we hold in our investment portfolio, which would reduce our operating results and/or adversely affect our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, reductions in workforce by our customers can cause unanticipated increases in the health care and other benefits costs of our Health Care Benefits segment. For example, our business associated with members who have elected to receive benefits under Consolidated Omnibus Budget Reconciliation Act (known as &#8220;COBRA&#8221;) typically has a medical benefit ratio (&#8220;MBR&#8221;) that is significantly higher than our overall Commercial MBR. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that our health care and other benefit costs, businesses, operating results, cash flows and/or financial condition will not be materially and adversely impacted by these economy-related conditions or other factors.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_151"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Stock Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total number of shares purchased in the three months ended September&#160;30, 2020, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase program authorized by CVS Health Corporation&#8217;s Board of Directors on November 2, 2016. See Note 7 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form&#160;10-Q for additional information.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Fiscal&#160;Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of&#160;Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased&#160;as&#160;Part&#160;of<br/>Publicly&#160;Announced<br/>Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2020 through July 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2020 through August 31, 2020</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2020 through September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_160"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_163"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Instruments defining the rights of security holders, including indentures</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex43.htm">Form of the Registrant&#8217;s 2040 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex101.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter re: unaudited interim financial information</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex151.htm">Letter from Ernst &amp; Young LLP acknowledging awareness of the use of a report dated November 6, 2020 related to their reviews of interim financial information.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex311.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex312.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex321.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a09302020ex322.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders&#8217; Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, formatted in Inline XBRL (included as Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="ia22d2c07ccb343e8b651f8e8c378e259_166"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia22d2c07ccb343e8b651f8e8c378e259_7">Form 10-Q Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eva C. Boratto</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eva C. Boratto</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a09302020ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="id68d81bb45664c48b4a03c20bcb60022_1"></div><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div><img alt="cvshealtha381.jpg" src="cvshealtha381.jpg" style="height:39px;width:221px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT AGREEMENT&#8211; ANNUAL GRANT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANT DATE</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> xx&#47;xx&#47;xxxx</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">Pursuant and subject to the provisions of the 2017 Incentive Compensation Plan (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;),  of CVS Health Corporation (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), on the date set forth above (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company has awarded and hereby evidences the Performance Stock Unit (&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PSU</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Award to the person named below (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), subject to the terms and conditions set forth and incorporated in this Performance Stock Unit agreement (this &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The Plan is hereby made a part hereof, and the Participant agrees to be bound by all the provisions of the Plan.  Capitalized terms not otherwise defined herein shall have the meaning assigned to such term(s) in the Plan.  On the Grant Date specified above, the fair value, as determined utilizing the methodology approved by the Management Planning and Development Committee of the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or its delegate, of each PSU equals </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$xx.xx</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:63pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:64.969%"><tr><td style="width:1.0%"></td><td style="width:48.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee ID&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">#####</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Number of PSUs (#)&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">#####</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">Each PSU represents a right to a future payment of one share (&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of Common Stock ($0.01 par value) of the Company, subject to required tax withholding.  The actual number of Shares (if any) that the Participant receives shall be subject to the terms and conditions of the Plan and this Agreement, including, without limitation, the Company&#8217;s achievement of the performance goals set forth in Appendix A and Section 10 of this Agreement.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">(a)&#160;&#160;&#160;&#160;Subject to the terms and conditions of the Plan and this Agreement and subject to the Participant&#8217;s continued employment, the PSUs shall vest and become non-forfeitable on April 1, 2023 or such other date as may be provided in Section 6 (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Date</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), based on the level of achievement of the performance goals set forth in Appendix A (and as determined  by reference to Appendices B and C), and shall be determined by multiplying the number of PSUs that are subject to this Agreement by the applicable performance adjustment shown in Appendix A for the attained level of the performance goals.  The &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Period</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall be the three-year period commencing on January 1, 2020 and ending on December 31, 2022.    </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Participant shall be entitled to receive (and the Company shall deliver to the Participant) the Shares, subject to any applicable withholdings, as soon as administratively practicable following the Vesting Date, unless delivery of the Shares has been deferred in accordance with Section 4 below (the date of such delivery of the Shares being hereafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlement Date</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Notwithstanding anything herein to the contrary, if the Participant is subject to the reporting requirements under Section 16 of the Securities Exchange Act of 1934, as amended, or becomes subject to such reporting obligations at any time during the Performance Period, the Participant agrees and covenants that as a condition to the receipt of the award of PSUs and the payment of the PSUs hereunder, the Participant shall not sell or otherwise transfer any Shares issued and transferred to the Participant pursuant to this Agreement (including with respect to any Shares that are deferred under Section 4(a)) until the second anniversary   of </font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Settlement Date (such period hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holding Period</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), except that the Participant shall be permitted, prior to the end of the Holding Period, (a) to sell or transfer shares to pay applicable tax and social security withholdings, if any, with respect to such settlement (or, alternatively, if the Company withholds such Shares pursuant to Section 5 of this Agreement, the requirements in this Section 3(c) not to sell or otherwise transfer any Shares shall only apply to the number of such Shares delivered to the Participant (i.e., after such withholding of Shares)), (b) to sell or transfer shares upon a Change in Control, or (c) to transfer Shares to the Participant&#8217;s personal brokerage account.  The Participant&#8217;s attempt to assign   or transfer Shares subject to this Agreement, either voluntarily or involuntarily, contrary to the provisions hereof, shall be null and void and without effect.  The Company may, in its sole discretion, impose restrictions on the assignment or transfer of Shares consistent with the provisions hereof, including, without limitation, by or through the transfer agent for such Shares or by means of legending stock certificates or otherwise. </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">(a)&#160;&#160;&#160;&#160;In accordance with rules promulgated by the Committee, the Participant, to the  extent eligible under the CVS Health Deferred Stock Compensation Plan, may elect to defer delivery of Shares in settlement of PSUs covered by this Agreement.  Any such deferred delivery date elected by the Participant shall become the Settlement Date for purposes of this Agreement.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To the extent dividends are paid on such deferred Shares following the Vesting Date and prior to the Settlement Date, the Participant shall be entitled to receive a number of additional deferred Shares equal to&#58;  (x) the amount of dividend per Share as declared by the Company&#8217;s Board of Directors on the Company&#8217;s common stock multiplied by (y) the number of deferred Shares held by the Participant on the record date of such dividend, divided by (z) the Fair Market Value of a Share on such dividend payment date.  </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">On the Settlement Date, the number of Shares to be delivered by the Company to the Participant shall be reduced by the smallest number of Shares having a Fair Market Value at least equal to the dollar amount of federal, state and local tax withholding required to be withheld by the Company with respect to such PSUs on such date.  </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">(a) &#160;&#160;&#160;&#160;Except as provided in Sections 6(b)&#8211;(e) below, if, for any reason, the Participant&#8217;s employment with the Company and any subsidiary of the Company terminates, all PSUs not then vested in accordance with Section 3 above shall be immediately forfeited.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.8pt">In the event the Participant&#8217;s employment with the Company and any subsidiary of the Company terminates by reason of death, PSUs not then vested in accordance with Section 3 shall become immediately vested based upon target performance as of the  date of the Participant&#8217;s death, and shall become settled upon thirty (30) days of the Participant&#8217;s death.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.16pt">In the event the Participant&#8217;s employment  with the Company and any subsidiary of the Company terminates by reason of a deemed &#8220;Qualified Retirement&#8221; or involuntary termination of employment and the Participant is entitled to severance, PSUs  shall vest on a pro-rata basis as of the Participant&#8217;s termination of employment date, which is the last day that the Participant is employed by the Company and any subsidiary of the Company, as follows&#58;  the total number of PSUs that the Participant shall be entitled to shall be equal to the number of PSUs based upon actual performance as of the end of the Performance Period multiplied by the following fraction&#58;  (A) the numerator shall be the number of months elapsed as of the termination of employment date since the beginning of the Performance Period and (B) the denominator shall be the total number of months in the Performance Period.  For purposes of this calculation, the number of months in the numerator in sub-section (A) above shall include any partial month in which the Participant has worked (for example, if the time elapsed between the beginning of the Performance Period and the retirement date is eight (8)   months  and  five  (5)  days,  the  numerator  in  sub-section  (A)  above  shall  be  nine (9)).</font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualified Retirement</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean termination of employment on or after attainment of age fifty-five (55) with at least ten (10) years of continuous service, or attainment of age sixty (60) with at least five (5) years of continuous service or such other terms as may be determined by the Company and set forth in the applicable award agreement&#59; </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;&#160; if the Participant elects to terminate his or her employment voluntarily, the Participant has provided the Company with at least twelve (12) months advance notice, in accordance with the provisions of Section 9 below, of his or her retirement date or such other term of advance notice as is determined by the Chief Human Resources Officer of the Company.  Any Shares represented by the pro-rated PSUs that vest under this section shall settle on the Settlement Date that would have applied under the original schedule set forth in Section 3 of this Agreement. </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event the Participant&#8217;s employment  with the Company  and any subsidiary of the Company terminates by reason of total and permanent disability (as defined in the Company&#8217;s Long-Term Disability Plan, or, if  not defined in such Plan, as defined by the Social Security Administration),&#160;the PSUs shall vest as of the employment termination date on a pro- rata basis as follows&#58;&#160; the number of PSUs based upon actual performance as of the end of  the Performance Period multiplied by the following fraction&#58;&#160; (A) the numerator shall be the number of months elapsed as of the Participant&#8217;s termination date since the beginning of the Performance Period and (B) the denominator shall be the total number of months in the Performance Period.&#160; For purposes of this calculation, the number of months in the numerator in sub-section (A) above shall include any partial month in which the Participant has     worked.&#160; For example, if the time elapsed between the beginning of the Performance Period and the termination date is eight (8) months and five (5) days, the numerator in sub-section  (A) above shall be nine (9).&#160;  Any Shares represented by PSUs that vest under this section shall settle on the Settlement Date that would have applied under the original schedule set forth in Section 3 of this Agreement.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Notwithstanding the above, if the Participant experiences a Termination Without  Cause or a Constructive Termination Without Cause within two (2) years following a Change   in the provisions of the Plan with respect to Change in Control shall apply, and the Participant&#8217;s PSUs shall become fully vested with the performance goals and other conditions with respect to the PSUs being deemed to be met at target performance.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;For purposes of this Section 6, transfer of the Participant&#8217;s employment from the Company to a subsidiary of the Company, transfer among or between subsidiaries of the Company, or transfer from a subsidiary of the Company to the Company shall not be treated as a termination of employment.</font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;The Participant shall be responsible for any applicable withholding or other taxes that may become due as a result of PSUs that vest as of the Participant&#8217;s termination of employment date or thereafter.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">A PSU does not represent an equity interest in the Company and carries no voting rights.  The Participant shall have no rights of a shareholder with respect to the PSUs prior to the Vesting Date.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">Neither the execution and delivery hereof nor the granting of the Award evidenced hereby shall constitute or be evidence of any agreement or understanding, express or implied, on the part of the Company or its subsidiaries to employ the Participant for any specific period.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.61pt">Any notice required to be given hereunder to the Company shall be in writing.  If by regular mail, any required notice shall be addressed to&#58; CVS Health Corporation, Attention&#58; Senior Director, Executive Compensation, One CVS Drive, Woonsocket, RI 02895.  If by electronic  mail, any notice required shall be sent to&#58; </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">equityadministration&#64;cvshealth.com</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   </font></div><div style="padding-left:27pt;text-indent:-18pt"><font><br></font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice required to be given hereunder to the Participant shall be addressed to such Participant at the address shown on the records of the Company, subject to the right of either party hereafter to designate, in writing, to the other, some other address.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">All decisions and interpretations made by the Board of Directors or the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive on all persons.  In the event of any inconsistency between the terms hereof and the provisions of the Plan, the Plan shall govern.  Furthermore, the determination of the achievement of any performance goals under this Agreement, and the amounts used in making such determination, shall be in the Board of Directors&#8217; or the Committee&#8217;s sole discretion and such determination shall be final, binding and conclusive for all purposes and upon all parties.  The Committee (or, if applicable, the Chief Executive Officer of the Company) may, in its discretion, reduce or increase the amount of a settlement otherwise to be made in connection with the PSUs to the extent permissible under the Plan.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">The award of PSUs pursuant to this Agreement is expressly subject to and contingent upon the requirement that the Participant shall have fully executed and delivered to the Company the Restrictive Covenant Agreement that may be required and provided by the Company. The applicable agreement containing the restrictive covenants that the Company may require in connection with this award is hereafter referred to as the &#8220;Restrictive Covenant Agreement&#8221;.&#160; </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company intends to require the Participant to execute and deliver a new Restrictive Covenant Agreement in connection with the grant hereunder, the Company shall provide such new Restrictive Covenant Agreement to the Participant and the Participant agrees to execute and deliver such new Restrictive Covenant Agreement by the deadline set forth by the Company.&#160; If the Participant is currently subject to a Restrictive Covenant Agreement and the Company does not require the Participant to execute and deliver a new Restrictive Covenant Agreement, then by accepting the award of PSUs, pursuant to this Agreement, the Participant affirms his or her Restrictive Covenant Agreement and intent to be bound by the restrictions in the Restrictive Covenant Agreement and to comply with all of its provisions.&#160; </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant agrees that failure to execute and return the new Restrictive Covenant Agreement, if required, by the deadline set forth by the Company shall result in the immediate and irrevocable forfeiture of the PSU Award hereunder and any right to receive dividend equivalents or Shares with respect thereto.&#160; Further, if the Participant violates any provision of the applicable Restrictive Covenant Agreement, any unvested PSUs will be immediately and irrevocably forfeited, and no payment of any kind, including Dividend Equivalents or Shares, shall be payable with respect thereto.&#160; This Section shall not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenant Agreement. The Company reserves all rights to seek all available legal or equitable remedies in the event of  the Participant&#8217;s violation or threatened violation of the Restrictive Covenant Agreement, including injunctive relief. </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">By accepting this Award, the Participant acknowledges that a copy of the Plan has been made available by the Company for the Participant&#8217;s reference and agrees to be bound by the terms and conditions set forth in this Agreement and the Plan as in effect from time to time.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">By accepting this Award, the Participant further acknowledges that the Federal securities laws and&#47;or the Company&#8217;s policies regarding trading in its securities may limit or restrict the Participant&#8217;s right to trade Shares, including, without limitation, sales of Shares acquired in connection with PSUs.  The Participant agrees to comply with such Federal securities law requirements and the Company&#8217;s policies, as such laws and policies may be amended from time to time.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">The Company intends that this Agreement not violate any applicable provision of, or result in any additional tax or penalty under, Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and that to the extent any provisions of this Agreement do not comply with Code Section 409A the Company shall make such changes in order to comply with Code Section 409A to the extent it considers reasonable.  In all events, the provisions of the Company&#8217;s 409A Universal Definitions Document are hereby incorporated by reference and to the extent required to avoid a violation of the applicable rules under Section 409A by reason of Section 409A(a)(2)(B)(i) of the Code, payment of any amounts subject to Section 409A of the Code shall be delayed until the first business day of the seventh month immediately following the employment termination date.  For purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment, references to the &#8220;termination of employment&#8221; (and corollary terms) shall be construed to refer to &#8220;separation from service&#8221; (within the meaning of Treas. Reg. Section 1.409A-1(h)). Notwithstanding the foregoing, the Company makes no representations as to the tax treatment or consequences of any payment made hereunder, and the Participant, by accepting this Award, acknowledges that the Participant shall be solely responsible for same.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">The Award subject to this PSU Agreement under the Plan shall be subject to the terms of the Company&#8217;s Recoupment Policy as it exists from time to time, which may require the Participant to immediately repay to the Company the value of any pre-tax economic benefit that he or she may derive from the Award. By accepting this Award, the Participant acknowledges that the Company&#8217;s Recoupment Policy has been made available for the Participant&#8217;s reference.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">(a) &#160;&#160;&#160;&#160;The Participant agrees that the Award covered by this Agreement is subject to the Company&#8217;s  Recoupment  Policy and the other terms and conditions set forth in this Agreement. In addition to and without limiting the other terms and conditions of this Agreement, if prior to final settlement and release from the Holding Period the Committee determines that the Participant has engaged in Detrimental Conduct (as defined below), the Committee, in its sole discretion, will be entitled to recover from the Participant some or all of the Shares (and any related dividends or dividend equivalents) paid to the Participant pursuant to this Agreement.  All such determinations by the Committee will be final and binding.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.8pt">Detrimental Conduct.  The Participant agrees that during any period in which PSUs (and any related dividend equivalents) remain outstanding and payable pursuant to this Agreement, including the Holding Period, the Participant shall not engage in Detrimental Conduct.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detrimental Conduct</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any one of the following&#58; (i) any conduct that would constitute Cause&#59; (ii) the commission of a criminal act by the Participant, whether or not performed in the workplace, that subjects, or if generally known, would subject the Company or its subsidiaries to public ridicule or embarrassment&#59; (iii) intentional misconduct or conduct not taken in good faith and causing significant  reputational harm to the Company or its subsidiaries&#59; (iv) intentional violation, or negligent disregard, of the Company&#8217;s or its subsidiaries&#8217; policies, rules and procedures, speci&#64257;cally including, but not limited to any of the Participant&#8217;s obligations under the Company&#8217;s Code   of Conduct and workplace policies&#59; or (v) any violation of the Participant&#8217;s Restrictive Covenant Agreement.  </font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.16pt">Remedies. Payment of PSUs (and any related dividends or dividend equivalents) on the Settlement Date is speci&#64257;cally conditioned on the requirement that at all times prior to such Settlement Date, the Participant does not engage in Detrimental Conduct.  In addition, releasing Shares delivered after the Holding Period is also specifically conditioned on the requirement that at all times prior to such release, the Participant does not engage in Detrimental Conduct.  If the Committee determines in its reasonable business judgment that the  Participant  has  failed  to  satisfy  such  requirements, then all or a portion of the PSUs (and</font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.3pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any related dividends or dividend equivalents), or all or a portion of any Shares delivered in settlement thereof that are subject to the Holding Period, as of the date of such determination, shall be canceled and forfeited as of such date of determination.  All such determinations by the Committee will be final and binding.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">This Agreement shall be governed by the laws of Delaware, without giving effect to its choice of law provisions.</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.01pt">This Agreement shall be fully effective only upon the Participant&#8217;s formal acceptance of the terms and conditions set forth above as required by the Company.   </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:0.36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.072%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name</font></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title</font></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"></td><td style="width:5.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 0.36pt 0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accepted by&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name</font></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title</font></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 0.36pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0.36pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:58.3pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:360pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSU Award Agreement_2020</font></div><div style="padding-right:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>3
<FILENAME>a09302020ex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i45174d6e36154c61acc01bcefad1dd68_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 15.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter re&#58; Unaudited Interim Financial Information</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">November&#160;6, 2020 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated November&#160;6, 2020, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended September&#160;30, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>a09302020ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i19893ca345954d5f9a8af3efdff9a98e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Larry J. Merlo, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:8pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;LARRY J. MERLO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Larry J. Merlo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>a09302020ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i6631c009bc6a4e12ab27769a5bd5e0c2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eva C. Boratto, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;EVA C. BORATTO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eva C. Boratto</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>a09302020ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i57456e0062f74aecb4dfc4ed245e81fa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2020 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Larry J. Merlo, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;LARRY J. MERLO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Larry J. Merlo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>a09302020ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4dc9a49c2bd942e3ac4df31353917d9b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2020 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eva C. Boratto, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;EVA C. BORATTO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eva C. Boratto</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cvs-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited_1" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Divestitures" roleURI="http://www.cvshealth.com/role/Divestitures">
        <link:definition>2110102 - Disclosure - Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresDetails" roleURI="http://www.cvshealth.com/role/DivestituresDetails">
        <link:definition>2411407 - Disclosure - Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>2112103 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>2313302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDetails">
        <link:definition>2414408 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>2415409 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails_1" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1">
        <link:definition>2415409 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>2416410 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>2417411 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>2418412 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>2419413 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>2420414 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>2421415 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>2422416 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>2123104 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>2324303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails">
        <link:definition>2425417 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>2426418 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>2427419 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>2128105 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>2329304 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>2430420 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>2431421 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.cvshealth.com/role/Borrowings">
        <link:definition>2132106 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.cvshealth.com/role/BorrowingsTables">
        <link:definition>2333305 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails">
        <link:definition>2434422 - Disclosure - Borrowings - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails">
        <link:definition>2435423 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>2136107 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails">
        <link:definition>2437424 - Disclosure - Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>2138108 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>2339306 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>2440425 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>2141109 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>2342307 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>2443426 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>2144110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2445427 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>2146111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>2347308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2448428 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>2449429 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>2450430 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.cvshealth.com/role/SubsequentEvent">
        <link:definition>2151112 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.cvshealth.com/role/SubsequentEventDetails">
        <link:definition>2452431 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofUnderPerformingStores" abstract="false" name="NumberofUnderPerformingStores" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_A2016RepurchaseProgramMember" abstract="true" name="A2016RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueJune2021Member" abstract="true" name="SeniorNotes4.125DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OutstandingSeniorNotesMember" abstract="true" name="OutstandingSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_Deferredincometaxesandothernoncashitems" abstract="false" name="Deferredincometaxesandothernoncashitems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueMay2021Member" abstract="true" name="SeniorNotes4.125DueMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_StoreRationalizationCharges" abstract="false" name="StoreRationalizationCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.75DueApril2030Member" abstract="true" name="SeniorNotes3.75DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.125DueMarch2020Member" abstract="true" name="SeniorNotes3.125DueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2021Member" abstract="true" name="FloatingRateNotesDueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CorporateOtherMember" abstract="true" name="CorporateOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareandOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueApril2040Member" abstract="true" name="SeniorNotes4.125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PremiumRevenueMember" abstract="true" name="PremiumRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2020Member" abstract="true" name="FloatingRateNotesDueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NonTaxDeductibleHealthInsuranceFee" abstract="false" name="NonTaxDeductibleHealthInsuranceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" abstract="false" name="LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes3.625DueApril2027Member" abstract="true" name="SeniorNotes3.625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtExtinguishmentFees" abstract="false" name="DebtExtinguishmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ChangeinContractwithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractwithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.25DueApril2050Member" abstract="true" name="SeniorNotes4.25DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJuly2020Member" abstract="true" name="SeniorNotes2.8DueJuly2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesMember" abstract="true" name="FloatingRateNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" abstract="true" name="BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberofPharmacyPlanMembers" abstract="false" name="NumberofPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" abstract="false" name="NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" abstract="false" name="LossContingencyNewClaimsFiledNumberOfStatesInvolved" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.35DueMarch2021Member" abstract="true" name="SeniorNotes3.35DueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ContractwithCustomerLiabilityRedemptionandBreakage" abstract="false" name="ContractwithCustomerLiabilityRedemptionandBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" abstract="true" name="USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BlueCrossAndBlueShieldOfNewJerseyMember" abstract="true" name="BlueCrossAndBlueShieldOfNewJerseyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LossContingencyAuditMethodologySampleSize" abstract="false" name="LossContingencyAuditMethodologySampleSize" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" abstract="true" name="ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.125June2021Member" abstract="true" name="SeniorNotes2.125June2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_CoventryHealthCareWorkersCompensationBusinessMember" abstract="true" name="CoventryHealthCareWorkersCompensationBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.7DueMarch2023Member" abstract="true" name="SeniorNotes3.7DueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" abstract="true" name="AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" abstract="true" name="ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DrogariaOnofreLtdaMember" abstract="true" name="DrogariaOnofreLtdaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.45DueJune2021Member" abstract="true" name="SeniorNotes5.45DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>cvs-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0566aadd-c507-4a1d-b7d7-30621a2f5987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_22e83e98-33cf-4fc2-88e0-dd7c471a8674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0566aadd-c507-4a1d-b7d7-30621a2f5987" xlink:to="loc_us-gaap_CostsAndExpenses_22e83e98-33cf-4fc2-88e0-dd7c471a8674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4589e507-52d9-4019-9fbc-2195861ebf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0566aadd-c507-4a1d-b7d7-30621a2f5987" xlink:to="loc_us-gaap_Revenues_4589e507-52d9-4019-9fbc-2195861ebf7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e613c260-9352-40af-8c64-fc0a2b65c761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_108234bc-3b60-4245-bf2f-0ac731e8b1bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e613c260-9352-40af-8c64-fc0a2b65c761" xlink:to="loc_us-gaap_OperatingIncomeLoss_108234bc-3b60-4245-bf2f-0ac731e8b1bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b5f527f7-1d62-490a-9344-4b65325d8b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e613c260-9352-40af-8c64-fc0a2b65c761" xlink:to="loc_us-gaap_InterestExpense_b5f527f7-1d62-490a-9344-4b65325d8b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8e772cc6-6976-46df-b429-e07be69c5b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e613c260-9352-40af-8c64-fc0a2b65c761" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8e772cc6-6976-46df-b429-e07be69c5b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_88f8eb77-55eb-4a3c-8c95-257edc270661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e613c260-9352-40af-8c64-fc0a2b65c761" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_88f8eb77-55eb-4a3c-8c95-257edc270661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eaf59f47-0d70-4a1c-bb4f-89155c882881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_96684e26-af75-4db3-a701-375939ddc0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_eaf59f47-0d70-4a1c-bb4f-89155c882881" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_96684e26-af75-4db3-a701-375939ddc0f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c09f9188-78f4-4be1-b3eb-0016f24830ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_eaf59f47-0d70-4a1c-bb4f-89155c882881" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c09f9188-78f4-4be1-b3eb-0016f24830ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dab8c0f2-7419-4fb4-b709-9e2b9711492e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_284f631d-7f80-467a-9075-c7fa06d5128b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dab8c0f2-7419-4fb4-b709-9e2b9711492e" xlink:to="loc_us-gaap_ProfitLoss_284f631d-7f80-467a-9075-c7fa06d5128b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a77b9093-713b-4a19-a7dc-1b8c3dfdca18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dab8c0f2-7419-4fb4-b709-9e2b9711492e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a77b9093-713b-4a19-a7dc-1b8c3dfdca18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1ed89289-7455-40e7-9638-f93a17b16cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8d0ad175-6f80-47ba-b93c-961f0a2cb49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_1ed89289-7455-40e7-9638-f93a17b16cf5" xlink:to="loc_us-gaap_NetInvestmentIncome_8d0ad175-6f80-47ba-b93c-961f0a2cb49a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_769a6a74-cb00-445b-b859-25a2685dba50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_1ed89289-7455-40e7-9638-f93a17b16cf5" xlink:to="loc_us-gaap_PremiumsEarnedNet_769a6a74-cb00-445b-b859-25a2685dba50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f0d88043-a583-4919-90e5-ef56acda1d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_1ed89289-7455-40e7-9638-f93a17b16cf5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f0d88043-a583-4919-90e5-ef56acda1d63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_06e0e3af-72f3-4c7a-8154-212f7b18478d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_41148835-deee-47eb-86ce-502f3fa77955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_06e0e3af-72f3-4c7a-8154-212f7b18478d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_41148835-deee-47eb-86ce-502f3fa77955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d00b9028-e9e4-4068-b20e-cdf4bd1c8e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_06e0e3af-72f3-4c7a-8154-212f7b18478d" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d00b9028-e9e4-4068-b20e-cdf4bd1c8e9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e83a328d-e27c-4085-8633-66bf94a83da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_06e0e3af-72f3-4c7a-8154-212f7b18478d" xlink:to="loc_us-gaap_OperatingExpenses_e83a328d-e27c-4085-8633-66bf94a83da1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45061e03-535e-4227-95c6-001de83ab58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1f383f82-366f-4fe4-af71-728ab524e66e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45061e03-535e-4227-95c6-001de83ab58d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1f383f82-366f-4fe4-af71-728ab524e66e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3682a020-ad2c-47de-a1dc-3c52928b0d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45061e03-535e-4227-95c6-001de83ab58d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3682a020-ad2c-47de-a1dc-3c52928b0d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_81c774d8-05f7-4751-ae77-e56f00154464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45061e03-535e-4227-95c6-001de83ab58d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_81c774d8-05f7-4751-ae77-e56f00154464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5830891a-20ef-4022-a876-69523169f773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45061e03-535e-4227-95c6-001de83ab58d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5830891a-20ef-4022-a876-69523169f773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_498876b2-6bae-46f5-96b0-7ce69acb00bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6d8efefa-a0ac-4cc4-9d38-a04506e60748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_498876b2-6bae-46f5-96b0-7ce69acb00bf" xlink:to="loc_us-gaap_ProfitLoss_6d8efefa-a0ac-4cc4-9d38-a04506e60748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_244c649b-8619-463a-9c0c-5e483f614eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_498876b2-6bae-46f5-96b0-7ce69acb00bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_244c649b-8619-463a-9c0c-5e483f614eeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_85cfd115-fab8-4909-a806-cbb4dab5f46e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e2d63b40-3b45-4152-b884-71b662a264c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_85cfd115-fab8-4909-a806-cbb4dab5f46e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e2d63b40-3b45-4152-b884-71b662a264c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1267e1bf-82af-4762-89ab-1e044c1d8ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_85cfd115-fab8-4909-a806-cbb4dab5f46e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1267e1bf-82af-4762-89ab-1e044c1d8ce0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4e9cdf12-a312-4c86-bf7c-6363544f6805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4e9cdf12-a312-4c86-bf7c-6363544f6805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_bf7d43c7-2577-44a3-9a83-f2eed6b92152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:to="loc_us-gaap_ShortTermInvestments_bf7d43c7-2577-44a3-9a83-f2eed6b92152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3c3ab214-36ae-4a97-add6-08e1c3a71268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3c3ab214-36ae-4a97-add6-08e1c3a71268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_83ba5624-c79f-4e59-a563-d9a7c8e03725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:to="loc_us-gaap_InventoryNet_83ba5624-c79f-4e59-a563-d9a7c8e03725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_26f52b5d-571a-486a-bcb7-2d100d6ef83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6c0311a0-9b6c-445e-b8f4-cb5e239e3505" xlink:to="loc_us-gaap_OtherAssetsCurrent_26f52b5d-571a-486a-bcb7-2d100d6ef83c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_814a2b4f-1fda-4528-8068-b63671eb2759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_LiabilitiesCurrent_814a2b4f-1fda-4528-8068-b63671eb2759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_16833821-225b-4517-a269-ce08615ddc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_16833821-225b-4517-a269-ce08615ddc8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e4d8c8c3-bf1d-485b-ac38-d9ab2db0cdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e4d8c8c3-bf1d-485b-ac38-d9ab2db0cdd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6726ceeb-d735-466a-ad3d-1695de25c4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6726ceeb-d735-466a-ad3d-1695de25c4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_58f23a62-d11b-40dd-ba9b-9d7b8578a8be" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_58f23a62-d11b-40dd-ba9b-9d7b8578a8be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d500a9c3-69c1-4f42-88de-2e8be57d7cf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d500a9c3-69c1-4f42-88de-2e8be57d7cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_8a4d2d27-d83a-4844-aca4-de7c790456df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1ceab6b2-874b-40da-a50b-96828fc74e16" xlink:to="loc_us-gaap_SeparateAccountsLiability_8a4d2d27-d83a-4844-aca4-de7c790456df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_32ce4699-2a9a-45f3-a4c6-4c6b14aad1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_LongTermInvestments_32ce4699-2a9a-45f3-a4c6-4c6b14aad1bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9e05f0d-1281-4a77-b097-46ec5ee05d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9e05f0d-1281-4a77-b097-46ec5ee05d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd6c88be-2b5c-4899-94bd-7052b5388a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd6c88be-2b5c-4899-94bd-7052b5388a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_774b86e2-44e0-443c-9191-2e4b2c320f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_Goodwill_774b86e2-44e0-443c-9191-2e4b2c320f89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c281e24d-a41c-4ab1-9338-52c55f790261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c281e24d-a41c-4ab1-9338-52c55f790261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_a1290e98-7496-4c71-a761-c6d0f139f690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_SeparateAccountAssets_a1290e98-7496-4c71-a761-c6d0f139f690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ab367425-7494-4b86-ac89-2fb644ee702b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ab367425-7494-4b86-ac89-2fb644ee702b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_362eeb3d-4443-44d0-97d6-833ad2aacf6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e08001a4-d32a-4e6e-a908-1c3e32fa4ad6" xlink:to="loc_us-gaap_AssetsCurrent_362eeb3d-4443-44d0-97d6-833ad2aacf6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_061f1e9a-4644-43ce-b28b-d36fd30e442d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c4742bf9-07f4-4720-8b18-a14da84e5338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_061f1e9a-4644-43ce-b28b-d36fd30e442d" xlink:to="loc_us-gaap_StockholdersEquity_c4742bf9-07f4-4720-8b18-a14da84e5338" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_680da833-68af-4d1c-929a-f5f34ff5d75d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_061f1e9a-4644-43ce-b28b-d36fd30e442d" xlink:to="loc_us-gaap_MinorityInterest_680da833-68af-4d1c-929a-f5f34ff5d75d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_07771b40-f6ba-4bbf-b08d-4065d3d2a09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_280a76d7-5182-4111-939b-e23495d92cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07771b40-f6ba-4bbf-b08d-4065d3d2a09f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_280a76d7-5182-4111-939b-e23495d92cf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5c868476-4c3b-4ee3-9855-08fa7025f6f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07771b40-f6ba-4bbf-b08d-4065d3d2a09f" xlink:to="loc_us-gaap_Liabilities_5c868476-4c3b-4ee3-9855-08fa7025f6f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c08eab37-68dc-417b-9cdb-aefe53141f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:to="loc_us-gaap_PreferredStockValue_c08eab37-68dc-417b-9cdb-aefe53141f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_a2e2ef86-1a8f-4316-a33e-67113a658a83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_a2e2ef86-1a8f-4316-a33e-67113a658a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_af6f3c95-d9d7-418a-8b87-cd6cf6b9023c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:to="loc_us-gaap_TreasuryStockValue_af6f3c95-d9d7-418a-8b87-cd6cf6b9023c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7a5eb384-c93f-4da3-9459-129eda3a429a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7a5eb384-c93f-4da3-9459-129eda3a429a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f1fee90f-9bf0-42e3-b275-ecb49c9d5527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cb525137-586d-4036-87ce-56f8aa1e0717" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f1fee90f-9bf0-42e3-b275-ecb49c9d5527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_cf0b2e19-5824-4274-a1b1-5fb13f8761e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_cf0b2e19-5824-4274-a1b1-5fb13f8761e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_8bc0f728-1d64-435c-bf2b-276ba5eba350" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_8bc0f728-1d64-435c-bf2b-276ba5eba350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bca1ed41-0c8f-41c8-bae7-467689bdf527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bca1ed41-0c8f-41c8-bae7-467689bdf527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_0bace341-1d2f-4eab-9eab-f310569d205e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_0bace341-1d2f-4eab-9eab-f310569d205e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a2e52acc-3768-4662-8113-3c8b59653f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a2e52acc-3768-4662-8113-3c8b59653f92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_170032a2-049b-4769-a04c-51c5dc148aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_170032a2-049b-4769-a04c-51c5dc148aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_6aee24e6-3083-4e92-8d47-5f4a1bb54f14" xlink:href="cvs-20200930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_6aee24e6-3083-4e92-8d47-5f4a1bb54f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_46d3b55a-d802-4d68-a81e-1b59e115876a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_59515aea-8be9-4d4f-9843-1fa67c8acafa" xlink:to="loc_us-gaap_OtherPolicyholderFunds_46d3b55a-d802-4d68-a81e-1b59e115876a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_c77ebde0-4fad-4420-b809-88d6e4ffb59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_c77ebde0-4fad-4420-b809-88d6e4ffb59c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0cf40cbd-c810-4e1f-986e-192f18c2ab44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0cf40cbd-c810-4e1f-986e-192f18c2ab44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f462d090-377e-4bd9-a851-ffbf20bf8b54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f462d090-377e-4bd9-a851-ffbf20bf8b54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f5d6ee7b-eb19-41b2-a14b-58737fa728da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f5d6ee7b-eb19-41b2-a14b-58737fa728da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_126f9f4e-4fbf-4e06-869d-4d8adf53b47f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_126f9f4e-4fbf-4e06-869d-4d8adf53b47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b9f2b638-19b5-4031-b2d2-02367a7c4cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb8e9e-4e28-4efd-85a8-d0946141d7b4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b9f2b638-19b5-4031-b2d2-02367a7c4cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bc6b30b0-8fb8-46ed-9b67-5bf0ee253aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_478563a4-dc52-459b-bf4d-a75b7af05fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bc6b30b0-8fb8-46ed-9b67-5bf0ee253aa0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_478563a4-dc52-459b-bf4d-a75b7af05fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35d44546-239d-41ba-bfb6-d79c438d2a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bc6b30b0-8fb8-46ed-9b67-5bf0ee253aa0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35d44546-239d-41ba-bfb6-d79c438d2a62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89741c8d-4004-48c2-bdc6-9fe316541814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bc6b30b0-8fb8-46ed-9b67-5bf0ee253aa0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89741c8d-4004-48c2-bdc6-9fe316541814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_54e337b4-8bd5-4deb-abbf-ea32cea48d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_54e337b4-8bd5-4deb-abbf-ea32cea48d13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_8dd71041-cc1a-4202-8b39-06700222786f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_PaymentsOfDividends_8dd71041-cc1a-4202-8b39-06700222786f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d1799e46-1fdd-4f54-99ea-99ff90f6dccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d1799e46-1fdd-4f54-99ea-99ff90f6dccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43cc14f0-f0e5-49f1-b55d-350753f8d199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43cc14f0-f0e5-49f1-b55d-350753f8d199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_19884bd7-5f14-4576-9a62-7071e9e529e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_19884bd7-5f14-4576-9a62-7071e9e529e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b68c0479-7a34-41ce-aba3-d410f51e0633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b68c0479-7a34-41ce-aba3-d410f51e0633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_4eab7a7c-2927-4267-90f6-602a70da9261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_4eab7a7c-2927-4267-90f6-602a70da9261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_eb8a4c87-c5d5-4b9d-981b-5b47d2a7c84a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c03a44d7-3ca1-4d36-80fe-457068144857" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_eb8a4c87-c5d5-4b9d-981b-5b47d2a7c84a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2a1ceab9-c585-4634-a319-20d37e2270b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2a1ceab9-c585-4634-a319-20d37e2270b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_021abda4-c066-4556-abda-ce820da19141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_021abda4-c066-4556-abda-ce820da19141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4e23c86e-7414-4e6b-b6fb-bd11a426ece0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4e23c86e-7414-4e6b-b6fb-bd11a426ece0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_426dc96a-36c2-447a-babe-ec6017e34b58" xlink:href="cvs-20200930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_426dc96a-36c2-447a-babe-ec6017e34b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b7bca77c-c3dc-4045-8407-7ae9c3085fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b7bca77c-c3dc-4045-8407-7ae9c3085fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6dba68fd-caf2-422d-bf5d-b57551154f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6dba68fd-caf2-422d-bf5d-b57551154f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a92e28b7-945c-44ca-87d4-c21de9b3f472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a92e28b7-945c-44ca-87d4-c21de9b3f472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2ee146c1-4d9f-401e-9d47-36da9a1a8e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_ShareBasedCompensation_2ee146c1-4d9f-401e-9d47-36da9a1a8e98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f4f6032c-7ea5-4696-be7b-0b1669e8bf32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f4f6032c-7ea5-4696-be7b-0b1669e8bf32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ef8efa9e-abb8-4622-834e-bcfe52c550a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ef8efa9e-abb8-4622-834e-bcfe52c550a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d1eb4b61-6551-4df8-bbd3-1f7d4a5482dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d1eb4b61-6551-4df8-bbd3-1f7d4a5482dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e59d0f35-6d72-4ab5-8cdc-57565b65b3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_619ed5fe-f798-44f4-8b8b-1bcc075559ca" xlink:to="loc_us-gaap_ProfitLoss_e59d0f35-6d72-4ab5-8cdc-57565b65b3c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_cdd1c52d-6c0e-437d-9e67-fd991130338a" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_cdd1c52d-6c0e-437d-9e67-fd991130338a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e2415447-ec8d-4ac0-9d59-0ca71d0da4de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_us-gaap_InterestPaidNet_e2415447-ec8d-4ac0-9d59-0ca71d0da4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_e3a0f70f-391e-4df4-a429-c4f669aa5ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_us-gaap_ProceedsFromCustomers_e3a0f70f-391e-4df4-a429-c4f669aa5ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_6137ae5a-2d26-48fb-a444-10338b9f1b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_6137ae5a-2d26-48fb-a444-10338b9f1b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_c226144c-fe00-4d7c-8ff5-cddd6ecfe0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_c226144c-fe00-4d7c-8ff5-cddd6ecfe0b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_8a831513-3c18-4a99-9fe6-493dc62a375f" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_8a831513-3c18-4a99-9fe6-493dc62a375f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1a8db9a9-c1e3-4c23-bdf7-3a2a6753570f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ac57464-cc0b-452a-9f4b-d6ab1acc6d35" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1a8db9a9-c1e3-4c23-bdf7-3a2a6753570f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70bc7f04-6c66-44bb-a28a-aed18aea0933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e22ddd6-d044-45e6-9c19-68f96e3f4913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70bc7f04-6c66-44bb-a28a-aed18aea0933" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e22ddd6-d044-45e6-9c19-68f96e3f4913" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ca10db3a-46b9-41eb-9129-f08cadcc257f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70bc7f04-6c66-44bb-a28a-aed18aea0933" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ca10db3a-46b9-41eb-9129-f08cadcc257f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cd483667-7495-447d-8b85-6f825f63e1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_4cbbf887-597a-49f9-ae3c-44346092005d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cd483667-7495-447d-8b85-6f825f63e1d2" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_4cbbf887-597a-49f9-ae3c-44346092005d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_da4a0881-65e4-416a-b4ca-296699990490" xlink:href="cvs-20200930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cd483667-7495-447d-8b85-6f825f63e1d2" xlink:to="loc_cvs_VendorandManufacturerReceivables_da4a0881-65e4-416a-b4ca-296699990490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_507b7d68-58cc-4bb2-bec2-89489c245909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cd483667-7495-447d-8b85-6f825f63e1d2" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_507b7d68-58cc-4bb2-bec2-89489c245909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_5b41ef22-6f9e-4621-9910-e63573aac31d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cd483667-7495-447d-8b85-6f825f63e1d2" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_5b41ef22-6f9e-4621-9910-e63573aac31d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Divestitures" xlink:type="simple" xlink:href="cvs-20200930.xsd#Divestitures"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Divestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#DivestituresDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20200930.xsd#Investments"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e3ffc49d-3dca-479c-ae01-a79cb7325d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f9018b4c-a436-4423-9de2-5b6f424e3dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_e3ffc49d-3dca-479c-ae01-a79cb7325d26" xlink:to="loc_us-gaap_ShortTermInvestments_f9018b4c-a436-4423-9de2-5b6f424e3dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_d56f4cf9-de15-43fc-a28c-745f5dfc9255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_e3ffc49d-3dca-479c-ae01-a79cb7325d26" xlink:to="loc_us-gaap_LongTermInvestments_d56f4cf9-de15-43fc-a28c-745f5dfc9255" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0ee1ea94-1798-4f0f-8be1-18cfa231cb5f" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_53a79739-e0ca-44ab-930a-0fd64da3712a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0ee1ea94-1798-4f0f-8be1-18cfa231cb5f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_53a79739-e0ca-44ab-930a-0fd64da3712a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_92b2313e-5da7-4e19-b541-fe0455f006ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0ee1ea94-1798-4f0f-8be1-18cfa231cb5f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_92b2313e-5da7-4e19-b541-fe0455f006ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_bb9e6799-8eb0-4e2c-9ace-fb04a2721743" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_291079fa-51e0-4e94-ae54-175b1d6afa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_bb9e6799-8eb0-4e2c-9ace-fb04a2721743" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_291079fa-51e0-4e94-ae54-175b1d6afa4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_79b1603c-5d58-4e1f-a976-ea97e63abd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_bb9e6799-8eb0-4e2c-9ace-fb04a2721743" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_79b1603c-5d58-4e1f-a976-ea97e63abd3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ddaaaaf8-4378-4612-b734-0b021f7d48b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_bb9e6799-8eb0-4e2c-9ace-fb04a2721743" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ddaaaaf8-4378-4612-b734-0b021f7d48b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_86f4f470-53ba-4682-9b96-a57bf94b245a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_86f4f470-53ba-4682-9b96-a57bf94b245a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_3ee698c2-af24-4e77-9d9a-a94e592dfba6" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_3ee698c2-af24-4e77-9d9a-a94e592dfba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_a13ccf31-1e58-4b17-beeb-7e13b1e859be" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_a13ccf31-1e58-4b17-beeb-7e13b1e859be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_fb1cdc50-90dd-4fc9-bc77-b64b4e4f1fdc" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_fb1cdc50-90dd-4fc9-bc77-b64b4e4f1fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_1c4cb977-5434-4f42-b362-88910974fd90" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_8e662794-8ad1-4f77-bb8e-a94d2c2c2fe7" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_1c4cb977-5434-4f42-b362-88910974fd90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4771bd9c-c7a5-420f-97c4-fb19a74aa30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4771bd9c-c7a5-420f-97c4-fb19a74aa30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_62781855-b3a3-4f10-95f1-2c479d0f08a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_62781855-b3a3-4f10-95f1-2c479d0f08a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_93c7b9ad-ad7f-44bc-ac31-55db673df555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_93c7b9ad-ad7f-44bc-ac31-55db673df555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_90cb74ff-d2fb-42f1-8035-63a463994bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_90cb74ff-d2fb-42f1-8035-63a463994bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_161c41d4-218a-41ea-aeb7-afe74a6cd1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f5b83b5-2a8e-4125-931f-32a8af611fc5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_161c41d4-218a-41ea-aeb7-afe74a6cd1a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_613d098b-0987-4bd4-8dc6-d43392d90044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6c1c0ba3-c560-46c6-ac43-5cbc4e3795d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_613d098b-0987-4bd4-8dc6-d43392d90044" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6c1c0ba3-c560-46c6-ac43-5cbc4e3795d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5956e170-1733-495a-b3ff-da3ee1a011c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_613d098b-0987-4bd4-8dc6-d43392d90044" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5956e170-1733-495a-b3ff-da3ee1a011c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_559d7fe7-a518-4add-a804-6f232b546788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db5c29a3-c977-43a4-8e6a-3461141643ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_559d7fe7-a518-4add-a804-6f232b546788" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db5c29a3-c977-43a4-8e6a-3461141643ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3a76e954-9749-4e84-bc00-33488d060f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_559d7fe7-a518-4add-a804-6f232b546788" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3a76e954-9749-4e84-bc00-33488d060f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bae4bf0b-8518-4de5-adcf-82ee39fe5432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_e286023d-bb5f-4915-8c43-667980e64abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bae4bf0b-8518-4de5-adcf-82ee39fe5432" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_e286023d-bb5f-4915-8c43-667980e64abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_415ca1c7-3757-41f3-a75a-b8a95ff8061a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bae4bf0b-8518-4de5-adcf-82ee39fe5432" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_415ca1c7-3757-41f3-a75a-b8a95ff8061a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_49c55e33-444d-436f-8b46-40f69f69706b" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_49c55e33-444d-436f-8b46-40f69f69706b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_95c2e0f0-36ea-4fcf-9177-6277d470e221" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_95c2e0f0-36ea-4fcf-9177-6277d470e221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_baa84a00-9633-4a91-93d6-ace0d987c5ea" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_baa84a00-9633-4a91-93d6-ace0d987c5ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_b0bce9f0-7f8c-43e5-8713-dbf651318509" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_b0bce9f0-7f8c-43e5-8713-dbf651318509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b20fc189-7130-4395-9706-d6faf9f070ee" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a08439e4-19ff-43e6-8e01-a8d8226779d8" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b20fc189-7130-4395-9706-d6faf9f070ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_aec5737d-7bf3-401d-98f7-7673828d5cb0" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_aec5737d-7bf3-401d-98f7-7673828d5cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_7da5224b-7ca2-4f7b-8aa7-9407727401ec" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_7da5224b-7ca2-4f7b-8aa7-9407727401ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_de795754-159b-493e-96eb-09288bd89f0a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_de795754-159b-493e-96eb-09288bd89f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c52afc79-10ce-4567-8acd-94f2a3ad911e" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c52afc79-10ce-4567-8acd-94f2a3ad911e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_b4fa9a74-fa30-42b2-8026-683bab992c63" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_24aba896-b572-4ded-8684-f07a99ac44b0" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_b4fa9a74-fa30-42b2-8026-683bab992c63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_db7fece2-744e-4938-8cc5-49cde4feb0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_747822c7-5f74-46be-9454-aa5fa9f9dc61" xlink:href="cvs-20200930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_db7fece2-744e-4938-8cc5-49cde4feb0ca" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_747822c7-5f74-46be-9454-aa5fa9f9dc61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_f3ec1456-a385-421e-9c35-6c8f22b2ee19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_db7fece2-744e-4938-8cc5-49cde4feb0ca" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_f3ec1456-a385-421e-9c35-6c8f22b2ee19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dfde1787-d91f-4e68-9776-5819838c1f6f" xlink:href="cvs-20200930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_3e9f2e8b-74a9-4001-9ab8-596beb057c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dfde1787-d91f-4e68-9776-5819838c1f6f" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_3e9f2e8b-74a9-4001-9ab8-596beb057c4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_b2115e90-eba9-4115-83c6-7f1b80643176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_dfde1787-d91f-4e68-9776-5819838c1f6f" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_b2115e90-eba9-4115-83c6-7f1b80643176" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsRealizedGainsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValue"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a46e5b07-d06c-4105-8fdf-aa678c7270ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef016aef-f080-4850-ac70-f567cfa0b249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a46e5b07-d06c-4105-8fdf-aa678c7270ee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef016aef-f080-4850-ac70-f567cfa0b249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_87398935-853f-410e-8628-4b080181d281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a46e5b07-d06c-4105-8fdf-aa678c7270ee" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_87398935-853f-410e-8628-4b080181d281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2e75fd5a-64d5-44a9-a019-c8bdad3bc5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a46e5b07-d06c-4105-8fdf-aa678c7270ee" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2e75fd5a-64d5-44a9-a019-c8bdad3bc5dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayable"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_81f68e39-d33c-4035-bcf9-f56f44e7e694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_20302ac6-de1b-490f-a23b-27c2f156256d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_81f68e39-d33c-4035-bcf9-f56f44e7e694" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_20302ac6-de1b-490f-a23b-27c2f156256d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_45081db8-bdae-4fb3-bb21-8a0c7388db70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_81f68e39-d33c-4035-bcf9-f56f44e7e694" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_45081db8-bdae-4fb3-bb21-8a0c7388db70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_db190991-5b81-412d-ab26-e1462ac99a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b342d9ec-020a-4b79-b9c7-e90cfaf358b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_db190991-5b81-412d-ab26-e1462ac99a36" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b342d9ec-020a-4b79-b9c7-e90cfaf358b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5b2c3ab9-1e60-4f78-9039-fc3ca62c2bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_db190991-5b81-412d-ab26-e1462ac99a36" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5b2c3ab9-1e60-4f78-9039-fc3ca62c2bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2a9b280-3b81-4834-8782-ea9d96eb1a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_20b09fb9-0e8a-408a-a40f-39d7b1a3f414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2a9b280-3b81-4834-8782-ea9d96eb1a99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_20b09fb9-0e8a-408a-a40f-39d7b1a3f414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_875892db-06e4-4c27-b7b9-985cb358e1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d2a9b280-3b81-4834-8782-ea9d96eb1a99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_875892db-06e4-4c27-b7b9-985cb358e1f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20200930.xsd#Borrowings"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_986119cc-6670-4dd0-b084-362dd05a680b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_66d5df8a-0d62-4fb6-98ce-a99faffde32a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_986119cc-6670-4dd0-b084-362dd05a680b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_66d5df8a-0d62-4fb6-98ce-a99faffde32a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_3df9577c-3db3-47e3-90da-ce0e2838e961" xlink:href="cvs-20200930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_986119cc-6670-4dd0-b084-362dd05a680b" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_3df9577c-3db3-47e3-90da-ce0e2838e961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_a0209e92-8cd6-4e4f-9a30-c23f4b4df4cd" xlink:href="cvs-20200930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_986119cc-6670-4dd0-b084-362dd05a680b" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_a0209e92-8cd6-4e4f-9a30-c23f4b4df4cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_1993dd96-5db2-4772-8a87-5779dfa8278b" xlink:href="cvs-20200930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_16be5aee-15b6-4d26-af5d-2168838a91e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_1993dd96-5db2-4772-8a87-5779dfa8278b" xlink:to="loc_us-gaap_FinanceLeaseLiability_16be5aee-15b6-4d26-af5d-2168838a91e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ba40c8b8-c835-4b3a-9e5d-618eac56084a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_1993dd96-5db2-4772-8a87-5779dfa8278b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ba40c8b8-c835-4b3a-9e5d-618eac56084a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030bc693-0bf3-4fa5-ac9a-421207c7a1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f6446c7-2620-4563-940d-0786b810e2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030bc693-0bf3-4fa5-ac9a-421207c7a1cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f6446c7-2620-4563-940d-0786b810e2a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f911c7c1-2423-4307-9d67-a47dc7e9e8ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030bc693-0bf3-4fa5-ac9a-421207c7a1cc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f911c7c1-2423-4307-9d67-a47dc7e9e8ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_45716ae3-c1e0-49ef-870b-e35305fdf422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b6e25282-42c3-46ff-b6ec-e866400548f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_45716ae3-c1e0-49ef-870b-e35305fdf422" xlink:to="loc_us-gaap_ProfitLoss_b6e25282-42c3-46ff-b6ec-e866400548f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1d8b0933-47c3-4f5b-9b2b-79ccbd39a37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_45716ae3-c1e0-49ef-870b-e35305fdf422" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1d8b0933-47c3-4f5b-9b2b-79ccbd39a37d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5d455924-6694-44c5-9884-217b02da8cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_45716ae3-c1e0-49ef-870b-e35305fdf422" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5d455924-6694-44c5-9884-217b02da8cf2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>cvs-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended" id="i2bcb79e44dae45d48979daa28fbea5ac_CoverPage"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i1fbb3c0950e2425590f6ffa2863a313b_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed417a5-27ac-494f-81bc-ee045617876f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed417a5-27ac-494f-81bc-ee045617876f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5fd834a5-10c1-48ec-a699-a79bb3e676f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_PremiumsEarnedNet_5fd834a5-10c1-48ec-a699-a79bb3e676f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_f77491bf-6473-4451-9de6-eaa08d9d1dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_NetInvestmentIncome_f77491bf-6473-4451-9de6-eaa08d9d1dca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bdaf78f7-9e52-42fe-ada4-b395f41ea242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_Revenues_bdaf78f7-9e52-42fe-ada4-b395f41ea242" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4a668fa6-5d9b-49e2-9dfa-3696affaf955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4a668fa6-5d9b-49e2-9dfa-3696affaf955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_e99c271c-282b-4ec2-8525-cd8898e5c348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_e99c271c-282b-4ec2-8525-cd8898e5c348" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1efd46de-3a7d-499a-a686-843ddbc19d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_OperatingExpenses_1efd46de-3a7d-499a-a686-843ddbc19d65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7cf80423-939a-42a2-a945-092069780816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_CostsAndExpenses_7cf80423-939a-42a2-a945-092069780816" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33b270bc-ece4-4e0f-9d8d-25b0d25af2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_OperatingIncomeLoss_33b270bc-ece4-4e0f-9d8d-25b0d25af2de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8fef87cb-b1eb-4189-a43b-ec506d70d760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_InterestExpense_8fef87cb-b1eb-4189-a43b-ec506d70d760" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8655ee14-965e-4868-b925-09819990c609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8655ee14-965e-4868-b925-09819990c609" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31b3bbaa-cb89-422c-abde-cabc86ceb992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31b3bbaa-cb89-422c-abde-cabc86ceb992" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d9b4eab5-b0ea-4c67-b9d3-c1d253b05aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d9b4eab5-b0ea-4c67-b9d3-c1d253b05aab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_28fbb76c-1efb-4b2e-8f2f-a31dd5288ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_28fbb76c-1efb-4b2e-8f2f-a31dd5288ca2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89223bda-d2e5-4401-83e2-349f3793d016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_ProfitLoss_89223bda-d2e5-4401-83e2-349f3793d016" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b216ff2f-7865-4844-ad48-d4925579dcb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b216ff2f-7865-4844-ad48-d4925579dcb0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27ff7e99-1f0c-4510-93a8-52963b4efcb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_NetIncomeLoss_27ff7e99-1f0c-4510-93a8-52963b4efcb3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc8ed870-65a0-4a9f-8714-57086588ea1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:to="loc_us-gaap_EarningsPerShareBasic_cc8ed870-65a0-4a9f-8714-57086588ea1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_447426b3-5662-47f0-8e9e-f98be4e03e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:to="loc_us-gaap_EarningsPerShareDiluted_447426b3-5662-47f0-8e9e-f98be4e03e8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f879c171-5c11-46aa-a9cc-5f5311e3d169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f879c171-5c11-46aa-a9cc-5f5311e3d169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0aa14da1-f791-4f27-a739-2030043664f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0aa14da1-f791-4f27-a739-2030043664f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b4630c61-f388-498c-be23-9f8c08387051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b4630c61-f388-498c-be23-9f8c08387051" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_ffc62c05-c284-490c-bd0a-6bb699c9fba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_ffc62c05-c284-490c-bd0a-6bb699c9fba1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:to="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f6f16c92-e157-43e1-a9f5-210a86864a7f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:to="loc_srt_ProductsAndServicesDomain_f6f16c92-e157-43e1-a9f5-210a86864a7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:to="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_fcca571b-7521-4449-9f96-9e132adf4afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:to="loc_us-gaap_ProductMember_fcca571b-7521-4449-9f96-9e132adf4afe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3fb5d9ad-91ef-45ae-b3d2-2dea192375f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:to="loc_us-gaap_ServiceMember_3fb5d9ad-91ef-45ae-b3d2-2dea192375f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended" id="id6a8416caf2e47da86a6389f10700c96_CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i53edd642a1af40aa821b223f09fc456f_CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i1e452863fca749e3a4cf4d40277e06aa_CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i37d8d67dd5c74752a5b83656716d0c00_CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i83514ce099d446fca65cbb85bcfe4cdf_CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1ce196dd-a2d1-4d90-939c-37f21b64ce1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_SharesOutstanding_1ce196dd-a2d1-4d90-939c-37f21b64ce1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_504ab561-b7a2-48b5-aa41-6d24865b35c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_504ab561-b7a2-48b5-aa41-6d24865b35c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_13facb0a-469d-44be-98f3-4ae0f0f5ef30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_13facb0a-469d-44be-98f3-4ae0f0f5ef30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_335fbd51-9f01-483b-94f2-b4d5b37d9bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_335fbd51-9f01-483b-94f2-b4d5b37d9bfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62465891-724c-4aaf-b2a4-3a8d6f59f560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62465891-724c-4aaf-b2a4-3a8d6f59f560" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b62797cf-957f-4eca-8701-825766f8935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b62797cf-957f-4eca-8701-825766f8935d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_c844b32b-cbc1-4a07-9ffc-f989623f1a46" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_c844b32b-cbc1-4a07-9ffc-f989623f1a46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_4b8ab0a2-6127-4de5-80cf-1a5f213cb7c1" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_4b8ab0a2-6127-4de5-80cf-1a5f213cb7c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_5c720269-fe82-4fd9-9ff2-ba70ede3f89f" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_5c720269-fe82-4fd9-9ff2-ba70ede3f89f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_03adf56e-9a50-4466-b5eb-5320c1687edb" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_03adf56e-9a50-4466-b5eb-5320c1687edb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_a4b8e178-ff10-4fcb-b9e4-acca99eff71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_DividendsCommonStock_a4b8e178-ff10-4fcb-b9e4-acca99eff71f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_11500db3-e816-4847-bea5-a2bccda34bd7" xlink:href="cvs-20200930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_11500db3-e816-4847-bea5-a2bccda34bd7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9c0cd646-6d16-4402-a486-422b47cf6c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dfa8abd-358b-444d-885f-695b28ff0d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:to="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e4c6be4a-55e1-41f0-b5a4-e8c919239303_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e4c6be4a-55e1-41f0-b5a4-e8c919239303_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8f4757db-2955-462a-bd84-6465f37c87ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8f4757db-2955-462a-bd84-6465f37c87ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:to="loc_us-gaap_EquityComponentDomain_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:to="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_516aa994-2f62-42a0-bb48-654dda1680bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_CommonStockMember_516aa994-2f62-42a0-bb48-654dda1680bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4f45d9c0-0f8c-4d8f-9a98-be766144c464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_TreasuryStockMember_4f45d9c0-0f8c-4d8f-9a98-be766144c464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_cedc163e-225d-488b-8391-f15a7d4f42e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_cedc163e-225d-488b-8391-f15a7d4f42e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e24bca7f-edb2-4f46-b60f-768b7e388883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_RetainedEarningsMember_e24bca7f-edb2-4f46-b60f-768b7e388883" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28128c2b-f932-486c-9dea-1993479feeb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28128c2b-f932-486c-9dea-1993479feeb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_73465374-452f-48ec-873a-e0df7f33eded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_ParentMember_73465374-452f-48ec-873a-e0df7f33eded" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_09c9c61a-9054-4faf-b01d-814b63f91d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_NoncontrollingInterestMember_09c9c61a-9054-4faf-b01d-814b63f91d4c" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="i990d56092c704dbc8a85e48e23453d12_CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_7720cb62-f85e-4326-95b6-ebecb9f84dde" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_7720cb62-f85e-4326-95b6-ebecb9f84dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_572d2348-be43-4471-9cf0-fa3549a35143" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_572d2348-be43-4471-9cf0-fa3549a35143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f5786ef1-dbb0-4896-92a7-984ee3b1e465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_CommonStockValue_f5786ef1-dbb0-4896-92a7-984ee3b1e465" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57c105cb-24cc-4ae4-ba79-7ed541647199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57c105cb-24cc-4ae4-ba79-7ed541647199" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_689c0e5c-2d64-4896-b308-5a1f881bfbba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_689c0e5c-2d64-4896-b308-5a1f881bfbba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2654ac0a-974b-4a12-b59c-5cfece735f17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2654ac0a-974b-4a12-b59c-5cfece735f17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:to="loc_us-gaap_EquityComponentDomain_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:to="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_67f2542c-222f-407c-8570-1e593b7cae30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:to="loc_us-gaap_RetainedEarningsMember_67f2542c-222f-407c-8570-1e593b7cae30" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended" id="i52091df3557d4f8a9421501641cf92d1_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="i6c8b48c1558441eb8ec10a398e19fb99_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended" id="ibc8c59005c2a485ca7a7e9cd1d2b36bf_SignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i0faf13f08cd34fab9518ef431d65a971_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_b2be763e-3078-4f32-8cdf-f1d830f6dc9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfStores_b2be763e-3078-4f32-8cdf-f1d830f6dc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_61e1cc71-cab8-4254-a1c0-49a101d2a097" xlink:href="cvs-20200930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_61e1cc71-cab8-4254-a1c0-49a101d2a097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_0819fea7-c265-49ac-b9b3-e5aca5005de9" xlink:href="cvs-20200930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_0819fea7-c265-49ac-b9b3-e5aca5005de9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_72c9f52f-f9ba-4bff-8b52-548bc0b80d19" xlink:href="cvs-20200930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPatientsServedperYear_72c9f52f-f9ba-4bff-8b52-548bc0b80d19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_5d4ec761-09cf-47cf-a4bc-a469b8379fda" xlink:href="cvs-20200930.xsd#cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_5d4ec761-09cf-47cf-a4bc-a469b8379fda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ffff041f-e4ea-48ea-a48d-45bece6abfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfReportableSegments_ffff041f-e4ea-48ea-a48d-45bece6abfc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6cabc8ee-795e-4aa9-b96a-50175539ea50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6cabc8ee-795e-4aa9-b96a-50175539ea50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_04138b3a-5f64-4a8a-980a-b19a1545ea66" xlink:href="cvs-20200930.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_HealthInsurerFee_04138b3a-5f64-4a8a-980a-b19a1545ea66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NonTaxDeductibleHealthInsuranceFee_0e198c0a-b21b-4492-98f5-62510dcf0566" xlink:href="cvs-20200930.xsd#cvs_NonTaxDeductibleHealthInsuranceFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NonTaxDeductibleHealthInsuranceFee_0e198c0a-b21b-4492-98f5-62510dcf0566" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_599cf154-7296-48fc-9476-b838b2ba4a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_599cf154-7296-48fc-9476-b838b2ba4a53" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3c3615a3-a4f7-4e01-9056-a0e7ba20ba31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3c3615a3-a4f7-4e01-9056-a0e7ba20ba31" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_8f2a7881-52c9-4d18-8724-e2e3b9c4c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_8f2a7881-52c9-4d18-8724-e2e3b9c4c7b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2b5fa3a7-2e81-4342-8cbd-01a2f6a2ceca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2b5fa3a7-2e81-4342-8cbd-01a2f6a2ceca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_2ffd1a13-5547-48e1-8207-538396a60fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_2ffd1a13-5547-48e1-8207-538396a60fc2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9489ca47-67e4-4be6-abe5-83ec7b11fd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9489ca47-67e4-4be6-abe5-83ec7b11fd7e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8c3de2a0-4e5c-4ba9-97af-af986f98204e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8c3de2a0-4e5c-4ba9-97af-af986f98204e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_5bdee53b-bf97-44d5-8776-3d754ba4b3f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_5bdee53b-bf97-44d5-8776-3d754ba4b3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6ba59170-f13f-4e85-9edf-70c83daa2ca2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:to="loc_us-gaap_EquityComponentDomain_6ba59170-f13f-4e85-9edf-70c83daa2ca2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:to="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ec9ae920-7961-4d84-936c-33e3072e3fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:to="loc_us-gaap_RetainedEarningsMember_ec9ae920-7961-4d84-936c-33e3072e3fa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8c13ba36-3eae-479c-898c-9aaedbfebea7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:to="loc_us-gaap_SegmentDomain_8c13ba36-3eae-479c-898c-9aaedbfebea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:to="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_c0dc7864-ae91-4f09-bd55-ca04c181a845" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_c0dc7864-ae91-4f09-bd55-ca04c181a845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_94008beb-cdc4-4135-baef-c250b6e8f187" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_94008beb-cdc4-4135-baef-c250b6e8f187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1cb23a10-8538-428f-b736-d56d5c84e031_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:to="loc_us-gaap_RelatedPartyDomain_1cb23a10-8538-428f-b736-d56d5c84e031_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:to="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_3ca642fd-e2cf-43a5-8d3a-e6da5c2e3b03" xlink:href="cvs-20200930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_3ca642fd-e2cf-43a5-8d3a-e6da5c2e3b03" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended" id="if6474d2229fb4b84b463793ba5e13081_SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended" id="i51527d37338447da9254fd7443cb7471_SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="ic9c118d8f8074e74a081e16f96ef78ab_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_363cc8ba-98e3-455a-8bf3-6e3d7fbe44ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_363cc8ba-98e3-455a-8bf3-6e3d7fbe44ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8ac46506-2280-4f1a-b633-f7dae6f2619d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_NetInvestmentIncome_8ac46506-2280-4f1a-b633-f7dae6f2619d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9e545075-bebe-4488-bed4-445e83b12aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_Revenues_9e545075-bebe-4488-bed4-445e83b12aef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b41e4010-49be-44a9-8ada-f74a079ed8d4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:to="loc_srt_ConsolidationItemsDomain_b41e4010-49be-44a9-8ada-f74a079ed8d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:to="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a77e89da-5bc2-4d3e-a1ad-5344f5fae8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:to="loc_us-gaap_OperatingSegmentsMember_a77e89da-5bc2-4d3e-a1ad-5344f5fae8dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c5f08eb1-fc96-4782-9b96-c2eea6c63506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c5f08eb1-fc96-4782-9b96-c2eea6c63506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7af73ffc-a978-4567-82ac-fa376ccb59a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7af73ffc-a978-4567-82ac-fa376ccb59a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_bedcc4e0-eeb0-4eb9-b0d8-00141d5cbeb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_bedcc4e0-eeb0-4eb9-b0d8-00141d5cbeb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_727b723a-238f-42da-bce1-fd2585e889fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_727b723a-238f-42da-bce1-fd2585e889fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_98d6aa66-e438-4126-9217-91fc4c584468" xlink:href="cvs-20200930.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_cvs_SalesChannelOtherMember_98d6aa66-e438-4126-9217-91fc4c584468" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_93165c02-0a40-45e0-b221-b257adffe9f4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:to="loc_srt_ProductsAndServicesDomain_93165c02-0a40-45e0-b221-b257adffe9f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:to="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_9993154f-d55f-44f5-8a55-54827663dff7" xlink:href="cvs-20200930.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PharmacyRevenueMember_9993154f-d55f-44f5-8a55-54827663dff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_fa0697c2-445b-426b-8fbe-e78623f51860" xlink:href="cvs-20200930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_FrontStoreRevenueMember_fa0697c2-445b-426b-8fbe-e78623f51860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_a64e9aba-c0ae-48c5-b843-4aebbe5d0e6b" xlink:href="cvs-20200930.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PremiumsMember_a64e9aba-c0ae-48c5-b843-4aebbe5d0e6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5f39d3d2-ed8f-423f-80da-4fb1110e325c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5f39d3d2-ed8f-423f-80da-4fb1110e325c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_69f14d89-1515-4628-9672-6214f76f2598" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PharmacyServicesSegmentMember_69f14d89-1515-4628-9672-6214f76f2598" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_41d9edd2-f567-49f9-8fe1-bc9adb11233b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:to="loc_us-gaap_SegmentDomain_41d9edd2-f567-49f9-8fe1-bc9adb11233b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:to="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_f5e3cb00-c2d6-43bd-8827-2a0db75fbdf4" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_PharmacyServicesSegmentMember_f5e3cb00-c2d6-43bd-8827-2a0db75fbdf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_a22ebc1c-1e12-4f59-a186-411d415081df" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_a22ebc1c-1e12-4f59-a186-411d415081df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_a86eacd9-7b45-4533-8045-f6778bb9cf7a" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_a86eacd9-7b45-4533-8045-f6778bb9cf7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_8abcc163-80bc-4256-b08f-7f6f4ffbca2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_us-gaap_CorporateAndOtherMember_8abcc163-80bc-4256-b08f-7f6f4ffbca2e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended" id="i1fd5ccc00f3d4a2094b97c1a1d240b65_SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended" id="ic96c7198c5354796a29c1b50160352de_SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Divestitures" xlink:type="simple" xlink:href="cvs-20200930.xsd#Divestitures"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Divestitures" xlink:type="extended" id="i257a4c532b574f0bb2c4dd1855692c20_Divestitures"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#DivestituresDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="extended" id="i771f6e46409a4f88b7c03d6368a809d3_DivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_75b6d37d-3d72-4452-8b9a-e5aa4d5b0cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_75b6d37d-3d72-4452-8b9a-e5aa4d5b0cf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_eb4ad4b7-2c6c-499b-853d-f4fbb8a3e205" xlink:href="cvs-20200930.xsd#cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_eb4ad4b7-2c6c-499b-853d-f4fbb8a3e205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b7551937-fd1d-4f82-ba33-5fec655ed08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b7551937-fd1d-4f82-ba33-5fec655ed08e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6fece911-5025-43a3-8eac-e2acb59f5e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6fece911-5025-43a3-8eac-e2acb59f5e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bbd3ffee-8297-4c14-aa4c-d0126f37ece7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bbd3ffee-8297-4c14-aa4c-d0126f37ece7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ac30bbd0-e60f-4dd5-ab0f-1153215df4dc" xlink:href="cvs-20200930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ac30bbd0-e60f-4dd5-ab0f-1153215df4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_3e5b0f32-32ab-4b26-991e-9335fe10f7d8" xlink:href="cvs-20200930.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_3e5b0f32-32ab-4b26-991e-9335fe10f7d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_738079d8-7dd0-4157-ba9c-c2dbfd095ab8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:to="loc_us-gaap_SegmentDomain_738079d8-7dd0-4157-ba9c-c2dbfd095ab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:to="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_4efbea81-b12f-40b1-b60f-697f96039f93" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_4efbea81-b12f-40b1-b60f-697f96039f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_e9288c66-3e7e-4d38-bfc1-1331bbe7d0e8" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_e9288c66-3e7e-4d38-bfc1-1331bbe7d0e8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20200930.xsd#Investments"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended" id="i84708d619b694a81b1afe075f7040635_Investments"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended" id="i1cfab844ed124341bb645be5a9a1656d_InvestmentsTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="extended" id="ia61b944f747a4c26bf85fad15c381914_InvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9e8f8490-dca5-4def-886d-0d60936230c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_ShortTermInvestments_9e8f8490-dca5-4def-886d-0d60936230c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_a6bb0006-db5d-4ee5-a503-42c76185c5bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_LongTermInvestments_a6bb0006-db5d-4ee5-a503-42c76185c5bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_fc2cd1af-5ea9-4b4d-9701-3e12b773be8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_Investments_fc2cd1af-5ea9-4b4d-9701-3e12b773be8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:to="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_564cc6e3-324a-479f-9086-a58a194a860d_default" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:to="loc_cvs_TotalInvestmentsDomain_564cc6e3-324a-479f-9086-a58a194a860d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:to="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_d6fa1707-1e80-4e42-bec9-08ae8219b899" xlink:href="cvs-20200930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_d6fa1707-1e80-4e42-bec9-08ae8219b899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_13bce264-cb50-4cc7-97d7-b08b64797447" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_cvs_MortgageLoansMember_13bce264-cb50-4cc7-97d7-b08b64797447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_78bf743b-17b4-4a96-86e2-85db7d55cf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_us-gaap_OtherInvestmentsMember_78bf743b-17b4-4a96-86e2-85db7d55cf0d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="i655f0a2794b447c0ab09a4f37d604530_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_286229f7-ac9f-4879-a6f4-a5de7c77a0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_286229f7-ac9f-4879-a6f4-a5de7c77a0fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c59ed03a-2b15-4af3-9ae0-e41c4c147d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c59ed03a-2b15-4af3-9ae0-e41c4c147d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3a971a98-d84c-467f-8fd5-234fe4c159de" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3a971a98-d84c-467f-8fd5-234fe4c159de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adec21d-757a-4ac2-bd02-9cf5e5e15af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adec21d-757a-4ac2-bd02-9cf5e5e15af3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7fc79b44-e4eb-46bb-85f2-31845b414ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7fc79b44-e4eb-46bb-85f2-31845b414ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34f11a72-3dda-448c-8efb-0480c94fc758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34f11a72-3dda-448c-8efb-0480c94fc758" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:to="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75db7ba0-3709-43d9-993a-f02542fa0af6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:to="loc_srt_ProductsAndServicesDomain_75db7ba0-3709-43d9-993a-f02542fa0af6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:to="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_67a5ac38-4115-4af4-b988-edc4a01df07b" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_67a5ac38-4115-4af4-b988-edc4a01df07b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:to="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_69ecae32-eb04-47f3-b8cf-dbaf4f126db8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_69ecae32-eb04-47f3-b8cf-dbaf4f126db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:to="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b4ec977-66d4-4d00-bc7c-7f9f84283ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b4ec977-66d4-4d00-bc7c-7f9f84283ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_58f64691-302e-4ff2-afcf-d557c6f1e438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_58f64691-302e-4ff2-afcf-d557c6f1e438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7db60f66-3840-4397-943e-de88b4ca149c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7db60f66-3840-4397-943e-de88b4ca149c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c2caa21-690c-415b-a86d-12e7d812060c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c2caa21-690c-415b-a86d-12e7d812060c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_348f6b2c-ed9b-429b-876f-b79e7c031cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_348f6b2c-ed9b-429b-876f-b79e7c031cd1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_99f3c20c-d04e-4425-ba48-baaf62167e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_99f3c20c-d04e-4425-ba48-baaf62167e37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d8604f83-88d5-45ac-b36a-b23fcfd9c7e1" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d8604f83-88d5-45ac-b36a-b23fcfd9c7e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_a1ca5bd3-f5ce-4161-a4fe-cdb33f1e9ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_a1ca5bd3-f5ce-4161-a4fe-cdb33f1e9ee8" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i38a6cbd36256460a86cccf85a1a53f90_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_00bcce19-0608-4bb6-ad9f-ac8d1171630a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_00bcce19-0608-4bb6-ad9f-ac8d1171630a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_272ce7f1-6771-436b-aba0-92fb33f6261f" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_272ce7f1-6771-436b-aba0-92fb33f6261f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2dcfcc58-4b75-4b14-b531-23ba5624f2c4" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2dcfcc58-4b75-4b14-b531-23ba5624f2c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_a55dfee5-aff8-4aa5-bba2-282b6a57954a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_a55dfee5-aff8-4aa5-bba2-282b6a57954a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_546f4543-9dfb-4f36-ae9f-4d910be05843" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_546f4543-9dfb-4f36-ae9f-4d910be05843" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2b05c2e1-2383-4c16-a977-db92ff271d43" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2b05c2e1-2383-4c16-a977-db92ff271d43" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fb8aefc-889b-4a28-96df-44598d0bfb99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fb8aefc-889b-4a28-96df-44598d0bfb99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a19b854f-b61d-48eb-a11b-479a313d55bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a19b854f-b61d-48eb-a11b-479a313d55bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e376eae-db9f-4ac0-850e-dc7c3fe0cdbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e376eae-db9f-4ac0-850e-dc7c3fe0cdbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b125786e-e65b-4b22-a256-620afa94acef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b125786e-e65b-4b22-a256-620afa94acef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9a2e6b8d-d505-4c66-8087-1dbe882ea19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9a2e6b8d-d505-4c66-8087-1dbe882ea19a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_457ca826-1194-4854-a1f2-d6c512394c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_457ca826-1194-4854-a1f2-d6c512394c59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6af6cc44-0678-4aab-9a75-997cff384ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6af6cc44-0678-4aab-9a75-997cff384ce9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5501da5d-0122-4678-9cf6-cffeda00a6a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5501da5d-0122-4678-9cf6-cffeda00a6a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_99615174-29fe-46d5-b606-49f35edee85e" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_99615174-29fe-46d5-b606-49f35edee85e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="ia11291fe035243beb949cbff85fe44cd_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_214a0add-29fb-4a15-8c1a-82d2949757be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_214a0add-29fb-4a15-8c1a-82d2949757be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d1901d55-2b88-405b-826e-b7b0777012a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d1901d55-2b88-405b-826e-b7b0777012a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_48609c77-f983-4442-b7d2-017cc77de966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_48609c77-f983-4442-b7d2-017cc77de966" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_33b9ec4f-9956-431e-97b7-bb97daa49246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_33b9ec4f-9956-431e-97b7-bb97daa49246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b1c99b2a-713c-4e68-9482-e577764810cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b1c99b2a-713c-4e68-9482-e577764810cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2e4d1510-74ec-4159-a7f8-e684da5fc207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2e4d1510-74ec-4159-a7f8-e684da5fc207" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ea55623f-ef12-4661-9476-9f1e95adc995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ea55623f-ef12-4661-9476-9f1e95adc995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c95f3c55-bc79-4888-a58a-e6fd782ab781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c95f3c55-bc79-4888-a58a-e6fd782ab781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c3f1b56c-3081-4974-b202-b6ecac928e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c3f1b56c-3081-4974-b202-b6ecac928e7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b1d4739e-4dd4-4eab-8ea5-c752e518e635_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b1d4739e-4dd4-4eab-8ea5-c752e518e635_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_88a09653-48fc-4316-a7bc-40bed2259679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_88a09653-48fc-4316-a7bc-40bed2259679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ecbe3db9-b7b0-4574-8054-3d1ad2cf2719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ecbe3db9-b7b0-4574-8054-3d1ad2cf2719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_99ea3511-a457-4ea7-aaaa-42e16fbae3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_99ea3511-a457-4ea7-aaaa-42e16fbae3f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4432808c-b842-4836-90c0-6a43a9fdefb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4432808c-b842-4836-90c0-6a43a9fdefb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d8d6639b-3ece-43cc-924d-866ae25dd949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d8d6639b-3ece-43cc-924d-866ae25dd949" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_50c12df7-5d66-4890-937f-c97b6bd58e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_50c12df7-5d66-4890-937f-c97b6bd58e3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_dee2bff7-040e-4ca1-9bcf-6a4f5b553441" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_dee2bff7-040e-4ca1-9bcf-6a4f5b553441" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="i6d659eaf3a79480cbf92685578bc470a_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_c0906761-5877-4d4e-bd74-9fe97526ceb7" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_c0906761-5877-4d4e-bd74-9fe97526ceb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_e604f54e-3840-4faf-a5d0-bf3782286a90" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_e604f54e-3840-4faf-a5d0-bf3782286a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_bcd2d9d0-bdbf-477c-8a80-fa6b71514b9f" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_bcd2d9d0-bdbf-477c-8a80-fa6b71514b9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_91c3dbad-d8f1-4f9d-be93-da0a32ccb84e" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_91c3dbad-d8f1-4f9d-be93-da0a32ccb84e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_962f93ab-2cc5-4b75-837f-b46caff3ad45" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_962f93ab-2cc5-4b75-837f-b46caff3ad45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ce9d076f-6135-4218-a102-5a130eb41e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ce9d076f-6135-4218-a102-5a130eb41e37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_e1a1a611-0514-456a-ad59-4758dfdab256" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_e1a1a611-0514-456a-ad59-4758dfdab256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d0fd159a-8d0c-4e71-aa6b-d7768c8cc8b1" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d0fd159a-8d0c-4e71-aa6b-d7768c8cc8b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_9d816e36-9a01-407c-8079-97994542ca37" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_9d816e36-9a01-407c-8079-97994542ca37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1df86ff7-57ad-43b3-96f1-2b98c4a70fef" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1df86ff7-57ad-43b3-96f1-2b98c4a70fef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0f0b2581-e287-40ee-ae80-ef5b7bc9eccb" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0f0b2581-e287-40ee-ae80-ef5b7bc9eccb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8b78d2c7-3362-451f-a162-993550579029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8b78d2c7-3362-451f-a162-993550579029" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:to="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5000b631-77d1-49be-813b-24db881e184b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:to="loc_srt_ProductsAndServicesDomain_5000b631-77d1-49be-813b-24db881e184b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:to="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_8ee91271-0705-4e3f-8b8a-e24031e15ca9" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_8ee91271-0705-4e3f-8b8a-e24031e15ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_f9e0363d-01ae-4aa5-9e01-bb4f60d684fb" xlink:href="cvs-20200930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:to="loc_cvs_SupportingRemainingProductsMember_f9e0363d-01ae-4aa5-9e01-bb4f60d684fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5cbbaed-c95a-4391-976b-5c1f801d2254_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5cbbaed-c95a-4391-976b-5c1f801d2254_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d6fea9e1-e31d-4159-b6ff-39aed82e552b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d6fea9e1-e31d-4159-b6ff-39aed82e552b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2e5aa53b-2e0c-478e-a448-6f629db328a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2e5aa53b-2e0c-478e-a448-6f629db328a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_8e78ed7f-0696-475d-a168-41e8228b3162" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_8e78ed7f-0696-475d-a168-41e8228b3162" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="if6ec790153d349f68668aec4afaf59a5_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_043574d2-a3f2-477b-bab9-cf87d56ac371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_043574d2-a3f2-477b-bab9-cf87d56ac371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_293d0e27-173a-4640-88de-334fff07ecf5" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_293d0e27-173a-4640-88de-334fff07ecf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_7a425857-80a4-4bcd-81be-285fb60a5ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_7a425857-80a4-4bcd-81be-285fb60a5ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b68c8058-2441-4288-8614-1cab61942e79_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b68c8058-2441-4288-8614-1cab61942e79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_524f4551-92e2-44a7-97fd-266d2aebecd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:to="loc_us-gaap_CommercialRealEstateMember_524f4551-92e2-44a7-97fd-266d2aebecd9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i3d47790590934334b244600f9b6a393d_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_fd07e8b9-78b7-4bf1-95ac-a19352f0ba96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_fd07e8b9-78b7-4bf1-95ac-a19352f0ba96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_c59b5419-5ea7-4b34-b84b-550317391192_default" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_c59b5419-5ea7-4b34-b84b-550317391192_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_d57d4f51-83f7-438e-ad28-3c5fa2113afa" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_d57d4f51-83f7-438e-ad28-3c5fa2113afa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_5f2c0673-74e3-40f9-b651-7d9f0001c719" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_5f2c0673-74e3-40f9-b651-7d9f0001c719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_4f4c9601-24f5-4b2a-bd08-2ea0c5f2707a" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_4f4c9601-24f5-4b2a-bd08-2ea0c5f2707a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_5f4efc8b-242c-4a2b-adbb-5569561df5c4" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_5f4efc8b-242c-4a2b-adbb-5569561df5c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_fa8f58ee-3606-40d5-92cf-6ecd7c2157a0" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_fa8f58ee-3606-40d5-92cf-6ecd7c2157a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_0ba74831-5f53-4f10-a2b7-0701b68bd1b0" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_0ba74831-5f53-4f10-a2b7-0701b68bd1b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_4d79578e-88b3-4a57-a415-44ed7ee4daa5_default" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_4d79578e-88b3-4a57-a415-44ed7ee4daa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_049822b0-6f3e-4187-a4f2-a6f8a3ab0411" xlink:href="cvs-20200930.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category1Member_049822b0-6f3e-4187-a4f2-a6f8a3ab0411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_47eafb66-b784-4d10-acbf-dc8978594339" xlink:href="cvs-20200930.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category2To4Member_47eafb66-b784-4d10-acbf-dc8978594339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_d742771f-2f3d-466f-bd28-900ad26f8c6f" xlink:href="cvs-20200930.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Categories5and6Member_d742771f-2f3d-466f-bd28-900ad26f8c6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_0a5de01f-80df-4c82-b655-5b7698a0d80f" xlink:href="cvs-20200930.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category7Member_0a5de01f-80df-4c82-b655-5b7698a0d80f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_c8127b17-0fb4-4d0b-b4ff-5746b66dce9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:to="loc_us-gaap_CommercialRealEstateMember_c8127b17-0fb4-4d0b-b4ff-5746b66dce9a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="ifc401ead3b064317af1b201ee2e972ae_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_30124538-e07d-475d-8aac-3a420de162c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_30124538-e07d-475d-8aac-3a420de162c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_dbbb22fd-161a-4e95-aa0b-89dae8290f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_dbbb22fd-161a-4e95-aa0b-89dae8290f91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_304333df-3d2f-49fc-8517-3d0a48192cac" xlink:href="cvs-20200930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_304333df-3d2f-49fc-8517-3d0a48192cac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_1aa02f2d-437c-47cd-907b-7fa09b012532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_1aa02f2d-437c-47cd-907b-7fa09b012532" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_214f6c30-295e-4ae3-a49f-6ddc5479e03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeNet_214f6c30-295e-4ae3-a49f-6ddc5479e03a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f4857cec-72b6-4a19-80d8-bcc54a4d69f2" xlink:href="cvs-20200930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f4857cec-72b6-4a19-80d8-bcc54a4d69f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_9d503ac5-06dd-4be9-ab0b-5c02d9e088eb" xlink:href="cvs-20200930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_9d503ac5-06dd-4be9-ab0b-5c02d9e088eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_8ef1ea8a-aae8-4dff-914d-c93bbfd6c7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_8ef1ea8a-aae8-4dff-914d-c93bbfd6c7f9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:to="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_87952ac5-a9ec-4c07-9afd-e6eb3e78679a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_87952ac5-a9ec-4c07-9afd-e6eb3e78679a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e303b59d-bc78-4cb3-b905-6bccc22eb064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_us-gaap_DebtSecuritiesMember_e303b59d-bc78-4cb3-b905-6bccc22eb064" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_e2bc6a82-48c7-49be-aacc-863e545cc7fc" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_cvs_MortgageLoansMember_e2bc6a82-48c7-49be-aacc-863e545cc7fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_ebd9710c-b2f5-4e59-928c-aace0cbd2067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_us-gaap_OtherInvestmentsMember_ebd9710c-b2f5-4e59-928c-aace0cbd2067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:to="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d053aef0-9645-402d-a73f-8fb8e6674a7b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:to="loc_srt_ProductsAndServicesDomain_d053aef0-9645-402d-a73f-8fb8e6674a7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:to="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_d6d13b96-e0b2-4884-b76f-a64063cfbde6" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_d6d13b96-e0b2-4884-b76f-a64063cfbde6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsRealizedGainsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended" id="i3d24e8f3934b408eb7d2152e1505c9fa_InvestmentsRealizedGainsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValue"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended" id="ie8aacaed34c34dc49624e0270c51b185_FairValue"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended" id="i5b55ded3bb2f47dc9f554d505b52cfc0_FairValueTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended" id="i1d8a72b0ded94c47ac22288ee2fb75e3_FairValueMeasurementonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_d3756a24-2651-457a-a730-ed487ca1145e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_d3756a24-2651-457a-a730-ed487ca1145e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c1e22fa0-b4b5-49db-a350-887bc076f38b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c1e22fa0-b4b5-49db-a350-887bc076f38b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16004c16-afc6-4e67-9c58-21afc1871a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16004c16-afc6-4e67-9c58-21afc1871a09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_340f4d16-6032-4d7e-b2a5-5869cf54686b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_340f4d16-6032-4d7e-b2a5-5869cf54686b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_69a93f4b-7d9c-4aec-91bb-589610fe5b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_69a93f4b-7d9c-4aec-91bb-589610fe5b13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f2439e92-fc91-46ee-8016-c28539dd57ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f2439e92-fc91-46ee-8016-c28539dd57ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_82eaa0c0-e401-413f-8f51-4b074d95da2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_82eaa0c0-e401-413f-8f51-4b074d95da2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_cde67fe7-e293-4ee2-a9b8-4c92ddde4417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_cde67fe7-e293-4ee2-a9b8-4c92ddde4417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbf5708b-0f17-4f4a-92dc-367f6fe56ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbf5708b-0f17-4f4a-92dc-367f6fe56ee4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c26da5d-6f75-45eb-b0f1-09705c5668f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c26da5d-6f75-45eb-b0f1-09705c5668f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4ddeca36-13a6-4d6c-975c-840333e55925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4ddeca36-13a6-4d6c-975c-840333e55925" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f012e04b-104d-42e2-8e8a-1e23433ef41f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f012e04b-104d-42e2-8e8a-1e23433ef41f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_1ac7ec3d-329a-421a-a2e8-0c3376936b97" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_1ac7ec3d-329a-421a-a2e8-0c3376936b97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_5540a962-e54f-4bd4-a616-476f340af1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_5540a962-e54f-4bd4-a616-476f340af1fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e23f1210-a5c8-4cac-8703-a5032f9a1222_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e23f1210-a5c8-4cac-8703-a5032f9a1222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2adfc76a-bcd3-4053-b90f-87fdb1f5a72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2adfc76a-bcd3-4053-b90f-87fdb1f5a72f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5dce41b4-6585-473f-b144-9417fbdecfdc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5dce41b4-6585-473f-b144-9417fbdecfdc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_93d2a583-39c6-4fcd-a84c-aa1cac9ef2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_93d2a583-39c6-4fcd-a84c-aa1cac9ef2c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_93efb2f3-fe82-482f-a9fa-0faeb20a5f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_93efb2f3-fe82-482f-a9fa-0faeb20a5f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a5fec8f9-22bf-4002-aa59-e071175fcd5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a5fec8f9-22bf-4002-aa59-e071175fcd5a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="i4853441e3a9b409caf893b8cb8d70a0b_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_8ba9772b-d7be-428a-81f6-ea8fbd6fc832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_8ba9772b-d7be-428a-81f6-ea8fbd6fc832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f8ecdd54-ee60-4163-84ab-b3bc91f68c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f8ecdd54-ee60-4163-84ab-b3bc91f68c27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_4aa54c8f-e8a0-4756-a30c-102718e3e781" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_4aa54c8f-e8a0-4756-a30c-102718e3e781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_75adc229-8330-46bb-865b-8c299a9f2333" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_75adc229-8330-46bb-865b-8c299a9f2333" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c86ac2aa-2701-49e3-a57e-74f609822646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c86ac2aa-2701-49e3-a57e-74f609822646" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98c6bf8d-77e3-402f-9ef2-04c24ce3953c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98c6bf8d-77e3-402f-9ef2-04c24ce3953c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_14afd1ef-76f9-4143-961b-08a8acfd390d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_14afd1ef-76f9-4143-961b-08a8acfd390d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_62056239-c3df-4e0c-ab80-4466f7620783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_62056239-c3df-4e0c-ab80-4466f7620783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_35c2b1b2-3c90-4589-83e3-75a7ea6a2da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_35c2b1b2-3c90-4589-83e3-75a7ea6a2da2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_0e3c7f9d-782f-4181-b730-c95b7788699f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_0e3c7f9d-782f-4181-b730-c95b7788699f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4798f1f-c9d8-424a-853e-d2ff8fbf633d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4798f1f-c9d8-424a-853e-d2ff8fbf633d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32cc4b20-c70a-4dda-a9db-009d06404d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32cc4b20-c70a-4dda-a9db-009d06404d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_28cac880-e529-433f-8f85-cdaef97c3c3c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_28cac880-e529-433f-8f85-cdaef97c3c3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d3b3cbe-4dd7-4623-98dc-c6b6ddd2cba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d3b3cbe-4dd7-4623-98dc-c6b6ddd2cba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c5be33d1-341d-4f1e-830b-d9cf7f63dec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c5be33d1-341d-4f1e-830b-d9cf7f63dec9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i59e0df0d740342bd8cd7a90bd62ff438_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_2f103b69-cc44-43c8-96eb-2c8f4143242b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:to="loc_us-gaap_SeparateAccountAssets_2f103b69-cc44-43c8-96eb-2c8f4143242b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c712402b-3026-45eb-b644-6c7b790b58ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c712402b-3026-45eb-b644-6c7b790b58ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e7f22f79-f185-4c35-9cb0-bba32a6c4dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e7f22f79-f185-4c35-9cb0-bba32a6c4dbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c41a69ea-c4cb-412e-836f-7ea572b4317f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c41a69ea-c4cb-412e-836f-7ea572b4317f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99bbcf82-5ae8-4d56-9ad4-70beea628db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99bbcf82-5ae8-4d56-9ad4-70beea628db9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ac015ec3-acf0-4c06-a762-6069e2d18c91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ac015ec3-acf0-4c06-a762-6069e2d18c91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a9ea255b-7a34-4d38-94bf-2676e304c4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a9ea255b-7a34-4d38-94bf-2676e304c4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4c803419-29ab-4937-ad61-7dd4e7f24c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_DebtSecuritiesMember_4c803419-29ab-4937-ad61-7dd4e7f24c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_87eb65f0-3fa6-4583-8397-e121a8174e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_EquitySecuritiesMember_87eb65f0-3fa6-4583-8397-e121a8174e10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_112e3c1d-0172-4bde-adb9-f671cc405d8e" xlink:href="cvs-20200930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_112e3c1d-0172-4bde-adb9-f671cc405d8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b03114e3-c9fb-4b5d-99e1-0f296b63f534_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b03114e3-c9fb-4b5d-99e1-0f296b63f534_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f82b8eb2-aceb-4154-aaab-f520496ee503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f82b8eb2-aceb-4154-aaab-f520496ee503" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayable"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended" id="ia50a08888a504872a6440407fb67a65c_HealthCareCostsPayable"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended" id="i7e952a503ad34ca0941ee37935f1f35d_HealthCareCostsPayableTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="i9b0efe6f0cf842edb10f396a03bb14c8_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_810c23b4-3131-4931-9b6e-00542e089434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_810c23b4-3131-4931-9b6e-00542e089434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_230e6a58-7d7c-4b80-824e-1c4eb654303a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_230e6a58-7d7c-4b80-824e-1c4eb654303a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_08b1034d-b6cf-4ce1-9ce7-b66f4a32c803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_08b1034d-b6cf-4ce1-9ce7-b66f4a32c803" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_52bb9647-0884-493e-b25c-2e6c9777b3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_52bb9647-0884-493e-b25c-2e6c9777b3c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bf24bf57-730b-415d-8784-95710642904a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bf24bf57-730b-415d-8784-95710642904a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2e53b029-885e-4ab5-8285-dbd25de16ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2e53b029-885e-4ab5-8285-dbd25de16ed3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64e008f0-feb9-4175-a26e-ee1f695248f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64e008f0-feb9-4175-a26e-ee1f695248f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_baf4c7a7-5450-4583-b531-f6b37753ea3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_baf4c7a7-5450-4583-b531-f6b37753ea3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d3409ff5-033e-4904-b807-f82545bde284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d3409ff5-033e-4904-b807-f82545bde284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d867248b-a500-456a-a883-442234ba3ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d867248b-a500-456a-a883-442234ba3ab6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_700d8790-ef08-4b9d-b6e2-7d50ddd277bb" xlink:href="cvs-20200930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_700d8790-ef08-4b9d-b6e2-7d50ddd277bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e9b0bae5-1497-495c-9f7f-566bd760154f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f719d188-4df5-4d22-a8cf-7514fcc419c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1e18008e-0291-4a17-a78c-dbeefc5a947f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_6cacf76e-12b4-424a-9e36-65032b1cf3de" xlink:href="cvs-20200930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_573cbd10-d042-4aee-ae28-0fd4c8030b9c" xlink:href="cvs-20200930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_573cbd10-d042-4aee-ae28-0fd4c8030b9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1bfd182-834f-4354-bd86-2804c4d16476_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:to="loc_us-gaap_SegmentDomain_e1bfd182-834f-4354-bd86-2804c4d16476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:to="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3ea84fa9-051f-40a9-a998-4656a3f84c49" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3ea84fa9-051f-40a9-a998-4656a3f84c49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_eb75d38f-f6d8-48c5-82c9-9462f0603c2c" xlink:href="cvs-20200930.xsd#cvs_CorporateOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:to="loc_cvs_CorporateOtherMember_eb75d38f-f6d8-48c5-82c9-9462f0603c2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:to="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_79b80c01-3354-4772-abab-cd1ee9ef73f1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:to="loc_srt_ProductsAndServicesDomain_79b80c01-3354-4772-abab-cd1ee9ef73f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:to="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_9a33737f-4156-4b3f-b5bf-2d5ca32a65b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_9a33737f-4156-4b3f-b5bf-2d5ca32a65b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="i38d606ab949642d4bcec0f65d660e9af_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_74697098-c551-4b94-aa3e-a1d02a5d9a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_74697098-c551-4b94-aa3e-a1d02a5d9a89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_b8d8cac0-8c64-475c-ab1f-2fd05ef1724a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_b8d8cac0-8c64-475c-ab1f-2fd05ef1724a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:to="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b00e1b5-b19d-493a-be5c-1b5ad5789156_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:to="loc_srt_ProductsAndServicesDomain_6b00e1b5-b19d-493a-be5c-1b5ad5789156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:to="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_424eccba-745a-4d10-aa55-4a27b1c3bc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_424eccba-745a-4d10-aa55-4a27b1c3bc8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20200930.xsd#Borrowings"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended" id="iae239eea7fce4fd09dfa9904ef2b7423_Borrowings"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended" id="ice764615f15f4636badc3239278e543d_BorrowingsTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended" id="i4b101cdbeed143a3a8545635d5c47989_BorrowingsScheduleofBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3e2f88a-d8b5-40e2-96df-cba3e752ac03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3e2f88a-d8b5-40e2-96df-cba3e752ac03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bd2937de-6874-4f14-9b08-0a403d1e402e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bd2937de-6874-4f14-9b08-0a403d1e402e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bcb7e689-a658-47f4-835e-82de14d5e2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bcb7e689-a658-47f4-835e-82de14d5e2d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_464d4c62-2476-42db-b350-5198b8422e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_FinanceLeaseLiability_464d4c62-2476-42db-b350-5198b8422e37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_3ad52bab-d9b2-460e-966b-b96004b5102a" xlink:href="cvs-20200930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_3ad52bab-d9b2-460e-966b-b96004b5102a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_5b914737-f7ae-41ee-af24-12996fc4e108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_5b914737-f7ae-41ee-af24-12996fc4e108" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_19acde82-9979-4659-a274-475bd757e27c" xlink:href="cvs-20200930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_19acde82-9979-4659-a274-475bd757e27c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_97c753bf-26a1-43d0-bea4-3b02add4c2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_97c753bf-26a1-43d0-bea4-3b02add4c2c6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_80a91401-afbf-4ea7-8357-63dadfc72469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_80a91401-afbf-4ea7-8357-63dadfc72469" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34dc6038-46d4-4d09-8615-00c4e66f9619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34dc6038-46d4-4d09-8615-00c4e66f9619" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2047d91f-0289-4f9e-823b-f6fe4fbac80d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2047d91f-0289-4f9e-823b-f6fe4fbac80d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_16debd3f-04df-48b2-bbdd-47569a3bde52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_SeniorNotesMember_16debd3f-04df-48b2-bbdd-47569a3bde52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_b9084074-2faf-4b08-880f-27060a7d074d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_NotesPayableToBanksMember_b9084074-2faf-4b08-880f-27060a7d074d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_a03c2a12-45da-4312-898f-197d70e6f6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_a03c2a12-45da-4312-898f-197d70e6f6e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:to="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_127655ed-c768-4715-9ab5-524030506484_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_127655ed-c768-4715-9ab5-524030506484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_da0d1bf6-d695-4e1d-aaf9-1f7fea8beb6c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_da0d1bf6-d695-4e1d-aaf9-1f7fea8beb6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_295ac237-2fbc-4009-9f1c-a1d5ee46531b" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_295ac237-2fbc-4009-9f1c-a1d5ee46531b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member_90192b73-e75e-4f12-a7a0-5daeb79b8a98" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.8DueJuly2020Member_90192b73-e75e-4f12-a7a0-5daeb79b8a98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_e96adc15-8632-4065-b80e-a1d62b3247a2" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_e96adc15-8632-4065-b80e-a1d62b3247a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_71450e92-5679-46a4-b2fb-e9870ca4593b" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_71450e92-5679-46a4-b2fb-e9870ca4593b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_db43a16d-f4dd-4ba2-b15e-033c219e434a" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_db43a16d-f4dd-4ba2-b15e-033c219e434a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_2e0f0bd5-95b1-4a9e-8e49-96181505c51f" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_2e0f0bd5-95b1-4a9e-8e49-96181505c51f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_30b45cc2-34e3-454a-8c2d-745c78832c3c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_30b45cc2-34e3-454a-8c2d-745c78832c3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_b217c173-8952-4e13-8ece-1b8d4f12df4c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_b217c173-8952-4e13-8ece-1b8d4f12df4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_b550435e-4d5e-4d91-a51a-91d49c9a52d7" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_b550435e-4d5e-4d91-a51a-91d49c9a52d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_cfae9542-420c-48d0-b779-81b0f199bf2d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_cfae9542-420c-48d0-b779-81b0f199bf2d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_4535c431-7558-4a25-b581-1b42aad8f731" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_4535c431-7558-4a25-b581-1b42aad8f731" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_ac447006-edbb-4c5f-8763-2b95560d37f3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_ac447006-edbb-4c5f-8763-2b95560d37f3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_44124c60-0729-4fde-869d-c92f0bb58c7b" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_44124c60-0729-4fde-869d-c92f0bb58c7b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_4942b84e-d66b-4f43-bb77-9d1852495ad2" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_4942b84e-d66b-4f43-bb77-9d1852495ad2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_9df0d5c1-3c48-486b-8f01-03062f09807b" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_9df0d5c1-3c48-486b-8f01-03062f09807b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_d3e7c817-c359-4395-8d52-714ba225145c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_d3e7c817-c359-4395-8d52-714ba225145c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_cc703668-4c7a-4d6d-bead-37fa4895214c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_cc703668-4c7a-4d6d-bead-37fa4895214c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_9b11c778-dba0-4476-b013-3a5323fff743" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_9b11c778-dba0-4476-b013-3a5323fff743" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_886bd328-96cb-4120-b6db-d34565a44c06" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_886bd328-96cb-4120-b6db-d34565a44c06" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_e56a78e7-30f6-4eee-a5db-b000fe331d37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_e56a78e7-30f6-4eee-a5db-b000fe331d37" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_50fd860c-ecad-40b8-a993-9a728132af37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_50fd860c-ecad-40b8-a993-9a728132af37" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_1e6dc41c-e87f-4a15-b8b4-701a53dac028" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_1e6dc41c-e87f-4a15-b8b4-701a53dac028" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_f29dce54-4666-4468-bd28-6046e7189e37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_f29dce54-4666-4468-bd28-6046e7189e37" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_eac4d3dd-1a8a-45d5-8689-d6e95e32e07a" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_eac4d3dd-1a8a-45d5-8689-d6e95e32e07a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_122617da-7c9e-40d8-8ad9-7d99ee67569c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_122617da-7c9e-40d8-8ad9-7d99ee67569c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_cdd60767-3d12-402b-8e6e-946cb7cec295" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_cdd60767-3d12-402b-8e6e-946cb7cec295" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_6a85f144-5e78-40e3-a022-17e6f08986cc" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_6a85f144-5e78-40e3-a022-17e6f08986cc" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_1f012f04-fdee-483c-af73-149b7c3afae4" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_1f012f04-fdee-483c-af73-149b7c3afae4" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_de206e0b-9eff-4d8d-b6fc-3fe5cb086c29" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_de206e0b-9eff-4d8d-b6fc-3fe5cb086c29" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_b6edfd85-4f11-43c6-934c-e11f11341ec6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_b6edfd85-4f11-43c6-934c-e11f11341ec6" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_803a95b8-1142-4941-a35e-893dafeb1a59" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_803a95b8-1142-4941-a35e-893dafeb1a59" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_4c7d7e97-f8e8-4820-8ca5-a31df6d0d704" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_4c7d7e97-f8e8-4820-8ca5-a31df6d0d704" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_0ffd549d-1c10-4b0c-abeb-1d387c4a09e6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_0ffd549d-1c10-4b0c-abeb-1d387c4a09e6" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_017414db-5b84-4b8c-b15b-adcf7692cad1" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_017414db-5b84-4b8c-b15b-adcf7692cad1" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_acb2abe7-6741-4c8d-97ea-4fa4b0615b79" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_acb2abe7-6741-4c8d-97ea-4fa4b0615b79" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_c719b7c9-a4b0-46d7-91e3-05271d23c431" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_c719b7c9-a4b0-46d7-91e3-05271d23c431" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_5cdf2034-e657-4c53-84ca-5987036960ab" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_5cdf2034-e657-4c53-84ca-5987036960ab" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_07679d6a-59e7-4e6e-8f6a-ab874455c30e" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_07679d6a-59e7-4e6e-8f6a-ab874455c30e" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_42e79097-0874-4e81-a44c-a76c7f3c89d4" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_42e79097-0874-4e81-a44c-a76c7f3c89d4" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_6ba0674d-54be-460e-be7b-2e0f555be1d6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_6ba0674d-54be-460e-be7b-2e0f555be1d6" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_5fcd4cd8-272c-4af9-907a-4efd2c2f2ee7" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_5fcd4cd8-272c-4af9-907a-4efd2c2f2ee7" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_390ffa70-04a9-48c6-a3fc-865bccb682ee" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_390ffa70-04a9-48c6-a3fc-865bccb682ee" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_2e2487cd-6f2c-4795-9775-653f0b1b379d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_2e2487cd-6f2c-4795-9775-653f0b1b379d" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_3c515729-8dd7-4c49-b669-8283e2f5b078" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_3c515729-8dd7-4c49-b669-8283e2f5b078" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_6d6edc44-6ed6-47d3-8e9e-82065d191549" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_6d6edc44-6ed6-47d3-8e9e-82065d191549" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_fb8741f9-c31b-48de-9926-8e7fc80a3ac3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_fb8741f9-c31b-48de-9926-8e7fc80a3ac3" xlink:type="arc" order="46"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="i724b175a46b945d195df9b02a962e87b_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c46810a4-6a5e-4018-a342-61253cecc1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c46810a4-6a5e-4018-a342-61253cecc1c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_273322ae-7256-42e4-b52c-40b89ba73c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_273322ae-7256-42e4-b52c-40b89ba73c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f2a253ee-2e8a-4a1c-b1b9-3433dc9f0175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f2a253ee-2e8a-4a1c-b1b9-3433dc9f0175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_9d256031-c868-45c8-92d6-bce3a23e2eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_9d256031-c868-45c8-92d6-bce3a23e2eaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8e540bd2-7aaf-4420-a640-1ecffbd085a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8e540bd2-7aaf-4420-a640-1ecffbd085a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a3bee150-30f8-4d64-b3d8-165e217a18d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a3bee150-30f8-4d64-b3d8-165e217a18d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_042336c4-2cce-4fcb-93a8-1ef1ef8c2b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_042336c4-2cce-4fcb-93a8-1ef1ef8c2b12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_9510b47f-e3aa-44f3-80dc-5728e242804b" xlink:href="cvs-20200930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_cvs_DebtExtinguishmentFees_9510b47f-e3aa-44f3-80dc-5728e242804b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b3f6b9a7-1c5f-496a-bcf8-73bc33f85ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b3f6b9a7-1c5f-496a-bcf8-73bc33f85ae7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_919a45ac-0481-4e4d-8ce1-e295f049246b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_919a45ac-0481-4e4d-8ce1-e295f049246b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e5d10419-7d40-43c8-aeba-eb40a75b0767_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e5d10419-7d40-43c8-aeba-eb40a75b0767_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1b42b91e-cd60-49c7-ad38-fda6f0b6669d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:to="loc_us-gaap_SeniorNotesMember_1b42b91e-cd60-49c7-ad38-fda6f0b6669d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_0dffa501-56fe-4d45-aef1-27b9a53ed7d0" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:to="loc_cvs_FloatingRateNotesMember_0dffa501-56fe-4d45-aef1-27b9a53ed7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c0fba494-d412-4ceb-b481-dcf98a639680_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c0fba494-d412-4ceb-b481-dcf98a639680_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_ead30fdd-61c0-4b6a-bc51-4393b0184426" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_ead30fdd-61c0-4b6a-bc51-4393b0184426" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_cee04bfc-e2ec-4cb4-bdf2-2baa9f02539d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_cee04bfc-e2ec-4cb4-bdf2-2baa9f02539d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_b1f1f3cb-08f3-4334-b91d-cc369cca1f36" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_b1f1f3cb-08f3-4334-b91d-cc369cca1f36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_2063beff-94dc-452e-ba96-fdf6cfb9f56d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_2063beff-94dc-452e-ba96-fdf6cfb9f56d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_e13af344-7d01-429b-89d2-9f26991f5fbc" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_e13af344-7d01-429b-89d2-9f26991f5fbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_a7373286-7c97-4936-803c-a0981a7a23d3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_a7373286-7c97-4936-803c-a0981a7a23d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_aa660769-6c4b-4b26-834d-d6d25121dc27" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_aa660769-6c4b-4b26-834d-d6d25121dc27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_8f9a3987-c9b2-4e29-a5a9-e47a73da6b04" xlink:href="cvs-20200930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_OutstandingSeniorNotesMember_8f9a3987-c9b2-4e29-a5a9-e47a73da6b04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_6118b644-2797-4ff7-b73b-f0e42d08fc2e" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_6118b644-2797-4ff7-b73b-f0e42d08fc2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_0518ee1b-2fe5-4b18-9ee4-50cb4424d656" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_0518ee1b-2fe5-4b18-9ee4-50cb4424d656" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_2890f4c2-58f0-45e2-adc6-eaf2f68cff14" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_2890f4c2-58f0-45e2-adc6-eaf2f68cff14" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_5bb4c6c7-8b14-4d51-a056-b281d72d1fcd" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_5bb4c6c7-8b14-4d51-a056-b281d72d1fcd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_e8265383-cdfb-4cbc-8a5c-78cfa8321550" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_e8265383-cdfb-4cbc-8a5c-78cfa8321550" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_4d14431e-29c7-43eb-a266-54b3a92385ba" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_4d14431e-29c7-43eb-a266-54b3a92385ba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_6a167ca7-e1af-4933-b57d-ccb04d85b655" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_6a167ca7-e1af-4933-b57d-ccb04d85b655" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_e25ae63b-c55f-4d6e-bd8a-bc17bd5cf8e3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_e25ae63b-c55f-4d6e-bd8a-bc17bd5cf8e3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_20ee60b9-e693-4f63-bc7a-5f00278be9c8" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_20ee60b9-e693-4f63-bc7a-5f00278be9c8" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended" id="i668318bbe2b243f6a014efb6c8358f0b_ShareholdersEquity"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended" id="iccbfc37be6334c78bfad416c9c55e0b1_ShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_22425daf-db88-4f22-abb2-8376295762c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_22425daf-db88-4f22-abb2-8376295762c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b9d614b-ec0f-4272-80a4-89b1b5ca7be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b9d614b-ec0f-4272-80a4-89b1b5ca7be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9c48fafd-5e6c-4f0d-9877-107cef211de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9c48fafd-5e6c-4f0d-9877-107cef211de7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_11a4fdc2-c776-4918-a82d-747437d1af30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_11a4fdc2-c776-4918-a82d-747437d1af30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_24b083db-5370-4cff-b6ec-ebac7b0738f0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_24b083db-5370-4cff-b6ec-ebac7b0738f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_24543e38-f56c-4f53-a0cb-76e3e1de5ba4" xlink:href="cvs-20200930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:to="loc_cvs_A2016RepurchaseProgramMember_24543e38-f56c-4f53-a0cb-76e3e1de5ba4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended" id="i4f9efb49ed0848c7a47dd255cfb0832d_OtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended" id="ib4dd7a6f39dc403c99ea2c2297ca0a79_OtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="i9769d2875f7140f2ac767ce0fe726103_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:href="cvs-20200930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90a5ab51-90d0-4769-8b37-159bb4aaf42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90a5ab51-90d0-4769-8b37-159bb4aaf42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c600de64-d902-49a3-a812-d7448fb0695f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c600de64-d902-49a3-a812-d7448fb0695f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_281cb7a7-083f-4160-9894-4c1628f11d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_281cb7a7-083f-4160-9894-4c1628f11d75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af15228b-f6f7-4d8a-819f-6d938b2dc046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af15228b-f6f7-4d8a-819f-6d938b2dc046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99d36c88-8888-4b04-b1ec-27e2e17edf9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fe04f2e2-1e51-43ab-86a7-dc3535779f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fe04f2e2-1e51-43ab-86a7-dc3535779f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_23354d73-2c1a-4c1e-acd0-9432c5390d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_23354d73-2c1a-4c1e-acd0-9432c5390d2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_f95415d2-af13-48ae-8f73-293c99a41eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_f95415d2-af13-48ae-8f73-293c99a41eab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c94a986-ede4-44ce-afbd-8247c3f1997a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:to="loc_us-gaap_EquityComponentDomain_6c94a986-ede4-44ce-afbd-8247c3f1997a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:to="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_20ee38a2-a3ca-47f1-a694-ec6714a4fd69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_20ee38a2-a3ca-47f1-a694-ec6714a4fd69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_30489996-27c7-45fb-97b3-97a22f2bc706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_30489996-27c7-45fb-97b3-97a22f2bc706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5c65879d-07c0-4f22-a136-dacf11b57738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5c65879d-07c0-4f22-a136-dacf11b57738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_502692d5-5ff5-438c-b94f-47eb897d1f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_502692d5-5ff5-438c-b94f-47eb897d1f29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_341028d7-34a0-4dd2-ae56-a58281ca223d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_341028d7-34a0-4dd2-ae56-a58281ca223d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended" id="i0c8a25f1ed8d43439216bc78dfbe1e3b_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended" id="i97a4c995b28c473d97c88bd53e220d7e_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended" id="i44b61d0c1a1340fc814b24b97e1aeeeb_EarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended" id="i185c517ad35c4c8598b5cfb0d7094d5c_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i3b2e3be557ee49b38c73a66a4c278767_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_84b605c3-1532-4b20-938b-f1dd8b308816" xlink:href="cvs-20200930.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_84b605c3-1532-4b20-938b-f1dd8b308816" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_039b5ab8-ef5e-491b-851e-0c5ba9e2e373" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_039b5ab8-ef5e-491b-851e-0c5ba9e2e373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_7f049b38-8b73-490d-bde0-1b1e4358ecfb" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_7f049b38-8b73-490d-bde0-1b1e4358ecfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_c4694fc8-19be-46bc-bd5c-28c90f94a9eb" xlink:href="cvs-20200930.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_c4694fc8-19be-46bc-bd5c-28c90f94a9eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7e6a4e6b-8955-4bd1-bcbd-a2e1c16a3cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7e6a4e6b-8955-4bd1-bcbd-a2e1c16a3cdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:to="loc_srt_LitigationCaseTypeDomain_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:to="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_8e6b5774-417c-4ea4-9bf6-c283ccc4d058" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:to="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_8e6b5774-417c-4ea4-9bf6-c283ccc4d058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_80d28ff0-ba10-4556-a9db-9a6560e845a4" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfNewJerseyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:to="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_80d28ff0-ba10-4556-a9db-9a6560e845a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f8935d35-62c4-40d2-8c10-f6423dda4bfe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:to="loc_us-gaap_LitigationStatusDomain_f8935d35-62c4-40d2-8c10-f6423dda4bfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:to="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_288fb65b-3aa4-4d1e-a0df-ee9b8b372180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:to="loc_us-gaap_PendingLitigationMember_288fb65b-3aa4-4d1e-a0df-ee9b8b372180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fe072feb-5a8f-49e0-b4cb-db33bca966ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fe072feb-5a8f-49e0-b4cb-db33bca966ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_61a08111-bead-428a-a324-5c0fc02becf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:to="loc_us-gaap_SubsequentEventMember_61a08111-bead-428a-a324-5c0fc02becf7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended" id="i74552b424a31448c88c6385ee9b236a0_SegmentReporting"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended" id="i3c80578a2043486785876a6d47ff53c2_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="if8b089a7741947edbc733b91db35b695_SegmentReportingNarrativeDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="ie7f697227e3946b7b3695af831cf85d6_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_527a5661-8f55-458f-ba54-ce38ae9c8041" xlink:href="cvs-20200930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_527a5661-8f55-458f-ba54-ce38ae9c8041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_204e9738-7c19-477a-b93c-e06643ffc9c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_204e9738-7c19-477a-b93c-e06643ffc9c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_60e16aca-5e7e-4eb5-bea9-1053f117a66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_NetInvestmentIncome_60e16aca-5e7e-4eb5-bea9-1053f117a66b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_27f0d686-deb7-451a-a8b7-5affa002b0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_Revenues_27f0d686-deb7-451a-a8b7-5affa002b0a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_e471197b-2b95-4dd5-b455-5df7ba375e39" xlink:href="cvs-20200930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_e471197b-2b95-4dd5-b455-5df7ba375e39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_7a8bffe0-22c2-4128-80fc-d28ee01f4191" xlink:href="cvs-20200930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_7a8bffe0-22c2-4128-80fc-d28ee01f4191" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:to="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9548d80e-209a-43b2-89fa-6c03cdaa4884_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:to="loc_srt_ConsolidationItemsDomain_9548d80e-209a-43b2-89fa-6c03cdaa4884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:to="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6db53734-a960-41f8-8ad0-8b263b4ae18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:to="loc_us-gaap_OperatingSegmentsMember_6db53734-a960-41f8-8ad0-8b263b4ae18c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_57b6dd9b-af2f-4ca5-81af-52810d78bcd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:to="loc_us-gaap_IntersegmentEliminationMember_57b6dd9b-af2f-4ca5-81af-52810d78bcd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3da8458d-e183-401b-90dd-741dc5889f24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:to="loc_us-gaap_SegmentDomain_3da8458d-e183-401b-90dd-741dc5889f24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:to="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_c901864b-f5c9-446f-b807-afda30ee983e" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_PharmacyServicesSegmentMember_c901864b-f5c9-446f-b807-afda30ee983e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d511860d-6939-4348-b8e3-79479dcf0601" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d511860d-6939-4348-b8e3-79479dcf0601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_8d1030bc-d8e3-4c8e-a28d-5420f76348f3" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_8d1030bc-d8e3-4c8e-a28d-5420f76348f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_53d02e65-6ffb-4fb6-b252-3149075317c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_us-gaap_CorporateAndOtherMember_53d02e65-6ffb-4fb6-b252-3149075317c0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="i2178963d36cf471c8d83103c4956ccad_SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_844905bc-271e-43e7-a410-e724c94c7f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_OperatingIncomeLoss_844905bc-271e-43e7-a410-e724c94c7f6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ee29a06d-893b-4a40-90ca-59f758b8acd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ee29a06d-893b-4a40-90ca-59f758b8acd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_c566deb1-ab6e-4abe-b810-f5ca66cd833e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_c566deb1-ab6e-4abe-b810-f5ca66cd833e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_8a8b0e81-5f89-46ec-9f17-8edbf3cb2912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_8a8b0e81-5f89-46ec-9f17-8edbf3cb2912" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_eae24381-6f48-4763-abe4-775c8a8e4647" xlink:href="cvs-20200930.xsd#cvs_StoreRationalizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_StoreRationalizationCharges_eae24381-6f48-4763-abe4-775c8a8e4647" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_86f4a0b3-3122-4405-8a30-1ee7115224cd" xlink:href="cvs-20200930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_86f4a0b3-3122-4405-8a30-1ee7115224cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2c83347e-651a-49f9-8a05-be327bbf9d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2c83347e-651a-49f9-8a05-be327bbf9d42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofUnderPerformingStores_8ca24f4a-8be1-4393-9b95-a1b5575edb08" xlink:href="cvs-20200930.xsd#cvs_NumberofUnderPerformingStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_NumberofUnderPerformingStores_8ca24f4a-8be1-4393-9b95-a1b5575edb08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ea580d63-00d5-41a9-978e-97db4ee31403_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:to="loc_us-gaap_SegmentDomain_ea580d63-00d5-41a9-978e-97db4ee31403_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:to="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_33334bba-897c-4256-ba68-169730b97383" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_33334bba-897c-4256-ba68-169730b97383" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_44127659-6c1c-43f5-a813-507a72d01935" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_44127659-6c1c-43f5-a813-507a72d01935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_2c4ef406-4c4f-4d0d-a1bd-35c55b3221fd" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_PharmacyServicesSegmentMember_2c4ef406-4c4f-4d0d-a1bd-35c55b3221fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d184ad93-4abf-4b6d-ad2f-76a933c03a71_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d184ad93-4abf-4b6d-ad2f-76a933c03a71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d86407b7-42ee-4341-ae09-54cd2dbc7750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d86407b7-42ee-4341-ae09-54cd2dbc7750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0764e4c8-e27a-42f3-9191-54da7066c735_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0764e4c8-e27a-42f3-9191-54da7066c735_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5d9eb8b8-83b6-42da-9245-0a4b3b17194a" xlink:href="cvs-20200930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5d9eb8b8-83b6-42da-9245-0a4b3b17194a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEvent"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="extended" id="i407c4df573e64eccadc07a821274ce1c_SubsequentEvent"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="extended" id="i97bee9ef463848f588bf44ab6d7eb61b_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_f5737ecb-fb9d-44b1-bc8c-6640f4a7da9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_f5737ecb-fb9d-44b1-bc8c-6640f4a7da9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_444a7440-c1a9-4687-975d-df4cf244b16f" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_444a7440-c1a9-4687-975d-df4cf244b16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_c7cc8266-dac3-42b6-981d-b6b5976a9d76" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_c7cc8266-dac3-42b6-981d-b6b5976a9d76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_bb92f798-d431-4072-bf3e-09faef6f98a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_bb92f798-d431-4072-bf3e-09faef6f98a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:to="loc_srt_LitigationCaseTypeDomain_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:to="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_c6969463-d83f-489d-9d65-8f36e4d072be" xlink:href="cvs-20200930.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_c6969463-d83f-489d-9d65-8f36e4d072be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_0727fa3a-8c53-4852-9402-279f9795dcd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:to="loc_us-gaap_LitigationStatusDomain_0727fa3a-8c53-4852-9402-279f9795dcd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:to="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c8eed914-b241-439b-b057-3aed9fc4c72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:to="loc_us-gaap_PendingLitigationMember_c8eed914-b241-439b-b057-3aed9fc4c72d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_52974c4f-b666-4ab3-a23b-b8aa52a02eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:to="loc_us-gaap_SettledLitigationMember_52974c4f-b666-4ab3-a23b-b8aa52a02eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_509ad110-7a64-45fa-aee5-357417f3fcb9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_509ad110-7a64-45fa-aee5-357417f3fcb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumRevenueMember_865ead81-5531-4654-9400-c38691cd4c9f" xlink:href="cvs-20200930.xsd#cvs_PremiumRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:to="loc_cvs_PremiumRevenueMember_865ead81-5531-4654-9400-c38691cd4c9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_60b3bfb6-35f3-4edd-bf56-2b1f9095741b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_60b3bfb6-35f3-4edd-bf56-2b1f9095741b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_56c5bc89-9abf-40be-b02c-bf45d2da6cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:to="loc_us-gaap_SubsequentEventMember_56c5bc89-9abf-40be-b02c-bf45d2da6cfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2a647646-dcb9-4a0a-94d5-721d2d225e41_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2a647646-dcb9-4a0a-94d5-721d2d225e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:to="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2588ee9a-04fe-4944-b431-316ddd0694dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:to="loc_srt_ScenarioForecastMember_2588ee9a-04fe-4944-b431-316ddd0694dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>cvs-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_bdc3aeba-608b-4226-a40a-cd4d7d180847_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_82052014-7449-4524-b82e-c8e7ff6259ae_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_23fa64b1-5016-42e2-b349-cd12e8506611_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b8923250-e9d3-4007-92ef-36e5233bdd12_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8256f53-03fb-4200-b60a-2c175fb67732_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b3406a38-c39e-450b-8ea7-c5a9b45963e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2d2fcaf9-97bc-44dc-b88a-868e2494ed8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_983065fc-58b1-4247-85f0-2c73f88a6d87_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_49365950-eff2-44b7-9084-a83747bdca78_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due May 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b72e574a-67d1-4c0a-a447-4d9f8714f891_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_6e7b741d-ffd5-4c9c-aa8a-11069a4f2243_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_332d4299-ed67-4335-9421-2b49fc5ebed7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fc748f4d-8eee-4ff5-9072-d51b8527251b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_881845f2-eaad-4149-8548-d81c44bc796c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5cbed6f9-c42f-4815-a1b8-b869ee18145d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4db4b48b-b6b0-4778-8665-8ef2763a0c82_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_e40ee2ff-3ca3-4867-bddc-ef06e267d511_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_f535d4a5-069f-4d99-b589-d32654f54c5b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_090bd0c1-b599-4e74-8249-f536c25c0de6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_12f27bf6-9b95-4abd-a352-53720e4ea6cc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_94493373-0bba-45ae-9efa-17e2de5019c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_2c0299dd-243f-4a96-b828-899c82bf1225_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_493d1f32-0e13-4d51-bbf6-db024f00bf06_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4092c2e1-4e65-4895-8840-c8643b6063ed_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_5622ed5f-6c93-425a-a042-d352280b2c6e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_de38fb97-6eaf-4411-82f0-2fff3776f288_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5ccb1a14-54f2-46aa-9a6d-d6bf24ce2a6d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_64822758-b77f-4c22-a573-4cb6b993c9ca_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_370b92f6-47f8-4ca3-ac6b-8874ea3f1b16_totalLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_690adb60-314e-48ad-b8f1-f0c213e23cf5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9e9a864a-e180-4c49-bb27-062bb591ff96_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6d43df4f-aef4-46f6-9e60-4786a67e13e4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_3efe7c2f-a7a7-4ef2-8fa9-807a3d4641a0_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20200930.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_71079083-49c4-44c0-8936-86e2a227bee5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_798c6227-3dc6-4ad6-b6f8-a1fd5b7c922d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_082e711a-27f1-414b-aff5-f79130bb4fa4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_6ed0af55-dd4c-4d9f-82b5-785fcad8fa69_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_72a6e3de-3d30-466f-a083-c205a457d410_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f04b4141-ded9-4770-98c4-b047cf44839a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2050b3c5-f715-464f-8f5c-0e36d71bfd06_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_e56a4ae1-cb1c-4350-8e9f-0016875c16e0_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_43060832-cc20-4b0f-bff8-23e61c79eed7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_18cc1e54-286b-42c6-b9d5-d44d4fc0dbde_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b5447b12-95b2-432b-8c52-c82a2e1e8851_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d9d1b7d9-bdd7-4aa7-af3d-9f678cb37764_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_c421eba8-b4e3-483a-97d4-c935d07b11c4_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2020 (2.515% at December 31, 2019)</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_166870c5-7bfc-4c0f-9d0c-12061ba6f742_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6f672ff0-d4f7-4e60-95f1-2d6b2b402cea_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b8851dbd-e548-46b1-9cd8-58eb83691ca1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bc165e6e-d12a-4f0a-b356-0cd2be01b565_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_e27d4603-9f6b-4812-af0f-0aaf7350e45b_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ba8d4bfa-121b-40c3-a9c4-b750878259b1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6abc0e85-e890-4b4f-9a86-26aa2db903c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_bb805168-0e4c-4006-90b3-49cb59edba34_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_feb45a68-0072-425b-a222-050a757fe17d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_6585d2f5-2256-49d9-b985-a1bcdf6885f3_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20200930.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_e0dafa75-a018-4825-8461-4cf0da936d0d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_d86d50cc-e727-43ad-8cfc-b7a24002c93c_terseLabel_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_label_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_documentation_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:href="cvs-20200930.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:to="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_b7bcf08f-d8dd-4f91-abed-ddfb6e8138e4_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_f1e10bd0-0c8a-485c-b919-c44f5eba1945_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20200930.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b38bb218-796e-4a81-b669-601ace061bc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_69b19ce0-3faf-4899-8176-acecf9be2fce_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_bbcef0f4-6fb2-46e3-a43a-b8acc3e8fe9f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_50766d7f-c935-4386-82da-833ae68fba36_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_8bb4c228-72ca-45dc-a667-0732e7de7514_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a620c1b6-59fe-4bac-a5c1-c1483f5f03d5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_9b85a4ef-b2eb-4b49-af8c-9d4628670648_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_831debf0-bd06-48a0-be37-a266cc9114fb_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_cc5167a7-b223-445f-974a-a16d1b881cb1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e540a830-d5ed-4835-9d19-9b13ff2aba6e_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_3b0de590-a1fd-46b1-ba0d-65e571406c31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ff69f9d1-c92c-42d0-800d-c9983009ce2d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_4bc05f83-419f-4771-b45b-7846c6313cbe_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entities filed claims</link:label>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_label_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number Of States Involved</link:label>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_documentation_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number Of States Involved</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:to="lab_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c78aa2c8-2465-4848-a57b-b85bb8dae7c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_85cae7e9-3e8e-404d-a2a0-c3c78cdc2329_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_13f68b3f-ca16-429b-87d8-3cb23692ebd0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ab69b1c7-551f-45d8-ba25-f16f8e52ea5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4a32a7cc-e37d-4e51-b870-8a75b9a8a65e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_617e13e1-127d-418d-80fb-9fd33df81524_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_1e9a60c4-af8a-4401-978c-c03fc49b02dd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d6682a4d-5c56-4746-86a1-9ed0dedaf3d2_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_018d74d0-3c7f-4183-8783-ba13d92f75ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumRevenueMember_2056dcb2-0187-4ba8-b99b-d5405030ce8f_terseLabel_en-US" xlink:label="lab_cvs_PremiumRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Revenue</link:label>
    <link:label id="lab_cvs_PremiumRevenueMember_label_en-US" xlink:label="lab_cvs_PremiumRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Revenue [Member]</link:label>
    <link:label id="lab_cvs_PremiumRevenueMember_documentation_en-US" xlink:label="lab_cvs_PremiumRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumRevenueMember" xlink:href="cvs-20200930.xsd#cvs_PremiumRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumRevenueMember" xlink:to="lab_cvs_PremiumRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ed3d97b3-e842-47ca-b9f6-318a99f4b5f9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_81278a21-9d32-4000-8f0a-23309addabf5_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss (reversal of loss)</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20200930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_82a812b3-291b-4e8b-9096-b64ebe8d19fb_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_57ac2665-0ae0-4f4a-9f5c-c36f7b82363b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b599f970-3d73-4873-813a-7b950f4e1c52_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_e182217e-9a68-4afb-a483-b174a60a086d_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20200930.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_dd5b9018-753a-4e1e-a0aa-246f28ce4573_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_16f717c9-cd4d-4a8c-8fc8-a11c9af88a24_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_1e5613a5-b3df-4263-b023-7f33aa4c803a_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0a95d095-01c0-4087-9665-f9ed6360bccf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_1741fd15-8728-42fe-a258-3ec29d0d7941_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_326a112d-7dec-4f16-8788-0a99275079df_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_82a0aaff-9c01-4498-ba2c-b4dc238c4c63_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_218da950-4d9c-428c-9cc2-648ab25ff6a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e1e6e5b0-3ec8-42c5-a674-e29aeb1addfd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_2958f1a7-bb71-4b84-ac01-f9a46a8e5e8a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_c0a0544b-000e-4078-af99-fdb5ebe0338c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_913dfed5-c12f-49ca-b64e-2745c1cd64b0_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_f7e2fb33-a043-4e8c-810c-e1c40c338f03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_6eee55cb-64b5-4415-bcb4-f44a43eb99f0_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e1f7f0bf-ac63-4fdb-b285-56ae5f80bf9a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d9105689-2399-4cdd-9beb-166d50ec428f_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_78e51b88-31bd-41c1-8df6-2f73a5f8ded3_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_263b498d-2628-495f-aa27-70a0a014b07f_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, before tx</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f5b381b3-c534-445e-ac27-95a358ddda3e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_18a5a1e7-0d2d-4af7-9d65-2d89c33fb50b_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_a65527af-5f0a-49e8-ad39-742d58e3ff89_terseLabel_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:href="cvs-20200930.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fcc9ec9f-d2e1-4b05-b8af-c43514705827_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_d0b935d8-4e6c-4eca-afa0-1f2b6c9db259_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_22e12978-3b1a-4630-b048-d44e1452783e_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_0fba3e4b-854f-45ba-8c3b-dd793ccb5972_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_07c7b2c0-7192-490a-81d1-294058e8ff66_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db97b96f-88af-415a-a84e-47957e8ed481_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_812d15c8-62d6-46b6-aa98-65164bba6472_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_b6f8cecc-287a-4686-aa60-41eaa992ab7b_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20200930.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_c2f12566-13f5-414e-bad3-aeee8b47684d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_71aaaf9b-98aa-493c-8cbb-6c70a52a350b_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7663fdb9-ce60-4934-8a3a-4c66fee8ee35_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_432bb846-dced-4044-92c2-ccad1476303d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_8d6480c5-eff0-466e-b6ad-0232c51f1d4c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b22b0857-37e2-4c6e-8742-ec1da1c6acea_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_26838362-7122-4f1a-99ac-e6aa4c4c7ebd_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_f9a3f178-5b28-4e6d-b192-67feeb07b82d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_16c5d390-a3b2-4a61-b239-fe3485697b4a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_04499625-b2d1-452d-86dd-80da24bdbb8f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_4e8d8b7d-9ae8-4991-8b8c-742e06962b74_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_95dd0f44-69fe-4fef-9e3f-e5ee42c207b7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_b3f55940-83c7-4b38-82aa-3c0393f641f8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1588405b-c765-4b6b-b7bf-ec78f858ee47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_414cef08-9e73-41f8-b6eb-e45ee6ec58da_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:to="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_9b1561b1-8eee-435f-9d1a-134c37db673d_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20200930.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_1bff1056-7701-412b-9e79-fda38c334642_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Expected Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea80ae86-04e3-4ebe-aaa1-f4b0d9dbb8fa_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_89472527-4d3e-4360-bb00-11fbfa7c30f4_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7898c69f-3ac0-4dae-89af-f320310f233b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_9f01ed20-741c-4922-a4fe-e086e4a027bf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7f87c445-df4e-4a49-8bcb-1883b30b9d20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_5b1c8e3a-04cd-49ff-9545-8284c4911383_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_192ca3b0-3f14-4070-86ff-ac3c1809ab34_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20200930.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_6ea8e9c0-f23e-45c5-934e-d88a08467f12_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_1d715c2d-b243-4cc4-9a81-b137bc05d409_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_de028102-bd54-44c2-9013-1f5230c3ccf5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_fa5ba800-79b1-4015-82d0-75887f657a7b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7856aae5-e84e-4505-9f1f-2d078266d8fe_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_ed98eed5-0586-4c82-83c9-1cee8585f136_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due March 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:to="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_c8b4ff4d-fcdd-4e25-96b7-6c3dc393caa3_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_399335e7-cda0-467c-bcb0-d8cb21c06b1b_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_27760d48-3c2f-49d5-97de-aa32300bbacf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f89640b2-2f3f-419f-a3ff-aad05f88d7fa_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_8b5f59d7-bf34-4374-adf1-b2ae5cdcd53b_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20200930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7c91338a-03da-4cb2-a1a5-99fa39d9d488_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_9d14290a-49f4-4894-a43a-68201b1f0ac2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b195f695-4741-4e91-bb4e-2cf7e37bc12f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_258dd95c-c4a1-4259-b5a5-ee9a76ab7fa0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_d59d0e84-e135-4eca-afcd-c7b5a857ee76_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_b136fea1-16c0-428b-a068-3667ffec4ab9_terseLabel_en-US" xlink:label="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served through health insurance products and related services</link:label>
    <link:label id="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_label_en-US" xlink:label="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of People Served through Health Insurance Products and Related Services</link:label>
    <link:label id="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_documentation_en-US" xlink:label="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of People Served through Health Insurance Products and Related Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:href="cvs-20200930.xsd#cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:to="lab_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_743fbe3b-ded8-4f3b-82c2-273141b25217_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_210ea42d-fdbf-40d4-80f8-f150289a9000_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_7adb4d7e-0707-4303-ae97-9f7311ba3c2b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_1f11a2f4-7c8f-427c-81cf-31331c655d8f_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience-rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_b0d9c340-e127-4d8e-9913-3725f65d24e0_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d9c508c0-011d-499d-bb35-3e57a38b0b09_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_52db5d09-6f9a-4d09-b73d-2c3a064c1cc4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_e454bf2c-4c18-4f6a-84e0-d7adfcf1f757_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_9bf911ac-4d72-48b9-acad-f388dda3e34c_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_debf70b9-dc03-4b2e-bd0b-b0d14113a728_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_e01b21bf-9fe9-4437-bead-4ecfaa56ce07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d9b4b649-2078-4ddb-b813-a734caf65ef3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_becdf05d-9347-4ecb-8642-4f16d39c96e2_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20200930.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4b1b4ceb-8125-4ea3-b67c-834e3e740907_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_1d2dae5b-bea2-4908-a21e-dfb75bba657f_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_c0948374-677f-4911-bec6-77b2dad58934_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b67c6911-b108-4687-bfb2-e6280b9b56a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_40a6456f-bb19-4cc4-9152-1a19b0f233c6_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fddf84d6-48e7-45ac-8718-a88aea870cb0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_49f4890a-3409-4645-a1d5-13f728f7acfd_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_25938c5d-65dc-4414-87cc-702220cf5449_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_cbe89ede-07a8-4c3d-85dd-267a57045d5b_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of entities filing claims</link:label>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_label_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number Of Entities Filing Claims</link:label>
    <link:label id="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_documentation_en-US" xlink:label="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number Of Entities Filing Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:to="lab_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_94bd9a13-c122-4b75-bfb7-e69c1d968d1f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_5821c8c1-2be7-4702-b1b8-3faa6102aa00_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f50d0c15-9ef2-40df-83c5-9a5b1750aa44_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_22ec5a36-8a99-41e7-b317-29abd4495c8f_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20200930.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_6ba56131-a248-4a8b-b0f7-e5b03e5bbcbf_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_306525b4-e5cc-4fc0-905d-9e708acb2f74_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_8541aefd-6880-4f54-87b1-03ebd0f2f21c_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_76fa4d77-778a-4468-a5df-13091fc2ec46_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_adb03f74-c6d9-45bf-ad8e-0a45d7f498cb_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_a2d9944f-5a53-42f5-a712-4a51dc4d9f04_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_73db7400-6319-4268-835f-ea5eab23b5a9_terseLabel_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda.</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_label_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda. [Member]</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_documentation_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember" xlink:href="cvs-20200930.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DrogariaOnofreLtdaMember" xlink:to="lab_cvs_DrogariaOnofreLtdaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_9d97ee8d-8bd7-4f9a-bce4-79dfc7e56294_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary impairment loss</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_67d43730-30a8-4477-bd10-07d5c341ff99_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_78235897-e339-45ec-9f6f-22ccc9cbf921_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_89625260-3431-4e07-8b17-2ff2c98369ec_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_ee72fb33-02dd-4f7f-bdbe-f94c66fed2a7_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20200930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_d0de5486-d9ab-4c68-9667-99af050795b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9291cba6-0c57-40f2-a153-0dce42c25936_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_77fe03d6-0f68-4324-852c-adcd6bc8767f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_87d7c7ae-0f24-4ad4-a70a-55d54125bd4a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_db73e1d8-96b9-4809-91c2-3a52e30c50f6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_d555bfd8-0869-4b22-835a-f455584ef64c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_6452c465-80ad-4699-a5d2-7fcafde0815b_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8cf88b9d-54b4-4a52-88a1-90db837f13dc_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9cca9919-8db2-46a8-9adf-dd370a26313e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_55bdc001-7b6a-4a47-b4bb-00db6c18ccc5_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0dd31bcc-e695-49e0-8149-773f7b70b8c2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_a35c5bf1-461d-4533-8578-412cb2d46fd8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_6be87ebf-5fa9-4056-9c75-4b00b60594d1_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20200930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_4bdf4920-2db3-4852-9f46-e4dec2a60256_terseLabel_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield Of New Jersey [Member]</link:label>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_label_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield Of New Jersey [Member]</link:label>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_documentation_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield Of New Jersey</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfNewJerseyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:to="lab_cvs_BlueCrossAndBlueShieldOfNewJerseyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_e66e34ba-58a9-44fb-a6e4-1190b93d860e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_08d29ff3-5b45-4a6e-a74f-f323ec8b2154_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_58653936-9dca-4f6d-9089-6e11fda15502_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20200930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_003fc4b7-5378-46bc-a351-2ead2572a1b6_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4b911e6-e0dd-4bd9-ba33-3d9d864b7c13_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a7486a17-3704-432f-9159-f8217ca4ccd9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_57d922cd-dc0f-4e26-8f96-6c71dbb44812_terseLabel_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_label_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_documentation_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:href="cvs-20200930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:to="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9ee4641b-bce8-491c-b884-cca098741ae0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_9fe93652-cc15-4e5f-a5f5-4d356081c256_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8e1169a-afa0-421d-9d7e-7159d2d33350_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_19ef5dac-44a9-4803-a75c-cf658cfa6277_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c4115f1f-733f-47dc-90aa-795c48c7eeae_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a484f7ae-5147-4386-9043-c6d856d3cded_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e5d01b58-eb1d-46a5-8491-5a1c5a91d7b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_b380c464-4361-4fb8-a5ca-b319920ae02e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_5c3c3a80-34bb-4805-aed6-c46c0cc81601_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_b58eb476-2448-4548-a2ce-155afeaa872c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_b3b1c3fa-9f4b-4505-bff4-3fbc87c0ae31_terseLabel_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers" xlink:href="cvs-20200930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPharmacyPlanMembers" xlink:to="lab_cvs_NumberofPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5624acf7-b4b7-47a2-8701-d01049fc5d39_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_95c5730e-32b5-49a7-b819-50b70d2038c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_3ccdd064-e914-45af-ab64-3cc46c4feb7f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_1a6ad2fa-ec55-4787-91e0-6df282eac19b_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20200930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_c71bdbc1-a9c6-4e71-9a4e-be2e916e68bc_terseLabel_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_label_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_documentation_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:href="cvs-20200930.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:to="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_14c823c6-3c36-453e-b924-bf60b0cb1720_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_3b17131c-3ba1-433c-868e-2417d27fb0eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_7fbd5a1c-4c7e-411f-bf87-a337f2f69807_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0ff58653-2ceb-4fe4-bd9e-da6568e746d8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c5b91fc2-59a4-45ef-8f15-1b9c720ce5f4_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_ee4b9718-04f6-455c-b867-4ba130dc66fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_96221a7f-bbd3-42d6-9d71-570a3c2c9afc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_894410e6-e831-4040-8d94-8e6ca81fd0d6_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_077c397c-f168-41ea-b010-5b644174ab01_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_55cba198-2dbb-45c6-82c5-4c99faecd886_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a521e359-0d1d-47a9-ac89-80e2bef04d7a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_84a39c24-1a94-4ae1-bbc0-1b5182d17c25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid in excess of debt principal</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_f4d6e64e-3f90-4d98-ae0c-daa5d74157f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_2e60e4bf-9d3b-4b2a-89fb-511ec39a459f_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_4cae4ad3-43ad-40d3-a95a-2c6b79f4cdf6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_6def6178-bebb-492c-9680-b65430e10f51_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% senior notes due March 2020</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:to="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_4e082012-3013-40c9-8699-4ac22df95e48_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_002a0f11-61b4-43ae-8e0a-6cb0b55e42bf_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2d469b39-53a6-4575-a3ae-ee05f03476db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1512bd9d-8d61-4d08-87f2-2dc96f3563ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6d341934-b73c-4f7f-8b53-6f62694695e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_828b086a-6c38-431c-812b-46d8b66f99a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_73f00143-c221-4c23-9d0a-c86f9fcd3aae_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d3ecb70a-020a-4139-89f0-0e6c9cae8bd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_c1cad5e9-ead5-4e43-b4d6-63671c0ee548_terseLabel_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_label_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_documentation_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember" xlink:href="cvs-20200930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OutstandingSeniorNotesMember" xlink:to="lab_cvs_OutstandingSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0a9ba6b4-e54e-44a6-aaa8-0149bb504aa3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8f684dde-d6cd-42d1-9c2c-b10f72ea4ad4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c30d6f5c-ea18-40fa-90b5-759f57e91d76_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_302c1490-4c4b-4ca8-bfe2-1786b4850ac2_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_c558cebc-e092-4b54-96f0-a0aaf0e04b8b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b5914dfc-15e8-4f0d-8ee7-99c98b86e4a9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CorporateOtherMember_b9ff432b-7b5d-44a5-97d2-aa9e4b5f9580_terseLabel_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_label_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_documentation_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember" xlink:href="cvs-20200930.xsd#cvs_CorporateOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CorporateOtherMember" xlink:to="lab_cvs_CorporateOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_343f13b7-a322-494e-b99a-526c8455a70c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_4df25331-f87f-47cd-b303-24b8bf5155d2_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1f196830-e94a-42f3-9594-c0d7a087483f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_6e4a2439-1798-4a3f-882e-877d3a9f7ef4_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20200930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a7fa151b-45f0-4e38-ac8b-8387e20af1ee_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7eea4da8-7743-4d8a-9eac-5316b913cfd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_15fbf570-9e33-4dc8-a5fd-3a6f5b9c6e5a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f459d242-3a43-478f-8e3c-984d81880909_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_637b1ecb-ea60-41dd-a920-d1796e70a5ea_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_237bd21b-d4b0-466d-8caf-576ed2657ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5303658c-c1a0-4278-8ad3-b7c9851e0098_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_e7e51830-cbb4-40b3-8231-cd7d3317aca7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_c65015c0-0997-4b98-8993-a90f2cb40868_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_43bdcef3-2b08-4ce3-b943-826492283287_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ef9a283e-e591-4dd5-9b9a-3745927756b1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_4559a0e6-4d79-4e58-8098-dd1366309d68_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_a101cf55-ba49-40bd-a88b-c208820e8f20_terseLabel_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:href="cvs-20200930.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:to="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_01677b0e-f2f2-4953-a9dc-40eb0ed725e7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_730460e6-02fe-46b6-974b-08d921149c05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8a7201a4-92b8-4405-80a7-57fe438ac6f5_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_29488477-ebcb-49fe-ac45-26a906fdfecc_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2b01829f-e128-47cb-8a88-fb16a6534217_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_06c74c28-ab31-4c80-ac9f-48cd11a6db4c_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2bfb20e0-6092-44c4-898b-2ddacf5ba11a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_425b5fa3-9f6d-42f5-9637-3028d46e99b3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_330d50e3-b59d-4556-8118-87e212bf42b2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a063a8ec-390c-41c0-b16c-e4bba1ca2200_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8da1877a-456c-4ee2-b756-17b5b04afe02_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_b1a35e96-52e8-4e02-8008-39704beb89b7_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_8385215d-63df-4c37-8e16-24a8c3e649e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_7f2a3164-1bc8-4acb-9cab-9778b2ea6c20_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_b4c1fba5-5089-497f-a62e-7faa869b1520_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before Reclass, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0d11b79a-7a53-4f66-a209-e334e79ba4de_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_5359254d-2939-4606-a446-4b7f5465b2b1_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_08ec8781-ae0d-44ae-bf6d-81d1d884f077_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_3bcceae0-0936-4305-bb73-47bd84f347eb_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain contingency, unrecorded amount</link:label>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_label_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Unrecorded Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:to="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_bc27dc7b-2a84-412d-8496-6bef0a58af51_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net borrowings of short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_2f698f77-db6c-41ef-a7b0-c61f6f2de9ab_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_d6cd8061-fad6-45ae-b751-458ef2df51da_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d332defb-31dd-48a0-a8ee-c667bdee72e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b82188d7-b67b-472b-8eee-4da26e063b1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7637eb45-f824-434d-966b-e3ba5e51f573_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_605ee44a-da33-4afc-9ad5-7c0087e14b9c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9b1ea757-db55-4eaa-93dc-f46c03a73d3e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_163b157a-7d7d-4992-9649-7179c855861e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_989c9793-d797-4047-a9b7-1081db1f14bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_8f6b1024-19ef-4eb9-9f3f-80fa2571eb62_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_f2b65099-97a3-496e-8353-68d915137eb6_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20200930.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dcc2f4dd-1b9f-46f6-87d9-f711c9d81cdd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_c1e8d399-14d2-4b8e-8f2a-648f44564cc7_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_4b9de44d-de1b-4977-a1ef-04518bebf193_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c49f0e73-7b0e-4d89-a904-4fd6888a70f0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_dbc23640-2a6b-4d1c-acd9-653b1775ea46_terseLabel_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20200930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_00aede53-9d55-4efc-91bc-902a6a870708_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_fad15b42-225c-4d04-b16f-ff9fc6c902cf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_18c23b17-1508-4875-87dc-0a229df24027_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8abcc56e-72aa-484e-9223-37a37568beb0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6140ec34-ed9b-4574-ace6-661d1ddfd6df_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_14e190cf-89b5-4887-bf6c-6bd119424aa4_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f2b2966f-bb92-4d22-830e-90f909ba2dcd_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b3367cef-2c11-4d7b-8619-39778c7e6398_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_afa0551b-92ed-418e-a4e4-bdc15cf6582c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a0527828-4eff-4b3a-b2a7-63a05d6dcd42_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_3ced629d-1f84-4cba-910b-3d91afce58b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_d9c9a636-12ca-4a8c-a9e8-91947b14bf8f_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20200930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b7ae6e11-ac08-4ebb-ae09-0449278be1bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_a825bab5-e5c0-4aa8-af62-fec211ee2a16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7e5dbc0c-36ca-4476-b01d-d355845c5a0a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_636b46fc-1521-4dbb-88b8-4f26855fb995_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_db3087c9-92e2-4474-aea1-5a54905727fa_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Accounting Standards Update, Transition Option Elected [Extensible List]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Accounting Standards Update, Transition Option Elected [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fae9a931-f619-4fe2-b1e3-0c6636e760b7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d6f12549-fb81-4e8d-bfd3-e9514f8f9507_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bafdb21-98a0-4780-9d32-bb018c67ba2c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofUnderPerformingStores_70c6ca1f-cc34-45b7-a750-348ddf1ae29d_terseLabel_en-US" xlink:label="lab_cvs_NumberofUnderPerformingStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of under performing stores</link:label>
    <link:label id="lab_cvs_NumberofUnderPerformingStores_label_en-US" xlink:label="lab_cvs_NumberofUnderPerformingStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Under Performing Stores</link:label>
    <link:label id="lab_cvs_NumberofUnderPerformingStores_documentation_en-US" xlink:label="lab_cvs_NumberofUnderPerformingStores" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Under Performing Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofUnderPerformingStores" xlink:href="cvs-20200930.xsd#cvs_NumberofUnderPerformingStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofUnderPerformingStores" xlink:to="lab_cvs_NumberofUnderPerformingStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_85f04d66-52f8-4d9d-a02e-1a56b8a5ed9d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_2e0b9f98-f340-4482-85dd-46f920260bfd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_7951eec9-56e9-4f33-8287-00c630e0648a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_f01f3cfd-9288-4436-8581-2121790b1c58_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_589d7e11-6a96-4ede-a48d-34844293adf0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_d8323347-fc39-4f0a-9227-eb58f27a074b_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20200930.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_afb4df54-0c69-4be3-b4ea-631912e34e9a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_a30992d5-ee3d-4693-b991-5728b0775393_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesMember_a9ff27a1-55cd-4a42-84c4-1c154abbb73b_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_label_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesMember" xlink:to="lab_cvs_FloatingRateNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_7e42ec90-7b2d-48b4-907a-b3399894d075_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20200930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0adc7576-5400-479f-97ff-5fa9ae393a62_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_661474b9-2a17-4df1-b156-273e77776216_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_389651d4-61ec-4755-991a-df5d85253182_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_b28ed433-26cb-4d67-b198-6c0165362770_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0d791f56-47a5-4529-873d-43354acb16a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_f4776b7a-935d-4e36-b585-8e21ee36fe1a_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6508837f-925b-482d-a6da-59b68a3e1420_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Earnings to Net Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_3e1631c9-66cc-4ff7-9841-c4c458317504_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d1bc820e-4743-45d4-acb1-8cb18c37663f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_08a04082-a567-42cf-9e71-8afe3c60efb3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_f8a4f0cc-89b4-4036-9465-09c82420c72e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_09a733e4-90d1-4075-a223-6e32e7c33fd9_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_740bfef0-3d56-436b-83d0-9069db90a0d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3542dcda-6df2-4608-bbdf-b55da28cc53b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_42130fdd-6c40-4d84-a8a6-ffce4974978f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_be11e087-2fb6-4074-b6a7-f85cfd6c17db_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_b89e29c6-c7c0-489e-934c-9eca5bc2720e_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_65fb829b-50cd-448b-9359-f0899f4b5c45_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_433919f9-decb-49ae-9704-aa624a0f579e_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20200930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_49a21ee2-3569-4396-bd5c-2c9914ebcf2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_ee8716a4-abd4-42b0-9bf8-6488f7aae361_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_92d53f7d-81a1-4e81-8d24-499d00bff738_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c7192f29-d3bd-4e70-8555-6ef6ddb8f4a7_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_246f3329-ffbe-4eda-8df9-0d51cff93e1a_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_b25e2932-deca-493f-9ed9-466b377fccab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_6174ee59-c8f0-4ca9-8172-6fc4bcda00ab_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_cc78e244-baa6-4f86-b9d1-285cf2758bf5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_21566fbf-f004-4e60-857b-3d487ca86bec_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_2236f2c8-707d-4911-a200-291bd02ac2ef_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_ecb72d0b-7b3b-4388-95ac-f90bf15da4f4_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20200930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_fd42db76-0679-45db-93ea-05ef9ad01a5d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_087950e1-a9d0-4f15-8ad1-abaaf547a5df_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_25f1660b-41b3-4fb4-b790-9492e24b8160_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_f79113ff-dcdf-4cad-ab9c-cd82415105f7_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a327e83d-1606-4c39-b831-9ea4d08deea9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_07c12da1-7ee1-4719-a32e-5a2615f88bbf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_ab764f72-088c-46cd-8910-ec5b4947b1d7_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2736781f-b146-4853-bbec-3e8a4a50da76_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_944d9455-bacf-4249-8b51-8442eca86eee_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.35% senior notes due March 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:to="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_5c3a551b-95b1-4abf-90bc-7b24cb0f5080_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_662d34bc-8083-4987-8039-36505ce5d457_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_4a886373-5ea9-4c0c-8391-28ad8eaf1b6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3039f685-6a8c-4c38-8e56-f94d7aaf6d1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_e6068adb-eac8-469d-8947-073629a949cd_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_85150826-ec90-4454-be4e-1d859bc9aae8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3a19a08d-4531-455e-b444-35e49568fa53_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_861b2407-f8a2-49d4-8359-526d474a5235_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20200930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_c2f58cc9-55c1-4907-b06a-2d53955faf4c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2578b625-569f-4280-8db1-3f3ea898fb66_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_681ba47d-4f8b-481c-a784-580a849652dd_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20200930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_18c4f1e3-97d3-49cf-8efe-a68d7ac905e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_da2dc205-8930-4850-a3cf-21e78d5e000f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_1c243a12-56be-4a37-b083-572562c42508_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1bb0c60e-82a5-465e-a495-77a53dcdb830_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a7cc7f14-8b76-41c5-9b0c-d1980e4d684f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses) beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_cd87acd4-cf04-43ed-a7a1-4e469c01f5f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses) ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_084dd147-7f15-45d6-9674-3ae94dcde675_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_fd34dafb-890e-4171-bf06-c1ba27c309fd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_e6b4a7d7-6f10-42bf-afd3-46394b95aafe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_3ffe2d5a-b27f-41dd-b61b-62fc6ebaab25_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_adfc1372-6165-45ac-bb75-e5f49a318dfd_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20200930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_7f0f7106-d4a5-4cf3-a1c7-00702665446b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_61ad9c09-b29f-4de4-ba01-d13413abd69d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2797d8a1-02a0-41af-ba73-e66d5f516a18_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f462c5c5-785d-43b9-8093-925fec2f4bf5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b43ca663-4006-4b21-a7ba-80a0f36365ad_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_a0686225-c50c-4994-8463-087db4502b93_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a501353c-33e9-438a-938d-6014e994e6c5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8699a68e-1e4c-4154-99d0-036b75b8ebe2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_358cc966-3215-4aee-b6b9-f0d50030e238_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_125e0847-2eb7-4de5-8fa4-3e34850c0550_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a16952b1-eb32-418b-a869-b90d75598db9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_2b681ae6-ad0a-42a5-a033-893a1c83b91e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_ac442f9c-514e-4534-996a-499bcdd64fa0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_da8c8c49-8b45-424f-ab8c-4bc62d914414_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_e6880a04-7154-46c7-9f4e-263e95e7c563_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_66efaabc-726c-4694-8929-cb1cbb056a60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_e6c24ec2-8173-4eef-a45c-ddc183deaacc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a93ac43e-899a-4cdc-8b5a-18a4a2c6ba0d_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ab36e271-44b4-4a21-b21b-494d6be3af32_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_7a51ed47-7d67-4f1a-9996-4016527ff71d_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e48d384c-3b8c-48c0-9ccb-0b4f9bd7f737_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_f7e5d448-737f-4cea-b02c-91ab0ca52956_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_098f4662-d770-4b9f-94c7-8b91f96910de_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_b05cac40-4fc5-4934-b1f0-8ce68499daae_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sample size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_label_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_documentation_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:href="cvs-20200930.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:to="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_5d5dd808-c57f-4445-937d-cd27f9a168e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_61445f97-be1c-4935-8768-d0a630cf0e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_693bcaa3-4d10-4ff0-8665-c03bd71380e1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_fd5ac81e-46e9-4d1d-89bf-1cf5a97f9c6d_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_50945a3c-d9bd-450e-9e71-6ce3b70f65c6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_9977ce97-5bd7-4ee0-8fa5-570c54b1c40f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_4fffd45e-fc06-4c1f-a216-92fa37f22183_terseLabel_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_label_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_documentation_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:href="cvs-20200930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:to="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4b959ea1-073e-4676-932d-0b881f22314b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2d111ec5-15c1-4a91-baf5-b588893a9a08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_de6de10a-d201-4913-b7af-a8522b3342a1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.45% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.45%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2021 with a coupon rate of 5.45%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:to="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_48af320b-23eb-47b7-8a1a-fbd61bdfed40_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_f60f1522-112f-42e2-8eff-d3a69e366a1e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_5a70a21e-f985-4a71-a616-848fcff72f1d_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ab442fbb-dac2-4653-b1d0-d25c5a4c84da_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bf0b6fe5-db5c-495c-9daa-bedc571da883_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_77febbda-db10-4926-b3c5-652b6dba3236_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_655ff7cf-52a7-4ee9-8251-21faa999e446_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_a8a58285-1072-4e88-b7e4-cfd02ab58446_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_27320165-9599-45d3-8f94-85f09bb11a1d_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_label_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_documentation_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:href="cvs-20200930.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:to="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a12a4247-98cc-4ea8-918c-be5918b87c02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_ac75735f-9d73-4ebb-8e72-1adc421f4080_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_e4f11ea6-148c-45fc-b737-31612cd0cc7f_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal of debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c7a1d97b-9d9d-4048-8dba-929b1b4db063_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_09f0c9de-1cb2-4a2f-8576-da58955a9ad8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_355acf26-85f6-438a-bce1-f5af593a069b_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_bf691a99-893a-42f0-a69b-fa186bec2438_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_91ac172a-61f1-407c-b41b-158566ae6f47_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f6789829-056b-481c-a794-49b1871b8edc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_94afe4a9-cff5-4ec9-beda-6e9487980848_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2596acf8-fa08-4006-b2c1-35b03155e560_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_82725479-2ed6-4990-8b1b-7983e83c0cce_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_961290f3-acf2-4321-9ac6-ad9f4de55dee_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1dc4257e-118f-49bf-99bd-5c26997f24b5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_a7f7d3a2-af05-4bab-bda3-5a178fcc644c_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7dea496d-17da-4efe-bc97-3e583139c726_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0ad5110-f5a4-4b0e-8dd1-6c627c366569_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_ac5b07fd-571b-49c3-a3fa-68968aa46e6c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_3c331f5a-f16e-4a73-8d19-8f0271fdd2f8_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_77c61f0a-6f3c-473b-8c78-28e5cd0fcb3a_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, net of tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d0a2da-fbf2-486e-bd51-fdc8c4fae5f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_f85b3901-1a2e-47d6-a51b-bd378653e97c_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_8598aa3f-2492-4569-bf64-b271c0def5c6_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a139496d-d012-47f5-b4d3-084710e0b955_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_5fe77ed0-7595-4a76-b6e4-703ce40988d7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3cd7b7d7-8edf-44f6-95db-12c7280f3e86_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_ee2536f3-8b26-40d0-b2a2-a0c3c69896f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_229e642b-289a-4665-b286-9c4282a22719_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_487b49e3-6dfd-4bd4-a80d-47533f7592db_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20200930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_b2b16a67-44f2-4f91-b3f4-a12112e4c632_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2a3102dc-35b7-4225-9411-e8083003e8a9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_054b3a55-5c2c-4390-838e-a6ef77486834_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_fdb98172-0948-4973-82d6-9ac19197be8e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7f5bdabf-045b-4390-83dd-7046911b9d78_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_60c11772-507b-4b3e-afb6-30e647a3b1df_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6894608c-279b-47a1-b4b4-c9b99006f699_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bc2b3410-2e3e-4ae8-8846-96ceee4e5661_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6486898e-da4c-403e-85df-8721402e59a8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_9c583403-d2f0-42bf-9f1c-c25d6ae4e890_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_9df1e92b-0e4b-4988-b96a-a88c1f08750f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_36ac4421-eede-4773-8b76-09d597a2d161_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues, retail copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20200930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0329b766-485c-45b9-86f5-fde2389c68ac_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2db97210-b898-4123-8027-133643d8b2d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4dc348a8-2da7-4ee7-ab74-dccd37663062_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_dcaafaf4-fd4b-44b6-af6b-40b861d5a1ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NonTaxDeductibleHealthInsuranceFee_c18ad125-7f01-4f98-9757-4b01e3ab981f_terseLabel_en-US" xlink:label="lab_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non tax-deductible health insurance fee</link:label>
    <link:label id="lab_cvs_NonTaxDeductibleHealthInsuranceFee_label_en-US" xlink:label="lab_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Tax-deductible Health Insurance Fee</link:label>
    <link:label id="lab_cvs_NonTaxDeductibleHealthInsuranceFee_documentation_en-US" xlink:label="lab_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Tax-deductible Health Insurance Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:href="cvs-20200930.xsd#cvs_NonTaxDeductibleHealthInsuranceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:to="lab_cvs_NonTaxDeductibleHealthInsuranceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_53d91c60-e10b-4686-afc0-3fcffd5d9043_verboseLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:to="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ba5cfbdd-42e7-49bf-850d-a0a4a17d1656_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2907a1fc-9f17-437c-9856-114460c8f630_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_bc178df1-530d-486b-8c98-ac32c373e027_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_3c76b8c6-f9ba-4ac7-af74-6e02d5b2936a_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20200930.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6952ee0b-9c5a-4f3e-af8b-7942fe8c9904_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_241a1d7f-c551-4165-b553-c10331ac88c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a8c91681-c40b-4bf9-9f9a-7865861cd0e1_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_5dfd01bc-724e-418a-9510-7470b20994e7_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_0fb0ff1d-fea9-4da8-b972-58c8d2923771_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_bfe09150-a7e5-4ec7-be71-3ba78db2782d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on divestiture, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_a75c0059-bcec-4fd9-90d1-21cf13340929_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.125June2021Member" xlink:to="lab_cvs_SeniorNotes2.125June2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7aecc530-ac56-4b60-b912-d5f38873ca65_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_cf5127f1-0638-418b-8c7a-c7932295db45_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_61558167-d427-4528-895d-5af099f27e1b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_50bfa477-ebae-48f2-ba98-cc34eb066509_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1b3790b6-0645-4d53-a5ce-f76ed6806a9f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_01eeda75-f84b-486c-bac3-b25aba30612d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_20ada4da-98ae-4911-bf23-c25ef5332113_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:to="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b43c78fd-d231-467a-b899-23e237993097_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_26030e18-502d-493b-ae54-9831646b85a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_9bc0fccb-e3bf-4854-be16-27e55488eb97_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a9e9bc46-84dd-4d17-8d50-c8e40ff7c56b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_f85efd8f-1ae6-4afd-bddd-e6b8ba302f07_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_9a70a429-ba96-4960-8b79-de2cd6281180_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20200930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_65f2af69-0700-4093-81a5-735eb145e37c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_37056421-a702-4db4-a21b-01edeadab59f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_0436fa1a-2a76-43d6-845a-15fa0ebb2e60_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20200930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtExtinguishmentFees_aba8a74e-6ce0-42c5-aefd-453e23fb9511_terseLabel_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_label_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtExtinguishmentFees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_documentation_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtExtinguishmentFees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees" xlink:href="cvs-20200930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtExtinguishmentFees" xlink:to="lab_cvs_DebtExtinguishmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_25699072-4582-4f5b-b20c-62dc84242a89_terseLabel_en-US" xlink:label="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of retail pharmacy stores</link:label>
    <link:label id="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_label_en-US" xlink:label="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Number of Stores In Subsidiary Sold</link:label>
    <link:label id="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_documentation_en-US" xlink:label="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Number of Stores In Subsidiary Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:href="cvs-20200930.xsd#cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:to="lab_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_6b5771cf-2e81-4155-bd14-78174ad22f37_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20200930.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d28bc5cf-9c87-45e2-aa89-404277f5337f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_7950b5f8-db6b-4eb3-bbea-3d28dbc91833_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due July 2020</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due July 2020 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due July 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJuly2020Member" xlink:to="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_64ff83be-6fa3-43cb-9c3f-e60d5f9cb4f4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,309 shares outstanding at September 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_0250dbd1-5e49-4b55-89f0-324a952cb966_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_fad9b3e5-85eb-42bc-8f16-ed37cf5cb8df_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_b5807e53-00fa-4637-be01-7f0fc0f1fb10_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_cfb631b4-d7d8-4f6f-a233-1660db6bd6ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_819d501f-dda8-47f7-9c10-f54da14656e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_7d0eb51b-669f-49b4-9963-c30c6e718ee7_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_bc7a5b1a-4f83-4406-9384-446cc5bdeef1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_209bd158-e0b2-4cd7-b0a9-c191c4153e1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3dd19f94-c2af-4264-999d-8e7e442c085f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a4186ea-5c9e-450e-8e9f-cca795b939cf_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_09b4e467-88ae-4afb-9ea3-1d12d5a94c65_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_0fef5699-9260-42a3-ac00-44e949e09f5e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b71fb492-7016-47d8-8c0b-b428b00ac90f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bb37a551-e7c6-4278-93b5-c06cda5825f2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_00fd3266-88c4-4a9a-a130-e430dd536ca0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_4054e612-798b-4d3e-97c9-fc73cf420714_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a221a1ae-8600-47ee-b137-379fd28722e9_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0fa1de62-d962-4d62-99b8-3f1a912c6e77_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_286ccbbf-8335-47cf-bc4b-5234db69b0b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_4c025386-b42c-492e-a9eb-b1d405880b47_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_e1c892fa-aa2c-4c40-972c-e05d44b403dc_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_17cb0796-cef3-41ac-96cc-8dc2b98d1fee_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_8cd4e0fd-e821-4db9-ba1c-d55f13b55265_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_856eee4f-1970-4022-b935-b361c65fea3e_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1ab8ceed-f3a1-4881-82b2-1021e18b220e_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_042904c7-d177-4e28-ba9d-778af14dd5d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_6827d628-93be-4926-8155-0e2a1aa087b1_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_6e5252a3-1b80-47f8-8f39-1973f9ffded0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0f9b9638-76da-4307-9044-30b10bc8af64_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_24f6d365-1bad-42d8-a6d2-f77833faeaa7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e1b10e0c-9083-4459-83ea-83295a35f430_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f8310b4e-c11f-4948-ad9c-5e00d37874d0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f39e3489-5d0b-4556-8ff1-7d12ff671b38_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e4ca434a-feba-4b93-8e2f-d6d325472199_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8170d93a-5c12-4c15-981a-03a7c382e535_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a906ba6e-fe5d-45d0-a389-bf7386801f7a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_5b4e706c-4fbb-476e-8218-4a90b4d635ae_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_4862762c-eb5d-46cb-a566-3e6c1e7759d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_3c5ffb96-9a93-4bec-9db3-54aabf523249_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7b81e69d-e7bf-47b8-9c18-6abb672d0c00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b32f6b55-a6e8-4850-8ba9-a893b7342619_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e2d1354-0abc-4a65-8fa4-c569a7053a4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a6888cc0-3a1f-4c25-9745-8585ce0e3139_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_fbc0263a-7a05-433c-b532-f6b610e11e73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_683dba2e-ac45-483d-a47f-0eacbc4ef48b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f8521ed5-bbc7-4b9c-876b-a59746185260_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b7a2e70f-96aa-465c-b6b3-e9e984821adc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c527cd61-938e-4937-8034-30a7f9242db3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3996754a-48a6-45da-bd53-c8e21451ab9e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_579d76ae-5b47-4e27-95f0-eed3815132de_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_8081bc80-fa50-464d-805d-4b5d578d8485_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20200930.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e38656fe-2b6e-40a0-94e0-4e404e76c37b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_2e0cf481-132e-4b6f-b148-042abe2809dc_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_a8846a7b-ce5f-4410-8cbe-d0c8bb34a839_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_002fdab0-467e-4283-81d3-cda8acc568eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_3e93922c-972f-48e5-b892-248c6c5a54b7_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20200930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e838a70d-1b41-4739-94f8-67f5a0671525_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0736add3-bb0c-4169-ab6f-f2b3e71cddd0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1e7691b3-c5f7-4e86-a33b-72ea8bc1f153_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_65eba6af-ce29-449f-ad7a-2bbda289c1da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_3f0de906-0f45-4235-8d59-9095de7d77a3_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Internal Credit Rating</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20200930.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_67ed4258-b390-484d-a611-d5fd32c17e3e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StoreRationalizationCharges_41cc921b-13d5-424c-847e-995a3bc51e7f_terseLabel_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store rationalization charges</link:label>
    <link:label id="lab_cvs_StoreRationalizationCharges_label_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Rationalization Charges</link:label>
    <link:label id="lab_cvs_StoreRationalizationCharges_documentation_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Rationalization Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges" xlink:href="cvs-20200930.xsd#cvs_StoreRationalizationCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StoreRationalizationCharges" xlink:to="lab_cvs_StoreRationalizationCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_8b0c2506-5c2c-417c-861f-e6ec745602a3_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_583233b2-7f42-4c39-b7bc-76a270d04dfe_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_03d2f6ce-cbca-41bb-a445-812f94c2875f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_d5328544-9b3b-40c8-8c2c-148326637c45_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2ed4cb7d-3556-4150-a3e2-cb2410dd2b56_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5fc08f03-65b2-4ce5-b217-5e3ad3320443_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f24e11d0-25d4-473f-bf8d-d91b472da986_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d3ab5d03-45a2-4202-ae63-d1f27e935fbe_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6858a98c-0827-4f0e-a3d8-6f2920b32392_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_806975a8-d875-41e6-adc8-982655a2e63c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_bfd9ae30-ae19-47a5-91ec-2c61b208e457_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_4d57337a-4826-465f-bc95-2fbcbbc23c62_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4ac5f29c-1541-4991-8fd8-5359b8ec5e97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_32ed923d-eaef-4157-9a56-2b1975d3376d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_227c389c-18e9-466e-8f34-903d2dca6bf8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5101aed1-3b1a-4003-8903-0615854558a3_terseLabel_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation business</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_label_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_documentation_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:href="cvs-20200930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:to="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_955af28e-60a0-49b7-ba6d-09585a2380b2_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_71bc6652-b233-40ca-a5e2-c3df07891616_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_a5227a65-e85d-4423-a451-4f73627cae24_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_fae2071a-4ee7-4142-82fc-dc0b722c01c6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_7ed9a479-b4a6-483e-82f2-0894657c92a1_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20200930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_fb14e853-130e-444e-807e-17a635dba1a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_6d6c1e6d-0d74-44a5-b840-e931eaf04bdc_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_39f42be7-fd19-4dd1-a001-8ff53d000c1c_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_cf48de1a-6fab-4cd0-8211-2a60856d1f2a_terseLabel_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember" xlink:href="cvs-20200930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2016RepurchaseProgramMember" xlink:to="lab_cvs_A2016RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_9c0ea827-6d2c-4c04-9cbb-86787d8fbdf3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_f54be07a-fae6-4e0b-9bf4-ce8706b4d865_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_900cc820-8ed0-478c-80ba-fd0bc0ec38f8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_c5cea35a-8403-47a5-a3fe-b88003a7ade5_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_ee68d301-8e5e-4939-a427-5839d8c5a4dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 423 shares at September 30, 2020 and 425 shares at December&#160;31,&#160;2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a5778b15-8abb-4ffe-89d6-930b3504549d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_c0ab860a-9483-4efb-b256-b8c716de490d_terseLabel_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross and Blue Shield of Alabama vs. CVS Health Corporation</link:label>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_label_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield Of Alabama, Et Al. V. CVS Health Corporation, Et. Al [Member]</link:label>
    <link:label id="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_documentation_en-US" xlink:label="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Cross And Blue Shield Of Alabama, Et Al. V. CVS Health Corporation, Et. Al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:to="lab_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_c05441de-7c4c-4f9e-bc3d-f9d5ef68ea58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_8e7d941c-692b-48bd-8c3f-ce39350b570a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_15b667bd-5990-4159-a1b4-63d383b4f1b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_b382e52d-23c1-43b6-8f18-eae8a28ebea8_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_4206d1b6-6717-4288-b3b0-16ea7b0ed093_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f805396c-3bea-4851-9736-7189816c77de_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_1bb3fc80-08f1-4789-bada-28c28fce50fa_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0cf13f45-f0b0-4be4-9491-258503b606d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_622cf726-0715-48b8-860c-d6198ceda866_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_578f4d21-b21b-4327-a058-ebdbb9dc608c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>cvs-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:28fcd7e0-4fba-4d1a-aa28-a971cc61c70d,g:d2608d95-d2ba-4800-8576-22f7caca4894-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8e793d2a-e8b1-48de-b3fd-da4e0be55fb0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentType_8e793d2a-e8b1-48de-b3fd-da4e0be55fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9c9d0221-b494-4a9d-bdfe-88cd3e7f1cc6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentQuarterlyReport_9c9d0221-b494-4a9d-bdfe-88cd3e7f1cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_05f3b5e5-a2fc-4e85-af87-815018f9fe1d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentPeriodEndDate_05f3b5e5-a2fc-4e85-af87-815018f9fe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_18fddfd7-fe65-4d4f-a8a8-40def0cad9a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentTransitionReport_18fddfd7-fe65-4d4f-a8a8-40def0cad9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3b32a23a-b76b-44c7-8856-fadcfec34890" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityFileNumber_3b32a23a-b76b-44c7-8856-fadcfec34890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7cdc0f6b-473f-46e4-9f9c-302ede2ea8b5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityRegistrantName_7cdc0f6b-473f-46e4-9f9c-302ede2ea8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_536d59d4-a2c4-408b-bd1f-168a38cb899e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityIncorporationStateCountryCode_536d59d4-a2c4-408b-bd1f-168a38cb899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c0fdb05c-2b0f-4e5f-8e26-d2fe92258a06" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityTaxIdentificationNumber_c0fdb05c-2b0f-4e5f-8e26-d2fe92258a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7d1edf12-156b-4620-a546-95aa3966869a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityAddressAddressLine1_7d1edf12-156b-4620-a546-95aa3966869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cfc39d70-a97e-4c90-9621-cbb4bf262da2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityAddressCityOrTown_cfc39d70-a97e-4c90-9621-cbb4bf262da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0ec458a4-a4f0-45ff-9b95-a2e8e7214c6c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityAddressStateOrProvince_0ec458a4-a4f0-45ff-9b95-a2e8e7214c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7d1a089a-80ba-4c23-8913-0c22fba1ed14" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityAddressPostalZipCode_7d1a089a-80ba-4c23-8913-0c22fba1ed14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0fce6481-67d7-4adf-aede-6d79504a936d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_CityAreaCode_0fce6481-67d7-4adf-aede-6d79504a936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_757670d1-1c45-4b63-b8d1-5d247280ae45" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_LocalPhoneNumber_757670d1-1c45-4b63-b8d1-5d247280ae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef325761-8334-4c9c-af32-8825cf1c980a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_Security12bTitle_ef325761-8334-4c9c-af32-8825cf1c980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c247640d-8946-4481-a8f9-24c7ec943837" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_TradingSymbol_c247640d-8946-4481-a8f9-24c7ec943837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6a4a8fc6-3b47-456a-87f9-7ce8e6dd1df0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_SecurityExchangeName_6a4a8fc6-3b47-456a-87f9-7ce8e6dd1df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_73cf58b4-781f-4550-93cb-c1b3e90ab551" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityCurrentReportingStatus_73cf58b4-781f-4550-93cb-c1b3e90ab551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4db1928e-f388-4026-a2c4-58f69c42243b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityInteractiveDataCurrent_4db1928e-f388-4026-a2c4-58f69c42243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f579c900-fca3-4fe5-b546-7f9a38a077b5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityFilerCategory_f579c900-fca3-4fe5-b546-7f9a38a077b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fddd6c40-e67f-42cc-bc4b-7fceb6b04263" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntitySmallBusiness_fddd6c40-e67f-42cc-bc4b-7fceb6b04263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a6a03226-6318-42ea-bc0f-f1f0230c8813" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityEmergingGrowthCompany_a6a03226-6318-42ea-bc0f-f1f0230c8813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f70d4857-c169-42de-aa0a-8229c4541cc5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityShellCompany_f70d4857-c169-42de-aa0a-8229c4541cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7dd9f2b7-a99b-4de6-8db5-d5f86c009b6a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7dd9f2b7-a99b-4de6-8db5-d5f86c009b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_65a1bc67-0fa2-4de6-8a52-c573c5f5a3b9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_EntityCentralIndexKey_65a1bc67-0fa2-4de6-8a52-c573c5f5a3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_400614fd-5c2e-40f5-bd39-9d502b635563" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_CurrentFiscalYearEndDate_400614fd-5c2e-40f5-bd39-9d502b635563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5e9eddf6-37b8-4356-8453-af765ef7761e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentFiscalYearFocus_5e9eddf6-37b8-4356-8453-af765ef7761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4ffa2da7-711d-4764-bc85-78ffda97a4f0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4ffa2da7-711d-4764-bc85-78ffda97a4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_432b3444-7ba4-4b99-9a24-d3c4c70cd106" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_074b1db9-e708-4f42-96e9-9ae3ade200fe" xlink:to="loc_dei_AmendmentFlag_432b3444-7ba4-4b99-9a24-d3c4c70cd106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_83b4fe20-48f8-4bd7-9bf3-0bec6a362112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_83b4fe20-48f8-4bd7-9bf3-0bec6a362112" xlink:to="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:to="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f6f16c92-e157-43e1-a9f5-210a86864a7f" xlink:to="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_fcca571b-7521-4449-9f96-9e132adf4afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:to="loc_us-gaap_ProductMember_fcca571b-7521-4449-9f96-9e132adf4afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3fb5d9ad-91ef-45ae-b3d2-2dea192375f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c8383bb-ff61-4b64-87fd-df911801328a" xlink:to="loc_us-gaap_ServiceMember_3fb5d9ad-91ef-45ae-b3d2-2dea192375f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4286403b-f8f7-47b3-9f0a-80062fe7be32" xlink:to="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed417a5-27ac-494f-81bc-ee045617876f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8ed417a5-27ac-494f-81bc-ee045617876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5fd834a5-10c1-48ec-a699-a79bb3e676f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_PremiumsEarnedNet_5fd834a5-10c1-48ec-a699-a79bb3e676f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_f77491bf-6473-4451-9de6-eaa08d9d1dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_NetInvestmentIncome_f77491bf-6473-4451-9de6-eaa08d9d1dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bdaf78f7-9e52-42fe-ada4-b395f41ea242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d35141ad-011e-4e65-882c-9df3a18edee1" xlink:to="loc_us-gaap_Revenues_bdaf78f7-9e52-42fe-ada4-b395f41ea242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4a668fa6-5d9b-49e2-9dfa-3696affaf955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4a668fa6-5d9b-49e2-9dfa-3696affaf955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_e99c271c-282b-4ec2-8525-cd8898e5c348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_e99c271c-282b-4ec2-8525-cd8898e5c348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1efd46de-3a7d-499a-a686-843ddbc19d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_OperatingExpenses_1efd46de-3a7d-499a-a686-843ddbc19d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7cf80423-939a-42a2-a945-092069780816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_9df26f40-71fb-45b5-b11b-765287088947" xlink:to="loc_us-gaap_CostsAndExpenses_7cf80423-939a-42a2-a945-092069780816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_33b270bc-ece4-4e0f-9d8d-25b0d25af2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_OperatingIncomeLoss_33b270bc-ece4-4e0f-9d8d-25b0d25af2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8fef87cb-b1eb-4189-a43b-ec506d70d760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_InterestExpense_8fef87cb-b1eb-4189-a43b-ec506d70d760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8655ee14-965e-4868-b925-09819990c609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8655ee14-965e-4868-b925-09819990c609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_31b3bbaa-cb89-422c-abde-cabc86ceb992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_31b3bbaa-cb89-422c-abde-cabc86ceb992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d9b4eab5-b0ea-4c67-b9d3-c1d253b05aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d9b4eab5-b0ea-4c67-b9d3-c1d253b05aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_28fbb76c-1efb-4b2e-8f2f-a31dd5288ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_28fbb76c-1efb-4b2e-8f2f-a31dd5288ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89223bda-d2e5-4401-83e2-349f3793d016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_ProfitLoss_89223bda-d2e5-4401-83e2-349f3793d016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b216ff2f-7865-4844-ad48-d4925579dcb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b216ff2f-7865-4844-ad48-d4925579dcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27ff7e99-1f0c-4510-93a8-52963b4efcb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_NetIncomeLoss_27ff7e99-1f0c-4510-93a8-52963b4efcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc8ed870-65a0-4a9f-8714-57086588ea1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:to="loc_us-gaap_EarningsPerShareBasic_cc8ed870-65a0-4a9f-8714-57086588ea1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_447426b3-5662-47f0-8e9e-f98be4e03e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8ea8450-dfca-4603-a7ba-d10ab86c6044" xlink:to="loc_us-gaap_EarningsPerShareDiluted_447426b3-5662-47f0-8e9e-f98be4e03e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f879c171-5c11-46aa-a9cc-5f5311e3d169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f879c171-5c11-46aa-a9cc-5f5311e3d169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0aa14da1-f791-4f27-a739-2030043664f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c4933bbe-1067-4022-b207-3cbef811e365" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0aa14da1-f791-4f27-a739-2030043664f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b4630c61-f388-498c-be23-9f8c08387051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b4630c61-f388-498c-be23-9f8c08387051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_ffc62c05-c284-490c-bd0a-6bb699c9fba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1374649c-9664-4f03-812a-e42ede342f05" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_ffc62c05-c284-490c-bd0a-6bb699c9fba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_90e20070-8e47-45e0-b898-8c599f07aa75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:to="loc_us-gaap_ProfitLoss_90e20070-8e47-45e0-b898-8c599f07aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_aa7b4afa-a0d8-4051-9a14-879ac07333d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_aa7b4afa-a0d8-4051-9a14-879ac07333d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_119ed4f5-4cee-407c-ae50-8a36807c8dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_119ed4f5-4cee-407c-ae50-8a36807c8dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b21eafb-9506-47f5-acd1-529f312a5b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b21eafb-9506-47f5-acd1-529f312a5b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_22502304-5c4c-4070-aad9-4aa188afa46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_22502304-5c4c-4070-aad9-4aa188afa46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc7cd304-b08d-4c5f-b108-2688f1a7c3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d486d563-f61e-439e-a0da-a01b06f77765" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc7cd304-b08d-4c5f-b108-2688f1a7c3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_54395d69-f12f-4b11-ab34-8df0e2f9940d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_54395d69-f12f-4b11-ab34-8df0e2f9940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf9d426d-274c-4b8f-8596-ce942f811bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf9d426d-274c-4b8f-8596-ce942f811bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c968ddcf-f1c6-4001-94af-3c394c955fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_07b72674-ec4f-438e-af08-891f540e6997" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c968ddcf-f1c6-4001-94af-3c394c955fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28cc59ab-c240-434c-9054-841273924cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28cc59ab-c240-434c-9054-841273924cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6807b0ae-4af6-492e-9ccc-5d28536805c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_ShortTermInvestments_6807b0ae-4af6-492e-9ccc-5d28536805c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_77a01cee-00c4-42ba-8b0b-6152144a63bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_77a01cee-00c4-42ba-8b0b-6152144a63bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_13dbdb82-125c-4821-a237-29b98161a616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_InventoryNet_13dbdb82-125c-4821-a237-29b98161a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_af7d6c38-39c3-40c3-9338-bef3093b9cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_OtherAssetsCurrent_af7d6c38-39c3-40c3-9338-bef3093b9cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_85822244-f495-4727-af68-11e0acce8a33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_AssetsCurrent_85822244-f495-4727-af68-11e0acce8a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_22fb4e4c-3547-4ea4-ab1f-329790b1a0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_LongTermInvestments_22fb4e4c-3547-4ea4-ab1f-329790b1a0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2c56e457-9dad-4196-a3a9-0e81ea1fd7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2c56e457-9dad-4196-a3a9-0e81ea1fd7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fc95117-0b42-4225-b4b4-31327f789d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1fc95117-0b42-4225-b4b4-31327f789d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9820f0a8-4a40-49ae-9530-0df83999b920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_Goodwill_9820f0a8-4a40-49ae-9530-0df83999b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7e549c04-841e-456c-8a5f-404882ec0423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7e549c04-841e-456c-8a5f-404882ec0423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_b910edef-b2bd-4294-aeb1-aa826b1f905b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_SeparateAccountAssets_b910edef-b2bd-4294-aeb1-aa826b1f905b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c201ad0-aec0-4e3b-ad3a-b30686d081a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c201ad0-aec0-4e3b-ad3a-b30686d081a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8f963f8f-722e-43d3-a2d9-3ec026e82a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_96424bc7-0168-4626-b8ea-ff16b2589e04" xlink:to="loc_us-gaap_Assets_8f963f8f-722e-43d3-a2d9-3ec026e82a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_f3c927c7-ee8f-4ebb-82bc-17a742224fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_f3c927c7-ee8f-4ebb-82bc-17a742224fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b66445ca-4513-42d9-872e-5e75a913f875" xlink:href="cvs-20200930.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b66445ca-4513-42d9-872e-5e75a913f875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_af35af0c-43b2-4f88-954a-55950466b9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_af35af0c-43b2-4f88-954a-55950466b9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_afc91434-d63e-4c37-bbfd-74bfcdac2a76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_OtherPolicyholderFunds_afc91434-d63e-4c37-bbfd-74bfcdac2a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2ac4cd29-c6ca-4ecb-8cad-143a307f8c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2ac4cd29-c6ca-4ecb-8cad-143a307f8c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_f547f212-e52a-4213-80ba-66215ea8dda1" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_f547f212-e52a-4213-80ba-66215ea8dda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_84e41ce2-d883-4a43-a9dc-d2f242494f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_84e41ce2-d883-4a43-a9dc-d2f242494f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c7a4b0cd-2044-41f1-a7e5-8d1c14516daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c7a4b0cd-2044-41f1-a7e5-8d1c14516daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e18b08c1-2001-4597-a91d-a6b22df2ef19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_LiabilitiesCurrent_e18b08c1-2001-4597-a91d-a6b22df2ef19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a7347402-a774-416d-aaa0-6c60525af337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a7347402-a774-416d-aaa0-6c60525af337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f2d8b4de-75ca-41ae-b545-94f800c3ce14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f2d8b4de-75ca-41ae-b545-94f800c3ce14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a12ee44b-7fc1-4f00-802f-944f95180595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a12ee44b-7fc1-4f00-802f-944f95180595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_7222d372-9e7f-4010-86ae-47ff3671125c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_SeparateAccountsLiability_7222d372-9e7f-4010-86ae-47ff3671125c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_85af159a-aa32-4b6e-b092-3e7f08ba5b94" xlink:href="cvs-20200930.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_85af159a-aa32-4b6e-b092-3e7f08ba5b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f8e959cd-881b-4d95-9129-fdce2a5ee963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f8e959cd-881b-4d95-9129-fdce2a5ee963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8b1d09bf-d5cc-4e4e-bf19-02f9ab485202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_64a11a44-eeab-44fb-9b40-5be67deed5c7" xlink:to="loc_us-gaap_Liabilities_8b1d09bf-d5cc-4e4e-bf19-02f9ab485202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c38a9ba4-cac3-4b33-a2ea-c918e30b4e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_PreferredStockValue_c38a9ba4-cac3-4b33-a2ea-c918e30b4e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_b4182079-1b5d-45e7-9075-12033e4fc0fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_b4182079-1b5d-45e7-9075-12033e4fc0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_75bfed5c-7b2d-42f4-baa8-43634304ea75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_TreasuryStockValue_75bfed5c-7b2d-42f4-baa8-43634304ea75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_761432d3-6c71-48e9-acd0-737d0947603c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_761432d3-6c71-48e9-acd0-737d0947603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84cfa82d-898f-48fd-852c-e132898bcaae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_84cfa82d-898f-48fd-852c-e132898bcaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a7ec3ad6-03bb-428e-82e4-30e38e67434b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a926675-f6dc-4683-8cfc-d56ef7f80bc6" xlink:to="loc_us-gaap_StockholdersEquity_a7ec3ad6-03bb-428e-82e4-30e38e67434b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_18b9b8c8-06ca-4dff-afc7-e083c1c84b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_MinorityInterest_18b9b8c8-06ca-4dff-afc7-e083c1c84b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da116304-290c-4b8c-8515-49ff5092fd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da116304-290c-4b8c-8515-49ff5092fd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6ef86266-f8b0-46b6-a595-69e6826a8999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_42f82a00-5fc5-4d69-a1f2-6352a57465e5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6ef86266-f8b0-46b6-a595-69e6826a8999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0c5ece1c-30dd-4194-8d91-5d0b364bf48a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0c5ece1c-30dd-4194-8d91-5d0b364bf48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_98996a6c-628c-4c2f-92b9-9d53a1344646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_98996a6c-628c-4c2f-92b9-9d53a1344646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_15aa45b4-145a-49c0-aa2e-7a2e5d35b0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_PreferredStockSharesIssued_15aa45b4-145a-49c0-aa2e-7a2e5d35b0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1e294bce-7c8b-4fae-bc34-b743d69f6dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1e294bce-7c8b-4fae-bc34-b743d69f6dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_08dc36f0-c156-4b84-9f5a-ae4f299f9a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_08dc36f0-c156-4b84-9f5a-ae4f299f9a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_922644e6-5ed5-4978-846a-1a4d31a17d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_922644e6-5ed5-4978-846a-1a4d31a17d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_906eaa22-b930-452c-9cf8-6e23083e550f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_CommonStockSharesIssued_906eaa22-b930-452c-9cf8-6e23083e550f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f2950e19-3bec-40f1-b1c3-0257583f37f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f2950e19-3bec-40f1-b1c3-0257583f37f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_6bcd7457-b6d2-4211-9805-1dc1dee55503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dbfc0992-c815-45ec-bee8-19617658b278" xlink:to="loc_us-gaap_TreasuryStockShares_6bcd7457-b6d2-4211-9805-1dc1dee55503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_d5498a03-2be4-42c7-9d80-cc22e230d29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_ProceedsFromCustomers_d5498a03-2be4-42c7-9d80-cc22e230d29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_20d892fa-b6d4-4fd8-b8a8-cf594aef3bed" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_20d892fa-b6d4-4fd8-b8a8-cf594aef3bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_5662fc5b-f66f-4dfd-ad72-cb114920e2dc" xlink:href="cvs-20200930.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_5662fc5b-f66f-4dfd-ad72-cb114920e2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_d3c6011f-cd50-4cc5-a01c-a1269aee7454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_d3c6011f-cd50-4cc5-a01c-a1269aee7454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_7a8e9aca-ffe1-421b-a31c-9f39b7b1b0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_7a8e9aca-ffe1-421b-a31c-9f39b7b1b0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fff95c68-aaa1-4af2-afab-7b93e995ca5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_InterestPaidNet_fff95c68-aaa1-4af2-afab-7b93e995ca5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_4f927ad3-2c92-4417-8b88-1032c4e16aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_4f927ad3-2c92-4417-8b88-1032c4e16aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2399659b-8800-4eb4-90e4-6d3626d7a6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f55b2fa8-7361-40b2-bd88-286f154c1bbf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2399659b-8800-4eb4-90e4-6d3626d7a6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_32b0aac6-b8cc-4a5c-ae42-78f7365f9344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_32b0aac6-b8cc-4a5c-ae42-78f7365f9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_4facdbd1-8f88-4d50-8396-c22659297663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_4facdbd1-8f88-4d50-8396-c22659297663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a3f92e36-4c55-4038-aa62-4f48018745b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a3f92e36-4c55-4038-aa62-4f48018745b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_42007658-9052-4f97-8456-f3ed0f20f96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_42007658-9052-4f97-8456-f3ed0f20f96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8df41a09-d666-4ad0-bcbb-6a6786554bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8df41a09-d666-4ad0-bcbb-6a6786554bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_323b79be-5544-4b35-b5da-2d87cf8902d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_323b79be-5544-4b35-b5da-2d87cf8902d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dd864253-d02b-449e-b81b-d4baf24b106e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d5bd9f2-e26e-48d9-8c65-38a6b4a5279f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dd864253-d02b-449e-b81b-d4baf24b106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7bacb90b-256a-4cc6-8484-9cccff8b338a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7bacb90b-256a-4cc6-8484-9cccff8b338a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4ed909b7-fec2-4025-8ab6-b08409848218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4ed909b7-fec2-4025-8ab6-b08409848218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_05377ceb-000d-49dc-a713-ec459837aaf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_05377ceb-000d-49dc-a713-ec459837aaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_67375a8b-cfa6-4ee7-8f57-c5e1fd05c6be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_67375a8b-cfa6-4ee7-8f57-c5e1fd05c6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_16b2078e-ba5b-4b20-8201-3650279930cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_PaymentsOfDividends_16b2078e-ba5b-4b20-8201-3650279930cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b199fb80-6a92-43a1-82dc-7591f5285b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b199fb80-6a92-43a1-82dc-7591f5285b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_54b0b918-0c39-4bbd-a6bf-de474e1605dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_54b0b918-0c39-4bbd-a6bf-de474e1605dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a4a3651e-4ecc-43e4-9a2b-51deae705ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a4a3651e-4ecc-43e4-9a2b-51deae705ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a439a512-f602-4f10-8374-d03794c2622f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_da453efa-602b-4945-86ba-e1144ad66427" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a439a512-f602-4f10-8374-d03794c2622f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_21fe3f8d-8413-4658-b10f-65629c753d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_21fe3f8d-8413-4658-b10f-65629c753d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77ecebb-3bab-45c9-bf98-76c21de474d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77ecebb-3bab-45c9-bf98-76c21de474d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a71c828-6635-4a06-a7e7-a2a5fe22936d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a71c828-6635-4a06-a7e7-a2a5fe22936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9ad1b95-c7a3-457d-b325-a8398061fbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_338a33a8-2912-43d4-96c4-92b2f593f856" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9ad1b95-c7a3-457d-b325-a8398061fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_33c0ce06-d547-4be8-b81e-a201091dc3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9ad1b95-c7a3-457d-b325-a8398061fbce" xlink:to="loc_us-gaap_ProfitLoss_33c0ce06-d547-4be8-b81e-a201091dc3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:href="cvs-20200930.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9ad1b95-c7a3-457d-b325-a8398061fbce" xlink:to="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7a30cfe1-4e69-4c67-9ced-cf57b4862fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7a30cfe1-4e69-4c67-9ced-cf57b4862fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_602a61e1-4d62-4e74-8617-67972cc128b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_us-gaap_ShareBasedCompensation_602a61e1-4d62-4e74-8617-67972cc128b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d4c94552-5ab4-435b-add3-fea53b6a8366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d4c94552-5ab4-435b-add3-fea53b6a8366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_10e75ea2-3af0-49d2-9588-e1912b948ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_10e75ea2-3af0-49d2-9588-e1912b948ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_b977c605-02b5-4b3f-bf18-1fc1949e0eee" xlink:href="cvs-20200930.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_b977c605-02b5-4b3f-bf18-1fc1949e0eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:href="cvs-20200930.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_3f55784b-cf6d-4cca-9dc4-a7b85fcda633" xlink:to="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b0e911f1-a6a8-4aba-af27-71e58d2f5256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b0e911f1-a6a8-4aba-af27-71e58d2f5256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_51ca488a-8b42-44b2-8fcd-3bc2dfa04522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_51ca488a-8b42-44b2-8fcd-3bc2dfa04522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d09044a8-fd71-4490-8943-f670fc445aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d09044a8-fd71-4490-8943-f670fc445aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e7ebcd16-cc0e-45f7-990c-ab2a3b2cb2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e7ebcd16-cc0e-45f7-990c-ab2a3b2cb2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_94c0fc04-0779-4d6b-bf05-b9225d97fac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_94c0fc04-0779-4d6b-bf05-b9225d97fac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8d36428f-155a-49fe-96c9-c02f1a71562c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_16c4e006-99d5-4126-8750-39045be5de78" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8d36428f-155a-49fe-96c9-c02f1a71562c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8f4614db-751e-4aac-9455-fef5d913931f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8f4614db-751e-4aac-9455-fef5d913931f" xlink:to="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e4c6be4a-55e1-41f0-b5a4-e8c919239303" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8f4757db-2955-462a-bd84-6465f37c87ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6c4b42fa-0f22-4601-b06e-051f15d27369" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8f4757db-2955-462a-bd84-6465f37c87ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aaea8e28-64b9-414f-90f7-8f9aa5b7b60f" xlink:to="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_516aa994-2f62-42a0-bb48-654dda1680bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_CommonStockMember_516aa994-2f62-42a0-bb48-654dda1680bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4f45d9c0-0f8c-4d8f-9a98-be766144c464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_TreasuryStockMember_4f45d9c0-0f8c-4d8f-9a98-be766144c464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_cedc163e-225d-488b-8391-f15a7d4f42e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_cedc163e-225d-488b-8391-f15a7d4f42e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e24bca7f-edb2-4f46-b60f-768b7e388883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_RetainedEarningsMember_e24bca7f-edb2-4f46-b60f-768b7e388883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28128c2b-f932-486c-9dea-1993479feeb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28128c2b-f932-486c-9dea-1993479feeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_73465374-452f-48ec-873a-e0df7f33eded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_ParentMember_73465374-452f-48ec-873a-e0df7f33eded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_09c9c61a-9054-4faf-b01d-814b63f91d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d9649db8-2ede-4f24-b1bc-48a5fbbfff16" xlink:to="loc_us-gaap_NoncontrollingInterestMember_09c9c61a-9054-4faf-b01d-814b63f91d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0739217d-296e-4611-9bce-562578e30c19" xlink:to="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fd6bb3f4-8f81-4350-a877-8b5f08ea19bc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1ce196dd-a2d1-4d90-939c-37f21b64ce1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_SharesOutstanding_1ce196dd-a2d1-4d90-939c-37f21b64ce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_504ab561-b7a2-48b5-aa41-6d24865b35c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_504ab561-b7a2-48b5-aa41-6d24865b35c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_13facb0a-469d-44be-98f3-4ae0f0f5ef30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_13facb0a-469d-44be-98f3-4ae0f0f5ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_335fbd51-9f01-483b-94f2-b4d5b37d9bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_335fbd51-9f01-483b-94f2-b4d5b37d9bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62465891-724c-4aaf-b2a4-3a8d6f59f560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62465891-724c-4aaf-b2a4-3a8d6f59f560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b62797cf-957f-4eca-8701-825766f8935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b62797cf-957f-4eca-8701-825766f8935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_c844b32b-cbc1-4a07-9ffc-f989623f1a46" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_c844b32b-cbc1-4a07-9ffc-f989623f1a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_4b8ab0a2-6127-4de5-80cf-1a5f213cb7c1" xlink:href="cvs-20200930.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_4b8ab0a2-6127-4de5-80cf-1a5f213cb7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_5c720269-fe82-4fd9-9ff2-ba70ede3f89f" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_5c720269-fe82-4fd9-9ff2-ba70ede3f89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_03adf56e-9a50-4466-b5eb-5320c1687edb" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_03adf56e-9a50-4466-b5eb-5320c1687edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_a4b8e178-ff10-4fcb-b9e4-acca99eff71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_DividendsCommonStock_a4b8e178-ff10-4fcb-b9e4-acca99eff71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_11500db3-e816-4847-bea5-a2bccda34bd7" xlink:href="cvs-20200930.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_11500db3-e816-4847-bea5-a2bccda34bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9c0cd646-6d16-4402-a486-422b47cf6c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_SharesOutstanding_9c0cd646-6d16-4402-a486-422b47cf6c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dfa8abd-358b-444d-885f-695b28ff0d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_70d5fcd5-7a4a-441b-8b62-26c0e3299078" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8dfa8abd-358b-444d-885f-695b28ff0d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20200930.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_68c60124-b7d0-448b-a6c1-83cb98c59e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_68c60124-b7d0-448b-a6c1-83cb98c59e3e" xlink:to="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d3ed85d0-3fc0-4170-8e90-5b88d7c8d0b8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2654ac0a-974b-4a12-b59c-5cfece735f17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e2bd601-292f-447e-83e7-4086696762f8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2654ac0a-974b-4a12-b59c-5cfece735f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0fe1bfc-e932-4c3f-b087-2cdca4fb5b38" xlink:to="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_67f2542c-222f-407c-8570-1e593b7cae30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_919c7c13-017f-4c18-835d-2da5e9e08a79" xlink:to="loc_us-gaap_RetainedEarningsMember_67f2542c-222f-407c-8570-1e593b7cae30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec3c5410-709b-4293-bba7-ae40f3e85e3e" xlink:to="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_7720cb62-f85e-4326-95b6-ebecb9f84dde" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_7720cb62-f85e-4326-95b6-ebecb9f84dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_572d2348-be43-4471-9cf0-fa3549a35143" xlink:href="cvs-20200930.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_572d2348-be43-4471-9cf0-fa3549a35143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f5786ef1-dbb0-4896-92a7-984ee3b1e465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_CommonStockValue_f5786ef1-dbb0-4896-92a7-984ee3b1e465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57c105cb-24cc-4ae4-ba79-7ed541647199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57c105cb-24cc-4ae4-ba79-7ed541647199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_689c0e5c-2d64-4896-b308-5a1f881bfbba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc859bbf-bd4c-44e6-8fc8-94ee4c8fdcc4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_689c0e5c-2d64-4896-b308-5a1f881bfbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d8b24a23-2acc-4dce-8af1-c0e1ac6c9e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bb4be69f-6bb6-4b9f-a156-fad8be653b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8b24a23-2acc-4dce-8af1-c0e1ac6c9e6d" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_bb4be69f-6bb6-4b9f-a156-fad8be653b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_d1623f74-de11-4ae4-964e-1d5d290aec12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_d1623f74-de11-4ae4-964e-1d5d290aec12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab9695a8-5ee3-434b-879c-78f1042c48f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab9695a8-5ee3-434b-879c-78f1042c48f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_b48a355a-c612-4133-adf9-635121807582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_b48a355a-c612-4133-adf9-635121807582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_28fadcaa-7522-460d-b2ab-8762e7e4bbfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_28fadcaa-7522-460d-b2ab-8762e7e4bbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_090fcbcc-c000-4178-96f2-2fdb136ab38e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_090fcbcc-c000-4178-96f2-2fdb136ab38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_739e8d3e-51b5-4b38-9883-157fc6f6cb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_739e8d3e-51b5-4b38-9883-157fc6f6cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ed534cb3-bd33-41b6-9c5e-d32527768356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ed534cb3-bd33-41b6-9c5e-d32527768356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_292a2772-5346-4df9-b348-f02086372376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_292a2772-5346-4df9-b348-f02086372376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_435e8a30-6ede-4b59-812d-a5c75289d826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_435e8a30-6ede-4b59-812d-a5c75289d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_77860d1b-512b-41d4-818e-17d80140d9de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_77860d1b-512b-41d4-818e-17d80140d9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_08f99070-0f29-4cc7-a71c-27f7255590bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfa28109-d775-43f5-8e09-23082edf34b7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_08f99070-0f29-4cc7-a71c-27f7255590bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f05d3db4-45da-4aa4-830e-f59b08825814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_909fc877-458a-4dca-afec-0244605ba77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f05d3db4-45da-4aa4-830e-f59b08825814" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_909fc877-458a-4dca-afec-0244605ba77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_11a3b292-e414-41d8-9706-3fe3ac6bf71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f05d3db4-45da-4aa4-830e-f59b08825814" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_11a3b292-e414-41d8-9706-3fe3ac6bf71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_cd6e38bb-b55b-49ff-a572-13942d474c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f05d3db4-45da-4aa4-830e-f59b08825814" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_cd6e38bb-b55b-49ff-a572-13942d474c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2aed3973-f45d-4125-9b96-25efe154fabe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f05d3db4-45da-4aa4-830e-f59b08825814" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2aed3973-f45d-4125-9b96-25efe154fabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c492da3b-4b1a-465b-b1ab-02b8840d7828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c492da3b-4b1a-465b-b1ab-02b8840d7828" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8c3de2a0-4e5c-4ba9-97af-af986f98204e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_5bdee53b-bf97-44d5-8776-3d754ba4b3f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1635feeb-dff3-4240-909a-a49ea43d17ac" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_5bdee53b-bf97-44d5-8776-3d754ba4b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba59170-f13f-4e85-9edf-70c83daa2ca2" xlink:to="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ec9ae920-7961-4d84-936c-33e3072e3fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e7b726d-2083-485f-b9e6-353c8974d6d0" xlink:to="loc_us-gaap_RetainedEarningsMember_ec9ae920-7961-4d84-936c-33e3072e3fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c13ba36-3eae-479c-898c-9aaedbfebea7" xlink:to="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_c0dc7864-ae91-4f09-bd55-ca04c181a845" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_c0dc7864-ae91-4f09-bd55-ca04c181a845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_94008beb-cdc4-4135-baef-c250b6e8f187" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b71dc302-ad2e-4733-b55e-5262349efbc7" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_94008beb-cdc4-4135-baef-c250b6e8f187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1cb23a10-8538-428f-b736-d56d5c84e031" xlink:to="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_3ca642fd-e2cf-43a5-8d3a-e6da5c2e3b03" xlink:href="cvs-20200930.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a7c8ed9f-607e-48ff-9f45-642d5c1171b6" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_3ca642fd-e2cf-43a5-8d3a-e6da5c2e3b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_054631b7-78a2-4b82-b24a-c04fd6855c4f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_b2be763e-3078-4f32-8cdf-f1d830f6dc9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfStores_b2be763e-3078-4f32-8cdf-f1d830f6dc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_61e1cc71-cab8-4254-a1c0-49a101d2a097" xlink:href="cvs-20200930.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_61e1cc71-cab8-4254-a1c0-49a101d2a097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_0819fea7-c265-49ac-b9b3-e5aca5005de9" xlink:href="cvs-20200930.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_0819fea7-c265-49ac-b9b3-e5aca5005de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_72c9f52f-f9ba-4bff-8b52-548bc0b80d19" xlink:href="cvs-20200930.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPatientsServedperYear_72c9f52f-f9ba-4bff-8b52-548bc0b80d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_5d4ec761-09cf-47cf-a4bc-a469b8379fda" xlink:href="cvs-20200930.xsd#cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices_5d4ec761-09cf-47cf-a4bc-a469b8379fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ffff041f-e4ea-48ea-a48d-45bece6abfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfReportableSegments_ffff041f-e4ea-48ea-a48d-45bece6abfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6cabc8ee-795e-4aa9-b96a-50175539ea50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6cabc8ee-795e-4aa9-b96a-50175539ea50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_04138b3a-5f64-4a8a-980a-b19a1545ea66" xlink:href="cvs-20200930.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_HealthInsurerFee_04138b3a-5f64-4a8a-980a-b19a1545ea66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NonTaxDeductibleHealthInsuranceFee_0e198c0a-b21b-4492-98f5-62510dcf0566" xlink:href="cvs-20200930.xsd#cvs_NonTaxDeductibleHealthInsuranceFee"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_cvs_NonTaxDeductibleHealthInsuranceFee_0e198c0a-b21b-4492-98f5-62510dcf0566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_599cf154-7296-48fc-9476-b838b2ba4a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_599cf154-7296-48fc-9476-b838b2ba4a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3c3615a3-a4f7-4e01-9056-a0e7ba20ba31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3c3615a3-a4f7-4e01-9056-a0e7ba20ba31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_8f2a7881-52c9-4d18-8724-e2e3b9c4c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_8f2a7881-52c9-4d18-8724-e2e3b9c4c7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2b5fa3a7-2e81-4342-8cbd-01a2f6a2ceca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2b5fa3a7-2e81-4342-8cbd-01a2f6a2ceca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_2ffd1a13-5547-48e1-8207-538396a60fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList_2ffd1a13-5547-48e1-8207-538396a60fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9489ca47-67e4-4be6-abe5-83ec7b11fd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_487a1472-d29a-4a6c-9801-e69066863579" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9489ca47-67e4-4be6-abe5-83ec7b11fd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_108fe74d-1019-4b92-ad40-5c86afc33a8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ea7f691-7d7a-4eb5-93b1-55eace8716b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_108fe74d-1019-4b92-ad40-5c86afc33a8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ea7f691-7d7a-4eb5-93b1-55eace8716b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ba9ef035-693a-44b6-a6b3-c05e520077fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_108fe74d-1019-4b92-ad40-5c86afc33a8b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ba9ef035-693a-44b6-a6b3-c05e520077fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c7889667-3d55-4a1f-9347-12a919c8fb1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_108fe74d-1019-4b92-ad40-5c86afc33a8b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c7889667-3d55-4a1f-9347-12a919c8fb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_498dbf50-9c4d-468c-bdd2-88b7f04778be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_498dbf50-9c4d-468c-bdd2-88b7f04778be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_9b839058-4762-495c-a36b-aa52fdd2677b" xlink:href="cvs-20200930.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:to="loc_cvs_VendorandManufacturerReceivables_9b839058-4762-495c-a36b-aa52fdd2677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_37fbd783-0bc8-4c50-b6aa-d09572a60e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_37fbd783-0bc8-4c50-b6aa-d09572a60e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_3e97c905-2c3c-45bf-a525-c45897b60145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_3e97c905-2c3c-45bf-a525-c45897b60145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_994ab8d4-f0d8-4754-a532-86e4cc5ff1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b043ed5-8200-4a50-bbf3-9fc35484b99d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_994ab8d4-f0d8-4754-a532-86e4cc5ff1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bcf1206d-a883-4bf5-84a2-1bb169e01930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bcf1206d-a883-4bf5-84a2-1bb169e01930" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b41e4010-49be-44a9-8ada-f74a079ed8d4" xlink:to="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a77e89da-5bc2-4d3e-a1ad-5344f5fae8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:to="loc_us-gaap_OperatingSegmentsMember_a77e89da-5bc2-4d3e-a1ad-5344f5fae8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_c5f08eb1-fc96-4782-9b96-c2eea6c63506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5ec86a03-0488-4686-bf46-5000c7fce0a9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_c5f08eb1-fc96-4782-9b96-c2eea6c63506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_7af73ffc-a978-4567-82ac-fa376ccb59a7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_bedcc4e0-eeb0-4eb9-b0d8-00141d5cbeb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_bedcc4e0-eeb0-4eb9-b0d8-00141d5cbeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_727b723a-238f-42da-bce1-fd2585e889fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_727b723a-238f-42da-bce1-fd2585e889fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_98d6aa66-e438-4126-9217-91fc4c584468" xlink:href="cvs-20200930.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d3bbb7f7-a9cc-4fd7-91bb-6984d49bcef9" xlink:to="loc_cvs_SalesChannelOtherMember_98d6aa66-e438-4126-9217-91fc4c584468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_93165c02-0a40-45e0-b221-b257adffe9f4" xlink:to="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_9993154f-d55f-44f5-8a55-54827663dff7" xlink:href="cvs-20200930.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PharmacyRevenueMember_9993154f-d55f-44f5-8a55-54827663dff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_fa0697c2-445b-426b-8fbe-e78623f51860" xlink:href="cvs-20200930.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_FrontStoreRevenueMember_fa0697c2-445b-426b-8fbe-e78623f51860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_a64e9aba-c0ae-48c5-b843-4aebbe5d0e6b" xlink:href="cvs-20200930.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PremiumsMember_a64e9aba-c0ae-48c5-b843-4aebbe5d0e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5f39d3d2-ed8f-423f-80da-4fb1110e325c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5f39d3d2-ed8f-423f-80da-4fb1110e325c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_69f14d89-1515-4628-9672-6214f76f2598" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d4a6c2ce-e9f2-4f64-99c8-f7467ec2a545" xlink:to="loc_cvs_PharmacyServicesSegmentMember_69f14d89-1515-4628-9672-6214f76f2598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41d9edd2-f567-49f9-8fe1-bc9adb11233b" xlink:to="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_f5e3cb00-c2d6-43bd-8827-2a0db75fbdf4" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_PharmacyServicesSegmentMember_f5e3cb00-c2d6-43bd-8827-2a0db75fbdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_a22ebc1c-1e12-4f59-a186-411d415081df" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_a22ebc1c-1e12-4f59-a186-411d415081df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_a86eacd9-7b45-4533-8045-f6778bb9cf7a" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_a86eacd9-7b45-4533-8045-f6778bb9cf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_8abcc163-80bc-4256-b08f-7f6f4ffbca2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6512757-8cfd-472d-bc74-ee53133fc3ee" xlink:to="loc_us-gaap_CorporateAndOtherMember_8abcc163-80bc-4256-b08f-7f6f4ffbca2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8cecc8e0-3fa0-48a3-9534-770870536b1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_363cc8ba-98e3-455a-8bf3-6e3d7fbe44ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_363cc8ba-98e3-455a-8bf3-6e3d7fbe44ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8ac46506-2280-4f1a-b633-f7dae6f2619d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_NetInvestmentIncome_8ac46506-2280-4f1a-b633-f7dae6f2619d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9e545075-bebe-4488-bed4-445e83b12aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2e07f6c-d6d1-4724-bdec-50b25a21ca88" xlink:to="loc_us-gaap_Revenues_9e545075-bebe-4488-bed4-445e83b12aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_507442d1-b4d2-4a35-b4bf-99b5e7841c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ccc8e14e-10f1-40a3-9313-be6026074faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_507442d1-b4d2-4a35-b4bf-99b5e7841c42" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ccc8e14e-10f1-40a3-9313-be6026074faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_01134398-7fca-4806-88b8-d072adb09705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_507442d1-b4d2-4a35-b4bf-99b5e7841c42" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_01134398-7fca-4806-88b8-d072adb09705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_781de60a-6e10-4ec1-bf1b-bdba0c87b73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_66e9af74-ccfd-4cfa-aff7-a7af334b2973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_781de60a-6e10-4ec1-bf1b-bdba0c87b73d" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_66e9af74-ccfd-4cfa-aff7-a7af334b2973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:href="cvs-20200930.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_66e9af74-ccfd-4cfa-aff7-a7af334b2973" xlink:to="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_beaeb422-4954-426f-8dad-20f82524c495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_beaeb422-4954-426f-8dad-20f82524c495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_fdba7917-d290-498a-af3d-123b37d6a515" xlink:href="cvs-20200930.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_fdba7917-d290-498a-af3d-123b37d6a515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_f60edc36-42f4-4494-bf2b-06c96b2948e5" xlink:href="cvs-20200930.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:to="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_f60edc36-42f4-4494-bf2b-06c96b2948e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_978d87f9-8ea1-42a2-b62a-1d80ecaac279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_82af33ea-e92a-47b4-bfd3-0e6a7a6e8d72" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_978d87f9-8ea1-42a2-b62a-1d80ecaac279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Divestitures" xlink:type="simple" xlink:href="cvs-20200930.xsd#Divestitures"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Divestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e42ff907-538f-4a1f-a0ff-b1b6ac0b4b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d8db22a4-259e-4a2d-a924-1b46b50bba4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e42ff907-538f-4a1f-a0ff-b1b6ac0b4b61" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d8db22a4-259e-4a2d-a924-1b46b50bba4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#DivestituresDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/DivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_33c79a0f-b941-47cd-99b5-69c6c98d194c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_33c79a0f-b941-47cd-99b5-69c6c98d194c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3cf9ab2e-8048-4dc4-b9f0-2606ce19e287" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6fece911-5025-43a3-8eac-e2acb59f5e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7c6946ad-600a-4ac8-ada3-c5d6f6f77f34" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6fece911-5025-43a3-8eac-e2acb59f5e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbd3ffee-8297-4c14-aa4c-d0126f37ece7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ac30bbd0-e60f-4dd5-ab0f-1153215df4dc" xlink:href="cvs-20200930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ac30bbd0-e60f-4dd5-ab0f-1153215df4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_3e5b0f32-32ab-4b26-991e-9335fe10f7d8" xlink:href="cvs-20200930.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2377fe1-7002-4ad3-bd81-3561179a2727" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_3e5b0f32-32ab-4b26-991e-9335fe10f7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_738079d8-7dd0-4157-ba9c-c2dbfd095ab8" xlink:to="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_4efbea81-b12f-40b1-b60f-697f96039f93" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_4efbea81-b12f-40b1-b60f-697f96039f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_e9288c66-3e7e-4d38-bfc1-1331bbe7d0e8" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc5a108f-4134-4c9f-815f-21847ebbc614" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_e9288c66-3e7e-4d38-bfc1-1331bbe7d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ee405afc-8f18-4958-832a-c39e466ccca9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_75b6d37d-3d72-4452-8b9a-e5aa4d5b0cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_75b6d37d-3d72-4452-8b9a-e5aa4d5b0cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_eb4ad4b7-2c6c-499b-853d-f4fbb8a3e205" xlink:href="cvs-20200930.xsd#cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold_eb4ad4b7-2c6c-499b-853d-f4fbb8a3e205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b7551937-fd1d-4f82-ba33-5fec655ed08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_b52c26d1-dec7-43c0-a0ce-fa6559e777ef" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b7551937-fd1d-4f82-ba33-5fec655ed08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20200930.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_8f608f0e-8851-424c-95c8-8c32c1652051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_defe3080-410b-4e1c-8b74-ce7572277331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8f608f0e-8851-424c-95c8-8c32c1652051" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_defe3080-410b-4e1c-8b74-ce7572277331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_83475e2d-116b-4469-af84-eed33181b730" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_83475e2d-116b-4469-af84-eed33181b730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ea48bec0-cd24-4a21-b76e-2f05e554a5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ea48bec0-cd24-4a21-b76e-2f05e554a5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ce8d7c59-2ce0-4230-8eff-a348bbacf821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ce8d7c59-2ce0-4230-8eff-a348bbacf821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_77015135-63c6-49df-a56b-69f7d0488bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_77015135-63c6-49df-a56b-69f7d0488bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_5dafa501-ff91-45c6-be6d-5853f79bca51" xlink:href="cvs-20200930.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_5dafa501-ff91-45c6-be6d-5853f79bca51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_af3a6f35-51d8-4295-a818-4ca96ca9ee4f" xlink:href="cvs-20200930.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_af3a6f35-51d8-4295-a818-4ca96ca9ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_92806cb8-6ee5-439e-af5c-253be0675622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_92806cb8-6ee5-439e-af5c-253be0675622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_e1284e90-8413-49e6-9ce3-b9ce09248452" xlink:href="cvs-20200930.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_cf83eb61-5822-43a9-936a-8d6f57efe9dc" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_e1284e90-8413-49e6-9ce3-b9ce09248452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3e013929-6464-4d6f-8c19-00dcac3c7714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3e013929-6464-4d6f-8c19-00dcac3c7714" xlink:to="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:to="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_564cc6e3-324a-479f-9086-a58a194a860d" xlink:to="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_d6fa1707-1e80-4e42-bec9-08ae8219b899" xlink:href="cvs-20200930.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_d6fa1707-1e80-4e42-bec9-08ae8219b899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_13bce264-cb50-4cc7-97d7-b08b64797447" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_cvs_MortgageLoansMember_13bce264-cb50-4cc7-97d7-b08b64797447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_78bf743b-17b4-4a96-86e2-85db7d55cf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_04de669d-913b-4dec-82ff-1d95c22e1b8b" xlink:to="loc_us-gaap_OtherInvestmentsMember_78bf743b-17b4-4a96-86e2-85db7d55cf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:href="cvs-20200930.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_6258cb8c-dc3b-4103-b06e-57c952601982" xlink:to="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9e8f8490-dca5-4def-886d-0d60936230c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_ShortTermInvestments_9e8f8490-dca5-4def-886d-0d60936230c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_a6bb0006-db5d-4ee5-a503-42c76185c5bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_LongTermInvestments_a6bb0006-db5d-4ee5-a503-42c76185c5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_fc2cd1af-5ea9-4b4d-9701-3e12b773be8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_6f2acfd6-502e-43d1-8b39-a33d8d780d46" xlink:to="loc_us-gaap_Investments_fc2cd1af-5ea9-4b4d-9701-3e12b773be8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_135fe38c-1836-463d-bcbc-17038531df0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_135fe38c-1836-463d-bcbc-17038531df0b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:to="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_75db7ba0-3709-43d9-993a-f02542fa0af6" xlink:to="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_67a5ac38-4115-4af4-b988-edc4a01df07b" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85b2edd6-8923-4841-89c6-c810496f3d82" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_67a5ac38-4115-4af4-b988-edc4a01df07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:to="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_69ecae32-eb04-47f3-b8cf-dbaf4f126db8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7fbe5399-69d7-4399-97f6-6cac86865250" xlink:to="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b4ec977-66d4-4d00-bc7c-7f9f84283ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b4ec977-66d4-4d00-bc7c-7f9f84283ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_58f64691-302e-4ff2-afcf-d557c6f1e438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_58f64691-302e-4ff2-afcf-d557c6f1e438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7db60f66-3840-4397-943e-de88b4ca149c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7db60f66-3840-4397-943e-de88b4ca149c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c2caa21-690c-415b-a86d-12e7d812060c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c2caa21-690c-415b-a86d-12e7d812060c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_348f6b2c-ed9b-429b-876f-b79e7c031cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_348f6b2c-ed9b-429b-876f-b79e7c031cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_99f3c20c-d04e-4425-ba48-baaf62167e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_99f3c20c-d04e-4425-ba48-baaf62167e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d8604f83-88d5-45ac-b36a-b23fcfd9c7e1" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d8604f83-88d5-45ac-b36a-b23fcfd9c7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_a1ca5bd3-f5ce-4161-a4fe-cdb33f1e9ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_4e6fa257-1b9b-49cd-a749-962d2a2c611f" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_a1ca5bd3-f5ce-4161-a4fe-cdb33f1e9ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b4a4d254-a215-4831-ba05-977bca3d4701" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_286229f7-ac9f-4879-a6f4-a5de7c77a0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_286229f7-ac9f-4879-a6f4-a5de7c77a0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c59ed03a-2b15-4af3-9ae0-e41c4c147d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c59ed03a-2b15-4af3-9ae0-e41c4c147d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3a971a98-d84c-467f-8fd5-234fe4c159de" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3a971a98-d84c-467f-8fd5-234fe4c159de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adec21d-757a-4ac2-bd02-9cf5e5e15af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adec21d-757a-4ac2-bd02-9cf5e5e15af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7fc79b44-e4eb-46bb-85f2-31845b414ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7fc79b44-e4eb-46bb-85f2-31845b414ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34f11a72-3dda-448c-8efb-0480c94fc758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34af4d9f-b1a9-4e92-8374-b3a6bf36a553" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34f11a72-3dda-448c-8efb-0480c94fc758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_66a84546-3c64-42c6-8e9f-74d9e47f558e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_66a84546-3c64-42c6-8e9f-74d9e47f558e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2ecd1ea8-7b6c-491d-b208-e062c5cf71cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6af6cc44-0678-4aab-9a75-997cff384ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6af6cc44-0678-4aab-9a75-997cff384ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5501da5d-0122-4678-9cf6-cffeda00a6a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_5501da5d-0122-4678-9cf6-cffeda00a6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_99615174-29fe-46d5-b606-49f35edee85e" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_df7d03e1-3963-4ec3-abfc-651520ea0a2e" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_99615174-29fe-46d5-b606-49f35edee85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_67d2b055-9ec3-4b16-80b4-7383743378ef" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_00bcce19-0608-4bb6-ad9f-ac8d1171630a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_00bcce19-0608-4bb6-ad9f-ac8d1171630a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_272ce7f1-6771-436b-aba0-92fb33f6261f" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_272ce7f1-6771-436b-aba0-92fb33f6261f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2dcfcc58-4b75-4b14-b531-23ba5624f2c4" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2dcfcc58-4b75-4b14-b531-23ba5624f2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_a55dfee5-aff8-4aa5-bba2-282b6a57954a" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_a55dfee5-aff8-4aa5-bba2-282b6a57954a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_546f4543-9dfb-4f36-ae9f-4d910be05843" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_546f4543-9dfb-4f36-ae9f-4d910be05843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2b05c2e1-2383-4c16-a977-db92ff271d43" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_8c68990e-12d5-4d06-9437-3a5e2a4a568d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2b05c2e1-2383-4c16-a977-db92ff271d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_670c698c-0264-4b54-a417-a77321ee4690" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fb8aefc-889b-4a28-96df-44598d0bfb99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4fb8aefc-889b-4a28-96df-44598d0bfb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a19b854f-b61d-48eb-a11b-479a313d55bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a19b854f-b61d-48eb-a11b-479a313d55bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e376eae-db9f-4ac0-850e-dc7c3fe0cdbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e376eae-db9f-4ac0-850e-dc7c3fe0cdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b125786e-e65b-4b22-a256-620afa94acef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b125786e-e65b-4b22-a256-620afa94acef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9a2e6b8d-d505-4c66-8087-1dbe882ea19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_9a2e6b8d-d505-4c66-8087-1dbe882ea19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_457ca826-1194-4854-a1f2-d6c512394c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66b9dd2a-3e7b-4a5d-84ea-14eb78b1aaf3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_457ca826-1194-4854-a1f2-d6c512394c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_751164eb-e39d-4d4e-8e62-64eb3ae759d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_751164eb-e39d-4d4e-8e62-64eb3ae759d8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1d4739e-4dd4-4eab-8ea5-c752e518e635" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_88a09653-48fc-4316-a7bc-40bed2259679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_88a09653-48fc-4316-a7bc-40bed2259679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ecbe3db9-b7b0-4574-8054-3d1ad2cf2719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ecbe3db9-b7b0-4574-8054-3d1ad2cf2719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_99ea3511-a457-4ea7-aaaa-42e16fbae3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_99ea3511-a457-4ea7-aaaa-42e16fbae3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4432808c-b842-4836-90c0-6a43a9fdefb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4432808c-b842-4836-90c0-6a43a9fdefb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d8d6639b-3ece-43cc-924d-866ae25dd949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d8d6639b-3ece-43cc-924d-866ae25dd949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_50c12df7-5d66-4890-937f-c97b6bd58e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_50c12df7-5d66-4890-937f-c97b6bd58e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_dee2bff7-040e-4ca1-9bcf-6a4f5b553441" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cc8f772f-5be2-4f6a-85cf-21865a420b76" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_dee2bff7-040e-4ca1-9bcf-6a4f5b553441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c0c8df5-e077-43f2-9844-61bd575530fd" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_214a0add-29fb-4a15-8c1a-82d2949757be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_214a0add-29fb-4a15-8c1a-82d2949757be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d1901d55-2b88-405b-826e-b7b0777012a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d1901d55-2b88-405b-826e-b7b0777012a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_48609c77-f983-4442-b7d2-017cc77de966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8044073c-6299-4c39-aa35-52411a3829e6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_48609c77-f983-4442-b7d2-017cc77de966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_33b9ec4f-9956-431e-97b7-bb97daa49246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_33b9ec4f-9956-431e-97b7-bb97daa49246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b1c99b2a-713c-4e68-9482-e577764810cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b1c99b2a-713c-4e68-9482-e577764810cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2e4d1510-74ec-4159-a7f8-e684da5fc207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_0e251131-f3a3-436b-a93c-eaef90860428" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2e4d1510-74ec-4159-a7f8-e684da5fc207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2e9cf72c-cb90-4344-b667-ffac6b643e0f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ea55623f-ef12-4661-9476-9f1e95adc995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ea55623f-ef12-4661-9476-9f1e95adc995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c95f3c55-bc79-4888-a58a-e6fd782ab781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c95f3c55-bc79-4888-a58a-e6fd782ab781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c3f1b56c-3081-4974-b202-b6ecac928e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_5d606c75-a0eb-47d8-baf6-0341181b5665" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c3f1b56c-3081-4974-b202-b6ecac928e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_723be043-f452-4b40-84cb-eeb15edca559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_723be043-f452-4b40-84cb-eeb15edca559" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:to="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5000b631-77d1-49be-813b-24db881e184b" xlink:to="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_8ee91271-0705-4e3f-8b8a-e24031e15ca9" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_8ee91271-0705-4e3f-8b8a-e24031e15ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_f9e0363d-01ae-4aa5-9e01-bb4f60d684fb" xlink:href="cvs-20200930.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c34fd017-0907-43e7-907b-5b63bf82e97c" xlink:to="loc_cvs_SupportingRemainingProductsMember_f9e0363d-01ae-4aa5-9e01-bb4f60d684fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a5cbbaed-c95a-4391-976b-5c1f801d2254" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d6fea9e1-e31d-4159-b6ff-39aed82e552b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d6fea9e1-e31d-4159-b6ff-39aed82e552b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2e5aa53b-2e0c-478e-a448-6f629db328a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2e5aa53b-2e0c-478e-a448-6f629db328a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_8e78ed7f-0696-475d-a168-41e8228b3162" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aec1e5be-a120-48a3-b193-699b294720c8" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_8e78ed7f-0696-475d-a168-41e8228b3162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c63ade25-8a6d-48a9-9935-5b7602ea17ef" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_c0906761-5877-4d4e-bd74-9fe97526ceb7" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_c0906761-5877-4d4e-bd74-9fe97526ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_e604f54e-3840-4faf-a5d0-bf3782286a90" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_e604f54e-3840-4faf-a5d0-bf3782286a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_bcd2d9d0-bdbf-477c-8a80-fa6b71514b9f" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_bcd2d9d0-bdbf-477c-8a80-fa6b71514b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_91c3dbad-d8f1-4f9d-be93-da0a32ccb84e" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_91c3dbad-d8f1-4f9d-be93-da0a32ccb84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_962f93ab-2cc5-4b75-837f-b46caff3ad45" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_962f93ab-2cc5-4b75-837f-b46caff3ad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ce9d076f-6135-4218-a102-5a130eb41e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ce9d076f-6135-4218-a102-5a130eb41e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4f82dd1b-c48f-4553-a206-6e07ad8ae02c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_e1a1a611-0514-456a-ad59-4758dfdab256" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_e1a1a611-0514-456a-ad59-4758dfdab256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d0fd159a-8d0c-4e71-aa6b-d7768c8cc8b1" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d0fd159a-8d0c-4e71-aa6b-d7768c8cc8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_9d816e36-9a01-407c-8079-97994542ca37" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_9d816e36-9a01-407c-8079-97994542ca37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1df86ff7-57ad-43b3-96f1-2b98c4a70fef" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1df86ff7-57ad-43b3-96f1-2b98c4a70fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0f0b2581-e287-40ee-ae80-ef5b7bc9eccb" xlink:href="cvs-20200930.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_0f0b2581-e287-40ee-ae80-ef5b7bc9eccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8b78d2c7-3362-451f-a162-993550579029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_43df1dbb-4621-42ec-bede-b8fd52a5e85b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8b78d2c7-3362-451f-a162-993550579029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3b380552-eca1-4be0-a6b0-724bb0df7343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3b380552-eca1-4be0-a6b0-724bb0df7343" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b68c8058-2441-4288-8614-1cab61942e79" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_524f4551-92e2-44a7-97fd-266d2aebecd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f06504de-6211-45a7-8e8b-8205d7aeec70" xlink:to="loc_us-gaap_CommercialRealEstateMember_524f4551-92e2-44a7-97fd-266d2aebecd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_171970b9-f987-4b85-aeec-fb2349b123de" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_043574d2-a3f2-477b-bab9-cf87d56ac371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_043574d2-a3f2-477b-bab9-cf87d56ac371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_293d0e27-173a-4640-88de-334fff07ecf5" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_293d0e27-173a-4640-88de-334fff07ecf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_7a425857-80a4-4bcd-81be-285fb60a5ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_5bc4e01a-61d3-4ce8-b750-807967e860da" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_7a425857-80a4-4bcd-81be-285fb60a5ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_380a6fa6-3afb-4dbd-9588-b068e1ffcdf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_380a6fa6-3afb-4dbd-9588-b068e1ffcdf8" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_c59b5419-5ea7-4b34-b84b-550317391192" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_d57d4f51-83f7-438e-ad28-3c5fa2113afa" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_d57d4f51-83f7-438e-ad28-3c5fa2113afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_5f2c0673-74e3-40f9-b651-7d9f0001c719" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_5f2c0673-74e3-40f9-b651-7d9f0001c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_4f4c9601-24f5-4b2a-bd08-2ea0c5f2707a" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_4f4c9601-24f5-4b2a-bd08-2ea0c5f2707a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_5f4efc8b-242c-4a2b-adbb-5569561df5c4" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_5f4efc8b-242c-4a2b-adbb-5569561df5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_fa8f58ee-3606-40d5-92cf-6ecd7c2157a0" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_fa8f58ee-3606-40d5-92cf-6ecd7c2157a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_0ba74831-5f53-4f10-a2b7-0701b68bd1b0" xlink:href="cvs-20200930.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_03975467-0f53-4df4-8f86-e8d649ee1970" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_0ba74831-5f53-4f10-a2b7-0701b68bd1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_4d79578e-88b3-4a57-a415-44ed7ee4daa5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_049822b0-6f3e-4187-a4f2-a6f8a3ab0411" xlink:href="cvs-20200930.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category1Member_049822b0-6f3e-4187-a4f2-a6f8a3ab0411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_47eafb66-b784-4d10-acbf-dc8978594339" xlink:href="cvs-20200930.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category2To4Member_47eafb66-b784-4d10-acbf-dc8978594339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_d742771f-2f3d-466f-bd28-900ad26f8c6f" xlink:href="cvs-20200930.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Categories5and6Member_d742771f-2f3d-466f-bd28-900ad26f8c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_0a5de01f-80df-4c82-b655-5b7698a0d80f" xlink:href="cvs-20200930.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_f06ee38e-c4b9-4ee6-9642-2c6956844ec3" xlink:to="loc_cvs_Category7Member_0a5de01f-80df-4c82-b655-5b7698a0d80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8adc3b4e-3b2b-4b0c-bf87-a51df17d11f5" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_c8127b17-0fb4-4d0b-b4ff-5746b66dce9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dbe0f09f-645a-4605-a282-a72d2a8f3891" xlink:to="loc_us-gaap_CommercialRealEstateMember_c8127b17-0fb4-4d0b-b4ff-5746b66dce9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable_cd420fce-6c58-459e-87cb-71b955fca0af" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_fd07e8b9-78b7-4bf1-95ac-a19352f0ba96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems_f1803119-d092-4ed6-8749-0a00a76cf03a" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_fd07e8b9-78b7-4bf1-95ac-a19352f0ba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_430d83af-fa8d-40db-8193-597ebbfe4ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_430d83af-fa8d-40db-8193-597ebbfe4ad6" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:to="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_87952ac5-a9ec-4c07-9afd-e6eb3e78679a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e303b59d-bc78-4cb3-b905-6bccc22eb064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_us-gaap_DebtSecuritiesMember_e303b59d-bc78-4cb3-b905-6bccc22eb064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_e2bc6a82-48c7-49be-aacc-863e545cc7fc" xlink:href="cvs-20200930.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_cvs_MortgageLoansMember_e2bc6a82-48c7-49be-aacc-863e545cc7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_ebd9710c-b2f5-4e59-928c-aace0cbd2067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_9a2e6e01-684f-4c7b-9010-999edc6d7263" xlink:to="loc_us-gaap_OtherInvestmentsMember_ebd9710c-b2f5-4e59-928c-aace0cbd2067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:to="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d053aef0-9645-402d-a73f-8fb8e6674a7b" xlink:to="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_d6d13b96-e0b2-4884-b76f-a64063cfbde6" xlink:href="cvs-20200930.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_14579abd-e8a9-4aff-9110-b3065089c951" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_d6d13b96-e0b2-4884-b76f-a64063cfbde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6bf28a7b-c06b-44e5-aa92-b8499ad43640" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_30124538-e07d-475d-8aac-3a420de162c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_30124538-e07d-475d-8aac-3a420de162c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_dbbb22fd-161a-4e95-aa0b-89dae8290f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_dbbb22fd-161a-4e95-aa0b-89dae8290f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_304333df-3d2f-49fc-8517-3d0a48192cac" xlink:href="cvs-20200930.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_304333df-3d2f-49fc-8517-3d0a48192cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_1aa02f2d-437c-47cd-907b-7fa09b012532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_1aa02f2d-437c-47cd-907b-7fa09b012532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_214f6c30-295e-4ae3-a49f-6ddc5479e03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_InvestmentIncomeNet_214f6c30-295e-4ae3-a49f-6ddc5479e03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f4857cec-72b6-4a19-80d8-bcc54a4d69f2" xlink:href="cvs-20200930.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f4857cec-72b6-4a19-80d8-bcc54a4d69f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_9d503ac5-06dd-4be9-ab0b-5c02d9e088eb" xlink:href="cvs-20200930.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_9d503ac5-06dd-4be9-ab0b-5c02d9e088eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_8ef1ea8a-aae8-4dff-914d-c93bbfd6c7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b2dbc9bb-2e2c-4b9f-8afd-511da0d5492b" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_8ef1ea8a-aae8-4dff-914d-c93bbfd6c7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2ec5b0b5-1b61-4ac5-8bd8-2b068d4445af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_771b050f-a5cc-4495-9924-66e83403d6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2ec5b0b5-1b61-4ac5-8bd8-2b068d4445af" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_771b050f-a5cc-4495-9924-66e83403d6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_726efd9d-74dd-48ff-bff3-ec7fbf005380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2ec5b0b5-1b61-4ac5-8bd8-2b068d4445af" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_726efd9d-74dd-48ff-bff3-ec7fbf005380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_fe4a1600-082c-4f46-9731-676fa598a2f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2ec5b0b5-1b61-4ac5-8bd8-2b068d4445af" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_fe4a1600-082c-4f46-9731-676fa598a2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_48da5191-c142-4258-81bc-9477e1b4aaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_ddec9663-f4a3-4847-bfb4-a1f2d23ce5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_48da5191-c142-4258-81bc-9477e1b4aaa3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_ddec9663-f4a3-4847-bfb4-a1f2d23ce5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_70f3cabd-9448-4a5e-b143-ac883e3db5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ae882ca0-72d3-4b11-80e4-aef776264eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_70f3cabd-9448-4a5e-b143-ac883e3db5cc" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ae882ca0-72d3-4b11-80e4-aef776264eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_adb2677a-8743-4145-ac2e-8119990b075e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_70f3cabd-9448-4a5e-b143-ac883e3db5cc" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_adb2677a-8743-4145-ac2e-8119990b075e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_3089dac4-dadb-4770-a82b-25c094455e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_70f3cabd-9448-4a5e-b143-ac883e3db5cc" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_3089dac4-dadb-4770-a82b-25c094455e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2da25828-5071-46e7-a2cf-a6da6b97b7d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2da25828-5071-46e7-a2cf-a6da6b97b7d2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f2439e92-fc91-46ee-8016-c28539dd57ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_82eaa0c0-e401-413f-8f51-4b074d95da2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_82eaa0c0-e401-413f-8f51-4b074d95da2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_cde67fe7-e293-4ee2-a9b8-4c92ddde4417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_cde67fe7-e293-4ee2-a9b8-4c92ddde4417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbf5708b-0f17-4f4a-92dc-367f6fe56ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_dbf5708b-0f17-4f4a-92dc-367f6fe56ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c26da5d-6f75-45eb-b0f1-09705c5668f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_4c26da5d-6f75-45eb-b0f1-09705c5668f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4ddeca36-13a6-4d6c-975c-840333e55925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4ddeca36-13a6-4d6c-975c-840333e55925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f012e04b-104d-42e2-8e8a-1e23433ef41f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_f012e04b-104d-42e2-8e8a-1e23433ef41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_1ac7ec3d-329a-421a-a2e8-0c3376936b97" xlink:href="cvs-20200930.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_1ac7ec3d-329a-421a-a2e8-0c3376936b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_5540a962-e54f-4bd4-a616-476f340af1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1b2d4e9d-d2e0-46b3-ba26-45dba83c37ba" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_5540a962-e54f-4bd4-a616-476f340af1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e23f1210-a5c8-4cac-8703-a5032f9a1222" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2adfc76a-bcd3-4053-b90f-87fdb1f5a72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea5b1409-f946-42be-8da4-60b281b4373a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2adfc76a-bcd3-4053-b90f-87fdb1f5a72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5dce41b4-6585-473f-b144-9417fbdecfdc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_93d2a583-39c6-4fcd-a84c-aa1cac9ef2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_93d2a583-39c6-4fcd-a84c-aa1cac9ef2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_93efb2f3-fe82-482f-a9fa-0faeb20a5f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_93efb2f3-fe82-482f-a9fa-0faeb20a5f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a5fec8f9-22bf-4002-aa59-e071175fcd5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5246fb01-9d6a-4db8-b2cd-4180dbe91e58" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a5fec8f9-22bf-4002-aa59-e071175fcd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8f283c0-2f2f-4d6b-9a9a-11238f2ba04e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_d3756a24-2651-457a-a730-ed487ca1145e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_d3756a24-2651-457a-a730-ed487ca1145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c1e22fa0-b4b5-49db-a350-887bc076f38b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c1e22fa0-b4b5-49db-a350-887bc076f38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16004c16-afc6-4e67-9c58-21afc1871a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16004c16-afc6-4e67-9c58-21afc1871a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_340f4d16-6032-4d7e-b2a5-5869cf54686b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_340f4d16-6032-4d7e-b2a5-5869cf54686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_69a93f4b-7d9c-4aec-91bb-589610fe5b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_949c62b3-23a0-4927-87ca-284e5713662e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_69a93f4b-7d9c-4aec-91bb-589610fe5b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_526c5947-e284-46ce-ba9a-e259587357ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_526c5947-e284-46ce-ba9a-e259587357ea" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98c6bf8d-77e3-402f-9ef2-04c24ce3953c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_14afd1ef-76f9-4143-961b-08a8acfd390d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_14afd1ef-76f9-4143-961b-08a8acfd390d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_62056239-c3df-4e0c-ab80-4466f7620783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_62056239-c3df-4e0c-ab80-4466f7620783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_35c2b1b2-3c90-4589-83e3-75a7ea6a2da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_35c2b1b2-3c90-4589-83e3-75a7ea6a2da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_0e3c7f9d-782f-4181-b730-c95b7788699f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9716bc6-67c3-4cad-a3de-a664b8cc0104" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_0e3c7f9d-782f-4181-b730-c95b7788699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b4798f1f-c9d8-424a-853e-d2ff8fbf633d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32cc4b20-c70a-4dda-a9db-009d06404d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_669e2a90-c824-4ab4-8f31-83cae9fbdab3" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32cc4b20-c70a-4dda-a9db-009d06404d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_28cac880-e529-433f-8f85-cdaef97c3c3c" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_eb3c8741-20c0-4f52-a9c2-0027da99a927" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d3b3cbe-4dd7-4623-98dc-c6b6ddd2cba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9d3b3cbe-4dd7-4623-98dc-c6b6ddd2cba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c5be33d1-341d-4f1e-830b-d9cf7f63dec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_47768868-bc11-4658-8ddb-8ea85670fcc8" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c5be33d1-341d-4f1e-830b-d9cf7f63dec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1631a981-1ef3-427b-9d82-7e0820da4247" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_8ba9772b-d7be-428a-81f6-ea8fbd6fc832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_8ba9772b-d7be-428a-81f6-ea8fbd6fc832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f8ecdd54-ee60-4163-84ab-b3bc91f68c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fb2e1667-c530-4abe-a8e9-64e2423bb54e" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f8ecdd54-ee60-4163-84ab-b3bc91f68c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b246af8-eed0-4f50-a102-8d06df24b9d4" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_4aa54c8f-e8a0-4756-a30c-102718e3e781" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_4aa54c8f-e8a0-4756-a30c-102718e3e781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_75adc229-8330-46bb-865b-8c299a9f2333" xlink:href="cvs-20200930.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_75adc229-8330-46bb-865b-8c299a9f2333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_c86ac2aa-2701-49e3-a57e-74f609822646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_84e0103b-6bbe-418f-9138-95b9aca40f8c" xlink:to="loc_us-gaap_DebtInstrumentFairValue_c86ac2aa-2701-49e3-a57e-74f609822646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_33d9efdd-d873-45aa-9ec2-80f632787ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33d9efdd-d873-45aa-9ec2-80f632787ae4" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c712402b-3026-45eb-b644-6c7b790b58ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e7f22f79-f185-4c35-9cb0-bba32a6c4dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e7f22f79-f185-4c35-9cb0-bba32a6c4dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c41a69ea-c4cb-412e-836f-7ea572b4317f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c41a69ea-c4cb-412e-836f-7ea572b4317f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_99bbcf82-5ae8-4d56-9ad4-70beea628db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_84f8a3fb-5d46-4a9f-a49e-fe8a1d331ca7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_99bbcf82-5ae8-4d56-9ad4-70beea628db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ac015ec3-acf0-4c06-a762-6069e2d18c91" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a9ea255b-7a34-4d38-94bf-2676e304c4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a9ea255b-7a34-4d38-94bf-2676e304c4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_4c803419-29ab-4937-ad61-7dd4e7f24c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_DebtSecuritiesMember_4c803419-29ab-4937-ad61-7dd4e7f24c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_87eb65f0-3fa6-4583-8397-e121a8174e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_us-gaap_EquitySecuritiesMember_87eb65f0-3fa6-4583-8397-e121a8174e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_112e3c1d-0172-4bde-adb9-f671cc405d8e" xlink:href="cvs-20200930.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6c61955b-6bde-4a34-9fd7-56ac5e413487" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_112e3c1d-0172-4bde-adb9-f671cc405d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b03114e3-c9fb-4b5d-99e1-0f296b63f534" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f82b8eb2-aceb-4154-aaab-f520496ee503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dccf12a9-bd8e-45fd-8496-69bf37fc019f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f82b8eb2-aceb-4154-aaab-f520496ee503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_b1757bf0-f69c-44ed-9563-6fef3062a385" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_2f103b69-cc44-43c8-96eb-2c8f4143242b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_5f7d7861-84e0-4023-9a04-9fbd040fb1bf" xlink:to="loc_us-gaap_SeparateAccountAssets_2f103b69-cc44-43c8-96eb-2c8f4143242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_9a1ab0ba-23e5-4838-9193-09b82250f92c" xlink:href="cvs-20200930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_c27e6e72-0f81-4e27-b368-364a4fbbe0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_9a1ab0ba-23e5-4838-9193-09b82250f92c" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_c27e6e72-0f81-4e27-b368-364a4fbbe0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_606575cd-f87e-4a8e-8a47-8abfae6d2fa2" xlink:href="cvs-20200930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_ec648753-9e0d-4f2e-8bb4-3a12bf1dddc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_606575cd-f87e-4a8e-8a47-8abfae6d2fa2" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_ec648753-9e0d-4f2e-8bb4-3a12bf1dddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_cebec4cf-eccf-471c-9a8f-d7d5fc59fa9b" xlink:href="cvs-20200930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_cebec4cf-eccf-471c-9a8f-d7d5fc59fa9b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1bfd182-834f-4354-bd86-2804c4d16476" xlink:to="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3ea84fa9-051f-40a9-a998-4656a3f84c49" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3ea84fa9-051f-40a9-a998-4656a3f84c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_eb75d38f-f6d8-48c5-82c9-9462f0603c2c" xlink:href="cvs-20200930.xsd#cvs_CorporateOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5d0ccea1-d44c-4db2-be2b-2738f680dd00" xlink:to="loc_cvs_CorporateOtherMember_eb75d38f-f6d8-48c5-82c9-9462f0603c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:to="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_79b80c01-3354-4772-abab-cd1ee9ef73f1" xlink:to="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_9a33737f-4156-4b3f-b5bf-2d5ca32a65b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c4f39a9-e5ee-45ac-a6f4-9c008e7d123e" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_9a33737f-4156-4b3f-b5bf-2d5ca32a65b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2a2b82fe-0c71-467e-84f2-9f136aa52649" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_810c23b4-3131-4931-9b6e-00542e089434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_810c23b4-3131-4931-9b6e-00542e089434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_230e6a58-7d7c-4b80-824e-1c4eb654303a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_230e6a58-7d7c-4b80-824e-1c4eb654303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_08b1034d-b6cf-4ce1-9ce7-b66f4a32c803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_08b1034d-b6cf-4ce1-9ce7-b66f4a32c803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_52bb9647-0884-493e-b25c-2e6c9777b3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_52bb9647-0884-493e-b25c-2e6c9777b3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bf24bf57-730b-415d-8784-95710642904a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_bf24bf57-730b-415d-8784-95710642904a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2e53b029-885e-4ab5-8285-dbd25de16ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2e53b029-885e-4ab5-8285-dbd25de16ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64e008f0-feb9-4175-a26e-ee1f695248f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_6b004e9d-d534-440a-b710-ac3f8d48016d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64e008f0-feb9-4175-a26e-ee1f695248f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_baf4c7a7-5450-4583-b531-f6b37753ea3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_baf4c7a7-5450-4583-b531-f6b37753ea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d3409ff5-033e-4904-b807-f82545bde284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d3409ff5-033e-4904-b807-f82545bde284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d867248b-a500-456a-a883-442234ba3ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_dd99a86a-081f-4b0a-b6aa-377c2ee6b1ef" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d867248b-a500-456a-a883-442234ba3ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_700d8790-ef08-4b9d-b6e2-7d50ddd277bb" xlink:href="cvs-20200930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_700d8790-ef08-4b9d-b6e2-7d50ddd277bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e9b0bae5-1497-495c-9f7f-566bd760154f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e9b0bae5-1497-495c-9f7f-566bd760154f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f719d188-4df5-4d22-a8cf-7514fcc419c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f719d188-4df5-4d22-a8cf-7514fcc419c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1e18008e-0291-4a17-a78c-dbeefc5a947f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_679a3d6a-e436-43ef-b8c0-5b67ebc355bb" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1e18008e-0291-4a17-a78c-dbeefc5a947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_6cacf76e-12b4-424a-9e36-65032b1cf3de" xlink:href="cvs-20200930.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_6cacf76e-12b4-424a-9e36-65032b1cf3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_573cbd10-d042-4aee-ae28-0fd4c8030b9c" xlink:href="cvs-20200930.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7d6c5fe6-0e98-4afb-8f55-537e00a0e8ed" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_573cbd10-d042-4aee-ae28-0fd4c8030b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_9564547d-335f-4eff-8c94-869590609fe9" xlink:href="cvs-20200930.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_9564547d-335f-4eff-8c94-869590609fe9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:to="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6b00e1b5-b19d-493a-be5c-1b5ad5789156" xlink:to="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_424eccba-745a-4d10-aa55-4a27b1c3bc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_60850740-0f6f-46f7-a215-68457b5ff99f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_424eccba-745a-4d10-aa55-4a27b1c3bc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_e9903cdb-02c8-4581-a1ca-002ca77aac44" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_74697098-c551-4b94-aa3e-a1d02a5d9a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_74697098-c551-4b94-aa3e-a1d02a5d9a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_b8d8cac0-8c64-475c-ab1f-2fd05ef1724a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_07cf70d8-dd37-469b-82e0-35413fe7465b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_b8d8cac0-8c64-475c-ab1f-2fd05ef1724a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20200930.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d86a75d1-ed07-4d2c-8e2a-a7edd4cf898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ce06b149-7aed-43a2-98d5-c90f26a59041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d86a75d1-ed07-4d2c-8e2a-a7edd4cf898a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ce06b149-7aed-43a2-98d5-c90f26a59041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d8d65280-2d32-477b-8c2e-744335d0dfd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_65333c1c-8d71-4c57-a6ed-d861749802ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d8d65280-2d32-477b-8c2e-744335d0dfd1" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_65333c1c-8d71-4c57-a6ed-d861749802ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bf4d2be1-11ef-4fa0-a82d-477af11ad3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf4d2be1-11ef-4fa0-a82d-477af11ad3a8" xlink:to="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2047d91f-0289-4f9e-823b-f6fe4fbac80d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_16debd3f-04df-48b2-bbdd-47569a3bde52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_SeniorNotesMember_16debd3f-04df-48b2-bbdd-47569a3bde52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_b9084074-2faf-4b08-880f-27060a7d074d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_NotesPayableToBanksMember_b9084074-2faf-4b08-880f-27060a7d074d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_a03c2a12-45da-4312-898f-197d70e6f6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3dda4bc9-075d-41b5-a23e-74e55b5c30b1" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_a03c2a12-45da-4312-898f-197d70e6f6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:to="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_127655ed-c768-4715-9ab5-524030506484" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_da0d1bf6-d695-4e1d-aaf9-1f7fea8beb6c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_da0d1bf6-d695-4e1d-aaf9-1f7fea8beb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_295ac237-2fbc-4009-9f1c-a1d5ee46531b" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_295ac237-2fbc-4009-9f1c-a1d5ee46531b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member_90192b73-e75e-4f12-a7a0-5daeb79b8a98" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.8DueJuly2020Member_90192b73-e75e-4f12-a7a0-5daeb79b8a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_e96adc15-8632-4065-b80e-a1d62b3247a2" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_e96adc15-8632-4065-b80e-a1d62b3247a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_71450e92-5679-46a4-b2fb-e9870ca4593b" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_71450e92-5679-46a4-b2fb-e9870ca4593b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_db43a16d-f4dd-4ba2-b15e-033c219e434a" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_db43a16d-f4dd-4ba2-b15e-033c219e434a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_2e0f0bd5-95b1-4a9e-8e49-96181505c51f" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_2e0f0bd5-95b1-4a9e-8e49-96181505c51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_30b45cc2-34e3-454a-8c2d-745c78832c3c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_30b45cc2-34e3-454a-8c2d-745c78832c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_b217c173-8952-4e13-8ece-1b8d4f12df4c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_b217c173-8952-4e13-8ece-1b8d4f12df4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_b550435e-4d5e-4d91-a51a-91d49c9a52d7" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_b550435e-4d5e-4d91-a51a-91d49c9a52d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_cfae9542-420c-48d0-b779-81b0f199bf2d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_cfae9542-420c-48d0-b779-81b0f199bf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_4535c431-7558-4a25-b581-1b42aad8f731" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_4535c431-7558-4a25-b581-1b42aad8f731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_ac447006-edbb-4c5f-8763-2b95560d37f3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_ac447006-edbb-4c5f-8763-2b95560d37f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_44124c60-0729-4fde-869d-c92f0bb58c7b" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_44124c60-0729-4fde-869d-c92f0bb58c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_4942b84e-d66b-4f43-bb77-9d1852495ad2" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_4942b84e-d66b-4f43-bb77-9d1852495ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_9df0d5c1-3c48-486b-8f01-03062f09807b" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_9df0d5c1-3c48-486b-8f01-03062f09807b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_d3e7c817-c359-4395-8d52-714ba225145c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_d3e7c817-c359-4395-8d52-714ba225145c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_cc703668-4c7a-4d6d-bead-37fa4895214c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_cc703668-4c7a-4d6d-bead-37fa4895214c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_9b11c778-dba0-4476-b013-3a5323fff743" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_9b11c778-dba0-4476-b013-3a5323fff743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_886bd328-96cb-4120-b6db-d34565a44c06" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_886bd328-96cb-4120-b6db-d34565a44c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_e56a78e7-30f6-4eee-a5db-b000fe331d37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_e56a78e7-30f6-4eee-a5db-b000fe331d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_50fd860c-ecad-40b8-a993-9a728132af37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_50fd860c-ecad-40b8-a993-9a728132af37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_1e6dc41c-e87f-4a15-b8b4-701a53dac028" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_1e6dc41c-e87f-4a15-b8b4-701a53dac028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_f29dce54-4666-4468-bd28-6046e7189e37" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_f29dce54-4666-4468-bd28-6046e7189e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_eac4d3dd-1a8a-45d5-8689-d6e95e32e07a" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_eac4d3dd-1a8a-45d5-8689-d6e95e32e07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_122617da-7c9e-40d8-8ad9-7d99ee67569c" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_122617da-7c9e-40d8-8ad9-7d99ee67569c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_cdd60767-3d12-402b-8e6e-946cb7cec295" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_cdd60767-3d12-402b-8e6e-946cb7cec295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_6a85f144-5e78-40e3-a022-17e6f08986cc" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_6a85f144-5e78-40e3-a022-17e6f08986cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_1f012f04-fdee-483c-af73-149b7c3afae4" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_1f012f04-fdee-483c-af73-149b7c3afae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_de206e0b-9eff-4d8d-b6fc-3fe5cb086c29" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_de206e0b-9eff-4d8d-b6fc-3fe5cb086c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_b6edfd85-4f11-43c6-934c-e11f11341ec6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_b6edfd85-4f11-43c6-934c-e11f11341ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_803a95b8-1142-4941-a35e-893dafeb1a59" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_803a95b8-1142-4941-a35e-893dafeb1a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_4c7d7e97-f8e8-4820-8ca5-a31df6d0d704" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_4c7d7e97-f8e8-4820-8ca5-a31df6d0d704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_0ffd549d-1c10-4b0c-abeb-1d387c4a09e6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_0ffd549d-1c10-4b0c-abeb-1d387c4a09e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_017414db-5b84-4b8c-b15b-adcf7692cad1" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_017414db-5b84-4b8c-b15b-adcf7692cad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_acb2abe7-6741-4c8d-97ea-4fa4b0615b79" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_acb2abe7-6741-4c8d-97ea-4fa4b0615b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_c719b7c9-a4b0-46d7-91e3-05271d23c431" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_c719b7c9-a4b0-46d7-91e3-05271d23c431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_5cdf2034-e657-4c53-84ca-5987036960ab" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_5cdf2034-e657-4c53-84ca-5987036960ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_07679d6a-59e7-4e6e-8f6a-ab874455c30e" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_07679d6a-59e7-4e6e-8f6a-ab874455c30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_42e79097-0874-4e81-a44c-a76c7f3c89d4" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_42e79097-0874-4e81-a44c-a76c7f3c89d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_6ba0674d-54be-460e-be7b-2e0f555be1d6" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_6ba0674d-54be-460e-be7b-2e0f555be1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_5fcd4cd8-272c-4af9-907a-4efd2c2f2ee7" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_5fcd4cd8-272c-4af9-907a-4efd2c2f2ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_390ffa70-04a9-48c6-a3fc-865bccb682ee" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_390ffa70-04a9-48c6-a3fc-865bccb682ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_2e2487cd-6f2c-4795-9775-653f0b1b379d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_2e2487cd-6f2c-4795-9775-653f0b1b379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_3c515729-8dd7-4c49-b669-8283e2f5b078" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_3c515729-8dd7-4c49-b669-8283e2f5b078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_6d6edc44-6ed6-47d3-8e9e-82065d191549" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_6d6edc44-6ed6-47d3-8e9e-82065d191549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_fb8741f9-c31b-48de-9926-8e7fc80a3ac3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d947a91-ee01-4c39-a101-b90ef73a64e3" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_fb8741f9-c31b-48de-9926-8e7fc80a3ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e1f1bb1e-6f78-44c4-9176-ed2cb4f81004" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3e2f88a-d8b5-40e2-96df-cba3e752ac03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3e2f88a-d8b5-40e2-96df-cba3e752ac03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bd2937de-6874-4f14-9b08-0a403d1e402e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bd2937de-6874-4f14-9b08-0a403d1e402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bcb7e689-a658-47f4-835e-82de14d5e2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bcb7e689-a658-47f4-835e-82de14d5e2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_464d4c62-2476-42db-b350-5198b8422e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_FinanceLeaseLiability_464d4c62-2476-42db-b350-5198b8422e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_3ad52bab-d9b2-460e-966b-b96004b5102a" xlink:href="cvs-20200930.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_3ad52bab-d9b2-460e-966b-b96004b5102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_5b914737-f7ae-41ee-af24-12996fc4e108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_5b914737-f7ae-41ee-af24-12996fc4e108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_19acde82-9979-4659-a274-475bd757e27c" xlink:href="cvs-20200930.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_19acde82-9979-4659-a274-475bd757e27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_97c753bf-26a1-43d0-bea4-3b02add4c2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_97c753bf-26a1-43d0-bea4-3b02add4c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_80a91401-afbf-4ea7-8357-63dadfc72469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_80a91401-afbf-4ea7-8357-63dadfc72469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34dc6038-46d4-4d09-8615-00c4e66f9619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a96c3ffa-00e3-4e68-9753-73fa4fe3ac05" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_34dc6038-46d4-4d09-8615-00c4e66f9619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_87e19163-5347-44c5-a6d1-68977e78ecb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_87e19163-5347-44c5-a6d1-68977e78ecb5" xlink:to="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e5d10419-7d40-43c8-aeba-eb40a75b0767" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1b42b91e-cd60-49c7-ad38-fda6f0b6669d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:to="loc_us-gaap_SeniorNotesMember_1b42b91e-cd60-49c7-ad38-fda6f0b6669d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_0dffa501-56fe-4d45-aef1-27b9a53ed7d0" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_01e90e80-f574-4e03-8661-ad8336d542dc" xlink:to="loc_cvs_FloatingRateNotesMember_0dffa501-56fe-4d45-aef1-27b9a53ed7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0fba494-d412-4ceb-b481-dcf98a639680" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_ead30fdd-61c0-4b6a-bc51-4393b0184426" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_ead30fdd-61c0-4b6a-bc51-4393b0184426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_cee04bfc-e2ec-4cb4-bdf2-2baa9f02539d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_cee04bfc-e2ec-4cb4-bdf2-2baa9f02539d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_b1f1f3cb-08f3-4334-b91d-cc369cca1f36" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_b1f1f3cb-08f3-4334-b91d-cc369cca1f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_2063beff-94dc-452e-ba96-fdf6cfb9f56d" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_2063beff-94dc-452e-ba96-fdf6cfb9f56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_e13af344-7d01-429b-89d2-9f26991f5fbc" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_e13af344-7d01-429b-89d2-9f26991f5fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_a7373286-7c97-4936-803c-a0981a7a23d3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_a7373286-7c97-4936-803c-a0981a7a23d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_aa660769-6c4b-4b26-834d-d6d25121dc27" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_aa660769-6c4b-4b26-834d-d6d25121dc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_8f9a3987-c9b2-4e29-a5a9-e47a73da6b04" xlink:href="cvs-20200930.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_OutstandingSeniorNotesMember_8f9a3987-c9b2-4e29-a5a9-e47a73da6b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_6118b644-2797-4ff7-b73b-f0e42d08fc2e" xlink:href="cvs-20200930.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_6118b644-2797-4ff7-b73b-f0e42d08fc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_0518ee1b-2fe5-4b18-9ee4-50cb4424d656" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_0518ee1b-2fe5-4b18-9ee4-50cb4424d656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_2890f4c2-58f0-45e2-adc6-eaf2f68cff14" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_2890f4c2-58f0-45e2-adc6-eaf2f68cff14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_5bb4c6c7-8b14-4d51-a056-b281d72d1fcd" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_5bb4c6c7-8b14-4d51-a056-b281d72d1fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_e8265383-cdfb-4cbc-8a5c-78cfa8321550" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_e8265383-cdfb-4cbc-8a5c-78cfa8321550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_4d14431e-29c7-43eb-a266-54b3a92385ba" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_4d14431e-29c7-43eb-a266-54b3a92385ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_6a167ca7-e1af-4933-b57d-ccb04d85b655" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_6a167ca7-e1af-4933-b57d-ccb04d85b655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_e25ae63b-c55f-4d6e-bd8a-bc17bd5cf8e3" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_e25ae63b-c55f-4d6e-bd8a-bc17bd5cf8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_20ee60b9-e693-4f63-bc7a-5f00278be9c8" xlink:href="cvs-20200930.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b67a589a-78f9-4bec-ace1-fba6216353f7" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_20ee60b9-e693-4f63-bc7a-5f00278be9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_88327f48-7639-49c0-8790-53a912ffc9ec" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c46810a4-6a5e-4018-a342-61253cecc1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c46810a4-6a5e-4018-a342-61253cecc1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_273322ae-7256-42e4-b52c-40b89ba73c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_273322ae-7256-42e4-b52c-40b89ba73c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f2a253ee-2e8a-4a1c-b1b9-3433dc9f0175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f2a253ee-2e8a-4a1c-b1b9-3433dc9f0175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_9d256031-c868-45c8-92d6-bce3a23e2eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_9d256031-c868-45c8-92d6-bce3a23e2eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8e540bd2-7aaf-4420-a640-1ecffbd085a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8e540bd2-7aaf-4420-a640-1ecffbd085a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a3bee150-30f8-4d64-b3d8-165e217a18d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a3bee150-30f8-4d64-b3d8-165e217a18d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_042336c4-2cce-4fcb-93a8-1ef1ef8c2b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_042336c4-2cce-4fcb-93a8-1ef1ef8c2b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_9510b47f-e3aa-44f3-80dc-5728e242804b" xlink:href="cvs-20200930.xsd#cvs_DebtExtinguishmentFees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_cvs_DebtExtinguishmentFees_9510b47f-e3aa-44f3-80dc-5728e242804b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b3f6b9a7-1c5f-496a-bcf8-73bc33f85ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b3f6b9a7-1c5f-496a-bcf8-73bc33f85ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_919a45ac-0481-4e4d-8ce1-e295f049246b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a484d102-a093-4f3b-b877-2bc47a2b7d75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_919a45ac-0481-4e4d-8ce1-e295f049246b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ed6849d2-1ad7-4e9c-98d7-28fa16820a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_be1b41b8-8d6a-4c0a-98bd-e18263f57e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ed6849d2-1ad7-4e9c-98d7-28fa16820a4e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_be1b41b8-8d6a-4c0a-98bd-e18263f57e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#ShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7677fcf5-19c7-4d5f-8332-7c09b118250a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7677fcf5-19c7-4d5f-8332-7c09b118250a" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_24b083db-5370-4cff-b6ec-ebac7b0738f0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_24543e38-f56c-4f53-a0cb-76e3e1de5ba4" xlink:href="cvs-20200930.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7efecb75-7aac-401d-8842-4eebc285298b" xlink:to="loc_cvs_A2016RepurchaseProgramMember_24543e38-f56c-4f53-a0cb-76e3e1de5ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_2a1f5deb-c070-447d-8964-a886ebcb7272" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_22425daf-db88-4f22-abb2-8376295762c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_22425daf-db88-4f22-abb2-8376295762c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b9d614b-ec0f-4272-80a4-89b1b5ca7be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b9d614b-ec0f-4272-80a4-89b1b5ca7be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9c48fafd-5e6c-4f0d-9877-107cef211de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9c48fafd-5e6c-4f0d-9877-107cef211de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_11a4fdc2-c776-4918-a82d-747437d1af30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ddd9e33e-873e-41e1-a2b0-a679ad57baed" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_11a4fdc2-c776-4918-a82d-747437d1af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cba10c88-e21e-4198-bab8-78d1dd2ec62e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_1b8a9957-3ee3-4968-a7de-f8665e75b4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cba10c88-e21e-4198-bab8-78d1dd2ec62e" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_1b8a9957-3ee3-4968-a7de-f8665e75b4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98a463d8-ff11-45fb-8441-34a8eab5935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f2d420b2-e33b-45b9-a276-143e6eef852a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98a463d8-ff11-45fb-8441-34a8eab5935d" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f2d420b2-e33b-45b9-a276-143e6eef852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3e420734-ebe5-4954-b0db-73986c845939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3e420734-ebe5-4954-b0db-73986c845939" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c94a986-ede4-44ce-afbd-8247c3f1997a" xlink:to="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_20ee38a2-a3ca-47f1-a694-ec6714a4fd69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_20ee38a2-a3ca-47f1-a694-ec6714a4fd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_30489996-27c7-45fb-97b3-97a22f2bc706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_30489996-27c7-45fb-97b3-97a22f2bc706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5c65879d-07c0-4f22-a136-dacf11b57738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5c65879d-07c0-4f22-a136-dacf11b57738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_502692d5-5ff5-438c-b94f-47eb897d1f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_502692d5-5ff5-438c-b94f-47eb897d1f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_341028d7-34a0-4dd2-ae56-a58281ca223d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7aa87820-d1d2-4303-9db4-575e2cc53bbb" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_341028d7-34a0-4dd2-ae56-a58281ca223d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_25e506dc-2e78-487e-9e1a-560d70795f25" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:href="cvs-20200930.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90a5ab51-90d0-4769-8b37-159bb4aaf42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90a5ab51-90d0-4769-8b37-159bb4aaf42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c600de64-d902-49a3-a812-d7448fb0695f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c600de64-d902-49a3-a812-d7448fb0695f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_281cb7a7-083f-4160-9894-4c1628f11d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_281cb7a7-083f-4160-9894-4c1628f11d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af15228b-f6f7-4d8a-819f-6d938b2dc046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af15228b-f6f7-4d8a-819f-6d938b2dc046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99d36c88-8888-4b04-b1ec-27e2e17edf9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_6ac475b4-d622-4431-bca8-07c37fd450ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99d36c88-8888-4b04-b1ec-27e2e17edf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fe04f2e2-1e51-43ab-86a7-dc3535779f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_fe04f2e2-1e51-43ab-86a7-dc3535779f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_23354d73-2c1a-4c1e-acd0-9432c5390d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_23354d73-2c1a-4c1e-acd0-9432c5390d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_f95415d2-af13-48ae-8f73-293c99a41eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d69a1deb-0435-40e1-9874-0dfc7c955f37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_f95415d2-af13-48ae-8f73-293c99a41eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b7228f12-ce64-432a-a6e9-ff3a680d32b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ef152627-4582-442b-a58b-40c00ac5297e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b7228f12-ce64-432a-a6e9-ff3a680d32b9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ef152627-4582-442b-a58b-40c00ac5297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_550b2995-7b1e-42d4-83a6-6ea87f4345db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_52a276d6-dbf9-47f3-b615-1e80fc894481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_550b2995-7b1e-42d4-83a6-6ea87f4345db" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_52a276d6-dbf9-47f3-b615-1e80fc894481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4cf265c8-251a-404c-bea5-983438f4e68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d36e2e24-2701-40e3-9868-c578281e1085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4cf265c8-251a-404c-bea5-983438f4e68d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d36e2e24-2701-40e3-9868-c578281e1085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:href="cvs-20200930.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4cf265c8-251a-404c-bea5-983438f4e68d" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_267ab67b-f9b4-4a5d-ba81-35ddaf44f1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:to="loc_us-gaap_ProfitLoss_267ab67b-f9b4-4a5d-ba81-35ddaf44f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_f4d9f50a-2313-489b-be09-225d0684924e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_f4d9f50a-2313-489b-be09-225d0684924e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2c07ad3b-a93b-4a80-a341-5ea65080cf26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2c07ad3b-a93b-4a80-a341-5ea65080cf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_31e7bde0-e33b-4c29-be7e-3bde8e5e8515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_f222b280-bccd-4fd4-a4b3-886f085abb23" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_31e7bde0-e33b-4c29-be7e-3bde8e5e8515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_715fcf0b-6dce-4131-9843-753727a978b7" xlink:href="cvs-20200930.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4cf265c8-251a-404c-bea5-983438f4e68d" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_715fcf0b-6dce-4131-9843-753727a978b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3fc9dfb4-1f2e-42bf-98ec-7f27bc7329fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_715fcf0b-6dce-4131-9843-753727a978b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3fc9dfb4-1f2e-42bf-98ec-7f27bc7329fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_90a65ab4-e0fc-4e03-a60c-4e3bdc25d5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_715fcf0b-6dce-4131-9843-753727a978b7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_90a65ab4-e0fc-4e03-a60c-4e3bdc25d5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc623c7e-aa32-4328-8ff8-1169e337b158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_715fcf0b-6dce-4131-9843-753727a978b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc623c7e-aa32-4328-8ff8-1169e337b158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1ce07fe5-d238-4fdd-b2b9-46e37ffbcdd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4cf265c8-251a-404c-bea5-983438f4e68d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1ce07fe5-d238-4fdd-b2b9-46e37ffbcdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1f01c0aa-bab0-45b2-b54c-46c9f8b60f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1ce07fe5-d238-4fdd-b2b9-46e37ffbcdd4" xlink:to="loc_us-gaap_EarningsPerShareBasic_1f01c0aa-bab0-45b2-b54c-46c9f8b60f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8ba5dfec-1a49-450e-ac63-4454a6b3817c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1ce07fe5-d238-4fdd-b2b9-46e37ffbcdd4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8ba5dfec-1a49-450e-ac63-4454a6b3817c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a515b7b1-2328-4863-8b37-b83ebfafba44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c6555e8-400b-4f8a-9a88-b839fbf0b01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a515b7b1-2328-4863-8b37-b83ebfafba44" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c6555e8-400b-4f8a-9a88-b839fbf0b01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3214ab8-d870-4f26-8698-7f43dfb918ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3214ab8-d870-4f26-8698-7f43dfb918ef" xlink:to="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9f7fb1e9-155b-4363-b7a3-d1fae3cbe4c7" xlink:to="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_8e6b5774-417c-4ea4-9bf6-c283ccc4d058" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:to="loc_cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember_8e6b5774-417c-4ea4-9bf6-c283ccc4d058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_80d28ff0-ba10-4556-a9db-9a6560e845a4" xlink:href="cvs-20200930.xsd#cvs_BlueCrossAndBlueShieldOfNewJerseyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3719f229-1576-44d2-ab30-dd5c5b1b06f1" xlink:to="loc_cvs_BlueCrossAndBlueShieldOfNewJerseyMember_80d28ff0-ba10-4556-a9db-9a6560e845a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_f8935d35-62c4-40d2-8c10-f6423dda4bfe" xlink:to="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_288fb65b-3aa4-4d1e-a0df-ee9b8b372180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7d9706c4-de71-42a6-a93c-a1eefe20191a" xlink:to="loc_us-gaap_PendingLitigationMember_288fb65b-3aa4-4d1e-a0df-ee9b8b372180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fe072feb-5a8f-49e0-b4cb-db33bca966ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_61a08111-bead-428a-a324-5c0fc02becf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c36468ba-22bf-40b7-954a-97544527fa65" xlink:to="loc_us-gaap_SubsequentEventMember_61a08111-bead-428a-a324-5c0fc02becf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caac07a6-5096-4754-9fb2-62504a0ca218" xlink:to="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_84b605c3-1532-4b20-938b-f1dd8b308816" xlink:href="cvs-20200930.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_84b605c3-1532-4b20-938b-f1dd8b308816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_039b5ab8-ef5e-491b-851e-0c5ba9e2e373" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims_039b5ab8-ef5e-491b-851e-0c5ba9e2e373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_7f049b38-8b73-490d-bde0-1b1e4358ecfb" xlink:href="cvs-20200930.xsd#cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved_7f049b38-8b73-490d-bde0-1b1e4358ecfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_c4694fc8-19be-46bc-bd5c-28c90f94a9eb" xlink:href="cvs-20200930.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_c4694fc8-19be-46bc-bd5c-28c90f94a9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7e6a4e6b-8955-4bd1-bcbd-a2e1c16a3cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c271ce-e368-4479-9ce6-d5a201975b7b" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7e6a4e6b-8955-4bd1-bcbd-a2e1c16a3cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d010ec88-5abc-4437-a16f-4e19b45bff03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_df92fd20-3d6f-4ec8-9993-eb25b8cc441e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d010ec88-5abc-4437-a16f-4e19b45bff03" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_df92fd20-3d6f-4ec8-9993-eb25b8cc441e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5632ae18-6045-42e4-b537-9d0e33f0b56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bd757556-a263-4f4b-b27b-a5f6805eba3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5632ae18-6045-42e4-b537-9d0e33f0b56d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bd757556-a263-4f4b-b27b-a5f6805eba3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6e46780a-92ab-4b30-ad45-d4f30736cd5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5632ae18-6045-42e4-b537-9d0e33f0b56d" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6e46780a-92ab-4b30-ad45-d4f30736cd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e08dd9eb-06e3-49f5-9b77-3e24d74ee8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_a63cbdaf-fff1-4d10-9c98-b187a8004d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e08dd9eb-06e3-49f5-9b77-3e24d74ee8cc" xlink:to="loc_us-gaap_NumberOfOperatingSegments_a63cbdaf-fff1-4d10-9c98-b187a8004d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_be392f34-94d2-4949-aab1-40a352937ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_be392f34-94d2-4949-aab1-40a352937ff4" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:to="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9548d80e-209a-43b2-89fa-6c03cdaa4884" xlink:to="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6db53734-a960-41f8-8ad0-8b263b4ae18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:to="loc_us-gaap_OperatingSegmentsMember_6db53734-a960-41f8-8ad0-8b263b4ae18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_57b6dd9b-af2f-4ca5-81af-52810d78bcd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9b17f458-819a-45d2-8132-2ddf5e54bda2" xlink:to="loc_us-gaap_IntersegmentEliminationMember_57b6dd9b-af2f-4ca5-81af-52810d78bcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3da8458d-e183-401b-90dd-741dc5889f24" xlink:to="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_c901864b-f5c9-446f-b807-afda30ee983e" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_PharmacyServicesSegmentMember_c901864b-f5c9-446f-b807-afda30ee983e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d511860d-6939-4348-b8e3-79479dcf0601" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d511860d-6939-4348-b8e3-79479dcf0601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_8d1030bc-d8e3-4c8e-a28d-5420f76348f3" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_8d1030bc-d8e3-4c8e-a28d-5420f76348f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_53d02e65-6ffb-4fb6-b252-3149075317c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e02d467d-9c40-480a-a573-03d7bdbf9b79" xlink:to="loc_us-gaap_CorporateAndOtherMember_53d02e65-6ffb-4fb6-b252-3149075317c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_ff47efb5-9962-451a-9202-b74cd495a0f6" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_527a5661-8f55-458f-ba54-ce38ae9c8041" xlink:href="cvs-20200930.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_527a5661-8f55-458f-ba54-ce38ae9c8041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_204e9738-7c19-477a-b93c-e06643ffc9c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_204e9738-7c19-477a-b93c-e06643ffc9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_60e16aca-5e7e-4eb5-bea9-1053f117a66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_NetInvestmentIncome_60e16aca-5e7e-4eb5-bea9-1053f117a66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_27f0d686-deb7-451a-a8b7-5affa002b0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_us-gaap_Revenues_27f0d686-deb7-451a-a8b7-5affa002b0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_e471197b-2b95-4dd5-b455-5df7ba375e39" xlink:href="cvs-20200930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_e471197b-2b95-4dd5-b455-5df7ba375e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_7a8bffe0-22c2-4128-80fc-d28ee01f4191" xlink:href="cvs-20200930.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_05c8aa09-25e2-4909-a43f-5aefaee58853" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_7a8bffe0-22c2-4128-80fc-d28ee01f4191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1def367f-498a-4306-b30e-1621f7a18fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1def367f-498a-4306-b30e-1621f7a18fb1" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ea580d63-00d5-41a9-978e-97db4ee31403" xlink:to="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_33334bba-897c-4256-ba68-169730b97383" xlink:href="cvs-20200930.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_33334bba-897c-4256-ba68-169730b97383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_44127659-6c1c-43f5-a813-507a72d01935" xlink:href="cvs-20200930.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_44127659-6c1c-43f5-a813-507a72d01935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_2c4ef406-4c4f-4d0d-a1bd-35c55b3221fd" xlink:href="cvs-20200930.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ac5068d0-b900-4ab9-bec7-6ed8df5ad294" xlink:to="loc_cvs_PharmacyServicesSegmentMember_2c4ef406-4c4f-4d0d-a1bd-35c55b3221fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d184ad93-4abf-4b6d-ad2f-76a933c03a71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d86407b7-42ee-4341-ae09-54cd2dbc7750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_cd8f379a-4fbf-4693-b2f7-28dffa6e0fcf" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_d86407b7-42ee-4341-ae09-54cd2dbc7750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0764e4c8-e27a-42f3-9191-54da7066c735" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5d9eb8b8-83b6-42da-9245-0a4b3b17194a" xlink:href="cvs-20200930.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_77d9a743-26e1-425c-8ab6-8ba0780576ee" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5d9eb8b8-83b6-42da-9245-0a4b3b17194a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_32497f0a-d1cc-4a54-9ea4-2378a8125660" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_844905bc-271e-43e7-a410-e724c94c7f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_OperatingIncomeLoss_844905bc-271e-43e7-a410-e724c94c7f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ee29a06d-893b-4a40-90ca-59f758b8acd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ee29a06d-893b-4a40-90ca-59f758b8acd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_c566deb1-ab6e-4abe-b810-f5ca66cd833e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_c566deb1-ab6e-4abe-b810-f5ca66cd833e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_8a8b0e81-5f89-46ec-9f17-8edbf3cb2912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_8a8b0e81-5f89-46ec-9f17-8edbf3cb2912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_eae24381-6f48-4763-abe4-775c8a8e4647" xlink:href="cvs-20200930.xsd#cvs_StoreRationalizationCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_StoreRationalizationCharges_eae24381-6f48-4763-abe4-775c8a8e4647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_86f4a0b3-3122-4405-8a30-1ee7115224cd" xlink:href="cvs-20200930.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_86f4a0b3-3122-4405-8a30-1ee7115224cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2c83347e-651a-49f9-8a05-be327bbf9d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2c83347e-651a-49f9-8a05-be327bbf9d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofUnderPerformingStores_8ca24f4a-8be1-4393-9b95-a1b5575edb08" xlink:href="cvs-20200930.xsd#cvs_NumberofUnderPerformingStores"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_f718a38a-f3a9-42c6-bd91-e1cfc812e2bb" xlink:to="loc_cvs_NumberofUnderPerformingStores_8ca24f4a-8be1-4393-9b95-a1b5575edb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e76dcad6-f13c-4bf4-9b06-5f37fb708efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_42d82432-37c3-4a55-acb0-52aec9561bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e76dcad6-f13c-4bf4-9b06-5f37fb708efd" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_42d82432-37c3-4a55-acb0-52aec9561bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="cvs-20200930.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_760a3fcc-4f55-4eb3-8143-486cfa671d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_760a3fcc-4f55-4eb3-8143-486cfa671d01" xlink:to="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6150d5c1-271f-40ac-94b5-b2eb1b3fbe96" xlink:to="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_c6969463-d83f-489d-9d65-8f36e4d072be" xlink:href="cvs-20200930.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c230375d-630c-425c-8f9e-12a00fef15c9" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_c6969463-d83f-489d-9d65-8f36e4d072be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_0727fa3a-8c53-4852-9402-279f9795dcd5" xlink:to="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c8eed914-b241-439b-b057-3aed9fc4c72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:to="loc_us-gaap_PendingLitigationMember_c8eed914-b241-439b-b057-3aed9fc4c72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_52974c4f-b666-4ab3-a23b-b8aa52a02eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5377469e-9584-439d-96c7-3d8f4ca05d92" xlink:to="loc_us-gaap_SettledLitigationMember_52974c4f-b666-4ab3-a23b-b8aa52a02eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_509ad110-7a64-45fa-aee5-357417f3fcb9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumRevenueMember_865ead81-5531-4654-9400-c38691cd4c9f" xlink:href="cvs-20200930.xsd#cvs_PremiumRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ea26ec0-66a4-4363-9069-870ebd33ce98" xlink:to="loc_cvs_PremiumRevenueMember_865ead81-5531-4654-9400-c38691cd4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_60b3bfb6-35f3-4edd-bf56-2b1f9095741b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_56c5bc89-9abf-40be-b02c-bf45d2da6cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f21f463-e3a6-4329-807d-24c3dffbf80c" xlink:to="loc_us-gaap_SubsequentEventMember_56c5bc89-9abf-40be-b02c-bf45d2da6cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_2a647646-dcb9-4a0a-94d5-721d2d225e41" xlink:to="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2588ee9a-04fe-4944-b431-316ddd0694dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_53ef707d-0aae-4b55-b3e9-ad2ea3a7eb1d" xlink:to="loc_srt_ScenarioForecastMember_2588ee9a-04fe-4944-b431-316ddd0694dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_beffb199-cc46-4b1a-963d-1c4d29846fc5" xlink:to="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_f5737ecb-fb9d-44b1-bc8c-6640f4a7da9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_f5737ecb-fb9d-44b1-bc8c-6640f4a7da9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_444a7440-c1a9-4687-975d-df4cf244b16f" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_444a7440-c1a9-4687-975d-df4cf244b16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_c7cc8266-dac3-42b6-981d-b6b5976a9d76" xlink:href="cvs-20200930.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_c7cc8266-dac3-42b6-981d-b6b5976a9d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_bb92f798-d431-4072-bf3e-09faef6f98a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_27bc0457-35c2-46e7-8af9-54c7090431a4" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_bb92f798-d431-4072-bf3e-09faef6f98a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cvs-20200930_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20200930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cvshealtha381.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvshealtha381.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>cvs-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20200930"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20200930.xsd" xlink:type="simple"/>
    <context id="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6240724c7d9c4678ae6da9372625561e_I20201028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-10-28</instant>
        </period>
    </context>
    <context id="i6e317fd9f8534d0cb3cf959627c9697d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25dd89c5723a44719ef9af5db71ec31b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i901f58f3faaf41e481c42824eca1769f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b2fd3771d794132920c7f4a242129fb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa740d08066d4d9abde1a5fbf7722b66_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i319e1b9809144db8acea0d84bd5a1ec3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if0adc77af7e44ca9b7a5e0aa1830398d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff8425b591444783833edd8e815331a8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib9882f3f29fd4b73b6e97734933e44a4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i83b41fef1b864e01ba3e78d118b8243b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1760dd0c327472392df2791068fb782_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6a7e2874d0ab43299169519779fbc2d9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7930220d914f419297614a660281ef47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5be942208dc1421797995bf453709517_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd8a0caabdab46cc88debaa0c046f3dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7a539619c134838a1d5f4cca14f9441_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3172dd72e85d49daa20d2cb9b4f7f9b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2286aab200f4a1892c679ab6e3b1b9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifea3ad7fbde3466cb0d05dc9cd11a22b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ca7c827c69941c5994247c772125139_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia87850112c6a4030818cf4c061f75276_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9860b6f9816341359067357c7c165e5d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4d35ebf9c824b0b907f4c0adae223ca_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie94974140e414714a3341c252c984f66_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i78a375bd4d6f48e89dfffc71946f4a55_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i99a44be297eb413184028063b42c5faa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i16cc05efec2c470d9c2d81b1369a192d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i91e1e6cd716a4e87bfd329666134d286_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i814ed0bf8ff04a1ab4a1a2b6668545f1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7fe3dc5bd7df49b582bcd4fb537c3ff8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8df330f945fe40ae939aeecf46b997a6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2f3de2ba29874b91820a6e8738735819_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i331e56114e3c422584fccdc1dc247161_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iec4c75a50fb4463093ce50049b985383_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3167dd9c7bcb4190a46ac3616a6096d1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i571ceac717c84c4a94f70faf7c363371_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibfe21c1301c6497aadc7f6002c446161_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if497738f73ef48128d544b2866a6b773_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icae7992d69654cb097446acf9b33e297_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9f29445f39bd4b9d9c0596805a0d36fa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6b7c1d38bf884811b17e7b37aa5fc599_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic54229e328244a16acdf5c0ec0ddae47_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idead255cd4d14401a0f371fbde8693f8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifafcb02d59004fedbb9332ce962bbb50_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbd79123bcc14c2fb1cc1eeb95efcaba_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id36f48bb62074ed38935780980244861_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia98a850eb95d4b82868c9616941ead34_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib59819bcb087468789cf0b7b87860688_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e254dc8fb204c0aa8e1af10b2125b4f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4e91a6c1593e4ec4ac7aad6c113f284a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i859721481833446fa96d26363301759a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i106be2d3ad604360afa2a6c2657acdef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i17b816b179cf48c3875bfe79f11415be_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i304666a201b045b7ba84e7a502222b26_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i514d9c71e8e34b73be0290f1502a1722_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i322a9dc17b8243e6b3fea397bd95e1a8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia7770f7a96734fbf946266bf7257161a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4657fb3ee8e24f7c8bd16ec46224e2f2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iac7aa78682f147f48082f382fecfef81_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i536638a93faa4b458e82d77598e46897_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id1aa9ee857c04106b4ddeb51bba6580f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i73aa0acfcc2a4286bbdbe36223128682_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i29d78d69f63e43bfbbf2c9b5b9e3a9c2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iebcab56786dc42feae377f091296982e_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1abb168a5e6441d18beffe97e1f3d94a_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia143f7ee313e44f7870d98c64e6439b5_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i3ae75737b267456a808c79a40b150435_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i06c27729e16e4e42ac7509026e75dd51_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2900867654474cd28dd5045d196ec575_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7aca7df593c34ab7b0fbb5ea78f926f8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ibfd1a561806047208b4db1ab9fce4f98_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="icd7700a44a0248e48d1b6d80b0fc2ae4_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3ab629bbd58a4de092289e615211980b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6599ba05330a4711990ed70a0a265e49_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7085a825e90c4759a1618f00e3ab81f2_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i203b5e3c33e4404c9d4ea2fe1f4e7ac8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id4364493f5734455bb1f6e765963518f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iecfc6612a6ec4564bba6c3ed1e8a1395_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7beb7ff5e17d4a42968bb035cef774e6_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iff2853021c8b491f9255dba3609410aa_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i463603c2f27845d28c9d3b99a405ff6c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4c617f7479a44823b94ae95b119c3a70_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i389b0e105fc642fda8f98138b1769f1c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id14f47d35d4043e5bc16b18b14abb993_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2525b67907774a24a2fbd98d30d59e57_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9f4d513c870c43be98b93640f3f9ccef_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iedfa97c4646a4f34acb951255063b626_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8030574e46c54dc78075514e087d6aa8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i48b23f611534468684876d12f664352e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i45b5cd1dd7304ec283b1ce0b506b7741_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic4a47d2a1fec45c3b9b7adb20e61d257_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i809b9db9db554177ae44049fc6336a94_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4a6a67cb47374fb9b4cc4ed07e526591_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4a73bed99bba493485113c4e922d1192_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iaa1b8f41c19444e9be024f7f3599370d_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i113463dad55e48bda48e770726d59193_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if0e1c13224e342d4bf505740f3a173b1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0f1e2d2eb6e14cfc96ce16ba745cd95d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if60c2fe38b9e4eb8b33cbc4e89326d14_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia68abf3331714f0cb8a2e46831fee06c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6f85725267e4b2da9c4bd28ed0c0d5d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5fcf3cc86944847b4a31907d7b35e8f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icd74224b2d0e435b95718f3c4dca914f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i98dc5453e7af45f08155c02c68159539_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9af031c4a92b4ad09fedaada5da439a2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i06443f5cef314ba49659eb8a8ac32230_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i681ef3f1a45145e38eba1e776de4f06a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica0c012858fe46d3aaab3baf1065534f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id2f456b2af8343678bde493f23d04c00_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ae828c5b2cf449c9ac7a99073a1bd39_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie5bfa1ea471448ce90b4228202b8064a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i152019c18b244202a6b98ccc912ef82b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icdea441b1eab46d9958833bd142b99ce_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ba29cf25cfe44f295754a8809ab4023_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57c12bcab38f4db5a180e1dac74519b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5785795924964ac09b3c91188817854c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae9c586bcf364c249392b219a423f528_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i40fb27941a97406982ff1445053b5d0c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idb3729dd099643528282f816f5be4d23_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i316742918ca24a9880fcfd2fb281fdc1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4e48083166d94041bb1bde8d8d498c7a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cfa15ecb949457f94a09cad78662bec_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i435b0304464f47fe8980149c5a3e3bb2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i18b91e17e6a24590b4303687758fe4b9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2467201147a4f38bd1790ba260c4d27_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0347d869b3534eed97cc367c2b34c716_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i432f620c091b4bd78b8965de6106dafc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d19937733dc48c19bbe4192a695643f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic2cd40721bbb44c7a65f88f72c256ff2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaeda413cd32f4c61bb785163c7baf76d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i47ac41f57acb41e09f8949a2f24746c4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i838b21cb58bd4282b74606c9a0a75ca6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i715ce306fefc4081b49c626cdda6c223_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i411aec8a49dd43e89d1ec6ac18e88d30_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i449b3a0364494dc2958f100fb42e4bcd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5bec87bd7c13489ba49dd87596bd5303_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i660decdad883483cafae88aabfe86ae0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifae42a1df12e4c469ad1f6c21e69a11d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0e2d37b8ab1f48a890ac86f4563c36d3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id1ff9ed846af4552a659faf486506f87_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i77e3a2bcfa204f0fbf7d7eebd45dafcd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i92e3a4c36dd343c2ba601ebcd3081b81_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0f9b827c136747b2a88c80753d888899_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifaa97cbcb3614677b33155fc7cf8cfaa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i015e3b88519741cfb822c70694388488_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iafb782656964430b9ec2cab98566a145_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i99e1d6d67a0041b280b5effb5c549db0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i533429b9306d4879913c046da9f37100_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i239d475ffe78452ea7477598c48a053e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1f98e97d40c5423b825abdc89e4ccb51_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e5e2b880bdb4f68b5c1392e7e118d42_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i98e3e29c4fa547aa815092b174966dd8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8e4c02ab9b2540858add46268ffa4322_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2ab42df5d6404b6aac64b89dd954f364_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i67b94001396f40909619fbef9b1c041f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd1a6a30d65c40cd90c753b012d08b88_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if12ff9d95029482297d72d6a5dac7ac5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93eb393efd5947c6bd3a1fa1231f671d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i087ffe62239e4208bc8c4970e058712b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib473644cf5364dc5b2441b72f3e53b43_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64a1c66ce18d42d0877b39057bc2673e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idd0d8f9bf90e4c8699e03540f1dd8563_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i47677f4138234c60890d66d2bf6418c3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8bef237b09b44c78b77e40b1baf100d9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6d6fe708235e4a8b85cd7b931c2f83e4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i94671fdaa22443daacafbd02d1f71e93_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ideb21a4e70f24d6fabbb04939d9545c2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b1d663af0b8401a87dc8961f33034af_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc7ca939d3fb408f88e8741191e0ec27_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i142289bb8d554d3dba89eaf41db49f77_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1aada21c113948f5a84bb2a89d8c538e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b0b26bd74b14fe0af4dc258245d4a4c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i73f4f797cb7d42768624772e06980a51_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc9f76f4e106478f9f7987221d24fea6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i146fec50f41a4066b18078ed43353a6a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3438bddea238412d98d4e213a4e7b658_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i150c031257f14e08a64ab6d6a0e1c8b7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f8342dcb699462da75f023641350930_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i607580aaee174297b74cd851382e412e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8776f7019c0d4b02bb20bab4edd1ed55_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9e4d5a1e39de4128aa906bd1685a2ae3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icbe61efd7ac648258b3bf73ea2907f45_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i320c9806d95e4a99a10d60ce8e71c1c9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9967f494d4c041b0b67ba0b3f772077b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i66f838618c784289b3828bffba708455_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i386fd0e763c84defbd4f0294954a23ea_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0c443934e4dc4f1e965f9c54fcfc217b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1f042616910a49ada119e413e89e0e93_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i64110bc1e619481eb011726e790e889c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0ea9166ed44a45cd9916cb9d1531b2b2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ica91574825624707af2b7d055d492214_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i34993c6bdba44671ad08a231acdcfe11_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i244b1545347c4b0fba00cd7e0537b12c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2eece7da79844b81a88e0f6c39018f57_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib25083b6bc234531b154c27aa6adaa6d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if67f1e55874b4139aedf9e515c8e7960_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia569eb9b80b044f3b51c6f4972c0f31e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3403a6bf73644e22b0ddb226f5361865_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib77d598c37e24619b64ce36f408cea80_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4f3cd5501d3844e8a92c6e7b9f858352_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i69cb1a487c21485497a1beff149953b2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib083a611dfa748bca057628defb1a140_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9660fb77d4984d64ac93c4db44804b30_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id6a9d2c4000f4239977b19d16ba37d4c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iebd799ddeb88438e89d5c5d78dceda1b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i521b36cc1f1249c78083a5dd3ae92540_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i237b71611de94c4aa41507133bd24f34_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6cbec7d8ab8e4c3cb30b140669a8cdf9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0add470a8c5f49b899b9f413ff91d02b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i46597caa3b364945b2d7360795884f6f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8ef78d632fbb4792bd265cce79e92c17_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieacdea7e3b834282abaee6b57e493b85_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i06b05ec92127409d8b14837cfb2ca48f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a486a6add824c1a92ba6c55d3d50c15_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0bf70ec2a8ba4060b9ae0ba5571df5d7_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i8cc9af3b8a554fbf97555c8eb6980261_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i48f4fdba61e842189cfa49c83ec10819_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if5a85409a01d450381c1b2224ea4c3b5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icc728f8b775348d4957fcbc0f71e7f96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id1d9eacd813548bba5ca12f875c2a76c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i120ad616a34646769659abc5ca27affc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2d2438801f7c44c98ea4e95749087498_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7b15565a9a35453b9b987af9593bf001_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6a75c0ebe2024f59be4523a9a37d16de_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ief1897d8c36747ee8a7fc20fb298b973_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf3e6151680b451eb6ef567620281acb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e576f48da934434adff3d93da16066c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01f4a654db5e4221b06e356876c0b885_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6e3c903578a4562993ab15cb728ca44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i383d7512151242da970974ef3fe1ddb0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i972eda3e75e84307a6e92704398a9a97_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if2258986997d4a6ca66cd9e77de4dd87_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia33d5501abdd4ab29455629f2219842a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i69dfbb0081244aac89b4345d22699e63_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i960e086fbf114fa085cd3503d8537bc4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff1e365008244ed5a70514a60e56cccb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6ab420c501cf46d49e7efcb16f91f34d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib7daccfbe8e14d87837c7793f712536e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibf0db8b085494ad9aa4eead23953af4e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia45efd93510c49a7ac479600054af81d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5bb089804391419e80d1a1823db3e201_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie795c4847dad4a2fa2321b0a489f207b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic175d1191a1c4781a30676aa11276f4d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i30256990638e428f824cbe808d6ed528_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iad431944c36d4aae9608be12244efbd3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i913a4bd7a8594a62a5156370bb48bcf6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i33b30e7ac4294106a93b48a59cbf0bac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6479057a341c45c984deedf142835644_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibd382360a1a54ca085c48b6b0eea3f9d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0610c938c1724db88d4cb79675b700cd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c351fcfc74e43169c42882a035900a0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i057fc0d413b94de5b39c6573f51d2e09_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42dddd2f744647acb266706378ec5df3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia4edce924dd046b6a5eaa1536dc0f333_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d795e3743e64e26965aa5f2e4573e19_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i68eb5bdcaf264b40b40588bd26e81268_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3754c364a7504543bf52097c1f644ce5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9122fa3ecf054a24bff9ed44808cb012_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ida44d0acf7984a62bdefb2c50f6d6407_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i194339829ef54e0bae1c684cadaded1e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8c85adc56b7c43e3996b5bce465f37df_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e53524f057f4999ad2443b434cce091_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9af70922f678434488f766f73af3cade_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id0d1c549803e41469de47806ff2e4fa1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i05f844fe095a41dfbceda6a1d04bfdc2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ica452037f76f48e9af4b93d468452d6f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie94354f726744ff8bee2090d1ad35db2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i00c125fab00b42f59120a0bca28c2067_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5c8ac8af61cf49b9a4ecdf639848435b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia08a76e0bcc84d49adefc8bbec4d213b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if90ec21d6d594b7da461da5300391997_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i71b4e703d104427790286808c54d1366_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ida34879a6c634fd1b420b3bb6585dd5a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic6ee7fd60e8a42afb969aa603a251749_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i154a60403daf439ea051436669caed62_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8567e379ddb1457cac777037b4375361_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3fbcdd26a0874198b1491985af3d6caa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i626f99181aa943b0b51f0d50e860b3cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id978749041e44e299bcf3f700443a8f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc1876da69d543fbbfd2d97bed949c96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1eeeb3c201f44e02925fb433c54875c9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id66c23adb4244b9cbd61f92daf51edb2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9980f4284414635a8f0e3dba2c1cf2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifce7c6728c90483e9b8bfdd9962b5710_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if749a1d078424bd0ac0f4ee34e5390a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i13c1913598034217b44872960f615f0f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie023e0b3bf5c4d45b331cdca88d01e53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5cdbe7b61cea4120b2f5472d61487f8a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibdf1cfbdd6b04ecfbd78c7310035476e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i186f364822c04e9d9d7bc13d20f7bc13_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa78344f4d0c46538a8cbcae3b2a7c42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e6acb9733404822913cf42bb35c9631_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67170a9e296943109aa58736f02ebaca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8430b0f5491b42719a2b3726e4de3cec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iccc0eb7aab1f475eae71c3312f0c686c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82c2af4550a64d90a95e4c647320413a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i20da4428912141408240e337515e04a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i622e43fcdd484d2aab4eae3e5164bc8c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa714440d01840109a1cf5efeef3955d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i396244e89f5b4c28ac5d4147e815e9b7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9b24009c9df475d90e186eab28b123b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d3306d339a94c2381177e129b5210ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8ac5e26c358547b0a83b36b4ba5416a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib681cd685e4741c485fded4dee9a4f19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i992d499671994e22be809371d4cfad4e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0374e01374ba4315b4b99fb4d6263f56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib818fadd5f0e4ddcb1522c0c0ac9d976_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2fae26ed04184bfdaca7066ae8a753f6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if716a3c271cf46b39d3e4ba483d859ac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i744c94aba9ef4754a45ccd4484daef93_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia04fde7379954a4981ed81ebf2b5afb0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2db42393af54e53ad14dbc08d486114_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6c00b913c81f4dd0bd7784fd75297758_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i67f6aae1b4284431bcdd2e4827898dc9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5690f0cca3ea4531914b67ef16f42948_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if045682f0a244fb9b7c118b70cbd74df_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i17291e3b05464689b6efa05815c1f0ab_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5c372f3418a4938be710525fc278530_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icbcc194ba2834984937ecc92d1e291ab_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic6f6b833db21459d8fe1d58b988e57bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i420d31c38e0944e3bb697025075df15e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6af618046aa747559d1a45f61351ac8a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9bb4ae865e534fa1bc341a84e105cb15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5cbb249c57e548daa8401983dea3fb69_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i63c1bd90c28e4931a7a6e2193905bc88_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib9888da910534133b2a13752e0039eda_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i002016e409a046ca82eb2a7e9dbf5f44_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9d4ea2ffdeae48c092313d22b4f64e1c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0535ddebc7eb4e54bebfe38fe2a9b22b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib03ca448ca5c45b495bb1c94af6ea7f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5a642414691e4b29b29ab8baba0a10a5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idec3f94d59bd417b802264c8aefae9b3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5f229849b6c24840ae258b5ab8a06762_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib2675c3b1d0543ea9aa4c53740042175_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i95925aab9f5b4fcaa0bccf22427e5e67_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2e3c6cdcdd4340a4ba6b3cb06502146c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7c8083ca7f924d47b17ce8940d650a38_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i468dd4fda3b442e99fc8328fba905b67_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1bf20fa45ec74aefb3382146c0b20236_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idd6d327fadfd4b23954ab240ff677c47_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8eb1a14e2e774b2d837d4d7cdc423714_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id7045e35aa3d42f8b85edee8aa4d38ef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i364069c2b8ac4c28b31b5e1a40e551c3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8997d1471cf34a75beffddbb3c6148e4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id37b8520c2d34c29948b799a01af328f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d1dfa73f59a451681e979540ce540ae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5e538c30b555469794e0be3a6f8ed046_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifdb8f83e7c124df8a6cbf59fd5ce2c8f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia29caa6d3bc347128a52855fa834c203_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7526eeb0a2fd4ef4b130b931e3eb519e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5a1dff5e36324924a4f2feec7a5a73d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibb4060526c2c496981cc55c6977adb37_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7f4c4734bcc24fb0ae7cab1d303bded7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8ec813f07a334f08955f4a12ac4902a5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ife9add6b9a8641dfba7ba3deccb48b41_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf45d10b231a4274b5a9ad0d08f997a7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iabe734fa96d842cc869a0c54975c7cac_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4eba4bdd839a45388341859be447f171_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2eecc9a6d3764bed91d04d9833777391_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia3d7a4047d05423d8090a70fc2fe604c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic92eabbcfc0e41129c6ebe1c3bb58c1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i167492c1a5134840a68af5838d92c0a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib4875b0b5876478ea38a39e3ca94f3e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i635d4a19627941fbabf18b73ba4a7f69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieaaedc48c33f4ce9b4d61713e708492a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i708f6416e0d84b7a86d62ca235435207_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i439528f07f334a2e9f9e37ae4c771d44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i229361a7197a4afeb15eb2425729c789_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i769f8ad79eaf46d4b177922dba08206d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2b8f23ae3b94a519cee02e63f7e0a3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6743b7888dc0448685e1853c25ff8440_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c704d6d14fc4be98279325dd3287aa2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3f13f39c72a49049b8ef64e5f5c7c0c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a2c5cc590d64e41aaf1d4feb53683e2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida5abbd3b9f046aeb99c9fba1e6dca0b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i129439a18c454d088d7a6a8c35f27f78_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7595fc1bc6054a7190199e2e60736d28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib748f4e8d7b5461196a5145bd6da1195_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9f855925c0344cb8356da40cd655821_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d8fd736ba76478e9162d84858b27634_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f07defd6e1d4056a5169e425552d20b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i809ae28eeac24a9f9310746684a864d0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i155016131fca4d64850212170f3783f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i060cabf68768492aa7a6026696eef9be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i96b2f88bdb4a467e9d789f375c58180a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id1a547cc68174a39b3376c9fff4a8994_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i198821e71bd845749eae39a08b218939_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i301877cb06e8403a8812ea5b4d398af3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic0efa799796949ae89d8f49114056097_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89390455960d4f9f9c95e118937a1dc5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d17013fe24947c1b861b4825165d690_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc84a509c29542e8b93af8e853807f78_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icdfbab09e275415b941c75475ce6fde8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieb0edebf547f4905a41bc330aa523177_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i49246bbb41534ab9ab8993460e449ffb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8d67531f617f4a779c4402a048cc3bb0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i995c07a91519440c88d67c6c40193064_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fd8f52e738441778cf1253aee1efcb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fe0ca53a694483a9013de0430acc1ca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ideb5308533d344a3a8a7f42fb04088c3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93b120b41b4c4aae917c5be4d6c7787a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i08dd08cbd4454361a90dbab797cd3aa2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if7a45a7920b14acea3f4b36636c4b5fd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i80a7cc610f9a46e2972dabe60f274ea7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifc004478531a4eadb516f49ab8f04d57_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifbc87fccbde24356929e17da657ef9be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ec68f98e99d43249445dac606bfea53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7fe31f16b9d42d596559a375bd059c4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ecc8d5ee49f4089bcaf72ed79a73d73_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f42424f53594322a0bc648503fa4144_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib3c32977c1a344a48577bd5d98e4ae14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i177b612dc9f549628390175ae5e60944_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib96792d9941740519779008d23a17bf0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic0d1b93e21d042618a7cdb163a1f9a53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d6a2a3e0816441b96633eaefaae2f1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i677b008b5750476a9b99ad7d720cd5aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i320389b0cf034ae5a57bfdd9b1a683c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e83a1132c904e35a130f8abd67d5f4a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2e5079511b3a450aaca64bc154348d61_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i804c778ec2814834b3d84dcb0310f508_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id17cc174a92c415eb0fc76b28ecf0e1f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i60fa68066dc24311b7c8ce0a1c65ccc8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62c741d96e344754add90a7638be6b23_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic24208d25b4f412ebb677befba70dfd9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb8de0cf862543a28ac57b9c9b4d9da1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8da6c47de724df685363819d15fd5d2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i435b788198344ed889fb7f41075b6e67_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i68cf955793ec45129bc32f05a30f217d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0e169ba85c734e9abcf8020fd97a8db5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5856fd2c216349b8aeedbb9e1974b765_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5c9b66131ca4a539a74369e6146272b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2bae9f24886e4178959c9e4374cf2d26_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b413c6d9cad4b9eacf86b8d064d8f7f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7aeba235b9cc4d79a2f135126e309786_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if156a997688c4e66837675d203bd1c98_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie178c63026e949e8b2151622fca0263c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2f09e46e454f4475bc40352c0231eb93_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c30244244a04895b2eb8f7a3183ed76_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i10e7590255dd44f183ff6175bce29c5c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5880b165e61f444ab0e29a376c321d60_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0914af72006548ebbba484408464ae69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c1a7383071e4cc980e6c0e5a4147dea_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic05a1bb77adf449c9b884c612d910d6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0bd7c4fa4868462fa55280d3ecac3953_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i290ff092291647068477c613b2614b53_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1687e1197697447ab1e252f736563f04_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1096032d00f44b71b617c36d63d7f27e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id39b967136734ffebac4fa125d5df5e3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieef7edab39324e21abec728d47812d6b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9c6b0f2f62c74a8681f9cf380a9e3f2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ee6ead635de4c95add163849dd94827_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie05261bf78de439e95e77a97f7a95197_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib12e87c001794aeea0e7834103d4e29e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifa5b12f048374362ba07cace90c8eba9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53697dbc20eb4716841fa78a5b6d61e9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i671fb7b57b204d38a5ec9cc8478dd71a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if99da7bf0574479c90df5ab707ce9ea4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9ee9602d63244d01b24b8058303bf440_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9b151bd651d4e21ad5aef18942c57f6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibae6c86974674b649712b3bfcb54b956_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc962ffe7759429a8437aeaf65091ad1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i30331d814224442fb860f94b9c7bdefb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dd553eacf7843ce91290bdb3c9f651e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie72d1e6a2e2e41db9701a9fd8bee5fa0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d529d43e45b4cdd914b2000673d53c8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1f2a6050d8c9472cad7e74ccbac0d7d3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i692d39424ece4bfe9add19706ba7a75e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8eb1eda40037470b87e5c84de8742351_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1068e9886f384012b47c77ddf7440959_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7982711b6d1a4518aa5760f4b6d81aca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i20445c4013da41559dd716a5e301fa58_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2390853230664b71977471726c73ba84_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2ddf756027c647808636299b132f954c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if4fbf2ddab2d45868cf34d8af1dc6657_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i725a1515335644b2aaaf163a4dacff94_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f09caa84ded47ba85c938f104c825d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i63c767f7afed44d296aad898e2be1125_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54826d3a4d644b189399b609a6f6a24b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe8e1cf76b454cd8a76cf064eb597d2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91d1a497cfd74fb8889de9ea721571bf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i36df838d786c4c5d9ef71e79fbde110b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic728b575d27e4aa8898383cf541680d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id1a690e438fc46c8ae47a61d1dbb1690_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if0b249377f2f4ddab5d99416f68657bc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id2b718b817d44528988a876de7fc8bf2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ice8172ab47664fa9a3cd78759a4453a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba7f24a8dbd0437fac060bebccc39eed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i853ba9286f1a4fcabce9a8524c725b25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i709dc9e5843a46c29f7c3a14b5732a22_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8d2b20e6c49d45d1ada51a71917b422a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4ac59124dea453b8f6a7a1027357fb5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i23ed3fbf4b98415aa629e39f421a73fd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee41f66d2eb34db7a37a170823c4e89a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i99ee350b35ee4777be370e11b5e0e8a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i403edd61e4434a99a5791f10cbd76c78_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iad6f61c9e98c4ce3b04854b705260b28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a81af6ba40a441fbb99ba18d09073bf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i53136fbe8f8d484aafe459d75dd67da8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id83e3ca5e5b74832b482dc21dac47b15_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic4832233814146d4a72a43f532a81304_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1421fac4a46640f488484d0d2bb2f5da_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8c2c6ca07a2948c2bb32301edab7a7ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i295cc3434aa14c899d92fd789d23e4c9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3f38e39469ec4110a0d65096dc00df6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5334156d0c3043a1a13513caab4134b3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if1d294aded084369be74447b0566b76d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53b2ae62b51d4971b13d4146936f76ea_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib0a403ce8c3b4b3984c2e9eae3632214_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7698bdf5f484e289bdc4f09e25197fd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i71438155734c4195a0f18f432a418662_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idac14079640e4ff682a4487baa41cc7b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id795774182b2476bac2cbbb06963df80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24823ffe3a604cfd87e5693bf137f94f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1b8323c41a0e402cb82a2088c5ac0ff1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibddae3f3a8b04e22adc4e54bc250df78_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2004ef6f6a8e4c5ab2d44ad733bf043e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7e5b0ad50d4e42e6b07ebd012cfdd8ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36748522e5764894aa532ad0b07acd87_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i525c1d0146e54a86aa63f93fea6b7bdc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i78d21c6312ff4432b75d3a29c30a960a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8f231c679a8f48f69959c46f3f43d5cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5cc6e467e0a04d77af59fb7584d3b906_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if0bf72645713412a86166f550c1f16e5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba1978e8f8a84e28a8a31288a3036505_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if0cdcd3fc23d468e902240ab83df8b0d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6d07faa35b614fb1882b9aa697a66dec_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia351b17fd331488f9c19c7092046c881_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icef337dc67864f7eace3d523637349d6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5af1f185b125480693a0d0bad7b64abd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i843befc9d57d4321b9c38aa68be69ba6_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-08-21</endDate>
        </period>
    </context>
    <context id="i061be2ce53a44ed8a847d35fea3c64f7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i87452d10eac74833a26ccdf16f72be6f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9e003f03dceb45b6a401dd0a2c15619a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if192035447e74302b3b24be7e300f710_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i498d25aa22054a10a2a7f7f86ba2b5ca_D20200331-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic4418eeeb9274602937c479510064c2a_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5e13a337db4543e2918ef2db378c71fb_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="id1fdce6ad75c4a94a2c9df47616acacf_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i19527741ed594ba2a6a1b439f15d1f49_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i8896274f8aba4673b336164474916d80_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i1086a45a45914803b4b5787dac081a9a_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="ifa43f5d114584fe4aa281801f4cb6df2_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i8025ef9777c14c2b9d133e87af8de5dd_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="ia3c9892023b049bb895d5033c451c441_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="if455866bb2bd467f974a25ce7e9a0bd0_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i8891142b6e684accbc9446f2c1da9ada_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i0f8d8f94b69f47a29ef2ae02ad7c9700_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i49583a4b71eb4d35821c7a34fc9f5dc6_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="ife76a2daf76247ed84df033b3381b3d4_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="if522a3140edc49cbb22c0b24dc66107e_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i36780b12a24c4197ae6e8c1e76989a48_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i6bf38eeaba3449eb825327fa22f6ee32_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i59d7b49b81174a188a7693f6caaa62e3_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i7e462393116f4c15aeb568f785179398_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i294e2fe0bdae40f7931db52b0a256b5d_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i34c3d891d1084f4599405d17248e8c8e_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="ic3a22a87b43d4b3db25373c50b610cbe_I20161102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-02</instant>
        </period>
    </context>
    <context id="i92c166ab9cb14308b8faee78e708c5d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i785fe01249e54049baf6e493c3802193_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia090d3a8eb844f89a10619bb3d2a6fff_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia3d6f831699a4635bb458cb2de3b84ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3c203fef43742668e532cda7f2c1fa5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id9584afb63464be1b5819075ebc120b4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i806e7c9717c24de5ae7010f0f10b6be1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i532f29edecec4969bbca5c16efb1f7f8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i887ee4a7facc4fa4b18507f044b04878_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i04d0c1e1127646cf9d2d9831c80debd3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a5c8430936e43eda7f07b5c38c9388f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if1f2fc8638c748e2aca4140e502531b2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i45fef1a06e3647a1aef2f530c536a606_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2ece21beb781421ebe511d131b9e50d9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i66dda08c143247a8bae039ee8451ac6b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ida4fa9aa910d43589adddf698dcbd90b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87f0779cac2746f3a5ecc01ccf789c9e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27d064b39213426da21f09c4238e271a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idfc549e0d312441788064313343cf78c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6190bd16f5314ec1bdde0d0603987e3b_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie4143146fd434706bd94dc49340308eb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3f4112b74f164d22820352e1af27ca00_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib11a29381a70499098c887d742f41133_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d24c8cf0b2f4ec892c7ae20e2399ec6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie10179039b234603bf7b505426fc8472_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i13d90c20531f46398a0d5445c1b3360a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i002debbf693d45699dc102ddca977a67_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9c1de9ff69c5421ebd0d98eec11a8353_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i06db64b58cdf443580404215eb0ca740_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i23da5ced3c0741f280bab78905895c3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice3b96dd953547cc8f60a7fa1546fe88_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2d6c79cc9de846d4be742316c0e6e179_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icd5756ad275741ff8df69fcff86a17b8_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i179f470a0b494d8983ec636725d8d119_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i36fa8765529c434ca15131ebec0fef35_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:BlueCrossAndBlueShieldOfNewJerseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i3ee66866f8fa4cbea112996fc3ef1389_D20130101-20130331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2013-01-01</startDate>
            <endDate>2013-03-31</endDate>
        </period>
    </context>
    <context id="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8388f3cbdf204618a0c21ce87efec0fc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4fa4c5da31094c308e8bb540b1f730da_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ae38a4835db41f4845bb963973a4035_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie9f49f9e47124de881a13135342b7fe2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a375fb5ee4c4b4d97090ae3ad666b3f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6fd7496cf7d94ef5b1210da043c5d38e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idd1a8fb583a743f49a6dc705dc12e525_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3a1f86796440475bb5dab254521c724b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7a503222dd594312b47e70f69e82a446_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2627fbff46e64b4f9394931c3b370f52_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id92c3e405f2548aba08212e6d6583ed7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iae8df98cf0a04c339a50aa5f67d358ee_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie7a36eaad3694582835456f3a0082533_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b9aea230b9c4ec19e0946224068182f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iac0a911dfbb042d1a2a8141db4da783a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3407b4198a444fda8eddc128dd850666_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8cc6d00c651d4a9881f30a84231714f1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5b3a1807d6d941108c13c5bb50477adc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i73b9b581f26241d4b1c1a12c4ed7691e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9869200a1f51442783697741cd784346_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i12078e54516c4cbea23a4ae0ac86658c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9f020cf3db944a72b9e11f66eafb85a6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i219c9f0ab1634e62be0cec75eb3d097b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i638894f045654cdb9cec4484de9042e8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iab600fe96ebf4cc0915b310db63417df_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-22</startDate>
            <endDate>2020-10-22</endDate>
        </period>
    </context>
    <context id="i775061c4d39a416ab23c7dc563cf24b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cvs:PremiumRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="building">
        <measure>cvs:building</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="person">
        <measure>cvs:person</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="entity">
        <measure>cvs:entity</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl8zLTEtMS0xLTA_ec841949-7c58-4564-8de1-ce7df316b46b">0000064803</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl80LTEtMS0xLTA_fb947b18-3592-44ff-8510-625b45408351">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl81LTEtMS0xLTA_5bd75e5b-7bb7-4ed9-9dee-c3b47196c4ba">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl82LTEtMS0xLTA_ad11a8ac-ebee-48c8-9251-dbeafc6671d6">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80L2ZyYWc6NDZhNDNjNDEwOGJhNDRkZGIwMzlhYTRiMWM4ZDdiMjUvdGFibGU6MWJhMjVkMTU0ODQwNDBkMjg2Yzk3MGVjNGJlNzkxMjIvdGFibGVyYW5nZToxYmEyNWQxNTQ4NDA0MGQyODZjOTcwZWM0YmU3OTEyMl83LTEtMS0xLTA_0763b79e-f79a-4796-b7fd-ce00bfa119e8">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_0cf7ad7c-7efe-4c9c-a45c-4fe5d88f19e3">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_0f7ba638-0984-46b0-96a1-1daf5b816298">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_54994f3c-bb36-438e-9f66-370e220863b5">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNTA4L2ZyYWc6NjdjYzA0ZGUwZjIwNDdjMzg5MDMxZWMxMGQyMzc3MTkvdGFibGU6MzA3ZWRlNDE4OGM4NGVmYmFiZTM1OTg1OWQ4MjVkMGUvdGFibGVyYW5nZTozMDdlZGU0MTg4Yzg0ZWZiYWJlMzU5ODU5ZDgyNWQwZV8xLTEtMS0xLTYwNTM_7053a555-8b41-41ee-8758-88dfdffe588c">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80Ni9mcmFnOjRhZTVhZjkzNjA1NDQ1OTk5M2FkZDMyMDMxODg4M2UzL3RleHRyZWdpb246NGFlNWFmOTM2MDU0NDU5OTkzYWRkMzIwMzE4ODgzZTNfMTU5_56efa174-a0f8-4777-b2ed-dc48ef3b9aae">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80Ni9mcmFnOjRhZTVhZjkzNjA1NDQ1OTk5M2FkZDMyMDMxODg4M2UzL3RleHRyZWdpb246NGFlNWFmOTM2MDU0NDU5OTkzYWRkMzIwMzE4ODgzZTNfMTYw_0c4059f0-e416-4ef0-bddb-160af0c229bc">us-gaap:AccountingStandardsUpdate201615ProspectiveMember</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList>
    <dei:DocumentType
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV84Nw_d61a8304-80b0-4692-8a14-68c0a2a3fb14">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMx_9acb462c-0ab2-494e-a92b-1febb422666d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMjU_2186b1ce-9db7-480d-bff2-438d1b281796">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMy_22a62f68-fb4e-4d41-a8ed-fc561cbf88c2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMz_b1168667-d3bb-4bdd-8b60-99bafe44ced8">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM0_1c9154de-d154-4c64-92e1-fe1cc409e3aa">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YzY5YmQwMjRkMGU2NDAyOGJjODFjMzRhYzRkODRmYWEvdGFibGVyYW5nZTpjNjliZDAyNGQwZTY0MDI4YmM4MWMzNGFjNGQ4NGZhYV8wLTAtMS0xLTA_c25723c4-1ed1-4f46-80c1-a9c7d8597c0f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YzY5YmQwMjRkMGU2NDAyOGJjODFjMzRhYzRkODRmYWEvdGFibGVyYW5nZTpjNjliZDAyNGQwZTY0MDI4YmM4MWMzNGFjNGQ4NGZhYV8wLTItMS0xLTA_b4f0ca5f-4f3f-4cf6-8288-653886498aa2">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTEtMS0xLTA_1b5bba26-7230-4dfd-b20d-adb9ef795f18">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTItMS0xLTA_fa295f82-2ef7-4659-b330-f593adcb1f81">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTMtMS0xLTA_ef76818f-cf07-4e9e-9a47-a4eabea44bb7">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8wLTUtMS0xLTA_5f1fcfec-a209-43e1-8c45-9d65e2d064f1">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8zLTUtMS0xLTA_d1540d48-1e43-4533-8c2e-b78223897aff">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6YjNjMzA2ZGI4MTUwNDM3MGExMWZlMjk4NzhhNzg5ZDAvdGFibGVyYW5nZTpiM2MzMDZkYjgxNTA0MzcwYTExZmUyOTg3OGE3ODlkMF8zLTYtMS0xLTA_0e23e0de-62b7-4839-853e-118b3e65df20">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTAtMS0xLTA_fa4ffc76-6d1a-436c-919c-bdd2a62f372f">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTEtMS0xLTA_661f6470-ae0b-49b4-977e-ad19cbcb3924">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZmQxN2MyM2I0ZjhmNGEwZThjNmYwODhiOWExMTJlMWIvdGFibGVyYW5nZTpmZDE3YzIzYjRmOGY0YTBlOGM2ZjA4OGI5YTExMmUxYl8xLTItMS0xLTA_0e6438c9-3b7f-4480-8672-6d0b284fb9b4">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM1_9cf20947-5fcd-484e-9f60-ddb9fe1a83c8">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDM2_d78267cb-114b-4b8e-a449-4b6630207172">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8wLTAtMS0xLTA_5a9927fd-992c-4176-af4d-ad6eb6d54ae8">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8xLTMtMS0xLTA_0ba6546e-082b-47c0-8f86-33cdc51ea940">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGFibGU6ZTIzY2IwZTg5MmUxNDA3MmExMGI2NjBiYjU3MjJiOTYvdGFibGVyYW5nZTplMjNjYjBlODkyZTE0MDcyYTEwYjY2MGJiNTcyMmI5Nl8yLTMtMS0xLTA_0826cfff-bf14-44af-8c9d-6b86b778bd01">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8yMDMw_67451c4b-81ce-4f3b-851d-925152182f89">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6240724c7d9c4678ae6da9372625561e_I20201028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xL2ZyYWc6Y2NiZjIyZmI2MGI0NDdmMThjZTVmMDc3ODA3NzI2NDUvdGV4dHJlZ2lvbjpjY2JmMjJmYjYwYjQ0N2YxOGNlNWYwNzc4MDc3MjY0NV8xOTgy_7398045f-aff4-400c-8ee9-07bb81f99cfe"
      unitRef="shares">1308913498</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e317fd9f8534d0cb3cf959627c9697d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy0xLTEtMS0w_243e3c82-599d-4224-90cb-a5479e208aeb"
      unitRef="usd">47738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25dd89c5723a44719ef9af5db71ec31b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy0zLTEtMS0w_21552950-409b-49bb-81da-004f00f6f604"
      unitRef="usd">47149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i901f58f3faaf41e481c42824eca1769f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy01LTEtMS0w_ec19bc57-076b-4bd3-9084-2dc6ef543dfe"
      unitRef="usd">141096000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b2fd3771d794132920c7f4a242129fb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMy03LTEtMS0w_d264e9b4-246f-4568-a5f5-edd770898c40"
      unitRef="usd">136023000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC0xLTEtMS0w_b137ab5b-5863-45aa-adc1-5076df42e095"
      unitRef="usd">17182000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC0zLTEtMS0w_625279e9-5230-4851-b346-81a3e5e32d4b"
      unitRef="usd">15539000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC01LTEtMS0w_83136cf6-78da-4a98-9651-168b88d1f328"
      unitRef="usd">51749000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNC03LTEtMS0w_25878371-e91f-489d-b7d6-5d13366231e7"
      unitRef="usd">47612000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa740d08066d4d9abde1a5fbf7722b66_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS0xLTEtMS0w_768d4b91-8dc3-43c2-87e2-fbd41a57d635"
      unitRef="usd">1932000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i319e1b9809144db8acea0d84bd5a1ec3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS0zLTEtMS0w_22095c0f-81d7-4ea5-b8b5-988b1fde7e23"
      unitRef="usd">1859000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0adc77af7e44ca9b7a5e0aa1830398d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS01LTEtMS0w_41a6333e-dea8-4a49-bdf9-b45933215055"
      unitRef="usd">5757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff8425b591444783833edd8e815331a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNS03LTEtMS0w_dcc17c7c-8f99-4be1-a5a9-8f35d2f979ff"
      unitRef="usd">5447000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi0xLTEtMS0w_92cda39d-c1ad-4a55-9e06-746cc11860fc"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi0zLTEtMS0w_4b1048bf-88e4-4e9e-b4e1-e20c22cabf16"
      unitRef="usd">263000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi01LTEtMS0w_074c48ae-a4ed-407e-941c-05c591d651b5"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNi03LTEtMS0w_f36cec3e-6de1-4e70-b5c6-9ebb18788519"
      unitRef="usd">805000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy0xLTEtMS0w_16e25f56-ccde-4b89-abf5-eabcad37faab"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy0zLTEtMS0w_ac8cbe72-66a7-4156-af32-a5b78e270219"
      unitRef="usd">64810000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy01LTEtMS0w_2eec0029-b9ff-4c9b-837f-0ae5f1f95921"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNy03LTEtMS0w_5433addb-aad3-48b2-b9f2-95cf359a73d2"
      unitRef="usd">189887000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS0xLTEtMS0w_e2de0286-33c4-45e5-9faf-46382c51491e"
      unitRef="usd">40940000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS0zLTEtMS0w_15461329-3b14-445c-b7a5-b0b416c9a34a"
      unitRef="usd">40437000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS01LTEtMS0w_1c70c9d5-a25f-457c-bc6a-53ae62bee6bf"
      unitRef="usd">121529000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfOS03LTEtMS0w_2e91f658-403b-4575-86c0-d750047ebd38"
      unitRef="usd">116654000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtMS0xLTEtMA_3d482f57-9229-41fb-b220-cb09d62dc103"
      unitRef="usd">14396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtMy0xLTEtMA_98331007-3d63-49d7-8bbd-61e906227a92"
      unitRef="usd">12850000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtNS0xLTEtMA_64bfe85a-c43e-489a-87f7-c308b99bce9b"
      unitRef="usd">40534000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTAtNy0xLTEtMA_eac1f33e-1327-4063-b7d6-8ec5c64a51b0"
      unitRef="usd">39396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:OperatingExpenses
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtMS0xLTEtMA_671039c6-1679-442b-82c5-424564615d2a"
      unitRef="usd">8471000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtMy0xLTEtMA_cc8b4f87-6016-49d4-9032-d112224f466d"
      unitRef="usd">8595000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtNS0xLTEtMA_d33cbfcd-2f7c-47e6-ba01-22c3373efe7e"
      unitRef="usd">25702000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTEtNy0xLTEtMA_536e3447-4740-41af-9f3d-0e858cc3f920"
      unitRef="usd">24887000000</us-gaap:OperatingExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItMS0xLTEtMA_5836abc3-1ff2-4711-b5d0-6ac41d77364a"
      unitRef="usd">63807000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItMy0xLTEtMA_f3f99196-53e1-41df-8d6c-438941f27140"
      unitRef="usd">61882000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItNS0xLTEtMA_355736a5-2a3e-4bad-8b46-8b187becf17e"
      unitRef="usd">187765000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTItNy0xLTEtMA_edc8430f-ab31-4373-8491-fadbfb97424d"
      unitRef="usd">180937000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtMS0xLTEtMA_69d683d6-ed69-4333-99d9-2e6b38dce50d"
      unitRef="usd">3249000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtMy0xLTEtMA_63af6ea5-58f2-4373-9199-37c0f6752a61"
      unitRef="usd">2928000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtNS0xLTEtMA_97a11e81-06a6-4498-b74a-6352ce0b367a"
      unitRef="usd">11387000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTMtNy0xLTEtMA_429e653d-6f1c-4a00-ae51-de48a9ac37ab"
      unitRef="usd">8950000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtMS0xLTEtMA_3842edc7-2147-4edf-9f8a-7ace56572572"
      unitRef="usd">731000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtMy0xLTEtMA_fdad0dc5-210b-49e4-84bd-a4f48333a8e9"
      unitRef="usd">747000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtNS0xLTEtMA_925b9fb7-6e91-4b35-bfeb-ebd07fd46f19"
      unitRef="usd">2229000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTQtNy0xLTEtMA_65a26435-a6a3-4b0f-ab05-0f174b09f807"
      unitRef="usd">2301000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMS0xLTEtMTEy_fb626a60-264a-4eb8-9528-76f9e6f5a2db"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMy0xLTEtMTEy_f2ebee42-8880-4385-906c-44b129ed2e87"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNS0xLTEtMTE1_3147ffb9-e209-45e0-986a-af7e98115c73"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNy0xLTEtMTE1_e83f3dd5-fdbf-4a3a-a6e3-d2196b59ce9f"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMS0xLTEtMA_d594af64-e321-439f-85cd-316da0bb9f95"
      unitRef="usd">54000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtMy0xLTEtMA_4e8591c4-0589-4b6a-8354-61736bd2b70f"
      unitRef="usd">31000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNS0xLTEtMA_06c3421d-939f-4031-956b-ab3e61b67391"
      unitRef="usd">153000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTUtNy0xLTEtMA_d268ff47-003a-41c5-9237-442853df799d"
      unitRef="usd">93000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtMS0xLTEtMA_63ca7fe7-312f-4e38-a2c2-fee85daa74b1"
      unitRef="usd">1806000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtMy0xLTEtMA_724796d8-cad4-415d-a9f5-bd67b5cdd99d"
      unitRef="usd">2133000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtNS0xLTEtMA_8bcfbd18-314e-4537-b0b4-c1b1ffdb6fb1"
      unitRef="usd">8545000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTYtNy0xLTEtMA_0aa566f8-7a6d-4240-8852-36ef68429c4a"
      unitRef="usd">6663000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctMS0xLTEtMA_0cbd00df-75ff-4980-8b6c-878690f706d2"
      unitRef="usd">587000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctMy0xLTEtMA_e6ff6bf2-f379-495c-9104-f7e8791dbb57"
      unitRef="usd">604000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctNS0xLTEtMA_2c0a7ae5-16a3-4ddf-8b35-16562fce2d34"
      unitRef="usd">2328000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMTctNy0xLTEtMA_41377f47-e23f-4ae1-900f-2fda9bc0309b"
      unitRef="usd">1776000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtMS0xLTEtMA_40e4c74e-bad3-4d6c-b1de-96a6000fbc62"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtMy0xLTEtMA_4ed34740-c9b1-425e-821b-c3fc049141ee"
      unitRef="usd">1529000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtNS0xLTEtMA_2268025f-fe6e-46a8-86b5-7b9d4c0289ff"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjAtNy0xLTEtMA_2c73ec5e-901f-418c-9d98-0dde24eaca50"
      unitRef="usd">4887000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtMS0xLTEtMA_c7d58cb7-c378-4b4d-94e1-4cb17c1fcde6"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtMy0xLTEtMA_286244a4-d88d-44f5-9ad3-ac03b14b64cb"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtNS0xLTEtMA_a51ad6ba-b563-4985-a4d9-ed2b3feb6751"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjEtNy0xLTEtMA_50e3b289-63bd-4a9b-bb6e-83e4e9aaa566"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItMS0xLTEtMA_d3c7fc2f-e78a-4ec1-b859-1a77c177fe0e"
      unitRef="usd">1224000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItMy0xLTEtMA_71e05385-f00c-44da-812c-67c7c3dc0d15"
      unitRef="usd">1530000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItNS0xLTEtMA_a4092de6-d63e-4aeb-a490-8445d520261d"
      unitRef="usd">6206000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjItNy0xLTEtMA_c524bad5-1a39-4dff-8619-4348e49767b5"
      unitRef="usd">4887000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtMS0xLTEtMA_7d7e2802-6833-4a0c-ae42-ba4076387bbe"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtMy0xLTEtMA_dcc1c113-6c9f-4fd7-a24e-bec2050abd21"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtNS0xLTEtMA_be465134-1fc1-4638-804e-c21734d6121f"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjUtNy0xLTEtMA_67cd104d-84b0-4fa4-a95e-7820acc32c13"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtMS0xLTEtMA_5c81ed09-5119-4ba9-a6c5-0a489dcf1a98"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtMy0xLTEtMA_e3392bc0-2eaf-44fc-b828-dea99764e9b1"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtNS0xLTEtMA_f9f5ffbe-5ae3-410f-b958-50bf948c7283"
      unitRef="usdPerShare">4.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjYtNy0xLTEtMA_47fb7afa-5022-4339-a8af-1d130dea8daa"
      unitRef="usdPerShare">3.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtMS0xLTEtMA_82a052ae-0526-4e62-8c88-961ace14adee"
      unitRef="shares">1310000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtMy0xLTEtMA_e1b7422d-b4d0-4276-92b7-25613635ae50"
      unitRef="shares">1302000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtNS0xLTEtMA_65dc8192-b31b-444a-a8ae-74285b737e4c"
      unitRef="shares">1308000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjgtNy0xLTEtMA_1397b619-08b8-4390-bb33-6896eda07668"
      unitRef="shares">1300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktMS0xLTEtMA_bcc933d0-7bd3-4107-8b0a-544a1f5abfc7"
      unitRef="shares">1315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktMy0xLTEtMA_ac5eeadf-7355-4060-a049-4f6fd36776bd"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktNS0xLTEtMA_38cd2c6c-9bbb-4bd2-a200-96ed9c953d24"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfMjktNy0xLTEtMA_0bc4b594-6365-4593-b15d-1fd933bf9424"
      unitRef="shares">1303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtMS0xLTEtMA_5e9c46a5-dfea-4156-8dc0-78ea15f23d9e"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtMy0xLTEtMA_f540d62e-9244-41d9-bd0a-46f062a0a14d"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtNS0xLTEtMA_ddecab82-0eb1-4cff-9ba1-a994fbe7fcda"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xOS9mcmFnOjhmMzk3MDk5Y2I5MTRmMTA5YjYyNWE0MjlkMDhiMzFmL3RhYmxlOjIxZWQ5OTJmM2Y5YzQzNzk4NjE4Yjg0OGIzZDE4YWFhL3RhYmxlcmFuZ2U6MjFlZDk5MmYzZjljNDM3OTg2MThiODQ4YjNkMThhYWFfNDAtNy0xLTEtMA_88edc237-06d0-48c4-82da-183d6842ef86"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi0xLTEtMS0w_40e4c74e-bad3-4d6c-b1de-96a6000fbc62"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi0zLTEtMS0w_4ed34740-c9b1-425e-821b-c3fc049141ee"
      unitRef="usd">1529000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi01LTEtMS0w_2268025f-fe6e-46a8-86b5-7b9d4c0289ff"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMi03LTEtMS0w_2c73ec5e-901f-418c-9d98-0dde24eaca50"
      unitRef="usd">4887000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC0xLTEtMS0w_0b45e1bc-ff7f-42e5-b893-b20734c62a89"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC0zLTEtMS0w_9ded0518-6a36-4272-80a5-6a61c8dec60c"
      unitRef="usd">136000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC01LTEtMS0w_eb7157be-1b1a-433d-9871-918f2615bf91"
      unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNC03LTEtMS0w_287c7c0f-177c-4541-bddc-189575e90334"
      unitRef="usd">721000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS0xLTEtMS0w_ee560bb1-f29e-4c3e-97df-f0ea33e9b642"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS0zLTEtMS0w_c5577455-d142-421c-87d6-c4c6f893e575"
      unitRef="usd">153000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS01LTEtMS0w_4b7fd8c5-c833-4160-99fe-7c1ec8e5e982"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNS03LTEtMS0w_fdc84569-4d8f-45fe-a02f-2d4ea22454a8"
      unitRef="usd">157000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi0xLTEtMS0w_cce6c74b-7cf4-49ac-a8c6-1e19dd516eb6"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi0zLTEtMS0w_7ab27a0f-d700-474b-a7f2-f0c720d3590c"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi01LTEtMS0w_9384b627-36ed-45df-ba7f-647d2052df40"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNi03LTEtMS0w_5a99f570-a0fb-41c8-a585-0c729c74dd66"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy0xLTEtMS0w_83ff2363-f299-4585-bdd4-df905ea1ac78"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy0zLTEtMS0w_f53bf969-f5b6-4681-b2d5-ec1acbc5568c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy01LTEtMS0w_61867a71-982a-4057-8524-838086e4ac35"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfNy03LTEtMS0w_5f3b287a-dc1a-438d-8186-c85c9d088c77"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC0xLTEtMS0w_98fe7f59-8510-44d8-8728-ce4d83a3a579"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC0zLTEtMS0w_450fe72d-68d7-4bc8-974b-d3b6a749558e"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC01LTEtMS0w_c24fd712-7681-4602-8442-395a359380d9"
      unitRef="usd">236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOC03LTEtMS0w_7586ac89-5e5f-4231-870f-755fa37e6e4e"
      unitRef="usd">848000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS0xLTEtMS0w_151ce4ae-fa04-4527-94e9-8257afeb0856"
      unitRef="usd">1261000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS0zLTEtMS0w_63095918-032e-4bc1-bdd8-8d025999abc2"
      unitRef="usd">1795000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS01LTEtMS0w_322350c2-73b7-44dc-a01a-62af9b9fc17e"
      unitRef="usd">6453000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfOS03LTEtMS0w_ad4121f8-0ca2-48ee-bd7d-0599ba70dc51"
      unitRef="usd">5735000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtMS0xLTEtMA_c7d58cb7-c378-4b4d-94e1-4cb17c1fcde6"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtMy0xLTEtMA_c69b4172-bb66-4308-9c7a-08c046e8e79e"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtNS0xLTEtMA_a51ad6ba-b563-4985-a4d9-ed2b3feb6751"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTAtNy0xLTEtMA_50e3b289-63bd-4a9b-bb6e-83e4e9aaa566"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtMS0xLTEtMA_589aa363-524b-4050-85da-5db48db70d5a"
      unitRef="usd">1266000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtMy0xLTEtMA_7e7914e9-7764-477c-8ac2-97154473dcd9"
      unitRef="usd">1796000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtNS0xLTEtMA_a939e931-09d8-43cf-85b9-10bdbfa2932d"
      unitRef="usd">6442000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yMi9mcmFnOmI3YWZjNmNjNGFjNjQwZGQ4YTU2NTBiNTc5MTljMzU1L3RhYmxlOjhhNDYzYjczZTcwNzQyZWFhMDM4ODMyMDdlZDgyYzkyL3RhYmxlcmFuZ2U6OGE0NjNiNzNlNzA3NDJlYWEwMzg4MzIwN2VkODJjOTJfMTEtNy0xLTEtMA_dfda088e-1218-45e6-aebe-4dbd14bb1d8d"
      unitRef="usd">5735000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMi0xLTEtMS0w_c2b03227-5572-4dbb-b56c-83e8bead8acb"
      unitRef="usd">9256000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMi0zLTEtMS0w_26abf10c-55bb-4ffd-b719-49bd753c9c7b"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMy0xLTEtMS0w_3bf6474e-b109-47f0-81d9-7daaa588fd4c"
      unitRef="usd">2831000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMy0zLTEtMS0w_c6307c42-78ca-4e2b-8031-f87380e63ea2"
      unitRef="usd">2373000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNC0xLTEtMS0w_d915c9fd-88bd-4c31-a779-b0c562a44e98"
      unitRef="usd">23816000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNC0zLTEtMS0w_c355723e-7c7f-469c-89c2-c4181ef26eee"
      unitRef="usd">19617000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNS0xLTEtMS0w_37b9c316-3fe3-433e-ba01-4170db258a20"
      unitRef="usd">17478000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNS0zLTEtMS0w_5b7fb2ab-cdf1-4887-a889-6e9ccf77889b"
      unitRef="usd">17516000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNi0xLTEtMS0w_4a6f874b-4b09-4d5b-861b-00eda0628ba7"
      unitRef="usd">5830000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNi0zLTEtMS0w_a9cc5b5e-cf55-4493-ab8c-695b5f58d31e"
      unitRef="usd">5113000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNy0xLTEtMS0w_750eeb7b-c776-49b5-af65-ccf7b269f522"
      unitRef="usd">59211000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNy0zLTEtMS0w_70547004-9f54-421f-a13e-761a3322a4c1"
      unitRef="usd">50302000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOC0xLTEtMS0w_45843e73-85de-4c6b-ab63-69786507310b"
      unitRef="usd">20216000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOC0zLTEtMS0w_f0090fb9-1b61-4a3f-8e7c-5bf14d16a838"
      unitRef="usd">17314000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOS0xLTEtMS0w_f418dcf9-97e9-400d-9ef8-12aa652ebf34"
      unitRef="usd">12349000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfOS0zLTEtMS0w_0d5385f2-b2fb-439a-915d-73618b0a02b8"
      unitRef="usd">12044000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTAtMS0xLTEtMA_ddf30ed9-b37e-4962-ad88-1f587b8995cf"
      unitRef="usd">20484000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTAtMy0xLTEtMA_c2982adf-a519-45b6-8a47-93ee06b0873f"
      unitRef="usd">20860000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTEtMS0xLTEtMA_b5512fd8-ff2c-4126-8c62-bb5ce008e9ca"
      unitRef="usd">79579000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTEtMy0xLTEtMA_6d6d8b3e-2649-495d-9f89-c09a8db2e3ea"
      unitRef="usd">79749000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTItMS0xLTEtMA_062179a7-5107-4e0c-af10-081d3799ac59"
      unitRef="usd">31697000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTItMy0xLTEtMA_0680dee2-dcfc-436f-b01b-86cb43686b9d"
      unitRef="usd">33121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTMtMS0xLTEtMA_13c9f9f3-f6e9-41a0-af3f-e3f945f32d5a"
      unitRef="usd">4793000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTMtMy0xLTEtMA_6d819780-df9f-4dc0-b046-1de0f1a0b7cc"
      unitRef="usd">4459000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTQtMS0xLTEtMA_f33be83b-fb58-4263-9aa8-3f0be7baf942"
      unitRef="usd">4569000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTQtMy0xLTEtMA_6981b9ef-cb1c-4418-b5f3-8672afd98c4b"
      unitRef="usd">4600000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTUtMS0xLTEtMA_0022791a-87d4-4db1-a676-83be1d7835c8"
      unitRef="usd">232898000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTUtMy0xLTEtMA_fa17c6ce-0c01-4a25-a302-13ef8b810156"
      unitRef="usd">222449000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTgtMS0xLTEtMA_83e4032c-285c-4290-acd1-e927fadae115"
      unitRef="usd">11677000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTgtMy0xLTEtMA_20d2b431-dc04-48b3-a0f0-557e5ab39464"
      unitRef="usd">10492000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTktMS0xLTEtMA_574cfff7-69cb-4452-ba90-0b7f82dade04"
      unitRef="usd">15722000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMTktMy0xLTEtMA_e551ddeb-e242-4fbf-92e3-5e2e50253f5c"
      unitRef="usd">13601000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjAtMS0xLTEtMA_978a94ab-1690-4fdd-8167-a4002551a840"
      unitRef="usd">7593000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjAtMy0xLTEtMA_9fcc4598-a64e-4779-a205-dac7e591b817"
      unitRef="usd">6879000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjEtMS0xLTEtMA_da4ef21b-2fad-4e69-9d27-25b6a86d8d01"
      unitRef="usd">3964000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjEtMy0xLTEtMA_0403faec-19ce-4648-a9ed-4673f2c84ff4"
      unitRef="usd">2991000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjItMS0xLTEtMA_a7b0de32-6b86-4aac-8001-1e3227e3173b"
      unitRef="usd">14329000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjItMy0xLTEtMA_f21d328f-982b-43ed-ad7b-982aed6ad960"
      unitRef="usd">12133000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjMtMS0xLTEtMA_8e571040-daf3-4f43-a3f9-e1ab979f3805"
      unitRef="usd">1527000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjMtMy0xLTEtMA_bf915cca-29b1-4080-a24c-caa3fa0be81d"
      unitRef="usd">1830000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjQtMS0xLTEtMA_1b71c37b-f163-412c-ba0e-88c39e605e90"
      unitRef="usd">1789000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjQtMy0xLTEtMA_1d296d63-36f4-45c9-a71b-c1d953379c1f"
      unitRef="usd">1596000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjYtMS0xLTEtMA_978bb31a-addd-471a-bcb1-d1c1850bf732"
      unitRef="usd">5443000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjYtMy0xLTEtMA_3059af10-2201-4f4f-8ef1-a668f7a5b131"
      unitRef="usd">3781000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjctMS0xLTEtMA_e392661c-8c64-474e-bf5a-74c8bdcdabbc"
      unitRef="usd">62044000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjctMy0xLTEtMA_a4c4abca-1511-499e-87ff-7f3146f7faf9"
      unitRef="usd">53303000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjgtMS0xLTEtMA_9b3eddfa-66b2-429f-a962-bd50d6dac47f"
      unitRef="usd">18489000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjgtMy0xLTEtMA_a28827d1-f310-4ed2-bb48-e4ba317c565a"
      unitRef="usd">18926000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjktMS0xLTEtMA_a13ab023-4b97-4a4d-8c42-cb42a67fac8e"
      unitRef="usd">61552000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMjktMy0xLTEtMA_3da871e6-3f2b-414e-b508-2e3f2508c14e"
      unitRef="usd">64699000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzAtMS0xLTEtMA_29a650b6-9523-4c9c-8855-b951e8658a24"
      unitRef="usd">7253000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzAtMy0xLTEtMA_8528b333-83da-415b-8a06-993f2da3103f"
      unitRef="usd">7294000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzEtMS0xLTEtMA_211b5a5e-e4e2-4e78-92b1-32b782b6cda4"
      unitRef="usd">4793000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzEtMy0xLTEtMA_74b93185-b421-4778-83be-303f7f639675"
      unitRef="usd">4459000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzItMS0xLTEtMA_399d6524-b233-4284-a78b-843e53069d03"
      unitRef="usd">7135000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzItMy0xLTEtMA_0aacf478-3624-49bd-acbe-371732fb3930"
      unitRef="usd">7436000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzMtMS0xLTEtMA_d7b2a5e0-d5d4-445e-91df-37bbc05e2347"
      unitRef="usd">2520000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzMtMy0xLTEtMA_13e0f1a0-b730-47bd-ae44-f35f54a474f8"
      unitRef="usd">2162000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzQtMS0xLTEtMA_105273d7-b2ca-4215-9216-1e63f32b9a0b"
      unitRef="usd">163786000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzQtMy0xLTEtMA_5715bc93-ca03-4f2f-be49-b21344345f7e"
      unitRef="usd">158279000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NDU_3aa82b0e-a1e5-4199-ac3e-8377f9cac95e"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NDU_586df305-4d4f-4df4-8f8d-ba63ac926a9c"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NzI_6441328a-6b8a-444d-befa-170da6c87925"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NzI_70efd269-7e13-450e-a661-68c4d7b63016"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_497cb6aa-229f-43f7-beb0-a27c0422ae85"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_4c70d3a8-b464-46cc-b023-bf9d13e4eb8b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_aa280098-0293-4a4b-a94f-1ed78fb2973d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjMxMTcwM2U3ZGEzMTQxZWRhMDA4N2ZhMTMxM2YyYzZiXzIxOTkwMjMyNTU2NjY_e7cfa6a5-f67f-4b34-ad88-d3948fd4f854"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMS0xLTEtMA_18075276-bc1c-46e9-aa15-918ff49fb912"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzctMy0xLTEtMA_613e2f89-228e-4b13-b5ff-1333010bad33"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDA_133ad208-a3de-4d2e-b0e4-dc19f283cd6d"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDA_a7752080-9ea6-4ff4-a009-95a0d686de33"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MzI_7d8e91ce-34aa-4f74-8402-706d7fe24c75"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MzI_ba641897-7bfc-4410-b43c-4d5dcff9bcd3"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NDY_8a562a42-5dfc-4e8e-93d4-b9b7c48fa4a5"
      unitRef="shares">1732000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4NTI_db036184-321a-4a52-a185-ef8f15fd612a"
      unitRef="shares">1309000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MjQ_aed5be30-9df5-4ace-9ad9-d7ac0ad5a18a"
      unitRef="shares">1727000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjY3MzJjOTlhNWNkNDQzNWNhZDgzZmI5OTNlMWQyYTQxXzIxOTkwMjMyNTU4MTU_699685da-bfb6-4b10-92a9-7a8d5028f286"
      unitRef="shares">1302000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMS0xLTEtMA_777fc57c-c9f4-4f65-8976-095076b662ab"
      unitRef="usd">46388000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzgtMy0xLTEtMA_ddfb0b04-c186-431e-9f61-8c0ef46a5eaa"
      unitRef="usd">45972000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjM5YzMxNjk5Nzk3MjQyZjY4ZDkxYTZiZmU1MjE2ZDg2XzIxOTkwMjMyNTU2NjA_2e6861ad-ea00-401f-89d0-04d687aaad49"
      unitRef="shares">423000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjM5YzMxNjk5Nzk3MjQyZjY4ZDkxYTZiZmU1MjE2ZDg2XzIxOTkwMjMyNTU2NTQ_4314189d-9b61-44b3-a39b-6c0615ad9061"
      unitRef="shares">425000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMS0xLTEtMA_136bd169-8f73-4cc6-8f8a-3d8358f473c3"
      unitRef="usd">28164000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfMzktMy0xLTEtMA_f189fe9d-fe1a-4927-b700-5648c81d2498"
      unitRef="usd">28235000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDAtMS0xLTEtMA_9ae51b24-ab28-4090-9c4a-9f39f7c2fb8b"
      unitRef="usd">49328000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDAtMy0xLTEtMA_d53bdd90-91b4-4b53-b5da-da6a44d35936"
      unitRef="usd">45108000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDEtMS0xLTEtMA_f8fb4d84-ed56-44d5-b7e7-79aa6c325c32"
      unitRef="usd">1255000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDEtMy0xLTEtMA_ed57fec6-a9a5-48e2-b051-61f1550a5a29"
      unitRef="usd">1019000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDItMS0xLTEtMA_45f7f0e9-f27b-4202-bc46-f46d2456b4a7"
      unitRef="usd">68807000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDItMy0xLTEtMA_ff62f909-b34a-4e14-a095-5e9aa6b1eaf2"
      unitRef="usd">63864000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDMtMS0xLTEtMA_e0b22085-4e43-427f-ac8d-52ddb7d1eeb9"
      unitRef="usd">305000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDMtMy0xLTEtMA_64f9a508-3de4-44cb-90d0-e854fb244404"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDQtMS0xLTEtMA_2229b940-b99a-461f-99a7-fd67c03a576a"
      unitRef="usd">69112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDQtMy0xLTEtMA_2b799bf0-6da5-4489-9bdd-1972069ab22e"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDUtMS0xLTEtMA_765daf29-eccc-473a-bc85-09cd6ab19e56"
      unitRef="usd">232898000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8yNS9mcmFnOjk5YTE5NDFhMDU1MzQzMmNiMGQyMTM2ODdiYmRiYWMzL3RhYmxlOjBmOWI3ZWJjOGQxMTRmNTA5YTZjZDdjNTJmMzgxNjRjL3RhYmxlcmFuZ2U6MGY5YjdlYmM4ZDExNGY1MDlhNmNkN2M1MmYzODE2NGNfNDUtMy0xLTEtMA_c5394edf-5123-4126-ae22-07173dd26e82"
      unitRef="usd">222449000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMy0xLTEtMS0w_f54bb764-c905-482a-adc6-daeaad00bf51"
      unitRef="usd">195554000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMy0zLTEtMS0w_34385c18-ba63-4e45-9677-88dc85b24424"
      unitRef="usd">184519000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNC0xLTEtMS0w_f0ccc698-03a7-4cf9-9e85-68f9d47e0b55"
      unitRef="usd">116590000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNC0zLTEtMS0w_fb1ac998-2c05-406a-8c0b-2ba4b2ad19e1"
      unitRef="usd">109958000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNS0xLTEtMS0w_caf75e8f-34f4-4cda-93c0-21a492dce99a"
      unitRef="usd">40221000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNS0zLTEtMS0w_ab8e984a-c140-47aa-8944-01f520630190"
      unitRef="usd">38812000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNi0xLTEtMS0w_c51415e8-6cdd-445a-91ad-2c8d9a48d410"
      unitRef="usd">22185000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNi0zLTEtMS0w_bd8bf17f-3281-41a9-af5f-432f45353e13"
      unitRef="usd">21411000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNy0xLTEtMS0w_bacea0a0-5a2b-4e9e-8ef3-967b5ed790a3"
      unitRef="usd">622000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfNy0zLTEtMS0w_9787e274-04b4-4b52-9509-dfd10e427e68"
      unitRef="usd">756000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOC0xLTEtMS0w_223083be-7301-45dc-95ec-55fbfe454e6d"
      unitRef="usd">2517000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOC0zLTEtMS0w_6c71f4d9-b1f7-4477-9b18-d93cc5849436"
      unitRef="usd">2675000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOS0xLTEtMS0w_ce83cb95-d3a6-4b89-99b3-be1498de7ae1"
      unitRef="usd">2365000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfOS0zLTEtMS0w_a5f0f91b-62e9-4b0e-a686-e21fd27a58ff"
      unitRef="usd">2205000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTAtMS0xLTEtMA_350f5fcb-8698-478d-98d7-b42b70a7d634"
      unitRef="usd">12298000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTAtMy0xLTEtMA_dde80eb7-68b2-4a64-91ee-a44c575b5c1b"
      unitRef="usd">10214000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTMtMS0xLTEtMA_f970070f-6d81-4c07-abd8-7340aab7570f"
      unitRef="usd">3790000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTMtMy0xLTEtMA_3b987535-dc96-4090-8cdc-6035ca3ebaba"
      unitRef="usd">5616000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTQtMS0xLTEtMA_ff8d8114-3e6a-407e-8884-065a00be33c4"
      unitRef="usd">6377000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTQtMy0xLTEtMA_d14198c8-6f59-4abc-8db4-e467433b4543"
      unitRef="usd">6011000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTUtMS0xLTEtMA_9f51c966-32c7-46e7-b34f-422cf5e7284a"
      unitRef="usd">1724000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTUtMy0xLTEtMA_bb73d770-52ed-4afd-99af-841319956e62"
      unitRef="usd">1890000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTYtMS0xLTEtMA_40a0dd36-5ba7-4418-94b6-98e0b1541da4"
      unitRef="usd">828000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTYtMy0xLTEtMA_0495b677-aa0a-45d7-9b22-c1d2c570cc67"
      unitRef="usd">361000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTctMS0xLTEtMA_e79016cd-9d98-4cca-ae5d-4bd64faa1dee"
      unitRef="usd">834000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTctMy0xLTEtMA_eba6fee8-7654-42cf-a061-e9bdf848c6e7"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTgtMS0xLTEtMA_35818ea1-7c81-4049-b66e-458efbb56404"
      unitRef="usd">-5000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTgtMy0xLTEtMA_9390ea12-b285-4f83-abb2-f03cd243535e"
      unitRef="usd">-16000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTktMS0xLTEtMA_3bd04457-686b-412d-82a9-eea666618e76"
      unitRef="usd">-4300000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMTktMy0xLTEtMA_7d292343-0c7b-4a0e-86b7-e2b021ecb1b6"
      unitRef="usd">-2630000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjItMS0xLTEtMA_2813c798-3ec1-499b-8fcc-ddcc11763ddf"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjItMy0xLTEtMA_ff9acee7-ae98-409a-b144-52921383c11b"
      unitRef="usd">350000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjMtMS0xLTEtMA_0539d105-1f19-40bd-8e90-5dda18a66e7e"
      unitRef="usd">7919000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjMtMy0xLTEtMA_49a134ac-7365-4f67-ae10-fa89c60dfc3d"
      unitRef="usd">3458000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjQtMS0xLTEtMA_c8509111-0f84-4b7a-82ef-591adfbee94e"
      unitRef="usd">10493000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjQtMy0xLTEtMA_1c84e9c6-f208-4a33-9d34-1ea2a4456edf"
      unitRef="usd">8350000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjUtMS0xLTEtMA_0c6475b8-15f0-4b14-b71f-bb1a6bf22b7d"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjUtMy0xLTEtMA_5bd39acc-eb6d-4c7f-95d8-1db4cafe4662"
      unitRef="usd">25000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjYtMS0xLTEtMA_be6da3df-fd96-4f40-b447-703d000d0197"
      unitRef="usd">1980000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjYtMy0xLTEtMA_23215908-068d-4e7c-a12c-3de6c9342059"
      unitRef="usd">1952000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjctMS0xLTEtMA_8b22f9fc-cda0-45b6-bf26-fca92df1f466"
      unitRef="usd">249000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjctMy0xLTEtMA_c09e49d1-c6d8-44e7-bd37-e39364b25195"
      unitRef="usd">183000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjgtMS0xLTEtMA_174da498-2e22-4ef9-8c1d-b408eeb08bb9"
      unitRef="usd">75000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjgtMy0xLTEtMA_9a3fc048-0e0c-4413-8ce9-b81ca7d45e9b"
      unitRef="usd">85000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjktMS0xLTEtMA_2e8a5583-16c9-4bad-8447-155570085284"
      unitRef="usd">-33000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMjktMy0xLTEtMA_28115b0f-22f4-44b8-9ad5-74f9b9487dfd"
      unitRef="usd">11000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzAtMS0xLTEtMA_eca96f30-fed3-4552-9169-ff4ec633530e"
      unitRef="usd">-4420000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzAtMy0xLTEtMA_23de2402-b391-4301-aadc-78d660fed96d"
      unitRef="usd">-6410000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzEtMS0xLTEtMA_2859fbde-09b5-464d-b6be-25211cad6451"
      unitRef="usd">3578000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzEtMy0xLTEtMA_720807d4-966d-406f-901e-7abc3982803f"
      unitRef="usd">1174000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzItMS0xLTEtMA_b1f7d448-eb57-4c3b-aadd-a55efed2aff8"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzItMy0xLTEtMA_1a2d078f-c73e-41cb-b4ef-a333d57e3714"
      unitRef="usd">4295000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzMtMS0xLTEtMA_73575e66-c091-4d1b-9cb5-fbc64de50e75"
      unitRef="usd">9532000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjc5ZjNjY2IzMzUxYTQzZmZhODkyMDFlZTA5YWE1M2I5L3RhYmxlcmFuZ2U6NzlmM2NjYjMzNTFhNDNmZmE4OTIwMWVlMDlhYTUzYjlfMzMtMy0xLTEtMA_61ae18aa-738c-46d8-9b1c-daca00e18641"
      unitRef="usd">5469000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMy0xLTEtMS0w_2268025f-fe6e-46a8-86b5-7b9d4c0289ff"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMy0zLTEtMS0w_2c73ec5e-901f-418c-9d98-0dde24eaca50"
      unitRef="usd">4887000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNS0xLTEtMS0w_92f18e07-b590-4129-8cee-c95554a833c8"
      unitRef="usd">3302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNS0zLTEtMS0w_e579efff-48b8-46fb-a3de-0dd9cd684c02"
      unitRef="usd">3275000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNy0xLTEtMS0w_83b0655f-14dd-41ca-9ced-fdcd9a5f746f"
      unitRef="usd">288000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfNy0zLTEtMS0w_1cce8c77-5a36-4475-9bda-30a0cefd55a8"
      unitRef="usd">355000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOC0xLTEtMS0w_482982ea-9816-4cc5-9aba-faefe4ef2d36"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOC0zLTEtMS0w_737dce46-765b-4220-8305-7120176da975"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOS0xLTEtMS0w_5f4d12c0-d604-43aa-a4e4-153be3db8884"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfOS0zLTEtMS0w_2ff8bdc4-b333-4727-875e-37924395171f"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTAtMS0xLTEtMA_0184c787-cb85-4185-af81-fb084812821d"
      unitRef="usd">-25000000</cvs:Deferredincometaxesandothernoncashitems>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTAtMy0xLTEtMA_4aa2f726-9ad0-4882-9124-0605da74bce8"
      unitRef="usd">-38000000</cvs:Deferredincometaxesandothernoncashitems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTItMS0xLTEtMA_8ed8fd02-e94e-48ef-a017-445b8fbe078a"
      unitRef="usd">3564000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTItMy0xLTEtMA_45cad997-ad5e-4d85-92d7-116d978bc078"
      unitRef="usd">2312000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTMtMS0xLTEtMA_6c00bb3a-8c6e-43d4-ba6e-46c08132e201"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTMtMy0xLTEtMA_7c1f9a2b-29bd-4d0a-acce-e31cac171664"
      unitRef="usd">-413000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTQtMS0xLTEtMA_77dad843-4c65-4133-ab41-be9fceaeaa0a"
      unitRef="usd">211000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTQtMy0xLTEtMA_b42f06f3-3e99-4f84-9b88-f28ecedc40ae"
      unitRef="usd">374000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTUtMS0xLTEtMA_08bc6b75-ef42-43e0-8555-6a870cbb25fc"
      unitRef="usd">3495000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTUtMy0xLTEtMA_36d60b8c-f12d-457a-9e7f-13e151a9c2cd"
      unitRef="usd">2330000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTYtMS0xLTEtMA_5280d934-77d8-4f0d-ad09-678e0ff80da8"
      unitRef="usd">-474000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTYtMy0xLTEtMA_c502743d-ee28-4fb1-8efe-75e5c1dddb21"
      unitRef="usd">535000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTctMS0xLTEtMA_478b47ca-aca6-48db-a41e-aa7f219f7024"
      unitRef="usd">2730000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTctMy0xLTEtMA_e4d47c02-8420-49d1-84ca-4aba7e18469a"
      unitRef="usd">859000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTgtMS0xLTEtMA_45a70abf-4742-41fe-ba85-900f1e9421cd"
      unitRef="usd">12298000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zMS9mcmFnOmVhYmQ2OGMwNGQ4YjQ4MGJiZDdkZWEwOGNiNzUzYmZjL3RhYmxlOjU5ZjYwMGY4NzY0YjQ5ZDA5ZDQyMmE3ZTFkNTJlODk0L3RhYmxlcmFuZ2U6NTlmNjAwZjg3NjRiNDlkMDlkNDIyYTdlMWQ1MmU4OTRfMTgtMy0xLTEtMA_7a92f789-5a6b-45e6-93c5-acc296a218f5"
      unitRef="usd">10214000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="i7930220d914f419297614a660281ef47_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0xLTEtMS0w_4fd87ab6-75ab-4ca1-b49e-19caff955270"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i5be942208dc1421797995bf453709517_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd8a0caabdab46cc88debaa0c046f3dd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5be942208dc1421797995bf453709517_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7a539619c134838a1d5f4cca14f9441_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS02LTEtMS0w_55682ca7-d24d-4461-9b92-55c05da064eb"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3172dd72e85d49daa20d2cb9b4f7f9b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS03LTEtMS0w_8e33aa92-b894-4687-92b0-222d60b793d1"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2286aab200f4a1892c679ab6e3b1b9b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS04LTEtMS0w_89508335-41eb-4b03-8ae7-0665b3f5cb3d"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifea3ad7fbde3466cb0d05dc9cd11a22b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS05LTEtMS0w_ab4578ab-b482-40dd-8454-3acdabb48355"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0xMC0xLTEtMA_bd551f50-efa6-400a-ad84-e87ca143fe34"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi02LTEtMS0w_3f8e2ec0-4eb9-45f4-b802-36fe08de89e6"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ca7c827c69941c5994247c772125139_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi04LTEtMS0w_0d894060-9463-45a3-8bc8-47b9f6fbe519"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia87850112c6a4030818cf4c061f75276_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNi0xMC0xLTEtMA_a810d541-ab6d-4a61-a3d2-1b331a95a310"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy02LTEtMS0w_9e4618e7-ec6d-46da-8601-32c134ff805c"
      unitRef="usd">2007000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy04LTEtMS0w_5c5ea346-a386-48bc-b86e-9985989ff854"
      unitRef="usd">2007000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9860b6f9816341359067357c7c165e5d_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy05LTEtMS0w_7103010f-1a44-4e4d-90b6-c8aa5891be91"
      unitRef="usd">5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNy0xMC0xLTEtMA_6d9e09df-92bd-422a-93a8-7814bfe1ba28"
      unitRef="usd">2012000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib4d35ebf9c824b0b907f4c0adae223ca_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC03LTEtMS0w_f759aea1-6606-4e02-934f-3f4395f5b8e8"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC04LTEtMS0w_1ac32a5b-2021-4d97-b618-d5e4e6b78c44"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOC0xMC0xLTEtMA_87522e71-ffab-4055-839f-ca23724cbbee"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie94974140e414714a3341c252c984f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS0xLTEtMS0w_49fcb724-0fe8-4258-b6c7-d9e74174b7c7"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i78a375bd4d6f48e89dfffc71946f4a55_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS04LTEtMS0w_ad6af61a-fe0d-4255-82db-8034db77b213"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS0xMC0xLTEtMA_00460b9c-72a9-46ac-a05c-a07a1186b4f8"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i68042278d5ee4022bdce3f82f62f12b3_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtOC0xLTEtMA_77e0ba07-3541-47cc-8cbc-00c7b00cc530"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMTAtMS0xLTA_5eb92ad7-b1cc-4297-aada-331861aabc50"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i22f7588454db44f6834b3ad5cd52cad7_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtNi0xLTEtMA_19fe7c7c-285f-4557-a735-4b87be2fc35f"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i94c5efbbae5747c89bb9f392085f8f66_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtOC0xLTEtMA_5da596c6-aced-43f0-a2a5-b69010e86245"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTEtMTAtMS0xLTA_69439fcb-6b27-4a43-8b0d-b92ac1c3fdee"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i9860b6f9816341359067357c7c165e5d_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTItOS0xLTEtMA_641536b1-6fe7-4353-9ed8-d2a1fef80420"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i2a9395a402fa4ec69799c2eac7099681_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTItMTAtMS0xLTA_370af8c1-9e6d-439e-be9b-c7b16186c98d"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i99a44be297eb413184028063b42c5faa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMS0xLTEtMA_619be8e8-216c-4c64-b576-eb42b77f57d1"
      unitRef="shares">1729000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i16cc05efec2c470d9c2d81b1369a192d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91e1e6cd716a4e87bfd329666134d286_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781"
      unitRef="usd">46180000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16cc05efec2c470d9c2d81b1369a192d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e"
      unitRef="usd">-28182000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i814ed0bf8ff04a1ab4a1a2b6668545f1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNi0xLTEtMA_0d6960b3-8c15-4d31-9d73-222f7a3e051f"
      unitRef="usd">46455000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fe3dc5bd7df49b582bcd4fb537c3ff8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNy0xLTEtMA_67b60f34-e1a5-4a19-a004-41f1631cfbaa"
      unitRef="usd">687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8df330f945fe40ae939aeecf46b997a6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtOC0xLTEtMA_ccf3eae0-1b18-4600-85d1-31ba8814906f"
      unitRef="usd">65140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f3de2ba29874b91820a6e8738735819_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtOS0xLTEtMA_759f758e-6c60-440c-aadd-9b982bed7575"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i331e56114e3c422584fccdc1dc247161_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMTAtMS0xLTA_725f810b-fb8d-40f4-b4a1-c3f3088f0916"
      unitRef="usd">65474000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtNi0xLTEtMA_31de8147-57fe-4b63-a188-33af5eea9986"
      unitRef="usd">2975000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtOC0xLTEtMA_c7013aa6-fe8f-4f9d-bc4e-6526c2448adc"
      unitRef="usd">2975000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iec4c75a50fb4463093ce50049b985383_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtOS0xLTEtMA_c2cb4bc1-4fc7-4029-adc5-aa819792fb14"
      unitRef="usd">11000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTQtMTAtMS0xLTA_bead2e45-1a49-49ec-9f44-63a62aacfa08"
      unitRef="usd">2986000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3167dd9c7bcb4190a46ac3616a6096d1_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtNy0xLTEtMA_ec8659cf-5fa9-49c9-ae75-90487c1d986e"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtOC0xLTEtMA_6952b2f5-fa30-4f50-8430-987516624e13"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTUtMTAtMS0xLTA_59e45177-132e-4927-a0b5-42a3bbaab5b0"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i571ceac717c84c4a94f70faf7c363371_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtMS0xLTEtMA_2f28c656-ad93-4bba-98de-47ddb130ea9b"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibfe21c1301c6497aadc7f6002c446161_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtOC0xLTEtMA_d0b6b509-51f8-488f-b865-9dfc8b3f2c54"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtMTAtMS0xLTA_d047a976-89cc-4095-af4b-e355e98f2d6e"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8"
      unitRef="shares">1000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="idf232947813e4b9aa4cfee4c1eac6e18_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctOC0xLTEtMA_5da83a20-dd50-418c-9be7-606a1258ab69"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMTAtMS0xLTA_608aa31a-91eb-4126-bd2f-51eda4744100"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i8a360574932e4deaa76bd0d0504a59c3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtNi0xLTEtMA_8be91890-6bec-4ebe-a3fc-88eb97646dff"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i896d743e7acd4e158469b1cf497888f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtOC0xLTEtMA_4ed10a71-e089-4a8f-a54c-566575a30d01"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTgtMTAtMS0xLTA_830b5a2d-d763-433a-8508-9111578f8bb2"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="iec4c75a50fb4463093ce50049b985383_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTktOS0xLTEtMA_beff93cc-6498-4232-bf43-b4803c1a1147"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i4944b9081e7946a4893d6e113d19ece2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTktMTAtMS0xLTA_95777f98-3e14-4e99-be3f-004f312ba323"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="if497738f73ef48128d544b2866a6b773_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMS0xLTEtMA_b819b7bb-1407-4538-b84c-071cab51981e"
      unitRef="shares">1732000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icae7992d69654cb097446acf9b33e297_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a"
      unitRef="usd">46276000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b8b0aa4b51f4f52b2814967a0b2e277_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f29445f39bd4b9d9c0596805a0d36fa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNi0xLTEtMA_aaf448f9-cfc5-474b-8d9d-295202aded9e"
      unitRef="usd">48768000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b7c1d38bf884811b17e7b37aa5fc599_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNy0xLTEtMA_673da8ac-c713-446b-baac-d078d9df9637"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic54229e328244a16acdf5c0ec0ddae47_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtOC0xLTEtMA_51af6c68-bd8b-4d45-9353-88fffdf076d4"
      unitRef="usd">68022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idead255cd4d14401a0f371fbde8693f8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtOS0xLTEtMA_763b6a03-752c-4067-a297-b9df13abe459"
      unitRef="usd">333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMTAtMS0xLTA_875bdcd0-8f02-42c5-bc00-1abc4dc1a4fc"
      unitRef="usd">68355000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtNi0xLTEtMA_b31450bd-6986-489f-a261-3ab5c78e4e25"
      unitRef="usd">1224000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtOC0xLTEtMA_e79187fc-d1af-4d3c-8bed-cc8c0c1611e5"
      unitRef="usd">1224000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtOS0xLTEtMA_f38e4e5c-7c1b-405f-bb31-d6fb7b0b0ba6"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjEtMTAtMS0xLTA_8107e5c9-cdcd-4f09-a1db-1e3b3c7008e7"
      unitRef="usd">1219000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItNy0xLTEtMA_bca3fc5e-b6be-4645-8efe-fcfcc71580e7"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItOC0xLTEtMA_9e509b9f-d6b1-41ce-9f33-371bdcc85d5b"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjItMTAtMS0xLTA_0b850786-d5fd-47be-9d1d-6aa643c3c3e0"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifbd79123bcc14c2fb1cc1eeb95efcaba_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtOC0xLTEtMA_ea0c4dcf-45cd-4705-b8a9-a8bac9600cdd"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtMTAtMS0xLTA_10c6ce53-6568-482b-86f0-f6b42fd187c5"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="id36f48bb62074ed38935780980244861_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="id36f48bb62074ed38935780980244861_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtOC0xLTEtMA_49500b7b-4218-43ab-84e6-a552f0f353a5"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMTAtMS0xLTA_259fbead-40f2-4a75-bc7c-d90e964c0f7b"
      unitRef="usd">71000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i07df0032a50c49169142d3d1b063d71c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtNi0xLTEtMA_e0dcde40-0b05-4ced-9b20-0eed3227dc78"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="if3693386ac4644a9b7e7db8911b2816e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtOC0xLTEtMA_d3dfc810-7c06-4ea6-b198-cea11b7de9d1"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjUtMTAtMS0xLTA_4fe597f9-0fa4-4554-9d17-9a9dd880050b"
      unitRef="usd">664000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i45f2603a727b4f0cabbc9e6ed9ac7cac_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjYtOS0xLTEtMA_af3faa6c-b88e-4ea6-85ea-03878943085e"
      unitRef="usd">-23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjYtMTAtMS0xLTA_47524aaf-bf23-4143-b15d-996576fd9ecc"
      unitRef="usd">-23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ia98a850eb95d4b82868c9616941ead34_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMS0xLTEtMA_f1623710-2e6b-4848-848a-72e026dac5f0"
      unitRef="shares">1732000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ib59819bcb087468789cf0b7b87860688_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e254dc8fb204c0aa8e1af10b2125b4f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda"
      unitRef="usd">46388000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib59819bcb087468789cf0b7b87860688_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d"
      unitRef="usd">-28164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e91a6c1593e4ec4ac7aad6c113f284a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNi0xLTEtMA_c5cd1dd5-956a-4b53-b6c7-63fffc5de911"
      unitRef="usd">49328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i859721481833446fa96d26363301759a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNy0xLTEtMA_76879a22-3faf-457e-949a-3ea3039c5f60"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i106be2d3ad604360afa2a6c2657acdef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctOC0xLTEtMA_1daa1b49-2572-4da7-a90a-4fb944a589c6"
      unitRef="usd">68807000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17b816b179cf48c3875bfe79f11415be_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctOS0xLTEtMA_e526d1d7-1912-4a4a-a390-775506992f11"
      unitRef="usd">305000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMTAtMS0xLTA_35625ea0-0720-409e-be6c-603a0d941078"
      unitRef="usd">69112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTcy_0c73572a-6878-495b-ba0e-c320120f29c7"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_165a15a9-035c-48bf-b3aa-3d8d6e1d0463"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_1d6eb76a-1f80-4ffc-8254-101d19e37b25"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_43d2d5b4-e3d3-499c-8b0a-cf24a89aa700"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i331e56114e3c422584fccdc1dc247161_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMjI0_ba76d0be-7d02-420a-87e6-f7fc16ed3d6b"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="ifafcb02d59004fedbb9332ce962bbb50_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_53ad5b85-df56-4f6a-9d17-54cf7dba2614"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_87052ec5-8ddf-4eb9-9b3e-7da45a202fe2"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i331e56114e3c422584fccdc1dc247161_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_aa0ee566-bc1d-4be7-b5d9-dc50ab4bd38b"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMzk0_c405a5f8-30b7-453f-891e-dadd53db4154"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:SharesOutstanding
      contextRef="i304666a201b045b7ba84e7a502222b26_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0xLTEtMS0w_ed08de51-89ab-4fda-9a94-677357454a2a"
      unitRef="shares">1720000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i514d9c71e8e34b73be0290f1502a1722_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i322a9dc17b8243e6b3fea397bd95e1a8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f"
      unitRef="usd">45440000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i514d9c71e8e34b73be0290f1502a1722_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac"
      unitRef="usd">-28228000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7770f7a96734fbf946266bf7257161a_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS02LTEtMS0w_9e0b00d9-1ca2-423a-beba-b605f24d6214"
      unitRef="usd">40911000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4657fb3ee8e24f7c8bd16ec46224e2f2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS03LTEtMS0w_5f6afe6c-ab1e-4b4a-be2a-5559dc6d2c49"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac7aa78682f147f48082f382fecfef81_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS04LTEtMS0w_e41fd32c-15b0-4ca9-b1cb-994a5e2c27d4"
      unitRef="usd">58225000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i536638a93faa4b458e82d77598e46897_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS05LTEtMS0w_7155417a-07f9-4900-99e2-5999fa110823"
      unitRef="usd">318000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0xMC0xLTEtMA_8678eb05-dabd-4a69-a0ff-1b281368075f"
      unitRef="usd">58543000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1aa9ee857c04106b4ddeb51bba6580f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73aa0acfcc2a4286bbdbe36223128682_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29d78d69f63e43bfbbf2c9b5b9e3a9c2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iebcab56786dc42feae377f091296982e_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy02LTEtMS0w_1ce92be7-e26a-4a76-8808-5a6246a8c0b7"
      unitRef="usd">1421000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy04LTEtMS0w_b79c5b18-8cc9-4e2e-ba26-d422828f3334"
      unitRef="usd">1421000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy05LTEtMS0w_ddfbcf36-b97d-4744-9585-a8b198764645"
      unitRef="usd">6000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNy0xMC0xLTEtMA_ea3210ab-dc36-4649-bc45-214d1d5bba4e"
      unitRef="usd">1427000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1abb168a5e6441d18beffe97e1f3d94a_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC03LTEtMS0w_8e05030d-2e27-46c2-866a-1970b4441db6"
      unitRef="usd">331000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC04LTEtMS0w_d0e1b166-9dc0-4f8d-a2a2-8cfa744cb607"
      unitRef="usd">331000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOC0xMC0xLTEtMA_bdd9bbfa-b596-4bd8-b12b-a6fbbc1576c9"
      unitRef="usd">331000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia143f7ee313e44f7870d98c64e6439b5_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS0xLTEtMS0w_5f9bd4bf-a587-47a4-963b-b8ada6a4194c"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3ae75737b267456a808c79a40b150435_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70"
      unitRef="usd">175000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS04LTEtMS0w_84bd7042-71cb-41d8-bb00-4a83a6c5dac8"
      unitRef="usd">175000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS0xMC0xLTEtMA_b358fabb-5fdf-4246-bd49-9f45101773bb"
      unitRef="usd">175000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i5e100dfeef954e08a223260a0ed8e45c_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f"
      unitRef="usd">7000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtOC0xLTEtMA_6b90a6c5-93e7-417d-86ef-0c146fb279ac"
      unitRef="usd">7000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMTAtMS0xLTA_301a6b1a-bf09-45a4-b568-1bc311729cc0"
      unitRef="usd">7000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="iebcab56786dc42feae377f091296982e_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtNi0xLTEtMA_e3d47582-8e5f-4fc8-b78b-b82872019838"
      unitRef="usd">651000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ifa7322da130845c085a5a33de1d1eeaa_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtOC0xLTEtMA_73c094f5-d952-43d0-abfe-76a7b13a0be8"
      unitRef="usd">651000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTEtMTAtMS0xLTA_d28a436d-1d57-4476-9030-9aadcf49a000"
      unitRef="usd">651000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ia27ff5ef5ba7414cb70e2532324751ac_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTItOS0xLTEtMA_fe58b632-5f7a-450e-b61a-d94848442989"
      unitRef="usd">-4000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i7d4b69975a3348f38ecda42219a17409_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTItMTAtMS0xLTA_14173ca4-0828-4846-9189-9a42cf3a3ec6"
      unitRef="usd">-4000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i06c27729e16e4e42ac7509026e75dd51_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMS0xLTEtMA_56249f4e-8316-455d-bd48-7451d8e135cd"
      unitRef="shares">1722000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i2900867654474cd28dd5045d196ec575_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7aca7df593c34ab7b0fbb5ea78f926f8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25"
      unitRef="usd">45615000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2900867654474cd28dd5045d196ec575_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425"
      unitRef="usd">-28221000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfd1a561806047208b4db1ab9fce4f98_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNi0xLTEtMA_81936578-6494-4612-b877-50ab609a3b00"
      unitRef="usd">41859000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd7700a44a0248e48d1b6d80b0fc2ae4_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNy0xLTEtMA_46a214c2-0ffb-48c4-a8aa-ec1e903085f5"
      unitRef="usd">433000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ab629bbd58a4de092289e615211980b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtOC0xLTEtMA_cd897660-5809-4609-b719-cbc405bc3eba"
      unitRef="usd">59686000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6599ba05330a4711990ed70a0a265e49_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtOS0xLTEtMA_d403db8f-794c-46bb-a8c1-b56b5906f53c"
      unitRef="usd">320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMTAtMS0xLTA_a6c89c21-322a-43db-a64f-36d914eefb0b"
      unitRef="usd">60006000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtNi0xLTEtMA_01ed7fc6-a4af-4086-9c4c-885ed4e9c63e"
      unitRef="usd">1936000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtOC0xLTEtMA_86648975-fdbd-4f8f-920e-eb2fc49a44f2"
      unitRef="usd">1936000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtOS0xLTEtMA_749d154e-8ffe-44b8-9384-eca26c7bd969"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTQtMTAtMS0xLTA_38116780-16ac-4d8f-a7ac-88d247d0af88"
      unitRef="usd">1931000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i203b5e3c33e4404c9d4ea2fe1f4e7ac8_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtNy0xLTEtMA_ce7e5dc0-a731-462a-977e-bc1e5ac28ee2"
      unitRef="usd">251000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtOC0xLTEtMA_511899a4-e9b7-4fd9-add4-98e348fd22ba"
      unitRef="usd">251000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTUtMTAtMS0xLTA_b2577296-ee37-4a05-a541-27e51ee41b46"
      unitRef="usd">251000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id4364493f5734455bb1f6e765963518f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtMS0xLTEtMA_4a6c6063-52b9-4142-a2e9-2f95becf6b10"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iecfc6612a6ec4564bba6c3ed1e8a1395_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6"
      unitRef="usd">104000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtOC0xLTEtMA_18a142ef-e2b7-43ce-a67d-b33d75ebfe24"
      unitRef="usd">104000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtMTAtMS0xLTA_bf6b1388-8c1a-4ca9-85f9-e64f51023a0d"
      unitRef="usd">104000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c"
      unitRef="shares">1000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="id9d61ba12ae34d15a43ae4d5eec39a90_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5"
      unitRef="usd">36000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctOC0xLTEtMA_e5f43b83-5f5f-461f-8bcc-00f7fe011711"
      unitRef="usd">36000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMTAtMS0xLTA_a829d266-f68d-4edb-b96c-a01cdb380030"
      unitRef="usd">36000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i569532a582b94ca89cdff1734a1554e7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtNi0xLTEtMA_885e0da2-fe73-4dfa-8714-aeb043554a3a"
      unitRef="usd">659000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i790756f977fb4fa68a3acce30c0f36ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtOC0xLTEtMA_713d424c-8bbd-4d0f-bb05-ef497483a11b"
      unitRef="usd">659000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTgtMTAtMS0xLTA_8559c578-67ab-4d3d-9439-cae2a357f78f"
      unitRef="usd">659000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i707d9750fa764d0fac871db6e00d8361_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTktOS0xLTEtMA_0231e503-e190-4cba-9b1e-c31a3c197063"
      unitRef="usd">2000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ifd15fee2f4bb437692fc69dc644103dc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTktMTAtMS0xLTA_d35c88e6-e8f7-48df-80d3-df99d23af901"
      unitRef="usd">2000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i7beb7ff5e17d4a42968bb035cef774e6_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMS0xLTEtMA_e12862f2-e938-4d8e-959c-60c3efb6edf6"
      unitRef="shares">1724000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="iff2853021c8b491f9255dba3609410aa_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i463603c2f27845d28c9d3b99a405ff6c_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79"
      unitRef="usd">45719000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff2853021c8b491f9255dba3609410aa_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb"
      unitRef="usd">-28257000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c617f7479a44823b94ae95b119c3a70_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNi0xLTEtMA_1d7ddbfd-cc6b-4f10-8a73-56f66c79d309"
      unitRef="usd">43136000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i389b0e105fc642fda8f98138b1769f1c_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNy0xLTEtMA_86c9cd90-608c-4064-aa9b-42befc75f3c0"
      unitRef="usd">684000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id14f47d35d4043e5bc16b18b14abb993_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtOC0xLTEtMA_128f146e-ead9-411f-9e55-f06decd18026"
      unitRef="usd">61282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2525b67907774a24a2fbd98d30d59e57_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtOS0xLTEtMA_d2061d8e-98db-47f4-9e86-4318db205b2f"
      unitRef="usd">317000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMTAtMS0xLTA_77ba1225-e75f-4317-8db0-b9eb67b1fa8a"
      unitRef="usd">61599000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtNi0xLTEtNTQ1_00648ce9-739f-441b-994a-689402a72d23"
      unitRef="usd">1530000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtOC0xLTEtNTQ1_38f7cb9d-3452-4e87-86ae-e7cd9e6a061c"
      unitRef="usd">1530000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iedfa97c4646a4f34acb951255063b626_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtOS0xLTEtNTQ1_53962c91-8209-48d1-8086-da3000957277"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjEtMTAtMS0xLTU0NQ_55c2d545-eabb-41f5-9f39-e49919d2f6da"
      unitRef="usd">1529000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8030574e46c54dc78075514e087d6aa8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItNy0xLTEtNTQ1_ef33e8cd-c6f2-4b25-ad95-7eafe00649c4"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItOC0xLTEtNTQ1_f82595e8-948e-4672-80ec-7e2d6f58e02b"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjItMTAtMS0xLTU0NQ_feeccd73-8845-4219-8882-3f10797377f6"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i48b23f611534468684876d12f664352e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtMS0xLTEtNTQ1_58a86183-dbed-4510-b51d-3afadad7e90a"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i45b5cd1dd7304ec283b1ce0b506b7741_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282"
      unitRef="usd">135000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtOC0xLTEtNTQ1_c59496b7-63d7-4e3c-b61a-c6bd0d394595"
      unitRef="usd">135000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtMTAtMS0xLTU0NQ_fa4a3fed-5e0e-4f6a-849f-183d664deffc"
      unitRef="usd">135000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="icb2574e2ab7b4a2ab64d3afd50df6638_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d"
      unitRef="usd">50000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtOC0xLTEtNTQ1_8ca45fb2-7b2d-4294-8539-f731731732f6"
      unitRef="usd">50000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMTAtMS0xLTU0NQ_6e3f6859-ea14-4089-90a1-39f03e1ebd66"
      unitRef="usd">50000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i718291396f8f4d0497fec43ae43c14ed_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtNi0xLTEtNTQ1_9972b4f3-2397-4f3f-9cc1-bfb7a2c3f3d1"
      unitRef="usd">649000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="id16e2e9aad394010878e2145ea2184f7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtOC0xLTEtNTQ1_dbecce7a-0f40-4e3b-b73e-a06cef3c2428"
      unitRef="usd">649000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjUtMTAtMS0xLTU0NQ_fd10fd91-07de-4778-b775-603195256e6a"
      unitRef="usd">649000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="iedfa97c4646a4f34acb951255063b626_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjYtOS0xLTEtNTQ1_c032d139-8fc1-4d01-9f64-7923cca06520"
      unitRef="usd">3000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjYtMTAtMS0xLTU0NQ_7c9c7ee2-5b63-44f1-ab46-b2691b7d3ac5"
      unitRef="usd">3000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ic4a47d2a1fec45c3b9b7adb20e61d257_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMS0xLTEtNTQ1_4cf5966b-54a6-4605-a312-111ca4ea1c1d"
      unitRef="shares">1725000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i809b9db9db554177ae44049fc6336a94_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3"
      unitRef="usd">45854000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2aab286caaea4c00ad9b6d762ac5b1c9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec"
      unitRef="usd">-28207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a6a67cb47374fb9b4cc4ed07e526591_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNi0xLTEtNTQ1_9b1bda8e-5c32-40ac-8f64-63b4f3704129"
      unitRef="usd">44017000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a73bed99bba493485113c4e922d1192_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNy0xLTEtNTQ1_53567611-4481-4ac0-9b95-9a4ab78d3d85"
      unitRef="usd">950000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa1b8f41c19444e9be024f7f3599370d_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctOC0xLTEtNTQ1_de899f9a-11ba-4ec0-8c73-a0f3a62612ab"
      unitRef="usd">62614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i113463dad55e48bda48e770726d59193_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctOS0xLTEtNTQ1_e2adbdf6-7af4-4a93-a96a-c196a534c48f"
      unitRef="usd">319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMTAtMS0xLTU0NQ_0348f69a-2927-4f30-9c2e-6707b2bd0fad"
      unitRef="usd">62933000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTMw_f61509d3-e4a3-44fb-b01a-054a0e00d368"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_00cc998d-eea9-4449-912b-f720bcb7a07a"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_42905d89-3d6d-4102-9de1-bba698a43d90"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_47a34913-9400-401a-8d41-8dfea913f5f0"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNTgy_83d78f80-c81d-4288-b2a0-42ac3a0b154f"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_57e87b25-b5cc-463e-86a5-3a822fd25bec"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9f4d513c870c43be98b93640f3f9ccef_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_936a7c25-e468-4bce-b3bd-e540593bbf28"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_9a785e57-45a8-47dc-b71b-6f39d942dafb"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7085a825e90c4759a1618f00e3ab81f2_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfNzUy_f2009d9c-a27b-4f00-8d86-519ea060e5e1"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1aa9ee857c04106b4ddeb51bba6580f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njg_7951009d-cbd5-4d9e-9115-14a83d50c10b">Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation (&#x201c;CVS Health&#x201d;), together with its subsidiaries (collectively, the &#x201c;Company&#x201d;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 103 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 33 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition in the three and nine months ended September 30, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2019 (the &#x201c;2019 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $363 million as of September&#160;30, 2020. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#x2019;s allowance for doubtful accounts was $319 million as of December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Certain prior year amounts have been reclassified for consistency with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2020 and 2019, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes. There was no expense related to the HIF in the three and nine months ended September 30, 2019, since there was a one-year suspension of the HIF for 2019. In the three and nine months ended September&#160;30, 2020, operating expenses included $255 million&#160;and $774 million, respectively, related to the Company&#x2019;s share of the 2020 HIF. The Company paid approximately $1.0 billion, representing the Company&#x2019;s portion of the non tax-deductible HIF in 2020. In December 2019, the HIF was repealed for calendar years after 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $5 million and $14 million in the three months ended September&#160;30, 2020 and 2019, respectively, and expensed fees for the use of this network of approximately $28 million and $26 million in the nine months ended September&#160;30, 2020 and 2019, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $15 million and $20 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2020 and 2019, respectively, and $58 million and $72 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &#x201c;Accounts Receivable&#x201d; above for a discussion of the Company&#x2019;s expected credit loss impairment policy for its accounts receivable. The following is a discussion of the Company&#x2019;s available-for-sale debt security impairment policy and expected credit loss impairment policy for mortgage loans under the new credit loss impairment standard:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of United States Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next 12 months, in which case it is classified as current within the unaudited condensed consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the unaudited condensed consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and other - Internal-Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 350-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTgx_0718fe02-000d-4f7b-8dcb-1881fb677d5f"
      unitRef="building">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjE2_208cdcd9-828e-452a-97f4-01433c3603e3"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberofPharmacyPlanMembers
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjk5_cc376421-36af-4f04-8f8d-68379baaebd8"
      unitRef="person">103000000</cvs:NumberofPharmacyPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzc2_308a593e-d56f-49de-9af6-e17fb3beabef"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices
      contextRef="i0f1e2d2eb6e14cfc96ce16ba745cd95d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfNDc3_cec299a4-b23c-4994-9f7c-9310547430b8"
      unitRef="person">33000000</cvs:NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzk_b25aceb3-967b-4b8e-93d4-4f67695940ea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMyNQ_f6f19f29-ee8e-4410-b743-118a7448fb19"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfStores
      contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzAxNw_0718fe02-000d-4f7b-8dcb-1881fb677d5f"
      unitRef="building">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="if0e1c13224e342d4bf505740f3a173b1_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMzA1Mg_208cdcd9-828e-452a-97f4-01433c3603e3"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NjY_df16075b-f436-47a4-b956-336da2536eab">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2019 (the &#x201c;2019 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njc_1a8ac574-163c-4ec0-a255-f216f7d9b220">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njc_a29e659c-07f5-4714-afae-e97e567a2478">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMjQ_0fefcae1-57f8-45f5-bcab-a172cfe94a03">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4Njk_f6cae31f-8460-4dfc-b6af-94a2ee76e1a7">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNjI_b25f112d-acb4-4e6d-a70e-e7a31e7cc714">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMS0xLTEtMS0w_c2b03227-5572-4dbb-b56c-83e8bead8acb"
      unitRef="usd">9256000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMS0zLTEtMS0w_26abf10c-55bb-4ffd-b719-49bd753c9c7b"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMi0xLTEtMS0w_f626d79b-3232-4f85-b9da-973843cb7eef"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMi0zLTEtMS0w_a732d875-dd3b-4792-a146-e03034aa5a5e"
      unitRef="usd">271000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMy0xLTEtMS0w_7808754c-05c6-453b-847d-da281776ab34"
      unitRef="usd">9532000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjlkODdjZGQwOWFkYTQ2OTI5Mzc1YTNjNjdmMmM3ODliL3RhYmxlcmFuZ2U6OWQ4N2NkZDA5YWRhNDY5MjkzNzVhM2M2N2YyYzc4OWJfMy0zLTEtMS0w_889e812b-d1c7-4012-8564-ffe8cbf62203"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzA_ff0f576a-95ce-4a26-bd83-f8ec4d119859">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMjU_3e0d6ada-38b8-452c-b07d-074b994ab95f">Accounts receivable, net is composed of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMS0xLTEtMS0w_f7e854b8-e46f-4f73-90e1-cbf1ad629f5d"
      unitRef="usd">7265000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMS0zLTEtMS0w_cee39850-c35b-4505-87b5-8f03e6254424"
      unitRef="usd">6717000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMi0xLTEtMS0w_20b7d012-f6c1-4353-b08b-217d9cd5f67d"
      unitRef="usd">10528000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMi0zLTEtMS0w_8b5a8966-3bd4-4615-b1d2-8cc1dffd4f57"
      unitRef="usd">7856000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMy0xLTEtMS0w_75487e4a-76b3-4b32-8d3b-6472df0e686d"
      unitRef="usd">2852000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfMy0zLTEtMS0w_63fc1c4f-8308-480f-a160-e21767c167dc"
      unitRef="usd">2663000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNC0xLTEtMS0w_c3a2f3d3-823c-4c28-8c14-65e2f7bc54b6"
      unitRef="usd">3171000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNC0zLTEtMS0w_0dfe7f3f-d0fd-4ed0-8d9d-5d3afc433975"
      unitRef="usd">2381000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNS0xLTEtMS0w_0c8e78b0-fb0f-4a1d-8144-1462c0e5760f"
      unitRef="usd">23816000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmFjOTgyNTdiY2E3OTQwMGM4YWQ2ODgzOTQ0YmJlMzMzL3RhYmxlcmFuZ2U6YWM5ODI1N2JjYTc5NDAwYzhhZDY4ODM5NDRiYmUzMzNfNS0zLTEtMS0w_b97b8e46-ad00-40da-bcf9-974952402859"
      unitRef="usd">19617000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNTc_bea399b3-2d80-4e8d-9158-e20a38d2d655">The Company&#x2019;s allowance for credit losses was $363 million as of September&#160;30, 2020. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#x2019;s allowance for doubtful accounts was $319 million as of December 31, 2019.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfODg0Mg_f068c62d-fbc5-42f8-8463-453e3f2a06b1"
      unitRef="usd">363000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfOTM1MA_f3a590cc-554e-4744-b017-f63a66383abe"
      unitRef="usd">319000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzY_77443db6-32fc-44b2-a24e-8a5e1e09ede2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Certain prior year amounts have been reclassified for consistency with the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if60c2fe38b9e4eb8b33cbc4e89326d14_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0xLTEtMS0w_c78619d5-6300-4928-9312-4030faa2c7f9"
      unitRef="usd">35505000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia68abf3331714f0cb8a2e46831fee06c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0zLTEtMS0w_d8ce6190-61b7-471b-99be-a7e3a09871a4"
      unitRef="usd">17608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6f85725267e4b2da9c4bd28ed0c0d5d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy01LTEtMS0w_8ceedf5f-7972-4933-adc5-a93aa9592364"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5fcf3cc86944847b4a31907d7b35e8f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy03LTEtMS0w_caa5134b-2771-43ca-b8c2-5faa7e577b39"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd74224b2d0e435b95718f3c4dca914f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy05LTEtMS0w_d1bab68e-0b98-4dab-9baf-da97ddf762c5"
      unitRef="usd">-10051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98dc5453e7af45f08155c02c68159539_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMy0xMS0xLTEtMA_c48a7974-7778-4aa1-ad6f-c50d489eb2c9"
      unitRef="usd">43062000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9af031c4a92b4ad09fedaada5da439a2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0xLTEtMS0w_b56dbc6c-d182-4473-8f40-7e2690067ca3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06443f5cef314ba49659eb8a8ac32230_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0zLTEtMS0w_73e48955-44f0-4849-bb91-0b4a49ba9d0d"
      unitRef="usd">4740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i681ef3f1a45145e38eba1e776de4f06a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC01LTEtMS0w_758a3447-22dd-4798-a6fa-367fc1b6f47d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica0c012858fe46d3aaab3baf1065534f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC03LTEtMS0w_21e45598-55ba-423b-90d4-fdc22025cddd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2f456b2af8343678bde493f23d04c00_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC05LTEtMS0w_1cee113e-5076-4be3-965f-ee6a1a88a6a4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ae828c5b2cf449c9ac7a99073a1bd39_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNC0xMS0xLTEtMA_4916d3a1-d416-4fb3-857c-9f429249713f"
      unitRef="usd">4740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5bfa1ea471448ce90b4228202b8064a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0xLTEtMS0w_a6229f1f-126b-449c-a18b-46f03dc6848e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i152019c18b244202a6b98ccc912ef82b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0zLTEtMS0w_d24ecc5a-672a-4a91-82ff-52fe66b359a5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdea441b1eab46d9958833bd142b99ce_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS01LTEtMS0w_9a7aa2bc-b819-4d52-bd56-acfdb23d96a1"
      unitRef="usd">17165000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ba29cf25cfe44f295754a8809ab4023_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS03LTEtMS0w_ac547e75-f96a-4405-8b04-f26372a1d954"
      unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57c12bcab38f4db5a180e1dac74519b5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS05LTEtMS0w_f7344e7d-5d70-40fe-a802-7bfcbe2ed545"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5785795924964ac09b3c91188817854c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNS0xMS0xLTEtMA_e80ccd5b-121e-4ded-9f55-2a026f235732"
      unitRef="usd">17182000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0xLTEtMS0w_fcee38e0-6ebd-4ac3-9832-e3a35784dc88"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0zLTEtMS0w_21f3f2ca-5e25-4f18-9143-82734a502593"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi01LTEtMS0w_6ae7fa67-a1b0-4332-96d4-bbb366b665e1"
      unitRef="usd">121000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi03LTEtMS0w_7a0a9eba-5a34-48b0-aab9-fbd28fcb8e54"
      unitRef="usd">83000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi05LTEtMS0w_ba8323ab-f2bb-4545-851f-04430afa57b6"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNi0xMS0xLTEtMA_8985122c-4c3d-453a-896c-dd4b4514cb6d"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40fb27941a97406982ff1445053b5d0c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0xLTEtMS0w_0afb284a-c466-4a01-8ad9-a01e25a8f0f6"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb3729dd099643528282f816f5be4d23_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0zLTEtMS0w_c940f142-faf1-4253-ad65-eb73ff174c75"
      unitRef="usd">377000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i316742918ca24a9880fcfd2fb281fdc1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy01LTEtMS0w_c4f9a73c-5c07-4fe0-a26d-019fb4bfb1c7"
      unitRef="usd">1412000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e48083166d94041bb1bde8d8d498c7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy03LTEtMS0w_c9c31bfe-67d2-4ab4-bd51-8d746fa58919"
      unitRef="usd">16000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cfa15ecb949457f94a09cad78662bec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy05LTEtMS0w_f354639f-dad7-476d-8165-63182a63a9f8"
      unitRef="usd">-143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i435b0304464f47fe8980149c5a3e3bb2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfNy0xMS0xLTEtMA_708ee400-1376-419c-b3da-d345aa440557"
      unitRef="usd">1868000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0xLTEtMS0w_13321d59-967c-4143-8e6d-d08ab7a75762"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0zLTEtMS0w_dbd70e17-976b-44b7-974a-10200144b0a4"
      unitRef="usd">22725000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC01LTEtMS0w_1c610931-656c-47cd-8e16-18bd2dccde4f"
      unitRef="usd">18698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC03LTEtMS0w_1230cca0-98cb-4623-8859-70089d5237dd"
      unitRef="usd">116000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC05LTEtMS0w_2aa9b29f-13d6-418f-9b88-aefa1e57d4b2"
      unitRef="usd">-10194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfOC0xMS0xLTEtMA_dac5424d-a261-494c-9220-2b500afec7bd"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18b91e17e6a24590b4303687758fe4b9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTEtMS0xLTEtMA_a4bcf958-3ea8-4c59-80e5-f8e40644a8ec"
      unitRef="usd">21473000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2467201147a4f38bd1790ba260c4d27_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTItMS0xLTEtMA_e53f8ac7-f456-45a2-858d-09688071e079"
      unitRef="usd">14032000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0347d869b3534eed97cc367c2b34c716_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTMtMS0xLTEtMA_5bca5515-5416-4171-9ce5-03b11c83faa4"
      unitRef="usd">206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTQtMS0xLTEtMA_8f694000-ca08-43f1-97b2-c2b0c7805bf7"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i432f620c091b4bd78b8965de6106dafc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMS0xLTEtMA_3d4e2a24-d646-44ac-946d-ebba322af359"
      unitRef="usd">35872000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d19937733dc48c19bbe4192a695643f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMy0xLTEtMA_97f17b03-06e7-4612-9c10-f3a96cd58076"
      unitRef="usd">16687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2cd40721bbb44c7a65f88f72c256ff2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtNS0xLTEtMA_20d884b0-af86-4382-bf90-844eab81822d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaeda413cd32f4c61bb785163c7baf76d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtNy0xLTEtMA_1222d257-d41e-4aec-997b-769f9b16ed15"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47ac41f57acb41e09f8949a2f24746c4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtOS0xLTEtMA_3096c796-2bd3-49ce-b342-fd0a1a4c699e"
      unitRef="usd">-9999000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i838b21cb58bd4282b74606c9a0a75ca6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTgtMTEtMS0xLTA_cd3617fd-2075-42a9-9991-5257a28aedd5"
      unitRef="usd">42560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i715ce306fefc4081b49c626cdda6c223_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMS0xLTEtMA_79a84557-e310-4d4f-87e3-a1de240a498f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i411aec8a49dd43e89d1ec6ac18e88d30_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMy0xLTEtMA_edd200b5-6a01-4dc6-b51c-85df1f0e421b"
      unitRef="usd">4614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i449b3a0364494dc2958f100fb42e4bcd_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktNS0xLTEtMA_c6a07b31-a662-4122-93b4-8ad5dda277a9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bec87bd7c13489ba49dd87596bd5303_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktNy0xLTEtMA_1eaee736-9e3a-4c34-9a21-16bd60d42b35"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i660decdad883483cafae88aabfe86ae0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktOS0xLTEtMA_a75730a8-d872-4df6-a09e-c50b451c33d9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifae42a1df12e4c469ad1f6c21e69a11d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMTktMTEtMS0xLTA_8cccb85a-502f-4292-a1b7-4ed06d06a95e"
      unitRef="usd">4614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e2d37b8ab1f48a890ac86f4563c36d3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMS0xLTEtMA_3b8f50c0-52cf-4567-95af-72111b08a768"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1ff9ed846af4552a659faf486506f87_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMy0xLTEtMA_99e8b98a-0be5-4b83-be5d-e44eca311a1e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77e3a2bcfa204f0fbf7d7eebd45dafcd_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtNS0xLTEtMA_b793f836-7022-4ce0-ad31-ccc0ea3ce9f5"
      unitRef="usd">15507000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92e3a4c36dd343c2ba601ebcd3081b81_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtNy0xLTEtMA_c1a1af85-dc69-4ab5-91f2-07894d5d5c98"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f9b827c136747b2a88c80753d888899_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtOS0xLTEtMA_fd2f3584-e8f5-4005-ae8c-06a8b13e70d5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifaa97cbcb3614677b33155fc7cf8cfaa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjAtMTEtMS0xLTA_76875f48-5e35-4b8c-85a0-d0c68ab5f9f9"
      unitRef="usd">15539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMS0xLTEtMA_11b867ac-f894-48c6-8c66-745939dfb89a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMy0xLTEtMA_e8bc5ce8-8f46-43fe-be25-7d64befc65a9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtNS0xLTEtMA_fe1b2512-20b5-4124-bda1-f378a5cfd749"
      unitRef="usd">146000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtNy0xLTEtMA_492af779-ee9a-426e-b208-ff0effecb122"
      unitRef="usd">117000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtOS0xLTEtMA_6d7972ef-d982-4495-b7c8-d1f905237b33"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjEtMTEtMS0xLTA_2b25f8e4-9f85-43ae-bb55-2782dd4046b7"
      unitRef="usd">263000000</us-gaap:NetInvestmentIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafb782656964430b9ec2cab98566a145_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMS0xLTEtMA_afb2efcc-1c08-44d6-9d6b-0ffb28122e69"
      unitRef="usd">146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99e1d6d67a0041b280b5effb5c549db0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMy0xLTEtMA_eefc493f-0fc2-4281-9868-cdddc12ad344"
      unitRef="usd">165000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i533429b9306d4879913c046da9f37100_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItNS0xLTEtMA_e4ca0cdf-3e08-4dc8-8313-b77835026d61"
      unitRef="usd">1528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i239d475ffe78452ea7477598c48a053e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItNy0xLTEtMA_0823ae02-d8fb-4e69-bee0-710e6dae0dcc"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f98e97d40c5423b825abdc89e4ccb51_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItOS0xLTEtMA_1cb51b48-8cd1-4a81-961b-a6e990d50c41"
      unitRef="usd">-8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e5e2b880bdb4f68b5c1392e7e118d42_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjItMTEtMS0xLTA_ee5ce337-cb6c-4ec9-9e49-99f9c6aaed6f"
      unitRef="usd">1834000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMS0xLTEtMA_76896e40-b890-4ee4-8113-21cc24c55fb0"
      unitRef="usd">36018000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMy0xLTEtMA_af6cc23c-5a2a-4ecb-a56d-ec771c5be17b"
      unitRef="usd">21466000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtNS0xLTEtMA_f10c9e09-ac5a-4966-a628-206149a311cd"
      unitRef="usd">17181000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtNy0xLTEtMA_76fe3ccf-ce07-4efa-91d2-7db6766b3476"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtOS0xLTEtMA_b640e26d-b6d3-4eb4-9eb1-690bd55f9c23"
      unitRef="usd">-10007000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjMtMTEtMS0xLTA_089c5cc9-4b53-4f61-b62e-643656b821fb"
      unitRef="usd">64810000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98e3e29c4fa547aa815092b174966dd8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjYtMS0xLTEtMA_289767d3-27b0-4ba5-ba8b-6a52c7703c17"
      unitRef="usd">22411000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e4c02ab9b2540858add46268ffa4322_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjctMS0xLTEtMA_215ddacb-99c7-4fd4-bb60-2497d16b79db"
      unitRef="usd">13461000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ab42df5d6404b6aac64b89dd954f364_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjgtMS0xLTEtMA_0f812cba-7fb1-45b5-9989-ab2cb4cccced"
      unitRef="usd">146000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjAyZDRjNmVhN2JhNzRlYjQ5NmYzMTA2NGM0NGRkOWRhL3RhYmxlcmFuZ2U6MDJkNGM2ZWE3YmE3NGViNDk2ZjMxMDY0YzQ0ZGQ5ZGFfMjktMS0xLTEtMA_5220d8cf-8b21-40b3-8cce-beba5ddb0c35"
      unitRef="usd">36018000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67b94001396f40909619fbef9b1c041f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0xLTEtMS0w_ee57d427-75f3-4ba6-a37c-e3bf62162f19"
      unitRef="usd">104924000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd1a6a30d65c40cd90c753b012d08b88_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0zLTEtMS0w_95d7f10d-37ad-423a-972a-085827cc1576"
      unitRef="usd">51833000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if12ff9d95029482297d72d6a5dac7ac5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy01LTEtMS0w_d1fa2c41-7770-4a97-9867-933366f95bf6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93eb393efd5947c6bd3a1fa1231f671d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy03LTEtMS0w_5a1c966c-6fad-4451-9d5a-d98807257b2a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i087ffe62239e4208bc8c4970e058712b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy05LTEtMS0w_d6986afa-45be-4428-8f94-5c894979af15"
      unitRef="usd">-30032000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib473644cf5364dc5b2441b72f3e53b43_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMy0xMS0xLTEtMA_2514f8cd-09c5-43cc-866d-f1585336b7eb"
      unitRef="usd">126725000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64a1c66ce18d42d0877b39057bc2673e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0xLTEtMS0w_a3dffcda-0ef7-4e2b-96e7-b095fb32a112"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd0d8f9bf90e4c8699e03540f1dd8563_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0zLTEtMS0w_b2bdbb45-5d9e-4160-b3b5-54b7a03e3873"
      unitRef="usd">14601000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47677f4138234c60890d66d2bf6418c3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC01LTEtMS0w_08eacb85-f2c4-4ae5-a04a-fb20eef53bde"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8bef237b09b44c78b77e40b1baf100d9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC03LTEtMS0w_11f2deb0-4aaf-4827-82cb-631c3e381c3d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d6fe708235e4a8b85cd7b931c2f83e4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC05LTEtMS0w_3108ba0a-44ff-4499-a7b8-f16e3ae588e3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94671fdaa22443daacafbd02d1f71e93_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNC0xMS0xLTEtMA_119a83b7-14bd-456a-88f2-93790d314d62"
      unitRef="usd">14601000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideb21a4e70f24d6fabbb04939d9545c2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0xLTEtMS0w_5f6d98b4-d836-479e-beed-8b4156663bc4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b1d663af0b8401a87dc8961f33034af_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0zLTEtMS0w_cbeedb3a-85ef-4e30-8dcf-f0463548030f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc7ca939d3fb408f88e8741191e0ec27_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS01LTEtMS0w_6f2febe7-d081-4a30-8bfe-21f3b13c5595"
      unitRef="usd">51699000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i142289bb8d554d3dba89eaf41db49f77_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS03LTEtMS0w_103ef18f-09e4-4037-8bc3-3c401d4195c7"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1aada21c113948f5a84bb2a89d8c538e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS05LTEtMS0w_a6863371-09ca-4302-b8eb-f52a8a42376c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b0b26bd74b14fe0af4dc258245d4a4c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNS0xMS0xLTEtMA_f69949bd-e53d-4d5b-9662-36fe45dff10c"
      unitRef="usd">51749000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0xLTEtMS0w_f943de20-a510-46e8-a3e0-fad4c9f7a36f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0zLTEtMS0w_82c2a638-6f6f-48f0-bd0a-45016fad29e1"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi01LTEtMS0w_2f67a743-4b17-47a9-b6f7-c3c1fce95e58"
      unitRef="usd">341000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi03LTEtMS0w_3dcc9a8d-441b-4fc0-8fd9-446423e5cae6"
      unitRef="usd">209000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi05LTEtMS0w_7a21d60e-5c21-496e-9b6e-1d462668c084"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNi0xMS0xLTEtMA_b7350639-9e09-4e57-a09b-75ad410054a9"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc9f76f4e106478f9f7987221d24fea6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0xLTEtMS0w_73b22362-e1df-4641-a1ed-5fa951353da7"
      unitRef="usd">659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i146fec50f41a4066b18078ed43353a6a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0zLTEtMS0w_c2c27eef-b175-445d-a7d2-f10e614ffd2f"
      unitRef="usd">702000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3438bddea238412d98d4e213a4e7b658_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy01LTEtMS0w_1554583e-c60b-4c51-bc3e-082128d9110f"
      unitRef="usd">4324000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i150c031257f14e08a64ab6d6a0e1c8b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy03LTEtMS0w_e4d6ec15-10bd-4fd7-ade7-78213300c900"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f8342dcb699462da75f023641350930_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy05LTEtMS0w_a9f28056-5002-4523-925a-3bac06b33056"
      unitRef="usd">-191000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i607580aaee174297b74cd851382e412e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfNy0xMS0xLTEtMA_55138e6a-ed8e-47ef-a6cd-e35b372012e0"
      unitRef="usd">5527000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0xLTEtMS0w_e0a53b68-f2eb-4b2d-bbe4-c9b6ea9f0485"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0zLTEtMS0w_53195ba6-e7b3-4400-a3f0-7f2a2fc711bc"
      unitRef="usd">67136000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC01LTEtMS0w_3db36c18-e645-4caa-8779-48202177c242"
      unitRef="usd">56364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC03LTEtMS0w_79327dcb-09f3-44a1-959f-f7da27370de6"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC05LTEtMS0w_28bf4789-a330-476b-961a-443770cac5e1"
      unitRef="usd">-30223000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfOC0xMS0xLTEtMA_9357d7d5-6c6e-4521-9c47-3facdd31b971"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8776f7019c0d4b02bb20bab4edd1ed55_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTEtMS0xLTEtMA_65c2c74c-d518-42f3-ae50-5807e55a4acf"
      unitRef="usd">63109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e4d5a1e39de4128aa906bd1685a2ae3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTItMS0xLTEtMA_fe0d8c3b-d1c2-4297-9afb-c85562e65a1c"
      unitRef="usd">41815000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icbe61efd7ac648258b3bf73ea2907f45_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTMtMS0xLTEtMA_27ecc178-46fa-43fa-84d7-43597aab2ef9"
      unitRef="usd">659000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTQtMS0xLTEtMA_00914a20-a819-4b26-9901-d0395bf0f990"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i320c9806d95e4a99a10d60ce8e71c1c9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMS0xLTEtMA_3fbd8d99-afd4-4879-a8e0-abb93037fa07"
      unitRef="usd">103983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9967f494d4c041b0b67ba0b3f772077b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMy0xLTEtMA_221abfdb-0637-4498-8b5e-284d56fd64fd"
      unitRef="usd">49197000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66f838618c784289b3828bffba708455_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtNS0xLTEtMA_4e0c1531-09df-4385-bf07-8ed2753adcb2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i386fd0e763c84defbd4f0294954a23ea_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtNy0xLTEtMA_b412e0ee-c521-4b7b-b7d2-4d01f2e26141"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c443934e4dc4f1e965f9c54fcfc217b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtOS0xLTEtMA_3da815bc-7348-4b29-9acf-57b8101773ea"
      unitRef="usd">-31416000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f042616910a49ada119e413e89e0e93_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTgtMTEtMS0xLTA_6e65b242-0471-4e9e-bc81-206cf99e09c3"
      unitRef="usd">121764000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64110bc1e619481eb011726e790e889c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMS0xLTEtMA_bcb63d99-7d1d-47ab-b0fb-4ca0a2971b7e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ea9166ed44a45cd9916cb9d1531b2b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMy0xLTEtMA_fbcfff77-b377-4f78-b4a5-b95311b7b475"
      unitRef="usd">14288000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica91574825624707af2b7d055d492214_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktNS0xLTEtMA_34a97f9c-133b-4adf-8be7-b497caf76c3e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34993c6bdba44671ad08a231acdcfe11_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktNy0xLTEtMA_80a8e695-08be-4cc3-a316-1c4990603342"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i244b1545347c4b0fba00cd7e0537b12c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktOS0xLTEtMA_a86bb973-d787-4c78-80e4-cb4093adcaba"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eece7da79844b81a88e0f6c39018f57_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMTktMTEtMS0xLTA_2aea3902-8700-4852-8f40-6809322e7b88"
      unitRef="usd">14288000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib25083b6bc234531b154c27aa6adaa6d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMS0xLTEtMA_4d636c60-3c45-4ba1-9d22-47389d1342c7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if67f1e55874b4139aedf9e515c8e7960_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMy0xLTEtMA_71eabe6a-5892-4327-bec0-119cd56d3e50"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia569eb9b80b044f3b51c6f4972c0f31e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtNS0xLTEtMA_85696d83-4b08-4044-9767-f5db7c1de180"
      unitRef="usd">47543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3403a6bf73644e22b0ddb226f5361865_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtNy0xLTEtMA_cf18e4ca-ec57-4b19-a95e-8e07b554512d"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib77d598c37e24619b64ce36f408cea80_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtOS0xLTEtMA_9d7a6175-786a-4c2a-82bd-309ddfed4fb0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f3cd5501d3844e8a92c6e7b9f858352_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjAtMTEtMS0xLTA_dde8f337-1641-4dbb-9643-4344fe9b7264"
      unitRef="usd">47612000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMS0xLTEtMA_489744cb-ecb1-4649-b033-d2f13e4155fb"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMy0xLTEtMA_ec2b5070-d4a0-426f-9d61-27c5b541ceb9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtNS0xLTEtMA_f3bd9b40-b4ed-4d4b-9b09-76f0a7e6a999"
      unitRef="usd">458000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtNy0xLTEtMA_444e237f-38bb-459d-947f-e52da4f5e65e"
      unitRef="usd">347000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtOS0xLTEtMA_da051905-6790-4a91-b1a9-e225da91f1ba"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjEtMTEtMS0xLTA_9f439ca9-c225-4708-b253-6f0179ebe75e"
      unitRef="usd">805000000</us-gaap:NetInvestmentIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9660fb77d4984d64ac93c4db44804b30_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMS0xLTEtMA_df542f86-8cd7-4e7c-8904-c89eb06d6314"
      unitRef="usd">435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6a9d2c4000f4239977b19d16ba37d4c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMy0xLTEtMA_1cf2bd33-c0ee-40b1-8b9c-240b6ab7c91b"
      unitRef="usd">543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebd799ddeb88438e89d5c5d78dceda1b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItNS0xLTEtMA_c94c04e7-5e93-4459-a5d6-59a137333423"
      unitRef="usd">4453000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i521b36cc1f1249c78083a5dd3ae92540_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItNy0xLTEtMA_10d90254-3f01-42de-8938-f6b9f768655e"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i237b71611de94c4aa41507133bd24f34_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItOS0xLTEtMA_26790e86-34c9-458f-bebf-06a128294e28"
      unitRef="usd">-20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cbec7d8ab8e4c3cb30b140669a8cdf9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjItMTEtMS0xLTA_16d5112a-1761-4d6a-aa00-94b3522547b0"
      unitRef="usd">5418000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMS0xLTEtMA_b1ca7332-934e-4b0f-802b-c70a36636543"
      unitRef="usd">104418000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMy0xLTEtMA_6c1a499c-8fde-447f-a696-31fd55b4ef42"
      unitRef="usd">64028000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtNS0xLTEtMA_23c8b838-cf9d-4c24-b577-64997b209abf"
      unitRef="usd">52454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtNy0xLTEtMA_d339927e-4fa0-47b1-833e-06484aa329be"
      unitRef="usd">423000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtOS0xLTEtMA_f5b8388d-7c9f-4843-b508-20262b5a4a9e"
      unitRef="usd">-31436000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjMtMTEtMS0xLTA_b487745c-203e-4bca-adee-7ed54c2fcf67"
      unitRef="usd">189887000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0add470a8c5f49b899b9f413ff91d02b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjYtMS0xLTEtMA_bfd507ea-f7f3-40af-8bec-6ad922ffea6b"
      unitRef="usd">65917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46597caa3b364945b2d7360795884f6f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjctMS0xLTEtMA_37914af6-43ae-4f85-a3bd-b011a3c72db0"
      unitRef="usd">38066000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ef78d632fbb4792bd265cce79e92c17_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjgtMS0xLTEtMA_67b815c0-2200-4227-905b-b72b57b9eabb"
      unitRef="usd">435000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOmNhNzRlMTU5NTIzZTQ2YThiNGQ5MWFhMjU1ZjY1Y2MzL3RhYmxlcmFuZ2U6Y2E3NGUxNTk1MjNlNDZhOGI0ZDkxYWEyNTVmNjVjYzNfMjktMS0xLTEtMA_c285a5ca-b6b5-469d-bcc7-57d8b045b693"
      unitRef="usd">104418000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzNDg_9e9bdf02-4502-423d-b74d-f1c6516b9d7b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjMzMzI_3aa5a710-0cfd-44b6-9f58-2de802040e65">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2020 and 2019, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMS0xLTEtMS0w_f7e854b8-e46f-4f73-90e1-cbf1ad629f5d"
      unitRef="usd">7265000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMS0zLTEtMS0w_df4301eb-4142-4aef-bf54-5103a481b5dc"
      unitRef="usd">6717000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMi0xLTEtMS0w_2e4ebdd7-9d70-4081-ac57-bd823bdd218a"
      unitRef="usd">75000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjBlYmI1YzlhMDQ4OTRiZTQ5YTdjMGNjMzA3NjYxODE0L3RhYmxlcmFuZ2U6MGViYjVjOWEwNDg5NGJlNDlhN2MwY2MzMDc2NjE4MTRfMi0zLTEtMS0w_9604c0a7-e503-4221-89b1-d8e68edddc86"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMi0xLTEtMS0w_9604c0a7-e503-4221-89b1-d8e68edddc86"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic1760dd0c327472392df2791068fb782_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMi0zLTEtMS0w_22ebcade-15cb-4b72-b6ee-788d49284b1a"
      unitRef="usd">67000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMy0xLTEtMS0w_1c9516f5-4e3c-4941-bfae-53097dbbe7d2"
      unitRef="usd">266000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfMy0zLTEtMS0w_45d1a240-9168-4d35-b63b-348ea84cf99c"
      unitRef="usd">269000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNC0xLTEtMS0w_2a971420-a4ed-4294-89ab-d9a459b3ea98"
      unitRef="usd">264000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNC0zLTEtMS0w_91dc4c3a-0c8a-41e9-8aba-02fd89e283ba"
      unitRef="usd">264000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNS0xLTEtMS0w_2e4ebdd7-9d70-4081-ac57-bd823bdd218a"
      unitRef="usd">75000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6a7e2874d0ab43299169519779fbc2d9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RhYmxlOjZiNzFmNjdjNDVkMDQzNWJiN2ZmNmZmNzJlNzQ4NWVmL3RhYmxlcmFuZ2U6NmI3MWY2N2M0NWQwNDM1YmI3ZmY2ZmY3MmU3NDg1ZWZfNS0zLTEtMS0w_2def2ae0-8ee3-4312-80e7-63002a7cf7b0"
      unitRef="usd">72000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzE_0ed22279-fe62-4514-ad08-0c1e9b94ed71">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes. There was no expense related to the HIF in the three and nine months ended September 30, 2019, since there was a one-year suspension of the HIF for 2019. In the three and nine months ended September&#160;30, 2020, operating expenses included $255 million&#160;and $774 million, respectively, related to the Company&#x2019;s share of the 2020 HIF. The Company paid approximately $1.0 billion, representing the Company&#x2019;s portion of the non tax-deductible HIF in 2020. In December 2019, the HIF was repealed for calendar years after 2020.</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTE5NjE_a8dcb410-a5b6-49f4-92d1-f1efcac39b1a"
      unitRef="usd">255000000</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTE5Njg_15cee080-4644-47ad-b1e0-42733586ec35"
      unitRef="usd">774000000</cvs:HealthInsurerFee>
    <cvs:NonTaxDeductibleHealthInsuranceFee
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMjc0ODc3OTA5MzQ5Mw_a2110dbc-ab8c-43e2-826f-0de8c59434ce"
      unitRef="usd">1000000000.0</cvs:NonTaxDeductibleHealthInsuranceFee>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzI_387aefe8-92cd-48fc-8e4a-476ad37142ae">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $5 million and $14 million in the three months ended September&#160;30, 2020 and 2019, respectively, and expensed fees for the use of this network of approximately $28 million and $26 million in the nine months ended September&#160;30, 2020 and 2019, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $15 million and $20 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2020 and 2019, respectively, and $58 million and $72 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI0Njk_8085e3d8-1bb4-47c0-a78a-1cba6443b141"
      unitRef="usd">5000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI0NzY_05b3e570-2d2c-4fdb-9742-a2c5852f95ab"
      unitRef="usd">14000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI1OTM_730a858d-54ff-4cf6-8d84-57a9634761d3"
      unitRef="usd">28000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI2MDA_702f7ff4-b0eb-4dfd-a3af-39e33dd68b70"
      unitRef="usd">26000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="ieacdea7e3b834282abaee6b57e493b85_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5MDY_c389ce27-9c22-4169-b486-1477d73ab95a"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5NDQ_8070ab6f-37b1-4779-8d45-dc158630048b"
      unitRef="usd">15000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTI5NTE_dcafe791-6510-487f-af98-988e8a48b238"
      unitRef="usd">20000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMwNTI_6d5997dc-7c17-428d-a7e6-bf0c9802ad3d"
      unitRef="usd">58000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTMwNTk_e060a93a-6e2b-4200-9950-f1e8ba461e9a"
      unitRef="usd">72000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTA5OTUxMTYzMDE4NzM_569e974b-cd96-41c7-b405-e80287392e3c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &#x201c;Accounts Receivable&#x201d; above for a discussion of the Company&#x2019;s expected credit loss impairment policy for its accounts receivable. The following is a discussion of the Company&#x2019;s available-for-sale debt security impairment policy and expected credit loss impairment policy for mortgage loans under the new credit loss impairment standard:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of United States Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next 12 months, in which case it is classified as current within the unaudited condensed consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the unaudited condensed consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and other - Internal-Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 350-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e9b24fa234b42ccb0f09b27bda781d6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80My9mcmFnOjhlMTM5ZDMxMWEzZTRiMDM4ZDBjMmYwNjRhMmMwYjdmL3RleHRyZWdpb246OGUxMzlkMzExYTNlNGIwMzhkMGMyZjA2NGEyYzBiN2ZfMTQxODY_3f8e2ec0-4eb9-45f4-b802-36fe08de89e6"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzgw_db67b980-efb0-4154-8145-77d2d98e6b53">Divestitures&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Workers&#x2019; Compensation Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, the Company sold its Workers&#x2019; Compensation business for $850 million, subject to a working capital adjustment. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $271 million in the three and nine months ended September&#160;30, 2020, which is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited condensed consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMTE4_24ed2982-37fe-4bc7-bb77-48388e775fec"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i06b05ec92127409d8b14837cfb2ca48f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzQ4_71e8ab6b-1ef8-4c1d-8875-b97dff1f22dd"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4a486a6add824c1a92ba6c55d3d50c15_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfMzQ4_e6e8f123-903e-4367-b00c-e70184c15a7a"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold
      contextRef="i0bf70ec2a8ba4060b9ae0ba5571df5d7_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfODI0NjMzNzIxMTM5Mg_d081c9ce-486d-4c72-bd40-938172eb4b0e"
      unitRef="store">50</cvs:DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i8cc9af3b8a554fbf97555c8eb6980261_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV85MS9mcmFnOjc5NjFjNGE0NDExMjQ0ODJhNjY5MmE5MWJkZmE1MmI4L3RleHRyZWdpb246Nzk2MWM0YTQ0MTEyNDQ4MmE2NjkyYTkxYmRmYTUyYjhfODI0NjMzNzIxMTM3OA_49e76c16-c0ac-4dab-b882-77c27a2c88ee"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU1MA_413b4ee5-c000-43da-93f9-413aa84d2d68">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.093%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;for Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At September&#160;30, 2020, debt securities with a fair value of $928 million, gross unrealized capital gains of $122 million and gross unrealized capital losses of $1 million and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at September&#160;30, 2020 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at September&#160;30, 2020 and December&#160;31, 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2020 were generally caused by the widening of credit spreads on these securities relative to the interest rates on U.S. Treasury securities, driven by the adverse economic conditions in the U.S. and abroad caused by the COVID-19 pandemic.&#160;As of September&#160;30, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the three and nine months ended September&#160;30, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at September&#160;30, 2020 and December&#160;31, 2019, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September 30, 2020. Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September 30, 2020. Net realized capital gains are net of other than temporary impairment losses on debt securities of $9 million and $22 million, respectively, in the three and nine months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, and $10 million and $33 million for the three and nine months ended September&#160;30, 2019, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUwNQ_b223dee3-1927-465d-86a3-2377f21bc842">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0xLTEtMS0w_cd93ac7e-d33f-415f-9ea8-65813c495f8d"
      unitRef="usd">2578000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0zLTEtMS0w_67549d10-31f5-417d-8481-8d6af5932913"
      unitRef="usd">17820000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i48f4fdba61e842189cfa49c83ec10819_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi01LTEtMS0w_fee62436-d1c5-4984-bdf3-6962afa65d04"
      unitRef="usd">20398000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi03LTEtMS0w_c9cbf007-8442-4ba7-a1b8-373547924a8a"
      unitRef="usd">2251000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi05LTEtMS0w_4dfcec4b-eba5-4049-a669-b21c827b6840"
      unitRef="usd">14671000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i90d6cad673fc4f5b888c93220ba6b3b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMi0xMS0xLTEtMA_17eb29fa-1a6f-4da6-8d14-d46d4c377eeb"
      unitRef="usd">16922000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0xLTEtMS0w_3e29dcd0-9082-401e-b027-a27660054c92"
      unitRef="usd">253000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0zLTEtMS0w_cd04fccf-3d0b-4f2d-9ea5-18561d30f420"
      unitRef="usd">871000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="if5a85409a01d450381c1b2224ea4c3b5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy01LTEtMS0w_298f2f00-4fe2-4c8f-ab46-87c51feb3c50"
      unitRef="usd">1124000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy03LTEtMS0w_a731c2d7-53c1-44f2-840a-e9b7d71a674c"
      unitRef="usd">122000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy05LTEtMS0w_376121c6-cafe-4087-adaf-beae95b73fac"
      unitRef="usd">1091000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="icc728f8b775348d4957fcbc0f71e7f96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfMy0xMS0xLTEtMA_a282000b-30df-4413-a5bd-661b2d194c55"
      unitRef="usd">1213000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0xLTEtMS0w_2f5a3705-4671-4264-a386-ad989d89a15c"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0zLTEtMS0w_5e11a0a8-4e5d-4654-94a2-2d3c5be2f806"
      unitRef="usd">1525000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="id1d9eacd813548bba5ca12f875c2a76c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC01LTEtMS0w_941611c5-22f1-487e-a7be-508d2908b737"
      unitRef="usd">1525000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i120ad616a34646769659abc5ca27affc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC03LTEtMS0w_58ac2183-0578-4571-8a2c-057095194c39"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i120ad616a34646769659abc5ca27affc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC05LTEtMS0w_e17ec6ab-fe7d-494e-a310-21c23a846dbf"
      unitRef="usd">1552000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i120ad616a34646769659abc5ca27affc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNC0xMS0xLTEtMA_12a8d32b-ce41-4c71-a1d0-b09d325ae30d"
      unitRef="usd">1552000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0xLTEtMS0w_583dc710-fd49-4765-b516-fea551dcc09d"
      unitRef="usd">2831000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0zLTEtMS0w_a1f4c050-1aed-4c21-8d12-8907f4d92d7e"
      unitRef="usd">20216000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS01LTEtMS0w_2ee4ba3c-a406-429c-b0fb-97d904eef3ce"
      unitRef="usd">23047000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS03LTEtMS0w_1e077436-2d32-4b3e-8574-9ddafea74c0d"
      unitRef="usd">2373000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS05LTEtMS0w_d87dae31-5ef4-44bb-a3d4-1fda1634abd7"
      unitRef="usd">17314000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmEwOGFkZDc1ODMzNjQ1ZGNiZTA5NDU1NjVkZmZkNTczL3RhYmxlcmFuZ2U6YTA4YWRkNzU4MzM2NDVkY2JlMDk0NTU2NWRmZmQ1NzNfNS0xMS0xLTEtMA_3e6db5a3-aa0b-4a64-8960-6a1c75b271fd"
      unitRef="usd">19687000000</us-gaap:Investments>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU1MQ_8c70984b-c9df-49fc-a975-ffcb9965fff0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.093%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;for Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At September&#160;30, 2020, debt securities with a fair value of $928 million, gross unrealized capital gains of $122 million and gross unrealized capital losses of $1 million and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0xLTEtMS0w_923b6d7e-d2ba-4ee5-9fe8-798b11f6675d"
      unitRef="usd">2455000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0zLTEtMS0w_97be8f6e-a83d-4006-94a4-eda69cc9984a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy01LTEtMS0w_38e5db15-c583-4e1b-93f5-c18dd482140f"
      unitRef="usd">2455000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy03LTEtMS0w_02f72e6a-8bfe-407e-aa7a-45c9708c1d7d"
      unitRef="usd">146000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy05LTEtMS0w_bd23857c-a0b8-4d56-a74f-0dcde772bc36"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMy0xMS0xLTEtMA_6c0090d2-ec38-493b-a4c1-0100b54a7b54"
      unitRef="usd">2601000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0xLTEtMS0w_1128db45-78b6-48be-927b-5023053549ad"
      unitRef="usd">2393000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0zLTEtMS0w_7348634d-da7c-421c-880c-5bc982784f87"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC01LTEtMS0w_b72b3443-a4e3-4bb4-bb6e-863e39979c98"
      unitRef="usd">2393000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC03LTEtMS0w_95c22409-1547-4a8a-b9fa-b4706cfec190"
      unitRef="usd">150000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC05LTEtMS0w_66ba4d4d-5af1-4e1d-8a44-e8ab306a3785"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNC0xMS0xLTEtMA_7d345453-2ef0-4f81-8efb-c4019af531c4"
      unitRef="usd">2540000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0xLTEtMS0w_3b05fe86-9b45-4460-992b-784fed97a1c1"
      unitRef="usd">7665000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0zLTEtMS0w_8feb5894-acac-456e-82f9-685988fd3cb8"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS01LTEtMS0w_319ef358-1218-41eb-b825-38ca0deda7e7"
      unitRef="usd">7661000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS03LTEtMS0w_1d4964b0-4504-4607-81fd-9131867ba676"
      unitRef="usd">878000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS05LTEtMS0w_cedf16cc-87bb-4e54-a031-252733627b6f"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNS0xMS0xLTEtMA_1a688190-c83b-4c4f-b251-66bc3ed58562"
      unitRef="usd">8524000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0xLTEtMS0w_2c0917ed-2594-41be-83e4-a1b090d43d37"
      unitRef="usd">2479000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0zLTEtMS0w_276dafc0-136b-4e2e-b86b-f62fea8ebc23"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi01LTEtMS0w_a3e4f6cc-7614-44a5-bd75-a081a88b7503"
      unitRef="usd">2479000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi03LTEtMS0w_54d69b87-32bc-43d5-842a-29552c40577f"
      unitRef="usd">252000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi05LTEtMS0w_7370d9cf-eb8a-4c79-a698-13c3bf6fe414"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNi0xMS0xLTEtMA_04d8f7a8-3ffd-4eaf-a3c5-07d69fb81851"
      unitRef="usd">2721000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0xLTEtMS0w_11f3aa4f-710a-409c-a2b0-9890ba41662c"
      unitRef="usd">680000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0zLTEtMS0w_739e9f5f-5b8a-494b-bf70-c691c46f49c9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy01LTEtMS0w_9d2d90af-0c2b-4e64-9919-a40d0df06497"
      unitRef="usd">680000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy03LTEtMS0w_4ce658e1-f0b1-4637-98f1-80ec230e30b2"
      unitRef="usd">33000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy05LTEtMS0w_a6234ca9-6eee-437f-b2df-4d4927385eb7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfNy0xMS0xLTEtMA_267005c4-f060-44e8-800b-4251371950dd"
      unitRef="usd">713000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0xLTEtMS0w_dd613281-07f7-4380-a3dd-351905d7e6cb"
      unitRef="usd">930000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0zLTEtMS0w_2f524015-c4ea-4c98-8dae-5a7f200424dc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC01LTEtMS0w_d971e434-5604-4876-a189-ba7c1d7f52a3"
      unitRef="usd">930000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC03LTEtMS0w_1fb6e360-b05c-4b2a-898c-883bb4f51ef9"
      unitRef="usd">82000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC05LTEtMS0w_ffc3d7cb-a97d-4fc2-b5d1-26fddf681afc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOC0xMS0xLTEtMA_e42b86ad-a14c-44d6-91f8-1d15ed01ee01"
      unitRef="usd">1012000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0xLTEtMS0w_df1054c1-2cdc-424f-b15f-12aa4591b5cc"
      unitRef="usd">2239000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0zLTEtMS0w_58731f6e-6725-4272-afcc-4671ca7c3c6e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS01LTEtMS0w_282ae7be-3dc1-4828-ac2c-de69ea0b8776"
      unitRef="usd">2239000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS03LTEtMS0w_297bef02-20a7-43e6-bb73-c259ccf70ddc"
      unitRef="usd">33000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS05LTEtMS0w_2ac49e18-d67d-4e52-9e1c-7b577291d6be"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfOS0xMS0xLTEtMA_682ccec1-a887-4b21-8515-5518672bb3c1"
      unitRef="usd">2262000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMS0xLTEtMA_19d1cef5-a30b-4880-a9d0-13ea1a286c20"
      unitRef="usd">22000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMy0xLTEtMA_aa97fb63-1b99-40cc-bb65-46cd818f4de7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtNS0xLTEtMA_0e3dba66-d7d5-4b81-bc60-21399ce220a2"
      unitRef="usd">22000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtNy0xLTEtMA_61abd418-b875-4dc4-960e-c22401b46d16"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtOS0xLTEtMA_55470918-7bc7-4c7c-b681-92ba42d5dabd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib18c0fd3e8bd4a1da4dbaf0296720a13_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTAtMTEtMS0xLTA_8ceb4eb4-6fcc-4340-a353-347d3c331315"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMS0xLTEtMA_4ab9cb92-154d-48aa-b72f-85c7f198d52e"
      unitRef="usd">18863000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMy0xLTEtMA_8aa1b22c-9f37-4140-b003-144a200f6e32"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtNS0xLTEtMA_328f2333-d7f0-43e2-b236-b3938bdcd6b0"
      unitRef="usd">18859000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtNy0xLTEtMA_e3444f80-5758-4d59-9092-3f187dff1378"
      unitRef="usd">1577000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtOS0xLTEtMA_eeb904fc-6ae9-47d2-b924-b34fa675092f"
      unitRef="usd">38000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTEtMTEtMS0xLTA_522086a0-cd28-4700-a9c4-111186e7f6d7"
      unitRef="usd">20398000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMS0xLTEtMA_146735de-8107-4ddf-9b89-7662623727ac"
      unitRef="usd">1791000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMy0xLTEtMA_b7dfc247-4cf6-4b5e-9b6b-bbe1ab57025d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtNS0xLTEtMA_b7c90a1a-59f9-43b6-836f-08b6c054251e"
      unitRef="usd">1791000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtNy0xLTEtMA_2d7dd4f8-b054-45c2-8bbc-51cf402f4cca"
      unitRef="usd">62000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtOS0xLTEtMA_1614155e-2335-4878-a8e0-ecbbed0dbca5"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTUtMTEtMS0xLTA_142a8fa7-99a1-4769-9190-b665edc1eb62"
      unitRef="usd">1852000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMS0xLTEtMA_f24d5dbf-73b3-4500-9b84-19953e34cd38"
      unitRef="usd">2202000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMy0xLTEtMA_6916ac69-b76b-4e7a-8be4-73dbc34f353d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtNS0xLTEtMA_afb17d2f-c5cd-41b5-b9dc-465095bf8b7b"
      unitRef="usd">2202000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtNy0xLTEtMA_61962029-74b7-47c7-80e8-5b31e656aeaf"
      unitRef="usd">108000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtOS0xLTEtMA_39f69c9f-4a15-4f80-b923-a2c8765de358"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTYtMTEtMS0xLTA_121a6729-2a5a-4547-8a4e-3d66f2fe0c72"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMS0xLTEtMA_11b99440-c830-4621-974f-5ac0ef230e07"
      unitRef="usd">7167000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMy0xLTEtMA_32c30da9-d9ae-48a4-abd2-863378f9bb8d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctNS0xLTEtMA_d266ea70-5791-46e6-bad8-39a1fd80c0cc"
      unitRef="usd">7167000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctNy0xLTEtMA_f406d7e5-62d6-46e3-927f-c71b7a4ec6dd"
      unitRef="usd">573000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctOS0xLTEtMA_5cf64e2f-2b07-41ee-966d-b62162ba8889"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTctMTEtMS0xLTA_eb2d3acd-e8d8-49db-9fd8-30faefdefb71"
      unitRef="usd">7737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMS0xLTEtMA_52188d8d-66f6-4e4b-ad3d-69bbd272c8e1"
      unitRef="usd">2149000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMy0xLTEtMA_0f87a39f-b80c-40a1-8cff-1f09e7fcba7f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtNS0xLTEtMA_bc8d2f26-4078-469a-9773-bda012ce3b07"
      unitRef="usd">2149000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtNy0xLTEtMA_0e9051db-2d8a-417b-a04b-f48700b148be"
      unitRef="usd">200000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtOS0xLTEtMA_d79fecb6-58e6-4a7e-82fa-084779bab1b6"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTgtMTEtMS0xLTA_bddc2835-4581-42c6-93ea-82484147c427"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMS0xLTEtMA_586e3b62-fcee-4d26-9235-92d9b9930a57"
      unitRef="usd">508000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMy0xLTEtMA_7c3c35f1-2482-4765-9031-ef9e285ed292"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktNS0xLTEtMA_faf8107c-a065-4a84-bf91-cb3726f05b9b"
      unitRef="usd">508000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktNy0xLTEtMA_fdf9e29b-562b-4680-b780-2fcac0c07932"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktOS0xLTEtMA_a436f497-fe3f-43ef-bfed-e93b307224d3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMTktMTEtMS0xLTA_ea0e566f-f11d-4b9d-b073-5ffffa8ec72a"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMS0xLTEtMA_0f6967bd-1cce-4b7c-a1ff-69c7b9de5656"
      unitRef="usd">654000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMy0xLTEtMA_4ebb9122-8290-49bb-a1ef-76042d6a0687"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtNS0xLTEtMA_08961af3-84f1-48cf-93c7-20c269c28342"
      unitRef="usd">654000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtNy0xLTEtMA_e143c283-5e7d-4ea4-a046-d8f49a5eb6a2"
      unitRef="usd">46000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtOS0xLTEtMA_37e8d315-bb9f-4acf-a92c-999ed9aacadb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjAtMTEtMS0xLTA_1999a38d-4648-47a3-a585-ece78b4181d9"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMS0xLTEtMA_4e5cede3-5db7-4b25-b6ea-f7da6e974b21"
      unitRef="usd">1397000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMy0xLTEtMA_8a134598-4197-4242-9f1e-1d1683938375"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtNS0xLTEtMA_71f640fc-50f3-4fe1-8e0f-e86554c6f7b7"
      unitRef="usd">1397000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtNy0xLTEtMA_7211cfa0-a7c1-489e-8e61-5f1f0368bb3b"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtOS0xLTEtMA_69918df2-a58f-4750-86ad-883eb8eb4cec"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjEtMTEtMS0xLTA_a00eabf0-9ba1-4d3f-b215-b99b02c76b24"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMS0xLTEtMA_ba4ba4a8-ba7a-4dfb-953c-353a41fce0c9"
      unitRef="usd">30000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMy0xLTEtMA_6aa4921d-ff1a-4e6a-adbb-48d4d11e8914"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItNS0xLTEtMA_43041ee5-678c-46ba-bf5a-2014af7a458c"
      unitRef="usd">30000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItNy0xLTEtMA_36db61b4-be0b-4d55-b2e6-f240b48f78b4"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItOS0xLTEtMA_e20a6aa0-05e6-437b-8f84-de5c7bb2df8d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe4e69d2526d4f92aedefaecc386e4f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjItMTEtMS0xLTA_efcd0ac8-fd28-4fb8-a52a-b489229ed8af"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMS0xLTEtMA_ea7b660b-046b-44a2-8279-9aaf9fd272cc"
      unitRef="usd">15898000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMy0xLTEtMA_5eecb7b9-3832-42a6-a184-30967b40af87"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtNS0xLTEtMA_eb089833-209a-4002-ada0-3ae73d440586"
      unitRef="usd">15898000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtNy0xLTEtMA_11092992-5b81-4cc5-b6be-ceff4438ac81"
      unitRef="usd">1035000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtOS0xLTEtMA_5102f107-ab7f-45cf-974c-0cc5de93f147"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmNhMTc4NWM1YzMxOTQ2YzRhY2UxMTk1NWVjZjRmNTVmL3RhYmxlcmFuZ2U6Y2ExNzg1YzVjMzE5NDZjNGFjZTExOTU1ZWNmNGY1NWZfMjMtMTEtMS0xLTA_3d8d7dba-69b1-4c09-b460-938679097c90"
      unitRef="usd">16922000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNjk2_3c8b97a6-19c2-4997-b4a2-8535a7253616"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfOTgz_ec6571ac-7056-40de-b72e-26373d6badab"
      unitRef="usd">928000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTAyMQ_a71aedd4-b05e-4357-8595-c0ad969bcece"
      unitRef="usd">122000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTA2Mw_484b80af-e670-4672-9200-f116e90ccfac"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTExNA_050333d2-26b1-41c8-95bd-e900b0215c98"
      unitRef="usd">965000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTE1Mg_d8e2f6e8-5ecc-410e-aebe-8dd7aa6f22f0"
      unitRef="usd">83000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if2258986997d4a6ca66cd9e77de4dd87_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfMTE1OQ_fa709083-c48c-45e5-a6ce-f20e2c13773f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTQ3OA_d3251461-3bc2-4392-9f09-2ce13ff9a75c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at September&#160;30, 2020 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMi0xLTEtMS0w_9fbf70a7-846d-4f19-b531-18141084dd50"
      unitRef="usd">1588000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMi0zLTEtMS0w_8fbae646-5b5f-4adf-aecd-e201ad66a8a3"
      unitRef="usd">1604000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMy0xLTEtMS0w_658892e1-a954-414b-8667-a0383613316c"
      unitRef="usd">6009000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfMy0zLTEtMS0w_9a072c18-dafc-4f72-8d1d-586f092dc6aa"
      unitRef="usd">6329000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNC0xLTEtMS0w_39f44df4-2fd6-45d8-ab7b-0e575af18e03"
      unitRef="usd">3466000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNC0zLTEtMS0w_201e5376-5f88-4786-9e59-a411eb1b3cfe"
      unitRef="usd">3774000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNS0xLTEtMS0w_2655860a-33cd-43d5-b0bf-642ce7fd08a2"
      unitRef="usd">3947000000</cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNS0zLTEtMS0w_fef3421a-bc52-4f23-ac9d-533ab71b15aa"
      unitRef="usd">4704000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNi0xLTEtMS0w_56607a88-1986-4abc-947e-a575ece33992"
      unitRef="usd">680000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNi0zLTEtMS0w_89f9ac99-dfc9-4460-bff8-6b53667a140b"
      unitRef="usd">713000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNy0xLTEtMS0w_52049013-dff7-4f5e-87ed-038067235d9a"
      unitRef="usd">930000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfNy0zLTEtMS0w_5f254cc6-edf4-4bd8-bbf0-92c44537c552"
      unitRef="usd">1012000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOC0xLTEtMS0w_e08dfabd-729b-4504-84ea-d3bc7c459330"
      unitRef="usd">2239000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOC0zLTEtMS0w_2455c347-1cab-45dd-994f-3acea9a27250"
      unitRef="usd">2262000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOS0xLTEtMS0w_6e9694de-b1e5-4bf5-8285-d1c867c4d6b1"
      unitRef="usd">18859000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjM0Mjc0NzQ3NDU2ZTRhMGZiMmZkNGFmZjRhNTdjY2NiL3RhYmxlcmFuZ2U6MzQyNzQ3NDc0NTZlNGEwZmIyZmQ0YWZmNGE1N2NjY2JfOS0zLTEtMS0w_311ced9d-0a9e-4a10-99f2-853acf8917e3"
      unitRef="usd">20398000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU3Mg_049d49d5-2e7b-454a-8cd9-7807c921e7f1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at September&#160;30, 2020 and December&#160;31, 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xLTEtMS0w_9ca4937e-a25f-47d3-8ec4-998867ded0d6"
      unitRef="security">58</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0zLTEtMS0w_28dead3d-2421-4fae-a509-42ffb3b02895"
      unitRef="usd">311000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC01LTEtMS0w_6c1f30d5-8b07-4a16-8eed-20976ce903a3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC03LTEtMS0w_bdb8fe36-673c-45fe-9c6b-8f9809d27fd8"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC05LTEtMS0w_963b8003-b084-45df-8fd8-2915b5cce8f3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xMS0xLTEtMA_e483e595-ba51-4289-9140-1b924ff1f555"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xMy0xLTEtMA_a9b734a2-717b-465d-b668-e9c5e251dc2b"
      unitRef="security">58</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xNS0xLTEtMA_25e9cd14-d056-4dc2-9a49-0bd149a3b8f6"
      unitRef="usd">311000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibdb7ca7dd7d1420eb8ede55e1cccef8b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNC0xNy0xLTEtMA_b7abb0b5-d94e-4f58-83cf-05ecc2fc875d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xLTEtMS0w_64b6efcb-3f2e-46e8-b3fe-764dbad341b7"
      unitRef="security">95</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0zLTEtMS0w_e33415db-ce03-4f67-bc44-e2289d7acfcd"
      unitRef="usd">196000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS01LTEtMS0w_80cf4152-c2c4-4982-86f5-f095394bc670"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS03LTEtMS0w_f3e6de54-5e9a-47af-84ab-7bc754e6acf6"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS05LTEtMS0w_01cdcc46-bde6-459d-8f48-71a5b30bd78c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xMS0xLTEtMA_20259b99-599f-430b-a67b-3133d597c92b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xMy0xLTEtMA_04932f3a-f750-45bb-9d09-febb099b5535"
      unitRef="security">95</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xNS0xLTEtMA_fea4f788-622b-4ea2-88db-f0b7ede7ead2"
      unitRef="usd">196000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2d2438801f7c44c98ea4e95749087498_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNS0xNy0xLTEtMA_8482f6c9-5917-45e1-bcab-9922eee4cb76"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xLTEtMS0w_98a77ee5-421d-4413-88e5-b466827b742b"
      unitRef="security">704</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0zLTEtMS0w_790782df-a0d5-40ba-94f0-9c550f5147c8"
      unitRef="usd">639000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi01LTEtMS0w_57e3b317-4daa-4754-901d-5773a9b24ea3"
      unitRef="usd">15000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi03LTEtMS0w_877c20b1-212c-4d9e-8527-ecdddc6f8696"
      unitRef="security">4</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi05LTEtMS0w_f79e5257-2fad-45f9-a826-2e1c7f4af660"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xMS0xLTEtMA_5fbb5354-e5f9-4cd5-b07b-09815e90053e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xMy0xLTEtMA_dcfd2986-aa0d-4c0f-a300-e69cf8698c74"
      unitRef="security">708</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xNS0xLTEtMA_2b5274aa-f119-4c9f-b203-771ac5ddda5a"
      unitRef="usd">641000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i15fbd570bda541e8a20f50e4aa1c99f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNi0xNy0xLTEtMA_ed1fcabb-1e24-422f-9061-29376fb1e461"
      unitRef="usd">15000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xLTEtMS0w_868f4d62-eae9-4dfa-9e7c-9298359dbdad"
      unitRef="security">198</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0zLTEtMS0w_75da5aaa-4825-4980-aa90-ecc1f08c536f"
      unitRef="usd">312000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy01LTEtMS0w_59c5f2b1-a74e-4b3d-9829-d8cd8e6612c3"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy03LTEtMS0w_d22b49b3-e709-4737-8ce9-b3f8653b2bfd"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy05LTEtMS0w_10355a11-cd12-4742-bb66-2e1649c181db"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xMS0xLTEtMA_d70659c4-7325-48c1-bb78-bb1ea202125f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xMy0xLTEtMA_b2425051-ecfd-408e-b355-ad00a493deef"
      unitRef="security">198</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xNS0xLTEtMA_88833548-21e8-4713-9c18-8d5d3a7ea50d"
      unitRef="usd">312000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i97d16b6ca80844cdb2f2fc69e0c4360d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfNy0xNy0xLTEtMA_7d4ee173-8061-475a-8a38-4784ce7915d0"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xLTEtMS0w_b821d548-0446-45e1-972f-f0e158c29852"
      unitRef="security">19</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0zLTEtMS0w_e13fd6d9-7759-4c16-aa47-530c119b8b52"
      unitRef="usd">70000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC01LTEtMS0w_a9f31c4e-bf11-4c22-8530-407510f3ccb2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC03LTEtMS0w_5518dd21-c168-40a4-bd95-539c3e33e0b5"
      unitRef="security">3</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC05LTEtMS0w_12a0fb42-b7fe-468f-8996-45d8ac32cce7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xMS0xLTEtMA_48cf3e91-ac81-4bda-8041-366c762783ab"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xMy0xLTEtMA_b823fa36-0fc7-4150-a3ab-27967e6e6711"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xNS0xLTEtMA_7e3ae4f9-b08b-4e93-b3ed-81f40205a029"
      unitRef="usd">70000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOC0xNy0xLTEtMA_2fb18a70-b3c3-4ce4-9007-8d2af9199369"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xLTEtMS0w_3269e977-1167-48f3-810a-35ab7ef2b088"
      unitRef="security">28</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0zLTEtMS0w_ad7ebad9-b92f-46cb-a176-0a068b78ef5f"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS01LTEtMS0w_77522f0a-c440-4f5e-bb4c-2a915694e086"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS03LTEtMS0w_fe377bf5-8b11-44d4-ab62-e1219ca55885"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS05LTEtMS0w_711426de-3f07-4de6-9b0a-cb61f7c583e1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xMS0xLTEtMA_c45761df-5b8b-46c9-985c-0a58da11a8fe"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xMy0xLTEtMA_57ba62c4-5dbc-4766-823f-32f4c24a5cf0"
      unitRef="security">28</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xNS0xLTEtMA_6d82c041-f9b0-4dc4-970e-ee8e6d956c89"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfOS0xNy0xLTEtMA_a96f5fab-d33f-42a3-9ca3-e365b4c56811"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMS0xLTEtMA_308d2116-e28a-41e2-b834-e195302068c9"
      unitRef="security">288</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMy0xLTEtMA_e31aeced-7911-4770-9ab6-42f8af130546"
      unitRef="usd">543000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtNS0xLTEtMA_61592467-2fdb-4a54-be3c-aa565f3dad34"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtNy0xLTEtMA_06b8c006-83c5-4d17-af42-dc95d0f44d94"
      unitRef="security">90</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtOS0xLTEtMA_2b199198-0f7e-4650-99a2-35457c6750e8"
      unitRef="usd">80000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTEtMS0xLTA_07462728-b177-4283-9b1a-bbcebf5e9f34"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTMtMS0xLTA_4a650d71-74d5-48bd-9247-bd3dc4fa8187"
      unitRef="security">378</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTUtMS0xLTA_3469a208-4287-4d03-9228-1fe38bcec3db"
      unitRef="usd">623000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTAtMTctMS0xLTA_b0eb69a6-e0d5-4b99-a531-7a4f05c905a1"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMS0xLTEtMA_eb3b0f28-ec5d-453c-9ed4-2b46ab17d4e9"
      unitRef="security">1390</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMy0xLTEtMA_405b9904-aa2c-4540-8a9c-04c10062a4d0"
      unitRef="usd">2177000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItNS0xLTEtMA_9b2a2b6b-3294-4783-ac68-f1d0a14776b7"
      unitRef="usd">35000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItNy0xLTEtMA_dced08ab-a2f8-4464-9304-bca480727e2d"
      unitRef="security">97</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItOS0xLTEtMA_19f93eca-177d-44f9-bc2a-865bcd73cd3e"
      unitRef="usd">82000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTEtMS0xLTA_b9b93df3-bbfa-4b39-ab50-08cda321e795"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTMtMS0xLTA_6ca8d9ae-7d8e-4671-ad7a-0a06411f9da0"
      unitRef="security">1487</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTUtMS0xLTA_d2ed233f-3068-4548-8746-dcacea08c5d8"
      unitRef="usd">2259000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTItMTctMS0xLTA_238cdb89-4f50-48f4-8d11-8b6d651f266e"
      unitRef="usd">38000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMS0xLTEtMA_812f586d-b0ca-469e-9a0c-67c74cebbe33"
      unitRef="security">52</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMy0xLTEtMA_e31df747-09c3-4321-894d-6c1889f5a191"
      unitRef="usd">168000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtNS0xLTEtMA_550fe1ac-19ed-45b0-a309-ba2f9afc23d1"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtNy0xLTEtMA_4f3bdeb0-ff0f-4d0c-923b-484f8cd09c01"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtOS0xLTEtMA_e50e20cc-eba7-480d-8208-45ac86fcff87"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTEtMS0xLTA_9ac9ba56-baa5-4af0-a772-a8b3f2d32d7b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTMtMS0xLTA_4d97e23c-d83a-48d0-848b-113be9e4fccc"
      unitRef="security">52</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTUtMS0xLTA_fa6c98b3-87db-48cf-b9a1-5d7bb3dbc6cb"
      unitRef="usd">168000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icf3e6151680b451eb6ef567620281acb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTYtMTctMS0xLTA_e60ab710-10e3-4fae-8894-488832c914a3"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMS0xLTEtMA_292460ac-377d-41a1-9bd3-f24f348d38d8"
      unitRef="security">66</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMy0xLTEtMA_5738e651-770a-4fb4-a9fa-382373a55862"
      unitRef="usd">115000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctNS0xLTEtMA_3f9bdef9-792f-41cf-8ed5-20b26f6387e7"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctNy0xLTEtMA_354a816b-c380-4a15-bd69-ce33e2e7b0f3"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctOS0xLTEtMA_fa58913f-2352-4abd-ad6d-2069f7d4db84"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTEtMS0xLTA_9add709d-8995-4647-ba83-753f23ac22c7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTMtMS0xLTA_519a7eb1-101f-41c6-80a8-53727259f4fb"
      unitRef="security">68</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTUtMS0xLTA_8dc5d1ab-6774-4980-9d59-0c8d98e086a2"
      unitRef="usd">120000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7e576f48da934434adff3d93da16066c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTctMTctMS0xLTA_20168bb2-c21d-450a-8178-31381fde028e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMS0xLTEtMA_5b7e2070-69af-4790-8880-da4ec3fc8428"
      unitRef="security">181</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMy0xLTEtMA_7176f5f4-eaeb-4dd2-949e-1a891bd1625e"
      unitRef="usd">305000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtNS0xLTEtMA_6b7d21c1-cc39-4b6e-95cf-5bf0b54dc4f0"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtNy0xLTEtMA_b1fd65ac-ac2a-4bdd-8363-6fc373d88df4"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtOS0xLTEtMA_2871a9a6-dd1a-4c4a-afc7-b3bc5c4db5bd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTEtMS0xLTA_4d5af369-34ec-417c-8ddb-d45d33602fda"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTMtMS0xLTA_2aa20ead-8fd9-4d3c-a06d-570179675a16"
      unitRef="security">183</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTUtMS0xLTA_f34ff34a-0128-40ef-9d55-ae1ea832cc76"
      unitRef="usd">305000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i01f4a654db5e4221b06e356876c0b885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTgtMTctMS0xLTA_45c43ceb-b5d8-4024-8477-273598fbf66e"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMS0xLTEtMA_94d902b9-fa94-4640-aeef-313cc1c2882d"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMy0xLTEtMA_b3c877da-9778-49d4-9552-38ab5bacc210"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktNS0xLTEtMA_cb0595d8-2101-4a3d-a5ec-270d2603d075"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktNy0xLTEtMA_2452ecc0-e886-491b-ab05-20daa7deccbd"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktOS0xLTEtMA_6ccbc831-a383-4aa8-91de-3bda5047ef6f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTEtMS0xLTA_49f20947-d8e2-4aaf-b03b-39b7a8239ecc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTMtMS0xLTA_29657f30-9646-412d-8c5a-0ed1403f430f"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTUtMS0xLTA_557b418d-1252-4b74-bc32-ec021b116e0f"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iec6f6bd13e6d4d928a396c5ddaf4b2f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMTktMTctMS0xLTA_28ed6ca8-c320-41c4-a548-5b5dc2ba96b7"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMS0xLTEtMA_74491007-500f-46b1-8e6c-8c32300e6d7e"
      unitRef="security">30</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMy0xLTEtMA_ad955adb-9a31-4f45-9b41-ce55095754ca"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtNS0xLTEtMA_df6f8e86-4974-4976-98b2-a5d0fae91d12"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtNy0xLTEtMA_e556b532-9850-4485-ba1c-996cc073ef05"
      unitRef="security">9</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtOS0xLTEtMA_8c9c027c-1af7-4035-8c4f-0a3a3e18b8f7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTEtMS0xLTA_3cfd7872-766e-4a64-a0e9-11666aa4e863"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTMtMS0xLTA_db3a6ff3-c05c-4965-8b47-1222228c183e"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTUtMS0xLTA_18bba438-671c-4299-8df5-49a7e1324d72"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia6e3c903578a4562993ab15cb728ca44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjAtMTctMS0xLTA_6985d676-ca7e-4aa0-a1e6-0efdad943f1b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMS0xLTEtMA_8db20dde-e60e-47b2-85df-d5a9a07fe93c"
      unitRef="security">16</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMy0xLTEtMA_bc24835f-01b9-4ee3-b9ea-f0a708d63c15"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtNS0xLTEtMA_c2768e3e-f771-49a5-aeb2-02aa5865d6a0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtNy0xLTEtMA_b445796f-4ee1-4d53-8ae7-5a92c084fb29"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtOS0xLTEtMA_92d04dfb-2095-4592-9cf5-b67367b3a766"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTEtMS0xLTA_d7d83f7c-9f2f-4c7a-969a-5e1663175c48"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTMtMS0xLTA_9b4c5d5a-2681-4cad-a416-3b7d10993898"
      unitRef="security">16</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTUtMS0xLTA_dca5d460-c56a-4bf3-8e3c-4c2d2def9980"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7cd6c0f278fa4a65a5bd170d02d70d62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjEtMTctMS0xLTA_42f3c0ec-202e-4dce-a4a7-691daece6d77"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMS0xLTEtMA_2c161761-0ddb-4991-be2c-4b51ecd6735d"
      unitRef="security">138</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMy0xLTEtMA_6a931989-2a19-4c61-9593-c54f9dd23201"
      unitRef="usd">254000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItNS0xLTEtMA_6017962d-fa99-4070-ac49-3a00070da1ae"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItNy0xLTEtMA_9e0e6c99-f2ca-4ac2-be6c-9a8b71377fad"
      unitRef="security">187</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItOS0xLTEtMA_d7e86775-8c14-4196-8e7c-6c220ef7d8e1"
      unitRef="usd">182000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTEtMS0xLTA_86dc3289-e95e-48e0-8a68-d130b3ef3e06"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTMtMS0xLTA_3144dfb8-64ae-4ae6-9e52-4c61f80542e3"
      unitRef="security">325</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTUtMS0xLTA_6d278a99-6e4b-45c2-b4fb-cc4512455fa0"
      unitRef="usd">436000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i383d7512151242da970974ef3fe1ddb0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjItMTctMS0xLTA_9078eeac-4658-4713-b909-98d174428f5a"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMS0xLTEtMA_82f0d4cd-29d1-49ea-997d-362a05bf2dfa"
      unitRef="security">522</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMy0xLTEtMA_327ec04c-ce4e-4b01-9bbd-75fbeb840d77"
      unitRef="usd">982000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtNS0xLTEtMA_23f10af1-c716-4328-9e95-cba4cfa46e41"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtNy0xLTEtMA_029a9b24-a0db-4937-a52b-eb912b7ef68c"
      unitRef="security">200</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtOS0xLTEtMA_5e40e765-da5c-4913-9891-7fec75f2fc13"
      unitRef="usd">187000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTEtMS0xLTA_384717a9-ebc5-4cc2-a3cc-3c678a50b793"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTMtMS0xLTA_5a996daa-89cc-4031-8d3c-5ce025858dad"
      unitRef="security">722</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTUtMS0xLTA_5b473c9d-b615-4ca4-9f65-e3837aa35425"
      unitRef="usd">1169000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjQxNTcyNDNhYWUxMjQyNWZhOWM3MDJhNzQ3NTUwMTE0L3RhYmxlcmFuZ2U6NDE1NzI0M2FhZTEyNDI1ZmE5YzcwMmE3NDc1NTAxMTRfMjMtMTctMS0xLTA_b598b03f-2950-486c-b9a4-06a3a1eb86ae"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0xLTEtMS0w_c4f3964c-aeb5-4c70-8521-8543acffe5ca"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0zLTEtMS0w_136ef4f4-3ba2-4741-83ce-aaed17e76364"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy01LTEtMS0w_bd06e5db-3a5c-462c-9d44-95aae407a3a3"
      unitRef="usd">36000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy03LTEtMS0w_31843af1-aec4-4639-b694-a2b814bd9eb2"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy05LTEtMS0w_eae9b1f9-e017-4c85-aae5-d57cb122546c"
      unitRef="usd">36000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMy0xMS0xLTEtMA_ee02f1b9-e6ca-464d-bd50-8a39b3d0e87e"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0xLTEtMS0w_c63f505c-11be-4af0-84f9-400dab27748d"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0zLTEtMS0w_e2221bfb-2e21-4864-a161-bd5e12c67076"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC01LTEtMS0w_f109f1d2-e8ed-4a24-b681-ac1ce275308f"
      unitRef="usd">623000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC03LTEtMS0w_2cbca3b8-1fe0-4f2d-83ab-95aefca7fcd1"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC05LTEtMS0w_9d629dc8-8c1b-415d-a914-518261138b78"
      unitRef="usd">624000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNC0xMS0xLTEtMA_2ebe50ef-88e9-4f52-8338-e29566b31613"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0xLTEtMS0w_4b36ab15-b36f-4374-a729-0db50122afac"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0zLTEtMS0w_7101217c-0b5a-4771-8bf2-6da47b595e2c"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS01LTEtMS0w_8a2db0ce-d166-4081-8977-9fdbd8636bae"
      unitRef="usd">493000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS03LTEtMS0w_6a6132bf-a598-4638-b7a6-5df993d42443"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS05LTEtMS0w_96bd8987-505c-46a9-be74-b2f099f743e9"
      unitRef="usd">504000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNS0xMS0xLTEtMA_34e8336d-904b-4732-ace8-7f2761d20354"
      unitRef="usd">13000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0xLTEtMS0w_bbc770ea-001a-4dbe-bf9b-d2e40dc437d1"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0zLTEtMS0w_a2b2211b-c94b-4aad-b6c8-70d3b7ece57d"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi01LTEtMS0w_e7d2fc8f-2462-4de0-9a88-e04c80f9bf85"
      unitRef="usd">285000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi03LTEtMS0w_9d323586-3618-45b9-b996-d04473d31b8c"
      unitRef="usd">8000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi05LTEtMS0w_1f1f6ed9-d90d-49c2-a7b4-9291f708847b"
      unitRef="usd">296000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNi0xMS0xLTEtMA_caa04f50-bc3f-4b30-a376-ec53e1f588e5"
      unitRef="usd">8000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i69dfbb0081244aac89b4345d22699e63_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0xLTEtMS0w_211eefc8-bf3a-4d8a-a688-88fdedb6b9c9"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i69dfbb0081244aac89b4345d22699e63_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0zLTEtMS0w_72040a58-2a5f-40b7-a0fd-bf49c3043b67"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i960e086fbf114fa085cd3503d8537bc4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy01LTEtMS0w_1522842f-eebc-40b9-bbf0-3c4f07b1d3bd"
      unitRef="usd">70000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i960e086fbf114fa085cd3503d8537bc4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy03LTEtMS0w_d720c9cd-4aac-44cf-b4a8-af90e32a2ca3"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy05LTEtMS0w_4d65b3c0-b8e4-4328-a527-71a198bf5e61"
      unitRef="usd">70000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i7b15565a9a35453b9b987af9593bf001_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfNy0xMS0xLTEtMA_aeb46949-6e01-4deb-9002-08626cae5110"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="iff1e365008244ed5a70514a60e56cccb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0xLTEtMS0w_e821ce5c-43b4-42ee-8f42-a23d229d9d7a"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="iff1e365008244ed5a70514a60e56cccb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0zLTEtMS0w_3ca98fd2-51cf-494a-b743-8d2c613429b7"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i6ab420c501cf46d49e7efcb16f91f34d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC01LTEtMS0w_1d36fe74-bd22-4da2-afc7-d6f266d8c604"
      unitRef="usd">104000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i6ab420c501cf46d49e7efcb16f91f34d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC03LTEtMS0w_ce68fe33-af0b-4852-8807-82d57f235bd4"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC05LTEtMS0w_09aa33fb-9a68-42a7-b328-392d9ee0ede5"
      unitRef="usd">106000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i6a75c0ebe2024f59be4523a9a37d16de_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOC0xMS0xLTEtMA_2675d6b2-d688-4fb2-a718-71eedf605c7e"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib7daccfbe8e14d87837c7793f712536e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0xLTEtMS0w_27dbcdd0-b264-42bb-8bfc-c716dfe9744f"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ib7daccfbe8e14d87837c7793f712536e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0zLTEtMS0w_5a8634b9-710b-4ffc-8720-f99c247d6ecf"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ibf0db8b085494ad9aa4eead23953af4e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS01LTEtMS0w_e5599fc8-d15f-4360-9dbf-cc08b5450873"
      unitRef="usd">616000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ibf0db8b085494ad9aa4eead23953af4e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS03LTEtMS0w_925d5a8e-717f-4a5a-9e8c-687005075169"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS05LTEtMS0w_7112fae0-a0bf-4f08-8664-803771f6fcee"
      unitRef="usd">623000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ief1897d8c36747ee8a7fc20fb298b973_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfOS0xMS0xLTEtMA_858f2254-32e2-4ca9-9822-d883a0c2886e"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMS0xLTEtMA_1d865ac1-9c3e-435b-8411-27ee0f1d2086"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i972eda3e75e84307a6e92704398a9a97_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMy0xLTEtMA_c1c9eb97-a261-41fc-afb6-ef0f7be383ed"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtNS0xLTEtMA_2cf7a837-1ae9-4bec-99b8-8b5c68140abf"
      unitRef="usd">2227000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia33d5501abdd4ab29455629f2219842a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtNy0xLTEtMA_c9a3df34-1b21-488a-9c80-de96d3259c34"
      unitRef="usd">37000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtOS0xLTEtMA_5327a49b-0508-41a1-8587-f74fcb3aa844"
      unitRef="usd">2259000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmVhMWRjMGM4M2YyNzRjNTZiZjdlMGNjOTM3NzI4NThiL3RhYmxlcmFuZ2U6ZWExZGMwYzgzZjI3NGM1NmJmN2UwY2M5Mzc3Mjg1OGJfMTAtMTEtMS0xLTA_51811ac3-f33d-4043-aa4a-bb3393857e29"
      unitRef="usd">38000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUxOA_1c629b99-08a0-4673-b576-8cd1fc57cfab">During the three and nine months ended September&#160;30, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi0xLTEtMS0w_e1ad07ec-4bbc-4eab-a2b9-f3c67a82c265"
      unitRef="usd">31000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi0zLTEtMS0w_0d1434ed-6712-462b-9a69-8149363c4867"
      unitRef="usd">12000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi01LTEtMS0w_ee01336e-9f80-43c9-8d78-01e3c3306817"
      unitRef="usd">55000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMi03LTEtMS0w_4c3451ff-7416-44db-a6fd-eb7f3c44a6d8"
      unitRef="usd">90000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy0xLTEtMS0w_24e9cc97-5922-4efa-8a15-9dc9af2fd0d8"
      unitRef="usd">37000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy0zLTEtMS0w_77503a7e-8338-49f2-a3a8-1f2ac3d5d05e"
      unitRef="usd">56000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy01LTEtMS0w_5028547d-8a76-466b-8be1-7cbaa4204124"
      unitRef="usd">114000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfMy03LTEtMS0w_99210835-2ef8-4a74-9817-fa9ed7c0f66a"
      unitRef="usd">127000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ia45efd93510c49a7ac479600054af81d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC0xLTEtMS0w_c23f9f35-5690-4ce7-84ac-7ecea14a8265"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i8751bce610ea4de59eee35af623d0b70_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC0zLTEtMS0w_e318d519-3f61-40f5-8587-7320a15c0f4b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i5bb089804391419e80d1a1823db3e201_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC01LTEtMS0w_621bd790-cf1e-46d3-932e-0829801fc081"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i3eec33977d064dd58dbb2c070ea37bb4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmIxYzZiNDNkOTZkZjRmODBiZDIwOWE3YTFkYzdlM2I4L3RhYmxlcmFuZ2U6YjFjNmI0M2Q5NmRmNGY4MGJkMjA5YTdhMWRjN2UzYjhfNC03LTEtMS0w_843c509a-bcbd-418d-bea8-337372d406bb"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUyNQ_f56b3cb2-aef4-4d85-b5b1-fdfc634bb8b5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at September&#160;30, 2020 and December&#160;31, 2019, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie795c4847dad4a2fa2321b0a489f207b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xLTEtMS0w_670fe64a-704a-4bc6-a208-7d576923ca11"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic175d1191a1c4781a30676aa11276f4d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0zLTEtMS0w_246d025e-e7ed-4619-875c-a956f2010a72"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i30256990638e428f824cbe808d6ed528_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy01LTEtMS0w_cebbf108-2f9c-40d8-8960-0e9254d00147"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iad431944c36d4aae9608be12244efbd3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy03LTEtMS0w_cbd117e6-3fdb-4ecc-8633-875d94fa782e"
      unitRef="usd">23000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i913a4bd7a8594a62a5156370bb48bcf6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy05LTEtMS0w_ba53bfaf-3771-4db7-a1ca-f053a7ec201f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i33b30e7ac4294106a93b48a59cbf0bac_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xMS0xLTEtMA_a7dc82c8-3be4-4650-afb6-918a1f936692"
      unitRef="usd">39000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6479057a341c45c984deedf142835644_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMy0xMy0xLTEtMA_e6c412bd-411e-4abb-a943-bac3e11fa68a"
      unitRef="usd">62000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibd382360a1a54ca085c48b6b0eea3f9d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xLTEtMS0w_31feb336-256a-4242-864f-1ae629a45001"
      unitRef="usd">57000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0610c938c1724db88d4cb79675b700cd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0zLTEtMS0w_fcf2f22e-eadb-475f-9451-9f31593c08ae"
      unitRef="usd">95000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2c351fcfc74e43169c42882a035900a0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC01LTEtMS0w_827ac913-1f0d-46d3-888a-f9994dcb0a3c"
      unitRef="usd">90000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i057fc0d413b94de5b39c6573f51d2e09_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC03LTEtMS0w_580b7cce-0012-42f0-bdf5-034c20812658"
      unitRef="usd">129000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i42dddd2f744647acb266706378ec5df3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC05LTEtMS0w_ba193551-98f9-491e-8bff-e5e6689b9714"
      unitRef="usd">129000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia4edce924dd046b6a5eaa1536dc0f333_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xMS0xLTEtMA_d33ba2e7-8227-446f-a356-e9367ae4cb1d"
      unitRef="usd">516000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4d795e3743e64e26965aa5f2e4573e19_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNC0xMy0xLTEtMA_dac1bd45-3055-4f67-b172-248aadaaa41f"
      unitRef="usd">1016000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i68eb5bdcaf264b40b40588bd26e81268_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xLTEtMS0w_3aafa34b-ef61-45bc-99b1-4ea1eb3d50bf"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3754c364a7504543bf52097c1f644ce5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0zLTEtMS0w_bbc6ddd1-c620-4c04-87a8-016ebd785394"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9122fa3ecf054a24bff9ed44808cb012_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS01LTEtMS0w_f98bb061-4acb-4040-a8e7-cadd4cebbe63"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ida44d0acf7984a62bdefb2c50f6d6407_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS03LTEtMS0w_83398114-78db-46e4-ac47-fcb77d01f56f"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i194339829ef54e0bae1c684cadaded1e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS05LTEtMS0w_1c5e6a8c-8f65-402d-b50b-07462ac3821a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8c85adc56b7c43e3996b5bce465f37df_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xMS0xLTEtMA_d4408f03-e403-4afb-b958-6c6d7268058e"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9e53524f057f4999ad2443b434cce091_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNS0xMy0xLTEtMA_e816e672-210e-41cc-911e-5f1fcfb3d383"
      unitRef="usd">37000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9af70922f678434488f766f73af3cade_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xLTEtMS0w_0dfd8bfb-d337-4c2b-a332-44048d92b212"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id0d1c549803e41469de47806ff2e4fa1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0zLTEtMS0w_fee9b6e5-6a79-4f36-a164-cde2e1282078"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i05f844fe095a41dfbceda6a1d04bfdc2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi01LTEtMS0w_fde93f8b-f4c8-4b8d-9b11-2d5c509a8b1c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ica452037f76f48e9af4b93d468452d6f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi03LTEtMS0w_83089c45-e234-4d73-bc2c-f7eb00561a1c"
      unitRef="usd">9000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie94354f726744ff8bee2090d1ad35db2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi05LTEtMS0w_7bc43674-6c61-4267-bfca-77c4a9409948"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i00c125fab00b42f59120a0bca28c2067_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xMS0xLTEtMA_89719a2c-1917-488b-a3f7-f77d909238d4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5c8ac8af61cf49b9a4ecdf639848435b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNi0xMy0xLTEtMA_9ccc2686-66a7-4c15-85c4-36c165eeb7dc"
      unitRef="usd">9000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia08a76e0bcc84d49adefc8bbec4d213b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xLTEtMS0w_be682d91-10a9-4931-8d9c-3a2a662fdbbf"
      unitRef="usd">57000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if90ec21d6d594b7da461da5300391997_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0zLTEtMS0w_2d097cf6-84e8-4e38-85b0-0327530e395f"
      unitRef="usd">95000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i71b4e703d104427790286808c54d1366_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy01LTEtMS0w_e53d21c3-8f0b-439f-a887-38930fc388df"
      unitRef="usd">94000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ida34879a6c634fd1b420b3bb6585dd5a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy03LTEtMS0w_798215d8-9860-4f25-9fe6-9cbb3714fbc3"
      unitRef="usd">165000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic6ee7fd60e8a42afb969aa603a251749_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy05LTEtMS0w_fd0d5c97-4abb-41f7-b588-92ac117fa159"
      unitRef="usd">129000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i154a60403daf439ea051436669caed62_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xMS0xLTEtMA_9c3fd1cf-e354-4c3c-b054-8109c76e6235"
      unitRef="usd">584000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8567e379ddb1457cac777037b4375361_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfNy0xMy0xLTEtMA_26753c1e-dda9-4bb6-b6ef-c792bc64e986"
      unitRef="usd">1124000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3fbcdd26a0874198b1491985af3d6caa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMy0xLTEtMA_62052f08-5a22-47b9-aca6-5ec5cbf8440b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i626f99181aa943b0b51f0d50e860b3cf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtNS0xLTEtMA_b0303174-80de-4bfe-8bb7-796af167e9d9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id978749041e44e299bcf3f700443a8f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtNy0xLTEtMA_098e2d39-2f4b-4665-9d25-1530398ab8dc"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icc1876da69d543fbbfd2d97bed949c96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtOS0xLTEtMA_8ded8fb1-58aa-404a-8ee5-7e7826e8eb3a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1eeeb3c201f44e02925fb433c54875c9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMTEtMS0xLTA_4b4f79ee-bc47-4277-a992-0acbb784c557"
      unitRef="usd">43000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id66c23adb4244b9cbd61f92daf51edb2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTAtMTMtMS0xLTA_d9a9457c-4772-4c23-a3bc-1e3970be79ba"
      unitRef="usd">58000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie9980f4284414635a8f0e3dba2c1cf2a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMy0xLTEtMA_4e93ba8d-e434-42a1-b44b-b0182085726e"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifce7c6728c90483e9b8bfdd9962b5710_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtNS0xLTEtMA_33a4f39f-c7d5-49ab-beef-2b41ee4a7359"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if749a1d078424bd0ac0f4ee34e5390a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtNy0xLTEtMA_b6d1de6e-4533-446e-8911-35ce08ec46ec"
      unitRef="usd">206000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i13c1913598034217b44872960f615f0f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtOS0xLTEtMA_30de4161-b9cd-4730-85c2-8c78528fd7a3"
      unitRef="usd">140000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie023e0b3bf5c4d45b331cdca88d01e53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMTEtMS0xLTA_06d8390e-49a4-4d01-b117-d54d683cc5be"
      unitRef="usd">611000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5cdbe7b61cea4120b2f5472d61487f8a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTEtMTMtMS0xLTA_c9e5223c-fd97-474f-871c-6ceffaaa6bf4"
      unitRef="usd">1143000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibdf1cfbdd6b04ecfbd78c7310035476e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMy0xLTEtMA_28fb4cb8-7084-4a08-ab50-d30dfa5d372b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i186f364822c04e9d9d7bc13d20f7bc13_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItNS0xLTEtMA_8d7a1620-a095-4d68-b16a-5021c6a887ce"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaa78344f4d0c46538a8cbcae3b2a7c42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItNy0xLTEtMA_7a075c0a-be60-4b52-96af-fad06edc7836"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3e6acb9733404822913cf42bb35c9631_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItOS0xLTEtMA_2d794091-d0af-4c4f-ace3-90fe19db686c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i67170a9e296943109aa58736f02ebaca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMTEtMS0xLTA_9339c0f6-fc71-4136-bc82-a5b751140c3a"
      unitRef="usd">12000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8430b0f5491b42719a2b3726e4de3cec_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTItMTMtMS0xLTA_f9364b85-e06f-4fc9-ba4a-da00f41668f7"
      unitRef="usd">12000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iccc0eb7aab1f475eae71c3312f0c686c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMy0xLTEtMA_7069bab8-5dab-47da-bc3c-314af1c1c76c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i82c2af4550a64d90a95e4c647320413a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtNS0xLTEtMA_8b490846-83b3-46ed-b9b2-1e2a11b6e8a9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i20da4428912141408240e337515e04a0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtNy0xLTEtMA_55e0eb51-ceef-4b42-b954-90dbe1260ebb"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i622e43fcdd484d2aab4eae3e5164bc8c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtOS0xLTEtMA_77445f46-b3d4-4f33-ba08-7c2d22d0b457"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifa714440d01840109a1cf5efeef3955d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMTEtMS0xLTA_7bf6b3b4-f08a-48ab-928b-164ae454c92f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i396244e89f5b4c28ac5d4147e815e9b7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTMtMTMtMS0xLTA_de6f486a-0a72-4181-aa39-5651c38d23b9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia9b24009c9df475d90e186eab28b123b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMy0xLTEtMA_b95bf3df-82af-4874-ae15-cb582460085a"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2d3306d339a94c2381177e129b5210ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtNS0xLTEtMA_b8980673-de06-4736-aa28-ae247c910123"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8ac5e26c358547b0a83b36b4ba5416a8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtNy0xLTEtMA_439cf9f6-97c8-4c7e-b3f9-244e5191fe56"
      unitRef="usd">221000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib681cd685e4741c485fded4dee9a4f19_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtOS0xLTEtMA_b4cc6871-f51a-480c-9f8b-b61f1fb023c0"
      unitRef="usd">140000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i992d499671994e22be809371d4cfad4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMTEtMS0xLTA_2e78cac0-c599-4613-89ff-298ecbc50f16"
      unitRef="usd">666000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0374e01374ba4315b4b99fb4d6263f56_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmE5YTM2YWM3ZGQyMDQ1NDdhMmZkN2ZiYmQ2MmNlODQwL3RhYmxlcmFuZ2U6YTlhMzZhYzdkZDIwNDU0N2EyZmQ3ZmJiZDYyY2U4NDBfMTQtMTMtMS0xLTA_492c71f5-9292-4c63-a327-5656aabc9509"
      unitRef="usd">1213000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTU2Mw_6f6e42ec-2b44-4885-97d9-d2d4d525e841">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September 30, 2020. Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September 30, 2020. Net realized capital gains are net of other than temporary impairment losses on debt securities of $9 million and $22 million, respectively, in the three and nine months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, and $10 million and $33 million for the three and nine months ended September&#160;30, 2019, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib818fadd5f0e4ddcb1522c0c0ac9d976_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi0xLTEtMS0w_b659cefd-0e7f-4bc4-b3b0-ebb75713d562"
      unitRef="usd">151000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i2fae26ed04184bfdaca7066ae8a753f6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi0zLTEtMS0w_c61492b5-5c8d-4f54-a12e-48ca2b82e05f"
      unitRef="usd">145000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if716a3c271cf46b39d3e4ba483d859ac_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi01LTEtMS0w_00e98c40-2ab4-4b40-aac1-3c3fd51a7326"
      unitRef="usd">441000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i744c94aba9ef4754a45ccd4484daef93_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMi03LTEtMS0w_9cb6a060-2ca0-433a-9f5c-fd45ccab6bac"
      unitRef="usd">437000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia04fde7379954a4981ed81ebf2b5afb0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy0xLTEtMS0w_31aebe41-dd94-4de2-9220-0a2f26633f45"
      unitRef="usd">15000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if2db42393af54e53ad14dbc08d486114_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy0zLTEtMS0w_76192faa-61a7-4326-abbd-77a73467aaab"
      unitRef="usd">19000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6c00b913c81f4dd0bd7784fd75297758_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy01LTEtMS0w_9f502343-b615-44e3-b9ca-3e709a838185"
      unitRef="usd">45000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i67f6aae1b4284431bcdd2e4827898dc9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfMy03LTEtMS0w_18173eb5-a79a-433c-8911-3ccadfb5ad02"
      unitRef="usd">54000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5690f0cca3ea4531914b67ef16f42948_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC0xLTEtMS0w_c6134ac3-680f-41c1-b20e-6664265d6291"
      unitRef="usd">37000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if045682f0a244fb9b7c118b70cbd74df_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC0zLTEtMS0w_904747d6-73a3-47e6-a8c5-5191c4a96586"
      unitRef="usd">60000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i17291e3b05464689b6efa05815c1f0ab_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC01LTEtMS0w_fd7d54cc-4096-473b-b5f3-20e83cb86565"
      unitRef="usd">64000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id5c372f3418a4938be710525fc278530_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNC03LTEtMS0w_c42d124a-180f-418e-81b9-1dc7d2f96dfd"
      unitRef="usd">163000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS0xLTEtMS0w_881cc885-f54e-4224-98e1-ee40918d243a"
      unitRef="usd">203000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS0zLTEtMS0w_f51f72cc-318d-4879-a2a6-c5438622178b"
      unitRef="usd">224000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS01LTEtMS0w_48e4b294-8b9c-498d-94aa-8a95a9588c5b"
      unitRef="usd">550000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNS03LTEtMS0w_61cc65cc-f7af-49fc-8f2d-a8a0db0f3290"
      unitRef="usd">654000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi0xLTEtMS0w_0cf41aee-db8a-47a2-8c81-7f6e98760889"
      unitRef="usd">8000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi0zLTEtMS0w_a176fd72-c1c1-4fb7-9eed-cbb437999131"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi01LTEtMS0w_36129893-ae3a-4433-a265-c038a8a83d01"
      unitRef="usd">25000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNi03LTEtMS0w_d5ca322f-114c-4ecc-8b0c-4f21a3cec76e"
      unitRef="usd">28000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy0xLTEtMS0w_55830350-85a3-40c3-a04f-a89d7c81a9c0"
      unitRef="usd">195000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy0zLTEtMS0w_1d7f933c-918b-40b4-95c2-afe59e1dd135"
      unitRef="usd">214000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy01LTEtMS0w_c6cbe491-a980-4945-8c57-6d1fb1545def"
      unitRef="usd">525000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfNy03LTEtMS0w_4be44a3e-2de0-469e-9f91-f09fc01cd099"
      unitRef="usd">626000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC0xLTEtMS0w_0c6418bd-49e6-4ceb-b2d5-ec5038a7ac18"
      unitRef="usd">9000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC0zLTEtMS0w_78aa0dbf-aacd-4a4f-9173-ab0c785c52ce"
      unitRef="usd">49000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC01LTEtMS0w_3c8a2049-869f-4ca5-86ed-9fa05f8df542"
      unitRef="usd">25000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOC03LTEtMS0w_df8903a5-3e5d-45fb-8622-60386920ad4c"
      unitRef="usd">179000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS0xLTEtMS0w_9084cff9-4dd5-4118-838f-7841a4f32ecd"
      unitRef="usd">204000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS0zLTEtMS0w_000fb1fa-0e7a-4915-9a3c-3153c8543658"
      unitRef="usd">263000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS01LTEtMS0w_f1654abe-f767-4b55-9247-1e899db2a2e5"
      unitRef="usd">550000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOjExOWM4OTQ0NDg5ZTQxM2JhZWE3ZWQxNTFhOTJjZjIyL3RhYmxlcmFuZ2U6MTE5Yzg5NDQ0ODllNDEzYmFlYTdlZDE1MWE5MmNmMjJfOS03LTEtMS0w_a25a7466-cdc7-44f7-8ee4-110074e2210a"
      unitRef="usd">805000000</us-gaap:InvestmentIncomeNet>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDU3Nw_7679174c-7051-405b-ae1c-b8be719b943f"
      unitRef="usd">1000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDYzOA_bb1cb827-9fc3-40af-a7b8-0216ba6b9d53"
      unitRef="usd">2000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDc5MA_6c91dd3e-f935-432b-801f-f2a09d13abbf"
      unitRef="usd">4000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDc5Nw_49195428-baa0-44cb-87c4-2365f4881283"
      unitRef="usd">44000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDk1Mw_f6d59a67-1d5f-44b8-8b13-f33a3ee27232"
      unitRef="usd">9000000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNDk2MA_df01916c-c8a0-4a9e-8488-13a3317a4736"
      unitRef="usd">22000000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="icbcc194ba2834984937ecc92d1e291ab_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTA1OA_c7dabe5c-1fa5-4d72-add7-14d49cbbf5a1"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ic6f6b833db21459d8fe1d58b988e57bf_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTA2NQ_5698700c-0217-4233-8d66-d714ed5b6271"
      unitRef="usd">31000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i420d31c38e0944e3bb697025075df15e_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTEwMQ_c07a1a83-bb14-4f88-b0d3-18f450f43b1e"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6af618046aa747559d1a45f61351ac8a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTEwOA_363a9df4-0c4f-4cdc-8378-02e85f365c7a"
      unitRef="usd">33000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RleHRyZWdpb246NWU2MzUzN2YwMWUwNDRmYzg2MDJiOWNiZTM4MzM3ZDRfNTUwMA_a1402bc0-3b67-499a-a84e-3211a15a5d16">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi0xLTEtMS0w_3bc45f77-e8f5-447a-b841-aba1293c3ae8"
      unitRef="usd">905000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi0zLTEtMS0w_2c85b632-4da8-4094-8da2-865274d7253b"
      unitRef="usd">1325000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi01LTEtMS0w_c9324b76-68fa-49dd-87c3-1b7733fe7fe9"
      unitRef="usd">2324000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMi03LTEtMS0w_0cc9ef65-d77e-455d-aac4-794029632ff4"
      unitRef="usd">4087000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy0xLTEtMS0w_111fd3ce-7dc4-476f-851c-8e4dd12d362f"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy0zLTEtMS0w_309fb649-e43f-43e7-8d37-97a6a27ed76f"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy01LTEtMS0w_7f624fe0-7c28-4024-8813-443626128747"
      unitRef="usd">60000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfMy03LTEtMS0w_289f471b-354c-4818-a4f0-3466e7ef9343"
      unitRef="usd">127000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC0xLTEtMS0w_c676ee8d-0d4e-49f1-9151-c86a5b4dcc52"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC0zLTEtMS0w_d0909f3e-b364-401e-b382-826134597731"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC01LTEtMS0w_dffaf5bd-d11e-48a5-9648-dba1ac9471d1"
      unitRef="usd">59000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV80OS9mcmFnOjVlNjM1MzdmMDFlMDQ0ZmM4NjAyYjljYmUzODMzN2Q0L3RhYmxlOmI0NDZjOWI0MTA0NTQ4NmY5MDAwMThjYWNmMmExNjA4L3RhYmxlcmFuZ2U6YjQ0NmM5YjQxMDQ1NDg2ZjkwMDAxOGNhY2YyYTE2MDhfNC03LTEtMS0w_250f3d5f-618f-4f2c-b7ed-31a8b33a925b"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY0Nw_fd81aa24-e7b1-4712-ad62-0000ba7e7ff5">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#x2019;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#x201c;Fair Value&#x201d; in the 2019 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 or December&#160;31, 2019. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2020 and 2019, there were no transfers into or out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMTQzNQ_4927195d-6036-421d-9e3b-a8c47aad471e"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMTQzNQ_94b2f75a-90e8-46f6-8376-6217e8fadfb0"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY1Mg_6379f98a-1742-442d-b473-bcb28fbc5b61">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2020 and 2019, there were no transfers into or out of Level 3.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi0xLTEtMS0w_ed743942-d8ea-4dcb-9c70-3a5de40ad163"
      unitRef="usd">5670000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib9888da910534133b2a13752e0039eda_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi0zLTEtMS0w_aef62c93-8408-4273-818b-13b3e9d6d7dd"
      unitRef="usd">3586000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi01LTEtMS0w_5f5f1793-416d-438a-8123-2c94c025128a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMi03LTEtMS0w_0c382210-9392-4990-a93d-7292bbe0c4a8"
      unitRef="usd">9256000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i002016e409a046ca82eb2a7e9dbf5f44_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC0xLTEtMS0w_7256af20-5a9b-4d3e-88a1-3e5bf6aaf443"
      unitRef="usd">2498000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d4ea2ffdeae48c092313d22b4f64e1c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC0zLTEtMS0w_92967ae3-c627-40f1-93d3-1e8ffb973d13"
      unitRef="usd">103000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0535ddebc7eb4e54bebfe38fe2a9b22b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC01LTEtMS0w_affba0e9-e4fa-4aee-af04-8327c574dca7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib03ca448ca5c45b495bb1c94af6ea7f7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNC03LTEtMS0w_d7c0ff02-9070-4ec7-86e8-c832d9686fa5"
      unitRef="usd">2601000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5a642414691e4b29b29ab8baba0a10a5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS0xLTEtMS0w_1ff52993-2c01-47ee-b531-df9d616c3497"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idec3f94d59bd417b802264c8aefae9b3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS0zLTEtMS0w_7ca85638-57f8-4c79-adb1-503b56a76605"
      unitRef="usd">2540000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f229849b6c24840ae258b5ab8a06762_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS01LTEtMS0w_99c43603-4997-4989-b131-8f5c6d90a8a4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2675c3b1d0543ea9aa4c53740042175_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNS03LTEtMS0w_b1297f35-b845-460c-80b6-a849db8a9e40"
      unitRef="usd">2540000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i95925aab9f5b4fcaa0bccf22427e5e67_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi0xLTEtMS0w_a860b18f-26e4-49be-b5ff-3269ff1330a0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e3c6cdcdd4340a4ba6b3cb06502146c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi0zLTEtMS0w_281c33aa-e5eb-49a0-8409-6f3004fecf14"
      unitRef="usd">8476000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c8083ca7f924d47b17ce8940d650a38_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi01LTEtMS0w_d7600107-26ec-4793-a7c9-9b3f94769a09"
      unitRef="usd">48000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i468dd4fda3b442e99fc8328fba905b67_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNi03LTEtMS0w_475be189-4286-4745-88b9-e434e537bde3"
      unitRef="usd">8524000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1bf20fa45ec74aefb3382146c0b20236_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy0xLTEtMS0w_c1a982bc-0bfd-4d13-85dc-7d0c6dbf512a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd6d327fadfd4b23954ab240ff677c47_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy0zLTEtMS0w_cafd25d2-a05c-481f-be52-68e8777315b3"
      unitRef="usd">2721000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8eb1a14e2e774b2d837d4d7cdc423714_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy01LTEtMS0w_d3c1347c-3d20-40f8-ac69-e02192834e4e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7045e35aa3d42f8b85edee8aa4d38ef_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfNy03LTEtMS0w_5c634fbd-1c4e-47d7-94ee-b4a30fb582b1"
      unitRef="usd">2721000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i364069c2b8ac4c28b31b5e1a40e551c3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC0xLTEtMS0w_fae90e49-2b22-4145-8918-a4d8f0462d8c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8997d1471cf34a75beffddbb3c6148e4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC0zLTEtMS0w_18b1e1bb-4782-49f1-9aaf-1f28ecad0c18"
      unitRef="usd">713000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id37b8520c2d34c29948b799a01af328f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC01LTEtMS0w_d23ba829-00f0-4d08-b703-3cbe0af2bcdd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d1dfa73f59a451681e979540ce540ae_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOC03LTEtMS0w_466f069d-54ff-4e0e-abac-2f80fdd8b752"
      unitRef="usd">713000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e538c30b555469794e0be3a6f8ed046_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS0xLTEtMS0w_cc0b6af6-ef24-4836-9c06-89e6b30c6853"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifdb8f83e7c124df8a6cbf59fd5ce2c8f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS0zLTEtMS0w_23cf689d-34e2-4620-94a1-c601c39d1459"
      unitRef="usd">1012000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia29caa6d3bc347128a52855fa834c203_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS01LTEtMS0w_4d962a83-0eb1-4a44-820f-7a9b4502ad87"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7526eeb0a2fd4ef4b130b931e3eb519e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfOS03LTEtMS0w_d6936507-6270-4709-85b7-a8aaa76d5b5d"
      unitRef="usd">1012000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5a1dff5e36324924a4f2feec7a5a73d7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtMS0xLTEtMA_0d250963-aaa7-41e4-a4cd-b4b8ff24cca9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb4060526c2c496981cc55c6977adb37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtMy0xLTEtMA_e3aac57c-8f31-45d2-ba16-d160869b18d8"
      unitRef="usd">2262000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f4c4734bcc24fb0ae7cab1d303bded7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtNS0xLTEtMA_aef4dc84-8be1-4579-977b-1793460986a7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8ec813f07a334f08955f4a12ac4902a5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTAtNy0xLTEtMA_b95abb0b-3d39-4047-9f0b-02a2ffe2d587"
      unitRef="usd">2262000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife9add6b9a8641dfba7ba3deccb48b41_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtMS0xLTEtMA_bb7eb60e-cac1-49c3-8b0b-cfbbf59e62ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf45d10b231a4274b5a9ad0d08f997a7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtMy0xLTEtMA_361e1b6c-56e1-42d0-8ad3-7b2ce2b7d4bc"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iabe734fa96d842cc869a0c54975c7cac_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtNS0xLTEtMA_e7c58d75-0c67-4b2c-92f7-4164650455ff"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4eba4bdd839a45388341859be447f171_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTEtNy0xLTEtMA_ca2c486c-28dd-44ed-9742-1c3d93a8775c"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItMS0xLTEtMA_652fe20b-c5fa-4990-a9d2-c9c68cf75484"
      unitRef="usd">2498000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9888da910534133b2a13752e0039eda_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItMy0xLTEtMA_69b30bee-b93f-4b35-9d32-169b1fb227e6"
      unitRef="usd">17851000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItNS0xLTEtMA_7b7d84ec-8cef-4c44-ac65-c41c22630417"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTItNy0xLTEtMA_8f0ffc4d-08fd-47b0-98b4-ca9ba3c021b0"
      unitRef="usd">20398000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtMS0xLTEtMA_46571cd5-80bf-4347-913f-19e50cdaf6d0"
      unitRef="usd">20000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib9888da910534133b2a13752e0039eda_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtMy0xLTEtMA_542fd0ed-5de8-4d07-b9f2-14c007bd1bb5"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtNS0xLTEtMA_e23e8d35-954d-4a52-a7b4-1007f738bb43"
      unitRef="usd">26000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTMtNy0xLTEtMA_89096c7e-b981-43d2-a97b-87238a7ffd44"
      unitRef="usd">46000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtMS0xLTEtMA_3c7daf5a-cf17-444b-bc95-7607e95c1bd2"
      unitRef="usd">8188000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib9888da910534133b2a13752e0039eda_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtMy0xLTEtMA_ba69006f-16c0-4413-8a02-f00a437f19d7"
      unitRef="usd">21437000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtNS0xLTEtMA_f5050fbf-ae12-4e4b-b5a6-31ee8feb63ed"
      unitRef="usd">75000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTQtNy0xLTEtMA_a1de1116-71cd-48bb-890d-5429fec57bdd"
      unitRef="usd">29700000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctMS0xLTEtMA_2b71bcd0-466a-45c6-ae2a-7bd60772b7af"
      unitRef="usd">3397000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctMy0xLTEtMA_fb032953-3aca-468c-b6bd-3ec7894a54d1"
      unitRef="usd">2286000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctNS0xLTEtMA_62819a1d-08f5-4e8e-9451-3c11aa54984d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTctNy0xLTEtMA_76877401-74a6-47ba-9944-de50d0ae49f1"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic92eabbcfc0e41129c6ebe1c3bb58c1c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktMS0xLTEtMA_499bbadb-041d-4ed8-94cd-758859a873ce"
      unitRef="usd">1785000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i167492c1a5134840a68af5838d92c0a5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktMy0xLTEtMA_a8a907c7-7673-4738-abe2-15d7c7ee8fe8"
      unitRef="usd">67000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4875b0b5876478ea38a39e3ca94f3e4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktNS0xLTEtMA_4b4c529e-5451-4372-8457-d444986cac43"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i635d4a19627941fbabf18b73ba4a7f69_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMTktNy0xLTEtMA_e59deee4-0c0e-4d1b-895c-04426a09336a"
      unitRef="usd">1852000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieaaedc48c33f4ce9b4d61713e708492a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtMS0xLTEtMA_4880a98a-e914-4d91-b027-10e4a302017b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i708f6416e0d84b7a86d62ca235435207_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtMy0xLTEtMA_2d5ea4a7-528e-46f7-bb9b-68ade9a15e23"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i439528f07f334a2e9f9e37ae4c771d44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtNS0xLTEtMA_0bc33fad-fcce-4a04-9415-13d5de69c87c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i229361a7197a4afeb15eb2425729c789_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjAtNy0xLTEtMA_a3533182-a15b-432b-8b4a-8b02b38483bf"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i769f8ad79eaf46d4b177922dba08206d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtMS0xLTEtMA_4fc7320a-6175-4987-8dfc-f0e21be8ceee"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2b8f23ae3b94a519cee02e63f7e0a3c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtMy0xLTEtMA_990c1592-b021-47bd-b3d4-885a1466ba82"
      unitRef="usd">7700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6743b7888dc0448685e1853c25ff8440_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtNS0xLTEtMA_defd87ce-7b26-42b0-a1bd-b70908579629"
      unitRef="usd">37000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c704d6d14fc4be98279325dd3287aa2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjEtNy0xLTEtMA_e916c160-a62c-4614-beb8-b4a35eb47d74"
      unitRef="usd">7737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib3f13f39c72a49049b8ef64e5f5c7c0c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItMS0xLTEtMA_03fc7d77-bc77-4da0-8ff7-23a84633cae0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1a2c5cc590d64e41aaf1d4feb53683e2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItMy0xLTEtMA_4e9a7bf1-f77a-47d9-a3eb-88491a7b646b"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida5abbd3b9f046aeb99c9fba1e6dca0b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItNS0xLTEtMA_fd5aa5cb-d7d5-478b-a529-3937fe64fdad"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i129439a18c454d088d7a6a8c35f27f78_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjItNy0xLTEtMA_3754eb92-7d4f-45f1-8786-f735c3d26c0c"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7595fc1bc6054a7190199e2e60736d28_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtMS0xLTEtMA_85d74bc4-bda0-42bd-8181-d8ad941456c4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib748f4e8d7b5461196a5145bd6da1195_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtMy0xLTEtMA_894d6e90-9476-44d2-87ae-696ac110051f"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9f855925c0344cb8356da40cd655821_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtNS0xLTEtMA_e7053df2-c07d-424b-b688-32d20e6d9372"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d8fd736ba76478e9162d84858b27634_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjMtNy0xLTEtMA_f8b966f2-f08d-42eb-9306-0c79d776eeb0"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f07defd6e1d4056a5169e425552d20b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtMS0xLTEtMA_733b0eed-5292-46db-b83e-12c7d2b0302c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i809ae28eeac24a9f9310746684a864d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtMy0xLTEtMA_7437394d-3d53-4586-b904-9e07fc4129fe"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i155016131fca4d64850212170f3783f0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtNS0xLTEtMA_38b04f02-6d24-4dc4-a0f9-f0a3a6788d9c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i060cabf68768492aa7a6026696eef9be_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjQtNy0xLTEtMA_9205c685-ac10-4b91-acd1-3fea74aa575d"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96b2f88bdb4a467e9d789f375c58180a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtMS0xLTEtMA_194d2dab-c9b1-4a4b-88ea-73b90104e568"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id1a547cc68174a39b3376c9fff4a8994_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtMy0xLTEtMA_0a4eda9c-aef3-4eb3-9f9d-31a35f16a8de"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i198821e71bd845749eae39a08b218939_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtNS0xLTEtMA_0b36a015-de98-486f-a17b-2d563940c77d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i301877cb06e8403a8812ea5b4d398af3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjUtNy0xLTEtMA_866c9850-f220-49ba-8bc9-9f26bd2158c0"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic0efa799796949ae89d8f49114056097_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtMS0xLTEtMA_97bd2969-8b71-4488-8e4d-d68bdb22ba19"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89390455960d4f9f9c95e118937a1dc5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtMy0xLTEtMA_66a751f3-ed97-4a9e-8f72-4f4d2d8318e2"
      unitRef="usd">26000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d17013fe24947c1b861b4825165d690_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtNS0xLTEtMA_4a926b93-af29-48bc-ade9-81a350a6b95d"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc84a509c29542e8b93af8e853807f78_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjYtNy0xLTEtMA_c66d461e-0dd8-45d2-883c-1f4c6cb9ff0b"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctMS0xLTEtMA_13bb8dbf-5b3d-4867-a807-e682f9ef4cd8"
      unitRef="usd">1785000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctMy0xLTEtMA_ec613497-801d-4a56-9bcf-5dad00c1df8b"
      unitRef="usd">15088000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctNS0xLTEtMA_a0501e4b-4b1e-4f36-baa0-292ceef987c5"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjctNy0xLTEtMA_46ce2e16-d55b-4565-9836-2a639a4c7fb7"
      unitRef="usd">16922000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtMS0xLTEtMA_f6a0906b-0d10-4174-8ace-fbacf70ae788"
      unitRef="usd">34000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtMy0xLTEtMA_e0953027-b173-4cc5-a1ab-eba4f10e3b82"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtNS0xLTEtMA_702c4c76-fe51-4615-8cb1-7f19462b4c5e"
      unitRef="usd">39000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjgtNy0xLTEtMA_62913e46-8135-49da-b540-8340c25ff97f"
      unitRef="usd">73000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktMS0xLTEtMA_a894e92d-3ef1-43a5-bc80-bf259c93cd26"
      unitRef="usd">5216000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktMy0xLTEtMA_8911a46d-79ee-4e44-b675-0462da84bd74"
      unitRef="usd">17374000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktNS0xLTEtMA_335fa1ed-fa71-409c-8bc1-877034d5060e"
      unitRef="usd">88000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOmUzMDk4ZDljMGI0MjQzMzFhMTQxM2NiZWY4MTFhOWM0L3RhYmxlcmFuZ2U6ZTMwOThkOWMwYjQyNDMzMWExNDEzY2JlZjgxMWE5YzRfMjktNy0xLTEtMA_7e759bb8-af2a-485f-9ed9-4b63d8a264f7"
      unitRef="usd">22678000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY2MQ_6785bf1e-4a06-4f00-b7d9-5401d4b43529">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC0xLTEtMS0w_b6886918-1703-402b-893b-f63bfa1c966a"
      unitRef="usd">1124000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC0zLTEtMS0w_ed7948af-459c-4e1c-88c2-b20aa498af5f"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC01LTEtMS0w_f47de689-53ff-44e3-960f-8b917263a602"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC03LTEtMS0w_32861a5a-9865-4d32-8b92-424958d9f9a6"
      unitRef="usd">1148000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i995c07a91519440c88d67c6c40193064_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNC05LTEtMS0w_c0c07dfe-3375-446e-8cc0-c9225c9e1961"
      unitRef="usd">1148000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfNS0xLTEtMS0w_9389d2a0-0c4d-429b-bbaa-283f5cebe672"
      unitRef="usd">146000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC0xLTEtMS0w_9bd82808-3ddb-4cb0-b9c6-eab10197d2ed"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC0zLTEtMS0w_90ce0882-9744-40ce-8eea-a0bd3396d94c"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC01LTEtMS0w_d4427de4-59d4-4735-b91a-e62ecf3feedd"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC03LTEtMS0w_e858f557-aad5-4865-be14-822d8e067464"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i995c07a91519440c88d67c6c40193064_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOC05LTEtMS0w_d503792a-9ced-462d-a584-513c23e6f057"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS0xLTEtMS0w_0d1236d9-999f-4711-ad77-7367590817ef"
      unitRef="usd">322000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS0zLTEtMS0w_25991d31-3a76-4421-b2a4-2b89683a3f8c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS01LTEtMS0w_8a0ab6e5-e2ff-4de8-af4f-4d314bf3290c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS03LTEtMS0w_d4aebf07-34d7-444a-a195-b01f2783c509"
      unitRef="usd">370000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i995c07a91519440c88d67c6c40193064_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfOS05LTEtMS0w_2bbb5bb5-82dc-436f-8f8d-bd3d846dbc0a"
      unitRef="usd">370000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icdfbab09e275415b941c75475ce6fde8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtMS0xLTEtMA_f17e2df2-077a-486d-84d9-cb471460816c"
      unitRef="usd">66995000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ieb0edebf547f4905a41bc330aa523177_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtMy0xLTEtMA_446a1d81-59eb-4cd9-941d-f255f4f1fad7"
      unitRef="usd">76642000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i49246bbb41534ab9ab8993460e449ffb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtNS0xLTEtMA_a9434cd1-5ed5-4080-a135-8e0047a57f6c"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8d67531f617f4a779c4402a048cc3bb0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtNy0xLTEtMA_bccd1baa-e660-404a-ab1a-91968263b159"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i995c07a91519440c88d67c6c40193064_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTAtOS0xLTEtMA_076cd3ed-f87b-4273-a629-51ee65855776"
      unitRef="usd">76642000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtMS0xLTEtMA_3fbbce12-fdf6-4fc7-93ac-afc7203df577"
      unitRef="usd">1213000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtMy0xLTEtMA_9b653b02-8a8b-437e-b9cf-791116102320"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtNS0xLTEtMA_79247455-9294-4f43-acb6-1344f4974e2f"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtNy0xLTEtMA_ff36d747-fa00-423c-bffd-23aed0e601ae"
      unitRef="usd">1239000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTQtOS0xLTEtMA_729b05a2-f3c2-4db1-b0e3-5c3f8eeab25d"
      unitRef="usd">1239000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTUtMS0xLTEtMA_5d192544-620b-4cb1-a3c1-2814898da411"
      unitRef="usd">149000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtMS0xLTEtMA_1fc3c64e-9df1-406b-9714-34f33338808f"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtMy0xLTEtMA_6b4215e6-3ad4-43f2-8e72-d1a3c94ff8af"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtNS0xLTEtMA_82b107e4-0e4d-4c70-9ff4-9d4e694ec489"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtNy0xLTEtMA_64353b95-68c3-4c73-bb76-6d75820c7041"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTgtOS0xLTEtMA_e3dd8ca6-5462-4043-a291-26845f798d7b"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktMS0xLTEtMA_4dd12a04-e28c-41fe-af55-81fc5a7bd745"
      unitRef="usd">372000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktMy0xLTEtMA_dda7acdf-e267-4abb-9a0e-35d347fc077c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktNS0xLTEtMA_3819d4c6-03b8-43d4-a2b0-b1758ddfeb98"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktNy0xLTEtMA_621f40cf-3282-4f6e-a8f2-bbb67b46d396"
      unitRef="usd">392000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMTktOS0xLTEtMA_f5cf18c2-0f81-474a-9473-f1fcd10fd61e"
      unitRef="usd">392000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5fd8f52e738441778cf1253aee1efcb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtMS0xLTEtMA_29604d85-d641-48e7-9ed3-f59e74e443e4"
      unitRef="usd">68480000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4fe0ca53a694483a9013de0430acc1ca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtMy0xLTEtMA_d28144af-5d76-4558-9904-0ab56c293295"
      unitRef="usd">74306000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ideb5308533d344a3a8a7f42fb04088c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtNS0xLTEtMA_9044dc37-5eb9-4de9-b6d9-b23c8a0f4ea7"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i93b120b41b4c4aae917c5be4d6c7787a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtNy0xLTEtMA_31ebe259-1c91-44ba-9980-03d37a371c6c"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iea3e86f9c2cc4cf1b88309fa5709f1df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjFiOTJhZmE2YmQ0ZDQ5NmNiMjBhZTVhZDc2ZWUxOWM5L3RhYmxlcmFuZ2U6MWI5MmFmYTZiZDRkNDk2Y2IyMGFlNWFkNzZlZTE5YzlfMjAtOS0xLTEtMA_fd2278e0-2839-4fcd-9c69-9483327edf55"
      unitRef="usd">74306000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RleHRyZWdpb246YzQ2MWYxYTI4YWNiNGIwNWE1YjVhNDJkZjhjNmVhNDRfMjY1Nw_9aa02cf4-f651-4754-92df-1046b5579a15">Separate Accounts financial assets as of September&#160;30, 2020 and December&#160;31, 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i08dd08cbd4454361a90dbab797cd3aa2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0yLTEtMS0w_18c9192d-28d4-4ff6-91b3-3edf65e35343"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if7a45a7920b14acea3f4b36636c4b5fd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi00LTEtMS0w_f6a7f6bd-1646-4e56-b39b-5aa1ae6b1690"
      unitRef="usd">72000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i80a7cc610f9a46e2972dabe60f274ea7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi02LTEtMS0w_5dc4da48-d39f-407a-a9fc-c445dc2a8e46"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifc004478531a4eadb516f49ab8f04d57_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi04LTEtMS0w_228327d7-14a2-4294-87d0-85bbc1fc7742"
      unitRef="usd">74000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifbc87fccbde24356929e17da657ef9be_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xMC0xLTEtMA_0650deca-0b21-440c-b505-100909fcee7f"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1ec68f98e99d43249445dac606bfea53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xMi0xLTEtMA_2f200d2d-2103-4b71-b17c-21a56324b932"
      unitRef="usd">143000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie7fe31f16b9d42d596559a375bd059c4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xNC0xLTEtMA_50524a1f-6853-4897-9054-5db641c87c58"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9ecc8d5ee49f4089bcaf72ed79a73d73_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMi0xNi0xLTEtMA_c2370de8-ea32-466e-9a65-db64105b8217"
      unitRef="usd">145000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9f42424f53594322a0bc648503fa4144_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0yLTEtMS0w_1ec7f5ce-e3b1-427b-b024-ebfb40d71519"
      unitRef="usd">1538000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib3c32977c1a344a48577bd5d98e4ae14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy00LTEtMS0w_d01c6eaa-b9dc-45d0-8604-2e8870e3fd11"
      unitRef="usd">2576000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i177b612dc9f549628390175ae5e60944_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy02LTEtMS0w_e546d124-50f2-492a-a805-a0ce2cb434ff"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib96792d9941740519779008d23a17bf0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy04LTEtMS0w_54432cb7-cea1-4bb7-9334-69bf65879642"
      unitRef="usd">4114000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0d1b93e21d042618a7cdb163a1f9a53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xMC0xLTEtMA_4521a098-3c38-4874-8333-39ec8214e4be"
      unitRef="usd">1224000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3d6a2a3e0816441b96633eaefaae2f1c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xMi0xLTEtMA_cdda6f07-e12f-4978-8dab-a25ec5cfa437"
      unitRef="usd">2589000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i677b008b5750476a9b99ad7d720cd5aa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xNC0xLTEtMA_9a6eae61-e4ed-4428-93a3-e17ea1b1c3bd"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i320389b0cf034ae5a57bfdd9b1a683c2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfMy0xNi0xLTEtMA_6798d1f9-bd63-40c3-8000-889e0a8930ec"
      unitRef="usd">3813000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7e83a1132c904e35a130f8abd67d5f4a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0yLTEtMS0w_e5538560-3737-4c2a-942f-f501df0de828"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2e5079511b3a450aaca64bc154348d61_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC00LTEtMS0w_33d7edd4-ec4e-4e05-9511-56bda2193495"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i804c778ec2814834b3d84dcb0310f508_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC02LTEtMS0w_8290784a-9e58-4784-b8c3-a3847622e0a3"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id17cc174a92c415eb0fc76b28ecf0e1f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC04LTEtMS0w_6b0d862b-8fba-442c-9c03-379630209063"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i60fa68066dc24311b7c8ce0a1c65ccc8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xMC0xLTEtMA_ebfc7acc-b112-4c25-9e7f-28305c50acdd"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i62c741d96e344754add90a7638be6b23_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xMi0xLTEtMA_af283df6-551c-4b8c-be02-c2bba4f8c23c"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic24208d25b4f412ebb677befba70dfd9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xNC0xLTEtMA_2c3e32de-dcd7-4b70-89f1-86a92b3ea2d6"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibb8de0cf862543a28ac57b9c9b4d9da1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNC0xNi0xLTEtMA_92b4b831-d321-4896-bc85-9183fe7a398a"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if8da6c47de724df685363819d15fd5d2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0yLTEtMS0w_00f1e704-60b8-40d6-b2b0-da63f8ce982e"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i435b788198344ed889fb7f41075b6e67_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS00LTEtMS0w_36ea55a2-1536-443d-83d3-8a23c4c2f4f8"
      unitRef="usd">603000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i68cf955793ec45129bc32f05a30f217d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS02LTEtMS0w_f92a9891-17d2-4160-af1e-f98bfed233fa"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0e169ba85c734e9abcf8020fd97a8db5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS04LTEtMS0w_f30a5b76-1de1-4baf-a43a-913475b37fb2"
      unitRef="usd">603000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5856fd2c216349b8aeedbb9e1974b765_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xMC0xLTEtMA_bc7efac7-e174-43ff-b995-2f08d55ebeb0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia5c9b66131ca4a539a74369e6146272b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xMi0xLTEtMA_b32fdc1a-2e70-4777-ab98-c647d896b690"
      unitRef="usd">499000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2bae9f24886e4178959c9e4374cf2d26_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xNC0xLTEtMA_6c407741-b124-4ad6-8c4f-c8e553287d31"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6b413c6d9cad4b9eacf86b8d064d8f7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNS0xNi0xLTEtMA_36d21a65-1ab0-4f2f-bd8c-0c725ac50bd4"
      unitRef="usd">499000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i63c1bd90c28e4931a7a6e2193905bc88_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0yLTEtMS0w_9b58e2b4-215e-45d5-bd18-72083f93d063"
      unitRef="usd">1540000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib9888da910534133b2a13752e0039eda_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi00LTEtMS0w_0fcff076-6b6e-474b-b5c8-c0aca8d3debe"
      unitRef="usd">3253000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iaf2bdff77dbe4d5f8ec549c5dbe7622f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi02LTEtMS0w_c7fad4cb-6666-4580-83e7-671ff72338e3"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5cbb249c57e548daa8401983dea3fb69_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi04LTEtMS0w_285d3234-9c5c-4a7a-a3ce-d9583120ea42"
      unitRef="usd">4793000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2eecc9a6d3764bed91d04d9833777391_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xMC0xLTEtMA_714d54fa-f0e7-477e-a803-89ce95e7d0ec"
      unitRef="usd">1226000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if26439b5d7ac49bf92a0c43c4e20cb42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xMi0xLTEtMA_69f9c4b2-1973-4fe6-801a-23598a939e73"
      unitRef="usd">3233000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia3d7a4047d05423d8090a70fc2fe604c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xNC0xLTEtMA_598d9568-20fe-49ba-9f2e-f491f155e546"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9bb4ae865e534fa1bc341a84e105cb15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81Mi9mcmFnOmM0NjFmMWEyOGFjYjRiMDVhNWI1YTQyZGY4YzZlYTQ0L3RhYmxlOjNkMmZkZWQxYjgyNDQyYmQ4NjE5YzQ0YmU1NTk3MzA1L3RhYmxlcmFuZ2U6M2QyZmRlZDFiODI0NDJiZDg2MTljNDRiZTU1OTczMDVfNi0xNi0xLTEtMA_e87d04aa-d61e-4575-9446-bc32121e54ea"
      unitRef="usd">4459000000</us-gaap:SeparateAccountAssets>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTgyMA_e5060f9e-37bb-4c9a-98fc-c2aab87f9d97">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the nine months ended September&#160;30, 2020 and 2019 in the table above exclude (i) $1 million and $6 million, respectively, related to a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $31 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $173 million and $213 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $448 million and $511 million, respectively, in the nine months ended September&#160;30, 2020 and 2019, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, the Company&#x2019;s liabilities for the ultimate cost of (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#x201c;IBNR&#x201d;) plus expected development on reported claims totaled approximately $5.8 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2020 related to the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTgwMA_e26bc72f-613a-453a-81a3-c93e1cb688b2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the nine months ended September&#160;30, 2020 and 2019 in the table above exclude (i) $1 million and $6 million, respectively, related to a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $31 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $173 million and $213 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMi0xLTEtMS0w_c902659d-a2a1-4155-b262-cd4e879bc767"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMi0zLTEtMS0w_b62f92c9-f15a-454d-ad94-5579e2ea95f6"
      unitRef="usd">6147000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMy0xLTEtMS0w_a29a8f7a-81c7-453c-95d5-6b8c4e461e60"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMy0zLTEtMS0w_5668820b-3c62-4b8d-80fe-344ff91d61db"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNC0xLTEtMS0w_67dd80c9-3d1f-4bd4-abba-8dc870f09594"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i7aeba235b9cc4d79a2f135126e309786_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNC0zLTEtMS0w_2014af84-67d2-4f5e-bbce-0490276a75e0"
      unitRef="usd">6143000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNS0xLTEtMS0w_15117df8-0b3b-4de3-bac6-cb50eada4412"
      unitRef="usd">444000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNS0zLTEtMS0w_bb6c028e-c3e7-4df9-b0bd-ec5de2f19058"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNy0xLTEtMS0w_800e2064-d580-41a3-b5c7-e81bc00551c1"
      unitRef="usd">40777000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfNy0zLTEtMS0w_b5f89e65-1632-4b86-b90e-5812100f3dcb"
      unitRef="usd">39657000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOC0xLTEtMS0w_fc1b6fb9-a351-486d-a5ac-124d22851265"
      unitRef="usd">-448000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOC0zLTEtMS0w_2fad76c3-ad5b-4f5a-8f69-9023766ed85d"
      unitRef="usd">-511000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOS0xLTEtMS0w_c762bb83-9d13-4907-9fbc-c2fcfe3eb46a"
      unitRef="usd">40329000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfOS0zLTEtMS0w_2d5433fc-f142-4cd9-ae76-bcacd2db196c"
      unitRef="usd">39146000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTEtMS0xLTEtMA_395a9a98-d8cb-4625-832f-7f4804caa659"
      unitRef="usd">34198000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTEtMy0xLTEtMA_e1ed6744-744a-4b76-952c-767cae8e34fd"
      unitRef="usd">33032000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTItMS0xLTEtMA_19bf1ffb-8850-4f47-92e7-2a8874d7e7db"
      unitRef="usd">5865000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTItMy0xLTEtMA_2cea8399-04ed-4f9e-8799-bd9669e6e12d"
      unitRef="usd">5253000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTMtMS0xLTEtMA_e33c608a-2da4-4339-9e98-64063004aa32"
      unitRef="usd">40063000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTMtMy0xLTEtMA_5acacbd6-979f-4729-a016-913c8006bc8c"
      unitRef="usd">38285000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ie178c63026e949e8b2151622fca0263c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTQtMS0xLTEtMA_fa885f24-d70c-455f-9145-b7a20062e6c8"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTQtMy0xLTEtMA_1f153d1d-75c5-4241-bcc9-ceb456d56abd"
      unitRef="usd">6000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ie178c63026e949e8b2151622fca0263c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTUtMS0xLTEtMA_5e5af134-1110-49a8-b631-adbb77074b97"
      unitRef="usd">7585000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTUtMy0xLTEtMA_95b09848-940c-408d-8401-cb31b825896c"
      unitRef="usd">7010000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ie178c63026e949e8b2151622fca0263c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTYtMS0xLTEtMA_14ea6572-c1d9-4ea5-865b-88e8a988ebf0"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTYtMy0xLTEtMA_9dc68f11-a724-4267-8028-b96a6b645c8f"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie178c63026e949e8b2151622fca0263c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTctMS0xLTEtMA_9d75367f-d263-4a30-9a30-d6c1b2a4bc00"
      unitRef="usd">7593000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RhYmxlOjRlMzU5M2JkMTkwYjQ0N2ZiNmM4NjZjM2M5MzllYjhhL3RhYmxlcmFuZ2U6NGUzNTkzYmQxOTBiNDQ3ZmI2Yzg2NmMzYzkzOWViOGFfMTctMy0xLTEtMA_cb22f8de-4950-4d8f-8eeb-67d828e2a39a"
      unitRef="usd">7014000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ie178c63026e949e8b2151622fca0263c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMjc5_fa885f24-d70c-455f-9145-b7a20062e6c8"
      unitRef="usd">1000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i226da8e13c7f44bb9ccb5b168c8b7710_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMjg2_1f153d1d-75c5-4241-bcc9-ceb456d56abd"
      unitRef="usd">6000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMzkz_2a747f52-9497-4f4a-a127-ae605d375842"
      unitRef="usd">31000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNDAw_f3d2ac6e-ab73-4281-8da1-537bbefff3d1"
      unitRef="usd">31000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i2f09e46e454f4475bc40352c0231eb93_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNjA0_4201f2db-9503-4180-991a-3dc4c1c321ac"
      unitRef="usd">173000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i2c30244244a04895b2eb8f7a3183ed76_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfNjEx_e7ef5ad2-532d-44f9-a74a-6bd01dcb5ab3"
      unitRef="usd">213000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if156a997688c4e66837675d203bd1c98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfODgx_fc1b6fb9-a351-486d-a5ac-124d22851265"
      unitRef="usd">-448000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i385fd97f7a3844a2add5fea03580cbcd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfODg4_2fad76c3-ad5b-4f5a-8f69-9023766ed85d"
      unitRef="usd">-511000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV81OC9mcmFnOmZkOGJlMDliNWUyNTQ5OWE4NzA3NWE4NmZkYTVhMmM4L3RleHRyZWdpb246ZmQ4YmUwOWI1ZTI1NDk5YTg3MDc1YTg2ZmRhNWEyYzhfMTY2MQ_70cea66b-a175-4de0-b02d-cb2b766b406e"
      unitRef="usd">5800000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTA0NDUzNjA0Nzk1NzA_a2775197-5f6e-4a87-8b9f-8a2040a28e86">Borrowings&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at September&#160;30, 2020 and December&#160;31, 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2020 (2.515% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;67,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;69,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;66,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(5,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;61,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;64,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#x201c;August 2020 Notes&#x201d;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2020, the Company issued $750 million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5 billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0 billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750 million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#x201c;March 2020 Notes&#x201d;) for total proceeds of approximately $3.95 billion, net of discounts and underwriting fees..&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds of these offerings will be used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness. Net proceeds from these offerings that had not been used for these purposes were held in cash or temporarily invested in cash equivalents and short-term investment-grade securities from the date of issuance through September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 8 &#x2018;&#x2018;Other Comprehensive Income&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Extinguishments of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.&lt;/span&gt;&lt;/div&gt;In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTcyOA_73714a92-9f82-4c67-924d-9f7d9c0a0116">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at September&#160;30, 2020 and December&#160;31, 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2020 (2.515% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;67,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;69,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;66,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(5,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;61,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%"&gt;64,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10e7590255dd44f183ff6175bce29c5c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0wLTEtMS0wL3RleHRyZWdpb246MGE3M2E5ZTU1YmIzNDdiOGIwYjMzMzBiYmNjZmI5NWFfMjE5OTAyMzI1NTU5Ng_792c08c6-632b-48ed-b634-3679f0730286"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5880b165e61f444ab0e29a376c321d60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0xLTEtMS0w_c07180dc-d275-4e9c-9c9d-4046725c56e6"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i10e7590255dd44f183ff6175bce29c5c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNC0zLTEtMS0w_b003d707-0afb-4269-9729-0a6fd824470e"
      unitRef="usd">723000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i0914af72006548ebbba484408464ae69_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0wLTEtMS0wL3RleHRyZWdpb246N2EwOGUzNzI5ODExNGRiOWE4YzFiNjM2MGJiN2I4MWRfMjE5OTAyMzI1NTYyNg_24255230-1906-47e7-8c50-38f3cc70c9b7"
      unitRef="number">0.02515</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8c1a7383071e4cc980e6c0e5a4147dea_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0xLTEtMS0w_9c990668-7131-496c-a8c8-2023ed3178f8"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0914af72006548ebbba484408464ae69_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNS0zLTEtMS0w_2e7b7a83-9ae1-42a0-8d3a-adba284e3e9a"
      unitRef="usd">277000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic05a1bb77adf449c9b884c612d910d6e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0wLTEtMS0wL3RleHRyZWdpb246YjMyMDZkNjBlYjA2NGE3M2I3NjUzZWZkNjk1NWI0MTVfMjE5OTAyMzI1NTU5MQ_5c10ce24-c780-408a-9015-0fd74978429f"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0bd7c4fa4868462fa55280d3ecac3953_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0xLTEtMS0w_a712f63b-4f66-4c38-9504-33fa23ec153e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic05a1bb77adf449c9b884c612d910d6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNi0zLTEtMS0w_48471301-1b33-47ce-99a3-71fadf07c5b7"
      unitRef="usd">2750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i290ff092291647068477c613b2614b53_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0wLTEtMS0wL3RleHRyZWdpb246OTk1NjZhMjFmNDRiNGIxODg5NWUwYzI4N2I3MTE4MTlfMjE5OTAyMzI1NTU5NA_c478db03-d6e8-43a2-955a-007d61aa8f4d"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i290ff092291647068477c613b2614b53_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0xLTEtMS0w_2cb915cc-d759-48d3-b939-a06e677c4004"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1687e1197697447ab1e252f736563f04_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNy0zLTEtMS0w_da9e0f73-0f7e-4edd-932b-16e7b463f88a"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i1096032d00f44b71b617c36d63d7f27e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0wLTEtMS0wL3RleHRyZWdpb246OGY3ZjVmZmY1OGExNDM2ZmIwMzdiZjVmZjM5OTZmNDZfMjE5OTAyMzI1NTY1OQ_9fffe524-cc3f-442b-9ae5-3013dda222cb"
      unitRef="number">0.00968</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id39b967136734ffebac4fa125d5df5e3_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0wLTEtMS0wL3RleHRyZWdpb246OGY3ZjVmZmY1OGExNDM2ZmIwMzdiZjVmZjM5OTZmNDZfMjE5OTAyMzI1NTY2OA_3ff38ec1-ed96-4428-8207-4b584a1da34a"
      unitRef="number">0.02605</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1096032d00f44b71b617c36d63d7f27e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0xLTEtMS0w_02ac3b6f-50bd-4737-be58-316dfd9a6785"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id39b967136734ffebac4fa125d5df5e3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOC0zLTEtMS0w_f362ec98-0ee1-488f-857e-08119012691f"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ieef7edab39324e21abec728d47812d6b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0wLTEtMS0wL3RleHRyZWdpb246YmYzYWQwMDhlYmY2NDNiNGI4ZGY0ZDY4ZjgxOWVlMmVfMjE5OTAyMzI1NTU5NA_e1a5a21b-4205-483f-a375-ec71fb4b60c4"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ieef7edab39324e21abec728d47812d6b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0xLTEtMS0w_adbfc993-d9c1-4ff9-953e-d2fa89a1cc09"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9c6b0f2f62c74a8681f9cf380a9e3f2c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfOS0zLTEtMS0w_44fcbf32-72f4-485d-98ba-537fbf8887a2"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9ee6ead635de4c95add163849dd94827_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmQ5MmNlNzRmMzRiNzRhMmI5OWQ5ZThlYWYyNmI1MTJlXzIxOTkwMjMyNTU1OTU_76accc0e-92a7-4b3c-8b7e-6e8c15e8ea92"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9ee6ead635de4c95add163849dd94827_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMS0xLTEtMA_08046627-421f-4184-8071-b97da40c3f3d"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie05261bf78de439e95e77a97f7a95197_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTAtMy0xLTEtMA_0dcfd32e-4ef2-42e8-a91d-e8f52acc2ebe"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib12e87c001794aeea0e7834103d4e29e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmNjYWI2YzQwMzQzMzRlYjdhM2RlZGY2ZDhmOTQ2MTFiXzIxOTkwMjMyNTU1OTU_e05065df-df93-41f3-8766-a78b4354437b"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib12e87c001794aeea0e7834103d4e29e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMS0xLTEtMA_c89e69e0-add8-41a8-9063-6facdede9a1f"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifa5b12f048374362ba07cace90c8eba9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTEtMy0xLTEtMA_b79ab6ae-3a40-4e63-a892-1af0ab539954"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i53697dbc20eb4716841fa78a5b6d61e9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjI1NjExODhhZmFjZjQyM2FhNjIxZTg0YWY1MDJjMmRkXzIxOTkwMjMyNTU1OTM_cea9055a-4bba-4a4a-bdf8-b4b4be00269d"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i53697dbc20eb4716841fa78a5b6d61e9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMS0xLTEtMA_516238aa-3b44-425a-99e1-1ff7938a3139"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i671fb7b57b204d38a5ec9cc8478dd71a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTItMy0xLTEtMA_b1f5bfbc-2b30-4866-a015-406dd85aa6c5"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if99da7bf0574479c90df5ab707ce9ea4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmRkMmRkY2EzNTlkYTQ2YTU4YjMzOTEzZjA4MWEwMjA3XzIxOTkwMjMyNTU1OTE_a0b28401-0dc1-4404-b0ab-3143c0c2428c"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if99da7bf0574479c90df5ab707ce9ea4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMS0xLTEtMA_8b184767-aa1b-4628-9805-85c5d0b87806"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9ee9602d63244d01b24b8058303bf440_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTMtMy0xLTEtMA_26c53af4-975a-4516-a2c4-8a3e2c5df990"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie9b151bd651d4e21ad5aef18942c57f6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjEwOTdmMGFkNGY0YjQ5YjY4YjA0OGY2MWZjZWM5NzAxXzIxOTkwMjMyNTU1OTc_524d2aef-9bd4-4b46-9bbe-80e37c097574"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie9b151bd651d4e21ad5aef18942c57f6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMS0xLTEtMA_885cec6d-6f8a-45af-a451-3a524d65c3a6"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibae6c86974674b649712b3bfcb54b956_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTQtMy0xLTEtMA_cba07b8d-1a1d-4c1a-b26d-5274469ee2b2"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc962ffe7759429a8437aeaf65091ad1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjE2ZWFjNDYxZDFiOTQzNmViZmQ5OWI3ZjliYmIyOGNjXzIxOTkwMjMyNTU1OTc_43c82efe-a08d-4645-b74b-bddc55067709"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idc962ffe7759429a8437aeaf65091ad1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMS0xLTEtMA_93426c1f-4ca6-4cb9-9918-570e5b953585"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i30331d814224442fb860f94b9c7bdefb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTUtMy0xLTEtMA_7f1668ab-e545-4889-a316-b6d6f27f6824"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9dd553eacf7843ce91290bdb3c9f651e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjZhNzY5NWEwZjM5MDQyNjQ5MTk1MTBkZmJkOGZlMDA2XzIxOTkwMjMyNTU1OTc_52f410dc-7c4e-4566-8a00-ccb0e311bbe4"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9dd553eacf7843ce91290bdb3c9f651e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMS0xLTEtMA_99826068-d730-4160-8e2b-7e45f71aba44"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie72d1e6a2e2e41db9701a9fd8bee5fa0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTYtMy0xLTEtMA_5f1e4036-db84-436b-9f5e-6c030b63d28b"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d529d43e45b4cdd914b2000673d53c8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmExNTUzZmE0NjBhMDRjMmNiM2RmYWE4Y2VmN2UyNTIwXzIxOTkwMjMyNTU1OTI_33c4710a-33cb-4147-bc03-80b2ddfd3429"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5d529d43e45b4cdd914b2000673d53c8_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMS0xLTEtMA_f1476fc8-15f5-4272-97f7-cffa5c07e520"
      unitRef="usd">3723000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1f2a6050d8c9472cad7e74ccbac0d7d3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTctMy0xLTEtMA_e09952d3-3505-48a4-aed5-ce5af29afe27"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i692d39424ece4bfe9add19706ba7a75e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNkNWFmYjExOWI5MzQ5MTBhYmZiMjgzYTQ1YTk1ZDNjXzIxOTkwMjMyNTU1OTE_5b18d48c-b4ac-41a7-8294-c8ebc4277b4a"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i692d39424ece4bfe9add19706ba7a75e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMS0xLTEtMA_a19fa136-27f8-4760-9307-6b22feb407e2"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8eb1eda40037470b87e5c84de8742351_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTgtMy0xLTEtMA_6d7f93ae-b14c-4371-bc68-dc2654ee6e3c"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1068e9886f384012b47c77ddf7440959_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjA2ZTNlZWQ0YjY2MDRlNDhiYjRiMTMxOTM2MDU3MjEyXzIxOTkwMjMyNTU1OTE_861949de-50cb-4079-85f6-f725535b81d5"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1068e9886f384012b47c77ddf7440959_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMS0xLTEtMA_8405b8ac-3423-4140-ad7a-d9eb5dc24444"
      unitRef="usd">527000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7982711b6d1a4518aa5760f4b6d81aca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMTktMy0xLTEtMA_58db42a3-5ffb-42c0-a59e-794533b02d58"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i20445c4013da41559dd716a5e301fa58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjRhNDg0OWMyMjAyYzQ4MjU4YjI5ZjZlNDhiMzFiYjJlXzIxOTkwMjMyNTU1OTc_7736e0b1-3d52-4020-822b-4752af91d28d"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i20445c4013da41559dd716a5e301fa58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMS0xLTEtMA_2f34b5ab-adff-4ad7-b972-2cc3e4c60c49"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2390853230664b71977471726c73ba84_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjAtMy0xLTEtMA_cc2b6bed-50f2-408d-9fec-798eef91a282"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ddf756027c647808636299b132f954c_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjAzNWNkNjUyNDk2NjRkZGQ5ZGIwMmY4ZmJhNzU2MmFhXzIxOTkwMjMyNTU1OTc_1c5a6628-36db-46ba-986b-ec6c1f2e739f"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ddf756027c647808636299b132f954c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMS0xLTEtMA_e101a58e-d7fe-46c7-88a1-4108fc5f46ab"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if4fbf2ddab2d45868cf34d8af1dc6657_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjEtMy0xLTEtMA_2d1cd50d-aec3-4d43-9005-8039d09acf6d"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMC0xLTEtMC90ZXh0cmVnaW9uOmQwMGU3NzhhMjI2MDRlMDdhN2MwNTMxOTE1ZjBhZjQxXzIxOTkwMjMyNTU1OTU_a9e8810d-df48-4c71-a2b5-02e27d6a3366"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i097de6a59efd4d8f8b89c2f76a4a1bb9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMS0xLTEtMA_9a585fc8-48ea-4a75-927a-2504741a42f4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i725a1515335644b2aaaf163a4dacff94_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjItMy0xLTEtMA_3f93bb37-3ef3-46a0-8aac-7bb964be9512"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5f09caa84ded47ba85c938f104c825d0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjMjQ1ODNlNzg3NjQ0ZDY5M2RmYTU2ZjMzNmY1ZWI5XzIxOTkwMjMyNTU1OTE_df6dd569-98cf-4848-9efb-0ff0dbf702bc"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5f09caa84ded47ba85c938f104c825d0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMS0xLTEtMA_3938caf2-ba04-4a47-80c7-35b26ff9eae9"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i63c767f7afed44d296aad898e2be1125_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjMtMy0xLTEtMA_2fcabf67-deec-4a89-85f9-3fa0d6c784eb"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54826d3a4d644b189399b609a6f6a24b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjM0MGEyYWYxNWI1ZDQ2OTU4NTk4NmNmNTAyYzZkMDg0XzIxOTkwMjMyNTU1OTI_e8381829-094d-4970-803d-92370e895f49"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i54826d3a4d644b189399b609a6f6a24b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMS0xLTEtMA_e03fad10-34a0-4e89-92b9-85e8c80d5513"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibe8e1cf76b454cd8a76cf064eb597d2b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjQtMy0xLTEtMA_14ed4292-7bcf-4bbf-9293-bf0c1915e2a0"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91d1a497cfd74fb8889de9ea721571bf_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmY2OWQyZGE0MDQ3YTRkZjliOWI2ODkwNzJmMTUzY2UzXzIxOTkwMjMyNTU1OTU_a951c6f2-f6e1-4c20-80e0-e9eba269146b"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i91d1a497cfd74fb8889de9ea721571bf_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMS0xLTEtMA_f8c89b4b-0add-4585-82a2-5dfb6180445b"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i36df838d786c4c5d9ef71e79fbde110b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjUtMy0xLTEtMA_831350c5-dc61-4dcd-ba72-088af0fed3e9"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic728b575d27e4aa8898383cf541680d0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOmE0NDdlZTg2ZThjNDRkZGZhZTJmOGY2NDYzNTgxNGM3XzIxOTkwMjMyNTU1OTU_f3cf8355-6add-456c-9346-6ca5d056caf7"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic728b575d27e4aa8898383cf541680d0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMS0xLTEtMA_9d964287-b3e8-4c17-9ead-84632a135d17"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id1a690e438fc46c8ae47a61d1dbb1690_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjYtMy0xLTEtMA_bc70f99d-1ac6-4150-9da8-90ad7fcc8613"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0b249377f2f4ddab5d99416f68657bc_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmE0OTFiMmY1YzYxMTQ4NzNiMGY0YTBkOTE3NjBlNzJkXzIxOTkwMjMyNTU1ODk_29a1d386-5e69-4c26-9e78-653c073d8284"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if0b249377f2f4ddab5d99416f68657bc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMS0xLTEtMA_dcbd60fa-ab37-4cf2-b86b-cb3d58da42ef"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id2b718b817d44528988a876de7fc8bf2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjctMy0xLTEtMA_b0547ddd-4ebe-4aa1-a7ee-c192ff19e76a"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjhkMTI1MGU1OGYyYjQ1YmRhOTRmYzU5YTUxYzNmMWMzXzIxOTkwMjMyNTU1OTY_09f31c0e-9578-4918-bbc2-f7dbd24b7fd9"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5d1c1b4bdbf549b59e879ec2f275534d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMS0xLTEtMA_a111e3be-3e31-4cc8-b920-ce501e9c6301"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ice8172ab47664fa9a3cd78759a4453a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjgtMy0xLTEtMA_ad9ba081-e5d0-457e-90f3-cc3e8fd3cfdb"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba7f24a8dbd0437fac060bebccc39eed_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmUxZDlmODdlNGIyNjRiNjJiZjdhNmU4MThkNWY3MzM1XzIxOTkwMjMyNTU1OTM_e4b8d9e5-ab3e-4a62-941d-766bbeb1f896"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iba7f24a8dbd0437fac060bebccc39eed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMS0xLTEtMA_4aa3814d-d52b-458a-af14-f714e666e8f5"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i853ba9286f1a4fcabce9a8524c725b25_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMjktMy0xLTEtMA_faaf3716-3752-477f-9bb6-799d088c0dfb"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i709dc9e5843a46c29f7c3a14b5732a22_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMC0xLTEtNzgxL3RleHRyZWdpb246MjgzODJkYWM2ZGNhNDM4Y2FjNjYwZDRiM2NlOWViODRfMjE5OTAyMzI1NTU5Mw_49eb3ce5-7eaf-4a8f-b7c8-48575b0291ed"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i709dc9e5843a46c29f7c3a14b5732a22_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMS0xLTEtNzg4_5405fbc1-7011-4d89-b2ee-a75988291124"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8d2b20e6c49d45d1ada51a71917b422a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMy0xLTEtNzg4_7e2eaf86-6c30-424f-a591-8bca2202af23"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic4ac59124dea453b8f6a7a1027357fb5_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmNjNTI0MTJiZTFjNzQ1Zjk4YTA0YzlkNmFhZjE3ZTEzXzIxOTkwMjMyNTU1OTI_76cd36fb-99d6-46fd-bbb9-957ec7aef820"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic4ac59124dea453b8f6a7a1027357fb5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMS0xLTEtMA_2feb38f7-5d2d-4924-9bd1-9f397e2123a1"
      unitRef="usd">9000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i23ed3fbf4b98415aa629e39f421a73fd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzAtMy0xLTEtMA_9f716c89-c057-41ca-8b30-499ff09a8565"
      unitRef="usd">9000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iee41f66d2eb34db7a37a170823c4e89a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjFhODc2ZjRiMWJjMDQyNDA5NGJlMzk0NjRiYmU1N2ZlXzIxOTkwMjMyNTU1OTU_921dec4b-63c0-4a24-896f-813390090c10"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iee41f66d2eb34db7a37a170823c4e89a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMS0xLTEtMA_bdb31e78-d934-40e8-ae2e-482edf052100"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i99ee350b35ee4777be370e11b5e0e8a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzEtMy0xLTEtMA_bcd5f827-7535-47ab-aa8a-12fbed91503e"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i403edd61e4434a99a5791f10cbd76c78_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmMzZWNmMmJjNjI2YTQ3ZTc4NWFkNjJhYWU3MDA3MzIzXzIxOTkwMjMyNTU1OTQ_d2763cbf-e7b9-41be-a2fb-afbce0639ea4"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i403edd61e4434a99a5791f10cbd76c78_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMS0xLTEtMA_25d01d65-78f5-46fa-868a-c9b2d11d973d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iad6f61c9e98c4ce3b04854b705260b28_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzItMy0xLTEtMA_89d7d84e-230b-4a5d-8481-0205c46efe9d"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1a81af6ba40a441fbb99ba18d09073bf_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMC0xLTEtNzkzL3RleHRyZWdpb246Mjk4YzE4YzI3NTdhNGM3OThhZWI5ZmQzZTFjZjU4ZTdfMjE5OTAyMzI1NTU5NQ_fcd00dcb-fe12-48e1-90c4-e0678e3f68ea"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1a81af6ba40a441fbb99ba18d09073bf_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMS0xLTEtNzkz_e8418f1c-0b17-412d-9bd2-7a7dd05b2bc6"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i53136fbe8f8d484aafe459d75dd67da8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMy0xLTEtNzkz_5a143341-5a21-456d-9f58-3b52d653fda9"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id83e3ca5e5b74832b482dc21dac47b15_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjRmMWU0ZDE1MGMwZDQ1NjI5M2Y5ZTNmMzcwNjMyZDU1XzIxOTkwMjMyNTU1OTU_b7ef5ae6-df44-4ce9-b6ce-b342afdf6c14"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id83e3ca5e5b74832b482dc21dac47b15_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMS0xLTEtMA_66adc3a7-3851-41a5-8d09-3eed0f401f10"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic4832233814146d4a72a43f532a81304_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzMtMy0xLTEtMA_3fcf4332-1ed5-4c99-8786-8d702795d952"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1421fac4a46640f488484d0d2bb2f5da_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNDFhYjQ3NDc4NDRkYjg5MDVjYzk5MDZiM2IxOTcwXzIxOTkwMjMyNTU1OTU_fa3ec316-51eb-486b-a9a5-27008a5a2289"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1421fac4a46640f488484d0d2bb2f5da_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMS0xLTEtMA_6f96e781-ba80-4f49-87e9-48d725388164"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8c2c6ca07a2948c2bb32301edab7a7ef_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzQtMy0xLTEtMA_60579b6f-9787-4a71-82c1-854d4359fb5d"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i295cc3434aa14c899d92fd789d23e4c9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjc3ZjJhMGVjMDNiYzRlYjliZTk0MTA2MWE2NWI1ZGZkXzIxOTkwMjMyNTU1OTc_ea2c9133-c2b4-496e-9247-68ba748ec4b2"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i295cc3434aa14c899d92fd789d23e4c9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMS0xLTEtMA_bf6d5650-c0ba-49f3-bb88-919e0b123d0f"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3f38e39469ec4110a0d65096dc00df6f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzUtMy0xLTEtMA_49c9bc93-0988-480e-be72-b42bba271bd9"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5334156d0c3043a1a13513caab4134b3_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjZmODE2NTEzYTk5NTQwMGI4MzViNzNmMTc5ODliMjI0XzIxOTkwMjMyNTU1OTQ_52cbe216-3b6f-481c-980a-ac3d0fe66bfa"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5334156d0c3043a1a13513caab4134b3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMS0xLTEtMA_e0828341-d628-4b57-93c7-14f1dca52765"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if1d294aded084369be74447b0566b76d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzYtMy0xLTEtMA_f0e2dd3c-a6d7-40f7-b022-17c4cd4f39ce"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i53b2ae62b51d4971b13d4146936f76ea_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjM1NTgwNTk2YjlhNjQ5OTliMzhhNDNmYjNhNWRlYWU1XzIxOTkwMjMyNTU2MDA_ff1981b0-d18a-4cdb-b584-376caca75049"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i53b2ae62b51d4971b13d4146936f76ea_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMS0xLTEtMA_c2a1500a-8f66-4633-a10f-03be371baea8"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib0a403ce8c3b4b3984c2e9eae3632214_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzctMy0xLTEtMA_26a9c359-353b-4b00-95f1-1ff1f00d5082"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7698bdf5f484e289bdc4f09e25197fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBhNjQ1ODMwNjI0NzQzNGJiYmY1NDI1NTg5NDZhYzQ1XzIxOTkwMjMyNTU1OTY_58d57713-6c5d-4e35-ac91-fc6c77a72fed"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7698bdf5f484e289bdc4f09e25197fd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMS0xLTEtMA_995e786a-890c-465f-b4db-78ae128f10a5"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i71438155734c4195a0f18f432a418662_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzgtMy0xLTEtMA_aa5e5e21-b855-4539-8170-66d767225852"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMC0xLTEtNzk4L3RleHRyZWdpb246MTgyNGM1NzQ2MmQ3NDQ0MDk3YWYwYTNiNWJhYTQwMTVfMjE5OTAyMzI1NTU5Mw_310aa345-8170-4c89-b079-8598afee7bdb"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i67caa9a02d144f1aa5523bad6c59c5fa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMS0xLTEtNzk4_4190f4e9-ce53-4e62-9ed2-b164e84dde49"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idac14079640e4ff682a4487baa41cc7b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMy0xLTEtNzk4_8ebe08fb-219d-45fd-8891-69e1ed5c1ae0"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjFmMDlkN2I2MDJkZjRhZmY4MWY2OGM0MmYxOWM3NzMxXzIxOTkwMjMyNTU1OTI_0d11d0de-2a78-4c37-87f0-62223eea7b61"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i66a9ff8f34f54cd283c69ecb1267dc5a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMS0xLTEtMA_c5051bcd-1e61-479d-98f2-92adbd41a841"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id795774182b2476bac2cbbb06963df80_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfMzktMy0xLTEtMA_b6105281-0bda-46ff-a7a2-baa7a4e829e5"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i24823ffe3a604cfd87e5693bf137f94f_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMC0xLTEtMC90ZXh0cmVnaW9uOjA0OGM1NDBiMGFiMjRjYTQ4ODAzNTljZWU2OTRkZjk2XzIxOTkwMjMyNTU1OTA_0f019e16-259c-426e-9f92-340355330db9"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i24823ffe3a604cfd87e5693bf137f94f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMS0xLTEtMA_93a6aa23-1edc-45b8-bcc5-f4e80003a67e"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1b8323c41a0e402cb82a2088c5ac0ff1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDAtMy0xLTEtMA_3eed6d70-fdc7-4d06-8b41-3bcda7e4813c"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibddae3f3a8b04e22adc4e54bc250df78_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMC0xLTEtMC90ZXh0cmVnaW9uOjVjMTJlMWU1YzU5YjRlYTY5ODhhNGMyMjIxODU4YjE4XzIxOTkwMjMyNTU1OTk_d016b50c-ed62-4f83-ac99-e5a535b8fddb"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibddae3f3a8b04e22adc4e54bc250df78_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMS0xLTEtMA_ad51a8ee-51fa-428f-9844-e1acccaf7b77"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2004ef6f6a8e4c5ab2d44ad733bf043e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDEtMy0xLTEtMA_394fc80a-b783-44f7-9a6f-ccb4e38e9767"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMC0xLTEtMC90ZXh0cmVnaW9uOjE3MWVmM2VhOWJlMDRiMmI5NDAzN2M1ZWY3ODYzOWIxXzIxOTkwMjMyNTU1OTU_bdaeb1c2-85d6-4783-a847-7a92387c42b9"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7cf4d4f12d34f6b89f3a75942deaa28_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMS0xLTEtMA_274871c8-32de-40c5-b67d-55eb46fe7293"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7e5b0ad50d4e42e6b07ebd012cfdd8ce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDItMy0xLTEtMA_a028ffbb-629b-47a3-9ec6-ef568a19f1a5"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i36748522e5764894aa532ad0b07acd87_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmM3MGRhMzA2NDVhMDQ3NGE5YTliNjY4ZTY3MTcwYTg2XzIxOTkwMjMyNTU1OTQ_2fa62041-eb7c-45ed-98fd-b23564ffcb5d"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i36748522e5764894aa532ad0b07acd87_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMS0xLTEtMA_9327603d-9c54-438e-8adf-6b665727065e"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i525c1d0146e54a86aa63f93fea6b7bdc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDMtMy0xLTEtMA_d5c65f4a-f94c-4587-b917-c367b234df27"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i78d21c6312ff4432b75d3a29c30a960a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMC0xLTEtMC90ZXh0cmVnaW9uOjQ1ZjgzYTg4YzI1ZTRhNmU4Y2EyMDkwMmMwMTVhZDlkXzIxOTkwMjMyNTU1OTU_44c2b3ca-346b-4395-afe4-2e2c431b9adc"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i78d21c6312ff4432b75d3a29c30a960a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMS0xLTEtMA_3d7668a6-e098-4cd6-826c-5ff2e881bae6"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8f231c679a8f48f69959c46f3f43d5cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDQtMy0xLTEtMA_af45d6da-f111-49a2-b37e-7386ba423cea"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5cc6e467e0a04d77af59fb7584d3b906_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMC0xLTEtMC90ZXh0cmVnaW9uOmYyNWQzMTcyY2IwNjQ5YTA4Y2RiMDMyZmI2Y2QzNjQ3XzIxOTkwMjMyNTU1OTc_ebc3da5f-478f-4528-9096-c0acbefa86da"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5cc6e467e0a04d77af59fb7584d3b906_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMS0xLTEtMA_73e7cf09-c99f-48bf-b5f2-d91adac0a4c3"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if0bf72645713412a86166f550c1f16e5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDUtMy0xLTEtMA_66b3d54d-99aa-480a-9b88-444ee439f6d7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba1978e8f8a84e28a8a31288a3036505_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4OWYwOGJhODI1ZjQ1NjI5MDM3YmM1ZDlkNTg3ZGE4XzIxOTkwMjMyNTU1OTQ_a749b7d5-6899-463b-8dda-1802c431e152"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iba1978e8f8a84e28a8a31288a3036505_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMS0xLTEtMA_3d8fdd99-8b26-41e1-86ec-1dadab709dd1"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if0cdcd3fc23d468e902240ab83df8b0d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDYtMy0xLTEtMA_b9f3eb69-a713-408e-9b5d-a8f45993abe3"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6d07faa35b614fb1882b9aa697a66dec_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMC0xLTEtMC90ZXh0cmVnaW9uOmIxMjc1YWM4NjdlZDQ0MDM4NjEzN2NmNWU4MmNlNThjXzIxOTkwMjMyNTU1OTQ_a3f023ab-5505-4b74-998c-40b6de80605d"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d07faa35b614fb1882b9aa697a66dec_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMS0xLTEtMA_04911ac0-36b8-4c0a-a82d-2177322c8704"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia351b17fd331488f9c19c7092046c881_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDctMy0xLTEtMA_15f8290d-b972-4863-8732-bf3938130d56"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDgtMS0xLTEtMA_ad247bd5-4178-47ab-9ae4-1e9f7242402b"
      unitRef="usd">1036000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDgtMy0xLTEtMA_bc8582df-45a4-4a25-ae7f-30a947be8d15"
      unitRef="usd">808000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icef337dc67864f7eace3d523637349d6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDktMS0xLTEtMA_0b0e9b4e-8575-485d-9202-91c1e775a6e1"
      unitRef="usd">276000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5af1f185b125480693a0d0bad7b64abd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNDktMy0xLTEtMA_1037f69f-e003-4f6a-91f9-c2d5b940de91"
      unitRef="usd">279000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTAtMS0xLTEtMA_76ce274e-12c6-4f88-981b-8e34e33f0d76"
      unitRef="usd">67721000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTAtMy0xLTEtMA_261c5e79-2f2f-4ce2-b835-9d478c0ef861"
      unitRef="usd">69246000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTEtMS0xLTEtMA_4913e2a9-d1c3-42b7-8814-07d7cb3bcff7"
      unitRef="usd">245000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTEtMy0xLTEtMA_c5c9c33b-3e1c-48db-971b-a068781c1818"
      unitRef="usd">262000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTItMS0xLTEtMA_39461eb4-f0b6-433a-9136-5e277a7a1a1b"
      unitRef="usd">971000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTItMy0xLTEtMA_0fc632d7-8290-48d0-9e54-bfc825f59ec5"
      unitRef="usd">1028000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTMtMS0xLTEtMA_946db5b3-fde3-4a62-84b9-c9904f58feee"
      unitRef="usd">66995000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTMtMy0xLTEtMA_3c0e09d5-a0af-438b-a221-e2cab0ad4847"
      unitRef="usd">68480000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTYtMS0xLTEtMA_6573f1c4-40d0-4dfd-b014-c6bc1f0d4910"
      unitRef="usd">5443000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTYtMy0xLTEtMA_aa40c2e2-4037-4a51-92f1-2621795c65b8"
      unitRef="usd">3781000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTctMS0xLTEtMA_545fc636-d803-44f5-bdea-5fc3d8053520"
      unitRef="usd">61552000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i83b41fef1b864e01ba3e78d118b8243b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RhYmxlOmRkZjBiNTUxYWIyYjRiZTZhZmNmZmQyMzAzOGQ3MWQ4L3RhYmxlcmFuZ2U6ZGRmMGI1NTFhYjJiNGJlNmFmY2ZmZDIzMDM4ZDcxZDhfNTctMy0xLTEtMA_42f37814-aab0-4eec-8584-8d6ac3ca2422"
      unitRef="usd">64699000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i843befc9d57d4321b9c38aa68be69ba6_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQzMA_93210a8f-9677-4a02-a4b6-0e5c8ed111e4"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i843befc9d57d4321b9c38aa68be69ba6_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ0NA_e2f2b135-aed0-4325-a733-a3b32dc38847"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ1Nw_3366a195-4dab-4f72-b410-e67808038632"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0b7fe0a06d8436f93ca63bd77f3f8b0_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ1MA_ba456f03-cd02-4852-b11e-ad6526489f12"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ5Mw_cd3d8bda-fd37-490b-a1d5-4a3a98d5010c"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idcc28a66b1034b0da3ae60b4f261ba5e_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ3Mg_efb0cc1d-b005-4530-a79c-1e0169cafbb3"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjQ3OA_47f571b6-d02f-4b9d-903f-97868461488e"
      unitRef="usd">3970000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i061be2ce53a44ed8a847d35fea3c64f7_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTY4_271ce3b3-c4e2-472c-932a-d1b52a96a947"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i061be2ce53a44ed8a847d35fea3c64f7_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjAx_2d58f738-884d-4f15-8d18-9b17e1ab5e3f"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i87452d10eac74833a26ccdf16f72be6f_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjQ2_6bc7e3f6-1ded-4c43-b3f6-2e3b24a3af90"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87452d10eac74833a26ccdf16f72be6f_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjc5_1548d19f-7ad9-47f1-b237-4ce076b591ef"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9e003f03dceb45b6a401dd0a2c15619a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMzI0_da766d49-1d26-48f3-83e7-5a0f7b0e0c85"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9e003f03dceb45b6a401dd0a2c15619a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMzU3_2482ec0b-cd38-4dc8-a191-47850d2a5918"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if192035447e74302b3b24be7e300f710_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNDA1_90ea6b69-c09a-4a11-a1d7-5733689590aa"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if192035447e74302b3b24be7e300f710_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNDM4_0baf885c-3405-40f0-9971-a3013cb6f037"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i498d25aa22054a10a2a7f7f86ba2b5ca_D20200331-20200331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfNTUx_c354662b-a04f-4625-bb7e-b47525b1b80a"
      unitRef="usd">3950000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="ic4418eeeb9274602937c479510064c2a_D20200301-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTQ3Ng_dc9550ee-600b-403c-9906-2ff21122bf22"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic4418eeeb9274602937c479510064c2a_D20200301-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMTU3MA_ad0beb28-600e-4e9d-bea8-d8c9a7937380"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i5e13a337db4543e2918ef2db378c71fb_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUwOA_5f9e6789-41f2-4485-9d8a-176b92183a43"
      unitRef="usd">6000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="id1fdce6ad75c4a94a2c9df47616acacf_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUyMg_c5b2baaa-6db2-4ad1-8bec-afd2afb02c6d"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i19527741ed594ba2a6a1b439f15d1f49_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjUzNg_6b60d057-87a3-4f63-8113-2f4f8fcdac99"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i8896274f8aba4673b336164474916d80_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU0Mg_719ec146-fa44-47f9-97c7-e96cc4c97ed3"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1086a45a45914803b4b5787dac081a9a_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU1Ng_f09c5f02-72ca-4506-98c2-0e65073c204b"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ifa43f5d114584fe4aa281801f4cb6df2_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU2Mg_756cbd80-f697-4d5c-a68e-4d7165325e92"
      unitRef="usd">3000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8025ef9777c14c2b9d133e87af8de5dd_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU3Ng_bc2c74ec-6258-412c-85c4-f94cb863e805"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU4Mg_93a4838f-2abe-4056-a8f8-db64c05c53cd"
      unitRef="usd">-706000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjc0ODc3OTA4Mzg0MQ_4a599a17-473b-4308-9038-14e161155baa"
      unitRef="usd">47000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjU5Ng_d10aa482-15dc-4c4a-8517-9674281977e9"
      unitRef="usd">13000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia3c9892023b049bb895d5033c451c441_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfODI0NjMzNzIyMjYyMw_248abbc6-5f81-48e9-b162-bab86c62fa04"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="if455866bb2bd467f974a25ce7e9a0bd0_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTAzNg_13af9a79-52c8-4121-93ba-b49b7474c4a4"
      unitRef="usd">4000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i8891142b6e684accbc9446f2c1da9ada_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA1MA_e59cee79-9900-4f69-9aa6-3ca3a5ff1946"
      unitRef="usd">1300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f8d8f94b69f47a29ef2ae02ad7c9700_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA2NA_46dcb06a-64c3-41b9-ad55-3a3a18171595"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i49583a4b71eb4d35821c7a34fc9f5dc6_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA3Mg_0c8d6e5b-efed-4748-a51e-baf8868b1ece"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ife76a2daf76247ed84df033b3381b3d4_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTA4Ng_51021b45-3218-4821-905f-9ad22dd15b65"
      unitRef="usd">328000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if522a3140edc49cbb22c0b24dc66107e_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEwMA_d9f25804-362d-4346-826d-b8fe7842baf3"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i36780b12a24c4197ae6e8c1e76989a48_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEwOA_14ed443e-332b-497a-8b05-b0fd300637b6"
      unitRef="usd">297000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6bf38eeaba3449eb825327fa22f6ee32_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEyMg_483f6d69-c750-4a8b-862a-c0cbb0b1579a"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i59d7b49b81174a188a7693f6caaa62e3_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTEzMA_10d09549-bd9d-4aaf-a76f-9979980f1277"
      unitRef="usd">413000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e462393116f4c15aeb568f785179398_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE0NA_537b371c-2b84-4cdf-81c0-dd1878150a37"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i294e2fe0bdae40f7931db52b0a256b5d_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE2Mw_cdfcd4e6-64a8-4ae3-8b84-944f6def759d"
      unitRef="usd">962000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i34c3d891d1084f4599405d17248e8c8e_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE3Nw_8cd1f15e-fbd8-405f-9749-88374b979154"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE4NA_fbc6ed54-7497-436d-908e-5fb447b12e12"
      unitRef="usd">-76000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTE5Nw_32f30f1e-d665-4e63-87c7-fd994ae8faaa"
      unitRef="usd">8000000</cvs:DebtExtinguishmentFees>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTIwOQ_17bec69e-a1ea-413d-b7ee-877ccf55e0ec"
      unitRef="usd">5000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i52eeda463e824af6819a9c4fd3bf97fc_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82MS9mcmFnOmYzZWFjMDBhZGI3YTRiODk5ZDJlMDIzYTk5YzkwY2M5L3RleHRyZWdpb246ZjNlYWMwMGFkYjdhNGI4OTlkMmUwMjNhOTljOTBjYzlfMjE5OTAyMzI3MTIyMQ_630aa8c3-33b0-45f9-abb6-9d5cb1212cbc"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTM0Nw_43034f01-8fcd-4527-a70c-b7cc8d966c85">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2016, CVS Health&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) authorized the 2016 share repurchase program (&#x201c;2016 Repurchase Program&#x201d;) for up to&#160;$15.0 billion of the Company&#x2019;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2020 and 2019, the Company did not repurchase any shares of its common stock. At September&#160;30, 2020, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. &lt;/span&gt;&lt;/div&gt;DividendsThe quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended September&#160;30, 2020 and 2019. Cash dividends declared by the Board were $1.50 per share in each of the nine-month periods ended September 30, 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic3a22a87b43d4b3db25373c50b610cbe_I20161102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTk3_42d72815-deba-44c7-bb24-685dd25e026c"
      unitRef="usd">15000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMjE5OTAyMzI1NjkzNg_6fad905d-9c6c-4538-ab8c-bb0becc1cb35"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMjE5OTAyMzI1NjkzNg_fc34cbec-1254-4c32-a90b-23fab1235178"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i92c166ab9cb14308b8faee78e708c5d7_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfNzcy_567b1f67-cc5a-47dc-afc1-9aa7dd1c941c"
      unitRef="usd">13900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfODk4_f6f0993a-4e96-43f5-adef-3d0bb189df7f"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfODk4_fe9f2578-ef25-4bd7-9a2a-de19516e3526"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTAwNQ_3eb4cf56-19fb-4015-a254-32cb73538494"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV82Ny9mcmFnOjhhNTJkZDkzNDZjYTQ5M2Y5NTFjMDJhYTQxMzhhZWIwL3RleHRyZWdpb246OGE1MmRkOTM0NmNhNDkzZjk1MWMwMmFhNDEzOGFlYjBfMTAwNQ_f3f9aaab-5488-4cb8-aca5-f247bd752a61"
      unitRef="usdPerShare">1.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfMTAxMg_fcde440e-2059-4608-8be3-7726d09ce76e">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($83, $214, $278 and $933 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(10), $(63), $47 and $(93) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(25), $(7) and $(25) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(7), $(14) and $(16) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $(8) and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $7 and $0 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$15 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(4)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfMTAyMw_5d098008-e06c-482c-b43a-bd0f763e5e48">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($83, $214, $278 and $933 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(10), $(63), $47 and $(93) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(25), $(7) and $(25) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(7), $(14) and $(16) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $(8) and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $7 and $0 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$15 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(4)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i785fe01249e54049baf6e493c3802193_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy0xLTEtMS0w_6cdaadf2-f7f0-41ec-94f4-645425108144"
      unitRef="usd">987000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia090d3a8eb844f89a10619bb3d2a6fff_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy0zLTEtMS0w_e5acac34-63e0-4cb7-90ad-637fa45ad14a"
      unitRef="usd">682000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3d6f831699a4635bb458cb2de3b84ed_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy01LTEtMS0w_ebf35c94-e26a-4f70-83a5-00e3b20b5587"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3c203fef43742668e532cda7f2c1fa5_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMy03LTEtMS0w_4dbb0ce4-b3e3-4e75-a26c-feba9a4b69a9"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc1Nw_20a067ce-b7e2-4de8-8f90-fe33846b7fcc"
      unitRef="usd">83000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc2OQ_9e15f8ef-4812-46e3-9149-f42b3f2b0b5c"
      unitRef="usd">214000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc3NA_b7356065-c030-4f7f-a131-05db40dd6a7c"
      unitRef="usd">278000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0wLTEtMS0wL3RleHRyZWdpb246MmYwNjZhZjgyZjk2NDg2OGE4NzU3MGVhMjdiMjQ2NTRfMjE5OTAyMzI1NTc4Mw_1894d8f3-7c6a-421d-bc47-80d82f39206a"
      unitRef="usd">933000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0xLTEtMS0w_68d84624-da55-4dea-938c-5cfde6aa9cc7"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC0zLTEtMS0w_c4f57fa1-1fb0-49af-8890-5bd0199eb894"
      unitRef="usd">192000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC01LTEtMS0w_19b679c9-5802-48e2-8f3d-11f8bdff864c"
      unitRef="usd">218000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNC03LTEtMS0w_3af51fc4-b2ad-4207-92c7-f19bdb0cf2b0"
      unitRef="usd">799000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTc4Ng_7d0e310f-59a4-461a-99bf-486970c4a455"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTc5Ng_7b02b3de-6313-4173-a461-3216cb3a5d30"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTgwMQ_85973069-8ad7-4a10-b3a2-34ad0e7d991c"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0wLTEtMS0wL3RleHRyZWdpb246ZDIxZDk0NDU5ZDA5NGQxOGJhMGE1YzkxM2JjMGRiYzhfMjE5OTAyMzI1NTgxMQ_0ec14bb7-0e40-4b93-8a08-caa08044232a"
      unitRef="usd">-93000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0xLTEtMS0w_e4729e22-234d-4e6e-8b93-00afa09e323e"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS0zLTEtMS0w_43d2ec23-3f71-42d4-aa9f-7916d00f2db9"
      unitRef="usd">-56000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS01LTEtMS0w_aec82515-d38e-4298-b7ea-7bc3d2f3c124"
      unitRef="usd">39000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNS03LTEtMS0w_93c7d777-4baa-42ba-b85e-9678f6c54171"
      unitRef="usd">-78000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi0xLTEtMS0w_be9f6680-bb6a-44d4-9de4-4143f8cdf543"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i24d97f4945f24eb2b073bfff17d8e30e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi0zLTEtMS0w_d9247206-6ceb-48da-b63d-1181f3e19e52"
      unitRef="usd">136000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9584afb63464be1b5819075ebc120b4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi01LTEtMS0w_1470494c-7389-47b6-b325-f29af6c06da7"
      unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia57de69260a5455ab79f8073bf5961b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNi03LTEtMS0w_7761045c-edaf-4d60-bc7e-879e6bd5ee83"
      unitRef="usd">721000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i806e7c9717c24de5ae7010f0f10b6be1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy0xLTEtMS0w_80d96037-af61-4ecf-a4ce-94353623eeaf"
      unitRef="usd">1031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy0zLTEtMS0w_8c3b745e-6477-4768-9af6-1c6e26ec7c16"
      unitRef="usd">818000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i806e7c9717c24de5ae7010f0f10b6be1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy01LTEtMS0w_527f4b62-5250-4652-827f-d7a8aa72ce16"
      unitRef="usd">1031000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief1a62bc976b4fb9b6a238e1d3220eeb_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfNy03LTEtMS0w_c2134718-caea-4049-a249-32368f665633"
      unitRef="usd">818000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i532f29edecec4969bbca5c16efb1f7f8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtMS0xLTEtMA_13b63c0c-6b07-4ca0-8762-d00bdbdab1f0"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i887ee4a7facc4fa4b18507f044b04878_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtMy0xLTEtMA_2bf67543-7e56-4d3f-b3c0-59bce90875f1"
      unitRef="usd">-154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04d0c1e1127646cf9d2d9831c80debd3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtNS0xLTEtMA_306efc45-fbd0-45fd-a170-e6f5fda35fe3"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a5c8430936e43eda7f07b5c38c9388f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTAtNy0xLTEtMA_2f468e7d-36f2-4d8a-b3df-320f17250210"
      unitRef="usd">-158000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtMS0xLTEtMA_5549e589-ceee-4e21-8644-a08f7a4b6756"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtMy0xLTEtMA_1883afd1-4f6f-40ef-b65c-e98348015b69"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtNS0xLTEtMA_890e3beb-3cb6-40f5-b3d9-022c941944f9"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTEtNy0xLTEtMA_0a163dd5-12e4-4c64-a1fa-e0a5a03fd979"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItMS0xLTEtMA_0ea80853-f843-4bf9-be2a-99c66823828b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItMy0xLTEtMA_7e1a18ac-b803-4c8b-9ba4-4e3b3da6a849"
      unitRef="usd">154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItNS0xLTEtMA_1f900ed2-1a88-48da-99a6-550ec9542586"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTItNy0xLTEtMA_87c27b3a-5a20-4148-b229-791009198b9e"
      unitRef="usd">154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic0f246cdc3b240fd8b62c357febcaaa9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtMS0xLTEtMA_87fd0c54-22e9-47ca-86f7-d74f05525350"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ideaedd92eb7b42788275816f55a4d54e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtMy0xLTEtMA_8800566c-38bd-4958-8b0c-4815f86ac1b0"
      unitRef="usd">153000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39a502d15d0442b4b97d1b22253b4da3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtNS0xLTEtMA_e6497d91-d86e-4723-b72c-caa8fd317273"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied3a35ce195446a29b187973d2ac66dd_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTMtNy0xLTEtMA_bf8d2223-eeac-4576-ae04-599ec6256d1c"
      unitRef="usd">157000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1f2fc8638c748e2aca4140e502531b2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtMS0xLTEtMA_79f23402-8b42-470b-ab74-2e9560e09920"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45fef1a06e3647a1aef2f530c536a606_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtMy0xLTEtMA_a2708201-48d3-45f4-9699-9298aa42d0e2"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1f2fc8638c748e2aca4140e502531b2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtNS0xLTEtMA_1e99204b-d89b-4866-9a4c-f53fb1ab6d8c"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45fef1a06e3647a1aef2f530c536a606_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTQtNy0xLTEtMA_e4a573ec-7341-4f90-8497-d570f5745d93"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ece21beb781421ebe511d131b9e50d9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctMS0xLTEtMA_be5a9c9f-74d0-4406-9aa2-0879c4050647"
      unitRef="usd">267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66dda08c143247a8bae039ee8451ac6b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctMy0xLTEtMA_e1cee1d3-f586-4194-ba8e-b8b541c55287"
      unitRef="usd">305000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida4fa9aa910d43589adddf698dcbd90b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctNS0xLTEtMA_5e507725-3e89-46c7-919e-134c2e75d621"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87f0779cac2746f3a5ecc01ccf789c9e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTctNy0xLTEtMA_f2a6900d-b90b-404c-8827-e579e3003f68"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3Mjk_d16feb34-aaa2-40d6-b082-ae56ecef1182"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3Mzk_6c0e80c9-5666-49bd-8abf-87b0a1ceb292"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3NDQ_754a1ac2-f441-4a6e-8a66-21a9cb963ab2"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQxYTZkMzFjMDQyOTQyMzA5Y2Q2Y2I0ZWEzOGNjNDAzXzIxOTkwMjMyNTU3NTQ_af5cb58d-dcf9-4eb5-85d5-0dfd37976d9d"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMS0xLTEtMA_71878114-8b36-4505-a378-0c863eebb09f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtMy0xLTEtMA_53bca2f6-e29e-4b2a-8acd-020ce16a1dba"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtNS0xLTEtMA_b0c3ffef-bff7-434d-861f-a1be485757aa"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTgtNy0xLTEtMA_491c4182-1dca-4856-b7ea-b847c0fbd1e9"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzIxOTkwMjMyNTU3Nzk_77eb0098-462d-4c7b-9910-02b3fbe05640"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2NzY_e224f66f-462c-4eb4-b068-95d56b18e940"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2ODE_16a0c8ba-8d5e-467a-a8c2-8a13a5958005"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjdkYjE3MmYxMDdiODRhYTY5NzQ2N2RmMzMxZjljMzNhXzI3NDg3NzkwNjk2OTE_85d2dd1d-3c59-4eb8-b28a-d85a89f88430"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMS0xLTEtMA_2bd0be5a-25bb-4ffa-bec9-e10ed5d7eeed"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktMy0xLTEtMA_2d871e50-d849-4f91-b805-ecccc2bbdf92"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktNS0xLTEtMA_e1bbdb27-57ef-46bf-8652-e1a1c48766c2"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMTktNy0xLTEtMA_c11fddf5-e32f-4a66-80b4-53811bf9a699"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bc9cbc98b314095a6ba8cf9e2ec756b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtMS0xLTEtMA_8b786bf8-bb24-44b3-9303-9557a94863d5"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27d064b39213426da21f09c4238e271a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtMy0xLTEtMA_1cd1f953-3e84-4fb0-9ebb-fa257f287c67"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e91824366654a4eb4a4d696c8d7553f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtNS0xLTEtMA_0e4f6edc-770b-4422-b06c-3023682f9dcb"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib009a76b6cbe43bba58dc6dae5ab3454_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjAtNy0xLTEtMA_c086454f-3f64-4662-989a-43b2d082b173"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idfc549e0d312441788064313343cf78c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtMS0xLTEtMA_ffa7ed06-c624-40c0-bf2b-c498ede30a24"
      unitRef="usd">264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6190bd16f5314ec1bdde0d0603987e3b_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtMy0xLTEtMA_fbd29e14-24ab-4945-944f-b1432a8caa57"
      unitRef="usd">282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idfc549e0d312441788064313343cf78c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtNS0xLTEtMA_6a852d39-d821-47a6-a8d9-2f52d092af66"
      unitRef="usd">264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6190bd16f5314ec1bdde0d0603987e3b_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjEtNy0xLTEtMA_e4c3d529-5052-4e45-844d-9f4889c2e49b"
      unitRef="usd">282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4143146fd434706bd94dc49340308eb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtMS0xLTEtMA_33d5530b-9c49-4e29-917f-0ec0f2c13cb7"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f4112b74f164d22820352e1af27ca00_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtMy0xLTEtMA_d9dfc464-5912-4ed6-9824-62488af7e911"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib11a29381a70499098c887d742f41133_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtNS0xLTEtMA_93ebb2de-5540-407e-b1e8-cf519370b1b1"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d24c8cf0b2f4ec892c7ae20e2399ec6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjQtNy0xLTEtMA_b5b7e045-ae45-45f5-9fe1-174c1fcadbde"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MjY_8a7a2de5-2062-4dd0-9b6c-7601ed41d73b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MzE_f678e11d-637e-4bfa-8f51-6e829331e9ea"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1MzY_da443afa-dc7d-4147-b47d-a558c071093b"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjcyOGZjZDFlMjY1MjQ2N2I5MzI0Nzc2ODkwNGQ3NTQ2XzI3NDg3NzkwNjk1NDI_02d1912a-8f81-422b-89e5-b2d2380c0ff4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMS0xLTEtMA_08b37113-e7d0-4ce5-bce3-e6ace9d0c58a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtMy0xLTEtMA_3e8a5ac9-35de-45b5-8ff5-79d95f862f7a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtNS0xLTEtMA_2fe79174-ff1d-41dd-9117-aa2927120f40"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjUtNy0xLTEtMA_47ce3e52-7bb6-4fbd-ac49-2667476f4977"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MTU_674f10c0-9412-4711-adb6-3dbfa63c552d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MjA_5dc23edd-24cc-4c2a-b203-44ef239e11dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MjU_4adf6341-aaad-468c-9f17-e866c1680cb4"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjM4MGQ1NDNiYTA1MDRhOWNhOThhYTBlNjViNzI2M2I1XzI3NDg3NzkwNjk4MzA_bed656c3-ca3d-445d-a29e-4cff7035a3b6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMS0xLTEtMA_a4b9237e-7330-456d-a982-4463d3a3b715"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtMy0xLTEtMA_cfdde4db-0508-46b3-88f2-2462fc0f53b6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtNS0xLTEtMA_339ac4ad-704a-4ad4-9a90-905d5464720e"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjYtNy0xLTEtMA_975f618b-c119-445e-a85e-8ae00f8d9540"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica270f2945d3434cbdb72247c7d25377_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctMS0xLTEtMA_501db79a-f722-4f16-b05c-bddc91384d2b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i269e9dfbd5d141b7a3f28f88caf45ee8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctMy0xLTEtMA_31f8b024-e5fd-4f65-96df-78954cdd7992"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie10179039b234603bf7b505426fc8472_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctNS0xLTEtMA_bf319cdd-facd-4186-963d-a480ebbe7598"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b92341521594d889a1668d3daecd7a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjctNy0xLTEtMA_052998ba-2e15-4ede-b617-6a57791a6ca3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13d90c20531f46398a0d5445c1b3360a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtMS0xLTEtMA_77bd4563-ddf6-483c-baf3-3fa4ae18eaca"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i002debbf693d45699dc102ddca977a67_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtMy0xLTEtMA_719a0426-b12b-4764-947a-7b846ff546ba"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13d90c20531f46398a0d5445c1b3360a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtNS0xLTEtMA_c5233b24-a323-45ea-a055-1fdfa3c395d7"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i002debbf693d45699dc102ddca977a67_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMjgtNy0xLTEtMA_782c9c53-5e6c-49ad-ac27-d1ff4326fbc7"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c1de9ff69c5421ebd0d98eec11a8353_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtMS0xLTEtMA_2b593809-da42-4353-b301-04c7d9243c38"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06db64b58cdf443580404215eb0ca740_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtMy0xLTEtMA_3f0a8b13-085a-4b9f-8052-9db53b35a30c"
      unitRef="usd">684000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23da5ced3c0741f280bab78905895c3c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtNS0xLTEtMA_c1413648-50d5-4079-bdeb-58fe6af0ff5c"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice3b96dd953547cc8f60a7fa1546fe88_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzAtNy0xLTEtMA_7f0309a0-f63f-49dd-9136-d5be52a9897f"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idbaf69e24d4e4b488d280cdd342071f1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtMS0xLTEtMA_bca3fc5e-b6be-4645-8efe-fcfcc71580e7"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtMy0xLTEtMA_fccc7b60-34ce-46f9-be4c-4527f6b6c001"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtNS0xLTEtMA_dc8b9682-12d2-4d63-aa34-740cbe47499e"
      unitRef="usd">236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzEtNy0xLTEtMA_e831ce69-fc13-4a11-9b1c-386507c8adf9"
      unitRef="usd">848000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d6c79cc9de846d4be742316c0e6e179_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItMS0xLTEtMA_6ba900fc-1b74-49f4-83a3-4f7f0f174b5e"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd5756ad275741ff8df69fcff86a17b8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItMy0xLTEtMA_7f3632c1-8866-40bd-8502-404ee72861ba"
      unitRef="usd">950000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d6c79cc9de846d4be742316c0e6e179_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItNS0xLTEtMA_50963bfa-bf36-43bd-9ea1-2b05bc8c8402"
      unitRef="usd">1255000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd5756ad275741ff8df69fcff86a17b8_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RhYmxlOjY4ODFiMzA0NGUzMDRjMmViYWY5ODU5Nzk0ODgwYzFjL3RhYmxlcmFuZ2U6Njg4MWIzMDQ0ZTMwNGMyZWJhZjk4NTk3OTQ4ODBjMWNfMzItNy0xLTEtMA_2448ea2d-168e-434a-a2f4-81ff0cb8b1a2"
      unitRef="usd">950000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="idfc549e0d312441788064313343cf78c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83My9mcmFnOjAxNGNmYTZiOTUxNzQzZmJiZjk1YTZlY2MxODRiZDE4L3RleHRyZWdpb246MDE0Y2ZhNmI5NTE3NDNmYmJmOTVhNmVjYzE4NGJkMThfNjcy_ca6ba635-2e14-45a0-8d9c-4ad31029fa75"
      unitRef="usd">15000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfODAz_35769693-945d-4967-bd5a-15ed59201917">Earnings Per Share&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 17 million and 16 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase 18 million and 19 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfMTM1_70defab6-e7cc-4835-b590-f1faa9ebd29b"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfMTQy_6a3cc2ec-12e5-4865-a6a4-5c06475b8ead"
      unitRef="shares">16000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfNDk5_fb2cc34f-e6cc-487e-be0b-d75c304694a9"
      unitRef="shares">18000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfNTA2_29320977-d57e-44b1-bda7-0bd175f83a6b"
      unitRef="shares">19000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RleHRyZWdpb246ZDczMGQ2ZThmYmUzNGY3ZmE4MGIxYTI2YTRmOTE1ZmNfODMw_ca280141-4334-497c-b7e5-566a6a57ccca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy0xLTEtMS0w_9eb49812-b171-49a4-8005-8446a6962172"
      unitRef="usd">1219000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy0zLTEtMS0w_298ff584-560f-4a88-be7d-6b6570721fb7"
      unitRef="usd">1529000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy01LTEtMS0w_7523dadf-16e5-44be-99d2-59e4e2d4972e"
      unitRef="usd">6217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMy03LTEtMS0w_48d58dfd-c254-4dfe-ab2d-422c5f8aed92"
      unitRef="usd">4887000000</us-gaap:ProfitLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC0xLTEtMS0w_2657533a-feef-4026-9cea-e7facdd41db9"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC0zLTEtMS0w_97192140-7b65-47c0-9069-b8090b85f160"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC01LTEtMS0w_6e5e72d7-4ad4-455f-af80-1baf5f47b9f7"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNC03LTEtMS0w_6381fcb0-fd14-4e47-8cd1-dab3cbc1aac7"
      unitRef="usd">3000000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS0xLTEtMS0w_0eea4882-d369-49c9-ab85-439b96d4a6dc"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS0zLTEtMS0w_3a15542f-9a99-4d70-aea0-20c4f22d425a"
      unitRef="usd">-1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS01LTEtMS0w_e2f1e04e-3de2-458c-9b15-95b9da1ae09e"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNS03LTEtMS0w_07fb8865-76d5-48ca-829e-1f426f1a5ccd"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi0xLTEtMS0w_e5bc22e4-1234-4b97-9284-5a2860e06e96"
      unitRef="usd">1224000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi0zLTEtMS0w_c14f6f56-d958-48f3-84fc-6a25896638da"
      unitRef="usd">1530000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi01LTEtMS0w_cd1edb3a-d216-48d1-84cb-a634ec628b3a"
      unitRef="usd">6206000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfNi03LTEtMS0w_53770fcb-37cb-458d-8fc8-49ea89b9dc99"
      unitRef="usd">4884000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS0xLTEtMS0w_82a052ae-0526-4e62-8c88-961ace14adee"
      unitRef="shares">1310000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS0zLTEtMS0w_e1b7422d-b4d0-4276-92b7-25613635ae50"
      unitRef="shares">1302000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS01LTEtMS0w_65dc8192-b31b-444a-a8ae-74285b737e4c"
      unitRef="shares">1308000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfOS03LTEtMS0w_1397b619-08b8-4390-bb33-6896eda07668"
      unitRef="shares">1300000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtMS0xLTEtMA_30587cb6-d89c-4b49-ac57-a33afa2ea106"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtMy0xLTEtMA_c9f037fb-780d-43a6-9842-c1c8ffc277bd"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtNS0xLTEtMA_2503a495-6d0d-44f9-a401-550698733a0f"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTAtNy0xLTEtMA_2f578c5e-51fc-452d-98ae-638d1c68cb65"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtMS0xLTEtMA_bcc933d0-7bd3-4107-8b0a-544a1f5abfc7"
      unitRef="shares">1315000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtMy0xLTEtMA_ac5eeadf-7355-4060-a049-4f6fd36776bd"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtNS0xLTEtMA_38cd2c6c-9bbb-4bd2-a200-96ed9c953d24"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTEtNy0xLTEtMA_0bc4b594-6365-4593-b15d-1fd933bf9424"
      unitRef="shares">1303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtMS0xLTEtMA_9b742e8c-9ec0-40b8-8063-1a21d4a264c9"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtMy0xLTEtMA_4e040dc8-43b9-4753-b56c-5aea7171b83e"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtNS0xLTEtMA_fd7295ff-a517-4fbe-ad9d-f68b17374abd"
      unitRef="usdPerShare">4.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTQtNy0xLTEtMA_7e46e5f7-6b3b-411d-90c5-2c684a4efdf1"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtMS0xLTEtMA_eeea538d-9613-490c-867e-3831a66a93a1"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtMy0xLTEtMA_93dcfa0a-c9fc-41a9-927e-4b6fee039b83"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtNS0xLTEtMA_11bab2f5-cace-4e49-8a41-06abb9996ddb"
      unitRef="usdPerShare">4.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV83OS9mcmFnOmQ3MzBkNmU4ZmJlMzRmN2ZhODBiMWEyNmE0ZjkxNWZjL3RhYmxlOjU2MjBhZjFjMzBkNzQyZTFhNzEwYzNjY2YyM2VhYjYzL3RhYmxlcmFuZ2U6NTYyMGFmMWMzMGQ3NDJlMWE3MTBjM2NjZjIzZWFiNjNfMTUtNy0xLTEtMA_64ca15c0-54ba-40d0-8023-097dfbfed762"
      unitRef="usdPerShare">3.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMzQ2Mzc_3f953902-0f4d-45d8-92d7-a8de54fc06f7">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. We believe COVID-19&#x2019;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2020, the Company guaranteed 76 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and this risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care insurers and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to numerous legal proceedings, investigations, audits and claims arising, for the most part, in the ordinary course of its businesses, including the matters described below. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. It is reasonably possible that the outcome of such legal matters could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company&#x2019;s retail stores overcharged for prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#x2019;s usual and customary price, and related theories. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corcoran &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;v. CVS Health Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Northern District of California) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Podgorny &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;v. CVS Health Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Northern District of Illinois). These putative class actions were filed against the Company in July and September 2015. The cases were consolidated in the U.S. District Court for the Northern District of California. Plaintiffs seek damages and injunctive relief under the consumer protection statutes of certain states on behalf of a class of consumers who purchased certain prescription drugs. Several third-party payors filed similar putative class actions on behalf of payors captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheet Metal Workers Local No. 20 Welfare and Benefit Fund v. CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plumbers Welfare Fund, Local 130 v. CVS Health Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(both pending in the U.S. District Court for the District of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rhode Island) in February and August 2016. In all of these cases the plaintiffs allege the Company overcharged for certain prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#x2019;s usual and customary price. In the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corcoran&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case, the U.S. District Court granted summary judgment to the Company on plaintiffs&#x2019; claims in their entirety and certified certain subclasses in September 2017. In June 2019, the U.S. Court of Appeals for the Ninth Circuit reversed the U.S. District Court&#x2019;s grant of summary judgment and reversed the U.S. District Court&#x2019;s narrowing of the requested class. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corcoran &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;case is proceeding to a trial on a six state class basis, and trial is scheduled to occur in 2021. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheet Metal Workers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiffs have amended their complaint to assert a claim under the federal Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;) premised on an alleged conspiracy between the Company and other PBMs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State of Mississippi v. CVS Health Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (Circuit Court of DeSoto County, Mississippi, Third Judicial District). In July 2016, the Company was served with a complaint filed on behalf of the State of Mississippi. The complaint alleged that CVS retail pharmacies in Mississippi submitted false claims for reimbursement to the Mississippi Medicaid program by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#x2019;s usual and customary price. In June 2019, the Company&#x2019;s motion for judgment on the pleadings was granted in part and denied in part. Also in June 2019, the State of Mississippi&#x2019;s motion to dismiss the Company&#x2019;s counterclaim for declaratory relief was granted. In April 2020, the Company&#x2019;s motion to dismiss the State of Mississippi&#x2019;s second amended complaint was denied. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Blue Cross and Blue Shield of Alabama&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, et al. v. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;CVS Health Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, et al. and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Horizon Healthcare Services, Inc. (d/b/a Horizon Blue Cross Blue Shield of New Jersey) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; CVS Health Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;et al. (U.S. District Court for the District of Rhode Island).  In May 2020, eight Blue Cross Blue Shield entities from six states filed a lawsuit against the Company alleging fraud and other state causes of action premised on a theory that the Company&#x2019;s retail stores overcharged for prescription drugs by not submitting accurate usual and customary prices, including by not submitting the price available to members of the former CVS Health Savings Pass program. In October 2020, two Horizon Blue Cross Blue Shield entities from New Jersey filed an almost identical lawsuit premised on the same theories.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Klein&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, et al. v. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Prime Therapeutics&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, et al. (U.S. District Court for the District of Minnesota). This putative class action was filed against the Company and other PBMs in June 2017 on behalf of ERISA plan members who purchased and paid for EpiPen or EpiPen Jr. Plaintiffs allege that the PBMs are ERISA fiduciaries to plan members and have violated ERISA by allegedly causing higher inflated prices for EpiPens through the process of negotiating increased rebates from EpiPen manufacturer Mylan. This case was consolidated with a similar matter and was proceeding as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re EpiPen ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. In October 2020, the lawsuit was voluntarily dismissed with prejudice following denial of the plaintiffs&#x2019; motion for class certification.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;County of Harris, Texas v. Eli Lilly and Company, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Southern District of Texas).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This lawsuit was filed against Caremark, Aetna, the manufacturers of insulin and other PBMs in November 2019 by Harris County. Harris County alleges that it was overcharged for insulin as a result of a &#x201c;price fixing conspiracy&#x201d; between the manufacturers and PBMs to artificially increase the price of insulin and other diabetes medications. The complaint alleges violations of RICO and claims that the manufacturers and PBMs engaged in an &#x201c;Insulin Pricing Scheme&#x201d; whereby the manufacturers artificially increased the reported prices of their insulin products while &#x201c;secretly&#x201d; paying rebates to the PBMs in exchange for preferred treatment on the PBMs&#x2019; drug formularies. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Direct Purchaser EpiPen Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the District of Minnesota). This putative class action (originally captioned as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rochester Drug Cooperative, Inc. v. Mylan Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was filed in March 2020 against Caremark, other PBMs and the manufacturer of EpiPen products and their authorized generics on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturer and PBMs caused the direct purchasers to pay inflated prices for these drug products. A nearly identical case was separately filed in the same court (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dakota Drug, Inc. v. Mylan Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.). The court granted a motion to consolidate the two complaints. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Direct Purchaser Insulin Pricing Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the District of New Jersey). This putative class action (originally captioned as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rochester Drug Cooperative, Inc. v. Eli Lilly and Co., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was filed in March 2020 against Caremark, other PBMs and the manufacturers of analog insulin products on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturers and PBMs caused the direct purchasers to pay inflated prices for these drug products. Two nearly identical cases were &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;separately filed in the same court (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;FWK Holdings, LLC v. Novo Nordisk, et al. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Value Drug Company v. Eli Lilly &amp;amp; Co., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court granted a motion to consolidate all three complaints. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. In April 2020, the Company&#x2019;s motion to dismiss was granted in part and denied in part. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states regarding its PBM practices, including pricing and rebates. In addition, the Company has received inquiries from congressional committees regarding insulin pricing. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several states. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company routinely is audited by the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;). In some instances, the Company is in discussions with the DEA and U.S. Attorney&#x2019;s Offices concerning allegations that the Company violated certain requirements of the federal Controlled Substances Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Mohajer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed complaints-in-intervention in these two previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cases. With respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#x2019;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mohajer &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by health care providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for these services and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#x2019;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by health care providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by health care providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of Health and Human Services (the &#x201c;OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RADV, Public Exchange related or other audits by CMS, the OIG, the U.S. Department of Health and Human Services or otherwise, including audits of the Company&#x2019;s minimum medical loss ratio (&#x201c;MLR&#x201d;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and/or its current and/or former directors and/or executive officers are named as defendants in a number of lawsuits and a request for access to information initiated by holders or putative holders of CVS Health common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between February and August 2019, six class action complaints were filed by putative plaintiffs against the Company and certain current and former officers and directors: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat v. CVS Health Corp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., et al. (U.S. District Court for the District of Rhode Island); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Labourers&#x2019; Pension Fund of Central and Eastern Canada v. CVS Health Corp.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al. (New York Supreme Court); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren Police and Fire Retirement Sys. v. CVS Health Corp.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et. al. (Rhode Island Superior Court); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cambria Co. Employees Retirement Sys. v. CVS Health Corp.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al. (New York Supreme Court); &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich v. CVS Health Corp.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al. (Rhode Island Superior Court); and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Waterford Twp. Police &amp;amp; Fire Retirement Sys. v. CVS Health Corp.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al.) (U.S. District Court for the District of Rhode Island). The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit, which allegedly injured investors who acquired CVS Health securities between February 9, 2016 and February 20, 2019. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Labourers&#x2019; Pension Fund &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cambria County&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cases have been consolidated into a single action based on the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Labourers&#x2019; Pension Fund &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cases have been consolidated into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and stayed in favor of the earlier-filed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Labourers&#x2019; Pension Fund&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cases. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a derivative complaint was filed against the Company&#x2019;s directors and current and former executive officers in the U.S. District Court for the District of Rhode Island by a stockholder.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Lovoi v. Aguirre, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. makes allegations similar to those contained the six stockholder class action complaints described above, including that the Company made false or misleading statements about its LTC business unit&#x2019;s financial health. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lovoi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint alleges claims for breach of fiduciary duty against the Company&#x2019;s directors and certain of its current and former executive officers and for violation of the federal securities laws. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lovoi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint seeks damages, restitution and equitable relief on behalf of the Company. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lovoi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case has been stayed pending the resolution of the two federal class action complaints described above. The Company&#x2019;s directors and current and former executive officers are defending themselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August and September 2020, two ERISA class actions were filed in the U.S. District Court in the District of Connecticut against CVS Health Corp., Aetna Inc., and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The Company also received a related document request pursuant to ERISA &#xa7; 104(b). The Company is evaluating these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information, arising, for the most part, in the ordinary course of its businesses. These other legal &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="ib9882f3f29fd4b73b6e97734933e44a4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjAxNA_7a338ac6-8c03-4b5b-8a38-2792b21aa9e7"
      unitRef="store">76</cvs:GuarantorObligationsNumberofLeases>
    <cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims
      contextRef="i179f470a0b494d8983ec636725d8d119_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfOTY3Ng_f55a075e-5b51-46f6-a12d-cdca5f2ecb5e"
      unitRef="entity">8</cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims>
    <cvs:LossContingencyNewClaimsFiledNumberOfStatesInvolved
      contextRef="i179f470a0b494d8983ec636725d8d119_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfOTcxNg_b4b448a8-4044-4d8f-b246-43b5e28ca1b7"
      unitRef="state">6</cvs:LossContingencyNewClaimsFiledNumberOfStatesInvolved>
    <cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims
      contextRef="i36fa8765529c434ca15131ebec0fef35_D20201001-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjE5OTAyMzI5ODQ1OQ_4b7d09c5-b1d0-4b75-8bd1-4cd923d54320"
      unitRef="entity">2</cvs:LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims>
    <cvs:LossContingencyAuditMethodologySampleSize
      contextRef="i3ee66866f8fa4cbea112996fc3ef1389_D20130101-20130331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjM3Nzk_68df1bfd-78d7-4972-9927-351b290585fc"
      unitRef="member">200</cvs:LossContingencyAuditMethodologySampleSize>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjY3MDM_85769abb-af9c-48a1-9554-5e9b9183d89d"
      unitRef="claim">6</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i23e16d7fab89454085dfefe26889cfd8_D20190201-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84Mi9mcmFnOjNmNDZlMmE5YmQ4NjQwZjliMjFjOTU1NzZiOWVlOGQ5L3RleHRyZWdpb246M2Y0NmUyYTliZDg2NDBmOWIyMWM5NTU3NmI5ZWU4ZDlfMjg1NjI_6846dea7-3339-4782-ae08-6d0bf3107090"
      unitRef="claim">6</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTA0NDUzNjA0Njc3MzU_811b6ab3-44e4-4615-a8cd-204e03a3b195">Segment Reporting&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.5 billion and $2.7 billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.5 billion and $8.9 billion of retail co-payments for the nine months ended September 30, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store rationalization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;(4)During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfNDE_2a20636f-8c9c-4c2b-973c-15b984cca652"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMjA4Mg_2471abf5-17af-4f3f-937c-f25cfcb0a5fe">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.5 billion and $2.7 billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.5 billion and $8.9 billion of retail co-payments for the nine months ended September 30, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0xLTEtMS0w_dcca9447-573c-487f-8bf8-6839b0a49939"
      unitRef="usd">33492000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0zLTEtMS0w_858bff52-6629-4fe2-aa35-644dbfe67b5d"
      unitRef="usd">14770000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy01LTEtMS0w_823584af-2b25-4d73-b281-5aee24599305"
      unitRef="usd">18557000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy03LTEtMS0w_a7a44c78-7424-4956-955d-ee731406d128"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMy0xMS0xLTEtMA_41cf1534-d912-4e7f-a813-a0d440cb9731"
      unitRef="usd">66852000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8388f3cbdf204618a0c21ce87efec0fc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC0xLTEtMS0w_a6af13ec-3aea-4671-86e6-466a78399774"
      unitRef="usd">2219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fa4c5da31094c308e8bb540b1f730da_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC0zLTEtMS0w_462e0d54-8bb7-4ed2-9993-434bd4cb961f"
      unitRef="usd">7955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ae38a4835db41f4845bb963973a4035_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC01LTEtMS0w_b2407eb7-3b99-4b5f-b6c9-d48d0dd43b9f"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9f49f9e47124de881a13135342b7fe2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC03LTEtMS0w_d5dd496d-131f-4272-9e57-5e30a913d872"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNC05LTEtMS0w_fd01afbe-20ff-4d0b-b3d3-4d25408b616f"
      unitRef="usd">-10194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0xLTEtMS0w_fcee38e0-6ebd-4ac3-9832-e3a35784dc88"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0zLTEtMS0w_21f3f2ca-5e25-4f18-9143-82734a502593"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS01LTEtMS0w_6ae7fa67-a1b0-4332-96d4-bbb366b665e1"
      unitRef="usd">121000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS03LTEtMS0w_7a0a9eba-5a34-48b0-aab9-fbd28fcb8e54"
      unitRef="usd">83000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS05LTEtMS0w_ba8323ab-f2bb-4545-851f-04430afa57b6"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNS0xMS0xLTEtMA_92cda39d-c1ad-4a55-9e06-746cc11860fc"
      unitRef="usd">204000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i5a375fb5ee4c4b4d97090ae3ad666b3f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0xLTEtMS0w_c1a9e876-7df2-437d-a04f-a20d9f3538a2"
      unitRef="usd">35711000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6fd7496cf7d94ef5b1210da043c5d38e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0zLTEtMS0w_4e6de545-affa-4c16-a788-5439e86a1dc1"
      unitRef="usd">22725000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd1a8fb583a743f49a6dc705dc12e525_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi01LTEtMS0w_f80daab3-a93b-49be-aaf0-fe59bfa0e8e0"
      unitRef="usd">18698000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7976a33b11244feba0cba6f777561dfd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi03LTEtMS0w_946d22b9-2c88-470a-8956-850d6b875555"
      unitRef="usd">116000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi05LTEtMS0w_560984f9-6470-4959-9f18-fee1916db605"
      unitRef="usd">-10194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNi0xMS0xLTEtMA_8e1a1081-6c78-4992-9414-d46d408dc294"
      unitRef="usd">67056000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0xLTEtMS0w_1f9262a6-d72c-4958-b3fb-3c4dde47690c"
      unitRef="usd">1619000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iae9c586bcf364c249392b219a423f528_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0zLTEtMS0w_acb3c950-8ea5-4294-89a4-ede7428fc301"
      unitRef="usd">1412000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i75cbd2415b5940e1a65da0ac96326c0a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy01LTEtMS0w_217c3d31-02b4-4e48-8804-8543ec17ff2c"
      unitRef="usd">1080000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i81e4241e075346fc86d5a01844fd6a0d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy03LTEtMS0w_58ca6c95-8a34-40da-8ae0-f33f376c459b"
      unitRef="usd">-303000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0cfa7a095ab64d85952fd265c85a25ec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy05LTEtMS0w_5278e528-a61f-4ba8-8a2f-7ab9bed3685d"
      unitRef="usd">-186000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfNy0xMS0xLTEtMA_e4bf09bf-8821-4cf6-9475-0a4eb60726f3"
      unitRef="usd">3622000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMS0xLTEtMA_71ff95f4-da16-4402-b143-6ed68636d33e"
      unitRef="usd">33680000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMy0xLTEtMA_7b3c3006-c6c8-4334-99bf-bd6e4ac1c9b5"
      unitRef="usd">13805000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtNS0xLTEtMA_dde99d67-cda9-4e8b-bdb9-0ebb2641fc55"
      unitRef="usd">17027000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtNy0xLTEtMA_bb9df328-e9ed-43c1-a705-8c6583f6c47f"
      unitRef="usd">35000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTAtMTEtMS0xLTA_9644588d-38f5-43c6-b99d-8fd3fc5ebfaa"
      unitRef="usd">64547000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a1f86796440475bb5dab254521c724b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtMS0xLTEtMA_ab242125-60b3-476e-8530-fd48bdb1e007"
      unitRef="usd">2338000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a503222dd594312b47e70f69e82a446_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtMy0xLTEtMA_f3ad5d3c-bfea-4ae0-bc68-7fd97c9a2224"
      unitRef="usd">7661000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2627fbff46e64b4f9394931c3b370f52_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtNS0xLTEtMA_c54bdbdc-e12a-473c-863e-fc0f2ee940ae"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id92c3e405f2548aba08212e6d6583ed7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtNy0xLTEtMA_42b76c3c-f4e8-4ff7-95b8-6974126500b5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTEtOS0xLTEtMA_c5effbee-e945-48f9-89f8-64c5b6dab44e"
      unitRef="usd">-10007000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMS0xLTEtMA_11b867ac-f894-48c6-8c66-745939dfb89a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMy0xLTEtMA_e8bc5ce8-8f46-43fe-be25-7d64befc65a9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItNS0xLTEtMA_fe1b2512-20b5-4124-bda1-f378a5cfd749"
      unitRef="usd">146000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItNy0xLTEtMA_492af779-ee9a-426e-b208-ff0effecb122"
      unitRef="usd">117000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItOS0xLTEtMA_6d7972ef-d982-4495-b7c8-d1f905237b33"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTItMTEtMS0xLTA_4b1048bf-88e4-4e9e-b4e1-e20c22cabf16"
      unitRef="usd">263000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="iae8df98cf0a04c339a50aa5f67d358ee_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMS0xLTEtMA_8527061e-6844-4ef7-b537-b5d0e1038607"
      unitRef="usd">36018000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMy0xLTEtMA_08b92ae1-7a6c-4499-9293-6932b3009e2a"
      unitRef="usd">21466000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie7a36eaad3694582835456f3a0082533_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtNS0xLTEtMA_5b73cc77-5633-427b-a648-b5fec03ebc9e"
      unitRef="usd">17181000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71085a7fcd944fef9abf8ababc304124_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtNy0xLTEtMA_2ca1d05e-db2b-40a5-9508-14ce3c86a4b2"
      unitRef="usd">152000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtOS0xLTEtMA_a65cbfde-e4b0-4aa3-8330-f79eb4153d10"
      unitRef="usd">-10007000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTMtMTEtMS0xLTA_0c3f49c9-db98-45cf-a707-edc72cfb1dff"
      unitRef="usd">64810000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMS0xLTEtMA_67e87567-11b9-4b97-bd9f-0fa64266f0e4"
      unitRef="usd">1439000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i16b8ec66694a4613b27013331c4b5e64_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMy0xLTEtMA_e7a98c93-1342-4466-9359-2a41bb452be2"
      unitRef="usd">1516000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i015e3b88519741cfb822c70694388488_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtNS0xLTEtMA_d7fc5ec5-905a-45de-8435-bb93ee6669e7"
      unitRef="usd">1423000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id9f816dab06444e3acdd6ea7d813ae48_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtNy0xLTEtMA_07f14265-12b9-49a6-9247-e7c7a584811d"
      unitRef="usd">-252000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib4e762a4c0be47729fc0a984603b29bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtOS0xLTEtMA_43b2f059-3974-44ef-bf91-8d34d9bead94"
      unitRef="usd">-179000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTQtMTEtMS0xLTA_24edd912-c980-45ed-9b20-bda52d1426dd"
      unitRef="usd">3947000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMS0xLTEtMA_9799b10e-7821-45e3-af81-773147087ed3"
      unitRef="usd">98233000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMy0xLTEtMA_e6f9f6a8-17dd-4819-9aaa-db51079e651b"
      unitRef="usd">44314000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtNS0xLTEtMA_f5beca17-b751-4558-ab1d-f33cfef9ab1e"
      unitRef="usd">55972000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtNy0xLTEtMA_4d6ce627-4253-4b16-af65-b2273c307dd1"
      unitRef="usd">83000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTgtMTEtMS0xLTA_48be7ce3-4c09-4698-9ba9-84cfe445333f"
      unitRef="usd">198602000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b9aea230b9c4ec19e0946224068182f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktMS0xLTEtMA_a0718ded-0915-47ab-8a18-b545a5c4c0c7"
      unitRef="usd">7350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0a911dfbb042d1a2a8141db4da783a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktMy0xLTEtMA_3bf9812a-c299-434d-bda1-ff0050c8bc81"
      unitRef="usd">22822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3407b4198a444fda8eddc128dd850666_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktNS0xLTEtMA_9590892f-8b80-4365-9862-78ddf0233b8c"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cc6d00c651d4a9881f30a84231714f1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktNy0xLTEtMA_d93d67dc-ac18-41a9-b240-e77c82ba5725"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMTktOS0xLTEtMA_c2404089-9f07-47da-a6b0-89ce3cd93310"
      unitRef="usd">-30223000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMS0xLTEtMA_f943de20-a510-46e8-a3e0-fad4c9f7a36f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMy0xLTEtMA_82c2a638-6f6f-48f0-bd0a-45016fad29e1"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtNS0xLTEtMA_2f67a743-4b17-47a9-b6f7-c3c1fce95e58"
      unitRef="usd">341000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtNy0xLTEtMA_3dcc9a8d-441b-4fc0-8fd9-446423e5cae6"
      unitRef="usd">209000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtOS0xLTEtMA_7a21d60e-5c21-496e-9b6e-1d462668c084"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjAtMTEtMS0xLTA_074c48ae-a4ed-407e-941c-05c591d651b5"
      unitRef="usd">550000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i5b3a1807d6d941108c13c5bb50477adc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMS0xLTEtMA_e5d19016-9563-40bd-b894-1c0b05de3cb9"
      unitRef="usd">105583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73b9b581f26241d4b1c1a12c4ed7691e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMy0xLTEtMA_f47eee04-5ba8-41a0-9e66-5a3f45236f8a"
      unitRef="usd">67136000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18fcd90d29134e43be0e7519e6f37d76_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtNS0xLTEtMA_ef50a517-d2b1-47a6-997f-6fa94a611e42"
      unitRef="usd">56364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65c88f7df38c418d8e65c5d725d5431f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtNy0xLTEtMA_00d65050-c5bf-4c5c-8b66-c9c32cac9da6"
      unitRef="usd">292000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtOS0xLTEtMA_a7292a34-c36e-47f3-9461-4b2197b89520"
      unitRef="usd">-30223000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjEtMTEtMS0xLTA_9baff770-9043-4893-bd2c-61811fb0c967"
      unitRef="usd">199152000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMS0xLTEtMA_5322a2a6-e628-48c2-a28d-6b13a9cb8c0d"
      unitRef="usd">4127000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7390cfff742b4d7aab54c05bff9bf57e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMy0xLTEtMA_764bc030-5beb-4699-be99-18097cebe88f"
      unitRef="usd">4371000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i73f4f797cb7d42768624772e06980a51_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItNS0xLTEtMA_301b019d-0583-4704-a359-ce90327e855b"
      unitRef="usd">6035000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3149d0e77e924a2d88535c5223fcb934_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItNy0xLTEtMA_85b5a8d7-55eb-421b-af9c-d81095cd7ae4"
      unitRef="usd">-931000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i42f16fc5126745ff9f0cd5c3f040847f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItOS0xLTEtMA_17b53bfd-19d6-44e4-a927-298069802f86"
      unitRef="usd">-539000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjItMTEtMS0xLTA_9548b6ac-3725-421c-8f4e-223aa13f6679"
      unitRef="usd">13063000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMS0xLTEtMA_b04f5a07-f139-4361-9ceb-fbbbe04ae9ec"
      unitRef="usd">95494000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMy0xLTEtMA_44dfc90f-fccb-4b4b-83a2-63932176c920"
      unitRef="usd">41536000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtNS0xLTEtMA_691a232a-2927-4ef2-ac3c-a1bc5411e428"
      unitRef="usd">51976000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9869200a1f51442783697741cd784346_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtNy0xLTEtMA_e3e3f8ec-b68a-44db-a635-acc77277ba9c"
      unitRef="usd">76000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjUtMTEtMS0xLTA_9f1479f3-06a5-42e5-9829-bcdac56c1a6b"
      unitRef="usd">189082000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12078e54516c4cbea23a4ae0ac86658c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtMS0xLTEtMA_ccb944d2-cf1f-4145-83ad-84911dc0fe97"
      unitRef="usd">8924000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f020cf3db944a72b9e11f66eafb85a6_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtMy0xLTEtMA_2a38ef44-8bee-4025-ac05-cb6dee6cc173"
      unitRef="usd">22492000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i219c9f0ab1634e62be0cec75eb3d097b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtNS0xLTEtMA_0b75b40b-b7f0-45d3-81b3-36e1a6c11605"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i638894f045654cdb9cec4484de9042e8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtNy0xLTEtMA_37586784-b533-4b52-b05e-b4cbd1be244e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjYtOS0xLTEtMA_93259c3a-533b-49db-96ad-1dae38e0b770"
      unitRef="usd">-31436000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMS0xLTEtMA_489744cb-ecb1-4649-b033-d2f13e4155fb"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMy0xLTEtMA_ec2b5070-d4a0-426f-9d61-27c5b541ceb9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctNS0xLTEtMA_f3bd9b40-b4ed-4d4b-9b09-76f0a7e6a999"
      unitRef="usd">458000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctNy0xLTEtMA_444e237f-38bb-459d-947f-e52da4f5e65e"
      unitRef="usd">347000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctOS0xLTEtMA_da051905-6790-4a91-b1a9-e225da91f1ba"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjctMTEtMS0xLTA_f36cec3e-6de1-4e70-b5c6-9ebb18788519"
      unitRef="usd">805000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMS0xLTEtMA_38d54ef0-3bca-4604-acda-69ee9cf86d81"
      unitRef="usd">104418000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMy0xLTEtMA_e4b4d0b9-c97c-4110-9b9d-9ab9030df612"
      unitRef="usd">64028000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia38525b1785140eca0d493eda0f80f59_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtNS0xLTEtMA_d59ec2b8-ab4c-407f-8e03-675bbde43f22"
      unitRef="usd">52454000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieeb459813c1c4614a59e35534faf3df7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtNy0xLTEtMA_0ede3688-95d1-4a3f-b01e-93470c422a0c"
      unitRef="usd">423000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtOS0xLTEtMA_57c1385d-1993-4d06-957a-0066507cedaa"
      unitRef="usd">-31436000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjgtMTEtMS0xLTA_91a0a86a-108a-47bd-b867-cd0626e76248"
      unitRef="usd">189887000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMS0xLTEtMA_05b4153c-16f6-4729-8a29-665291fae3c8"
      unitRef="usd">3682000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib083a611dfa748bca057628defb1a140_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMy0xLTEtMA_fe4a216e-7264-4307-8933-b2eedad4122e"
      unitRef="usd">4674000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ibb772066848a4d19b3b721a88cdbd6bc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktNS0xLTEtMA_8969028c-3da0-46b8-b266-5f8b9cbd4aa8"
      unitRef="usd">4423000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9869200a1f51442783697741cd784346_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktNy0xLTEtMA_847fe914-bfa9-41d2-b451-cc0ce64486df"
      unitRef="usd">-685000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0857e2e206f944ac81f3ae42f6e78942_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktOS0xLTEtMA_72a83ffa-5d86-45c9-84b9-667baee7ae02"
      unitRef="usd">-521000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOmMyYmE0OWY1MWQ0ZTQ4MDliZjYxNGJlYjE4Njg4MmViL3RhYmxlcmFuZ2U6YzJiYTQ5ZjUxZDRlNDgwOWJmNjE0YmViMTg2ODgyZWJfMjktMTEtMS0xLTA_76457844-253d-411e-b207-22648b5d1a80"
      unitRef="usd">11573000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i22d8d2fcb2ab490aa632a3a454def62c_D20200701-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTcxMw_b65d29ae-70f2-4c2e-839a-957bf04d99b3"
      unitRef="usd">2500000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i2c7676d47aec440ebb432cc1f0cd1f00_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTcyMA_afafee93-0a58-4e06-a6ba-de7cd576b897"
      unitRef="usd">2700000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i23913481f3b94653b1ea17b1a1835da7_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTgwMQ_675d14ba-de47-4b98-84a3-132980d0f7f6"
      unitRef="usd">8500000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i69cb1a487c21485497a1beff149953b2_D20190101-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMTgwOA_122ead16-23e9-417d-bd1f-09c9477c9477"
      unitRef="usd">8900000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfMjA4Nw_ee2194f3-5e9e-43ab-92b5-15b54d8f9b05">&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store rationalization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;(4)During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment.</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi0xLTEtMS0w_69d683d6-ed69-4333-99d9-2e6b38dce50d"
      unitRef="usd">3249000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi0zLTEtMS0w_63af6ea5-58f2-4373-9199-37c0f6752a61"
      unitRef="usd">2928000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi01LTEtMS0w_97a11e81-06a6-4498-b74a-6352ce0b367a"
      unitRef="usd">11387000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMi03LTEtMS0w_429e653d-6f1c-4a00-ae51-de48a9ac37ab"
      unitRef="usd">8950000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy0xLTEtMS0w_50099e62-198b-4c05-ab6e-5805862fc869"
      unitRef="usd">587000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy0zLTEtMS0w_54b25589-588d-4c34-8e97-2f3b899e6842"
      unitRef="usd">607000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy01LTEtMS0w_9239cda1-319f-491f-bef5-fc921bdc4ef6"
      unitRef="usd">1751000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfMy03LTEtMS0w_7e89216c-8d61-4976-a862-b02678e723ed"
      unitRef="usd">1822000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC0xLTEtMS0w_1f6b9042-8b9a-4f39-af0a-a001382f0e70"
      unitRef="usd">57000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC0zLTEtMS0w_d58fa948-ac12-45a8-9bc6-6f70cb5d94a3"
      unitRef="usd">111000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC01LTEtMS0w_e1c73087-dbd0-49cc-9ba2-f2ac8528e217"
      unitRef="usd">196000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNC03LTEtMS0w_78e0f20d-0ddb-438a-ae6c-c7455c5879cd"
      unitRef="usd">365000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0xLTEtMS0xNjA0_fbd57d02-3835-4e31-8426-c8612f6cb2ec"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0zLTEtMS0xNjA0_25060fcb-fe36-430c-a415-e624983f2b4c"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS01LTEtMS0xNjA0_53499d52-cd7e-4ec5-9711-db5099a79bd0"
      unitRef="usd">271000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS03LTEtMS0xNjA0_34c0de12-be3c-4f38-ae2b-e2b6d76f3030"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:StoreRationalizationCharges
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0xLTEtMS0w_830812a6-5225-4897-b34a-10bacedf5c3f"
      unitRef="usd">0</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS0zLTEtMS0w_0c22c60b-a788-453b-b0ab-332b198ee883"
      unitRef="usd">96000000</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS01LTEtMS0w_45b524b0-0dc4-473c-a124-9ef1cc63db7e"
      unitRef="usd">0</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNS03LTEtMS0w_beae2782-b11c-4678-84e3-39180b260579"
      unitRef="usd">231000000</cvs:StoreRationalizationCharges>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi0xLTEtMS0w_e4bf09bf-8821-4cf6-9475-0a4eb60726f3"
      unitRef="usd">3622000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i76205a2ba49747aba473ba9d529085ca_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi0zLTEtMS0w_24edd912-c980-45ed-9b20-bda52d1426dd"
      unitRef="usd">3947000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi01LTEtMS0w_9548b6ac-3725-421c-8f4e-223aa13f6679"
      unitRef="usd">13063000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6c0b2c561c6d4946a351d16b3d133425_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RhYmxlOjhhYmE5N2ZlZjVkOTRmNmViN2IzM2YxNWU4YmI3YTQ1L3RhYmxlcmFuZ2U6OGFiYTk3ZmVmNWQ5NGY2ZWI3YjMzZjE1ZThiYjdhNDVfNi03LTEtMS0w_76457844-253d-411e-b207-22648b5d1a80"
      unitRef="usd">11573000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9e52aea9b440487e95192c684b9d1a14_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxMjIxMg_199a6b9e-39a1-4df0-8070-5fbf3bbe6b0b"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <cvs:NumberofUnderPerformingStores
      contextRef="iad827e0b73394ee8aaf8b05822a518a8_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2Mw_d534b416-6b7a-443a-97ae-394ee8df09df"
      unitRef="store">22</cvs:NumberofUnderPerformingStores>
    <cvs:NumberofUnderPerformingStores
      contextRef="ifb27034ece694cdbb33f7dd39aa481d8_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2Mw_fa5c0c93-670a-4b28-bb0c-a608aa38f87c"
      unitRef="store">22</cvs:NumberofUnderPerformingStores>
    <cvs:NumberofUnderPerformingStores
      contextRef="iea35850d0ac0451582fa9b14ad77ffb9_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV84NS9mcmFnOmEyNTA0ZDQ2ZWQ1NzRlM2FhY2EyZDFhM2ViMTFiMzFjL3RleHRyZWdpb246YTI1MDRkNDZlZDU3NGUzYWFjYTJkMWEzZWIxMWIzMWNfODI0NjMzNzIxNTQ2OQ_78537d59-d223-4db3-ab2f-85b29fb14ed3"
      unitRef="store">46</cvs:NumberofUnderPerformingStores>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8xMDQ0NTM2MDQ3OTYwOQ_c08aaca8-9e51-4116-844b-8c8b8eec8240">Subsequent Event&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. At September 30, 2020, the Company did not record any ACA risk corridor receivables because payment was uncertain. &lt;/span&gt;&lt;/div&gt;On October 22, 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the fourth quarter of 2020. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company expects to record pre-tax income of approximately $305&#160;million and after-tax income of approximately $220&#160;million during the fourth quarter of 2020.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="iab600fe96ebf4cc0915b310db63417df_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjcxMjY0_eacb3440-81a6-4890-8436-8ff7fba81f4e"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjcyODIx_96b95e44-a729-47c5-a10e-99c7e7000ab2"
      unitRef="usd">313000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="i775061c4d39a416ab23c7dc563cf24b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjY2NjY0_9e1aa5bc-a758-4854-a159-fd29f018ed54"
      unitRef="usd">305000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax
      contextRef="i775061c4d39a416ab23c7dc563cf24b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xNDY2L2ZyYWc6N2FlZjIzZTRmNWQzNDhhY2IwMTBhNGRjYWNlMjdmYjUvdGV4dHJlZ2lvbjo3YWVmMjNlNGY1ZDM0OGFjYjAxMGE0ZGNhY2UyN2ZiNV8yMTk5MDIzMjY2Njc4_1cc69667-7db6-4968-8bbb-2eec122f8387"
      unitRef="usd">220000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="iab600fe96ebf4cc0915b310db63417df_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xMDMvZnJhZzo3YTg2ZjA3NmU4MWM0M2IzYTZmMGVkMGUyMTMxYjAzOS90ZXh0cmVnaW9uOjdhODZmMDc2ZTgxYzQzYjNhNmYwZWQwZTIxMzFiMDM5XzU0OTc1NTgxNTU4NDM_eacb3440-81a6-4890-8436-8ff7fba81f4e"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i681f50e3e6d7434b9607f78ef2f6cee8_D20201022-20201022"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8xMDMvZnJhZzo3YTg2ZjA3NmU4MWM0M2IzYTZmMGVkMGUyMTMxYjAzOS90ZXh0cmVnaW9uOjdhODZmMDc2ZTgxYzQzYjNhNmYwZWQwZTIxMzFiMDM5XzIxOTkwMjMyNzQ3OTg_96b95e44-a729-47c5-a10e-99c7e7000ab2"
      unitRef="usd">313000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtMi0xLTEtMA_d5d1b1d2-324b-4651-aff0-8a69e8e8b1f1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctMi0xLTEtMA_a67ba013-39eb-4772-b548-d358b783c21c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNS0xLTEtMA_81ec928a-d748-4185-9fa1-c44033bb063d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtMi0xLTEtMA_4201fc3b-a48c-4d8f-b9fd-5a3d083e59f6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNS0xLTEtMA_9b6c4ff2-95ae-4cd4-ac54-bc22a0bbad1e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS01LTEtMS0w_c03f84f1-d81d-4d46-99c7-c62e17e43948"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtMi0xLTEtMA_25e0dcda-08f1-47c5-970e-2dcf1636236f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjQtNS0xLTEtMA_70b52ad8-6b76-460b-a113-a279d353fb62"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTAtNS0xLTEtMA_3fd3c69f-8b49-42d7-aaeb-03180173e3b2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctMi0xLTEtMA_85808c1e-a8c2-4fc7-9fb8-4646606a03b8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtMi0xLTEtMA_2ca852e2-d598-4990-be4e-d27e1a2b130d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS0yLTEtMS0w_7aa4cde6-cd3b-4b08-8b06-3277494148b5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTctNS0xLTEtMA_03bf414e-e6b8-48e9-9491-e67ef8f29c68"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNS0xLTEtMA_1ecf8c3c-c49f-46e0-8f19-c62999b0cc0a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1Mjg_4ff4e1a1-271c-4449-8f97-1cbbf40ce871"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 842), which resulted in an increase to retained earnings of $178 million during the three months ended March 31, 2019.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfOTU4_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi0xMC0xLTEtMA_1f2cccbd-c890-496c-b992-b3852c75effd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi04LTEtMS0w_b6fc3f3d-a247-4c9f-ae7a-f864a040a205"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNi02LTEtMS0w_0d485448-e2ec-4830-b7d2-d936444c8ecf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzM_84735f07-99f2-417c-82a4-47b4a6b024a2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctMi0xLTEtMA_5014a53c-bfd4-41bb-8901-6fee4219923c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtNS0xLTEtNTQ1_bb11eb96-d7bb-4952-9c4f-e3c4f141ce7d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtNS0xLTEtMA_32ea24bc-1131-48ed-8828-e7d592fd757f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNS0xLTEtMA_5605d81a-6c87-49a1-96d9-da0d9230f425"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNS0xLTEtMA_39ffd1bd-8300-4d2b-8939-5db623370ffb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS0yLTEtMS0w_9c70eef0-03b5-4ff5-9331-e4177dc511f6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS01LTEtMS0w_a18598e9-b34b-4d6f-9d02-c5ab4e5b02ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtMi0xLTEtMA_9a4626a7-bebe-4a1d-be80-423582a5de5e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTctNS0xLTEtMA_afd9c25f-d9f6-489d-bf22-4676b2a53ed5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNS0xLTEtNTQ1_342d74a6-105a-42e7-b3fd-00cd463ad0ec"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctMi0xLTEtNTQ1_e96ef0b1-110a-479b-8469-c1a905449e4d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtMi0xLTEtMA_95ca4285-deb2-4b4b-8d2c-8d2464e1eaac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTAtMi0xLTEtMA_38f7bef9-228b-4098-be71-92756647065a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjQtMi0xLTEtNTQ1_ef649ab1-ab17-473f-8881-a6c168fc59ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzE_42f8eba8-dcfa-4d43-80f9-4e62e4fc9448"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTYtNC0xLTEtMA_60bb0418-d6b8-4173-ba79-d72c825315be"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjctNC0xLTEtMA_5d99f4a8-6ee9-4e8a-a24a-277c6ed80cda"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMTMtNC0xLTEtMA_5029ee59-fc10-4742-bd40-f3b14dd06781"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjAtNC0xLTEtMA_d5fb9035-4a21-4a30-9203-e86376ae4b9a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfMjMtNC0xLTEtMA_aee2f6f1-48c7-413a-9cb6-0cef2b00c38f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfOS00LTEtMS0w_19fdea3d-8081-4071-9fce-caba422fddca"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjc2NjI4N2UwYjA2YzQ2YzViOTM0YWMwMDRmNjU2ZTAzL3RhYmxlcmFuZ2U6NzY2Mjg3ZTBiMDZjNDZjNWI5MzRhYzAwNGY2NTZlMDNfNS00LTEtMS0w_b7283d9f-c291-4774-8019-61f66151ea20"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzA_7def482d-ae16-45bb-a5ae-40597b19723e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjAtNC0xLTEtMA_99e1098e-6116-4bb4-8d63-f197692a0b79"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTYtNC0xLTEtMA_9e050845-9c38-4bb5-9bcc-8b5bad8287c6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjMtNC0xLTEtNTQ1_6e1dc497-8eaf-4958-9bef-fca4c075b282"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMjctNC0xLTEtNTQ1_4a20afaa-1feb-48be-addf-52dde93159c3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfOS00LTEtMS0w_c0408e74-b212-456c-868c-2c47869b9a70"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfNS00LTEtMS0w_9069943a-2e18-48e9-a305-f5d289edf23f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RhYmxlOjE4MWEzNmE3NWU3YjQ2OGY5ZDk3ZGExNThkYzRjYzg3L3RhYmxlcmFuZ2U6MTgxYTM2YTc1ZTdiNDY4ZjlkOTdkYTE1OGRjNGNjODdfMTMtNC0xLTEtMA_13419dbd-838a-4266-9f8f-dc8fba177d25"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmEyMmQyYzA3Y2NiMzQzZThiNjUxZjhlOGMzNzhlMjU5L3NlYzphMjJkMmMwN2NjYjM0M2U4YjY1MWY4ZThjMzc4ZTI1OV8zNC9mcmFnOmFmZDliZmNkNmJhYTRiZThiYjU5NTg4YTgyMWI5MGZmL3RleHRyZWdpb246YWZkOWJmY2Q2YmFhNGJlOGJiNTk1ODhhODIxYjkwZmZfMTgxNDE5NDE4NTk1MzI_3ffcff2f-9ddb-40b7-aece-ddac52873c0c"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169482888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,308,913,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559163070040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 17,182<span></span>
</td>
<td class="nump">$ 15,539<span></span>
</td>
<td class="nump">$ 51,749<span></span>
</td>
<td class="nump">$ 47,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">64,810<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
<td class="nump">189,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">40,940<span></span>
</td>
<td class="nump">40,437<span></span>
</td>
<td class="nump">121,529<span></span>
</td>
<td class="nump">116,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">14,396<span></span>
</td>
<td class="nump">12,850<span></span>
</td>
<td class="nump">40,534<span></span>
</td>
<td class="nump">39,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">8,471<span></span>
</td>
<td class="nump">8,595<span></span>
</td>
<td class="nump">25,702<span></span>
</td>
<td class="nump">24,887<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">63,807<span></span>
</td>
<td class="nump">61,882<span></span>
</td>
<td class="nump">187,765<span></span>
</td>
<td class="nump">180,937<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,249<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
<td class="nump">11,387<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">2,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">766<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax provision</a></td>
<td class="nump">1,806<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
<td class="nump">8,545<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="nump">6,217<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="nump">$ 1,530<span></span>
</td>
<td class="nump">$ 6,206<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to CVS Health, basic (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to CVS Health, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 47,738<span></span>
</td>
<td class="nump">$ 47,149<span></span>
</td>
<td class="nump">$ 141,096<span></span>
</td>
<td class="nump">$ 136,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 1,859<span></span>
</td>
<td class="nump">$ 5,757<span></span>
</td>
<td class="nump">$ 5,447<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166225480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="nump">$ 1,529<span></span>
</td>
<td class="nump">$ 6,217<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">6,453<span></span>
</td>
<td class="nump">5,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 1,266<span></span>
</td>
<td class="nump">$ 1,796<span></span>
</td>
<td class="nump">$ 6,442<span></span>
</td>
<td class="nump">$ 5,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167178760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,256<span></span>
</td>
<td class="nump">$ 5,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">2,831<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">23,816<span></span>
</td>
<td class="nump">19,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">17,478<span></span>
</td>
<td class="nump">17,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,830<span></span>
</td>
<td class="nump">5,113<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">59,211<span></span>
</td>
<td class="nump">50,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">20,216<span></span>
</td>
<td class="nump">17,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,349<span></span>
</td>
<td class="nump">12,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,484<span></span>
</td>
<td class="nump">20,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,579<span></span>
</td>
<td class="nump">79,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">31,697<span></span>
</td>
<td class="nump">33,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,793<span></span>
</td>
<td class="nump">4,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,569<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">232,898<span></span>
</td>
<td class="nump">222,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">11,677<span></span>
</td>
<td class="nump">10,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">15,722<span></span>
</td>
<td class="nump">13,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">7,593<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">3,964<span></span>
</td>
<td class="nump">2,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">14,329<span></span>
</td>
<td class="nump">12,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,527<span></span>
</td>
<td class="nump">1,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">5,443<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">62,044<span></span>
</td>
<td class="nump">53,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,489<span></span>
</td>
<td class="nump">18,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">61,552<span></span>
</td>
<td class="nump">64,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">7,253<span></span>
</td>
<td class="nump">7,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">4,793<span></span>
</td>
<td class="nump">4,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">7,135<span></span>
</td>
<td class="nump">7,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,520<span></span>
</td>
<td class="nump">2,162<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">163,786<span></span>
</td>
<td class="nump">158,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,309 shares outstanding at September 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus</a></td>
<td class="nump">46,388<span></span>
</td>
<td class="nump">45,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 423 shares at September 30, 2020 and 425 shares at December&#160;31,&#160;2019</a></td>
<td class="num">(28,164)<span></span>
</td>
<td class="num">(28,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">49,328<span></span>
</td>
<td class="nump">45,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">68,807<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">69,112<span></span>
</td>
<td class="nump">64,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 232,898<span></span>
</td>
<td class="nump">$ 222,449<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167222712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,732,000,000<span></span>
</td>
<td class="nump">1,727,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">1,309,000,000<span></span>
</td>
<td class="nump">1,302,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">423,000,000<span></span>
</td>
<td class="nump">425,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167223960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 195,554<span></span>
</td>
<td class="nump">$ 184,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(116,590)<span></span>
</td>
<td class="num">(109,958)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(40,221)<span></span>
</td>
<td class="num">(38,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(22,185)<span></span>
</td>
<td class="num">(21,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(2,517)<span></span>
</td>
<td class="num">(2,675)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(2,365)<span></span>
</td>
<td class="num">(2,205)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">12,298<span></span>
</td>
<td class="nump">10,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">3,790<span></span>
</td>
<td class="nump">5,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(6,377)<span></span>
</td>
<td class="num">(6,011)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,724)<span></span>
</td>
<td class="num">(1,890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(828)<span></span>
</td>
<td class="num">(361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,300)<span></span>
</td>
<td class="num">(2,630)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net borrowings of short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">7,919<span></span>
</td>
<td class="nump">3,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(10,493)<span></span>
</td>
<td class="num">(8,350)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(1,980)<span></span>
</td>
<td class="num">(1,952)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(4,420)<span></span>
</td>
<td class="num">(6,410)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">3,578<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">5,954<span></span>
</td>
<td class="nump">4,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">9,532<span></span>
</td>
<td class="nump">5,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">6,217<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiary</a></td>
<td class="num">(271)<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">766<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Deferredincometaxesandothernoncashitems', window );">Deferred income taxes and other noncash items</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(3,564)<span></span>
</td>
<td class="num">(2,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">3,495<span></span>
</td>
<td class="nump">2,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="num">(474)<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">$ 859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Deferredincometaxesandothernoncashitems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Deferredincometaxesandothernoncashitems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559163450344">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th" colspan="2"><div>Treasury Stock</div></th>
<th class="th" colspan="2"><div>Common Stock Including Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th" colspan="2"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th" colspan="2">
<div>Cumulative Effect, Period of Adoption, Adjustment </div>
<div>Retained Earnings</div>
</th>
<th class="th" colspan="2">
<div>Cumulative Effect, Period of Adoption, Adjustment </div>
<div>Total CVS Health Shareholders&#8217; Equity</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,228)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 45,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 40,911<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 58,225<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,722<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,615<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">41,859<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">59,686<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,228)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">40,911<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">58,225<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,207)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">44,017<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="nump">62,614<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,722<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,615<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">41,859<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">59,686<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,724<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,257)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43,136<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="nump">61,282<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,207)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">44,017<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="nump">62,614<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">45,108<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">45,108<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">49,328<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">68,807<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,975<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">48,768<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">68,022<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(664)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 69,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 46,388<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 49,328<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 68,807<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="17"></td></tr>
<tr><td colspan="17"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of September 30, 2019, June 30, 2019, March 31, 2019 and December 31, 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 842), which resulted in an increase to retained earnings of $178 million during the three months ended March 31, 2019.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of September 30, 2020, June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167199368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury Stock, Value, Shares Held In Trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">$ 69,112<span></span>
</td>
<td class="nump">68,355<span></span>
</td>
<td class="nump">65,474<span></span>
</td>
<td class="nump">64,170<span></span>
</td>
<td class="nump">62,933<span></span>
</td>
<td class="nump">61,599<span></span>
</td>
<td class="nump">60,006<span></span>
</td>
<td class="nump">58,543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">$ 49,328<span></span>
</td>
<td class="nump">$ 48,768<span></span>
</td>
<td class="nump">$ 46,455<span></span>
</td>
<td class="nump">45,108<span></span>
</td>
<td class="nump">$ 44,017<span></span>
</td>
<td class="nump">$ 43,136<span></span>
</td>
<td class="nump">$ 41,859<span></span>
</td>
<td class="nump">40,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 842), which resulted in an increase to retained earnings of $178 million during the three months ended March 31, 2019.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559258691832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 103 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 33 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the three and nine months ended September 30, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 (the &#8220;2019 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $363 million as of September&#160;30, 2020. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#8217;s allowance for doubtful accounts was $319 million as of December 31, 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.549%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.068%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.962%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,032)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurer Fee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes. There was no expense related to the HIF in the three and nine months ended September 30, 2019, since there was a one-year suspension of the HIF for 2019. In the three and nine months ended September&#160;30, 2020, operating expenses included $255 million&#160;and $774 million, respectively, related to the Company&#8217;s share of the 2020 HIF. The Company paid approximately $1.0 billion, representing the Company&#8217;s portion of the non tax-deductible HIF in 2020. In December 2019, the HIF was repealed for calendar years after 2020. </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $5 million and $14 million in the three months ended September&#160;30, 2020 and 2019, respectively, and expensed fees for the use of this network of approximately $28 million and $26 million in the nine months ended September&#160;30, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $15 million and $20 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2020 and 2019, respectively, and $58 million and $72 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Accounts Receivable&#8221; above for a discussion of the Company&#8217;s expected credit loss impairment policy for its accounts receivable. The following is a discussion of the Company&#8217;s available-for-sale debt security impairment policy and expected credit loss impairment policy for mortgage loans under the new credit loss impairment standard:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of United States Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next 12 months, in which case it is classified as current within the unaudited condensed consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the unaudited condensed consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559161087096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Divestitures</a></td>
<td class="text">Divestitures<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for $850 million, subject to a working capital adjustment. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $271 million in the three and nine months ended September&#160;30, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s unaudited condensed consolidated statement of operations within the Health Care Benefits segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559159107960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,216&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.093%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for Credit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2020, debt securities with a fair value of $928 million, gross unrealized capital gains of $122 million and gross unrealized capital losses of $1 million and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at September&#160;30, 2020 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2020 and December&#160;31, 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.494%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at September&#160;30, 2020 were generally caused by the widening of credit spreads on these securities relative to the interest rates on U.S. Treasury securities, driven by the adverse economic conditions in the U.S. and abroad caused by the COVID-19 pandemic.&#160;As of September&#160;30, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the three and nine months ended September&#160;30, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2020 and December&#160;31, 2019, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September 30, 2020. Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September 30, 2020. Net realized capital gains are net of other than temporary impairment losses on debt securities of $9 million and $22 million, respectively, in the three and nine months ended September 30, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, and $10 million and $33 million for the three and nine months ended September&#160;30, 2019, respectively, related to investments supporting experience-rated products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.549%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559161027096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2019 Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 or December&#160;31, 2019. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2020 and 2019, there were no transfers into or out of Level 3.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559159126136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2020 and 2019 in the table above exclude (i) $1 million and $6 million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $31 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $173 million and $213 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $448 million and $511 million, respectively, in the nine months ended September&#160;30, 2020 and 2019, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $5.8 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at September&#160;30, 2020 related to the current year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559159205368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.125% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (2.515% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.8% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">67,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">69,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">66,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(5,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">61,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">64,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750 million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5 billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0 billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750 million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95 billion, net of discounts and underwriting fees..</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings will be used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness. Net proceeds from these offerings that had not been used for these purposes were held in cash or temporarily invested in cash equivalents and short-term investment-grade securities from the date of issuance through September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 8 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div>In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559159072632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$15.0 billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the Company did not repurchase any shares of its common stock. At September&#160;30, 2020, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. </span></div>DividendsThe quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended September&#160;30, 2020 and 2019. Cash dividends declared by the Board were $1.50 per share in each of the nine-month periods ended September 30, 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559157981432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($83, $214, $278 and $933 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(10), $(63), $47 and $(93) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $(25), $(7) and $(25) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(7), $(14) and $(16) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $(8) and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $7 and $0 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$15 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(4)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559160492744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 17 million and 16 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September&#160;30, 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase 18 million and 19 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559157754888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of September&#160;30, 2020, the Company guaranteed 76 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and this risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care insurers and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to numerous legal proceedings, investigations, audits and claims arising, for the most part, in the ordinary course of its businesses, including the matters described below. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. It is reasonably possible that the outcome of such legal matters could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits, including the cases below, that allege that the Company&#8217;s retail stores overcharged for prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price, and related theories. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Northern District of California) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Podgorny </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Northern District of Illinois). These putative class actions were filed against the Company in July and September 2015. The cases were consolidated in the U.S. District Court for the Northern District of California. Plaintiffs seek damages and injunctive relief under the consumer protection statutes of certain states on behalf of a class of consumers who purchased certain prescription drugs. Several third-party payors filed similar putative class actions on behalf of payors captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheet Metal Workers Local No. 20 Welfare and Benefit Fund v. CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plumbers Welfare Fund, Local 130 v. CVS Health Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(both pending in the U.S. District Court for the District of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rhode Island) in February and August 2016. In all of these cases the plaintiffs allege the Company overcharged for certain prescription drugs by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price. In the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case, the U.S. District Court granted summary judgment to the Company on plaintiffs&#8217; claims in their entirety and certified certain subclasses in September 2017. In June 2019, the U.S. Court of Appeals for the Ninth Circuit reversed the U.S. District Court&#8217;s grant of summary judgment and reversed the U.S. District Court&#8217;s narrowing of the requested class. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corcoran </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">case is proceeding to a trial on a six state class basis, and trial is scheduled to occur in 2021. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheet Metal Workers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiffs have amended their complaint to assert a claim under the federal Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;) premised on an alleged conspiracy between the Company and other PBMs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of Mississippi v. CVS Health Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (Circuit Court of DeSoto County, Mississippi, Third Judicial District). In July 2016, the Company was served with a complaint filed on behalf of the State of Mississippi. The complaint alleged that CVS retail pharmacies in Mississippi submitted false claims for reimbursement to the Mississippi Medicaid program by not submitting the price available to members of the CVS Health Savings Pass program as the pharmacy&#8217;s usual and customary price. In June 2019, the Company&#8217;s motion for judgment on the pleadings was granted in part and denied in part. Also in June 2019, the State of Mississippi&#8217;s motion to dismiss the Company&#8217;s counterclaim for declaratory relief was granted. In April 2020, the Company&#8217;s motion to dismiss the State of Mississippi&#8217;s second amended complaint was denied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blue Cross and Blue Shield of Alabama</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. v. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">CVS Health Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Horizon Healthcare Services, Inc. (d/b/a Horizon Blue Cross Blue Shield of New Jersey) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> CVS Health Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al. (U.S. District Court for the District of Rhode Island).  In May 2020, eight Blue Cross Blue Shield entities from six states filed a lawsuit against the Company alleging fraud and other state causes of action premised on a theory that the Company&#8217;s retail stores overcharged for prescription drugs by not submitting accurate usual and customary prices, including by not submitting the price available to members of the former CVS Health Savings Pass program. In October 2020, two Horizon Blue Cross Blue Shield entities from New Jersey filed an almost identical lawsuit premised on the same theories.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Klein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. v. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prime Therapeutics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, et al. (U.S. District Court for the District of Minnesota). This putative class action was filed against the Company and other PBMs in June 2017 on behalf of ERISA plan members who purchased and paid for EpiPen or EpiPen Jr. Plaintiffs allege that the PBMs are ERISA fiduciaries to plan members and have violated ERISA by allegedly causing higher inflated prices for EpiPens through the process of negotiating increased rebates from EpiPen manufacturer Mylan. This case was consolidated with a similar matter and was proceeding as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re EpiPen ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In October 2020, the lawsuit was voluntarily dismissed with prejudice following denial of the plaintiffs&#8217; motion for class certification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">County of Harris, Texas v. Eli Lilly and Company, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Southern District of Texas).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This lawsuit was filed against Caremark, Aetna, the manufacturers of insulin and other PBMs in November 2019 by Harris County. Harris County alleges that it was overcharged for insulin as a result of a &#8220;price fixing conspiracy&#8221; between the manufacturers and PBMs to artificially increase the price of insulin and other diabetes medications. The complaint alleges violations of RICO and claims that the manufacturers and PBMs engaged in an &#8220;Insulin Pricing Scheme&#8221; whereby the manufacturers artificially increased the reported prices of their insulin products while &#8220;secretly&#8221; paying rebates to the PBMs in exchange for preferred treatment on the PBMs&#8217; drug formularies. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Direct Purchaser EpiPen Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the District of Minnesota). This putative class action (originally captioned as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rochester Drug Cooperative, Inc. v. Mylan Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was filed in March 2020 against Caremark, other PBMs and the manufacturer of EpiPen products and their authorized generics on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturer and PBMs caused the direct purchasers to pay inflated prices for these drug products. A nearly identical case was separately filed in the same court (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dakota Drug, Inc. v. Mylan Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.). The court granted a motion to consolidate the two complaints. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Direct Purchaser Insulin Pricing Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the District of New Jersey). This putative class action (originally captioned as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rochester Drug Cooperative, Inc. v. Eli Lilly and Co., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was filed in March 2020 against Caremark, other PBMs and the manufacturers of analog insulin products on behalf of purported classes of direct purchasers of these products. The complaint alleges violations of RICO and claims that rebate agreements between the drug manufacturers and PBMs caused the direct purchasers to pay inflated prices for these drug products. Two nearly identical cases were </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">separately filed in the same court (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FWK Holdings, LLC v. Novo Nordisk, et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Value Drug Company v. Eli Lilly &amp; Co., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court granted a motion to consolidate all three complaints. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. In April 2020, the Company&#8217;s motion to dismiss was granted in part and denied in part. The Company is defending itself against these claims.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states regarding its PBM practices, including pricing and rebates. In addition, the Company has received inquiries from congressional committees regarding insulin pricing. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several states. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company routinely is audited by the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;). In some instances, the Company is in discussions with the DEA and U.S. Attorney&#8217;s Offices concerning allegations that the Company violated certain requirements of the federal Controlled Substances Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Mohajer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed complaints-in-intervention in these two previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. With respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#8217;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mohajer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by health care providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for these services and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by health care providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by health care providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of Health and Human Services (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RADV, Public Exchange related or other audits by CMS, the OIG, the U.S. Department of Health and Human Services or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and/or its current and/or former directors and/or executive officers are named as defendants in a number of lawsuits and a request for access to information initiated by holders or putative holders of CVS Health common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February and August 2019, six class action complaints were filed by putative plaintiffs against the Company and certain current and former officers and directors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat v. CVS Health Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., et al. (U.S. District Court for the District of Rhode Island); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund of Central and Eastern Canada v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (New York Supreme Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren Police and Fire Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et. al. (Rhode Island Superior Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambria Co. Employees Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (New York Supreme Court); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al. (Rhode Island Superior Court); and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford Twp. Police &amp; Fire Retirement Sys. v. CVS Health Corp.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al.) (U.S. District Court for the District of Rhode Island). The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit, which allegedly injured investors who acquired CVS Health securities between February 9, 2016 and February 20, 2019. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambria County</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases have been consolidated into a single action based on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases have been consolidated into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and stayed in favor of the earlier-filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labourers&#8217; Pension Fund</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a derivative complaint was filed against the Company&#8217;s directors and current and former executive officers in the U.S. District Court for the District of Rhode Island by a stockholder.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Lovoi v. Aguirre, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. makes allegations similar to those contained the six stockholder class action complaints described above, including that the Company made false or misleading statements about its LTC business unit&#8217;s financial health. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint alleges claims for breach of fiduciary duty against the Company&#8217;s directors and certain of its current and former executive officers and for violation of the federal securities laws. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint seeks damages, restitution and equitable relief on behalf of the Company. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lovoi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case has been stayed pending the resolution of the two federal class action complaints described above. The Company&#8217;s directors and current and former executive officers are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court in the District of Connecticut against CVS Health Corp., Aetna Inc., and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The Company also received a related document request pursuant to ERISA &#167; 104(b). The Company is evaluating these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information, arising, for the most part, in the ordinary course of its businesses. These other legal </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167220360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.5 billion and $2.7 billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.5 billion and $8.9 billion of retail co-payments for the nine months ended September 30, 2020 and 2019, respectively.</span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.</span></div>(4)During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559161115704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Event<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. At September 30, 2020, the Company did not record any ACA risk corridor receivables because payment was uncertain. </span></div>On October 22, 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the fourth quarter of 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company expects to record pre-tax income of approximately $305&#160;million and after-tax income of approximately $220&#160;million during the fourth quarter of 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559253444264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans and individuals throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products, cosmetics and personal care products, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of September&#160;30, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 (the &#8220;2019 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable, Expected Credit Losses</a></td>
<td class="text">The Company&#8217;s allowance for credit losses was $363 million as of September&#160;30, 2020. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#8217;s allowance for doubtful accounts was $319 million as of December 31, 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Insurer Fee</a></td>
<td class="text">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes. There was no expense related to the HIF in the three and nine months ended September 30, 2019, since there was a one-year suspension of the HIF for 2019. In the three and nine months ended September&#160;30, 2020, operating expenses included $255 million&#160;and $774 million, respectively, related to the Company&#8217;s share of the 2020 HIF. The Company paid approximately $1.0 billion, representing the Company&#8217;s portion of the non tax-deductible HIF in 2020. In December 2019, the HIF was repealed for calendar years after 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $5 million and $14 million in the three months ended September&#160;30, 2020 and 2019, respectively, and expensed fees for the use of this network of approximately $28 million and $26 million in the nine months ended September&#160;30, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $15 million and $20 million for pharmaceutical inventory purchases during the three months ended September&#160;30, 2020 and 2019, respectively, and $58 million and $72 million for pharmaceutical inventory purchases during the nine months ended September&#160;30, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Accounts Receivable&#8221; above for a discussion of the Company&#8217;s expected credit loss impairment policy for its accounts receivable. The following is a discussion of the Company&#8217;s available-for-sale debt security impairment policy and expected credit loss impairment policy for mortgage loans under the new credit loss impairment standard:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of United States Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next 12 months, in which case it is classified as current within the unaudited condensed consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the unaudited condensed consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4879-115612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167873096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,954&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Accounts Receivable, Net</a></td>
<td class="text">Accounts receivable, net is composed of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.549%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.068%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.962%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,032)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contracts With Customers, Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559253263464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,216&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.093%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.222%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for Credit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At September&#160;30, 2020, debt securities with a fair value of $928 million, gross unrealized capital gains of $122 million and gross unrealized capital losses of $1 million and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at September&#160;30, 2020 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at September&#160;30, 2020 and December&#160;31, 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.494%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at September&#160;30, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Activity in Mortgage Loan Portfolio</a></td>
<td class="text">During the three and nine months ended September&#160;30, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Mortgage Loan Internal Credit Rating</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at September&#160;30, 2020 and December&#160;31, 2019, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Net Investment Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $1 million and $2 million, respectively, in the three months ended September 30, 2020. Net realized capital gains include credit-related and yield-related impairment losses on debt securities of $4 million and $44 million, respectively, in the nine months ended September 30, 2020. Net realized capital gains are net of other than temporary impairment losses on debt securities of $9 million and $22 million, respectively, in the three and nine months ended September 30, 2019.</span></div>(2)Net investment income includes $10 million and $31 million for the three and nine months ended September&#160;30, 2020, respectively, and $10 million and $33 million for the three and nine months ended September&#160;30, 2019, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses for the three and nine months ended September&#160;30, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.549%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166124536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019 were as follows:<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2020 and 2019, there were no transfers into or out of Level 3.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at September&#160;30, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text">Separate Accounts financial assets as of September&#160;30, 2020 and December&#160;31, 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121639652&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559159031048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,014&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the nine months ended September&#160;30, 2020 and 2019 in the table above exclude (i) $1 million and $6 million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $31 million and $31 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $173 million and $213 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559160553272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Company's Borrowings</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at September&#160;30, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.125% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (2.515% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.8% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">67,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">69,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">66,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(5,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">61,552&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.8pt;font-weight:400;line-height:100%">64,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559160497112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($83, $214, $278 and $933 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(10), $(63), $47 and $(93) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $(25), $(7) and $(25) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(7), $(14) and $(16) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $(8) and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $7 and $0 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$15 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(4)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559158851112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559158976536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,018&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,007)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,223)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,436)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.5 billion and $2.7 billion of retail co-payments for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.5 billion and $8.9 billion of retail co-payments for the nine months ended September 30, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Earnings to Net Income</a></td>
<td class="text"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,063&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and nine months ended September 30, 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Health Care Benefits segment. During the three and nine months ended September 30, 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations within the Retail/LTC segment.</span></div>(4)During the three and nine months ended September 30, 2019, the store rationalization charges relate to the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. During the nine months ended September 30, 2019, the store rationalization charges also relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Retail/LTC segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169466024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> person in Millions, patient in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>patient </div>
<div>clinic </div>
<div>state </div>
<div>person </div>
<div>building</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>patient </div>
<div>Segment </div>
<div>clinic </div>
<div>state </div>
<div>person </div>
<div>building</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPharmacyPlanMembers', window );">Number of pharmacy plan members | person</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year | patient</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NonTaxDeductibleHealthInsuranceFee', window );">Non tax-deductible health insurance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, expenses from transactions with related party</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Related party transaction, other revenues from transactions with related party</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList', window );">Change in Accounting Principle, Accounting Standards Update, Transition Option Elected [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201615ProspectiveMember<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">$ 69,112<span></span>
</td>
<td class="nump">62,933<span></span>
</td>
<td class="nump">$ 69,112<span></span>
</td>
<td class="nump">62,933<span></span>
</td>
<td class="nump">$ 68,355<span></span>
</td>
<td class="nump">$ 65,474<span></span>
</td>
<td class="nump">64,170<span></span>
</td>
<td class="nump">$ 61,599<span></span>
</td>
<td class="nump">$ 60,006<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | building</a></td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk in medical clinics | clinic</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices', window );">Number of people served through health insurance products and related services | person</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">$ 49,328<span></span>
</td>
<td class="nump">$ 44,017<span></span>
</td>
<td class="nump">$ 49,328<span></span>
</td>
<td class="nump">$ 44,017<span></span>
</td>
<td class="nump">$ 48,768<span></span>
</td>
<td class="nump">$ 46,455<span></span>
</td>
<td class="nump">45,108<span></span>
</td>
<td class="nump">$ 43,136<span></span>
</td>
<td class="nump">$ 41,859<span></span>
</td>
<td class="nump">40,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 842), which resulted in an increase to retained earnings of $178 million during the three months ended March 31, 2019.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NonTaxDeductibleHealthInsuranceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non Tax-deductible Health Insurance Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NonTaxDeductibleHealthInsuranceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of People Served through Health Insurance Products and Related Services</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates transition method applied for adoption of amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109261464&amp;loc=SL109261606-128450<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120431994&amp;loc=SL118172731-207502<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 405<br> -SubTopic 20<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997009&amp;loc=SL77997016-210199<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120431994&amp;loc=SL118172731-207502<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL77916155-209984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98513396&amp;loc=SL94080479-196980<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 853<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109199533&amp;loc=SL109199563-203033<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109261464&amp;loc=SL109261606-128450<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 405<br> -SubTopic 20<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997009&amp;loc=SL77997016-210199<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117337699&amp;loc=SL117340306-165695<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117337699&amp;loc=SL117340306-165695<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL120154346-209984<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL77916155-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL119206272-209984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121329987&amp;loc=SL119206272-209984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 853<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109199533&amp;loc=SL109199563-203033<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=98513396&amp;loc=SL94080479-196980<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520240&amp;loc=SL117035239-210619<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166077512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,256<span></span>
</td>
<td class="nump">$ 5,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the statements of cash flows</a></td>
<td class="nump">$ 9,532<span></span>
</td>
<td class="nump">$ 5,954<span></span>
</td>
<td class="nump">$ 5,469<span></span>
</td>
<td class="nump">$ 4,295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559158879080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,265<span></span>
</td>
<td class="nump">$ 6,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">10,528<span></span>
</td>
<td class="nump">7,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,852<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">3,171<span></span>
</td>
<td class="nump">2,381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 23,816<span></span>
</td>
<td class="nump">$ 19,617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169263112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">$ 805<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">64,810<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
<td class="nump">189,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">36,018<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
<td class="nump">104,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">21,466<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
<td class="nump">64,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">17,181<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
<td class="nump">52,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">43,062<span></span>
</td>
<td class="nump">42,560<span></span>
</td>
<td class="nump">126,725<span></span>
</td>
<td class="nump">121,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">14,601<span></span>
</td>
<td class="nump">14,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17,182<span></span>
</td>
<td class="nump">15,539<span></span>
</td>
<td class="nump">51,749<span></span>
</td>
<td class="nump">47,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,868<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
<td class="nump">5,527<span></span>
</td>
<td class="nump">5,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">36,018<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
<td class="nump">104,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">21,466<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
<td class="nump">64,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">17,181<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
<td class="nump">52,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">35,505<span></span>
</td>
<td class="nump">35,872<span></span>
</td>
<td class="nump">104,924<span></span>
</td>
<td class="nump">103,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17,608<span></span>
</td>
<td class="nump">16,687<span></span>
</td>
<td class="nump">51,833<span></span>
</td>
<td class="nump">49,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Front Store | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Front Store | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">14,601<span></span>
</td>
<td class="nump">14,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Front Store | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Premiums | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Premiums | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Premiums | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">17,165<span></span>
</td>
<td class="nump">15,507<span></span>
</td>
<td class="nump">51,699<span></span>
</td>
<td class="nump">47,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">377<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">702<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
<td class="nump">4,324<span></span>
</td>
<td class="nump">4,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy network | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">21,473<span></span>
</td>
<td class="nump">22,411<span></span>
</td>
<td class="nump">63,109<span></span>
</td>
<td class="nump">65,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Mail choice | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">14,032<span></span>
</td>
<td class="nump">13,461<span></span>
</td>
<td class="nump">41,815<span></span>
</td>
<td class="nump">38,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(10,007)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
<td class="num">(31,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(10,007)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
<td class="num">(31,436)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">7,350<span></span>
</td>
<td class="nump">8,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,955<span></span>
</td>
<td class="nump">7,661<span></span>
</td>
<td class="nump">22,822<span></span>
</td>
<td class="nump">22,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(10,051)<span></span>
</td>
<td class="num">(9,999)<span></span>
</td>
<td class="num">(30,032)<span></span>
</td>
<td class="num">(31,416)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (143)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166291960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,265<span></span>
</td>
<td class="nump">$ 6,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559160355800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinContractwithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses) beginning balance</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage', window );">Redemption and breakage</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses) ending balance</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinContractwithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinContractwithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer Liability Redemption and Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractwithCustomerLiabilityRedemptionandBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559256003016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Drogaria onofre Ltda. | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold', window );">Number of retail pharmacy stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Number of Stores In Subsidiary Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559168015832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current investments</a></td>
<td class="nump">$ 2,831<span></span>
</td>
<td class="nump">$ 2,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">20,216<span></span>
</td>
<td class="nump">17,314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments</a></td>
<td class="nump">23,047<span></span>
</td>
<td class="nump">19,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current investments</a></td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">2,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">17,820<span></span>
</td>
<td class="nump">14,671<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments</a></td>
<td class="nump">20,398<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current investments</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,525<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investments</a></td>
<td class="nump">$ 1,525<span></span>
</td>
<td class="nump">$ 1,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169452760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">$ 18,863,000,000<span></span>
</td>
<td class="nump">$ 15,898,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">18,859,000,000<span></span>
</td>
<td class="nump">15,898,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,577,000,000<span></span>
</td>
<td class="nump">1,035,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(38,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">20,398,000,000<span></span>
</td>
<td class="nump">16,922,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,455,000,000<span></span>
</td>
<td class="nump">1,791,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">2,455,000,000<span></span>
</td>
<td class="nump">1,791,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">146,000,000<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,601,000,000<span></span>
</td>
<td class="nump">1,852,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,393,000,000<span></span>
</td>
<td class="nump">2,202,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">2,393,000,000<span></span>
</td>
<td class="nump">2,202,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">108,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,540,000,000<span></span>
</td>
<td class="nump">2,309,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">7,665,000,000<span></span>
</td>
<td class="nump">7,167,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">7,661,000,000<span></span>
</td>
<td class="nump">7,167,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">878,000,000<span></span>
</td>
<td class="nump">573,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8,524,000,000<span></span>
</td>
<td class="nump">7,737,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,479,000,000<span></span>
</td>
<td class="nump">2,149,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">2,479,000,000<span></span>
</td>
<td class="nump">2,149,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">252,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,721,000,000<span></span>
</td>
<td class="nump">2,348,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">680,000,000<span></span>
</td>
<td class="nump">508,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">680,000,000<span></span>
</td>
<td class="nump">508,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">33,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">713,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">930,000,000<span></span>
</td>
<td class="nump">654,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">930,000,000<span></span>
</td>
<td class="nump">654,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,012,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,239,000,000<span></span>
</td>
<td class="nump">1,397,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">2,239,000,000<span></span>
</td>
<td class="nump">1,397,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">33,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,262,000,000<span></span>
</td>
<td class="nump">1,405,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">122,000,000<span></span>
</td>
<td class="nump">83,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 928,000,000<span></span>
</td>
<td class="nump">$ 965,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559157146440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet', window );">Less than one year</a></td>
<td class="nump">$ 1,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet', window );">One year through five years</a></td>
<td class="nump">6,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet', window );">After five years through ten years</a></td>
<td class="nump">3,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet', window );">Greater than ten years</a></td>
<td class="nump">3,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">18,859<span></span>
</td>
<td class="nump">$ 15,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">6,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">3,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">20,398<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">930<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Net Amortized Cost</a></td>
<td class="nump">2,239<span></span>
</td>
<td class="nump">1,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="nump">$ 1,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559250403048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,390<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,487<span></span>
</td>
<td class="nump">722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 2,177<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559250271928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">$ 1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">623<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166566440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559161333960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 1,124<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member', window );">Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member', window );">Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member', window );">Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member', window );">Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember', window );">2020 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember', window );">2020 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember', window );">2020 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember', window );">2020 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember', window );">2019 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember', window );">2019 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember', window );">2019 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember', window );">2019 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember', window );">2018 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember', window );">2018 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember', window );">2018 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember', window );">2018 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember', window );">2017 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember', window );">2017 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember', window );">2017 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember', window );">2017 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember', window );">2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember', window );">2016 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember', window );">2016 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember', window );">2016 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember', window );">2016 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember', window );">Prior | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember', window );">Prior | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember', window );">Prior | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember', window );">Prior | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems', window );"><strong>Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559253281656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 203,000,000<span></span>
</td>
<td class="nump">$ 224,000,000<span></span>
</td>
<td class="nump">$ 550,000,000<span></span>
</td>
<td class="nump">$ 654,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">195,000,000<span></span>
</td>
<td class="nump">214,000,000<span></span>
</td>
<td class="nump">525,000,000<span></span>
</td>
<td class="nump">626,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">204,000,000<span></span>
</td>
<td class="nump">263,000,000<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="nump">805,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss (reversal of loss)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Other-than-temporary impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">151,000,000<span></span>
</td>
<td class="nump">145,000,000<span></span>
</td>
<td class="nump">441,000,000<span></span>
</td>
<td class="nump">437,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="nump">54,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="nump">$ 163,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166324792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">$ 4,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559163225864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement on a Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 20,398,000,000<span></span>
</td>
<td class="nump">$ 16,922,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">9,256,000,000<span></span>
</td>
<td class="nump">5,683,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,398,000,000<span></span>
</td>
<td class="nump">16,922,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">46,000,000<span></span>
</td>
<td class="nump">73,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">29,700,000,000<span></span>
</td>
<td class="nump">22,678,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">5,670,000,000<span></span>
</td>
<td class="nump">3,397,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,498,000,000<span></span>
</td>
<td class="nump">1,785,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">8,188,000,000<span></span>
</td>
<td class="nump">5,216,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,586,000,000<span></span>
</td>
<td class="nump">2,286,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">17,851,000,000<span></span>
</td>
<td class="nump">15,088,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">21,437,000,000<span></span>
</td>
<td class="nump">17,374,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">49,000,000<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">88,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,601,000,000<span></span>
</td>
<td class="nump">1,852,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,601,000,000<span></span>
</td>
<td class="nump">1,852,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,498,000,000<span></span>
</td>
<td class="nump">1,785,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">103,000,000<span></span>
</td>
<td class="nump">67,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,540,000,000<span></span>
</td>
<td class="nump">2,309,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,540,000,000<span></span>
</td>
<td class="nump">2,309,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,540,000,000<span></span>
</td>
<td class="nump">2,309,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,524,000,000<span></span>
</td>
<td class="nump">7,737,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,524,000,000<span></span>
</td>
<td class="nump">7,737,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,476,000,000<span></span>
</td>
<td class="nump">7,700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">48,000,000<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,721,000,000<span></span>
</td>
<td class="nump">2,348,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,721,000,000<span></span>
</td>
<td class="nump">2,348,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,721,000,000<span></span>
</td>
<td class="nump">2,348,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">713,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">713,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">713,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,012,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,012,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,012,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,262,000,000<span></span>
</td>
<td class="nump">1,405,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,262,000,000<span></span>
</td>
<td class="nump">1,405,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,262,000,000<span></span>
</td>
<td class="nump">1,405,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559167077608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 1,124<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">66,995<span></span>
</td>
<td class="nump">68,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">76,642<span></span>
</td>
<td class="nump">74,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Total | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 76,642<span></span>
</td>
<td class="nump">$ 74,306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559162564392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 4,793<span></span>
</td>
<td class="nump">$ 4,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,793<span></span>
</td>
<td class="nump">4,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,114<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember', window );">Common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">3,233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,576<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559163330904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">7,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">$ 6,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">6,874<span></span>
</td>
<td class="nump">6,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisition</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">40,777<span></span>
</td>
<td class="nump">39,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(448)<span></span>
</td>
<td class="num">(511)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">40,329<span></span>
</td>
<td class="nump">39,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">34,198<span></span>
</td>
<td class="nump">33,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">5,865<span></span>
</td>
<td class="nump">5,253<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">40,063<span></span>
</td>
<td class="nump">38,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">7,585<span></span>
</td>
<td class="nump">7,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">7,593<span></span>
</td>
<td class="nump">7,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559158914888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Incurred but not reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="num">$ (448)<span></span>
</td>
<td class="num">$ (511)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559174243896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease obligations</a></td>
<td class="nump">$ 1,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">67,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligation</a></td>
<td class="nump">66,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(5,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">61,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.125% senior notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due July 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Floating Rate Notes | Floating rate notes due March 2020 (2.515% at December 31, 2019)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.515%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Floating Rate Notes | Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt interest rate</a></td>
<td class="nump">0.968%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.605%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJuly2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJuly2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559168157608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="nump">$ 3,970,000,000<span></span>
</td>
<td class="nump">$ 3,950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Loss on net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">$ 766,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 766,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Outstanding Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.125% senior notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 328,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 413,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember', window );">Floating Rate Notes [Member] | Floating rate notes due March 2020 (2.515% at December 31, 2019)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtExtinguishmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>DebtExtinguishmentFees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtExtinguishmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559256025080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Nov. 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember', window );">2016 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559161365240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,355<span></span>
</td>
<td class="nump">$ 65,474<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 61,599<span></span>
</td>
<td class="nump">$ 60,006<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">$ 65,474<span></span>
</td>
<td class="nump">69,112<span></span>
</td>
<td class="nump">68,355<span></span>
</td>
<td class="nump">65,474<span></span>
</td>
<td class="nump">62,933<span></span>
</td>
<td class="nump">61,599<span></span>
</td>
<td class="nump">60,006<span></span>
</td>
<td class="nump">69,112<span></span>
</td>
<td class="nump">62,933<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="nump">$ 684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559163140104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="nump">$ 1,529<span></span>
</td>
<td class="nump">$ 6,217<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Income allocated to participating securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="nump">$ 1,530<span></span>
</td>
<td class="nump">$ 6,206<span></span>
</td>
<td class="nump">$ 4,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares, diluted (in shares)</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559165329176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>entity</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>state </div>
<div>entity</div>
</th>
<th class="th">
<div>Mar. 31, 2013 </div>
<div>member</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Guarantor obligations, number of leases | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyAuditMethodologySampleSize', window );">Sample size | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of pending claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember', window );">Blue Cross and Blue Shield of Alabama vs. CVS Health Corporation | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims', window );">Number of entities filing claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved', window );">Number of states in which entities filed claims | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfNewJerseyMember', window );">Blue Cross And Blue Shield Of New Jersey [Member] | Pending Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims', window );">Number of entities filing claims</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyAuditMethodologySampleSize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Audit Methodology Sample Size</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyAuditMethodologySampleSize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, New Claims Filed, Number Of Entities Filing Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, New Claims Filed, Number Of States Involved</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfNewJerseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_BlueCrossAndBlueShieldOfNewJerseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166630664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559166823016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from customers</a></td>
<td class="nump">$ 66,852<span></span>
</td>
<td class="nump">$ 64,547<span></span>
</td>
<td class="nump">$ 198,602<span></span>
</td>
<td class="nump">$ 189,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">67,056<span></span>
</td>
<td class="nump">64,810<span></span>
</td>
<td class="nump">199,152<span></span>
</td>
<td class="nump">189,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">3,622<span></span>
</td>
<td class="nump">3,947<span></span>
</td>
<td class="nump">13,063<span></span>
</td>
<td class="nump">11,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">36,018<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
<td class="nump">104,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">21,466<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
<td class="nump">64,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">17,181<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
<td class="nump">52,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from customers</a></td>
<td class="nump">33,492<span></span>
</td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">98,233<span></span>
</td>
<td class="nump">95,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">35,711<span></span>
</td>
<td class="nump">36,018<span></span>
</td>
<td class="nump">105,583<span></span>
</td>
<td class="nump">104,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
<td class="nump">4,127<span></span>
</td>
<td class="nump">3,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Net revenues, retail copayments</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from customers</a></td>
<td class="nump">14,770<span></span>
</td>
<td class="nump">13,805<span></span>
</td>
<td class="nump">44,314<span></span>
</td>
<td class="nump">41,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,725<span></span>
</td>
<td class="nump">21,466<span></span>
</td>
<td class="nump">67,136<span></span>
</td>
<td class="nump">64,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">4,371<span></span>
</td>
<td class="nump">4,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from customers</a></td>
<td class="nump">18,557<span></span>
</td>
<td class="nump">17,027<span></span>
</td>
<td class="nump">55,972<span></span>
</td>
<td class="nump">51,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">18,698<span></span>
</td>
<td class="nump">17,181<span></span>
</td>
<td class="nump">56,364<span></span>
</td>
<td class="nump">52,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">6,035<span></span>
</td>
<td class="nump">4,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from customers</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
<td class="num">(685)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(10,007)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
<td class="num">(31,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(10,194)<span></span>
</td>
<td class="num">(10,007)<span></span>
</td>
<td class="num">(30,223)<span></span>
</td>
<td class="num">(31,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="num">(539)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">7,350<span></span>
</td>
<td class="nump">8,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,955<span></span>
</td>
<td class="nump">7,661<span></span>
</td>
<td class="nump">22,822<span></span>
</td>
<td class="nump">22,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169557448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,249<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
<td class="nump">$ 11,387<span></span>
</td>
<td class="nump">$ 8,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,622<span></span>
</td>
<td class="nump">$ 3,947<span></span>
</td>
<td class="nump">13,063<span></span>
</td>
<td class="nump">11,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofUnderPerformingStores', window );">Number of under performing stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (271)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (271)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofUnderPerformingStores', window );">Number of under performing stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofUnderPerformingStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Under Performing Stores</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofUnderPerformingStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreRationalizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Rationalization Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreRationalizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140559169498840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details) - U.S. Department of Health and Human Services, ACA Risk Corridor Receivables - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">Pending Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount awarded from other party</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">Settled Litigation | Premium Revenue | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax', window );">Former gain contingency, recognized in current period, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cvs_PremiumRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cvs_PremiumRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M!8/NTX8V_NB OP>V8^66U5<67^[>E]OX<@=\W5>LR+8%F".MI=]8JIJWF^
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ML9Y[%I,QWZD\8_19(+DK"B)^/M*<'^X=WSE.?,DVJ2HGW,EX2S9T0=7+]EG
MR&VT)%E!F<PX0X*N[YT'_V[N!Z6 1GS-Z$&>?:.2RI+S'^7@<W+O>*5'-*<K
M5:H@\+>G4YKGI2;PX^]:J=/8+ 7/OX_:?]/D@<R22#KE^;<L4>F],W100M=D
MEZLO_/")UH2B4M^*YU+_HD.-]1RTVDG%BUH8/"@R5OV3USH09P*@QRZ :P%L
M"H0= D$M$+S70E@+A.^U$-4"FKI;<=>!FQ%%)F/!#TB4:-!6?NCH:VF(5\;*
M1%DH :L9R*G)E+,$MITF"+XDS[.$*!@L%/Q!/BB)^!J6"LC"M$R//46?V8H7
M%%V],+)+,D!?HQOTLIBAJP_7Z /*&'K*\ARR0(Y=!2Z6AMQ5[<YCY0[N<"=
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MVV_J\3?1*Y2Z^4I5F_8O>>QEHP4I#\:J73\8$.QDT_WG/WM#' V >? !M!]
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MFE49FV<5,O^C8626QM>6]AX?V?&Y[]QFQ3@?UC/]_3"?U^?I/OOKOVS]U4L
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M81( SQ>4BLV-?$%]@#CZ!U!+ P04    "  K-691T!P@5&XB   )<   &
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MS)@ICA<#OF;(44P(=C>'Z([Q@8TN"NXD6(?G? J"P]5VIW X!^ .R #14_*
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M-E=X@+Y?EQ3#FU^P@?OK?]_]#U!+ P04    "  K-691ZU;I<P<#  "K!@
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M79/>,0\^VXS&9D.F"N-H88B'6U@6_&^"UAOP_=(8VFQ\@.[_:?H74$L#!!0
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MJG6.OQ4ATZJI:$@VR]@(R&IZ3*&W.0]RZ+,6@G-9I 2/F@JQAJ.VWFDU^=H
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MK >CP)$,U6S[BO\Y5:3 /;*\X+A9NUASSMXT2(BJRH&C\PJ=)^FP^YNR8./
M';?<++TU48-"'GAR<?$GE@63/,0W";+I!%\'X/@"K5D09Q/0-K<  OAV2CMG
M'\\^G+$[=2]T0R@9S+$X2&=3 "#I3XF#21BQ#Q2(X2'JMI&%7/&U_HFBE:(.
MN1;3SDMY+XUC<;,_2\.=GB, MKURECV\OULW#=)\PM(I&EF<$BR1KS:'5L9!
M'D<[O??">(<'HFJE[1WR]1=S7GR&2@\<D4?)5AN.H!:Z^,[=41!&\4[OGRX
M.#B>V!D'\23>Z;T7I4 =0TX*J=1":'UD;PKXQ-D:,>6VBCLUYL$TBU@Z X:"
M! .O@1O$S^'"@6H@[\GZO)\@]V@ZQ3>.@C3)T<@SZLV"/ P/H/T4/A/<32>
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M[C.4BF_D8P4.]:*F(@=YC<72$Y^'%JRUJKZSP6YQ)[:5.?D%;8'Z8(TC[2Q
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M>3B[H^7<M*Z6&N\(;*N4H-T*:[-=1--H?W OR\KY@W@Y;T2):W1_-'?$NWA
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M5M3-HV$"^K[0VFTGK&#W_X'S?P%02P,$%     @ *S5F47KIO00U!   8PH
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M*02'(]IF^Z!+CF20)3'_XS3\9^$?PTU[) ^IS%EQ%+()9#"E[T7P0[XQ_"1
MAG\R#OWLF?(\A\M Z!W$P_.,W1^V&SH\XV!DP[,I7'>HS^BDK<X$GKNG1D<7
M/V7<+CQO^#:@S&S? +VT?T%=M ^'[^KM\^N3L#M%E47CEI;&9#%J"\]AX$T=
MGA$;X^E1$KH%O0+1L@+-;XWQAP$;Z-^5J[\!4$L#!!0    ( "LU9E&I?ZM^
M-"@  .*&   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;-4]:6_;2+)_
MA<@#%@F@R,><F60".'8RD]DX,>+,!(N']Z%%MJ0>4VPMFY2M_?6OKKXHRG:.
MV;</V)U8/+JKJ^NNZN*S:]M>N:7677&SJAOW\X-EUZU_.CAPY5*OE)O:M6[@
MSMRV*]7!SW9QX-:M5A6]M*H/C@\/OS]8*=,\>/Z,KEVTSY_9OJM-HR_:PO6K
ME6JW+W1MKW]^</3 7WAO%LL.+QP\?[96"WVIN]_7%RW\.@BC5&:E&V=L4[1Z
M_O.#DZ.?7GR+S],#?QA][9*_"US)S-HK_/&Z^OG!(0*D:UUV.(*"?S;Z5-<U
M#@1@_%/&?!"FQ!?3O_WHKVCML):9<OK4UA]-U2U_?O#C@Z+2<]77W7M[_:N6
M]7R'XY6V=O3?XIJ?_>[X05'VKK,K>1D@6)F&_U4W@H?DA1\/][QP+"\<$]P\
M$4%YICKU_%EKKXL6GX;1\ ]:*KT-P)D&-^6R:^&N@?>ZYZ=VM3(=8+ESA6JJ
MXM0VG6D6NBF-=L\..I@"'SPH9;@7/-SQGN&>%.<PP-(5+YM*5_G[!P!:@._8
MP_?B^-8!+_5Z6GQS."F.#X\/;QGOF[#>;VB\;SYGO<69<65M7=_JXK]/9JYK
M@6C^YY99OPVS?DNS?ONUL/P%PQ6G[_YX??;XZ$GQ8:GCCS4\J%>F+$IZN(<'
M.UOHC:TW>EI\U,5,UT9OXAM_^Z\?CX]^>.H*LUH#&@I@(=L#"_0.H'%.NTD!
MHJ%5.#.PIP,V@$NE<LMB#JQ.D!W8MIB;1@%@JL:9*T.\N&X-B !3;X':ZQJF
M+JH6F+,I9MNB Z@7VBY:M5[B<GAZ7=%*\:8#*%O3;>E"U2,$"-N<;OIE/LU^
MC:P%;_\^O9S2*(O:S@! #1#:%4Z*%^$'B"H-2]9+M3&P%+RZU*KNEK!.H)&^
M,[7Y%\^_5EVGV\8]#7!V!OAU,2E<"7BBJW[V>>'@9E_WKJCUPKB:AU"NN ;Q
MA/]:& !0IRM < U#=*KC(6I; J +"RAHD #@!^!^#:#RAJ:KG@(%6*<%VUO&
M<0N+:W&WM[ ;M*-7C;VN=;70?M5=:^MI<0(/RKY.:%B!/E 4;1U@1G]5TC"N
MZ)M2MQTHE D,V:5SE[:O*R075>%*&&(0S4 /"D .H*G:6;B^E<D+TR"B81Y\
MOM6+'C!N 2/KUI9:5P FP&>:C89]6=!F" G4RJS@SP4 X[JB=]/BC08=4/S2
MJU8UG0:DO]#=M0;2/7KRY#MZ"?[X@3$&? I[L2V<!:AAO6[=(Z'. ;%-OYK!
M#B,I]#-G*@/LH F(LNX1H.*%G06RO01HA2K? (H!.KKU_=,&MIBAUZI<XG#7
M2P-_X*#ZGST0"/#8W,#V%J# 07\U5VV_[LKMA 8[5ZU;JKJ&=;UN &$ *^P2
MPG&]A"4I? DY(,"X!3S" \",0), 4[Y.0.?&5'1WX1'D&7-GI+ X&K&PLSJ@
M'D&E76^ )F#7^ G8Y15!C5/IFTXL ^04#9.L^];U,"5R 1)NHZ_A5;L6@2.0
MX="&N9]'!>; V:QGV0!P98"M'!$ER$=$!PF?9+> 6UO_' P-[Q%T)5!IT\E<
MP,OP@)>YE><+6&6&NH",122L5J-1!>\ O.M:E8!L%#VV7RQYMSUZ8.7E$M8"
MLRU:(&=<C4$1T)CY-ML@@JC9CJ \?>I:X>3_[$W+8SEXQLVW0"-S>MN+6C^M
M*V38/5N-J)HK4^-8*W6EZ:$PP5IM69/U '+K"8M!S,DK</\(</"@S9<T";3B
MS (P84HD#B\XHB@.0@/(Q/6 UF1=7DZ-+ @8M440&76M<5?PA^IR1(IRNQ>\
M)'$!'K!X.DW"P9L].18"A53%#]\SQ G&7/%0WW@1$JD\(RL0?@S+/EG",H1$
M^PQ%6PN*L26^1IU0&S4#O0<*6-1HWRB8#\=$,0XC\E\@]4Q%4X%N!3D/S(-F
MJGL$$QA0H?@J6+*@"%="ZPASPNO$X[*0ELC^^/";PZD7OMOB%9 ,8 U6[8B$
M)BC0KL"3N>P(1%'-2 ?O2*&^M<WC/VP-[(FB[#UNVN42]A.FN+!@21>_$PTN
M_ 1SG*!6H+'TC7&DSH 906"R1B9YC=8BD$IE\:Y7@2QC<(?Y01"K#>DM A90
M\A >6%G0*7*_7^.&@%_ERM;,X($:K ? %;&LJ,.,88%2#*(8K*:.H2 4ET0E
MAHV!->Q N5V"]A%B9H4&2W-3L@YK,]>I51/'"2@ B"VH:)X48&#:R*2^:CM3
MFC6M@WB A9P6CH9G 0^$13951$ Q\&2RPF)JVRP>T[:3:17P2D8/@AFO1#,I
M!1MN\:*&(E5% @'#LD&+"I0B&4&DRJQ7=& 5,'<0R=E1^9R:?[!;*].OG%<H
M;*71#@BSDYCT3\$BV:R+X)[*Q@H1 &#@5Z3PPA@D/THT^!#6#2(4M10:B?.Y
MT_R03%)TZD;#N)=V%2B/V-@!-=6J];L0U_CK^;L@YA@ZD,<6L$R"!29I;/<8
MD/,8-.C<=,$H?LPFJ ZD QH*" 0,* 5$"HQ>Q=TO3DY/R, X/CQ\PL+L0C>-
MV]8;(%4%=SS5D6/C4*TC(*CSJCV$02,4'T $ XV^!1,,?/_B!  #,9\/2#2*
M5 2#$M=T+I?D#\&'IB#!1M=@%^%6'Q\^3<:G*T=/'^$^M^ +D/0CCD = U<1
M.K BR4;G8,-,SRT#RT0N]E9FEJUU1]:%6%-,.WU+!@R@&=#;B:9,I\3I+$EA
MT"F58O,D109J;T$=FKWQ,?P)\K%$,7KT0\8K0"0ND?*)B"=[J:.--2L2YF P
MMH3(>=^AHYR2*[AO:KT&H0-$\,G2!4BD0_,?U:IM8 1 D05BP*%(K B;R;RI
M"&)3'\'/@,>Y]<T:-5)&]($-HP1BL<86!G&,"GY%L!GT?*ZC\SB4#",>SYA_
M0U(X>$(3\19QV:B-#$H8#"1I) M$YYWV2S?JY0N0GOQVA4_J:MQ;]J(A#,Y$
M ?""R0$0H23M!G0$:R=2J;>)X%I9VC)@%_ WY@A.KF0SH2?:'GFBQWF(65K0
MATA_B:CS$G"2H2A:9JBKDW%Y=\' (-D</.^-]@(P\0R9CT6?D2[V="=S3EET
MPA1E+L1'=61EX4XP#A#)( K^1&I"9DXMF+@K*[9EW(XMPQN)]/+8B?6R1NME
M0MRZ.[EQT>X R[9=("Q>]<%\?8L[Q+[NI #ZD>!+6:S($'5+LRY6YB:9? [X
ML0.%FPA_%YB0;'_KC8!,5@3EFT@,Q<$!OQ,B%H8X9AWBZ6Q .ZEALF5<5QID
M0(6&4K_>P[TH)D ;H'!B20%4$20%O,DK238-!XD3>SY.H(IBR) 6I3@+K):%
M>A0-M"0<HT!CV7-8OL 5>I2>V>.L./+(VI*UH$\*IA*21[33B,Y21$GH#VBW
M(PY6%2@IG!@DF6XW;$P2)WNS("!\"DZ$CYD0#MY''KJ(T96,3I >"9HMCMN@
M.6$Y%(;.[/Z0#" 9_8P\- -L0%$V'S,@HQH'GWA] 5H!D-V2_XBB4VR -%H5
MF8Z=$@SE(6J],3[#Y$5.[*QN'+K[;:]JIG+;=["=[+/P<OQ8%$\!]*:H!CS
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M?RT @7 L<>V7>$Q%^W5?8S&H%)$/1AU;:R5^(Y@D"=\S89NX"<!N(&DZJA(
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M03A"8]'H0SKS0G> ZYR6HP,1L_,II6>=WCVN=@*XU&.(&A+&YBVA60SU$I-
MPZU ^YY% 0,(JN\0R, 2V4HK%^D>U.JNM<IW@."]L7,J> -,DSRC]FQ!TCCR
MF\98=)2@<VW)(/@N?@P!)?/#U&TVE53D8Z&HHN/?#H"O&CGZ<\]]G1FTR:@O
M&QL5.&O<)6SM(R=AR=7:HV?D[ #':9 )$ +IJT.1:,9TI/.-1ND)%"AW (RA
M78E$:UDX@_5J7'P=W RJ+\$'"8]FO&G:C$H2:+/,CF!@; MU#01GI(W\'>!]
M:B/.8)!OK??M3E3H9'RG;B>1_R1B/#]#@\B?%!?]#)P,;*+$J/4J+%1E"!,!
MTP.B)EXYI6T<LN#]?DV;QHE28RF:6&.X12<7.R-[>41MD<CG#0;;^9OWB9<Z
MXT9?J8P,P1$JWIR,-#?B(!%U^.+&DNCFQEY?]^AQ>:^N_M/(&=%%,!57B0RC
MMB'*0W=C%HBJ(,_@O]3V7="&-0^CF01/>'GB8)]A"G>)2I<8418/0C(_>K06
M8=2H3AF,=2E&J,' H57OS2/\NP/7:%$A;F\KB-V;(,B-SIC0#O$R;WY.XC:_
MHH/34GX1MG!R2PN&9%QRY+!W3(R\8=5@; )-9)!V'[+8#\<HY'%0P[9X;TH;
M5"6Q[A^F70!:^"2Y6*4YH4@<SHW;;"%6!@I,J@?0V(6M"?J'=L<_%@F#&N<.
M&T$$1.4=(=*Z&\Z!)/W!4V.$G&HZ5<"]WV/55!)*\6%*X5(.80X[3.SF=S^K
MQB7#)78)L>45MR$OSJ716A;@99#(9A&V55GG?2Y)MS$XKV]TV9-M8(D>)?8<
MTBQ)X>IM1[>5#QQS>K>D3"\92RG[</"3?4SII6Z3YD_AVCRMD<%:9&I9!4N?
MAH^$[.F0]&1"30FR8T!)A4/2W@NWW4^<MD[:<VC;VZ$)6CU.(^(PIN01_!-H
M8-5>@?>VV[>AF'YARX:GQ1LULY0J\.&0"_F*!S6X0@QJM =8,?EC'*>J494:
M;7\5 0K)Y\L>[0<YS@%3GDJ4]*-"%!07V!.?U= K-+3>ZT[J[XK+K1MK5\&S
M3'F:=#TXE2;+)\RE5C/0JWC&IG@)VV>W6(M^WRGN6,BK5@.2:K3(;Q_A=ABY
MI RKG'>&N 2F:KD/PTE>.OZ0B28[D?81C8@YAB0^7,/+@E@.K7\2:NFXWV=W
M ?FPS#@A5'%Q$7#HIX0>E69*V.G8P;K:"T@7L4#]B+GSHK>N?6./L2K/1.J0
MV1R\P& 5(/+3XS,RPO"K VDZ88_)\N;#:6PHW3?H8+&W%ML;8'N]ED(&*(VM
MZ E5RL=(DKU(ECP;2JHG$RH>88Z)QY_HZA-&_^U<3<6#@3'H!#SO3?S R*#K
M(+71P#QW'1OJJZ3%Q^WS!<')P"5L0Y#DXN!N2.[FE4&])FC6+0=JYFIC6[^!
M>!;0Z/8QRW$O9?&%.Y;#]88#M?P)95=)G3"P&Q8@M&8CYTZS+D-[^W\$HLOT
M\)A2&='+7]!4D+IUL IE)3LMWMB-I0YC)PN@8BQ0%:F'389=QI:AT,U*(!]]
M38[D4(Z:N@!%PV2?\HUM;V&;-CK/KPRR_<3U;-YARL,XZ7,5FWP['*7OR-;9
M8>&1?K\<U!8VH[7O'HI-+,E9Z[\#YINC;(NJQQ,7]]_5&+H:&&2W;++<C<77
MP]KK@5 =7Y 4GG.'T E:E93#\(R%H9%.L=E-;;EV_(>0%DE&Q_A@\*F$-]?A
MNT*4& "'(849ZW_#N9G[4<7XEV<^AUVX7_T\ K@"]L:&X7L97,Q(4O9)0T??
M>8D;PNSM%WL+>\JMW+=B-QB@CL?&!Z)1FJC(:7Z2B'+DY#8,8#?RH96?-*"B
M(0-B$=$@(Z/,_:!J'/@<+,4%6QRG_BS@3\5[594U& =TLCB%+3D[_8HRN^/W
MOX*%\2FF _,PAE!3%O9?I4R:HH#/MC0SPV=P%:"CW+4FTJ;_?D-YB=\>'CV\
M>D2YC4$Y.7]:H)&TS9:E9# ,0DGI-Q-N #5J&$R80OGK(A1$&5:G?8:),U(6
ME(0I0A+*Y\>];Y=^&9"YX6__=?0]Z-FCPV\?SA[MZ%9IFR_\E[87Y]JG-^%3
MDO?\V $"FGSQ0.IZAI\[\.=ODV9BB9\]_!1"/ @;,MV^ZU420I,A[W+B!R$B
M# Y-DB(K#!?XEL>^'!KC03Y+D7V.-"EU"E6DB3\]^2J?;/#]L&]#91HJ"[5N
M64T\QFS:C%UF"OMT H8F(?#*N8AY.&2\4K7/5D_\0.MP>&>25OG#^$F3I F=
M2!@6 \5/N^[4D6$0;F%6%-6E;\%00IR^)HG5>Q,J+I0,UQ=5%TY"**GPQ5<@
M\GMJD#&L/.QY.Q+V?<RVN;PI&7?*KP9+( P?$D:/2+V7,2B6?L(.M<4"+2VI
MUO:'5.CS.VT"@J,=R:D+6VV@>L"&@A@DB0?0I2(G -''OO\3W[DC?OUA0F=Q
MJ/"G9^J""8&!Z]S:U^3F$Y6E]8N7\3,*MY$I+XB<RU )S#T>!BW%V\QL'VD>
M<(=/$(Z!R*'8H,2";#O!#/9HP9'4 B9-UQ/6"CLZ$5TCQ7(ALAASA(/#@+'"
M+1V.&E<F?L-0*7A+ W'VPE?'.KW@K_#,V_!YM<%'EJB-O..$3@^T1K&^>5]C
M$BM4?'$'&GXN_WRP&L4.9\=]QVK\GDI-]B7:+K:BA+U\:%$^=T$/X'@&T\VQ
MDD6RD2-X_:+T3$XBE*.-E156""8IWN9%4B]O4B \ &9M4(5E^63\F&7ZK;(:
M/_["1\]]_155:U*2<[;-\W/47"N8-&FQ+&9_.8'A"\_&ZU_'EI^4^H2/):5%
M05SXS$9"**PV($M!V"5)S?"5+GK<%R+M:60A^58JTO#?'9MD'P9?!9LT^]X.
MJVT.SWL2\"J'OMO)717B4<(%*/M-.!VDJ!5[IGCRRD>0%?C5P?L)]IVG^ M0
MI:3,OY[,#Q>]K;^5[K4X%2R][*/[N#\#&FOTXQ$'O[$A$0JLIKFF6[7TE1GY
MP-K=:H<^]Q9I)!P2D-Y.6"#>TQ>W=F[X!MKAU;CY28E;@OBL$Y4/_X0E2,N2
M;!.XZ_T \^R@R)EX[+!%V2+3A.:!8'<:F %VP(&GY%)J]A+7EQ&G]S8@'C""
MA;*'^BN3'TNNDD?]Z++28KI]QSH>2:&/#Y$TON=&RK)E6KD14Y.^(MNXX7&#
M$://>_540S;FMSL]]AK*_S454G11<J=@D D<Y#@M&WRI)JFNRL4"!W^#5IF(
MM;[QM8FH0-@0)W?;R*=$1@LODF^7<?T"HYJLNS:T6MU;7!!D7++7:2U.7G!#
MZWEVT#U_=F <_*>$_P,-PG_I@\YGJE//GP$%+?0IV$O2%.;G!T</DJM8Q?'S
M@Y.CGTZ.'QS F_'QY\_6P"+G"C.R^!&X.;QZ./WANP=%BR3G?W1VC4/B][Z
M7.E/(!0@)'P [L\MZ&WY@1,0=R!XS_\74$L#!!0    ( "LU9E'O$SL)#@L
M (PA   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;,5::8_;N!G^*\1T
M4,P REB')<NY@,FD>Q3=39!)NQ^*HJ EVF8CBUZ2FF-_?9^7E&3Y&B>S+38?
MQCKX'GS>F\KK>Z6_F*40ECVLJMJ\.5M:NWXY&IEB*5;<7*FUJ/%FKO2*6]SJ
MQ<BLM>"E(UI5HS@,L]&*R_KL[6OW[*-^^UHUMI*U^*B9:58KKA_?B4K=OSF+
MSKH'G^1B:>G!Z.WK-5^(6V'_OOZH<3?JN91R)6HC5<VTF+\YNXY>OAO3>K?@
M'U+<F\$UHYW,E/I"-S^6;\Y"4DA4HK#$@>/G3MR(JB)&4./7EN=9+Y((A]<=
M]^_<WK&7&3?B1E6_R-(NWYSE9ZP4<]Y4]I.Z_T&T^TF)7Z$JX_ZR>[\VGIZQ
MHC%6K5IB:+"2M?_E#RT. X(\/$(0MP2QT]L+<EJ^YY:_?:W5/=.T&MSHPFW5
M44,Y69-1;JW&6PDZ^_96+ "Q99_$6FDKZ\7KD05;>CDJ6A;O/(OX"(LI^TG5
M=FG87^I2E-OT(ZC3ZQ1W.KV+GV1X*]97+ D#%H=Q^ 2_I-]CXO@E7[M']L_K
MF;$:'O&O)]B/>_9CQW[\>R#\1A;L\U*P&[5:\_J1+;EA=JF%8(A%S=U[XRE,
MP#XN.;RS>&2W0M_)0N#1)V&YK$9_^WS#>%VR'P2O[)+=<"W8.U&+N20Z,+U'
M,- OAR@-R=R*T0>[%+IC?S74X\]_RN-H\LKTLAD%/235>++F1,WFLN9U(7G%
M9.TS!D(O<%K8 YR*I13SP:Y*44@7[BO^!5I<$ TMCL-7-Q_>_^0NHU>73-SQ
MJH$\X[AV^K1L!_RT,(A.PRC\<;-H*NZ"6!KHYZ25M&P)@UO%>%6I@G8!,M5H
M0,GX2N']4(C;"XBY,<*8@2D8I+HMUX5H<8/*.ZH.UC U/XA)+XB23>E4+_^#
M1$#7_<9D7:B5"-C]4A9+ANT@$<&G2K+F[BIV\?WU]4>V$MPT6@"\AZ)JW+Y)
MO(3TPI(RV"M\[S=G,KHGV]8+.:N$VVR[=>7\0UJQ@@])4-6/ 1AQRVHAW3LM
M*@(1@!)_I2$*Z9X5@-0<W?6L 98 E-6*.,PI:Q]<V"#)Z.J1U.]IMI"_19P0
MH1:%@BM6TFW(D.!3R) /',.:S:B ,<AA\T:[C8*_%0^6'(OK#: $30LR^,RU
M6NTS<]YGA49&IZ='I6X%(&L,N>11#6%[1#9;:]S+-6*PW1AM_8"3^O5,U$NZ
M,P?1YC, :!\)F8)>@=F:&SN(\R'#>S@ BI;6>Y+@.+SFU>-OXI0!?:X A])<
ML9]5_<*9:".OW=.6NJR4IJB4H=QG&@0$=@;C&%7)DA-43T206:JF*N%V%A9V
M5!+Z$0U8H4I(VU!>4SJ *^,1&$A<6!4<4JHS*HF"@_"J:"JG 66,HD P;("B
MC7G[SA4RS[W3RKA$-?1<LMX!2:>R1QM^6S!897EE7K(?D6!E5;FPV"L?["*Z
M["K(5NG8U @PP#8[E[H9BOCLZM2P(0#C-4)BAH#I:CK8WXFZ@2P7'8@AH>$=
M;;\#SNR<)4DPGL:XB,;!9!+211ZDZ<2]PA^WX_@5KK(LR--X6R?="8B#.)JR
M23!-4XCNJ2ZB,(BFX\O^P<_H?V5])XQU]&U$=6^[WRB.6)[TMW$X9I\)TXV\
M) TF4<3B.)C$*:F<37,61=E&8C8)PC1CUT?#^ *>;"Y9%&30/ K&48R_81ZR
MBR1,+L$HSRY9$F1QO <M"+X.VBQWB"9!'J9T 9UB!VVZ#>TX2,>3H] F20YH
MLPR@;"$;AI-O1G:< :;)!MHLV8,V"\(H9S$@R3)2.<HC%L'RO4BHFT?AUT [
M3@C:%';!=9RPBSB-"=K)E*"=8L\_(XC_%WX\S8/8.>QX'"31&!=I&DPGY-GY
MMA]'6)J%QQQY$B1I2'Z%%HBET09O*!/'R;?BG8SAI.&TOT_!? ?O*$R#%#K"
M8:,D8VD6)-F8Q0C*7F8TG09D@9.(CX,(_@4$)A&#&>%F%],$>>8B38 X_#"$
MO9_GS=,4B8)P'<.@T!, 1P"8+MR? <#Y%'%T#. \F,9C IC2SC!5).0NV;<"
M/$YS@+QQ: JT/8#'B.Z<W#:,<Y9"=#IFSAT[F:1RGD]. TPA'0/@; (.WJ6S
M/"6 8\ < 9I)PO[]+?]<'=C1N"TZ^S6C0Q-*4=O#^'JMU8-$_R^J1W8>7Z5L
MYBN.J^]X,.D?@*EVY0;%ZL6:/_KZ18T6R?*#S\H'HC@6B,24'":@WGTMW*A?
M/?K!XSS?E9Y?3;]2>DU9X'G"=TL[E= #/>E6@=ZS[I,=Z39$I,4WJ?OR4+'>
M3WO#9L'1N\#<7'TXT52CJ 3Q>(K?&!&64QQ&09)3M4'((>U<GYP[R!-34&3A
M!/EZ@NP7N31X7?S:8%XDPA=^ZJ!&RXJ%]LP*98@:F1U]0X2R'$TSE!$DG^\Q
MM5XR"AT:L$I)T8Q.K^V5T?=A,*2AY8(*;CR!_!CQN[FZM8K,Z<3PJE.^0%PL
MJ(,:-!:0V->T)'HBD,_;FG[>%J#S+BV>_X[P/=32;T#S9V*XA,Y+?B?:>=FW
MJ]T,M:CE$Q.AP1KPHX;9-?:.;"AB)>Q2E6Z^1/_;U&[+?FQUS3:&"0PL*ZXE
M$@7E%\U+@=LOZ.6[-.\F+3JN,2-G9O+%I5S3"H7,Q"EBJ8%OIQ3TX!A)1;&L
M5:46R +(17?4U6-$M>ZXT\4 #>;.WOT8XO3&5J[8>QJG,<F]J. :Y:&-P_SM
MP$S&O/,[EYJ1(ZV<)V):FS<5(PY>(-%8X:Q/H4N3M]0N;=XO1<THR5HZF"BE
M.X5P0[7KX;G6;E[R&J_X8S>ND'T@FD,QGVY.S_#2=./UQLS[,S9O2DD+7"@#
M_5+4=!BQE:R,Q8]/EYO9FK($N&Z\6SRLB=:XF0=O!(?E^^.E:TP7JEDL#RCJ
M;"YGS>8H85?-MBRQA:A;V8%WOY,@E$IXCREA[L+"\[8/+9PKWVOI=G!DTI(U
M\IN;YN!>95/0F9H_*&IK8CO4MM8^>/S5MS'M L.KHR<DG10WAK8R &!92I^$
MJ-SM[G0;BM84S#ZNX6$@8/,*'/WI5'_:Y/2 5_M!7*Z>@.! *D'9NW9S+LBJ
MQV!K2I^)2@H*ANT3J-/F>OJ(PIW'40)7NC\"/'!N<1#3$V<9=)QR[#R#2O,S
MCC1^/&&BX;&13\&^KM5'CT*P9(W$[:=^4.!"^NS4N/Z6K $&;?P=@F&'[R:P
M-R>W.[$&?K-';SUC%*CLP2Q))]<^58GG[>T47G+WI.TK(9N)@C=&[/E? %M6
M\HO8XM/N/2!IM!L^G_OT"0@&:4^YPU#X%+@5[J39G1518:Q<=:GWXQ-Z( &8
MMA;X4R-GP_TJ,A=>PCX3E]+OI*'"1<W.^T9WL?7,UC 8AO83K=5VUKP6MN;#
MIJRM25_%RK?'?V!A\O*.? :A/O#9L/HLN* /)4\VFSMQC)L7EC_TA+L%XA=T
M,F*3\@@K;,ACVJ6A[@O!, T#*)?H_]J@ F#0]*:G&K4SM>5HSMO6WUORT!:V
M^@GNCR^I3KGH/(CW_\>V RL>^MZU,>4SS4A!032G9X8C9NP(AV;\4*NY[C_C
MJ,+5FHUQ(B_8@W](\*9S]H'5'_NBTJ)P]R75=9'-BLZB04T]=FU\']V.EZX+
M=0D47;I?*+IO/51 M5C2A_@[T7]KH*J[TTK^$;8>?.KL+'SHD^YH\(4<#=?"
M_3\ ZC%1(OW'\OYI_U\-KOT7]LUR__\4?L*,A]Z/56(.TO!JDIXQ[;_]^QNK
MUNY[^TQ9='?N<BDPU&A:@/=SI6QW0P+Z_X#Q]K]02P,$%     @ *S5F428D
MD'JB P  Y <  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULI57;;MM&
M$/V5 5L4"6"0$N4DOD@"9">%\A# B.KVH>C#BAR*"^^%WHMI_7UGEI(L([5:
MH"\2=W?F[#ESVVEOW8-O$0,\:V7\+&M#Z*Z*PE<M:N%SVZ&AD\8Z+0(MW:;P
MG4-1)R>MBG(T^EAH(4TVGZ:].S>?VAB4-'CGP$>MA=O>H++]+!MG^XWO<M,&
MWBCFTTYL<(7AOKMSM"H.*+74:+RT!APVLVPQOKHY9_MD\+O$WA]] RM96_O
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MMH%>A?1)6:'HL0&=-]:&_8(O.#SL\[\!4$L#!!0    ( "LU9E']&QJ\-1P
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MD0V>^@V>\@9/#R*\(@ENDU]T5=;89XR(QT%\6NODHMQ4JM@E:]4DR[*K21T
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MAAH9F]?#;,WDNF%"3C!)X4Y4>J;@596S?)=^B JU6I&-5M>DE^$#FY^![SI
M7.+V\/-;*WW+S_^^E;=<9850M60*_KX:*RT1&/_TR A:&8&5$9S2&>,EKPL&
M8@);>0Y<*<6T EKE\);3,2^XYBC[CE&C1 X(S7N6U5+R:@K75'%U[ #Z9;_F
M%:TR3@N@C;1RPYUJF!AE%M9X$P882AMI8R/-+.H9@TS@X54*:7"D1,%SJG$R
MI@6R9F AI@P_/!S-RC&3[0E9XVY9ME[US*J7PI))A@K!1!08^^H<WE0(X:+
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M9V<WR(2M8,XTPEP9:V#!-FPI$$X_N(<YFX:6>)QT6/28UQUF<@!S K=*VLK
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MY8"P9R7[H/C.G$\67.%IQ]QN\7C)A ;@]S7'V:P?] #M@77^+U!+ P04
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;(U5VV[C. S]%<([6+1
M$-^2-,TF 9JVB\[#%,6DTWD8[(-BT[$PLN25Y*;S]T-)B3?=7M 'ZV;R\) B
MJ?E.Z9^F1K3PU AI%E%M;3N+8U/4V# S5"U*^E,IW3!+6[V-3:N1E5ZI$7&6
M)).X85Q&R[D_N]/+N>JLX!+O-)BN:9C^M4*A=HLHC0X'7_FVMNX@7LY;ML4U
MVF_MG:9=W*.4O$%IN)*@L5I$%^EL-7+R7N"!X\X<K<%YLE'JI]M\+A=1X@BA
MP,(Z!$;3(UZB$ Z(:/R[QXQZDT[Q>'U _]O[3KYLF,%+);[STM:+:!I!B17K
MA/VJ=C>X]V?L\ HEC!]A%V3S)(*B,U8U>V5BT' 99O:TC\.1PO0MA6ROD'G>
MP9!G><4L6\ZUVH%VTH3F%MY5KTWDN'27LK::_G+2L\MKIB676P-WJ&%=,XUP
M<L\V LWI/+9DP(G%Q1YL%<"R-\#.X8N2MC9P+4LLG^O'1*QGEQW8K;)W =?8
M#B%/!I E6?(.7MY[FWN\_./>_KC8&*LI.?YY!W_4XX\\_NC#^*\%\5T,5X4S
MT[("%Q&5F4']B-'ROD:HE* 2(GC@!AA51*%DP05G/KU5Y;*3%\!D"247G<42
M\,"G)3[&^TMU#);0"+I%7Q+N)U>EF<%]K1&?W2'<$KOG)Y\EY:$09-,, )\*
M;.T1/&M4)ZWQ%T9#>GZTNNT:U,P2 4?B%6X%$T4GO#\SN*6.Q&6A&H1/D XR
M G#S.'/SA/9G-(\&T^D94?)BC.)3,.>W5= R;7G!6T*CB!DL.LTM1P-__C'-
MTNRO%_-)?NIMG@2CIR"4H3A;J_FFLZXD'*RDF%,T--V%OPEID2))#H\AA9,T
M/>WQCOC_'^3R80TWR(2M@VO9*+B6)\&U9+)W;017*!65_8>C]MVW(0H!>Z18
M;S'(T$V%Y$@'>9JX,<G\./5C M=51<G@DLBGCLN*HY"-(8<)?6^"'_+-P8\]
MI!_3D5_G</V"]0Q6GM G2(;GN7-_&"YT>.:"D0_/)G"U1WU%)@LR8WBM:..C
M=D@9M_5-WT#A,C-TQOZT?U<N0CO]3SP\2E^8WG)I0&!%J@E9C$"'1A\V5K6^
MN6Z4I5;MES6]C:B= /VOE+*'C3/0O[;+WU!+ P04    "  K-6912,@92I\)
M  !;'   &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6S%66MOW+@5_2N$
M:RQL0/'H+4W6,> D^TC1W01)NONA* K.B#-BHY%F2<KVY-?W7%+2O,>.VV+]
MP4-)Y+V7YY[[H'1]WZ@ONA3"L(=%5>M79Z4QRY>CD9Z68L'U5;,4-9[,&K7@
M!I=J/M)+)7AA%RVJ4>C[Z6C!97UV<VWO?5 WUTUK*EF+#XKI=K'@:O5:5,W]
MJ[/@K+_Q4<Y+0S=&-]=+/A>?A/G[\H/"U6B04LB%J+5L:J;$[-79;?#R=4+S
M[83?I+C7&V-&.YDTS1>Z>%>\.O/)(%&)J2$)'#]WXHVH*A($,_[H9)X-*FGA
MYKB7_J/=._8RX5J\::K?96'*5V?Y&2O$C+>5^=C<_RRZ_5@#ITVE[7]V[^8F
MT#AMM6D6W6)<+V3M?OE#A\/&@MP_LB#L%H36;J?(6OF6&WYSK9I[IF@VI-'
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MV",//(IX[ 7@%Q#( @8W@F87XPAYYB*)@#AXZ,/?SV/S.$&B(%QC.!1V N
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MH+NSPU+@4*-H I[/FL;T%Z1@^)YX\Q]02P,$%     @ *S5F49W'7%B&!P
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MV#..8X:#G9J:.%9 #RR!S@2;A KU'2E (&G!W8\0>X%C"*P_F@F>;C^2P*
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MBJ?%)5#"B DM ,]GG*OUC9Y@\TN-\_\!4$L#!!0    ( "LU9E'N]ZB:K0(
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M(ZQ4SDR7T5L:_3U^^=B//8"N?MT"&$HCES ?Q(ARZ?)!(>_Q5]1H/GVKZ%-
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M/DSAA)=Y$9WM9IP7;3&D^Q]P.P[V]3S2^(TC#,LBTF6$]P%![P)>J7 "MOJ
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M))H,+P-&%F?1F$G?:'N5]1@YLAYVH K_A[QOE+Y*O31U;8FE&D0CI7ZCJ.O
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M[+"HH!ACT*80O""<:.C+2N<OA9W]AB#087!-^PU[]R/=;TC.L=^0ZJ?'=D"
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MNT]OFG)_W"']5#9-N3N^W.ALK:L.T/[]N2R;+V^Z3=>77?;W_P=02P,$%
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M0CWJ]70_Q[N_5W/3W:^Z^[/[W:=F.MHYH>V<T%H><\J[TN12S9L1'Y&W-V;
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M"U54#<SORSS7=S?52?OV/RO._@=02P,$%     @ *S5F474B/=G* @  ?@@
M !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULI59M;]HP$/XK5M0/K;0U
M;P36"I *85JE,E5%W3Y,^^"&@UAUXLPVT/[[G9V0!0BTV[XD?GF>NWO.%U_Z
M&R&?50J@R4O&<S5P4JV+:]=520H959>B@!QW%D)F5.-4+EU52*!S2\JX&WA>
MU\THRYUAWZ[=RV%?K#1G.=Q+HE991N7K"+C8#!S?V2X\L&6JS8([[!=T"3/0
MC\6]Q)E;6YFS#'+%1$XD+ ;.C7\]Z1J\!7QCL%&-,3%*GH1X-I/;^<#Q3$#
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M$AJ;@QVF^(, T@!P?R&$WDZ,@_J78_@;4$L#!!0    ( "LU9E$J\_9/U 8
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M !>%J\L5IH7M5]V!D!'R"V"DF'2Y8F[5%0 WX=WE"F"B<'6Y8OJFZ$#(F/;
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MV\4.-&28&;!V@K/VO:SSE=PVG6EA4U;-.EO+[Q;9\FN[5$X=1PJDFWJI?*1
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M?*Q_0Q2=8-K2 0 BMA/Q3_VV5[_/Z '0#+-!>P#HP[R_'O":NN2X ;:0:HF
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M)V36)+KC6\I2M,@HRQ6BO'Z\2/\VQ6#6CT:?'LT:5H#^O!%9ADPQ[ZE,_QJ
M$M90P@)*.%P+B<UK4N1U6^;U!-W#FG'.^-I6@MX VH)D(CU!'+0KI^5$XV(B
MRR0/\_$D-N%Z<,"+:GC1<*1 J;/G>-@P#;@\KFV.?]9E,,%_F[/E%-&!LW$T
M#=S.QC6P^"W OG"UDY0G@)92I+M$HZ]&<,#Q26U_\G^7W;2&,CURV;F2,.TD
MX47%E4M[VBU+',;N3&&_H5!_T(&R,&^ U<F2D(@'D-8)-^7Y';11"ZI#).P!
M>L#U^+]:X-5,K7B';2<<4CCL61J8-'Z003\NDN\[IIC=!SBQD6[HP@ZTKI#?
M@ZNA<CS,Y1=I>M;JFHPG.RDA19MV[ =6#FX8&P]3]L(:-XOS":ATAB+LAL*/
MX[@=C*Y8,!U'?2NC86P<#<);FAJ2!3CW,H@ZTWX,PTD;G$,JPK@'6\/\>)CZ
M?Q.:9F_.3P6X2_6A'Y VS3C$@BD.QSV0FYZ XZ-U0-QT CSY=S4TZ7H3XFDG
M30ZQP 2GQ^FF.^#A]O!:#76)/YJ,.VSJD")1#Q&1AOG),/.7-93T):3:CCJ8
MW!RR@A9$AU@P(9.H!V-#^F28] M26DK(V2ZW!QR6,.#)D^E1"N0#.!%W:1NW
MT3J8O0=I0^MDF-:/LADC75Z/HTF['EQ2/NYI *1I "1X/=8_LA&H[!WB:*\K
MATC/1H T;8/\]$Z_$VDG[&Z_>+'EK9 [I'S<![YI*N2UIO)#M=SM'IU:[HKT
MU7+37<B;#A;%&?D2N($ZV/%)TP/(\7H :7H &>X!%<2J&&S52G/:MB=W82I!
MHJ:BL^K@P'H*VM$%.O$>E'GI0=,FR'";6 BY%9)J0![ZU6(>.ILW!!_X1XMV
MT%!R,$S)1XMV-<_A@0;'[67H$"*XW?J\@RND'.2ZN%E3!N&.Z_)NI7Y;W]Y=
M%'=6K?>7^&Q1WL$U9LHKP6LJS1E#H0Q6QJ1_&IL"D.4M6SG08EM<5-T+K45>
M/)I=60K2"ICO*R'T\\!.4-]USO\!4$L#!!0    ( "LU9E'(Z\+*P@(  -@&
M   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;,55WV_:,!#^5TY1I;52
MVX3PJZT J4"G(K45*NKV,.W!) ?QZMB9[93RW^_L0,8Z0'O;"['/]WWWW=EW
M]%9*OYH,T<)[+J3I!YFUQ4T8FB3#G)E+5:"DDX72.;.TU<O0%!I9ZD&Y".,H
MZH0YXS(8]+QMJ@<]55K!)4XUF#+/F5X/4:A5/V@$6\,S7V;6&<)!KV!+G*%]
M*:::=F'-DO(<I>%*@L9%/[AMW(RZSM\[?.&X,CMK<)G,E7IUFTG:#R(G" 4F
MUC$P^KSA"(5P1"3CYX8SJ$,ZX.YZR_[9YTZYS)G!D1)?>6JS?G 50(H+5@K[
MK%;WN,FG[?@2)8S_A57EVXT#2$IC5;X!DX*<R^K+WC=UV $0SWY O '$'P&M
M X#F!M#TB5;*?%IC9MF@I]4*M/,F-K?PM?%HRH9+=XLSJ^F4$\X.[I$)F\&(
M:821,M; E*W97"!<P!/3FKDJP^D8+>/"G)'U93:&TY,S. $NX9$+0;=A>J$E
M,8XR3#:!AU7@^$#@:WA4TF8&[F2*Z9_XD)*H,XFWF0SCHX0S+"ZA&9U#',71
M'CVC?X8WKH_(:=:%;7J^Y@&^!\[F7'"[!FHU& G&<P-,IMOE;?J#;I?ZP<+=
M._6D0?CV0!PPL9B;[T<4M&H%+:^@=4#!1":EUIC"O+0@E:6F*Y2V9#B=#)^>
MSR"IE(BMTG.0:/?=9!6GX^.XL? V:%]%5..W/>K:M;KV476;AS>1IM1,)@A3
MK=(RL>"*<"3[3LW?^4_U[]8*ND<S'&-"<Y5XJ4\*S4G%&IDVGR#SJ2>NY1+?
M<D75<OM*W_VK]!>MUE5=^NIE[W%J-QH?[B?<&1(YZJ6?G884E-)6759;Z_%\
MZZ?2!_N0QG8U97_35#/_D>DEE_2B<$&4T667GH"NYFBUL:KPHVBN+ TVOZ1B
MI*B= YTOE++;C0M0_YD-?@%02P,$%     @ *S5F42"42/7 #0  +F\  !D
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M>&H^&NQ+457%JOGR,9_=Y>6N0?W[^Z+^8V^_V7W:V/$C\J[^#U!+ P04
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MJ]-PW$UY'#:A%9GYBDQP19^C.$9"F4-1?"S<>(-6HD9 &[I<4^6Z]M;, S]
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MG%9/5CLS78>9")KI6_*>"GGGZF$D&S7,E(%\OZ94["?*0=GZ3?X 4$L#!!0
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M0O-%Y-OZ1OI]+D2^J3^N>;S@1060OR_S7#Q]J1K8ORUR_A]02P,$%     @
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MH.P"_+Z1TAP'5J!NOJ?_ 5!+ P04    "  K-691 KDRD0("  !7!   &0
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M?6[0IT#X)792 D%VLC$&(!K9&0D <=HCR]2$>NH/]5_6B<BZM/L/[:/6U*@
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M8K_%9M4KF9U4'[.NQD /?XP[RA8^Z+WPJR^RN.H(L-6I_K<T7E*A@Y,F(5P
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MP4$\N]Q0 MRT 8RO.%?[&WT:+S\(C?X#4$L#!!0    ( "LU9E'.9=-_  ,
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M7D*U*:";CI%+7U)FTM@"Y9L+^].!RBVP\W,IS;;CJE3U&]/_ U!+ P04
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M)4*;*^G!/7TDK1%2W&%,RCT%LWL23!@WNJ?H[UV!-#7&I"Q4,%LHP5RHK70
MLL\X?+*J1UFH8+;0R^/OMW%,B3$I"Q7,%J(P;R3ND$K*0B6SA= T 30Z5%AW
M@&A78G< 8U(6*IDME&!"^.#6C+,&^TP.8U(6*KD'/@/+"8/I9DE)J&26$#7_
M JP8DY)0R2RAH?F7H5"2R_?LZ_?$.D.2N9>4@4IF QW.$R5/$<:D#%0R&V@(
M\TY5%J+9:)G<F)2!RE>?=4.8Z9LEE('*5U[%&7QZ9I1\9KU\QOM7Q6JUTD;5
M-U"[A_)*-M6M$_%KM_1=E''5:M4US064?3&0?-?[-\_V;\V]_P]02P,$%
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MY2_+KYUXOV@O."?X=^?Q+U!+ P04    "  K-691=-+&8MX!  !:(P  $P
M %M#;VYT96YT7U1Y<&5S72YX;6S-VEU/PC 4!N"_0G9K6.D7?@2X46_5"_]
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "LU9E$.4_XG.P4  &05   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  K-691RKQ_1.D&   C(   &               @(%]#0  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ *S5F44$^,O04!   ZPX
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M965T-RYX;6Q02P$"% ,4    "  K-691&>U5/2 %  !,%   &
M    @('$.P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M*S5F4= <(%1N(@  "7   !@              ("!&D$  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( "LU9E'K5NES!P,  *L&   9
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M970Q-"YX;6Q02P$"% ,4    "  K-691,C^]\W4#  #F!P  &0
M    @($5C@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M "LU9E$*E4KQ=04  "L0   9              " @<&1  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ *S5F47KIO00U!   8PH  !D
M             ("!;9<  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    "  K-691J7^K?C0H  #BA@  &0              @('9FP  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( "LU9E'O$SL)#@L
M (PA   9              " @43$  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ *S5F428DD'JB P  Y <  !D              ("!
MB<\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  K-691
M_1L:O#4<  !Q7   &0              @(%BTP  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( "LU9E$7O,_ % D  !<:   9
M      " @<[O  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ *S5F49]/4;OY#   J"P  !D              ("!&?D  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  K-691-B.K'#<&  "=$@
M&0              @(%)!@$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( "LU9E&4'T8?0@0  ,D*   9              " @;<, 0!X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ *S5F4=D=MJ,!
M!0  O X  !D              ("!,!$! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    "  K-691PH'=EX8%   X$   &0
M@(%H%@$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( "LU
M9E&#0XWS40,  'D'   9              " @24< 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ *S5F44C(&4J?"0  6QP  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( "LU9E&&QF]Y=@(  '4&   9
M  " @3%" 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M*S5F4<7RA<'@ @  DP<  !D              ("!WD0! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    "  K-691+6HG3HD#  "^#   &0
M            @('U1P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( "LU9E$%&ES&2P,  (P-   9              " @;5+ 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ *S5F45BJQ!RC!P
MIS$  !D              ("!-T\! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    "  K-691RA#$4U@$  #]$P  &0              @($1
M5P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( "LU9E'^
MW%^L^ @  '$_   9              " @:!; 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ *S5F4=C&_M#L!@  93$  !D
M     ("!SV0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "LU9E'3/%D(* H  (19   9              "
M@<I] 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ *S5F
M45P,'JUJ!   VA8  !D              ("!*8@! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    "  K-691*,'H/@X%   )(P  &0
M        @('*C $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( "LU9E$SHZ,0ZP0  /<4   9              " @0^2 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ *S5F4<CKPLK" @  V 8
M !D              ("!,9<! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    "  K-691()1(]< -   N;P  &0              @($JF@$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( "LU9E'CP\VI
MMP<  #(U   9              " @2&H 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ *S5F4>#SV0,= P  !@H  !D
M ("!#[ ! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  K
M-691Y]M!"#4(   Y,@  &0              @(%CLP$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( "LU9E%PS-)H;P0  !@1   9
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M970U.2YX;6Q02P$"% ,4    "  K-691SF73?P #  #2"   &0
M    @(%2TP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M "LU9E%SK46T)@(  -D(   -              "  8G6 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ *S5F49>*NQS     $P(   L              ( !
MVM@! %]R96QS+RYR96QS4$L! A0#%     @ *S5F44HZN#*P!   N2<   \
M             ( !P]D! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "LU
M9E&8&UJ>^P$  ,LC   :              "  :#> 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "LU9E%TTL9BW@$  %HC   3
M          "  =/@ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !$ $0
*DQ(  .+B 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>716</ContextCount>
  <ElementCount>404</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>133</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110102 - Disclosure - Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Divestitures</Role>
      <ShortName>Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112103 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2128105 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2132106 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2136107 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2138108 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2151112 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2324303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2329304 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2333305 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Borrowings</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2339306 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2347308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/DivestituresDetails</Role>
      <ShortName>Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Divestitures</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/InvestmentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2417411 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2418412 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419413 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420414 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421415 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2422416 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2425417 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2426418 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2427419 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434422 - Disclosure - Borrowings - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails</Role>
      <ShortName>Borrowings - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2435423 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437424 - Disclosure - Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2440425 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2448428 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SubsequentEvent</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cvs-20200930.htm">cvs-20200930.htm</File>
    <File>a09302020ex101.htm</File>
    <File>a09302020ex151.htm</File>
    <File>a09302020ex311.htm</File>
    <File>a09302020ex312.htm</File>
    <File>a09302020ex321.htm</File>
    <File>a09302020ex322.htm</File>
    <File>cvs-20200930.xsd</File>
    <File>cvs-20200930_cal.xml</File>
    <File>cvs-20200930_def.xml</File>
    <File>cvs-20200930_lab.xml</File>
    <File>cvs-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20200930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20200930.htm": {
   "axisCustom": 3,
   "axisStandard": 23,
   "contextCount": 716,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 609,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 6,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 11
   },
   "keyCustom": 65,
   "keyStandard": 339,
   "memberCustom": 81,
   "memberStandard": 50,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110102 - Disclosure - Divestitures",
     "role": "http://www.cvshealth.com/role/Divestitures",
     "shortName": "Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112103 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128105 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132106 - Disclosure - Borrowings",
     "role": "http://www.cvshealth.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136107 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138108 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - Earnings Per Share",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151112 - Disclosure - Subsequent Event",
     "role": "http://www.cvshealth.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329304 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333305 - Disclosure - Borrowings (Tables)",
     "role": "http://www.cvshealth.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339306 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofPharmacyPlanMembers",
      "reportCount": 1,
      "unitRef": "person",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetInvestmentIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i98dc5453e7af45f08155c02c68159539_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i83b41fef1b864e01ba3e78d118b8243b_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Divestitures (Details)",
     "role": "http://www.cvshealth.com/role/DivestituresDetails",
     "shortName": "Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i0bf70ec2a8ba4060b9ae0ba5571df5d7_I20190701",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cvs:DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Investments (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDetails",
     "shortName": "Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417411 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418412 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ia45efd93510c49a7ac479600054af81d_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419413 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ia45efd93510c49a7ac479600054af81d_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i8567e379ddb1457cac777037b4375361_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420414 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i8567e379ddb1457cac777037b4375361_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421415 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422416 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425417 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)",
     "role": "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
     "shortName": "Fair Value - Measurement on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancialLiabilitiesFairValueDisclosure",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i5cbb249c57e548daa8401983dea3fb69_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdfbab09e275415b941c75475ce6fde8_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426418 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdfbab09e275415b941c75475ce6fde8_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427419 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i5cbb249c57e548daa8401983dea3fb69_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i83b41fef1b864e01ba3e78d118b8243b_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i1fa4fdc2286b491c8cd157b11b1a8f3a_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434422 - Disclosure - Borrowings - Schedule of Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
     "shortName": "Borrowings - Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435423 - Disclosure - Borrowings - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i35b32fba8153471cad0fd6d3c6437213_D20200821-20200821",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437424 - Disclosure - Shareholders' Equity (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDetails",
     "shortName": "Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ifafcb02d59004fedbb9332ce962bbb50_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440425 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id820c242081147b0ab5f3f6eadb0727a_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448428 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "icdf5b07122944ec98fcf5bf0958ec6f4_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "iab600fe96ebf4cc0915b310db63417df_I20190831",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyUnrecordedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.cvshealth.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "iab600fe96ebf4cc0915b310db63417df_I20190831",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyUnrecordedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i304666a201b045b7ba84e7a502222b26_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "i7d4b69975a3348f38ecda42219a17409_D20190101-20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "ib9882f3f29fd4b73b6e97734933e44a4_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20200930.htm",
      "contextRef": "id97dbd03b0a44fd1affad3727e1f3525_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 133,
   "tag": {
    "cvs_A2016RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2016 Repurchase Program [Member]",
        "label": "2016 Repurchase Program [Member]",
        "terseLabel": "2016 Repurchase Program"
       }
      }
     },
     "localname": "A2016RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "label": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Blue Cross And Blue Shield Of Alabama, Et Al. V. CVS Health Corporation, Et. Al [Member]",
        "label": "Blue Cross And Blue Shield Of Alabama, Et Al. V. CVS Health Corporation, Et. Al [Member]",
        "terseLabel": "Blue Cross and Blue Shield of Alabama vs. CVS Health Corporation"
       }
      }
     },
     "localname": "BlueCrossAndBlueShieldOfAlabamaEtAl.V.CVSHealthCorporationEt.AlMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BlueCrossAndBlueShieldOfNewJerseyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Blue Cross And Blue Shield Of New Jersey",
        "label": "Blue Cross And Blue Shield Of New Jersey [Member]",
        "terseLabel": "Blue Cross And Blue Shield Of New Jersey [Member]"
       }
      }
     },
     "localname": "BlueCrossAndBlueShieldOfNewJerseyMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "Categories 5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "Category 1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "Category 2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "Category 7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeinContractwithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability [Roll Forward]",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractwithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "label": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractwithCustomerLiabilityRedemptionandBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with Customer Liability Redemption and Breakage",
        "label": "Contract with Customer Liability Redemption and Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityRedemptionandBreakage",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CorporateOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate / Other [Member]",
        "label": "Corporate / Other [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateOtherMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CoventryHealthCareWorkersCompensationBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Coventry Health Care Workers Compensation Business [Member]",
        "label": "Coventry Health Care Workers Compensation Business [Member]",
        "terseLabel": "Coventry Health Care Workers Compensation business"
       }
      }
     },
     "localname": "CoventryHealthCareWorkersCompensationBusinessMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss (reversal of loss)"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtExtinguishmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DebtExtinguishmentFees",
        "label": "DebtExtinguishmentFees",
        "terseLabel": "Debt extinguishment fees"
       }
      }
     },
     "localname": "DebtExtinguishmentFees",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "totalLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Deferredincometaxesandothernoncashitems": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Deferred income taxes and other noncash items",
        "terseLabel": "Deferred income taxes and other noncash items"
       }
      }
     },
     "localname": "Deferredincometaxesandothernoncashitems",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Number of Stores In Subsidiary Sold",
        "label": "Disposal Group, Including Discontinued Operations, Number of Stores In Subsidiary Sold",
        "terseLabel": "Number of retail pharmacy stores"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsNumberOfStoresInSubsidiarySold",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_DrogariaOnofreLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Drogaria onofre Ltda.",
        "label": "Drogaria onofre Ltda. [Member]",
        "terseLabel": "Drogaria onofre Ltda."
       }
      }
     },
     "localname": "DrogariaOnofreLtdaMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FloatingRateNotesDueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2020 [Member]",
        "label": "Floating Rate Notes Due March 2020 [Member]",
        "terseLabel": "Floating rate notes due March 2020 (2.515% at December 31, 2019)"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesDueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2021 [Member]",
        "label": "Floating Rate Notes Due March 2021 [Member]",
        "terseLabel": "Floating rate notes due March 2021 (0.968% at September 30, 2020 and 2.605% at December 31, 2019)"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Floating Rate Notes",
        "label": "Floating Rate Notes [Member]",
        "terseLabel": "Floating Rate Notes [Member]"
       }
      }
     },
     "localname": "FloatingRateNotesMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "terseLabel": "Former gain contingency, recognized in current period, before tx"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodBeforeTax",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "terseLabel": "Former gain contingency, recognized in current period, net of tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodNetOfTax",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareandOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities [Abstract]",
        "label": "Health Care and Other Insurance Liabilities [Abstract]",
        "terseLabel": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareandOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "xbrltype": "stringItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LossContingencyAuditMethodologySampleSize": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Audit Methodology Sample Size",
        "label": "Loss Contingency, Audit Methodology Sample Size",
        "terseLabel": "Sample size"
       }
      }
     },
     "localname": "LossContingencyAuditMethodologySampleSize",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, New Claims Filed, Number Of Entities Filing Claims",
        "label": "Loss Contingency, New Claims Filed, Number Of Entities Filing Claims",
        "terseLabel": "Number of entities filing claims"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumberOfEntitiesFilingClaims",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LossContingencyNewClaimsFiledNumberOfStatesInvolved": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, New Claims Filed, Number Of States Involved",
        "label": "Loss Contingency, New Claims Filed, Number Of States Involved",
        "terseLabel": "Number of states in which entities filed claims"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumberOfStatesInvolved",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorAxis",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorDomain",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Net revenues, retail copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NonTaxDeductibleHealthInsuranceFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non Tax-deductible Health Insurance Fee",
        "label": "Non Tax-deductible Health Insurance Fee",
        "terseLabel": "Non tax-deductible health insurance fee"
       }
      }
     },
     "localname": "NonTaxDeductibleHealthInsuranceFee",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of People Served through Health Insurance Products and Related Services",
        "label": "Number of People Served through Health Insurance Products and Related Services",
        "terseLabel": "Number of people served through health insurance products and related services"
       }
      }
     },
     "localname": "NumberofPeopleServedthroughHealthInsuranceProductsandRelatedServices",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Pharmacy Plan Members",
        "label": "Number of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberofPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofUnderPerformingStores": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Under Performing Stores",
        "label": "Number of Under Performing Stores",
        "terseLabel": "Number of under performing stores"
       }
      }
     },
     "localname": "NumberofUnderPerformingStores",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OutstandingSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Outstanding Senior Notes",
        "label": "Outstanding Senior Notes [Member]",
        "terseLabel": "Outstanding Senior Notes"
       }
      }
     },
     "localname": "OutstandingSeniorNotesMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Premium Revenue",
        "label": "Premium Revenue [Member]",
        "terseLabel": "Premium Revenue"
       }
      }
     },
     "localname": "PremiumRevenueMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues from customers"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Mortgage Loan Internal Credit Rating"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.125June2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.125%, June 2021 [Member]",
        "label": "Senior Notes, 2.125%, June 2021 [Member]",
        "terseLabel": "2.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes2.125June2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJuly2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due July 2020 [Member]",
        "label": "Senior Notes, 2.8%, Due July 2020 [Member]",
        "terseLabel": "2.8% senior notes due July 2020"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJuly2020Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.125DueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "label": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "terseLabel": "3.125% senior notes due March 2020"
       }
      }
     },
     "localname": "SeniorNotes3.125DueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.35DueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "label": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "terseLabel": "3.35% senior notes due March 2021"
       }
      }
     },
     "localname": "SeniorNotes3.35DueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3.625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.75DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3.75DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.7DueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "label": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "terseLabel": "3.7% senior notes due March 2023"
       }
      }
     },
     "localname": "SeniorNotes3.7DueMarch2023Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4.125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "terseLabel": "4.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "terseLabel": "4.125% senior notes due May 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueMay2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.25DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4.25DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.45DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents senior notes due 2021 with a coupon rate of 5.45%.",
        "label": "Senior Notes, 5.45%, Due June 2021 [Member]",
        "terseLabel": "5.45% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes5.45DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StoreRationalizationCharges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Store Rationalization Charges",
        "label": "Store Rationalization Charges",
        "terseLabel": "Store rationalization charges"
       }
      }
     },
     "localname": "StoreRationalizationCharges",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience-rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchases of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury Stock, Value, Shares Held In Trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables",
        "label": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]",
        "terseLabel": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables"
       }
      }
     },
     "localname": "USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Period Five [Member]",
        "label": "Year Of Origination, Period Five [Member]",
        "terseLabel": "2016"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Period Four [Member]",
        "label": "Year Of Origination, Period Four [Member]",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Period One [Member]",
        "label": "Year Of Origination, Period One [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Period Three [Member]",
        "label": "Year Of Origination, Period Three [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Period Two [Member]",
        "label": "Year Of Origination, Period Two [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year Of Origination, Prior To Period Five [Member]",
        "label": "Year Of Origination, Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20200930",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r187",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r213",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r187",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r213",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r144",
      "r152",
      "r265",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r144",
      "r152",
      "r265",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r144",
      "r152",
      "r265",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r616",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r219",
      "r355",
      "r357",
      "r495",
      "r575",
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r219",
      "r355",
      "r357",
      "r495",
      "r575",
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r312",
      "r377",
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r394",
      "r395",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r24",
      "r48"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r20",
      "r37",
      "r224",
      "r225"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r68",
      "r73",
      "r76",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r63",
      "r73",
      "r76",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r73",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r73",
      "r76"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r40",
      "r71",
      "r72",
      "r73",
      "r547",
      "r585",
      "r589"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r76",
      "r141",
      "r142",
      "r143",
      "r409",
      "r580",
      "r581"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r227",
      "r268",
      "r270",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r124",
      "r293",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r76",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r135",
      "r195",
      "r208",
      "r215",
      "r261",
      "r402",
      "r411",
      "r433",
      "r514",
      "r545"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r61",
      "r135",
      "r261",
      "r402",
      "r411",
      "r433"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r241"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r237",
      "r277"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Gross Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r242",
      "r245",
      "r533"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r242",
      "r244",
      "r532"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r242",
      "r246",
      "r534"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r242",
      "r243",
      "r531"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r233",
      "r238",
      "r277",
      "r521"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Benefits, Losses and Expenses [Abstract]",
        "verboseLabel": "Operating costs:"
       }
      }
     },
     "localname": "BenefitsLossesAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r18",
      "r45",
      "r126"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r26",
      "r127",
      "r132",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r116",
      "r126",
      "r129"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r116",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r130",
      "r131",
      "r178",
      "r179",
      "r296",
      "r297",
      "r304",
      "r305",
      "r364",
      "r365",
      "r385",
      "r386",
      "r387",
      "r395",
      "r416",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r459",
      "r460",
      "r580",
      "r590",
      "r621"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates transition method applied for adoption of amendment to accounting standards.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Transition Option Elected [Extensible List]",
        "terseLabel": "Change in Accounting Principle, Accounting Standards Update, Transition Option Elected [Extensible List]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r247",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r276",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock Including Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r141",
      "r142"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r36",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r36",
      "r38",
      "r336"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,309 shares outstanding at September 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82",
      "r89",
      "r526",
      "r560"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r79",
      "r81",
      "r88",
      "r400",
      "r415",
      "r525",
      "r559"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r87",
      "r96",
      "r524",
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contracts With Customers, Assets and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r342",
      "r344",
      "r356"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r342",
      "r343",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities (included in accrued expenses) ending balance",
        "periodStartLabel": "Contract liabilities (included in accrued expenses) beginning balance",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r355",
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r355",
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r92",
      "r495"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r33",
      "r34",
      "r515",
      "r516",
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r34",
      "r324",
      "r516",
      "r541"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r445",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r52",
      "r325",
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r137",
      "r332",
      "r333",
      "r334",
      "r335",
      "r444",
      "r445",
      "r447",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r444",
      "r447"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r239",
      "r277",
      "r285",
      "r286"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r255",
      "r283",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r255",
      "r283"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r255",
      "r283",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r255",
      "r283"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r251",
      "r279",
      "r288"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r252",
      "r280"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r253",
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]",
        "terseLabel": "Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items]"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityCreditQualityIndicatorLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Credit Quality Indicator [Table]",
        "terseLabel": "Debt Securities, Held-to-maturity, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r389",
      "r390"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r124",
      "r190"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r17",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Divestitures"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Divestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r376",
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r336",
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r236",
      "r367",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r90",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r158",
      "r161",
      "r168",
      "r171",
      "r172",
      "r176",
      "r177",
      "r527",
      "r561"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r90",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r161",
      "r168",
      "r171",
      "r172",
      "r176",
      "r177",
      "r527",
      "r561"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r146",
      "r155",
      "r157",
      "r181",
      "r265",
      "r331",
      "r336",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r46",
      "r115",
      "r132",
      "r260",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r27",
      "r32",
      "r258",
      "r542",
      "r611",
      "r612",
      "r613"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Aggregate principal of debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r418",
      "r431",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r418",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r419",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r418",
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r418",
      "r419",
      "r421",
      "r422",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r367",
      "r368",
      "r373",
      "r375",
      "r419",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r367",
      "r368",
      "r373",
      "r375",
      "r419",
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r419",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r418",
      "r419",
      "r421",
      "r422",
      "r423",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r269",
      "r272",
      "r273",
      "r274",
      "r275",
      "r282",
      "r284",
      "r287",
      "r288",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r236",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyUnrecordedAmount": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.",
        "label": "Gain Contingency, Unrecorded Amount",
        "terseLabel": "Gain contingency, unrecorded amount"
       }
      }
     },
     "localname": "GainContingencyUnrecordedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r124",
      "r410"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "(Gain) loss on sale of subsidiary",
        "terseLabel": "Gain (loss) on divestiture, pretax"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r124",
      "r326",
      "r327"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r326",
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Premium paid in excess of debt principal"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r289",
      "r290",
      "r513"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Insurer Fee"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r138",
      "r195",
      "r207",
      "r211",
      "r214",
      "r217"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r376",
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r3",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r15",
      "r16",
      "r301",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r156",
      "r157",
      "r193",
      "r391",
      "r396",
      "r397",
      "r562"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Shareholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r292",
      "r294"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r189",
      "r443",
      "r446",
      "r528"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r113",
      "r120",
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r187",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r213",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r19",
      "r59"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r95",
      "r563"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r563"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r258",
      "r511",
      "r535",
      "r614"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r49",
      "r135",
      "r209",
      "r261",
      "r403",
      "r411",
      "r412",
      "r433"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r43",
      "r135",
      "r261",
      "r433",
      "r518",
      "r550"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r135",
      "r261",
      "r403",
      "r411",
      "r412",
      "r433"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r568",
      "r571"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of the period",
        "periodStartLabel": "Health care costs payable, beginning of the period"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r569"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r540",
      "r568",
      "r571"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of the period, net",
        "periodStartLabel": "Health care costs payable, beginning of the period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r321",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of pending claims"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r58",
      "r135",
      "r261",
      "r433",
      "r517",
      "r549"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r116",
      "r122",
      "r125"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r16",
      "r77",
      "r80",
      "r86",
      "r125",
      "r135",
      "r145",
      "r150",
      "r151",
      "r152",
      "r153",
      "r156",
      "r157",
      "r165",
      "r195",
      "r207",
      "r211",
      "r214",
      "r217",
      "r261",
      "r433",
      "r523",
      "r556"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r80",
      "r156",
      "r157",
      "r406",
      "r414"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests",
        "negatedTerseLabel": "Net (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r158",
      "r159",
      "r167",
      "r172",
      "r195",
      "r207",
      "r211",
      "r214",
      "r217"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r330",
      "r406",
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r152",
      "r176",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r392",
      "r393",
      "r394",
      "r395",
      "r496",
      "r497",
      "r498",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r336",
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Floating Rate Notes"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of stores"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r195",
      "r207",
      "r211",
      "r214",
      "r217"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r400",
      "r401",
      "r408"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r73",
      "r435",
      "r437",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before Reclass, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r73",
      "r83",
      "r435",
      "r437",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "negatedLabel": "Loss on net cash flow hedges",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r64",
      "r71"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r83",
      "r87",
      "r331",
      "r435",
      "r440",
      "r441",
      "r524",
      "r557"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r69",
      "r71"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r71",
      "r74",
      "r75",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r250",
      "r278",
      "r367",
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings",
        "terseLabel": "Other-than-temporary impairment loss"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r121",
      "r570"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Financing Activities",
        "terseLabel": "Derivative settlements"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r100",
      "r103",
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r111",
      "r112",
      "r119"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r522",
      "r555",
      "r566",
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r110",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r106",
      "r109",
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net borrowings of short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r97",
      "r98",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r104",
      "r380"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r16",
      "r77",
      "r80",
      "r114",
      "r135",
      "r145",
      "r156",
      "r157",
      "r195",
      "r207",
      "r211",
      "r214",
      "r217",
      "r261",
      "r400",
      "r405",
      "r407",
      "r414",
      "r415",
      "r433",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r28",
      "r29",
      "r298",
      "r551"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r226",
      "r230",
      "r231",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r44",
      "r132",
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Expected Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r83",
      "r435",
      "r439",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r207",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Earnings to Net Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r25",
      "r135",
      "r261",
      "r329",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r538",
      "r567",
      "r568",
      "r571"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r374",
      "r456",
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party transaction, expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Related party transaction, other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r374",
      "r456",
      "r458",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r236",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r23",
      "r30",
      "r129",
      "r619"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r39",
      "r336",
      "r388",
      "r548",
      "r584",
      "r589"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r146",
      "r155",
      "r157",
      "r265",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395",
      "r580",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r186",
      "r187",
      "r206",
      "r212",
      "r213",
      "r219",
      "r220",
      "r222",
      "r354",
      "r355",
      "r495"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r133",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r85",
      "r135",
      "r186",
      "r187",
      "r206",
      "r212",
      "r213",
      "r219",
      "r220",
      "r222",
      "r261",
      "r433",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73",
      "r440",
      "r441"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents, and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r53",
      "r137",
      "r332",
      "r333",
      "r334",
      "r335",
      "r444",
      "r445",
      "r447",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r539",
      "r593",
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r539",
      "r593",
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r93",
      "r94",
      "r563"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r195",
      "r198",
      "r210",
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r222",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r195",
      "r199",
      "r211",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r544",
      "r592",
      "r593",
      "r596"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r546",
      "r592",
      "r594",
      "r595",
      "r597"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, balance at end of period (in shares)",
        "periodStartLabel": "Shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r32",
      "r519",
      "r520",
      "r543"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r573",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Incurred but not reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r222",
      "r291",
      "r300",
      "r306",
      "r307",
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r141",
      "r142",
      "r143",
      "r146",
      "r155",
      "r157",
      "r181",
      "r265",
      "r331",
      "r336",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r181",
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r35",
      "r36",
      "r331",
      "r336",
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r331",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r35",
      "r36",
      "r331",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r36",
      "r41",
      "r42",
      "r135",
      "r229",
      "r261",
      "r433"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r135",
      "r141",
      "r142",
      "r143",
      "r146",
      "r155",
      "r261",
      "r265",
      "r336",
      "r385",
      "r386",
      "r387",
      "r394",
      "r395",
      "r398",
      "r399",
      "r413",
      "r433",
      "r435",
      "r436",
      "r441",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Cumulative adjustment to retained earnings as a result of new accounting standard adoption",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r336",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r442",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r442",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r442",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r442",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r461",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r569"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r569"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years",
        "verboseLabel": "Decrease in prior years' healthcare costs payable"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r337",
      "r340"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 423 shares at September 30, 2020 and 425 shares at December\u00a031,\u00a02019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible List]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r367",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r367",
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r166",
      "r169",
      "r170"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedLabel": "Income allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r160",
      "r172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average shares, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r158",
      "r172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=117337699&loc=SL117340306-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=117337699&loc=SL117340306-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513396&loc=SL94080479-196980"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513396&loc=SL94080479-196980"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109261464&loc=SL109261606-128450"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109261464&loc=SL109261606-128450"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6283291-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "405",
   "URI": "http://asc.fasb.org/extlink&oid=77997009&loc=SL77997016-210199"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "405",
   "URI": "http://asc.fasb.org/extlink&oid=77997009&loc=SL77997016-210199"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL119206272-209984"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL119206272-209984"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL120154346-209984"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "853",
   "URI": "http://asc.fasb.org/extlink&oid=109199533&loc=SL109199563-203033"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "853",
   "URI": "http://asc.fasb.org/extlink&oid=109199533&loc=SL109199563-203033"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639652&loc=d3e7104-158389"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884803&loc=SL65671395-207642"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(k)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=SL117422267-158473"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=SL117422267-158473"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638699&loc=SL117422397-158474"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638699&loc=SL117422401-158474"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491204&loc=d3e4879-115612"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120520240&loc=SL117035239-210619"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r631": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r632": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r633": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r634": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r635": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r636": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0000064803-20-000041-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-20-000041-xbrl.zip
M4$L#!!0    ( "LU9E%JQ-5)+Q\  &K(   2    83 Y,S R,#(P97@Q,#$N
M:'1M[3UI<]M&EM_W5_3:LQFJBJ)(7=;AI$J1E,2[B>VUE4GMIZDFT"0[!@$.
M#DF<7[_OZ&XT0("B?$1PPE3*DDB@C]?OOOKE?UZ]N;SYO[?78I;/(_'VU^]_
M?G4IGNWN[?UV<+FW=W5S)7ZZ^>5G<3@8CL1-*N-,YSJ)9;2W=_WZF7@VR_/%
MV=[>W=W=X.Y@D*33O9MW>SC4X5Z4))D:A'GX[+N7^ G\JV3XW7^\_,_=77&5
M!,5<Q;D(4B5S%8HBT_%4_!:J[(/8W35/72:+9:JGLUSL#_>'XK<D_:!O)7^?
MZSQ2W]EQ7N[QWR_W:)*7XR1<?O<RU+="A]\^T^'Q27@R&H\/CXZ/#X/#D_&A
M'!X$^\-Q,#X>#O?W_SF"1>[!X_Q.EB\C]>VSN8YW9PKG/SLZ&1PL\O,['>:S
ML]%P^%_/*D_FZC[?E9&>QF>T7OAVDL0YK".%<?G7E>%;7K)?!TF4I&?/A_3?
M.7ZS.Y%S'2W/_GZ1:AG]O9_!<>QF*M43_CK3_U9GHWU8)_UYQTM_ 6]'.E9V
M*Z-]7/WU_4R/=2Y&P\&HND*WSN]>ZOE4R"B'M=QF -<HG\F#D]'@]\7TF<C2
MH/ES7KV9[.!T<6^@MK\_6MPW@=F#0P!'J=+'0N\SO+4!T"_A^2)=BA^3?*:#
M-NB/-H+^Y3_>BY^N+WZ^^4E<OGGW]LV[BYM7;UYW?=5OK]_]\.;=+Q>O+Z_%
M^YLWE_\C?GW]ZD9<_/CN^OJ7Z]<WWSP_V1^-SL7%Z]>_7OPL?GQW\?I&='U3
MO,JKBYMKN](ONHC#QD5\\_SHY%S\(0MHAH*XO__F^>&+<_?C_OX/HKSU;RUD
M&()@V(W4)#_;?P%[\<;YO<AR/5GR1SH.8=BSW=')XA&<=#,8#C>"X6CP10ZP
M/GD3!IU7X'0Z.!XA$-X6:59(6(J,0Y$5X]]5D(L\$?E,B46:W.H,1'DFD@E]
MLC\<O1"O8CP<?:M ]LX7*LXDBGOQ-I*QZ.%32./[P_,_9*<M7 C6\F2 1E(%
M (S.=_H" 4>,G"0@ "Q=)"G#JR.@PC.4\;(3T *H(%!"T/9$IG(Q25( FAPG
M@&L= =>/*1++%:RP$Q!#H)@3%#.9"7DGTQ!49:3FF4K5>"G4K0:N%ZB,'GZK
M4H#J7,('XGV>!!_$KS&H>+VGA^S;][]V *3B B'H.*!*,T#*6,X!IF,5)7==
MP<.W,LUUH.'@\PY K5\7'2"[YQEA89#$(=F#F4_2\(6. \,-%?X!K^FL#3WE
M-%6*;,$>/?;T\+^P*^H ] ="W"!IHP &X!BZG\M0"2D6@"CT43+I$]R)"Y38
MP[#-\.#&2HR3 AZ!MV44M>@ . W,>"D7.@<=Z]]P>GS:<9(+V)5*[W0&3%Q-
M8,',A>!TLQF..)/ R7&0N9(Q&O,RRT!+4T1P61',:*A>ML,(X29[PW^5S%=D
M"Q7HB496A^*!.>%$ZE3<RJB OX$9A@I'HU44N8:EXHP\>SY+0CBD*6QT@5M4
MM&G\[A<9RRGC&D[.JP287*E;H/\%?0$<=Z[S7"D+D^\39!KPQY5.@0J2-.L*
MGW!+[0">BB05.L=SB=04#K&/$%,23AUXOU#_*F24?1D#9S-8_>W^?E#:-$\
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M-9;3DR#I1L?#\]5_WW\R@C9%*BIZK<%)&##7<0$DITB%8N2FIU$:,\D \?"
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M3,ADP#8S(<\QOQJ'K=ER5 CHC-\)Y6TDL;4Z+YRA!P>9)VDU):A<'EB*^0R
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MQV@*C_7*<YD-D7HNP? [2HH8.A'2%=]6 0=)Z9HC(@0F EF2+-%2!LK<FQJ
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MD[H*!#7NMCZ9?&&KG4G\+RITC)2=Z=TJSWAKW[A67X/L=ZGS?P!02P,$%
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M:%$M" ?" D(>@^/<?57L?Q)Z6@PJ^R_J[Q"E?OLM9=^=4JP]NDH(K5:M7FN
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M*%$ ZB%(=22QBSN/B+X?@07,;GLSWLP2O! 4-;0JH7L(<LPY!HX,"=1:#G,
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M.?,.9C=^*?,.+CSJ#9A7IJ2UU3K;C!!\0LZ%<SH'F3*7=L:\7)Z%I"63]>L
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M7OFU%M/A<L*\==B_2*][DT(\TRWZY.%!G[WBP7$%,561_JD@:*B<2+S*B8<
MS"6)2+STST[GCXVUY[M_=)YLOR#5M;8[B\<VS?[]:>,]AND,!IU1[HS/Q=_!
M26=RE$)ID! [O6&G-YUTPL',;?LR/G2^9(+CU[UAY4?3Z6CPJ!@!I^],1T>/
M+ET4H>>>EL8'9V?PLR6?BIZ_CT>3].CLQ6^Q-SGJX\FCWG#V%+,O_?8VC:>]
M@/W34])5/J[1K++Y.LUT3'_CV?E//UZ=??3K-'[Y&:A59^57/V:K_*N??>NT
MW*V"4@L_K>2K0HMKG?;7V4C,1X.&M8CP?U?D.2&>+F(]$D?O._S2]:O/1GLN
MY;MG0G8G?L^D-)4X&H_>EKGQ::Q@3I6E]\2\R]UIUXOT9'0\G(Y/GI!?UTCF
M?-KSSU[JO0][:F_P][ONX8LWW6<OZ;.UD^UG?QYNKS\]G*>,OGBSO?YBL/?O
MQNEW_J%KJ>'^[M'AUF&_MT_';SW[^]W^[A[KKF_"WJ +W7_I>9X]/:3W8>O9
M_L'>/_;=\[)!?;;/:NU5$,H(&:#B*?(*,NC*LD!.E LF6N5,8'GE\7KJXSL<
MIZ\Y4&<SX!O@9@7:*]<Z]('.@\]AOHOO-T\[Y<R;JS38*KYK@&^> ]Q#9@%5
M)FQ+^A$R 5Q86VDEK=7@+*(@@UI5#!PP^"*2]@G$%TWD@UZ,_73W%L@,P#_-
MJ+-#/N^H- KM'!Z/>Y/8"S._ETR2WD6:G1TV?HW#WH?9[S_?\]2_WY';7'VQ
MNK/:V1@<]4<G-'2?SM/.UFCUYR]Q\^O,<KK2=K/-M-U6E8/%FVYZE8OKV5@W
M.JU8)3)>_&F+1?CUKW[O:8589;<QMNQVK&U8M>9Z=WM--OTQ^AB7>7L)Y)?5
M:EB+<9PFD]-_GM,-\"9;#*3WNQ_6Q/ZS3>CNOGRWM=Z5W6<;[[O_[M/]O &Z
MKX.M#Z\560:?6PR]KNA^Z*[OO]D[?/U^:W>-T3V]V]O=>+\_>'FRO?M:;C_;
MH&OVWW2?%HMAX]QBX%YYCT)79!B7N@,Y5EZP6&'T+F7C5.9VY?'V,'5*+&)]
MW'N;?OD!P_C:*F_Y0?N$7FZ/=T?OABUDKP'9CT9N1D&PM*(2!-#27*O4;"3P
M9N4DQN!YMGSE\;^CTL<]O$G3+_#:^3' EO3;)8;KC2,4IWB>&=C;X[_H2#*F
M&QV:N#-0=\]!35#6EMM<A5+G&))+E4,P%4)"GTA\WIN5QR\.RF+^YJ2/PW@;
MX0G=$O;7"?NO$4V%_G[OJ.F1MSN#]\MS>),9D4-.H4+!7 4R\<J&LH$H:I5$
M9!HR<383UJF;QR2XJ#=L+_>KYSE-/YV"J\0@CL9$G+TC['?2^Q2.IV1KT=NY
M=')>2 2BYK/[F\-$TZY3YMTEH8;I^//%5I@]_W>.DOL1G^P.#OV!*7"9Y7(>
M5OYJC$:>;Q^Z:]E_7";^O_]C!3>_33K3U$]'!R/R1X:S /$O)7+7/RY/W,%Q
MPDY)=WO4N=Z>BUL/YST<?[QX,VLT_JUNO(YN_'!1-Y8,@-+:IN()9 5*2M*-
M(E7>6"&D=89$L?+X)V#\Y\5ZWDONR'P$Y_,1/>!?A36:OZIT9P#=.P<H2T(F
M%E.EQ2Q96[K**IDJSJV72:N8!5MY;+2JN&+?L:;$U3(JKZ?D1Z?Q#(6_S)QJ
M^@5/C3URW\[>RKT)/4^G;!4@799+\LOP=8J=27&B.WV<3#OC6<+SHRMTU[6L
MNZ]/^6^-X*5K,O?!$5N_KETR"C=9<+H7/,SWV9))/^Y->W3&>?Y3&I.8CX['
MD^.2"#4==>B(V8H:%S_YGXM#4-)SU\+GDE^R1"AI5K7Z^L??O31C;F79"_BJ
M-G81*SZG(S_;S$^SM#,9]7NQ<X;#TT^+'+_\L*ZY(Y<3X6YOVI^E_24,!YU
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M6?J1\^!SB,"R#B!T4N!=F246.-<\Y:33WCZ3;4UJ->HM!O J+?T*X(4!/-N
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M__[#,*I_:F6\O)KYN/;\A?FY^:5,266C6['1C<I,T8F4&?7 LHL@DK)@(]/
MI%?.J&@BH7O[O&U5DTK-5@?'Y@F-BMWE8'>NA((@/+L4@-J 2D()U!0V(8J5
M1A8.1N0L]O99V]KJT5AGN,S@(L56FHCGFO^XYOB2,AES86G5LWH7&KI1E,EI
M3V+B#!1N'B"<"V (H4#Q.:83ISB5>_M4M#EKDD53G16;IR$J?I>&W[DP=D8C
M9R:#-:RTFT %X:+VY9\N1>6B563<;H+R)CD;=\PC,:FAT.D-+P:N%U*K.\-
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MS%I>X?YG7%0VFE;G4"&D%Y?<\CH_+TYIM+0*+2UOL^@,2<C(63(<&"A$AD#
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M"S<+-PLW"^_$&)I:.')Y,,6YW.Z$^?P8XN&9.G].\S_;$G2E)>CA[/6BJ-J
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M8W_@MU.%6_9: 'Z+Q[5V<8"SP??T;D8G@28#Q?<'%4+KU&^=#2N??[:O5?%
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MZIA$2H4.M4$&02L63+3,J)QSU*G< Z((2+^O9!.0C1T;.YZSH]/>2@%..*4
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M*+VM\%XZAA*3\]88SK2K?1=*8&;!"L]BB,!UB(H"[AUHOV^<:0C?,80;[7U
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MI8DV)&_\WL'5HM-VBO2A!YL4MV4BF2$$4-;X0JO&IV@ !%<IMJBZ,W"]-#+
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M!+8! KN46TN!RJUHD?$,O-8-!A:L(H;<1,HJ2I"N$5@CL-VQ\$H*;-,U@XW
M-D!@'Y<%)L%S\H)QFXB!M:Y0F-7,<"6\EMJ0P1Y1V.Y4!,Z[2 Y'L2:AR[L.
M1X/1I3ZJY9EY(]56"MAV31[&7JW4J]V*S5[-7LU>S5X[9*_[G8ZQ*$"XW"?_
M7-YU0G!^^NGP3 T^I_F?;7&STN+F[>69%Y$KF83RS.4H&*3B(Y\-,.NEBA&Y
MT9+O':A6^+1MA3P-1W>-HX^2!#;Z:(DDT\$H!I#K"14P+$CC1;!)8=0/@J2=
MJN&QUX+L6SRN!6L#G V^IW<S.@DT&2B^/Z@X6:>4YVP2]ORS?:V*!]+X-!Q3
M-PW[YCG96YBT7/$4'11R2A)%W2_6404?+*8@.1F1I+9GH^?7&;0S/SWW^G0V
MG>&H&K,1U$H$%2\WHH.8M3<F, UH&!BN&2HAF1 B(A"**%*=E&/EI@XW;P([
M][3'\,E+_>35;B?8;]ZAN!;M$C%(9R(BU8Y<'),/)A6Y4D):$-'?C/8;IMXU
M;*^-[4M'8KVAS(,H8.;(P/K '!C/HD#/-8 G*-@&">OO3VP.*0]<R/A@D;]O
M>RS__1"\OH+3^Z2%KIL^XH-/]9?6(*Q% N#@<S1*&?2P"2%4MW"/QL?%K-,7
MOYT.9Q\^.W:P31I<GV$OM:@$E!PS(BN"-S!P@5BYFS/3,B7R2F@?56%8O>_T
M59+=2OG4^+'QXR8*7#:@'1M3]IPIE]>9"F2R=8DIN"Y:5))E0>7$.(\)C,+$
M*>X=2+<ON;UC.=I(LI'D5HC( A<T-@:PRD(./D",0(E;TM)H+YJ(W%IJO'24
M(XB0T!'344D&'"-S=:_-J'K PW(0TA<1"?M<7*7&)B(;/SY>?K0J4/(^U+U1
M!4X+H0I#>BF3$%[>S(^-!/M @LNS/[72QAHA&( K7S!RYH/7S"-@L"ZIY/3>
M@5^UV4%CP,: .\R B"*X#"(*#U"(+Q"7D&U6VONB'%)3B-M*CI?/RI'S_Y^]
M-V]NZT;:1[\*2[_WWLI4"3*6QN;,597'=C+.;R0GL3,I^Q\75HDV1>HE*6^?
M_C;.X:;-%B5*)B5X)A)%\N#@ .BGGVYT-VRVCC#FT7A."(XF:$$<S<(IKAAW
M?FM7\6W%JINQXF/%QRD^(A\$):*+4B8P:&6!25I3S55$^]F*RA#7&P07/8B)
MN^AC5D2[#,@0+>*?58Z@[E-."@A@\M:N8.>S[2H"5@1\J BHG$[<:(C4>1#<
M6J:L9%9KFWW@\1O[+)4AKC<XGHDSI@+Q3R%'Y)8W!6'0@ X\$87JSG,?:7:Q
MX8A6+!ELO)8(V40O/VI6%/Z.W8^[_VQ^K%0:U8[\GCQR^O_\?#P8=<LP/AZF
MGAMW/Z:?RT,3T5Q]]BG<*)4&MG;?+?-O-C73)ST3"4X*:C]F[2V;D>SV8^J/
M'Z/)L,-E$^)TMT#%FQUA-MNZN_.[_WQZ:':L:$8!5WX>#,;]P3AM),[TTK__
M_/+V[WCL.:@W?[_]\/+OWX[>\#_XFZ-?#O=__0W[]5MW__4']O+9X>'+9R\^
MOWG_X=/;H[>YX,O^L^<2_X/R^=[7Y^^ 9Y.\,R2&C(9E!$$,S19-3,43Y& !
M3-$$[7C].2B3=S@>'S]^].C3IT\[G_VPMS,8'CSBE(I'".CIT?2[6[NO3Y_)
M4]+U42FDSG(QIK>HOTHZS 4'L_P[]7#9O!Z>;+Y.NO9:V7^]]^E=5DQ2&P5)
MX)K,%4\\98Y0"8XF2J-0YJ(353HHR;TRLY.)/\0!+24:QF5(.ZX?%XYK:JJK
M3E;&J/,_RV1%42.=X3)9&D!+ZYAB)E.:A/.&Y:GS7PAV\X71GJPV6QTO'OSJ
M./CRCM(0K#61I.00,  LL8Q[DC6G/GCMJ';KPE3KA%YA0H%;*J.Q1$05"3#*
MB8V)$>^=LL:!B)8N=U0-TXK&2(/@&C07EL?,M654F>RU:274,%XE])8F5#L!
ME@EBD1X1*-!M(C#\D5%DF<@R+S>A-D.43 2C$7*%3]9X*Q30++)%DR!/)%15
M";V="34B:I,-)<&P<AR%,<1SAU/+71".>B8A;^WR\PZP:[PQ4^*-39-09P\N
MT>>C<@#C^?3*[<YO)_VT\.>>&X;#CF#MWPT/>);"Y*+V7;/3:3HR)9&[FVKV
M\&KVK(ODG#=[7KP3.8><>48%%STBH]?$X5(D,;H@D8.(0,-US9Y3YP:411[<
M<7?L>AV$MN/>R6C.=L>'J7/LAIV/!>J*$(7%2_'O9>CP'?CY%BH'-NC\<,'X
MZU]?WDF=C/9<$B]#(*!$(D8Y200:)3Q'+GT):%X/[5IG\*(9Q-%U.N ,)E"&
M@$< \,*C02.!2BN\SZ4"[7H0WCJ#%\Z@TT8FJ0E(AS.H8R!>,T]4%C9:X-%E
MOURIE=MS*M09O&@&,ZI0G*I '->HB7&HT3PQBJ#J2HXJFF1B6[L7Q#W?A-*N
MEK+>#\8J9HRU,L494]Q[9T +-),UL39S DP'8K@#Q!H/3GG*P?'K,L5UL0T0
M^GHIC%M"ZN+@N$%)E) G(0Q.^N-23_=5*<C@AG'4^>LXHCW8^:D4SN/TYR>O
M_FI>L9__4<1!$<JW.[=K_#0-/BZ<NANNL+3_T]8(_F$&&0K7Z\%Q-W0,\']L
M=SX==A%3T(X^Z16S&NUH[,^TE'&QLH=I[+")V$ENV,>Q'RUK"D3FG$W)2!TH
M(/GP$&/RDA5'GC0TKX"&U"W_&R'-R]=_P3L:P4@ 0Q)/:$ 809&\1$YB8?T
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MVG3.N4<057A,Q=U3HDVZS:(I6WP3\G)^/30^1-?!18 VV^DU-FNGS+X;ETW
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MM%6X-T6XYULTC&4>4RD+[UPF8+@FA@=/E&"AJ&W\&:MP/P#A5E'EI"GJ;9G
M&<3[$+6WN QX-B)!%>Y-$>[Y)H9@U'A''0'(*-Q@+7':&Y*92@+UN#%)5.%^
M ,)M06F6HW.< PC\'5SVD?+(LF;)5KM[LR1\T??/F'5&>$T8^$A *D>,R9Q8
MH='V$@RBXFMH>3^TW*9A.NJ>'%V>-O_@SY9 $LJ9 Z0@F>.:S<Y[3\&*$KX*
M,O#*/S8#G5XM^/UE5M$:#R0:H0AH6TIBIDCP+2:54L('N,?Q7U6X9Z>&>Q9Q
MNEVFW@!ESN@8C%4L"T$%N&4S_:IP_S#AGKO\0Q%E+Y!NR(3&11*4F!@RR124
MD&"HH+D*]P,0[A!T<$51B^R!FHQ6I=& O)0EF@+7U;C8* F?._Y5YCGYI$FD
MAA%P1<)]3H0C;GLF@I16-EEQRMHJX/=7P!EP;JSW)DH)443OC$TN XL>;-97
M$? JQ7<LQ0L>?BI29B83:A,0H$*C% =!1$ F%H%9&31*,:T2?(\EV+GH. N,
M"0LF2V? >XYB'$V0PM2@NHV1Z[ESWRFCA-"L!/TZ H)RXDWR)$N<6 =<:!4J
M_WX PBT\]5SYJ,$SR(FB9HZ!2\-!1G 0*O_>* E?=.YG9-9@?21)BD@@RA(X
MJS@1*B><W9P9#0T#U[!.#/R!Q?7OIW&GV_^81N-2*A=?!I2%&N%_Z>E6PC(!
MIAB1%I1$4S(YICUSS @9W;+^@LO(",[*B]FDO&CFI$+1,E#47?#D9PLB)DZ)
MDXP24,D0)Q+%M10AH WH$)%J),$#$%XM+ WXF!JXAZB=\Q("E3Z7J'ZI5V5)
M5.&]L?#./?6&!^Z4,$1E56+\,B4^EJ@@25FIS,!M8E5X'X3P9LC:ZN";\HQH
M0'+0FB>JK*&([$L[\JJ8WEA,Y^YVGI5V&DK!3*8):&>)5UF3( ++(5F9I-G:
M%;!.83Q51%<=ABN#,5G'+$P 9J))^(Z,FLLH05RI)FX5T16+Z-R7+F((UIE2
MRXAY CE08G*T^*<"+I(,+JFM74YO;(Q7$5U?$06>D38%R;C2()'XEF.991"9
M C6@5Q7,4@7WQH([=Y9KQUE4-!$9R@G-5B5B/?Y@$117R@2<N4J!'X#P1JLC
M&C_"4P=0ZCEG-("$YCJQ+"2_2DG4*J:K=C,M>+R]%I(J88E-%/5JDIHX:CW1
MTD7 V9;@[-:NO/EV=8UEOZZT??M<O >_'1>*/U1E2(PJT ;I@;9&<]0_'')R
MJD;+K!L"+1Y=H87G7"A.$HN9(*UGQ+$4B<S.2B:DB$YO[2JY3MMM=4=]Y0%O
M*J<@:0;F@"KEF:':I @"%X!3KHKP^HGP0F Z#TCG4B:>:5FJ#D?B=.0D,YH4
M@YPCSUN[FIZOVUE%^-Z(L !A?(S)<6& \6A-A,29*!EF7LEZ5,MF2??<2\ZD
M!&E$(D%13R!(1GS /VDQW4VTC)6T$]@6]_%DJ2K?,Q4M::""<:DS@T2-4^"\
MBLK1Q(+Q-29]#85X[D=/$%4*3!)&2])ZCFCEQZ2)1B$6@M)@*=W:O8]G+=US
M"5ZFB+[,1@"/P9<@1\71L)*9HNT%:&85>5VFB'Z5Y3N6Y84X=)NYH5(122DG
M(+D@EDM'!*YKJCR*LU1;N\R>W[;>Y#+Y]UR.E]FQIEH:ZEQ*3 .WVFL(T<A2
M C(A\UXV(JPR[1_L"EMPQLLRBTDYDJ))!#3:U$Z%2)*07FA.<7913<MMR?4:
M:>I51I\SML/7W1__>C!VO67W/?Q@&-.0C ?'C\NSC@:];NQ,^WJ?S_A8^OGO
M#5"O..[^*D ]JNB[!/J^7*R9GZC#*5*&9)X\ <\C\3X!"25N 3D7!2/+&=J(
MON;&=M*R0O&#PQDJN%5PN]V\A INMP!N\RT:*9B5WBF2M!<$</:)$YD2G;GC
M.6C&?-C:57J;"56QK6+;0\>V&Z=M5&R[96QC"S'B7JC #$D*)('@'#%:VU);
MG7*F=># T6A6VT+=>(>J8EO%MLW&MI7GNU0 NQZ S3?GM!5<Q^ )M;F0,\>(
ME383G"7'M= T-DDN]L;Q,Q6]*GJM(7HMLX>Y@ER@:Q\$7B%N28B;[UERXS-H
M8]'J%)2 5J6N#BOG9 BM:7!!EHQX0;<Y/^];N_JV906X"G!K"'!WFRY58>VV
M]PP6=FRMD#KJ*(D**I5@#.1N 301V848!?-6LQ*,8;>9W!C^-MG0G79DNI9E
M UZKCN>X0AL+#RSPD>+@Q/?2N2>^R1UJ+VLO:R_'9P#@]*W4TA$=:\U&?C]T
MJ"?#E\ZK-/S8#=AP[([&PZX_:71T.'3]?NH]OC3O<A79X;6-VL9MM+&B!.DK
MRV_L?IRV/6F"E.\_;I.K?[2 ]]/XTV#XH3,5Y95V1NW(*_3FY^/!J%MPY?$P
M]=RX^S']7/"8B.;JL\/J1JDTL+7[$YO;OCC&UPOKNV_&X46/>&_L/Z.URIHR
M&V@$3[GWG'KG(<7(4I35_OO1]M]>Z]*:VG]*!AXT!!(E,P1X%L0E28DT5"<I
M';B0MW:5V&8WKU&UQD'YM8W:QFVTL:+0\LTF,GNNVT-[9(!&RN91F,Y/_!(.
M<Z6,G@OF\_YE]-@$43J6A(TE@\<X9ZGRD2DC'7?I-DZ+KDI_.:7_8E'IYT2C
M"<*3R (G)0>+6)<]"49*Q9/"N0Q;N\"V#9-K5#9K7:S3VD9MXPZ\%[6\V[U0
MCL$GQ5*.V@4%ADOCA<]:),<MU1F6+R!9->"U-.#>H@;D.H7 -%J\*I>ST/"'
M@:CQE;0E%X2G;.][U;;:1FUCC6W>FDY]+[W?#S<TJJ93KSU'^&.1(^ ,,'#E
M"#/#;$FH5L1:G)Q(A94^TXQ_/=2$ZMI&;>,N;.@:PE?;J&W\ +Z^*<%R]@Q+
MTQ<?N(OO=/;P:X>CSO-^3+'S*AV/TY%/PXZ@VQU.F:V!<K6-C6OCK@/E?LSV
M\?O!L',P&,31H]$TUK5\;72]X-9-P.3:1FVCQI5<-4!V\Z)*?A++!L9>,('W
MU#5X/[U_@M-@#571R@3.6L=H5#0DDS0++-CB_6-VXOW#%[7J[3H["@\6'84B
M^VBBM<3E" 2,QE<F4>*\QUD4.CNJBZ-0;-N5.0K7R!=8(>N>0I:U2F>P$"%0
M8)YZI;VC7F2M.=7:5\C:,,CZ,H]_X,SY'#VA2F@"8 TQ7B;"#42I<E20X]8N
MV&UF;URINR)61:R[*@ZFLA%&,1.T 6ZL%Z94;LG>:6J@S3Y: K$N.VF[@M7M
M@]7^G%]!HH%)P0BUY8A-823QF6IB4N1:"A>#Y_?X+.Z*5O<4K1"I<J1)*Q%0
M[2:T(B!3;L%*<%PD5]%J<]!J3JU\.<.&ID1"*:8#7GOBRVFB$"G+/''%@%6T
MJFBU%L^V3.E"&@"$%9 @!L@L626S#1)RR(&S*YF#URY=6,'K%L'KY8(K*SK#
MI ]$"S EYLT2ZT(F4GN#$ZM+WL+6KF#;P,[7V5^ZSF&%K0I;MW[N:Z: .E=9
M1AU8%QUC-@$3R5C4TE94)]9F@=6\?L63=RHIZ3EP0D$CU4HV$1],F4@5LL7Y
MM4%L[3+.MO7*2N>O K,>6((@RD-_W'DU'@Q331.\U'4%C%$?6%+,@F')4\8T
M5TE;FHRQH1J#&P)1'Q:W!GWP2I2M01U9)* =&H,TEV/H'77<:N9U6IDQN,:Y
MA@]>O&EREBF5(H #&7!),!6\C<6OZ;GGE89LF(S/'3[9-^?(:>(%_H"L#?'@
M)/$6YQ8%W(,N!R_"-C>FBOC]%?& $BYU2?$OQVU1[3+W.E(I(UC.&50-OC'2
MO;#Y),!9G6T@3 C4VRYF8GQ"80>K@\M:!5$U^$,0;P'6BJ!\] Y :>8B-8X+
MYD(,.3%6Q7MSQ'NNO UU)BDK"46I1EH>!'&"*<("3C=55 A8W=YR%>_U%6\.
MX)D$*4 '*#::HS1$G:@4VC->[>_-$>^%_0QGE/=6"Q*U06X>D)L;6@Y%]X S
MZ&)PWE7Q?@CBG5)(.CIM#0JZ8<Z81#.2-Q1IDZ6N]O=FR?CB-@!WR>$\<F(T
MI02,Q%<9*%$&IY'SI+TQ:VB K[).T@;L OP^3$?=DZ/1M;8 KKH+N]$8Y;FD
M1GCE Q=0_(+(1P+7_S][;]H4Q[%M@?Z5"N*^"#N"Y.0\2.\1(0O95PZ#CBUD
MA?1%D2.TU'1SNQLA].O?SJH>B@8DA@8*2)]C##U4967F6GO,O:V5-L"/4%20
MAT%/GU^T0P \2":]Q(CYW-[;Y>ZX@5+$%=,F$+ OO'K$^6 %WC-X)ZD2B4)H
MQ1TGS-@8DHF""*^C,A(7>#\<>"\<"(I$ZZ*T2&@#H&94(1<]1H08'X0,+ I<
MX/T$X&V%--$9I['#G"?F!/$R<:.HQXF16"R,AX7Q5@Q P]+*H!E(;ZP1A^5%
M1DF%D@A.>1(BT8!QKM8%?X3G>PO$%R$ S*S,U;LEYY%2AT-PE,HDF"1:7N9X
M6<'QG>-X(:M](CIR;U'T0@&8B4'6B(ATQ,H)P06A86U3WKCH=\%P=S'LE K"
M:,]4I%P2XR3WD8&@QMI'JXL6_G"0W?+SFZ"L)$H@I4$5YYY:I*D+B&$30HJ!
M)U>T\*< ;U"\P>P2F 2F049K:ZB743F3M-!,E#R[!X;QMI\_A*@38PH1R0GB
MP3ED) >MG(&]%8U35/):#9>$=@CC3RS;?R=.JM[@:QQ/#N(@_^H!#"7O_\*\
M?^,=L5PK3PG7@AMEB8/')MP8P:Z<&'R1/@*K\GJ^**_K-2E<="4N.M4VEVNC
M./<.+ D'5"2Y00XSA@)-A$5.A$BNY!4\ ?@ZK!EHGB0DJ[AVWF*A)-6YF@.Q
MA*_*G"CP70%\%XZ Z*D36&$4N,6(4YF0"1*62'GA!"<^.E/@^Q3@ZW(M.RDU
MUY8'8AP#+3(G!_G@@G27R?HK0%TU4%N>]\1<,(YCY'@,H/)S4/D=-DC)A*V*
MTAH#0.6B2WD]!:0K!FF,C@NC"?/$<TFX%28R(1A/-K&0+I.[5T"Z<I NI"G/
MP1"F$F(:3')8JH ,AS^CH,'R)*(4<6V3\1M7DBP@[2Y(L18JT@C"-!G.K<]]
M[FSD-,FHM.'%CNT.=%M^\P#V"BR&0%(94(2M(0CL%H,BI2+ 7XF4_/@G 5_I
ML:->2.)EX(9+RP0)1#H62#X"=?70=@'J"BS6EO/;),Z,!VAZ@";B"FODJ& (
M%&&B3'1192&KL>@02DN7$@#AF\E^'#VF%B4EV#@OD"\E3CFA@!O-@P2MQS#/
M@^-<8^[899Q_):)XMZ3ZNNW%#TF @JHETCXHQ*/R2!O,D== J%@&R4@.*+(;
M<VK)&.@NB(.T)E /U\&)4V:,4HZ8K/M8!LB^N@NP@/@.0+SP/A"?J N,(9^+
M+G/L"-+.>$3A5VF=\H:XM<V2F?NH01Q=4,:$$)W6G.FH31!>!*6#C\&2TJKF
M@>&[%0+P)K<?B@J):!CB7!AD19!(&$N88MDZ92"DU[DH"'_$"!>4.":])XE0
M;KS2.? N0F V&BHN%6@O,+YS&+?$- X&PT(AEF"). T1=&VF49+.)"6U%-E_
M\0B;39T#X0>(U*LT"J!,.45R4DP$[N;6<B*PRO73 N6)7:80WKQ10,'L76.V
M%1V@LJX^+!'CWB N=$(NNH2PM(1J:GBD>FV3XDMW N@V+)^H9)7>1:^"MBX?
MCF+>,;"A.);26.U#*IUI'QB VU$#(H,@A%I$E,PI\](B:S%&ACLF*(ACE<_%
MB'5.;IQ!T]&,>4(V:-=3YG>'$]N_:H#&#4<ACE!VY>=G'0_[O5#-QOJ8VY5<
M^?D?#U.O]JS 99AZ7.CW2O2[?:KZ/_%6,491[IJ5BP<DI#%UR"MLF91,"I[[
MDV"^"OZ]*BSN.?6BT%NAM]L]2U'H[5;H;>'2D1Z$D3$>Z12 WG+*IY4&K$62
M@A".QY1K)TN^CFEAM\)N3YW=;G[4I+#;;;-;*^Y$F==.,XU\,B&7E.#(":60
M!,I3CF)C70+3F:YS<>/><H7="KL];'9;^1F=0F'7I;"%@A88,X8JT,U2/N:J
M<FH,8Q%AR36WEE'CXMHFIS<.G!?^*OS50?ZZ4G?SFY]?NG9W\T)R5R6Y5I R
MB:REZ8"4-PD!L3'0T["&5:*2.F&Y-;%I6<YNTK*\4%RAN Y2W-T>\2K$=NON
MM5;PUG&M%!<>EH/E\(&WR(88D8HA-X9(/DFUMDFT6==Z56>K;YW?IK'=V4!F
MF[DYG[7JW(Y+7*/UP P>*0R/7#^>>>*;W*&,LHRRC'*R1 "G;R6OG-S1:77D
MO_L6!*4_J=[&T=>>APN'WG@RZKFC6DC[?3L8Q/ZS"ZLBKN)(>[E&N<9M7*,<
MZFX#?! GQ\/1EX=XOIO\6EUXQOO&&;&=H^3+6XCG/>*C,0(Q/!57V&HO$C=.
M&^-,XH2E9$C ]#8.RA4C\&I&X(=3*60I"*RB14DEACBV=?MYCZ0-AM*4HI5N
M;5.*=4,>\]F9<HURC=NXQHHRS1^V,K-M>WVP289@J#P\-:;ZA?Y C[G4*9\G
M4>"+2V&4MY8Y)KGAPM&@F,3*"*UYDJD(_GL7_+XM^)DRA-LD$6<V!_"U0+!V
M 3E,B&5>T9!/[C"]CN79L-;C*<Q7KE&NT6$OQD-IRE(7H2N=UR\2CCHFI8-D
M-#G'E:$N4"E@^R@3#?6D9*_=D03<:TM J9PFPF-$*<Y-&JA"!@N'G*).*&>B
M=>ZQ5V<KURC7Z+#=^R1.6#<#/R^^69*H5C9!CT:5*&>T.Z]E?&EK&9YJ886W
MR$DG$)<&3&SO%1(J:(>Y<-+<UAGM%>"FF.GE&H_Y&K6>\I^)!7#,7+OUC[OV
M3]-K^Z<_7>6?TT[LBX(%1,\4B=X@Q,'D&<JOK%HTZDO,29U%<"LQ@\O<_?FI
M6=$;LIZ%L[E7A\O)&KTQ2-P$5PN5'5>^;WL'XRKU^OW\PJ0:Q4F.B-@!,/DA
M2%[;GYS,7IQ>JQ?'Z[FU;5.MJIKLQ^KE\  FX*3NE:*>C\]^H;[@7[LO3UW#
M'4VJ.*MZ56W;'J@2 SOP<+W;"\B(#7J##4\W](\V/(A$Q9_?VZ98VZRR;/[:
MFYRL5\?[/;^?E[M9*EC>X]YDOS>H%^Q@$?:JO)W$O>'H9..<):@.X^B@-QE7
M\(![O2RF?;^76QL?]N'9#N*!BZ-Q-1G6.RA?N3?*UYY?Y7 4QW[4.\Q3"9_;
M!_+;VV_N7HMYV(M]F-S1"?R9MY^M7O[[MIIOX^D^&D^&HYA5PWKL8] #X<)Y
M=+"#%]?:>( ,0KO/(.VM\A/RL-4%7V_6.@'N^^V]V6S,<8MIFILUUZW?'L/N
MJ(:I>CO_R,OA8!#]I)##U<EA.K&'/?\%%NSHL%FSTV0-JP-+>QP!SO#?T_A=
MK/3E2!\4G=A@]CQF&0WW1O;@(:*6=0VU+V'/P0QG5@22/(D6R/0 ]$P@[GT+
M '(Q#F!]8/W'XU[JP1IF,@7;?=P;P[( 7K-LJ%?*'XU&-<'#X(:AW@#PI\T;
M8&FILCV8S?_>X*A^NZ6>;OZ_;O2?S3,K>VL.C/J*SWH3@)R_Q +.RF]6O]E^
MWI+C<T;:&+L[1P=P4[_4-<.HX )F#EO.4R V)1N8HBJ2Q$1SF(SBJ9L#?JG=
M'%>J!?I?,'K]R2[<\;?^T']YF)Z-?OS??TX^O@^'CG+YYH]WW[:_][]L?W_U
M[</N3G_GC]?'V]_WOVS_L7WR\?,+NO/'*QC_;[T=^C&?!?N^L[7WR43C0L(4
M<9%_4!:04SR@1+P41#H3E%NK@*#L(4SM9'04[]Y%=GH_]7O691&7R0^P>&!'
M<#, WA1%Y]+FT(&<J &4]2BXSF"<@#4SS/.+ME_M#8=AG!6D\4RHP@<M(+79
M+#66&XG:NCX /U.RCR">0@-U(./Z/NNU-CZ5OM6K;W#/WX[\E_%])4!=W\!L
M1.KM)*!?<NW_B<=V%!H#YV@PBB'& YCPV2KL]=($-&SXQ$:UF^FUO1"+]1G%
MK#6/\ZHN[Z43N.RD=]XN6% [R-*OO:SBYQU4DWBS-3:JUX/Y3EH_M3W@UL.]
M 3SHN'*C:+_8/="S!N>,N\K3'?)[^[VLB.>%J/)S'M1:075H)Y,X&HP7TN$4
M=9ZA__-DP^V2[7D,FXLL3UX,PE^S6=[-?I:GS+C;WU]_8M8*JPA&V*> .'<2
MF20THB%JF%R.HQ2-SQ^$?@POLJ->*B^LC,K1I#CUV-  OQG,H_4>2W^&H6]3
M$?@A5#/^TK#?'Q[7?HN\X#/D9&NC"3WD+6W=\&@R!6?^5(/N,\C,+)] @L_?
M&3=JU Q]XV<7ZK8@&?9Z@YD7/'/<])7,>M/SP/7X9I[#QBD.,]6WA^/X;/;+
M\] ;@RE^\JPWJ)^W_M(R7\(UGQ_WPF0_1W0V<!/5F09 I]>?OKU1O[7DRF_>
M4V2#<G;AVWB#7/C>CRY+Z 9GZEJ7_?%[3-/;&:R^U&5_$F3NQ(%.\U/U69V7
MJUR/-8#X:(38L]K*:^3QZT$3%()1]+/%>(E#GC^8"0\J4QS=\5S\X,G7-M_&
MPTGM\ZH87J_E6)8Y5WC*2P0)'M2$; %'-O-!9O-!S*GYN.M3!O>283&RH$BW
MY<4O<Z<K6.4@!QM;?/&)]>R/O[T"/(\[Y^(II50XHS5-+%&3 G>*.1F-4HP;
MQB+GEG]ZO=!ZKYE)<:%ZO!,G+QMOT.-(LOC\6__#P6ORX7M_?WOK;_X&OO-Q
M]V_Q83=\WOYC!^[S@L$(OKW9>H67DRRV__BW]^'SOY_?O']UO+.U)W;^^+._
ML]7?WZ%P#PK*\Y:'T;_BV[O_I'F"Q5M\_"FIJ 5W&D4N$^)),61P),B[1&R0
ML*PBK&VJ=2I7U;S\H>1/%+(K9+><BLX<)RDFXK3D$1-G650Z$**=!N/#9;(C
MAE!&"MEUA^R^S\DN),XPB0YQPBGB-B;DDN!($,PLU\2)X-<VY;JZ^7GM.R[9
MU6D[[I) /-=+O:RHCH[@U_CM, [&<7Q&03WGU,SC/AQS??7KY[0S=ST6WKD&
M[_1:2A:-/+H0%#)!8<2Q)LAZH9 +FC)X@Q)M0<FZHH9U>[K2%?HR/FYX75_@
M%WC=-KP68MU(S#VV"D6!63Z,1I VCJ"@H]0QA."U!'A=L9+ZRJ3SZ139,]&G
M\[(49F.8[EN>'?!G(Y!SG_G_<[IZQ=1KCQ=?L0XTCZ/)Q5\YX\2[IT@U84LY
M'*V?^Z/%TNQ%5$<%D4TPV&>V?VQ/QFO_.1W#Z U0>P*7G_WB<-_E(H+M56L0
MRXA+@7$<,.4<$VFYL3A8*G,#;2G8<FA*\>#@79^TPEP8D.7."*'A?U+89,3:
M!??Y:4CK'H-86T>C6=;M -ZL#N ;^^,J#K(.-_=/-\AC>+W*^DD=OLI,VH2
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MMG?;,O:*0<1\X<4>J4YODIRP!__MGP#&AX=YXY^->W<LE_=\%\9VM#D=J":
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M2JW9RS![A\-!8U2_'E0QSWZC>!_OQYJJ;+7TE7H.XS=@WZ4!U9P<ZIQV6$5
MZJ1^F@2\-1S-SH?FL@.-L_W;;&H;VLFOM38 S/&4V^S@PHT%JDJ 21O'A14
M=@B(=V 3GP,1RV?4:L_7J''(+"!3<V0 FRM/_ZC:B[G,["&,*K..?=[4R+(G
M4_$^.@(>7IQLFUWF^>P)^JTW%_<[M?]A- ?V"[S@]\&ZZ]?;N;&G\_U!IH%I
M<]B?WS0_9QT3.9DUFIL]S]1(6KZ^.\E]\9KW&LDWM=D.:E?+].-+.V2^%69(
M:QP8X]/NFOJ(U$+SB0M_QWG 7)]C[/2M?[03&^ N^G<WLC:_/8K[^3SSU[B
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M<N538J4"H4RML(@+#D+9\HA8D#+1%+%7N;_5.L,W+J.W0C@_Q7-%?C@Z'(Y
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MS!O,A-*6"TF-82">A'>*:F\Y7Y'.49ST-V.F+Z><]!H6S4F*$NQ0Q ,%8J+
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M_O??OG]S],/9FZ,?Q>M?WQS5O\MY^]4_R][X0NW_LWC_KU!B<8(<>+09L,@
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M#!7I6=2(33]!:P<4L?6"$9O#!;=R:;Z ^>[2W!+L"Y=&"<E&.PNF> _HO(7
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M7E6&LX4*P2NBA."RM-$F\L)C#1FC*JHD&U@DU%;D+L/91-HZ6Y+A>.L+9JN
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MR;EGUKENY."B-,8:"E0-E]$QQ. =E6""CD4(V24]&TAE+[]9DO1$KV1N3HE
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M[;YW.<]:L+LDYW&LB;$$B,*WTEA!0]2<P<N"=<(,"17Z+GO'[EVYXUWC<R<
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M5"D=]9N.^N[5K$0"BQ,-)RO4I4L@HB% YR3X6!383.BB"8956L-99^> X7+
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MV,'_O%%\>_<W)]-9)X";$<#2]0HE4)#QH,A45T9$!R1*KGQ08QHML/JTKA/
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MD2@5]=XI 26$I-!ERZD,42G1"6#=!%!$CCX*;]K14ZX1+#)35CH8306[A=]
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M\3E<?*+*]1]5'*+%2M=16>N$U<YS,KETW<!]XW/YS$X&;9H[ZTL #)+!QU*
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MW/4%[M)S$';@?BO@SMTBOCH-E:3P63?/L 81@C("@&6M4SHP!V]MNV5E)NS
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M1O.9T_<=L*L [$*11N]:%E3?Q&\6T Z.H<]1Q-3\L-XQ@N/6-O10NS5&*[C
M0K<6- E 4XRU[1.'FK ER[BJ"MTE[RT >6[?@[>)5(@"=' ,9#;R0T@MGL<
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M$K2Z'#>NMMFQ.5QL?KUAWK&Y?&PN6-I11I=]<ZX'Q>INJYX3?1+!:Q/0UUH
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M,F;NT$["!O- U0Y,3+9XS!!3C1IE!I.!M,P)>L:^(?/ 0E+@[)2!Z$60BGD
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MFVI/YX[7R4ZUX99J VA%DS0$\%OB#;H"3AC0BG-T!42UIR\ M9'I$)@&9WD
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M8LN7J +SW$$ICSD*/MD99P7- %!SCDY5:JW4ND#RN5+K0E#K1$P'CQ;1Q$3
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M]%> P<X;N@5(4YE'3]!#1A@P0XFUS!$1 P06!&<NH*S3EV./#Q=V 34\H*0
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M\6"9$ 3Y%PB@72:6@R;*>*?!E/-?Q1&]8YY ,X545EB1J;64[*U'H!\$O&H
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M8#&X[E'/V?+ E'+>!L_*645OLDL)G7--39#QM+/0!5F=Z8S U8;7'Z>/.[;
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ME)"EP"D0D(X2$VTHO9D$H]QFI^72,KL<"V@A\';QES>-3BW4ZGZ^.56Q6[@
M_4LTVD$9NR3K*-O=D5IN@%(^.1+O?5RH%N.MO6:I+O#8:#SMPST$>1C^702P
MLW_8R/CS8+K_>V'40PEDD(S+BII2D\UHXQQU45DON$H*O<(AU/ [*;XO0&%*
M*TESX$GGYI0@CX@WKV@J9P1MG'8?932/(,J90@>2)>L->$CX2W19T'CQ/AH=
M4X@Z,F8"& XF:.E%MD$)Q:2#43?=2RMQQ2L+Q>Y35N&.LWKS+-U=FS06Q76Z
MI.B'QIK9/[T ND6#7AIT>HTB:/FTGW)!XD4E,_ST_"SBFZ6@-=4R&:T8%,_M
MLEMWU(F#[=,XR\2W1GXP'7_%>1SJX6#Z5R:\W9"*.IDW#3!Z*Q[@]@*[3?S<
M[HUI;"L1WTON!W$9!_O.[1ZYX_[2O\\]$]J[9'("+S[[\ F7_Z_O_7OYJKM>
M^Y%RGT;*'>>1!ZI#\*C2$^)"LFR2"4*;Q*7=U';I)IN3ZXM,7%YY\"705RZ!
M??L@K'2KNY^G)=8$&<]BB",5-X?\\//FTP?7*[5V^O]-O3^WD0W6\>*_[G;#
MCR>V@];^'-E!>U_$ZLFO/]I[7P'MG]W5DS_VVFC;K*W\VEG]]N&XO?>!HDWT
ML_WM^\Y%.^C[2CA9_?2%X[71_OEZTOZT(;[O?8#53Y]_;JQ_YAOK?Z!-](%]
MWVOGM97W)YM":F65%:3T[B)@E28^2D>83%':YI"]OJ@.'2ID[<%QY'9(PGG/
M+:H'@5:N#X&B/9G0M#PH--,[3$O+IQ/>PAEO-5-^V8JY@+7I0+Q2]=PXHO-$
MX7I;R!4CVN0HIZ-72MR,/P(0K^;"LVE";=+J;[NAFUSTX&%1.8?]XAX7[30X
MZI)&@;;VTF"[&]^VFA!XX[FD8GB6>6F"F/VA/CQH=%/Q<PX.>V';H2<UU:-I
M;MR_%*K/TE/-.+< *5B3 [Z0J94F!95AQOYNUWHW[W%Q8P>U%ZJ\/\\B6A]^
M#C5V:6?Y6S,ES6.NY8MH'MH8"^/</#:H5]=7V::F,67G%4FHIDJ)<TF\M)1D
MEIVSR4=$!SHW>JISTXC-;"(RAX,[540>242^'&\J)P):^($PGB2*B)+$*0=$
M(EL"VNTF.33TV>53.V<B,I2"8OXB1>V5%QH2.DHET'<X0 MYOZCV-RU_.!B^
MFD8+-#3YFY"DVPV'NV=1RF9-\?UTF0F+[=]PWW8OI48\\1-IY"*7='G\VI_I
M (URGWK#J(V@)2;)\2>.LT1Z4%IVCW$\*;C#?KE4ZO1P4*D7.OCG 2HB?)YF
MI%MH:Z*=B1]Q0X? _8T6_A;>S_5^H,_>?/8LKCIZ_.%\X-#>E)=["8><W@R#
ML3GC[5M'W</=B+?'SXSE]VWKX^C1^BCC.%37+\&%_@,S^AR.QU:X/@I<VRL_
MY&;V/ 0!F235,+I&?RA13Z)&GYP".MX.W0YV^;3./1A]#F>ZJH@\CHBLO^>;
MW I.K=8D2I0. ,_0DG>:4!^9EMD(IXK2OUQ*Z3DP>FM(YLR>)_/+>SS7.@X/
MZ%3^&;93/-Q-EV7S5]?OA/?[<64X%>M-$LJK=3E7CS:#XX8R8 201M#EU(%X
MC4:(5,J5_F(A!'?1A7R [(I;>F5EPRAW=W>[1\7]0H?,E?!E=S]T=CMG8N[+
M&C<R? N!'POPZ'Q?_]W4@.!Y5U6>=U7E^3RYLT!>DY8R#@XVJ3 X7;ONH)_>
MG?[R2^ST#W;=\;O.?O/0S9<NIHO@7<9AM+=T&$H;G< <77_T]MOFK0L)/,/W
M)'TK%)OZ-GT[_;WK+LOH6VGEG2Y[_7O"0!WL<QJLHOQ6E[WA_/"-Q_SMI8]>
MD:TZ1.$C)67>%&(=GBAN%.QPW[?UH>C51CN>TZU3RW^]_.EI%ZMCAMFYI10]
M;2+SZ9,W%WS7&>#-PHUS,1PK6NC=X6[6NT.<CMXP7?#S_M"I'MF*_3?#/]$
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MXF_KMP>@A,GQ>KI>CJ;^<+),8U]&>CGZZ.$XX'_G\  X.N_@@*?PB)5>I4<
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M$(!@9[&2+T)L;983-P$VX^/EVND:+WKTX]PT[. =4$&%]I]A 7#K\4_%#S.
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M99*)\R9[,8):-]ZWQ@+TU6B>V4[FM<,ON,L+& 5%XR\<5SY5W#;*] DRP=C
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M*E,;4M*'AR!(D)%=8!/OT"'[PM ^B_J7GZP_6341_X\3@!^<NW=;$1H]P]L
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M?4=<*2YP/*KXTFF/O+9Q9;MY>"_.JE?.I;BT?\T7DW\ =NG 8A+H.Q !P*Y
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MJDZZI?-3C\(;*+#Z"RQCVZQ!HITGW0",I\FR_3I8N;&<#S\8SW$RV[E=$RO
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M\>WO_SY^\_?+[(]C?-=A_O;%X=F?O_\[O#[+/OW\_N7J];OLXU_.6JTX+XG
M=!XNRT"D"9(4DBD,RRK%U,%3QL9<Y><R>[;\CE^!F)HW7@$Y^]05!_[U0/F7
M]LH*61@;6,%MSH&*<Y-3I7G.@LCEP+_N-?_ZI^%?4@"[@ALE19$KPH//B=9,
MD()S9X(O2B/<P5/*QV69#?QKX%_WA'^5PAJ7<RJ,4#SS5!?"Z4Q;!7I883,]
M\*][S;]HR[]R)B37@8!X$H2[DA&32TJ$]C[G M2O3 #_DF,ARH%_#?SKGO O
M23T']N6S4C!>!"L+)W1&):9Y%CISE^!? Y.Z8R;%&B:E2\VY+24IX5()5Z+
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M8?\BX@-\;RB_?8#O#<*WM>R\-%98,.IDX 7A+'AB< Q]Z0IN?+"%T&J [R.
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MW#0D*/0[T7Y \6V@N/4T!,]U3@M/RKS@A+.L)%(Q1DSNP=9PG.:YQ_GT1?D
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MGS[^^O73!]C'QU]^?/[XYOOEQS<_+C]>#=Z^?J-=?<4]PV=?X?^OO^B^3YS
MISW3)WK/B@9:S]-<K6</@H$9!-0)-)S2M'1&$S!74@O,140\Y0F!H4+@GVAA
M,[MBH5A[&A':$I:_4P(.D?(*)??/8&D-T "M)>:&C(RZ!Y]YN,G/$D:N'FPS
M\MLT&^2T8M,L9%9RPYXZ?S$'_J(7-SX_UU]%I?' 1QB)-EV5P @GHPF/.V%T
M("UX!$ A+-#*_&=F^I%0_!#WP70-FOXY!=^ZP&?%:'KF+\PXP?O ]3M:DCAY
M_L>'5S6&9\H).5E?3<!#C$/^;Q1><3IAJRTO\^R2+?>OF5USN48]4P^(&]+
MLZPP-(@1:;9.J1[:GN%[/A?3\ R-+E"V1IYCZ*8#XI-:ED$'@189\&/'-D%4
M&VZT[#VF-S \W0L&ND\MWW:);^B&KX74#FP=WCG['LTC@\  =4!,UQKHD4_\
MT(M,6S>U,'),3U1]SF%BP2>=L@$60V=3J#X,I4>*JN+>4N%I$WF<D#1%!@0Q
M(T3:4@. K3MC I#(,URJ!:YI^A:E'B$#+]" # UBZQ[Q'K@7>G/U:_OV![@5
MCI,-_L*0P)\\!@"08#GYC7K73EB]7WWXCW&);7I-*[!TI^<$+NE9EDEZODM0
MVR,20-O[T>">^[U%F 2:=#73HB%U?"N,@L T!VX4@?U +$^/O ?2RR0F-\/D
M@-BA%OIFSW$UP&1@>+T@P)9'#L@) A+8<[';T7Q"[=P'/) VKF$-G(XZ4AD#
MXX](>,?E0JV;!W%>E,I_)R0O08( WZ.)/F4F;4OB 'UD6Q8[E)@V&*^11D+-
MLG60-P-P0W2+1*X[& 2^%#O;)]:W__GB>K;I1K;?BPS#!*\B,'LD, 8]SP:%
M-@#XT\A\]M*:+Y==DS8+BJ;A-'%6]O#]M#9K&2/!-?9I0DD!SZ*Z[V6#'L8P
M11"PN4VJJ5;<.>T]!K30U'W8AEH>(EK=VGWYKR!__G+UA1YXC+$/,8S("#4W
M# /3,JD7.+8^\*@7FJY'#=O_HEN.\^RAMQGN[+;QDR?/HW$76NFZT7\2BW6E
MU\_$]ZR^79FLC?NSA6S(Z6C,>W![Z7\G /A?V+WK!UC\YR0+O^U71GZ_>OW)
M^,/X?/?I8^A<&;\FG[^^@?7?8;K,CZO70Y"1;VXO/_P\O/KMW==/'Z_@/='H
MT]>_;J+?_K:BW_^=?#:2F^!K9G[Z^/?H\NM5<O7;)_WSZTOM[6\@([]>?+_\
M[1?M\V]7L,Y?=U?&Y_@*WGGY^C_:U8=+ _XTWW[X= MR,D3='>+L!)R,;>E@
MJ(&G%O2\T L\2D//L.:<)]W4P:3S;=^R;<LFF@_(CAS'-0,,K!G6,X6"(AH#
M$LI\0I^];%"@,!S,>[Q+N':*:_Q[F7:A__+P1F>\0FU "=$]#=Q(*PHM;Q"
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MN433OQ?\2D164)@SMQXT+0JS>#*J\ZVJ4!=*M^%\K.MB4/+TV +S6WFJWJ
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MX1&.&:<L-QP#8UDQ ^9%[,/N#O#EXE$.T3CEOCZNA?DS\"]V6["AHKL?A3'
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MS2I#2P34ZG2**N0"9#G"AIYCP@O+4:)@*)BPGF2LEBCBM4:B%9EP]$0#,+9
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MT@H("($UE8P.S]845E';M-Y;'!(1U7JCCI6(+$8PAKHB428K8,0;5S<N,PD
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M9,X6(Z?3V8]M9[FBC!?U/KF.5$6G(1;TJ-46%N=.DDG1A&*S="H3FW'O8*5
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M@R?XLI0YM:E*FLV96Y >NT)6'=J.&Z2L38T(9+'"BF?0QZA;*X JDDD =1*
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ME*=6+^\Z&X[..M#@W$'B2#;:[CR*)!MU'T>2C;J.(D?V,>@\CCS'[^]'V'7
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MH6&A_))&-%+>TW%)1P'-.<V8FJH8FJ$I-T4?_J+[RMS)JC.-2'X=IRURZ1I
MYG#. /*.WM!T0HNEYQ*$W$.]>*Y[%</' *ZT/._A)[N_XC*J9![#J?EZ]UMX
M,0T;"]GLV<L/&<!>R05<\1(NIZ0 VOJ'T3>4($Z2.$M5)<L5LV__4X4?*.60
MPO\C,8XX,=)[B3',1F.2PP_*C#TZSF-8[8Z27(GR&-ZK!'<*R+3;<EBMSN_[
ME%?PF/(S3>D@+@N%I)'RCI8D3I[_\>&54M!KY(VB+VEA6[3P9X*H!\A2A>U0
M>_&> UFY2$ER5\0%^UA_H22D9$,. 5MQ =0SSO)2&0!:<=D2* 9H*D[A@Q'!
M?RDDR"8E0VU-:=F _?L54D=ZQU+=W!?%/6@]" 'U=DQS.')ZK=#O8YH6\"Y)
MG]NBSP7 C6@MKW3#4D8M>:7WK2W+J[ZR8 <$_H^O -^A<4&N*2/N:<%Z2T&6
MZ4;?^>?Z6U(54A\4EW8U)2# C<HXBX%5[MWQ!_AW_2R\.9L_P2T< 1X!DP#0
MJ$03EG9Q%O\$;_V'X>H54.$WM(>]5J\)KL,/49"$5JS\,<N_T;P0K,PX&U[
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MZ=,D Y&KD!N@ZFO<2U!NXE6];UCNC_B_$_!!RSLF%U^1,=(<R+TB \U$-^7
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M&Y),N$/1$%:MA^>9 F-[\(_K24)RH=IAU_@VYDP,LUND*-"N68BGR*LXAD)
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MX);SY6/(C8' B+19&"PU@$:"7MTD9"$=3@*/19:'L5B<=-/A+V4;;HOB>(
M6 ,ZAH,J*;5+(1C:1Y\+4#OQK% G0<EBEQ^ 4&+"LK)#WOM/\%<'A@K7?&K;
M2E!RYG='9R/X(<37(^$>3Q<<P3X8CRL*R(/%!C//X7WD&9%:L16. G8.AYV
M"DLH&%0$)6T-*24F#0=ZZ!N+5QZ\K3EKWTJU3<CFL'4X!(+66%C^G(GHJ.<N
MW;BXMY2PK"G%V'!#H'-PZ1A"CU8@#8(P(IW#<P.L. O "4S*3 21B>*X.
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M5KC6;D!7H&C_!!\M(NUG +RC?66KF"VG+.0(Z75T(.9N1WL ="-5:TW?=K4
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MO*K18:PH69$/,\ZMQ2F>88LZE^^/DSE9O#N'1< C </\_,S@9N?3P)\&5HC
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MQ@NF?0A"F,"*V;O?X)^A%O%5&5N1O;3"N>O?\":&M[T4M3_^>1J^^W'OSU[
M.40CWKHQ$+M=0-.HDD@^!$O<L16NM1OM]T4(&/H$'RTB[6<@8$?[RE8Q6TY9
MR(,.O8ZN=3O=CO80&? 7<Z)M['DG0$Z_[6K>^%)NB=@ KG[:P4=+)TX9WKT(
M:]=:0I&WS3X*V0RBVBIT@=QA4HV$,4,^7(6!D]@Q9[S'A6LO!/LM8?5KS0^
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M7!^4QI+;?#&S%SY@9[ZF<6>N3Y+=8<!@Q.3P?KI%*XH"&XQ%X#P$8>4^,_%
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M[X9".!6J6<]$(VF.UH@L9!0@*7_.I)#7-R2\(.14-M/SG)BJ?RK&@<@ABNK
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MD1\X!?N=2,$EU*[%\-6QO(PV@;;Q0,-S.+@KR-+\1-:'"V>1+B@7ERW+H\
M\H,E'!CY$0-]:/#J.K.+D5H6O'SE9H9&1K&LA?D/;ACXB*F[2BTKN%U@5M#'
M'1Y6 .P\:D0)6X@0PJ*UQK]F1Q<1=\R6SC4C8#NR0U><7,(D"U#R*&C:?4R4
MR=O!C>S1QQ=J4S@ <T/S:R&6<;E/,^"9C&('/#I$& 2HP#D5M -1,QK/5@Q
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M6!DPY0R2C]'KD%NY; :8%UN4")-&BO6L'R="!*LQJ]8F>E5A0PC8.<LY)RJ
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MSKH<[<"N'RQ^DZ/#YB'CG=\*FTIQ0<>Q_%)(-/,5_"UX1*>XSOF36OVC1TI
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MWZ-R,VO^TN2'-X%>#YIN\,]8 ![H_4**C] !/DH:;:(XB\&=(L;C.+RHN!L
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M7&5'MD":23YW,5G%DJ_E]S%,YKM!T&[V^J<@\9QSH3WX_,FF#7:B7>P ;+7
M;+*]WA$L$/[S*,*?))):'ZAC-@9)#%1I6HX*KE/5NH;VI):DE(KY['0<<1%@
MX0-LM8 FF_]]>^O:I>=L11E?UH@X/'A<1H1TXMP<*V*_VS_&;##=S@>G^.YH
MO8X>UWIQP]3-62XU^GZ$M\S67HRO-\S<6QR<\H]6Z(Q0C1&NRMIOE&6QNR.
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M!7$/6/:M[EFWXZ(B #*&3)Y@ST.IG?EGEAL-(3F,C_E%F";_<4D,3@>:^SM
M!D(*%!;3''"MDD7X-FI7<% !B<QLDL0V[(DQ^B@#9 HIOA82Y3#]Y@JCVYC#
M[4:+;!Q?),78-2CFS$V)\E\?8')!F1YB%ZRC@Y#HG*6AHA IDL4ER_'OE;FR
M#AK"!+W'JV#2WB=Y@523$Z7/>GPBVNM;88UKS-<J6!K^<3<Y3<QR?P: ?,C+
M_HZ7<:!QY=G<[=^<?GYWYM^5J3_,?T+FA^.L<J'FD:(X+%3(',Z3BGJ=<M6T
M,B:&L +8*(C8ZG7Y:3*&<B/8U81N (.+0?$TQYJC0SKM=9S&0ZZ'U\"PY?6]
MHFCBE=(0LP4&(H])^&NF:5AGC&8.@\*!Z!0HY$&8,RF8<3+Q<)F7#WA<'*FS
MZ6A.@],Z^LN9,VZM&Y(%8\ 3+K64V FVES<GQ<A3?F'G1,;3/C<UIF-B:<"M
MSZG*H$*,.Q&&'N+/<31HJ/=MKB>8&BZ)NT503/KD!G['1T'9M?7R]8A2UF<*
M38'-TZO2R+-HK5SY!O7F'E".G T?D,::QTDD<MV.*]L8A PKIWR$F;N),1DK
M+C.DY>T&[V.4FH\[HGVI%7*&[WF+3U@@-/4J, 0S&&ESZ[JI4M@7^)!)8NEB
MVN2@&,5C8UP85WZ/"SR(:%U>+2/3$!"6D%'\3.S)_8@QJ_ N/ 0BP 3GH>(,
MS( AX(I]KQJ)J%:<-%FSO!ZTM=LI3<)Z5::_7&WRHL>>]SNK2H0PF>QTE'P:
M184B"9(_;.7QV-XW'DN.2!_@4DH=F7:C8HVBR288:QY"K+G3NM%_I5E2%%V@
MF-%"*%$\EXQ5%BB93L!"N0E.6]+J>:3BCMP603CMF6BT)MW$##G)/6R"4.9%
MW% 8+P LQQY<O;V1N7M=BAI3&B7A19I1@:%+8$1\&N>URM$1[W;248H_#"Z3
M(BF5,0H */F]PEH=HDH1BQJ.T[GEPDZL-?NLO)-;()P I_KH+_Z)&@5%O'BS
MM#A-5['BT/PB/AF2,7F2":7N=$]-@7G)I5DSV+,$Q>MH-G:2W2#*JXN:C$;.
ME6],NB>#.H<4KFB;Y.*5N;NY_;QP-93:0M%<)(0ZP.MT@]V^6M-0I;'QC3,B
M!Z*1F:$U]/$HF5Y[?EK:?D(8LH8?<_MNONK3ZY_,*B04BFH51D@XP?!0!8PK
MXJ]&>1$.SFZI':?\Y!X6N3DT\X#M3,GI*Z***^STP=LV%Z6*7.*LX+EWP/&R
M4,8NS[36RST9LW*YJU?(@2Y#F)M.X3/'G2[RD(];4H[H$6ZK\88+@*L/;R M
M90R\HH'N7.YZS'$=)+D5S$0(ZT&IR$? B9E^JF@FUIF$1Z>ZHV+2\0Y.7&LG
M1R=J'B?O8D9V4;C^:](-/I)MDH#O[@;E0N!'')&,1*N*!IK5X8?K\N JQ11>
M;/1\6KD]<.W.28:=YBNUB0>.[2*.Q>9/\G;]TKR3,Q^N&$=6,1X"U4P3"1%C
MWE-Z5L,L89:N^9<U^\CH+Z.,; "J6#1J4K*.%XS:F RH/E7>@FQH\_TP&3\2
M^IP/J2T_A%%6BU"ZZ38FAKIG0_*PJ&;3S!(C9:XPK<;/)FL8C+:MLV=D+Z3@
MHEL"X:GGDMY!:$R"['Q,Z%)*.=5,3BYO\1$Q?-QZU9-Z0P0KD^L>F*A=([>*
M[DWA4)$';4U\78:_D:*1\\.'_9B3;VK?U$5).=@)MKV"J/+)6(4O:X.YK>:0
ME+.@D.\,H!ZAK52[8:8%H4;\XBF]'*J(R%$DN*9 0:#R\#EK$O(WI$#A*BF
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MMDR?I^KN?-FU 8#,(MR_5)*=<;@P!_@(7^:#531@ ADFENN&0AY4P"T,(+-
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M,JSPFE6"F:9+O2352R[Y+)9>IRU6WB )FN;:OBK:>KL=-UX%]/,;14]_C4@
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M^H^=R>T/L*HK]A#+_<"JF!-CBF0?;#G*XM#^4$UB"#*A1<RR38[D$9KZ9MV
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M&C"XIZ%5<+01@<]TM[/6,E1-=W5ZF=]VK)8!_H4?IT](8>R&RQ-;;X;3Q15
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M0[X3T03G$_')Y-+K(9)R!HTHE8(V(F75IIZS&@=]"$S["]UJNC\.=-?03&-
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M*:C3?<1KE76R!:]IZH<B4;M,DSU8Y4,1W'&>@GVXLD[7P?=!\H]P5HO.O?V
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MS#V_]!M^/AM_'$^6HUZ%FYC"/4;!2JJ%NIR7+$3Z*DE$L,DJVLNTD,&]J)Z
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MBSA?S" M1CY9'P)'<O;K;)VYK7M$QQ08E*#!6-\D;;;%8$X]Z'07E>X6=#H
M^7U7O;_WMGR%O^9$I1H)40_[[XSL7^/%A_'D]03_"V%V)R6&\YAJHS5&VU=/
MUHZ600W<A.2S$$Y8Q:&#.]<<Z/"J/;Z6.B<Z#2V$03/HN@WN15G@C,;V[L-L
M>O[^PR_CS\MASN^,4SJ9T!7!K'.":64C@QIX%F2I/I:5=OU>L)G@NV+^IOW3
ME$?/%>SZ&"?4<=;170[T'4ZVC#.GDI*I;[HC,J+0+!HEF%21B)"ZR*0'>@VZ
M8O[V&IRF/'J\%.F0TWOO^*ZL4,<I^.:Q@3&Y+ N/ED(#!# L1I!,>ADM&!>,
M/MSE.1SG-[F?C@QZO,^Y?VSS&Z]R]=>FYXL'K%V'8K0MVFC%0BZ1Z:+(=\-:
M>",'P2-RXW67GA4]P_HFX*.1W.-%TAYE%F3D)DFLJX57M;,A(:V1.SF2%U6D
M$_E .9Y&B8M'HK:#*>KQAJD'TZT,96T,.4NH#4GH=0"3F=<(3&B,SD<! Y7!
MV!WZMP.XWHAM$.C7=02W3E-^@?'L/^'L'$>Z1 ]86^3Y>CD$TK-@,\W2V@2?
M>2QQO1[JL++<#/M139Y["65/G?; \A$UNNW4XWH@4$O(&EU8M"(S[3$R$"+6
M L:@A,JF4<>+WD;P3;F#<#] -:Q[![+AS.)Z(!R5LPA8O9=22R9QY@VY4#FY
MI KRE$] Q/>-X)N(!^%^@')9]P[D+OHHI''>(D-KEBV6)0-I++.20X% P\$F
M24J'P?XFUW8L#UXNZ[:OL_$HXGHD 23:Z#/+AM/NM/:#]-P[)G)$[R72DC)(
M,=[]A_!-N\.PWR"4N7-%,6U< B\M$R+0!M;7#:PHDF6;C) JZ&2.L <[9MFW
MD];@GLPU.);J4IS"NEP/SPP+F%2]&:LO0=3,J5KA3"GGVRS9C[86W"''27T3
M<NQ:< ]E]$M,62!XYJ)-3 ?:ET7)/4-N93*I.)&:Q!D^PB(Q.]'>L4C,+N8_
M]6H;7<;RK4C,/D5B=E))R[(;^U!\ZK+-Q66ND.04++W6]=V&6!*S1AC)$3CY
MH,]3KGL6B3D9M>["; .5=L_8M%!L2EHS;MTR,"2R (X6FN!2*<KKA$VV#R><
M/WL\(>R==[L+BPUJS'3.]32&BUQW4UQ(67M2^%KJWS("B1DX!PM-DG).-^_V
M9,36A,.>8^<?3#0-P0HCG&8R%"1LV;!HN:65H"A3LQ&]Z=)OYO3R=8\ND][-
M/WPKP-L-'GZ?SI>?WDL^Y_T?W7,VYP[C6,OE!"%D$ 6Y,E*KB#'HD&(IWA34
MFOSGSD\9,I-3(LTO3B:68J@U:VB9B]8Z5@HD&ZU6R)L<0ATMDW-^ZQ&O)INI
MF/_O<_KA A;CS_C3>%Y/=,YG^-MY?1-?EZO?N@ZVXUISI^@UER$PG51@ ,HP
MDH(0H+P,V*4"_T$'Q4U&=NHA9KOH][[#Y./+8O#NA2^GY/U.SJ?G6Z:C7W$^
M?_<!)D+^@W[SP_S.,$=2:%K/<JY+4CW)%X;Y)(!YF27-?LZXV&2+W7A<Q[U5
M.0$E[G1V/JR,FA=]W75XJV&]GOTZG;S'V=WA91'(J3>&R>AI_\A-I)%99-%%
M[IPC3[_-OJSQN+Z]):<KHQ:%*.\=WN9!W1V$]I:'Y&A]#C5;0&M)^+,D];I$
M/\X8;!,_J1?TWQ1_;$D,FB"Z>0!702Q7)N0HC1!*L*) 729Z![(H I; :W4N
MZ3N<B_0"YBFZZ\=AZN0<C74_:J14#)AT82$82Z,1R(*+CL487 ;00>HCS*6[
M#F,XQ1Y)1TV=Z9U$<'*27G=Z1E&D$*($Y@294Z/U+&@O&1KR<*SV@J<CA$3M
M.HQODAY,!"?BZ-*ZIK,P@C.G<5G2F=PH5SPC\#J#*4GR)C5O]P'[39X]$SIH
M-LA#K].-SMOUQU<6--ERFYQAP&NG;9=K$>!B&5?DZ'L1C;5FV%#F/4?R%%W<
MTZ!]\,ET5V]G;9 C!&.L5(5A$?6VW I:*9QEH1:X-9!I'6FBZ::C.J68_D%4
MU]1!/D0R)^\OKP\N!5-4,J;V,PI,>^\9& ^T:)7LO(3H_!&ZRQ\XJF_OPZE(
MYD2<[3M#4*5:,#'%O6 Z.%WC4B6MNI@@!>G1-4DE[ '[-VT/2W\#3[U+A@E/
M//E<#$/N:MO#(EGPY!=:$;-QQBA>FB3C/-I,KT-\Z+X).?5,KRBR=BH@T[FV
M,T2(S).7P^B5E&B$1ZN:.,&/,--K)]H[9GKM8OY33YGI,I9OF5[[9'KMI)*6
MN3/[4'SJLDW)%^=D828B[>F*!>9-*DP*;PUHR:-K<A%V^G+=,]/K9-2Z"[--
M6O5V;"GL/?!@C:(-5$GU%LXR<)&^XA&SE"98UR31ZW3;.Q]/!ONVA=Z%PR:M
MQ#NU(\844>48EF%?3!O:[7AN-%-90):I%EQMI+33; M]0CKKG;\6YX^=&AF'
M@*",J"WCC*OSOV- _S M4=@2 6G+W62_>IKMI$]&8_VSU^!(KUL+9*VDYSZQ
MZ#59P2O+ NW.F 6M(!1B-<HFF]:3;$-],@+KG;L&!V[=$[>SS]:J$)G"V@-3
MI<2"U)EY:P&ER3GH;^GW1U):&Q8;U#SLGKK-DY"Y.&8(+[T6@;.@7&$IN&AC
M-AY5DV2H9Y)^?XC8FG#8<V>,A_L\(\I8"!O7G-Z#!(*%2 :@:;>8:(S2^G&V
MRSZZ3'HW_]:"@@.GWU^78VR8B'_W(8.DY#\PMK7D?)NM(;>X*'!!>YYB"=)Z
M8YR/23L.#R?GWWW>D&GZNGB9LX@L:5]HVV@4 \DML\@=9 _(99/"Y(.DZ3\<
M)OK@W73W=J6CQ .WS@IF?+T$RAI9S+0-#P6#,](FC*[#/#H8X%./=]Q%FMU3
M>H[%^*!MEP\;Y+:^#".TG-8D&J7RFM,:"(6!R9S%HIR7TEM8[\X^N,*W8?\F
M]B/I8-!&S#V,=T,KAU%,6>90!Y@CD>-<8AX\9P5L=,(('</A#9G;8/^F^R/I
M8-#.RSV,]VJ00225(V26?1'T<H?,(@;%,G!0,J7H=9=J;(,!_J;P(1D?)E&^
M7%0E>&B0?W9H"&%E"0HBHW&8BU;1OAZ\1&T3%-JV96WV5W-O.)^9B(_#;X-#
MW+U2 !/2&N)L858HPBR%9R"X9 :$XABU0/4,<SJ'$^9@Y W:86;?,'NM<A$Y
M1J:M%/4N-]'LGVDGZTLV$@QZ$[_E;QY9JL>EO<<^-H,>T-S)T1,@P K!./GJ
MQ( %!MD$\N2-SR5#E,8>V;6]#_]32.K927;'.-0[1#./[:QCP]G.^O S+UF8
M ,QG7FMF.,& =KLL.V=]\BGYV.5R\ 2&\NWM>3Q*>FR')QL.B]:''[(7%FM(
M$Y OI'D].^(NL.!"T$;+!.M._\F<(7Y[D1ZMD@:M:]CCF=3ZF$4NWM8@"4.N
M,M,J*A9L$4S&X),&Q\MZ2\/C'DI^>V4>EV9Z/!IJ>.SUXN-TMJB__7(Z7XQX
MX>1\>L%0>D?S "(#])QA,='%%#"EN/\[T2O6;_H_(2TT.)7JH]R"C\YGF1Q3
MRDK::(G"0-!7(2ACN'&!RR9!U=^J;>PM[V/1?Z2^RLDJR"@-\V!I0?$0EN@8
MO6*6U][B[EM?Y8$.YW<GY-C5-N:SQ>CWV32?I\7KV44T,BYSH@WG/%HEF'.Y
MEIF)R+Q0D4F=H_<"A===SM_I\V\HBKY;5],V *=<5V,G@J<]&KK'D[P;>*X#
MT7$55MX%U Z5,791P5TTPY:VZ(>HNZSW9.7!))"4+ID+QWC@M7@,.D9?1!*Y
M59%F4 RN2PCV*5*_I4S$@,SO8MR>C^_?GG_Z5'WTR?N?O]"\.,9)PC?5WUFA
M7=4'0 Q".L&XXX9I5(7Y6"OE2<T5C=DD"!WV<1T?-YROVB,QT[96[3DV^QKB
M&ZQCI2_6P)6 7%E5N[$"ULZ_AM%/!(M1%\NS];ITV;H_^*"G0W8?EFQ0]F!;
MH1LP*4; S%(P0 ,.@@5G:<!)%,]%+?NAFZ2A/[[::?OX>'V:OT&E@EX3#[N,
MY5OMM'UJI^VDDI;5J/:A^-1KIP$F@8:F"1 D*WJM%8LB*&9K"XZ@G>3)/T^Y
M[ED[[734N@.S#52Z0X$'6Q ""H9*Y(M6&]&6PE0@,Y+388QL$MGX7,IT["2$
M_<MT[,!B@_)IG4L\$!+R/NMF%6M\B_-D%ZT]L\7*D*.2'II,>,^D3,<A8FO"
M8<^G!0_6B?!(<+(KC-M@:_AAKA<DGMX(K#F740DK.^P9GWB9CGUDTKOYMVXI
MFI7I6.GZURG9LI>:'!L_L><"' ^C7JNV42PF%[@P*BL=BO76>F)<0X%B IC1
M0Q^^__GMK8][/7E#H_IY7@LS7E]WF9@T<@',BJR83NA9=(8OH[.L0V]Y[M(O
MHM-![L-P#EWXMC[A-_SSUI^-N%;&Z2P9U,+GVKG((L3 4O$N&PM)N295'3LC
M'/88K&>EK"]F;7CI^0ATNPWJ#WXY/SO[^@8_P3B/9%"9HW1,.$7;&JO)"CXC
M4TJ74KC#5+HD:'9^X)/00CL3-]BP;05:BT)>]A&?CQQH:;QQ-&[03,>4F1>T
MCDMO2K0<#!8^Z"1R$]V3$$T[/GH\0KUW_*OHDXN#8^%$<)SFLQ)JS%OTA@%B
M8B5*<@ZBD"IWJ8MXV')["U+K*)R&XFAD]U.(NMDZK)]PGF;C3Y6ANK%X77Z?
M33_A;/'UHE=!S4KAQC.I=0V(\YYY*S03":(504OL5'K_,'G="W'H6YU6&NDB
MP?ZXZCFN8[L[!A]Q!;)"7O5)Z0"U[X"?'3$.'P8T!.U=5-8C9T>66>'6<$U.
MGI6"(!N@A1Q]9%YRDUU]%UT7=^KQR.N>4*,35]<N5#5PSZ\/1Z^1KJH62UVT
M,8(%66O>:D(67,E,6ILE8,24FX3D;X=T(HYX'TQN/:,^B(:M^_AACAY?SC"/
M%V^@ANS,7TWR>*F^_@\D[W].RV/*'4:X=GBILG8N<!-H=)KVWI'F%<MY"=&"
MHBWZUL/+^Q_99][#W_$LOYNNTHPNGON_S^&,OKEZ[O4^HPC/E1"!91Y(EY@M
M\TX'QH%S<#85K@;HC[L3YF9G&:.2.6VMR.-U/E:/M]#K:B Q$$$967B$T*17
MW%9$PU_D#*6ES@<:.Y'2X.YX=X-<AL1E+7E)M(XD<C^T"4C&2)$Y$8,Q)0&'
M 1*-.N,=*OGH6/H:@L9C'Y3<>Z)<TZM?E]>S\?OQ!);,5O\XF1"-)I.:V@E*
M1Z5KXY[(C"%+.Q7(VETNI'=[ZFE$LC;20)?3_<.YZ#EPH3O253!X!ZR;3T .
MU,\Q3C=:<[F79 X@XMCBX2HXHZUCO-2.FKEHYHNW#'VV.B#68\='(YHM9Q:G
MK)E=[-^S5NY ^AUGXVE^/5GMD[-Q61?:)WM5:I9)C=[*TC.53 ':D2LHT$$;
M#SUG.,>Z/4/31N;M.9Q@"[9W?TY71R1%)FZ=8DXC#9HVU2Q:@NIR*)QSD>YT
MK]V%^JOG/"_J]S/O,&_].V)Q)4Q== J6MC.2Y$F3GP06,_=,(G#2IG3<'?#>
MWWC2,Z-_3Q/W7+QO"[I?IN>S*W5J+,G7-&&9F 89:6**=?&SP5B1BTEZ?_ZO
M'_2\Z-_3P#U7G-L&;OQY)<T"OAB/R)3EEN:F;%B0M7\>INR2%,9!%X_PP0<]
M,_;W,W#/==3N@B-LLW?3.QAY!*>]$LPL1U\$9Z125Y._1;0^9A'W$\'FYST;
M+?1@[I[;F6XUQN93F.7N2&<73$WF\#X27#".@1:TCFG,#E%G@(-B3+<_^MD?
M5_7$2L\^Q8YP+U^K+H#[.+BZ#\0)G5[U1>W^,CJ EZ'.L>X%7KA%K/OHI&-@
M&M&R8+5D,E6_RA/^I!Z7D/8YT3H9'>U"1\_Z>4G8WD]G7\5J@=7!2QDYLT4A
MT\+7@1?)P!8/"B+7HDO9_;6//1&WI3\2IOU8L.?3JA44^6ZJ5_MGAU"BM2PZ
MK\DCJPY3BH7EY(/S)FBENIQ/W?WDYT#IGG9L\XJ2.V5@DNWJ4-1IZ9PH3!:5
MF;:VL%@/10/GD"5I+=DNA<DW?O@SX/8 :_;L$J[$YE;S!YB,G*!XG@O3R<MZ
MY'E1EBAXX-GS'8A=?>PSH'0O"_9X:G1 Q*^'G%2L?8VCC$Q'GE@L=>$P(A?A
MLA#KN8A//>7C&/O)@0@<2G);8H6[0/V6!]* ]@,B]??A[,AY(#DB+SP49G6M
M&F6Y82!I)@8GLP1?E ]=<O,?C[SZSP,92EV[4#5L'DCR0KI8RW>66+UN'EG4
MI3#CM"5G/"<,30*]'VL>R$Y,=L\#V86&X?- ?L/%]7>O)O0KV$O>QSV?VW.>
M1]<1K!>E29H+A*PBMUH)!T5$23_!6M96 HZZ/>*PM_>Z,</ZY[_!6D(7\XN/
MTW-"\./7E9_^ZU5P=)0YIA!KV:MZOQM)N1Y*9D:(3'ZZT:%-H;Q#0!\ZW:T_
M\=5D@3/ZR8M)_FG\N=:FRR/%A=1&>8;<Y8N:3QX@,07DU6845J8F^6\=L!VS
MV7%CA:W/B'TSU2#1XR[$U?>U2/EDCK0DQ"@EC5A804L"!EH2@"9P'S*@EX&7
M3GY8#U):0_:LA70(2ST?+ZZ#^_E+.CO/X\G[E_!IO("SOY%IY]-9[96$<]*[
M5DKEPE26A>E0$O.&/ .5.6@O@DR0'EAB=W[H,U!*6R(:5!I_<]E9ZQKT$MXE
M.$'BE476YH>NEK-,^:+LOBO 0Z0ITRC98M*Y%]4SD%'_[/1X6+5M-B37="2%
M+C8ISF0PM9L"*@:Z[F-R3D:[VFNAR49O Y9G))-#F>@YZ.XRW1R7O?E>??P$
MXUG%5E5[?S^'-YBF[R<7@O\99K5;QWQ4M#<N86).1DL#$:'>!W@6$XT#=+:A
M=,D2[!74,]#6<8GL.>;OO\9XEOL:1\B&WIUD&*=WB:R)@4'DM8X^EYG>*^^Q
M2^^=/C$]$ST>C<:[<CRX7^BR7O2[#S!YAQ_)8##[>O"(/!:!X(&V'.AKU&YA
M0>C:[T'%6+)-KC0Y;>A_*,] SR>B@[O*=H<J>P]37MSUVEBD!W)@$[>QANC5
MS7.0-1$U!,A:6=VD@NN^@(?OF3NP-@=A\MB%*^XZT?4BYN+BS@4CZQ(!@=P6
MG;ACH=H.+4:%SEO7YMKJ+I1CA6T,HX"MVYF]F&APM7D;T2KT[/\N4UQ6[1TZ
M(&S99>UAB,?IG78HF?=JHS<FCJ.9 )) $9>URR0AI=<E<,%9" %SLME)JYZ2
M5AYH7#:\5'8AH(%$;OMVEYA0<15-R+0O=N2]I:A8#-PP2_OD)"762^(6HM@$
M9G@_O&_2[JW$M8?%6[:Y6,&1,5GPDFF?W$4/:X"4F+<*C3:)W/<N5S,;/OK)
MT-F'Z1J\S\N]W,TBG)>H8@Y.U*@O66L?H DL2)\J-.0I9LFM:[8OOP/GR8B@
M1ZOWW']B8VOZS(T"++S&PA,>+C,#5YN*E^C16J?)6^XKD'(3@&>QA>C%^FW4
ML*&K>1=0?8=P;T4S?+#VX43=9;TG*_<<=+T=G-"&7-A('FWM6ZYA>59'$U]4
MM12X#RF8WL*K!Z;^GD#J@9C?Q;@]1^.\/?]4)[?QY'T-#9J-<9+P3;VW6*&]
M:DZ;A8K!,N2QNBU>L^AL84"3FU6IQ(RV@[/7\7'#1CWW1,RTK56'#W1>174L
M8SEZ"7'>^(D]!S<_C/I.N7JIT1<5E(Z:>XPN2V$D"L--"@5&.PQ@1V/_ N/9
M?\+9.>YAUNN_VX<!MR!9,Q766%/ K'12.B<=+)F.2\>3$5%X,]H(:E^C+-VK
M?12W_@F]&F@3JC4SF6@,?:<BN?3:91*1,3J3G**1J20^N@?@OL;Z!T+M9U=5
M.IW FWIV,*/YYT>8CP]X=W?Z^%[-O/-XUC@0F7QR&3G]).BD'20II?>(LD1G
M4(UV>M)A^^VK1RW[+M=UYM<QQ/'9Y>'.\O&YIMM</II^X;?I9'8+R?5-6= A
M61D5DPHXTT&ZFFH*3'K:>CBAK)5=V@'NO$WO=12''F%<=<:^@>$*X$_C^65[
MQU%6SEB0FLE:QI.6<ZC.&F>8=36:H!6^C;&ZX1O^D.-X6EP_#VE!88.4AY<P
M_T!&J/_Y^;_/QY_AK#H"FX F@5(6LD/4D38&(4<&JK:C]"XF3GZ=\DVRBSHC
M?,YJ:T-C@\/9]="9ZVN VY<"(V$YUTE8!B59IM$Z%FKQ 2GH!\([ ;Q)&%57
M@,]9;4U(;)!645^%Q==K/+]\_FT\4IH7G0F3Y8IVI=DABQ(,,]Z&5(RVWC:9
MQS:!><XB.IB<!LD4%T;9-&W: $$5'6NM]%H[&1,+HM9.]L$*7M!$T21(8"NB
MYRR=?FCJ,=^B3Q-=7+MD7Z17B3-9:D):MI'1T( )(17]402N3W8;-&A8YNFH
M\CCDGTK@YM5^Y]5D3L^K'[F\3RA2JX!!LI("[6\L(O.<)O@DO5$A9^.P[1;U
M-IYCW;\>21S;-J4'D-1@4_!N!I-YP=GU'04-^779@'9>8Q?FF_]H5?>NPUA:
MAH#V.9CC!(OVHI+IB5%\ZK(546:-(;,LD58>6\/?0-*FR>0(]+XK%YM$N9^^
M7!^(5SUYM>["; .5_O/MWZ:?<399&N8]$LCU;?HJ8ELB *>%!37)1(OEI7\]
MDXS<Z1Q,AC8G[UT!#K_C.9X,I@-PV. T^9]OW]9"9]5>OT^K;Y/@[.UYS.//
MX_HNKU"FC-85= QE4+4TK6008@WZ#3+GC%J+)J&8W> ]:YWUSE^+@/WI1YP3
MMI?36<W5K(4?-[P*.1;CN(^,%^&8+AH8H4M,$71;T-""T":"OPNZ9ZRQ_MEK
M<'+\RW2&X_>3^S'J)&T&DYDMSM#8,;)(<!D/CIMDK/7K-3%ZVMIV />,!=8[
M=PT.FM_@O%:\6]#@5QD4/T+Z _-=H#2?)E"6"06V;O<3"\XDYC572J$Q078I
M9KZSR#HC?,9*:\-B@W/IZVJT#^ L7) 9=&2"Z\RTI)7=HP<F4"I-0(L6I87:
MN@)\QF)KPF'/%7Z624#+$\XMV 0DATEEIF0 PB: T8[$,YZ4<C8H&\.:Y[\Q
MT/JAYSQ#F?1N_@;5=MY@1OQ83[%_)VYQ-B.(BVGZ8]6?UF@.P4J&IJ:?Q:P9
M6$'#KE$I]$=%E"8W\_?#>H9::L!7@PHW5U<J/WZ]$>3ZRPS_^QPGZ:+H/TUY
M1<C:7LJDNC\%6G(=5_0M5[($$%*V<=$?QO;,;Z)Z)J_%'G!#"/45P,NWJPO$
MEI=-'3 >Z0ZI;WZWZ:=G<AH<5W6""B8*S0,K0=,$*NE5]ADTLSQ*+Z)6KDW%
MUJ/IYZ%+G5.0SPZ<#"2;^=6L?+D$2\@E.0LLIJR8YF99-*.0(4J.HAAPLLE^
MK0NX(T:H]<5J!]4<1$F#*Y@;;\[5EW\?XXP>\N'KK_@9SY8OC\D)-0V76>,-
M>6RJ,#*+9D$+5Q,S4\FIL6-T#[QOOE'/%#8XPMSX,MS%>_G:=0$[M*.T%>W1
M7:;>:.\R@?7*V5 +X7;04ML220 ATQRL<_0LRI1KZVB>(P:!QC]1@77WJ4Y$
M7SM0U5)7KR:?SA?SI056;<>#RA*,5TR%FKA2"!5X7<L6"?(S Q:9VIX;W,5T
M&NY43VQNT\V!5+3TIVY DU?0L$19%"NXK'9&*SV$ HP7P"@YF&*:A!C<@^FY
MJ60?*@::2]0E-'HV)E\"DS*2*\BY).V:4'N<">$,"=JTW=O?Q?3<5+(/%5M/
M%/NM2',%]R7,9E]I$['\!B;Y^@_.8#X?ES'F>+%,]U#P8O>']5K^XL"QKA7#
MT-XHK04J")%V]@F*#RKZ%'UV''@<'?#<OC;C< :3A&\_("[^-IN>?R(05Y<V
MRYB[^D*\A&7SXIOY2)'>!!H/0\R<%C_#&0A2K<_<YB)U#+GM"K,G\ ;91/.K
MGUULSC<AF[^(].N0%B-:#%!8ZU@RB@P'M0:IQ\"L1JFEBM$TRI\[$/@19^8A
M--HA(:D=SPV\PU4HQOSO>)8OL^$WY:7Z",$Y&5EVA%!+#\R+8AF"ISV5+<FW
M:>'7$=\15#<H\=/VK#5P*M<SY/\U7GR8GB_>(.3QV5=:H7#VD4P6;X"_*.(Z
M*AY3SD;3*VG).,(JYLE$+*J8 HW )]DDP'YOQ,],@,,PV^)._#ZKW3@KO]]T
M7B,77$5F8WVOA*^%)Y5GP<0 "30OOLWE0Q_HOZW0C1GON0;L=7W+E]/)$LWR
M=?ME_ 7S/V!1W\"OFR9_33M#39O%6AV5UU[DEH'BB9'AG/!8^UZ(![9;!SS^
MQ";$-D1O;-?<CJ5AA$7S^(.HG8&<I S,*[4,RHO,6T/_2C($"$4JI?;75@<$
MW^35A*L&*V[-7KDVV17 4?(6D@1@TM5,SU ["QN'S.EB>?!26FU;K*%;\#PG
M0?5)3<N+^1^_;AK[17P".8X"@A=,8%&TM:FM/K*7S"'WDF?04C?9(70!-WCI
MH*/X57VS=#*%@+I=,P>?;"P^,^>PADE)>O&P2,9UDCJA"D8]YP"DWE2Q7VS1
M+NP</>2C"]AOL46]TWY0[,<^G!U=:"DX86.RS+JD:L1QILU&1@;6ZNA3(D^B
M[6W,8X\M&DY?NU U<&R1T% R3=W,V1+(Y=2*!2LBXQX\I))5X/E;;-'^;.X0
M6[0+%0/'%EG)C94JL*1R8;1+20RB)R]36UL<_:GS30K./N+8HKY5L@\5 \<6
M*9-D%%$RE0(!,KX>4]#4Z@PX! LRPV!QBH\DMJAOE>Q#1<MLQ9O3G'PQR2M\
M'%5R)=#:6X/CM*#]0ZR-)E(PT3GO;0AM4X6V 'MN>MF;E+9'15O3[*)VP1=1
M"%/VM-O4P+Q1M)N5I?@2BU6JK;MRPBG4 ^S2>^'E2-G172!^RX[N@]\]TEOW
M(>=(V='6!I1 JVKR4M=0"\U\48+6UP082LP0V_K"CS [NK5\=N%DJ(.;F[F8
M*Z],IJ0CL9L<KY'D&1C4GD><A\RMYCKS+IU]^SFRN8OO-)R?@[CM<DQS(#%M
MTZ1O %TF\"Y?'^D3)$^;/#0R,*V6A72]82D#ED">8&I^/;$)US/S>/;CHX&C
M_'OM=TQFOK[EW1 JL"H T %J2Z]G!ZRGY/WLR?5T6*):+F77 .OU\D7 YZJ,
M%T:5O-."2$_+J^9:<CE)FBZERU #4=I$]'8!=T(^4#\BZIV1!JK91>C:.>N]
M]2PF45LA&,]\IK76(WAC'2\I-<F)/]),M*,CU!O)!TQ%NS#4I OL15[<&_Q$
MH#%?&&$[W) 5&:8&3.7L"*Y4+/B<6++1YIQEBM!D0[8CSN%%U8SS._U>VQ'6
M(I-EOAA_A 6^+AWLDDQ$VIP2^5ID>N<$TL:#1Y9#*H[VK1E3D\ZONX!\NLIJ
M1M70^=1O\1/4\N\O4EK.Z->C.#Q]^L'/[C5;>K>1K"5'FX \%YZ=YDK+F'W*
MCK;V,5M9BE9^U/TQA\T!;],'S.=G_W][W];<QI&D^WY^Q<:^E[;NEQ-G3X1$
MVS/>T%@*R]Z)\\2H2Y:$&1+0 J!MS:\_60!!D6"#Z :J&B3DB0E9UZZO\\NN
MRLS*RWW%>I>WUT1CSO]C-K_ W_HXFW]YE[\F;K^]2[M4V21C-2,E>;=DD>!F
MYJDD)3)!)<V!A28W6=7>X-CM=&O-=;7:)<\ED5D[$J.4:/%&2YR&0'BTN:0V
M<*2_B5BZT(R_09Y&O[:WS^.I:6#>'2N:=7@G,*-,R)1D76;K2DC$*2V(SI %
MU=P+VV02117T8^64/Q,M')WP%Y9]'@WC*-) !%WU0B_C7S1^FCJ:8/!T5-:W
M':_\++//3Z VAZ6G#Z'O]%G#/<#^F9Y>G?;CTH</X.SDBF9EME[D0%0JK8V]
MR\1+!Z4EFF=)"!9]VQCQ2T]/'T^_AE U<GHZF,QY-HYD5OI_1J&(BX&2$+S@
M7D>90MN;SY>7GCZ(S0'IZ4.H&#D]/4KFM0-/HHR!2,9+Y$=G8L KPX,4S(R6
M3?I"TM-K:\DA5(R<GNY<"#%;3I0'2V12&GV8)(FA <!K;E-H$LI]P>GIM;7D
M$"H:I(O><Q+P7ZQ.6Q\I4Q %\1&=!1FI)MYH3C0MZ4>)V>B:I&8]AO+M^EM'
MTM)<46[?>O(O7_C8=''M@;"E0[4?XFF\J&/)?%(WJC'1X CJ@51'S9Q2I<]'
M MQ610FD)4.4]E&!9$+:)K[1J71ECT,TOJH,(:"!BESXQ:?7TU3^4YKO_>:O
MRBF\46.TGGC!9@HLF4K_%QDRX=IH$%2BH=W$Y7D*U/AV2FT2'Z4L5&*@@:>S
M8T2XI4(R1[CS:%<[88A/FA&3DBR>F8RFB7WR/,:Y-]:&HR4^0K_56U360- *
M]T21R^SN,HK""F<(,,Z\948"HTWR43KAG)TF5)!Z13.T-(LKD[91H+A7S:ZN
M("XGO\$O\YO%W6;%T,46D27DS/ R]Q9038-#^]NP&"55R>[+).FQS-D075ND
MIZJ#I8(Q"8)$A]ZY# K=+ >,T,R=#EID)1JWXG]V=;"G]U]K$S?2G+Q'M9@]
M(/Y9*%N#WT,*90\@YT2%LBG&S+AW).!^B8=F3L1*IXEV(0N3T<-KW./A)1;*
M-E:?(9R<:HQPMCQ8"!Q]?RA7"$H2[]$$SXI3Q J@Z&@%UB]CC/ @5@\9(SR$
MDIT><=W4ZK^N?GWAYW Q0]/MO?^RRJQ[ *)7'O6.!]5(FNZ#<2M#VBOJJ<7_
MX4_0?.5>2TDE-3EHX[6*E_OA5A'DRAHZ)"W]R<>U$VH7WBW1&G"*EWGL/@D9
M/762 0CCA,HL"Y5VB/8Q]"H"1B?D\VQ:/K99OOCDIQ]A,NW^FX>7"-1:N1UM
M1TIABV$7*&30F<9L)8<4&,W":4]%"$Q&NX/AX2"..P4W_<"__(">R)6?7)?9
MWK<_2?^X6;LCW__Q&>T*>'N7@FN2C@K?CE!P%KU=M ]L5HHH88#BI@$6FK0^
M.@CML8;"_45_G7[VD[1OZ9]@>=='71OG11G6"%)H(@5D$FRD1.$F"B$*I4*3
MXH.C4(]O6K37PVUC8SQ:&\3EAXCKTC(:N0@25424MOOX@PL:"*4*=R9JG6P3
MH!D"\K0:UYC_)S2O*GD-O*2?\?Q!4[PT-D%#?/8;S%?#M_:*;'')!07ME24F
MF8CNHZ7$<@F$15D"V%*@\=-"ZPY&_"VIX#BT-LB".4ADE]2B^25D(D''3&0$
M_(@B&/RESM(+7J[7GLTA_"WI87LZ&P2NAX-^<[- FV6Q>!W_YV:R6+&YN%0\
M!*>E(>ACR[*S PE<1<)!1V>,*1TVGH=2=L'_4TN;$OY8;>7X:OOCM(3>8//'
M=Z(,E$IPB215<E(D]2081HF/(MLD+66ZN?=WS O\J;J-27^LO.KH2NV;SY_7
M%;%EKEF>S:]7M^_X5N_GL\\P7WZY\(L;?[7\\N/&L/EUBDO_/I\L8;ZX**\T
M7?X_\/LM[E &5&5EB"D=.R13B5B#'ZQ3^+Y:<D=E$\-UO%=\"1] #37<+OY^
MGCK4P&L[\DW?SR>S>:_WY*!$H&4&I%4E[24H] :L(BDDKA(P#:F)83W6"_[Y
MI3P?_7D6WN1#8;-++8%26W)T()1!.481SS40 ):U4US:W#RV=A#R;U2SQV7\
M63B?Z]]^CW_S3H(I.><M6I34,G2@0Y&@]IX(8R('T(%!DW28&N!?@N*>SGH_
MDNS'"JM/J;#W3"YV&7R6T7A#E%1TG?@<E& DZX"OH@3X-@'E6B_P$A3W6/6I
MJ+\'<]_ GC[F/>Z,(3P[DI#4Y:P(%0+-'?0"<"^@AF3+\<5" FZ?B;70B?]/
M#1Z%^0:&[GO_95U=/YN_G2T64/"7GSRVR)/5!FV80+RBY4M#L7F+GYN4G L9
M\#L+NH6*]D;X#2IA&_8J&J>EDN7]'*XG-]??(2%Q4A)"?X8%S'^#.^E=&DJ3
M-8X2R-22,@0>10"<F*1HZ;5LS'8J3&=YT-Z%7H*&'&LAUI?X8W4PI[FL!1=H
M\* (D\[@5JDB<=EDHK0.R6C*E'PFSLFCR]HQ\RNR82XQ6UJ6X+$B$^?XJ<=,
MC&(RQRB9:W-]6"F_HG'.$P-FT4T'0KEC1'IFB#<VDA0 <E3>R39MF [/>:J]
MV^KH8S8:".-!KN><.<#]12LJ>& QB]2G&'/@;COL+8XY6;__(U[=)$@_X&[\
MRVP5J%P':K;292^5$3$D1DFBDJ,J !"/YA:A.:WJJFEPL8<@QL!ZSGF7SY+O
MQC'E?6^WKO/DG@?+,^Y5T92I! :(E9GCJ<<$FHB*:]FD&=A@I&/UBCYM,G!]
MTIY+#^@/2[]<3X.Z34_YL'[N>C 4L)#1H.#$"HD>BE"RU'!IPNVJS0C3TC3Q
M_)Y$=:H*[L8*L7W?5HV8%I?):RR;P4\]P+2LR'Z YC2UUQ79>C0DX5A1-^=?
M)1HC>$:2E!'=CL!) !X(-\)F;=&MI$V:OHS ^YZ:Z;%H'R+ABG07^^RK*?4&
MIBC5Y>8=-[-IP>.>YAVAJ@2Q*/[,NW+8:J6]R!;?U/4PI?<L<X(1*8<3,&LC
MO8HU0^LV,_//L])\Y-WR$\PW792#40E?B61=)F';6)(OHB-.:IZIIB+R/HY1
MU[-?*H5'RZGB![F8+]'[GJ6;N'PW_X ^]R2N&Q(:%RR-98LLNXPTAA,??" Q
M,0 'V8C<I_\:/O_>]HN_VMYZ=P$X;YNLBM@K^I7W\)3WO46TF</9!]0 <VR(
M3CQ&,ZXY5H>HQZQ7DG*;G: #'(TR"X>'"2@H'3=\)%YG25PL 5"3&!=]1O8\
M1^IW6&0C,C]$N UL[[5)<9=D>8NSQ#PVW<N]$$:87'*,-9%!9!)4Z0^:5%S-
M0E"A22_.?<#&,P J\C=K*/R3MJ+YR<_1J)G\5KU_QZ,'MVO/\?0[;'7?$#9I
MJGUPTFG)DPP1(LU:):TI.)]W=-]XM,8IFFM0$[.A:&FF),I(8A?0W 1*<$MC
M(H-!=Z%YQXC>:%],I0**S1F*WE94BI6K\-(V2@#Q+%'N57+>-@FR?QN5"FVT
M^V1E"4.4I<58TD^S^3+=S%=O=_<J%[/I*E]DL;GX>G.S_&FVW$PZ_S%,;U_L
MCIB231%LLM%'2FS4Q212>  &AF=43E1!9H8WJF:K]P[?A&J?B/+&R;+]W'1P
MCHJ8 J$\VI+=R_!+BYY0_+4WQOLH3]Z@Y@5<@!ZC?VU)._4%Z$Z'L902 0N*
M!.92*<GW) !^+_A;/BEC'1KV?X;2!M.]+Y0V1.RCQ5'Z@/K60FF#B.H54#E$
MRN.I +6*&HDL98U>O<Z&>,X4T58J$U3.KE>;Z.=(_=!06@/F!PCW%*$TR27$
M&#PQ4GDB2P:9]TH1Z;D)+(H0;9-A1R\EE#:(OZ&AM"'"'RF4]F8VG\]^GTP_
M'A(NN_>/:X3$=F'9[M@,7#@ ;W($B=:^2]GCN2TA\V D%Y?=L X6S,&=F1\]
MHJZ0>G1@CF"TU$QE_+_40@>?HD#I<6-!29$NGX)XL, V@T%F^>OO'1Z3[??<
MNJ+M_09;\I:!419+^GUB4GCAK9)*"Y54E,99=]EOB>/'F>$FA*Y&L6^_>D[>
MZ2AR+M8L"")!6^*,$L2([&4&@<ZT:K'U[\!38VK;U\?^B*[4'!;+G_T25CE,
MZ3TZ"B6(]A$NLP">K?4D63SK)05.G$Z9X%8LP"B.;]ZD@4M_B.-'?VIH2==8
MMP:4-!KYUXWT^YS7$ZKN@0V).V$2H!5@))&92>("M81Z245B("GO<_E<47\Z
M4)Z["AU+3 -K^R'8"S^??\%M_/5UF7QU&6(P^.J.>*TLD29+8H4"8GD")I,"
MGGA[I7D(ZAQUY BQ-RB,^6$R+;;_6_"+>V5J4LLDH^:$2Z.)Y"F0(!0EBCD;
MK.0<1)/YPYUHSD,)CA=TY=+PM[/I1]RMKLO+_F5>"M>G:87N7;B:?%Q=>5P*
MGQ0ON3K)!8[>)04\]31B=)I2&12CW.\QAWLN];));B'/!LUF'[[RKU-_/9LO
M)_]"0V==3WJI@F/2"$.R\4#*^!OB,Y>$<>=TCF6*:9/RY7W 7K9V-!%_Q7:N
M17MW8OMNLEA-QO33M/H[B\7-^A)TL5R4>TWF?$Q@T1QVQI6L>3S)N%G=<(9D
ME %N^N2K'[K^R]:,T23?HH48[G>_W.YWJTGIGR=+?[6UXY4[\JN;A.;.;>>H
MO_GE[>3D2V<BRF<U-MTS(D6B)("7I/2>] F/11Z;E#8>"_QEJ]Q)Z&O1QJ07
M_EO8EY9ZW%I1%WQ&Q!*\*5:V(5HDGW(T7.HVU=Q#4'Y+BG4(,8^UR(ZC19="
MIJBI*%5A"3?81!VQFBD4#Q[*6F>GV0G5YUO2FT%4/%885]>$OLW"8)F%P(#H
M;!"7C)(XANX<)!Z#S):A;=_>:AXU%ZJ]>3Q<M*?.9[JOR!M'\!?\-ZN;>TZE
M28YE0KE%8RV[$N$1@62=0>;@HZ5MQG-T@#E5?M/1!'?L&$<)ND6>Y1:FVVOZ
M/JA:-FCHAG6:3@W'T[9'#XZ0^7@:(5+R,D1'J%$)??U0.I8+($:"4D%%0=O4
MB(VI"7MZ-XRE"$-$W:15QW0RF_\T6\+B-J^&Z00A"7Q'F=#HM:40/J14/'?M
MO @)5).KED=(3I#$7X&B1XTZCI%O@\O:%93-</#9&S_]YP98<-1*:B3AV:_Z
MS5IB+447VE!-O4GX1TVL@)V(SD(!ZLB[P9>_ZE=17O0#Q-NPR2TP7_I3>,:)
M5,D3*?!GUME,F#/)4-!90Y/<EIV(SD(1ZLB[P2WK0\MW=<XQ;K12D$@TNMS[
MH@OKRJ0=Q2455%$MVW2=?PSE7-R!(X7<G/:?_/5&R?O@:ND.[ )V&H?@6.*>
MU(,CI=X\"^<>/K1[I?&.$0"D3$;AB&?X,SS%2I<,KR6,D/;76AOV. 5C*<,0
M85=NZ';/8!6O&%??W<#?\.&?"CVWYU7R-+&0-4G:*2*!)>)]=H1ED\'; $'W
MN57=O]*I8\>',C)K)L[*3=Y^N)KYY63ZL:0$KC!VP.-.^<B%03,U1"*1P](,
M*Y;*=@4@M1*LSPR&'DN= =VU!=KNX^:O+&+[KYNK+_>@.<H<#T80,&6X8D9+
MU!M/"=JE$$JK)._LL"^[:YDSX+FF("O:=H]V''%_PV&;[H1.^Q3QH+):H--!
MM2J3A5:]*C0/@J-$^-#]NVNA\^*Y@C K)TD^M=ELX!DF%07'B=*K/!PO2<!]
MAX"SAD8OE1/'[M[GPW9M@5;,DMQ21GEG2WRYART%*3S3B619 HK!<Q(8[C]4
MB,B9 RFV.[?L^[ [USD#IJN*LG*VXX.S!;']U\T4[B'C0#,-"=T,%<J<FG('
M 1)M",TL4U1%Q?+0,_K1*N=%\;%BK)B@N$/YML )&J2*D1,A2Z:"DI[8R%,I
M=8[&6L&C&.AA=2]T7C17$&;%7, M<.J5[, 6.#.1H9UHG>+%]\.?003"@DW%
M:DQ9#B2Z<YWSXOEX459,UGMD):JOW@#?0%.*RE(W54JF\ =\>Z^8)XXEZ:+S
MBB<SU.!^O,QYD7RT("OFUSTZ3DS!]M/LMQ6J>_AB]N!4F2'%*;KVMJ0=&S03
M+0LT,^="YFGHV;QCK?-BNXY(.Z(E1X7''@/\#G>4+8!2"16E8,2H4B/I.3J
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MC7"*V(0.HF$EJ,<5DVKP977W4N=%=Q6!=A!>*W+&7VG>B2]&0X4NN1C1E+Z
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MSN]+*KD0.DK"8RQC4&(@3GA\$<CX?QMY8$UTI]H;G(>JG8;0REWS"Y:'V'^
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M]4!L+B_J2F3>2P:^R<[<[I7^U/?GI#,-W(5M]'V%?)O*HT!1G="  X/VG#5
M'.!'K31-AAKTV_DHWNX@U&,EU3U+31Z/[V>3K5?F<)<'W28Y;MRWQ2J71$<G
MO;.:0 +TT67$PRB'1"R7Z+IEYIQI% Q_ M6I<O9&5(Y'0>Y:)#6P<K<PW::H
M] '5,J>O$]6)DOGJL;<],[::Z$?3"^.]-18I2PQ/=2FH("X%2911P",:N"$T
M,0)'U(=]J7LCJ\,0B3=0@WL;)+KD/T[QK%Z=\AM/_I!0T[V";V$]&H<BHJMD
M,B->.TD@:L-DJ:+0KH4NM7NEDY6\'*,SLV=)>(,,@WMOADX+3#Y.UW<<\<M7
MX_6(MQ-46N><)MR4UC,J!^),0,D;SWGF(1K:Y-JA[6N=F4J?FOBV._3F&WT0
M<[U[LR=?0D6MK'&I7.K0V[IL)C1)/F;&@C)&V,;:>SCZ,U/2D6AL$'Z\]Q+?
M%18@O8$I_F3Y_LI/%U^_-CQ9*IPGBG+M>%)$Y:Q0W#:2X&3&DP6"=2:QS%L;
M$.W?\LQT^YFI18.@X^M9G!QSFDA&N4V&".GQ"TXE> I*$Z]L2;[ (T4TN3@Z
M#O99:.EXQ.U,8JA;@/.]GY<N!W=%Z@?4+3QZ1(U"A:=Q;54FT(@N@\H,DDU2
M2.$XTVA3V90#,!#A\BF(1PKLX,*:'0]J(;P>A31HB<KHG K<1FE$<B9:&Y(2
MP#E-!AZ)\.@"FNT''EXXL^M)+439IU!&RJ!9HI&A725ICI;)P&5P!I@'@,?J
MV %XH#!+WXG)ZH!<^&FZP!T(GX_NR^0@U7SJ:36$VAOMEF"955$QXY-044:K
MG VK8KIDJ)-)Q<N>P.L)]W"E[?'0QJ+NH\HB<-P_02D#(%U 0\D(KS7N%=S8
M,L&]Q_./'>".7L[]Q[Z]NP<,!06+0$!H6QHI..(BH">C/*?,&15,DTCS;DC'
ME%[]Y<;/_13__%VXFGR\31&_*7;#++\%OX#%I<6-A:HH"%."E[DPE)3L1Y)9
M2C8(:BWK,ZYA_TJGF&A=A>;[14^5!5IYSN7#%_[R$_Q^<>4GUXL?)E>0UC#?
MY>_QSTNZ!/XF_KWU7[BDP@7E@R60%93V08%8Q8#0J()W@!^LZ=,Z^&  9Z$<
MXXB_<I.$7J!7MT_H'/\VN_H-TJ7)=+5Q$QN,0+@TD9" $A882*$LX %:2UL>
M+OWMZ,D1(J\\;',+[FMT5-'Y7'Z:I=G5[..7#[Y8)A\F_X++*+63:)L2Y@*J
M,?I+I+3*)FC_.YK+%24<H!>[%SQ';:@DW@81IAYJ>VD [3C0962D*M.*4JG9
M"(EX#BPR[45,(YA/G=A>O+*TXJ%!:<NC-U]G,T7O(S5>$T6=)M(H25P.G&BN
MJ/0T>LZ:W/9TPQDK9W$4-3A(QJ=.)US,EY=O4>9K0_JB=$$MV2PNFXS'FD,+
M6@4B16G);[P@B64/(@:0L4_S#'SZ/17!7VVK1_?RITH4K,'GK)I<*UJ9C]'\
M@O_B-G+>!]. C+\#./\*9MQ$OQHD[>3[2 F/Q;XPS&7."[;2M5:6RPMTD4E"
MLT8%%JC.[&6ROB.=;RS2APBVLD/YYNH&+N:XF;V>IO+S#Y\F<)7>Y=?X]_RU
M_W[Y^NK5?[^Z^.\/?UV%%2]F\\^S^>H=OE^^>GVUF6F+QHLR1A+)3"02/&Y[
M(6L2N14Q1IFHZC/AI@J8\2S'>IS.3DE(Y;#6KA= R_>_8+Z +QN(-'&;,R7!
MLS)#L]R"NA2(\UII"E:J7BT=>RYWIEIQC% ;I)E]?>\2$+E9ISMGZX1*0I$R
MMH-(1$AL1'192RY2\C)D:.)'=( Y W.QFJP;I'9M8[K5^CZH6A:*=,,Z3:7(
M\;3MT8,C9#["CK!)P4G.4(W $AA&)/=EGQ*1> :0H7C3K$G1V9B:L*=&9"Q%
M&"+J!@KP'J8E5>HKN+L1VC8'C?:S\+[,52XU\#1E N!":<N&.U^3.0$[\)P@
MWEB!KEE]6;?HVG@3%O _-Z4<ZC?\H9A#:V4':GB&0)2W93XKH-DB8R I"!&B
M=UK[V$(%=N Y(]N@AL0;W$ETP-J<5CV -1T/L0O9B<I):_"W7R>.$'Z+J1 [
M 4:AI;;!$\X# J3!$*>D)PX_"JFXR>C=G(%6["LJ'54IALB\O3)L)GHS3RUC
MC 3P"0]'ZXD77!(5:8Z4!XBYS;2\+C0G&!A1AZVG=>  48\T*N+#^O[J9_A<
M\NZG'P_(N7STB"K3@9_$M95/::12/$@NO6!2VFAMU,*J8HIQH3V]? KBD0([
M.%-]QX-:"*]'IKJ(EBIC/:=22*N-5=9HKY,T.2L1^2,1'IVIOOW G_Q\ONI)
M<\3 ZGV/;"'<IW%OB3G;0*WSQDCFI($4HL$#Q3$\5U303CT2\U.O<*3 ?X8X
M0]OX:K)R:V;YA\G4XZ_]U=]6P]5@,<NW_V2QG*$QO9A=35(I)?MEMO171R1I
M-P+2@MP6,MI2"3!9.\.Y >&D#B8(U .?K6 Q6Y7T(Y6HA.G(+B4EB?/+WR<)
M-1!/N!OXF__';'YQ@TM>P_SM77X'5=%Z3QWA"DH7;OR9ER*C786V+X"R5HD6
MUD5/?,=<RKR?P_7DYGI1ZDY6/1M>3]/M8J5'6W$_YSXN_SY9?MJL^_T?MU5N
MKQ<+P/^GTJL-30FOM&;$YI*II-#@#!X]TUAZ-H##C5FR/5]413@G*"ALH$KW
M[WE.P5.#B,\AD/$T!V>$)28R1Z0QGH02^ *J-8HN1Q>;?'W?O-Z-15H#+_%!
M\YEU)[9+38&AQ^N) @-$0E#%A7&$424R8\;K-LVA.["<IYX<*_0F RQ6+[NX
M1$^7)FTU21!*FQ6&7JO%GZ&1DCU%MY5N)Q54W41.4!DSXLXP3+P5X\>KN9:K
M!A"0WGV&XF24ROI-_]E+D(8Q9P+AP:E258_:AVXV42F;X(51:*[VL$J>6.*\
M>*TISXKYZ 46;BX;;?MY9?Q?S-[[+RL'X=*@KN4,E' >\549M\32'$GB%H"R
MC'YJ'^/SB27.C^9:\GQ,LSHZQ!L_0;HI7:$?">'-EP=B6+SY<N=1;MS%]259
MSM) QM/&.<W7&Y)#PDDP,B:)OBG-3?JI5< ^5D'#& ?$V%0^AU*(K]$*)&TE
MPG5RL)(V60JH.<X3*0(GUF5/=*0B)N^EM7TLD%Y)TMT03G6//;H2S*J243F+
M_C&B389_#TRU:RAV@1F_AJ(&44_R?H241]. P$R6RI;Y58BMC#ZP3'#"4\H*
ME S)\Y?)_!-U%*,1/T"X+>8!;<SIS;ZVN4Y-00DC)/%.4[2U,@+TB1(;N!9!
M>F"V2:[3#CSCIL/7(6M[(DD%23<(?:X:OMV:%]]?3:XGT_N9>,H$G9(+Q&>>
MB8Q>X0M[-+*X9309&V+J4T(U6 V>1'4&RE!/ZBUR63;=X-_<+-#<7BPV&KO:
M 47R%M\Z$51,021EH0PH3L1(EB):W2[S)B&K)U%]:S9D?:H:1#EOL6Q*B7J
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MCC()=]0\\Q;*<+1T3YWZ75JI?M7H"[]8#P/63-&D(BN-%,H@6!^)DV4:#X?
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M:X\I1Y7BV&<C@8_)$#?FX?B:-\9%,$?35%Z]6IZ.7 I="#Q:<^W[O';@G'O
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ME':IRTF)RE#_0_HQ?:V77Q^\<<IKR!E[\!R$ZZS:S/'BF'/H(5\J2S$.=34
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MW]9*.*C:YF!/1*Y+H!=)5Y=_HI#H GPRBEW?H11)8K4YT4&&N=D'M0HYT$J
M6@M]5E-<HBH"%#YU98XN@V1&+2-#/[9#54E?YJ.MY5<T5/^^4*7Q[ZU*5\6
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M#Q%6_X-=G\"(QH$CD7!9X%E%$A]U,3=6WDK8)^7E,9!FE-H/GK&M33MD[ .
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M[&@MPZ2TV!6A0S[LW([]9L>=6"5I]CE=B]Q_MQ'7F_M-OE;@U[OZF(<(.RR
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M%4UL!1AO)NB3?J9$!T^5[("^@+26&Y"MX';T83$69I0R#L(CTXP&5TL-OC3
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MA)+U27,Q+TJ_UB17BB')",QSE$(D"8-4,0%Q&F><QJG0TJM=T4!RC^WDUV@
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M(*AZN8:=46IQ#Y\?8S 7L;,ZNVYB]X>&:MQ<_?JK_625]VL+#,033*C,;1&
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M5;F7&=1"WVP+^LV#M!4<_&Y%=R1S9^C;WY5# #KTB68(+)TIQQ>@%DO=W.K
M2C?_=6RA.Z\U"@OY:KXE'^_K^CGW7Y1Y]VU6-A?@BQ++[VK5L%I'QY]REB(F
M<Q'EQO6W9==28<B9V06)$HP2QF6:2_^$F=[R3#.+Q@[Q_C=PH)0MQ-QJY5GP
MTW^KXBS/)&4(1C&+($9,FZW*$JC25!)-4,H0]<V9&7&CAD^DN97R[7?)+>PS
M"NX#OWL.D3Y0PK5G7<"6=%>C&3*DU%^840-.5V-V'(ZZ_H;]WGU_5<7#HW'/
M;NV*#^JWC;7A[_7[8KXQOZWFD93WFW5I8^O&IYMIG,:"" (S2B3$"<\A-4X0
MS&-BWLZQQEQ[!;L]UY^:-;X5'[!:?B!KP6N7M@3+O>C5M*/ZUYZYN[Y[Q'$B
M6)HF$$?&3\(\1I!EG)F-8I%.TB0E3/HT@QERCT9H$7.R1_4FW.SV:K2-<7N[
M#0CWP.^T'=*-Z*"6O:HVJI^' [EM77&E4;@W64_D0KZ_?$48]:W5$Y_C=U7?
MV_A'A#X5Z^*ABM?>L5)],S=XOWQBQ6+&HI2F<4R@()& .,\QI-@P7D0SR3&)
M8IX[]:!N6V1J[YJ]G, *"GZOQ?2(\ER$LSNR$P*D@=G'&Q^OR$T7 -=&:R[>
M?[0(39>&AU&9SL_V;$O9G!QL1^&]8V4A9HQ$*"&)@$FB<F-S4@;SA$J81@@K
M\^BK5)"9X2*^=.Y/>6X=GZ_RX6K#?:-_4^OFQ.-@:"9;KU<%WZPK;W&]!'?_
M]17\AV+S]>,-X%:/(&,US^\$3?.<I51!I+"A740PS'-IOLI)RC/"J>(J]NH3
M>NT^C)++OSW.VF$Y/-!NEN+5\ W,R#OD#B:25C(&[#':!D'05J-G%QJWXVB;
MKB>-1UL_W(^>MY9>T_)E\?!5/=1QNZ1J'YRF,(EMF0]3"O*4YU!'DAA-(Q4G
M7OT8+JXT-7+8>SC+K:B@;&3U(X++X+J101#(!B:$/5H[*<'7+K2\.:$3B9"\
M<'FQ4;FA4^=C?NB^H&>W/&.ME.M"W"U7STN;ZF&S!_9) TTZ$(J)BBC.8*QX
M9@_."*2:89BHQ/9T$A$A7C7_3JM.C3O^\O/7GX'82GR04^/9!,\)<3<2"8[C
MP(12);DU\MGZXZW8-^ O7P<83^H%3]!N=$X+C]MRS@>+D[YR7A?W'X"^;TFW
MZ]?/4)J3F".H>!(;'X9RR(Q? WD>R8R0G$J>^XX_/UUF:EQ3/2B'C1Q[#C^X
M *HCNUP-U1ATXH=2K^GGET$(/?O\S$JC3SZ_K.VYN><MG_;/Q_^J%L5R]=MR
MK<KXYS0F[S?J=O.P*=<&,MR\&6.>4L14"IF,&,2V"1&+DL1VF&1(T(3GR*G2
MT'&]J3%#)>?_:ZP/*SE86-&!W"A0RPVLX.Y)X2YXMW/% "@.3!JUM* 2]P;4
M<-Z ]Z\A[)%@[X*E>UI]8$Q'2J8/A*U76K@'4BW)X"YW&2T%W$.EP\1OG\O>
MJ".HC8+/F, XUKF !&%EQ]+:L'3*[+D@%U*F6#,O;S*(5%/C>;]FDKY]*8+L
MHYL5.?KN#/S^"+4QX[?V/ 1R4FT]*\'^OEIZ'F(9O)WGJYOWC/VK]1TK'S^O
MEM\+J>2[E[^42GY<_%(LV$(4BX=;L2Z^5\[[3#(JJ, YI!P38U!C#1FG F(N
MTECF"&.$??+/W)?VXMP14L_L :XPHH--65? Z:W,@.V$]CPF<-\'QW.#0= =
M^B#! &NE!ENQ;?/JG_Y2H_PGL!,>W';#['^^X(U8T ,']]7'/8'P1N7D2,+_
M#GT+?I[92W78<:\_+1</W]3JR88>9BJE-DD6P\RF-N!49##7QJ2,TT3E1&6"
MI,ELH1YL9>PW=WORTGI.#U1>/U GJP[W<.W%M2=U<R,P- ;J4U7*[%L(<@%H
M-VJZ"K>QRC@.L?JTP^I]&U8]2C3:@0A;@7%AK9$++-HU/JV?Z/A\W]E?EHH6
MLKQ;/CTM%U_7=B!!FBK-&!<PBU-CU:0V^32/<R@X$IQ')&5IU(,ESJTU48:H
M)02E%1'(K=R^L[O.0.MXCM 7J;%F;#7BV0/)"JA*PI#SLB[K'W8&UIEU1IYK
M=5G3TUE5+9_M]_COTUR_JO5ZKBS!W#Y9=^OV#V;N(W\Q$M=3VMEJ_6+L!Q%C
M)6)(499 K)3Q?# 14$J!:"(58\)KCKKG^E,+.=6B E;+6C<'J;MZ/%MQ_?C"
M=R_<J&1 A =FF8-T][WH-Z#!_/80\TI^\+D5<V\2ZHE<2'[R%6%4ZNJ)SS&K
M];U-[UFGYP?[/2^-+W:OW[T<MB_+$R9PHHSUDS.(A120<L(@H@RS6*2<15[]
MG'T6GQK5M0W/K,2W[@%_J9IM><\X==\25_MI&* 'MZO<,1XB^:L':H$GDKJO
M/_;T46]DSDP:];]'WZE4._NPBJ7/&$]2%6<(8LPQ--R%((\1ASC',N4J83KQ
M*FLY7F!J9'7HE=QLCYX^EN6FI1C7#4DW_KD&GX$YI@\T/:;:G-<_[ 2;HS5&
MGE9S7L/3R307/M?37VLB/P<]&&<9(TA).X%&IAG$&C&8YWD*<812$F=:9TCZ
M50^>6<7G&SQ.[> ^%%GLQ?3TN,Z@Z>A578?0T)[3#IJ/#M#X.T:7E0_J_)Q9
M9EP'Y[*>)TY,RT?[/>D?J[+8KVNVKCRB=_4HMZ^/2ME6E;=2%M9^8/-]-FGY
M[L5KFGG5\E!A*A.*!4RJ VPJ(I@+P6'$L<ZYS'269#Z6P3AB3\W>V"H *@W
M;^:C7ATJ1]YT-XZ;WE8.[W[Y[J(W=XX+:D@Z'DGR41E^W-TX?FF,O/I5Q07I
MSYG-CGVO1.6@QE&2-1$9G2DB,:;0O"DTQ$(QR*-8P!PQ'@E&XIRD/:H++BXX
M->ZW@IZI+M@*#JSDO7+B+T/>SM]# #DP\[[.@J\0K9/@7Z%X78G!93A[U1@$
M@?5-B@SZP]NWRJ 3*[<R@\NW>8LZ@TZE+A0:=%]W9148-7?_S\U"&2B3YAL>
MY53C-(VAS+((8IYKF&.10<ISI/,T1Y'L5P%VNM;4Z-G(>(:=K<RVM";I6:UT
M!F,O4KX6N5'YV$)8\\4.MFNKO<[@U[/2ZSH<WZC*JP>>_2N\+B/D6MUUY@YO
M4]EU696+55TME_CS[*=E6=Y59O:#6HB76V-ZKW]5Z\>E7,Z7#R]?V=/S7'TM
M_E?->$0$$]B0K18$XCS!D",=02I42G&>2\:<&==YU:EQ;RT9*(UH[CSACG$W
MXPZ"W.#!V[($!T+?@$IL<" W:(#].A"P[E0\", CD7(HH+V8V1NP%HYVO]=H
M;.VMWB%O^U_<_WA<K43!YE\4FW\H;0"F,4*()%+2B$)!;# #8P+S))-0R#C3
M.4,I54[!C.ZEIL;5>TF!%174LOJ?EE\ UOW<_'JX1CA!/T5J@'R<;C1"GZ=?
M6&WTD_5VK<^=L7=<<6WQ_K8&M3(J/RW9PHZJV-5M?3&^?/&]FK*J?JS?S:L:
M"F3(0^<9Y K9!MX)@31+*9012Y-(Z$C%3F/< L@R-:K9C0O>RWH#?E.>I5?7
M;(X;&XT$^="^?*-%-?*MT>-FZXI6NE0#>/85I7MUFHI\8-4"E5Z#%.?W1G>8
MDGQ_<=ZH$+\W;I?+[_O?LF^6PS9?HCX,^[@P!&1^8U;=5KO,TCSA@K$$8HFL
M/VV]Z#0E4$0)EQE*:*207XI"YYI38\P_KZROLL]S:IJF^R87=&/MFAD0%,&!
M"?"@PT@M[@W8"EPQWU;DD(?\SOB$/:'O7G;DXW5G'$[/QMTO[>D%/IHOB;FO
M]3AM$[Z_%NO'NTVY-HNM/A6,%_-B_;+K_Z@E88(B!7%J1S1()"'-N89(:,)R
MXQN*U*L4Q&OUJ=%1+;QM][$5'_QAY =;!8Q=L56A=Q].O^UQ="^' GUHCS,L
MWOZ.:!_<@OJF7@*,ZZ[VP>;$@^UUDZO.B9.?:74._9^;^8M!G6P#8%&."4L$
ME#F7$)-(P5QE"*9")3R+=$I$GVR>\ZM-C=<J*<^>%L]?[#$=Z77:>0%IK_/B
MZ_$;]<2X!G)[QMF =]V9\044>YT:7X_FFYP;]T2U[\EQ.TIN9\<7[O$6I\?M
MZEPX/^ZXJ&=8<<-+];>-^?I\^+YK#9GG6294GD%BG%K;62&R R,()%DD".9(
MX$A[Q0O/+#(UOMW+""HA>[;F/ >G8X3O2I"&)E5??/R#<"T !(VNG5MGW+!9
MBZ8G\;"VS_I;7;5U5WY<W KSUMC,;1.CJJ'!W?+I>:4>U:(LOJO:S[5GH.]>
M[!^6"[/TE^5\_LMR91LAS+#66F*BH!9VZK% &K(8I3"/-4LR'<>(.HT$#2?2
MU/BDT<HZ2@=Z-=U!7FG61(+ 3U:Y/]F:^IU^[M9)H'WM-@3'WZU1'-K2[(+G
M1KT[V"CPNU4.--IY6)6!]LW=]!Q__T:R3T?=1R\[-BSD+<9NH(5&LXC# G-H
M-@>^<^_<GN.U?E/K>_V-_=C52GU>KNQC<7LP9_;;\C<#G8V^&$G,1[;AYAGF
M.<D50S#*$AO\S<S[-HDEC#BER+QS$X2Y3ZOGP/)YO8%'Z ?]^IGO<TH5>@,=
M(\-OMRU#OVHOLW"5=&'3 HR6]DRLT1,TBH+;HT',KW7=':(%37@:8A<"9TD%
M%7'LU*HA\#V3CS7(,OVGY'U<E.O59C^'(Y8((24(1$0@B%F.(&>:0$XHM5.Q
M<A9Y3?,]L\;4?*/#-*#779S!7O*R7P3F',1NO'LE<$/'7\)@UFN"W@540H_/
M.UYF]-EY%_0\-SCOTD>O.@<C/V.R+Q%"VV,%E4J%(@9E;'##.4H@SYB&C)(X
MYDF"8^:4<^2RV-28P@K94C*)>AW?G(?9ZPSL:O!&/0*K4'Q=Y8>N.P&[\$WM
M<P!V-90CQ1>^/18E*-;J":R4,2G*BFY/OID5M%5"! -BN3$N):A&3!G6KG;A
MY^!'8ZWXN9V,G;_%6QR,M2ISX5RL_1I_0O[5F(,/[$%5*:?WBWT>?_6+7S;S
M^8L=@%#(&::V667$89PH#G'&,T@98E!SF2(NM9+8:12>UZI3H^BMX&!>Y6]K
M*ZE]1(RH[M3BCGDW30^"Y,!\O0.Q3H(WK'%0SK--C:]$!U\&@]:=O@>!>"0>
M_ZQ6:U88.-=+P.K^[8:<GRY_BP-1MC=F+=SM?J_12-Q;O4,V][^XG__]:[%8
MKHKURRXBI]-((V-&0X1B#7&L8DB5UE F+,U5DJ;,;1SUI06F1M9'8;.B$=.S
M5^D)C&X.]C7@#&TOVZ:XC\NY^2J5_P(^_&UCTU='CSE> BBDHWVRQJA>]B4-
MCUWLBY_S-^?^KV*K>WV_*AZ*1?5J,2^ 8BE_,=^=;9XIRR(6(P5U3@G$+$.0
MI2B%%%,MM,YBC9SRZ9U6FQHCQ!'R: G7#6:W?184HH%YP<H*[C4XD/8&U/("
M*W /+[H;0G<[+"B4(]E?UT/J978Y0]1B;G7?8S0SRUF=0_/*_:*@XXKKNJE7
MLT1W13*,VRGRG$/)1 QQ2A+(D8R@C(D@# N*)?,QO/Q%F!H15Q-V]7SY1UG/
MD2JVHA],+_ZW(..+V_;%S9(;%NV!.;UCG/%.B8-QQH-4,O4'<80)QVU23&'2
ML0-*CA./7>YT]>B;KX_,?(7KT28SKB.>:D6@Y,2VXS#_L#W8(%=2D Q)1MV2
M9SO6F1S!O9KV4DMZ]22<5\"ZD5< N 9FJ%Y(73,8YQP. \W'>;746XW).:=O
MR[2<LQ_OR0F&@6X7TO[+1AF^L[D]1[HUS+1:O1@2JB<[99E6G$MF&,*VF<CC
M%/)$$)B2F*>2LR1._%I_N:PZ.;ZP[VC;%$'8']1>;D^R<$+<D3I"XS@TD6PA
MK'XX$/D&,&L$U5+7D[<"$HL/2D%IQFGA<4G'!XL3"O*Z^-J^8A\6ZV+]\E=C
M&WU1W]5BH]Z]_,K^>[G:%G^7[VP0WN;*+1Z^JH<JWZC.KTH)T3H3&I*85?6"
M.:0Q03!&FK$\SQ7&7G050*:ID=EA^E:CBG4[*F5VO1/,8\FK [Y:(;#5J&<M
M8H"==:/%D?=KZ+. 0;?JBMYD5X,[3(^R_F*]4:^RJW&\W+/L^EL'S%>Y6RE9
MK/_/ALVKDQ195%^U]\LG5BQFC#)"8TH@BK+8<#:ED&<*0Z%E%#-.J"-G]Y9@
M:@S=D8)1JP(:7<!.&?![K8['"4"_#>L^6!E\&P8FWJGO0(#\F% [,=)9S;4[
M,G3JC N<?=)H6N_[]BDU+FH[I=<XW:A'DX&F==0?YUI'?5%2/3U7T^06\MU*
ML?\QDLWB+(GMC&"8DSR'F,@$4IUC2(F.<LX18DC.%NK!%G)^<^PKX"V%TQ.8
MUT_@B2S#/85[62M?GC?2>A29^^]']]MF('C'BK">ZUUWT+KN"/-W8V#N4<0_
M*/9C%>R'W@._HOS>$+85X/O?=+QB^]X*ORJL[W^7J<Z>_E0LU$=S]W+&4,QP
MC#.84R&,3\0HS!$5D"MB_LUI)J)X6@.H=[)/S9MJBKMWNM^ 1GM0J5\]T'L
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MK>TCF8((46W/5C3,<RXA$7&:YYF.,2<^IRQ="T[SS.70 ;!96Z$.7CKA=PN
MA 1U8++^=(3DAW;4>I0+ND$1MG2P8\V1RPC=$#@M*72\KN?LM4M-J'Y9KM2V
MW'G&,IW)A,60Z8A S!F'7+($$H8RJH5(,19> ]E<5IV:17@\4K,1U;?*T UQ
M-X8)CN/0-N&'.[!MRWD#4 SC_.:P>5T5;&6+HFJLO_=PBP7HZ'EWH&_ P6\^
MZ :=!N>T\+@CXGRP.)D;YW5Q3Y-I699W5>N%![6PN;B?=HE4F50,YZF$*),,
M8J45Y"+/8*((35"2BRSV:H1]>:FI49:5%+P2]8H\M1:$'>VA(+@-;0GUA,S?
M).I$(Z@Q='FU<<V@3JU/#*#N*_HQQJTPOOIF;I/3[]>/:G7F$,BN_9M:W^MO
M[,=,1TP2A");M82-$10I2*5$,!5IG(DD34F:^Q4Q>4K@\Y2,4[=TH !86@V
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M3&/SWK41*,Q3R'1J?HHX39$D#"FOK,FN!:?V1JCJJ[>]*/Q8IQ-;-\8)B=C
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M]ZT)X77-=_G.&!IK];!<O=1=43!-XRRU[1&Y?:^G@D-&TA0F*A5(91G)I5]
MOZ<@4WOLMWK8H/Q!DGJMBDUG;[HD--K< /X"M@KU:UO3>PL=/<$1-F9P,^-H
M'\)WOKD6I:#>6%]9QO6MKD3LQ%.Z]G[]"-2X8;9]1/F+4?!]81<NUIN5D>+=
MIBP6RK8>G"6":,WS%.8L3R#F2L!<\@02S!C7)$YBG/MPI<.:4Z/%K<C ?A&
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M0:PC!5DB*4QUG,<13^(DCZ_U20[6FQHA7#*K#T2^WBLYQ+N_6](3Q3?R2UP
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M;D, =0S ! &:*$ W#,";..R/ROD,3S\;30#ZR 1ECW<;@H?\AP_P]@<71QZ
MB4XSCC$03N<8SX"QYW"CSU,G._%X1LC=8Y#G/,8S1ZT70'[4^>YC]?3FI<D)
M845,%4P10Q#G/(.<I1*B7'^7L#BAB+OM7CQNY]*^-!HWP=Y/QWST!)R6J>CY
M((V=A1[@,\)6Y@$8@B:?)TQ-FW?VQWN0<@Y<[D<$-XO%Z@O3_KY?K>]66[XI
MMHL;(4P[[_+#3L5^ED5<I"F)(8^3Q*A2,,B(.3J=R )E-(_2R.E,E)W92Z.)
MG=?57K2F+X!1$'*=9K-$W8X^PF,Y,INTSH&]=U?@-;9- PVS>!F.8-R "LDW
MEI8GI1\W--ZRD>/=OKUDVZ+ZHW[ +=NH1W/\L_L-RT@<9RPE4%$B(<9Q ADF
M$<1%EJ1Q)IB*L0LQ#9N\-%)ZI0-SMWIB\Z7CVJT%S'9,%!:\D5G("3>/YK"V
M4(1M##MH=>*FL+8H'#:$M;[371WFKJG(JV8 <_/(#^IYM=[,"DT7*#/3:$IE
M$$<XAC0N!)0"\2R.!8J$M4+,*2.7QA^MGV#O**@]M5>*.0EH/V^$@FEDIO!
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MYN3#-#+5=4;HYLT(W>]&Z I\M]$_7X/?3@V4N>):7^)1N(89.?OB=O(1G*@
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M/RC%'K,S+:7V1'I H7W7GJ+,[J#\J'_Z]IOV-_H/SDKU[3?_!U!+ P04
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M].5JPJ551OE$\2")@8)W"8[7YD.JW@B72A2VXPAO0&_UFI1QD#*@0S*0E#O
MR1O\C/,+7%W[[5EJKCCAG'&.H&I#$><$L9.+#-P1#[BCY/!TE-PEI!.G]4C%
M+@:4<C\H^97D]'0QW[#P]^GZP].+U9J"O^7S+VEV48\GGZQ62/_/[\*7"3&A
MN WDL]F00'E52%XQ 2)3VG#KK-DGZCD62(?0.B[63@/';J0UT]318/R,R[@8
MS#G&C].+CZOG83G'_#NN)[ID)Q6QP%FJG?0P03#>0[ ^1HF&.-AQJCR$@WR'
MDG&WMD&A=)J4.[!:1/*+^6=<K:LAO\Q338JURO-8P"@KR<W7G&2!!C"$VN<U
M\YSV";8/!LH.6L;I4]<$*J=*N@NK<B612<RAV.H,>M0":&-'"#DH\O<].?D<
M@U!-TKI7!(S3IZ[E=G283(\W'8MUF V"A5]PCF6Z7KU<U'V2XLKG7S[5@Y9O
M4B'NA2F*@>4E4CP8-41>TP=&"V>9<U[MN+9W.DB^2UDGP=4PCO.P>NC"S#Q=
MK-:ORE\7BWPS7_%V,<L3%8QQ)1C0N1;W>11UD060QIM02BA>-XG0'R9I7,]X
M8.TOFBBB T?G]6(V35\_$.6XO)(9L?1T%J8?5[0=U]JP_.^;L^.G)/@)>I^$
MY0F$$\0>)@%."PTID\ <ZMHMLHFW?!B=XUJRMN!KJ;(NS-RV\F#^_DIL$XXE
M*Y,19+"9%I4/%#VX6G0F<XZ)^VR:6+=[E(SK>+?%U6EB[\"65:M\4RH3FXIC
M2DCPDDA7(@@(7FE@7C#CK6..[ZCF&F93O$G(N%YY^ZWP:*%WX*Y?H_XR]JQ"
MFD@9A64UC960W$YDA?9PET'HR++0H8C<Y,QT!RWC&IR!7?)39=T!7#9WO'&U
MWL)]X@H69U.D!8.T=+CS$)2,Q(UF)EN6K=E11#Q$E=HM.L:U, /#Y!09=[ -
M_35,YUMC^VK^_$O%^\5T]:'*YU5YAG$]<49K1*Y(.!I!.>,@>E%-I*OSFE@R
MK$G*^;N4C=/:OA&,AM7#X<#RE\":X_M:6OMN,'R]6G_ Y>^+^>*V-;U:+9)'
M&6,(4'MMT_XK$H1(/EP*,3F3,'K?) 7Y.%GC-,IOM8\-IX%^8/5M3[XZ 9S.
M+XBW;W7@OV!9+/'R<^_"%US]-ITOEE>-3\A@DQMX^RG/__."?OT;KC\L\K<L
M_VJ2?508JIO)L#;=-)867I:0.&WY,C(=PHZ>,T/5=I^%QW%Z_3?;D?O$1A<.
MX9;E[>K?1EL3X4J,UB2@()J<EB@07!$%@N0Y4UCETJ[6WT-!_!X]XTP2: K'
MTV3>1:;K]7)!=&_B(.>%D#$'R (U*,5J.TH4()4OLL[Z8VUR%=](&&>20".(
M'"G9#@S*YD#\RE ^6:^7TWBQKN6&[Q;D<J1:F;.8S39.QZ5EG43!3:DXMZ[.
M\')*0<C*05;DS&KK<]HU2W.@PH1#*!UI($$CB+555#^.X2T^)\*68M%[X(4E
M4)K7MH?!@1;>2-JY2XH[NBT,#+:1IA:< T@'";@#<U5+O CCJ]>XW+2<N4XJ
M%X?!*<T@ET1^G"&)!!O)"G,6(H5!AJDF%PL>(FBD(0:-,#.(V#M(EMWEXY>P
MFJ9)2@ZSLPR,#JP.L2W@+%>@+2/+Z8C%73-@A\?.AIIQ"QF&4?1WT'.XU+MP
MG^^R\6PZNZ"M;Z*45<)$"=H8 <H6!@X]0O$NHD(FT36I'W^ GG&+$<X"H&,D
MWP6$_H[3]Q^(\B?TT/!^.Q;B5;G7/>U::DEY*6-$X,S8VLU70!3,@DP1B^,<
M99M2A$,)'6E82Z/MKJF:.M@&]^7OTE 79WWBEH-.G-/*#0&"3PETT;*REKEI
M<GYT$)7C;IMM 7,D.@_77K_0W%K\^VTF60A<Y<"A6$_L%6%I6Y&>,"494Y+6
M?FER"_! .L?=E'N YR :[ "@-YJ>/IM^GF:<YV]^":89_94G41G)DN';)OS>
M)8A8BY2*2\Q)\GIWC<,8HA3L^\2--%:KT58]N#HZ@-@[^MRK4DO=:LWW=;^1
MY[4#UFH:9_ARNB*'NB0C$M.0A".I>49,91; Q&B\3[Z.$VR!L;VH&VEL5R.0
M#:^0'[<576T-OL0/E?'/VQ/8ICWI'GW?F9K3[<_S0%WJKE_^JER^KE;<WR?B
M1B_%:(6Q"C"I DHZA%"8J[-%BU8,"7]-[G@=2.> !YB>U0Z1M@;\F\%9R" Z
M3QPG[7UA-@3;)# ^\ "S_:%  X0\<KIYB-@[V$DWI5,[Q%)Y^1U)=N_"E\M.
MLO3S)895]1DV?W^[5*J<R=I(**9>*I6>!,<R!5&,1V:*M;;199"32>_D?N49
M 'IF-7<,[">?PW163X7+8KD*,]P.'9SBZDG^/Q>714_7$JD#Y@@,M\Z27V^4
M.Z%U'%4HE?]<IXC5._$4IH&S/B1FI92YR8;2F*]Q;?:Y8;KG*AD#,QTOH4W%
MX&*)T_?SRUD%Z>N[99BOZJ@]XGR>-]_-+E%S3T 3SCUF532HA'6,@4T04-.&
M&:1Q])UKU+>C#3OC[B&=+I@S(J3S=?(TK#[\.EO\\>^8WV.] ;$I3BKT\C<U
M][):3<LTA2NI$.\R"HZA1/":F7IBIR&D.@%=^"(I'-?1MKGK-B 3XUZ2ZWA-
M-$5#YROA=?W!AK'-IUXO2-:XGBXW+O"V8OCUC,S"#H,@A*Z#]13HI%(U" Q"
MR!Y4"-PYVE&52>=>%"?P,^[MP([7Q[DP<FHQY]E"[TE.-N7*560NTWZH"T1.
M09\PSA4>;))MRCOW(6[<VXD=P_@H[750.[J#G2M6Z+O+;I,[XYL'ZJLUB51G
MXZ%P44!%SB%$2?%.+@Q%\5ZQ)F6# _/1R9W_,Z2)Q@1 !_@_X@9!\5D)DT'8
MNNE$5\!I;R"A5Z+6 <38K@?EX%<]VA]IGP'#;978A>?PR#*=)&]<SJD.HTX4
M,3#"CE>A@$S2J^2U+MC$57Z$IDZZ&(QK/P]2S&"V\"R'W[\$<LD3OOV N!Y^
M_-H#3V]XL+T//\,?8_\ZG=-;IV%&4<]TLSBN$%F-D B,@2Y)@ZK[:>!%@)%:
M!&V5T=AVVL,CQ)UJRFKS\O6-SE=&"163)6J, V6$@>@P0"G<1*&=1];DDM)M
M,KHYN!X&$W>MU DR[R#'5'-HU8337[5EP><PJR4H3]9/PW+YE;;U_PBS"YP(
MEY+V(4(2BI$5IXW=,TV>I^+"2B]4BFWZK^Y#W;CX.D7]=_>[P771 <#>?J (
MYQTN/][L@E'/'2(+"+1ET^[M!8)/M4@\"Z?KJ81.;6SP#F+&/7(:$#XG2[H#
MM#Q):7%!=+_!A+0 *,X@CV\[PGUB;6"\GF$QEA0H$0.XR"(8K@57*A@9F_35
M>8RH<;,9 Z)G,,EW@**Z .;TD:]U-@>7.>;H!'"A*1YU@D,0TH+PT3MN>#!M
M6H_<)&+<?,& *#E:LAV@8I-COI3%%:Y#L=DDZ4#Z)"F*3+6O*WT;L4B*HZ)/
M;<8#WB=EW*A^0(2<*.4.<'*;>*>=$$(I*,I3:&#K=:%"4N$<64@)79!-CHP.
M1T>S_H)#[C)'R[:#A/;+Q?S]7?]*B!(5D@\N=2U0QJ @1%Y "F\]BSRP-@-H
M=] R;D^^ 4%RJIR[N'K_>EG[9ZZ_U@/VVAZP1G2?MD?L$Y&T0:4M^!PR*.X-
M!!D\,'0< R_9MO%D'R-JW!YZ \)G,,EWL!==]Q1_68_:W]2;KJ_*WU:X$=>$
ME^0UYR2EJ.KL**$AJJA(ZU+88IW/O$W5]&-4C=MH;TA/9C#9=P"D>I'PC^EL
M-O%.L,(""2/4])$/"%Y+TG(N3GI/KKMHTD[OBH"1N^0-B(^C1-H!%%Z0O.?O
MZS722V&06;R>?GK-DT6M?&*;M"*"TB:!"[J0]ZZ<$YCJ#(PV4?/WB1NY/]Z@
MX?3 JN@ 7F^1Q!C6N$TH73(VB9XSS%@@BDC[KO#DOV'D$((3AAPYSW03CV<G
M-2,WRQLRYWNRL#M S(V40:TIV0:'.@G&0V9$>B*KBC)"R#) E,PXDYGC;5I,
M[Z1FY'Y3;?(S1PJ[ \1L<>Z*-[*X E:(6G&:)021/4AB0AAT(K2YW7&(%?D1
MLKI'B+.'=,PTQ.GL\N+@E12,"IP'I0 Q1%"JWO6(Y)3IB,9FQ*Q3DXAH!RW=
M7(=N4_9PJO1[L"+;(Z_7X>NFHG$9,EZE)HM,7EA:3HBT(!3&"$[$!-P&JVK2
MLN0FIT:/T#1NG</)^G[@O/%4X8^(H_1Y-7G](2P_AO3U<CYIF.=GT]4MQJYX
MBL8HI6LK4LTE^61D5YTE,ZO1ZN YV=V[#43N%?0=\KYQK<]08&DFX0ZLSY6,
MOOZZ6/YM_BE,MS-NKX?=?KN5M1T$4O.7H4@=-JW3912@BG/@M0J@M==,&1-]
M;&*7CJ)VW.*(H2U6>X5U@,KM3<%O,YA_O9CG%7&1/%=203:27,,D+<18,E@5
M2\HAD6O8!':[R1FWG&)H7 T@\@Z 0_OY\H+>^DTX5W99A*12%AZ2J<89$^WF
M*60@YH)DMKBDVT1I#U$T;JU% T=J ,&/[$9MUL"+^>IB6>\*[."E:&6+X *0
M0A/:W&F'=RP&,$9PC<'E?+?[Y$[WZ7OO&;?08DBW:5")=F!?;I_&7>_%UZ4D
M"A5/*" [)^M!C(3@<X(LBE!">56,:[)!/4K6N"49@V]4PZF@ T!=59G46;F;
MJOM/TYJ9JJR]BK/I^\O)CU?,)1M49"D3#DAXBA<.P:(&EWGB%'"8')H,W3B(
MRG%+. ;WMYLIJ ?TW3?(R%UD+G'B@'"@M+>T?GB&8*(0N0@LO,G<@R-WP68E
M'*WBMB-%W4&F^P'#>^/\)EBIK&*",&\K^@WQ$@*#.N=&"PI I3Q#)= .RD8N
M]SC3%GBD)GJP0WL9V4D1V465$>PFP<8#0M1* VWJCK$D$_(FA?+[D3=R0<@X
M&]]!.ND :<^VK[T>;WQ#;)M$&1>(2D6P)=6Y'(Q1/"(*L:.*U]PQ[9O<"?P.
M72/7B@R-K2&UT &H[M2_K*XM\L0*VLFE%>#1UEHI3HR8>@_2EB*-Y?7.TAD*
MCKY1-'()R=! &D;RO::=;FSHCO9LKGV@;5P*4-&0F65>@"3NF(M!1W]GZSLL
M\W2HK]1]7KN%8#LP-1N6=G-2''KM*?9TCI.4LJ=-F L/)2<402-ZTZZMX E0
M^F%RW /)O@,4W6!BXB+/S,<"Q'H"A8H6  6>0/NM#U$Y36IO'/#OAY/N$]ZG
M2K>#&'\S4NSR_&]5;RRMOWZ32/#"&*NAF$R<&"?!I9*(,8/%DK,?4Y/#UX=)
MZJ:'8YO:MH%TT8&Y>7WUW@U+EPUDDG3!QZ @A7H=.\I:YHD!DN<.)8NJT?SH
M';2,W1IJ&#7?NW]XFLP[@,V-*8>KZU:E3W+>+#%:;&%* >0V+S&)BCO!K <>
M=:XSFBQX1J+C@DF)JB16FESM.(3(L8MQFP"MF98Z0."[VEOZ8OGUQAJR.I:Z
M^X.-HMYJ*0IBJ+?NI)%*,H6-1K#=)V7L[:\)FDZ4^*FM7-\-!ITWN [3.>;G
M83FG!;%ZDM+%QXM9?<DS+-,T74^LX4J*+,$DRT%1"%$'03"PTI+/J*QALDER
MZ/NDC=U9N FT!M9(!^;I!@=[M:YW*I7@:!$Y7RO:7:&OM$B 7 KZ44PAM*J!
M.X3.L7L+-T%?2UUUT6KDOMPFP6*2(1M@,E(0+1R"$ZA ,I2.XF@E59OKMO=(
M&;>BKA&D3I1X!^F&WZ;SQ9+HOF[;SEWTT24';%,LFDN!4.H5'.9DXLFIZ)OT
MWK]+R-@;8./4PDER[V#CNX_\HT99Y,"YJ:-<1!U;KD@ 9&,Y"=.7HID7)8LF
M:!N&_+&WR;.GOYKKN .+>#,7/<\[+#QM"\[0E@'%148;1C00M-=@/!HG3'#>
MMZ[/VTG8V#OL&2\:GZR7/\,HB,OQMQ]P/4UA=INQH>="W'[5V8=$/,+I.2=&
MY%@2\UY <M5\:4P0$1UP;[@UVD5AF]PM.,?$B-O):A+XJ^7FM7F3 7J-R[<?
M2 D3EHAKY(G<V;QIFU>G3GD..K,HC8I%N2;[]7[DC7V,,#"&'C]0&$1''7B2
MM[G:L+!Z<K'^0.[Q?V&>>#+;)I@$1I#CH%*M01/1@\]:!BZ5,JK)H>?C9(U]
MCG!6I)VDDTX1]F*UNB!.N Y!Z:B *TU1ET]UO*E L/2'SE)'%LZ&KDN2QCY3
M& %91^BB4U2]NEBOUF%>(Z0)1^%53$1_<A%4J67922J(5DER?(O)N4FJ]SMT
M_0!YE:'Q=:Q6.@#9C:/=A_=[EY,TA4'BVM3X6H$OM(("JB*\+SZ()G<R]J#M
M!TB0G *VH;73%^#N;_M"&*70@,9<TS?6@5,F  \J2QZXS6T.WA^AZ0?(>0P$
ML).TT2.PMKN^9P9IFQ<0O60D'I' I^+ H)#,2=2:-:E">X"><6_JGQ]01VBA
M1S#=W.+)K&J&W(.,)!K%"H?(DP0FM-5.%FE+DW+JQX@:]T;^^6%UK#XZP-:M
M^J=+;B8FIFSKM(AH<FWRSSEXQS3PG'A&6AV:-;G8L8.6<>_D-T?2J=(?#$!G
M2>Q?BW.U*'7<YZ^SQ1_#SWK^SEL:IO,/X6_X3/[U&Z^1*64=)14<",]%[6Q,
MSKA)JF:O1-%>%J<;W:!XF*A3[54=STC/?+U<?)Z2^'[Y^K=5O=9[W:'@25I/
M/]^^6E.T)GY)#%8:3A8YTKZ?'4G%F<*U2CS&)C[7X:1VD]$_#4MWK5QCG76P
MBQ)K"3&O?B6A/KU8K1<?Z=&3K)5W@4D0$>O\T%3G+SF*C9,0U=/,PC?*B>V@
M9EQLM8; _6%8)^IC[ ;+X>MF(RF+Y?7P47(P7Y/:TG+Z:=,*X]ETM>FWFN/7
M3:GQC(3\QV+YCVWKX'H;4+#L/ FQ^A+$<<D.HB.1)EJR*F A'S5_9X\=CIIQ
M3Y'.A,"1E#?^/81[C&]OP?^"<RS3]6JBC1$EZ0C%F%)+_C*$;,EMCIPK+QB*
MG [%XIUWC'N:-!;"3A'T^+BY-ME;EMXMWEY\^C2;TH/K%$.* A9?D59#ELDP
MS@NDK!FHE#34Z=P0N# ^(%+(U"3O_QVZQCU@.O>V.J"..D+>#6?AJHSS26VX
M7V4ZSZO+V?"8)S8X]"'5Z3+(:V0>(4ABSQ?IHXT\LC;3,?8E<-SSIQ%=O,&T
MUD$H<<5+O<=:6U.54KQ.QM5^>D1^* )""1%L]!(]_2JT&2%WAXYQCY[.C*U3
M=-"/7;MN=H:K*T94\<*&3!%0\A3%*V[!11(*9U(DA=R$-M/E[I,R[LG3V?%T
MDB;Z@=3^<IL(Z;W1/H)SK,[6BPH\H[#;9&F$R388;)+\V)_$<4^IS@S!1IKK
MX ;+ YS5R'OU@"!5UC%[LN(H#()R=692,AJD"R:JH(7UY\P(/T)J-Y6W9\D(
M#Z6S#MRXF^[IVS!#<DU_"^N+>@GR5?DM+/^!FVMD;S'5G]5E)T5D(:0ZP+)V
M[@HZU:HI =856N^Z>*G:!+B'4MIE)GDPZ#P29@ROQQZ >AW3/TG_>3%=XJ4D
M-S\C+R6D'#,'5R=XJ1K5.^D-)"%HAQ#>FC8M'A\CJLLT<C/X#:6=4WW(-E@C
M,9(#LO[Z>A;F-7JO=QL_U8],@B0'&:4!E;0F7T?6X,O447+*,>ZL(E?H+,A[
MD,0ND\UGP^$PFNL3E;]<K*9S7*WPLCM*E?/V-WFBB(9:U4,NL:X\>8K;E#90
M)&96!"O>M&DC> "17>:DSX;,H;373]1]TP=Y-MV(D3P0?%6^L3IQN2@>F(=L
M#"V].M0^IAC!!&.=T5K%-NT(]Z"MR[3T.?S%(735D8?XZV)YD[MML_-[8B0'
M6$;K(P)QHFK73PU1YP B.YN*\TQDUM)$[DEGEQGMUE:RA0[[,93["W62LS-*
M: F9B=IOVR/%:SQ"5C$4H2)GYISIR6/Q>>X,>2M\-M)<O^G);3WY3D'FH+3$
M$L!L./1*@S,Q '*N:+<PQ'Z3L6:'D]K-]>VSI">'TED/>_J-3> -?MKN#J_*
MVP^+Y?IJ"M?$QI"B9Q&$-J'6<QARE^N5SI12*2Y6&;=V*A^DKLLTY& 0><2M
M'$9?G8&PWLRK56RORLTY<!.%V3,?+11,M(J9()F%:" RIY@GY@1OTH3H^Z1U
MF88\!_P&T%0'V+NYB&[QP;2T-F$$QE@F,>4$P7()F)3V3MH02I-CF(<(ZC+-
MV IG@VBEGWCD@:CK&2ZGGTF%M0\S">VB?F:'1"?&2JN#BY!*,* 0+;BB+22-
MO&2FDXEM[H^<1':7V<=FAO%\&N[ :+Z^7IS79983;J)@UE$0%C1)C[X!)RJF
MC&84\7G)4M.$^ U:NDPTMD;>L;KHX^CEYNEZO0/]ZO)VS/,ON$Q3DM\D<N]+
M= QJXW(*XP(GELCZ6^UYT<+I:)K$PM^EK,OTX3G\O]/UU)$E>X.;"0GO%N_"
ME[]/UQ]JCUT2'YGSS6W\7\+FBO?'>E5KH]N)5I%%SQVP)#TML9@AF#IN#Y6M
M99M,Y]S2W!U*<)=9Q-8VL:E6.W(O;ZS*&X[()JF_R]L(*M!.P)$<C5J9)%&!
M#R1DS3,&M$R'W-R6[D%GEW6YY["L0^NP SN[OS2),^F#Y@(*B1%4J0.TI560
MF;1>)6&$.&=1[K' ;-:,YLS ;*2Y#DYD*EOUOUJR]#G,+C<,DM@TD77>E(O,
M\^T?W/CD:XKL%B2'5#OWX#.\_/MZ4L3S+^E#F+_'-V3IGY>"I 3!"\KB,CC%
M):A:?1(Y*V"T$3Y9+3-O$L6?E\UN&JT.>Q+4,59^])4T*=9BPAA!QCKR6B</
ML7@'UB3!-YY7F^NT)U'=38_7CG!^D":/ANVGS6HB"2S7'8!7!<N3$PZ,D1I4
M8 :"10M!!%U0""]-DSBP/7C/T3^V)_ >HLD3P?M\/DS:;--]82/*,+L2Y8MY
M62P_AENM"8L/F4>O(=E VXFV&:(4&H*3WC'#2TQ-7(\]Z>NF^^RP<&RAG0Y"
M.8H$RG1=9X:2=!)+2 LE:V5!1:R=B2@F#8)QYGE.M \T2B1L21BY4UX+#=]/
M#!PC[I'[ECW)_^=B>SUIB9=%]_1A3 N*&<G<XGJZN0J_7M"7B23W:1M>QJ^+
MJYO(X7X<*XO6UJEZ3&9RK6L)X#.MQF"CTR7E8.2=:V@[6T<U(6[D&[H-D=B'
M/CNP?,^0WIRF&XG2US/<B':>GWRL<R'_ZS*%3')E:=-A!HTGGHP%GS#7;FTV
M*E=;<C49KKX/<>-8RT[PLVBLS X ^L"IAF$B&%ZYR/7^'5H%SG +QGHK4N+"
MQ2:C.T\XB1K<4/8)P@$4U@'L_AJF\^J@O)K7F_'?KCA-LDI>:2U AZC(>]81
M0LX2"@8MHZ%-QS3)[#Q$T#@U='U";Q"E=5$\4CE955:0F'G^I<KJ8KKZ<!G2
M;:H&.4.K,0B0H;!:-2C :^< .45UT2N70I/JX>]2-DZVO%] #J?&\4_GJY2?
M;=^\%69M_!7F>5$/=><D:9+K=(T?5Y/HK4V&:6 BZGK-KD LW $OB7OED>'=
M)ED[ YL]7S=.[KHOU+72SLAQ]]/-2=)T_DU<M)[6E:W9MT'B)-Q%P<U)TZKJ
M)]1K\9?33+X)E9NDD#$#WM=!6UP8<%8SD)XI'5%GO#OV>2<D!R-HG)QU?Z =
M1\,=>)GWST^?I+2XV"3Y:XO7VGYI$AEZS@N'0(X*J! #A"(L6([:95&T:#/J
M9!_BQHN^1\+,_>Z7PRIP_#W^8=:N&O[7NAC-4U#.!7!1U1Z?48"C%0XR)I%+
M(,F)5MU6'Z9JO#"\5S0>J[*>8;BI'_S6W',CZ$EF)!]%RZMDR^O->0;.*XKP
MC&4E*:5#:#+1=#_RQ@O2>P7FR4KL&:%7>\#K\'6S :#%F#(WD!)#4+I8$B)+
M$*((,HI$?S5)5GZ7LO%B]5YQ>8KJNG0HKV>HO/PFUXE7B1844\"L]34C&RGZ
MHV P>B%T]K:$=":7<A=YX\7RO:+R9"5V"<W;>\!-UER61@E7@&L=0/F"M43%
M0V*B\&"Y-J+)@>,!-(X7N_<*TF'4^6<:^SKAM[EJ-?B5WC/:Z->[/%X/?_VY
MG:0W1XSUXANIO)8[KK\VG;3[V.O.)/>].1Y^]N[F3NRM5U_;#U>4X2I'L)M;
M6R$DJ,=L0(:'-B NO>1-KC7M1=W)A0=7+WFW<029E5YPFT'XV@'.U-'5,2&0
M[=+6H62)MRDXN$5&-U-T!T+%O>*!XX4^HHNS6JXG3R\^7LPV;3$N[[M<7I!Y
M59[DQ>8^^9,OT]4$5>UZH0)H72LA>&$0=5" +GGN!8EFK^GS]+X; *+O[H)G
M7X(Z@=,1REXTE'SG2'I&WMQT/B'?+:HZ0I45(4A<I/W(2'!,\\)U%E::?0S2
M(%BZ)&D<-+6!P 'X.D(?G2/LV^G@;_@QXK*:=*LMF73A:]][(T*=SJ3 **.+
MM,G9L$\'[F'LUAWB^D7=,< XQ*Z=HJ4.$@+7YO_2?ZC5@HMY=7<WJS4$# [K
MU245/:U65<"S4GM(^1!TM-&PMK[E+JHZ&5EU_'XYO.P[ -(='K;++GNC?(X.
M!&823Q$*(H\)E NZQ%A*X4URG#NIZ<31.EW;BZ%%WP%^B/R/B_DFHME:4EUG
M5'JO0)1:K"P"N0I1D82TRCEPXUAL8GSN43(N;@;0[MWKK">)N@.LO*O)SHOE
MUYLLJ*(HL$VDT.)(#-G1 @K>041K*!)629DF;55WT#+N!C4\7DX5=P>(N0'Y
MZ_883W+>I.+#K,[,?3%_&CY-UV&V93!A3MQ(A'J.0V)RL<X^XT#>8K"9V!?8
M9#+=P92.V[^WJ75JH*H.L/@&UR0CS,_#<DZ\K;9<H% Q!5L <]P,,S-0-WVP
MQD6+TM'_F@!N-SGCMML9'E4#"+T#Z#Q)Z3(>Q;PYZ*L26N('G*\VG8!KM?"6
M,>&X<$E$*%X28\XD\!D#<.^ELKX@QB:.]]X4CMOG9GB M5%-!YA[O1'HEG8K
ME=&U]9K2HA#MF,!9&0!9+K9(B1F;=*6Y2<2X36:&1\[1 NX '+\O"-GS-3V5
M/O'^Q9R>C*LK7IA//AD>ZC!$8JB$ I'Q#(ZK:&3Q/*LF!22/$35N2YCAP3.8
M CH TW6&Y"7MU"\V-Z1*-C'*HNH$8E[OC#((SEIP41?F,' ?FT#H/BF=3*(:
M,.MXG)0[P,G]JJ?[!^%O:$'\NEC^$99Y8EFN%Y\TV* "*,4I/HA&@#")H13>
ML[LWSEH5LCU*9R?IR2-A\=W*M.%TU $$-Z5 JU<7Z]4ZS&N$.N$)N3<Y0Q"Y
M]E?P#+ST":0M@D>CZ-=M6J'=I61<&#75^ZXF%T<KH9L^D?<%=)WW>%U;QI#B
MUNOE-%ZLJ^U_M]B]Y4\T4R%JPR':4,.*J"$$Q<%D03&&CE*W*2<?AOQQ<Z9G
M1>WYU=T-U'_']64H7-LQ?)=MHA+Q8_WV 1EP64**C#1@?*Z7Z1"\*Q)40%98
MT5ADDT'0P[(QKF=Y3NB/J/ZCE\!G7,;%0%[#0XFA*@Z2S:OR+GR92$E!7];D
MT1="GG(R@J>8$&(=?RQM]C>&MP\)ZGV(&S<K?$ZH#JZJ'IS6S9G*:G6!^=G%
MLJZ\2_.^<:-V3UTRHO:(]QRL4*F6$1>((BB0P653M"_:-+&PAY,Z;C[Y[ Y$
M.S7V"]3_"+,+?& ZF!'6VU3 :UOJZ)H SK(Z(DQ;8XKS4C?)2Q],Z;C)ZPY@
M.I 21VZ']/SMZ]=7<XHOMX.;-1*72_%)NNSI\W11$[+K#XL\28Z\%"DBI)AX
M;05O:>LH"8IWW@A9>%!W8K2=O8^.>_NXJ>]S0.],FND:>YOUM8-!%5T@7UF
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M$RPNBWJOV7FQ94=;D854M2N8DC5TX.!385""U,K3'US)0[&Q^U6=>+8# V0
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MO2WF=5>C7WQ:K,+LK\O%Q:=O@2V2F2G^<AYIN1RO$U@I$'DT(;&HHFDR\>U
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M_ 9@)Y75*#)P;@C RG@(Q=6FX)F@ZWBT<I_Q@8^_I3]C<HAR;WKM TJSBX[
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MSHZ'#)Z';=E.9Q?>)#(NO?!@E%&@<NWBFK@'QG(*229KV]1JGR,1.S%".S+
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MW5T@9S]F=X<<HF7U8?F()A:#54YRT!MN%<Z 3H2M8V!X-"YF'O<#T.[UYLF
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MSD+0H)WQB5Q&XTP3#;IK,Z=OGDX#P8,%U8->W#!QEX(W9*K+HB+8[%,=#9'
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M'RS\SJSF853_?E$KIW#[ZUO61\84^@Q9UTX;B@6(EC,(21:7E6/<- ]F'$+
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M_ZGW9C(A,Y$K#S8@N98R"/ N:TB>%6&"]DPU:=3XQ'[FO9(G0,)#U3(%WT]
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MU6J3QG9#2*B#J@(G;U/G $K25\Z[ MS;;!F:8E"W -&3.YHY(7IZ$$W#^PY
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MK6%@.<DP[#3\[0<OZB?K[EPXN77A&+>*JQR!]*0B8ERJQ=$10JX3Y+U(X>$
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M3<$"\E!JT$="U+8^-I##EHD2HT>.Q]VYSC"0G&K8]4"^]H,1]5T?WEMB4.B
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MHW1>*N1I_GDT\?A_/_XK^.+TS*<;0V.^>*F,2_^7,RHS*Q%21\'5X%)MM1A
MH)<J)'$E=5TZZ8CWH?3!]T)Q5UHJ5*ESK^^S+.^^'O\8)03^-Y@\P+O'O_J_
M3V?7#\C]^])K\_'I[4^6Q#(E )=L( =4!TXC3TI''(?+(,'(F*13GN8J+7Y[
MH+U157L*R@[,K;F(1 >N%GS6"RBT92Q\51JGI$V6 F+'>2)%X,2Z[(F.5,3D
MO;3VF'UZ5*W@;A(&AM:E43#M523-@6J=0.<",UDJ2RPK:RCC+2T3G/"4L@(E
MT9+A]6 U= EJ'X(]B),.7&X@K/+*J-WD1J;BP:,6]TY3(EG&!?E$B0U<BR"+
MMU_%A=I#3TNXZ2+H[=&U/7"] ? L^^S/5TMX/QXM^U\^UX<H$S0Z78'XS#.1
MT2MD$#I+BEM&D[$AIBIC  ]2-5Q9:14@]2>!!N"TS"XJ*WGW,!]-8#[?[(ZE
MIA;)6^12(K@)T(6G+!!'4R)&LA251:W-ZW@OAZ@:." [D*'4O\!:0-^*]O6F
M!,J3U"81%R5JXA)9]LH(0D4RH4S'#*9*[\\75 QLAO<GW=TWZAU8/7 6X><O
M?G;OX^,-S+Z-(FPXLE:WT5%FM0PDJ^B(E#J38*E![9N\H #.BK=B8&^^I FG
MOXO@IC6X.# <?EU&\3Y,)W>_P>S^&EGX<BE),5P*340[@4L1LK3@ T&,D\:E
MF*FF[ A O/&:)BX%SX1$GYP<&!3KMC"EK2U,((\66_BVB5%!0R2I+$!&"\1S
MU*-*<IJ-QJ7E8ZHCWGC-L/GI_8"B3TXV8&!L.@7!U21]6GR!V<9*%XERT(KH
MG$NWSJ!)X(JC92 =-4HP$ZOT+]A#S[#YZ.<CIT]V-X":5Y;]"[O^PU,2-571
M>E_F+RHH87?\SDN!OIZ'[ '0(E-5\F"/I&]@?32PHU1#B$.;PC.X'SW<STN?
M=4@?88';;+VXU33NR?(ZZ(\1:O#U.E?3NLM=T7R.[@2DW_R_;Q4W7FG-B,TE
M.5]9-/>\DB2"L!Y<M%0>8R/U1,[ 4Q9JP&0ZK,P:4*%=ELBI!&>$)28R-#B-
M\224ACE M496Y^AB%75:"[/U9CE4Q.RE!-C$I+GEX-!O,%]V85Z-$+W5%)CV
MT1-51H)*P-,G@'>$424R8\9K72>]ZS4M X_4O #*SA5 .YIN?LM-IDE;31($
MLS)6O,7OE,_94\H#W>[5V:OZ&KC]QP5UTFFL'GB [U7Z._( TM/UX_.DXEN0
MAC%G N'!X9F>$B)=XNFN4C;!"Z- N"/LL .O&+;^M+9MU1=O!S;K40END+V*
MR5U/U^,NY[<&<9TS4,)Y1-:P,D6P3+M,W )0EB5SQYCJ!UYQ%$3TCPJ1OGC[
M@Z82%X9O[8[%=,^VJ95%W(6&2R00G\V;VKG#+$$6VI3&?;;D25%-@J! F.8L
M&\]L#E62.6KE#I]7=K0," DN'9[]GB06(Y'% 7:ESSL7QGK+.'K(5>*VYY/>
MQ"7B>1CKMXSL9'DV8.L?OIX'KRR:I8)0BM:&9.BS.&,!OZ0@ 023E=HBG)TM
M4PUWEX;(2<DRI\BK!?"]N*;Q45%M$R7!48IL"0Z]Y&B(AF135CYQ5[.PI/UD
MF9.D>S!9YA16-YX=(?"?#,$3Z\J(%-P\)'AM4=T[(V@HP;MC+L+[R(ZX4,+,
M2<([(3OB%$XVGATAT?4Q6CFB(\.EB*P(*E9!%#7>\$29$^H(4/21'7&AE)FN
MH.B3DT/?)1Y,".-10I9H#,HHT39,-!'/0B)"1:6"X&@<IB,@<7Y:W8729;H"
MHC\N-F!@_#2:?YW._?C/L^G#U^NQG\]'>117$BDG:F)6^N1$X0\N)VA<3N*9
M&.V=$)$*;ZKXHV_0-:QB&=C"[5-F;4-PTY(^V2Q,*=K(94$:EQ9X-H3C/LU>
M \VQRO3<-RD;UNCI%0?'8ZR#4-I 65SVKWQX"O3AIEPM$W^2WSW>^#%LTF"M
MEM24:R8.4-)@&?% '5$R)IY"-$95"3F=0F2SV.N"C]?HJR.L!H"X"BX_^[%^
M["<1;K[ ,DWH*J516:P?/[<_G+][?,'N.3YBE8BQFT_+S4^-EB"C)< -RH!G
M01QS#+F2O*%:1[-MX/=5%7B)Y0UK1PY\_C>(H ;VU4D+_.CO-_-NC$G.&RD(
MUU!&MJE(K ^:V."IL509#56:O':D=UBUWR+T#EDNE7 PL!]_/2W3E6:/SZ&)
M/Z:S?^"CKZ?W7V$R7[6B7 =(-^GXI2V7#998@8N2/)6T:JD(]3*(P QS<JLA
MXT[OOL.K&S)4:L%A>CG9-*!I]UZQ3^Y*XL;/T]GA _'E>?B<[Y$-LUY83[+P
M#MD0-0D)=SVPF".>B<!#E2S,2NL9-C=OZ%NX!C#2P%;9E:5FI714A4BX8<5?
M 4.\9)2 X3(Z&4W655KC=DT5O%B"PB 8V=<QIJ/ &L#<U7UAYW_6^_X7%.CD
M;H3[N63M+^:W -QYJA.Q3@3<U9(21TOFM<M&X2'D8ZH2VSA,5A,W14TAL4<Q
M-@#*C<6#5E!8-\\I/77N5H;7KS NC+N>SG%E$<^5!($1-+>@Q"Z!!%LFL*OH
MT?1/5FRW=^@'H,>3V,0M5E-@K23>!H#[9W0&"@,_34K(\5/>K/063:! P:)3
MFBVR2T,D+C-#+*2010S<L6/:_)T,TWT$-5%/WA0H>Q'=Z1!T*PA.X&ZYE'.=
M_1O\"'[UJ[C*^CRX_N)G=U#RG8!+@0O165HBC1:XJT 28TKJO 6IY=9 ZYU.
M_8%7#%M,TA*J^I3%P/&C0S4T%LGW- A4.YP3*:DBR"I*&(!A3'$T>8_) CFW
M/JE:\4EKD.I+%@T<E<BO")"6W/II5"H\1XN'V7>*MU3Q13S?I0&B2P&?=-GA
MDFBI]A3<A)!=DE5.S2-H.PJ7YK\!E[4$.G3-W7I&^.\3%.5GF)6I3:7]2%'J
MN-FBYQ+W&[&A!'R%$\25,D+/@E)&H6E [1&*[^!+CH*8_6^ 6+_R:+=2[R',
MX9\/^*SWY5K@);W'U=EM/:&G*KE#=/55X_;R'?/G(3%&I^B3)IF)2&3($B5+
M-5KCPN1@J(7M1-.>XOQ["#K[/F3KN<_3LB1/%HU"3H2))0U+(7QCH$1Q#]$I
MS4*HDH2QEZ*! [Y](.+534,OW/]1-,@9!;N['U1%GU0MG=T'(J.I%[G<5"V[
M)0':S99)%+S5,7MM6-KN OI#J975G5R G -SCL0H->Z4TAU-BT18E(D[*W6.
ME] H+92W]H&#-Y3)Z3P?>"C)A]%B=+<*2_@Y+'-I-%,TJ<C*[54NTX$B<;+T
MU^$06! Y@#MF\M)1XTA>O[XIC'00Y[0WWC:%C-_P+S9YNEQ0850B6M"X3G3)
M#@CCGM(,F:EX3 ?V#OAX)F*XL2/G"G4O/CIR>& 7^?>;GP"9MFS-]2FO<IBN
M)NDO#_=^LJEWNKJ^^G4T_\?U=#8;I>D,O4@8?5N.!M]T%M=..ZD%258@ ZU+
MQ"6M<-%"@TS4\'!,?_8^:&D%6%W1,!U0- U$%)^96%).'S;)H=QD+SRQ4953
M77'<GY3C=G79&:=23%5,H%W$#)RVT-?QUAN_&\3,>MLI88S4N,^<LK*$DQ#Y
M.AHBDLTR>JJ2JQ)XWDW.L&;1^6)^ S<=>-X <CZC>SJ:W#TO9J,T+4!R3*(%
M()>1R$ "5;@,CS_.44;#J\2K]M#3%G:ZB'K[FJ$'OC< GQM8+,8E+KZU#,6=
M61:#!ZUU27@1Q'.!:['>*SST.:0J^9Y[Z!GVR*H GS[XW@!\MDIK/DR_J^15
MU/G$&"7&:V2/RIZ4!HA$*".9R2+'4&5*U@&:!LZ!Z]ORZ8O[[0)IO=,X>*XA
M4J*U+SL-?0%'M2/64 A)B C.7A!*+9A#O<G^.$QU$,30?6-6\PPVW5K74X&T
M I]*$IT2>#KK4ATB*2516.U83#*ZK:8,AP9*O'AVDW#H(K;7,R&Z\[ !S;*M
M=?'/5A$S&D0H WZ$RN@Z0$HD9*4)#RP[ZLI6J5.XM9N>@3-A^SZ:^N!ZF^#9
M&'^9LUR"4B \,D=PW$W4),)E% GYEBVM,@-[+T5M75ITDO?;&.K _/90M#'U
M=50A6D?<LM,-+34%E$?D3QGSG'RY^+L @EHXO7J2]&'\=&#[P-=?3\?Y382)
MGXVFRRW%T:@S&C5R0C,.742*:EDF10QG2#_G"K:'8G6_^]I)P<#I]7U>CY[/
MX:$ALJ;[]\G\*\11'D%ZBDY -F6K4.\!6:(4"0)<Z:8%7G@#@1T3 #P.)ONH
M&.XJJP?)3OMF<R-8^7DZ@^CG3\T?E;4 SA,J,Z[ 24F"%$6^.J6$;H),QU@R
M)P'E)0D#HJ0?N>Y RAE,;L]B^?"4-LU-B%26>+8JHT@T&&)]7O8M,]117%*=
MV5'["!JX+J>RV]2-[PW@IU0Q7B];U=S!)#[^/L'-4(21KNZG#Y/%;59&&(B!
MY. 2D<@D@C99)%I+FJ4WR;LJMU-OT-64%=Q1^#OJ2?N2Q, 1/52I]S#;6E"I
M![F;C/X#Z9?)]<.L\/DSH/Y-[R"C"B[3'J7$=4A)22R]]:6VAKB2RY*RC)F7
M)>MC@GX=7]]4ML5YF+J4$'XHG'V$Q:=<5AA-C)9KM"U]R=SG01-G62)!!^5*
M^]ID=.\PV[R]J9NM2Z.LDP@:."6_NU=>7@<7=V6EEJ_^Y8N.+G5LR_'TG_UL
M\7@;@N/9.$M2,1TE-9R$+(!0ESUDG9WU58H%3J2SJ5!V/Z=H34G5K^)9?U"^
M!#^'__V?_P=02P$"% ,4    "  K-691:L3522\?  !JR   $@
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M,C R,&5X,S(Q+FAT;5!+ 0(4 Q0    ( "LU9E',+>G6W 0  &$3   2
M          "  68X  !A,#DS,#(P,C!E>#,R,BYH=&U02P$"% ,4    "  K
M-691PC9>GO<N! #_-3H $               @ %R/0  8W9S+3(P,C P.3,P
M+FAT;5!+ 0(4 Q0    ( "LU9E&+KZ-S$!@  +P5 0 0              "
M 9=L! !C=G,M,C R,# Y,S N>'-D4$L! A0#%     @ *S5F4=@$^F<4+P
M@/8! !0              ( !U80$ &-V<RTR,#(P,#DS,%]C86PN>&UL4$L!
M A0#%     @ *S5F4?=="X-]AP  0?0% !0              ( !&[0$ &-V
M<RTR,#(P,#DS,%]D968N>&UL4$L! A0#%     @ *S5F44?_\BG$#@  ?@\
M !,              ( !RCL% &-V<RTR,#(P,#DS,%]G,2YJ<&=02P$"% ,4
M    "  K-691.,9>47 G 0!L0@P %               @ &_2@4 8W9S+3(P
M,C P.3,P7VQA8BYX;6Q02P$"% ,4    "  K-691:D&W <VU  "T3 @ %
M            @ %A<@8 8W9S+3(P,C P.3,P7W!R92YX;6Q02P4&      T
,#0!% P  8"@'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
